Authors,Author full names,Author(s) ID,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Affiliations,Authors with affiliations,Author Keywords,Index Keywords,Document Type,Publication Stage,Open Access,Source,EID
El Sherkawi T.; Bani Saeid A.; Yeung S.; Chellappan D.K.; Mohamad S.; Kokkinis S.; Sudhakar S.; Singh S.K.; Gupta G.; Paudel K.R.; Hansbro P.M.; Oliver B.; De Rubis G.; Dua K.,"El Sherkawi, Tammam (58631184300); Bani Saeid, Ayeh (58635250800); Yeung, Stewart (58822848100); Chellappan, Dinesh Kumar (35811890500); Mohamad, Siddiq (58979414800); Kokkinis, Sofia (58631105400); Sudhakar, Swathi (57194115158); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Paudel, Keshav Raj (56539588400); Hansbro, Philip Michael (6603119390); Oliver, Brian (15919869900); De Rubis, Gabriele (57196257973); Dua, Kamal (15759138700)",58631184300; 58635250800; 58822848100; 35811890500; 58979414800; 58631105400; 57194115158; 57206711834; 15047988400; 56539588400; 6603119390; 15919869900; 57196257973; 15759138700,Therapeutic potential of 18-β-glycyrrhetinic acid-loaded poly (lactic-co-glycolic acid) nanoparticles on cigarette smoke-induced in-vitro model of COPD,2024,"Pathology, research and practice",263,,,155629,,,0,10.1016/j.prp.2024.155629,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85208772046&doi=10.1016%2fj.prp.2024.155629&partnerID=40&md5=077ce9ec97be2a7624c8fe42ed3ff3f5,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Malaysia; School of Pharmacy, International Medical University, Malaysia; Department of Applied Mechanics and Biomedical Engineering, Indian Institute of Technology Madras, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, India; Centre for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Punjab, India; School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia; Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, Macquarie University, Glebe, NSW 2037, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India","El Sherkawi T., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; Bani Saeid A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; Yeung S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Malaysia; Mohamad S., School of Pharmacy, International Medical University, Malaysia; Kokkinis S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; Sudhakar S., Department of Applied Mechanics and Biomedical Engineering, Indian Institute of Technology Madras, India; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, India; Gupta G., Centre for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Punjab, India; School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates; Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Australia; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Australia; Oliver B., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia; Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, Macquarie University, Glebe, NSW 2037, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India",18-β-glycyrrhetinic acid; Airway inflammation; Cigarette smoking; Oxidative stress; Poly (lactic-co-glycolic acid) nanoparticles; Senescence,"Cellular Senescence; Glycyrrhetinic Acid; Humans; Nanoparticles; Oxidative Stress; Polylactic Acid-Polyglycolic Acid Copolymer; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Smoke; 18alpha-glycyrrhetinic acid; glycyrrhetinic acid; nanoparticle; polyglactin; reactive oxygen metabolite; adverse event; cell aging; chemistry; chronic obstructive lung disease; drug effect; drug therapy; human; metabolism; oxidative stress; pathology; smoke",Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85208772046
Thapa R.; Magar A.T.; Shrestha J.; Panth N.; Idrees S.; Sadaf T.; Bashyal S.; Elwakil B.H.; Sugandhi V.V.; Rojekar S.; Nikhate R.; Gupta G.; Singh S.K.; Dua K.; Hansbro P.M.; Paudel K.R.,"Thapa, Rajan (59423580800); Magar, Anjana Thapa (59423443700); Shrestha, Jesus (57214237167); Panth, Nisha (57094240100); Idrees, Sobia (55429771900); Sadaf, Tayyaba (58669468700); Bashyal, Saroj (58557689400); Elwakil, Bassma H. (57218377675); Sugandhi, Vrashabh V. (57475497600); Rojekar, Satish (56386152000); Nikhate, Ram (58235033900); Gupta, Gaurav (15047988400); Singh, Sachin Kumar (57206711834); Dua, Kamal (15759138700); Hansbro, Philip M (6603119390); Paudel, Keshav Raj (56539588400)",59423580800; 59423443700; 57214237167; 57094240100; 55429771900; 58669468700; 58557689400; 57218377675; 57475497600; 56386152000; 58235033900; 15047988400; 57206711834; 15759138700; 6603119390; 56539588400,Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review,2024,MedComm,5,12,e70018,,,,0,10.1002/mco2.70018,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85210083119&doi=10.1002%2fmco2.70018&partnerID=40&md5=39f8369cb49b997f11b9127c29379b1b,"Department of Pharmacy, Universal college of medical sciences, Tribhuvan University, Rupendehi, Bhairahawa, Nepal; Department of Medicine, Kathmandu Medical College Teaching Hospital, Sinamangal, Kathmandu, Nepal; School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Department of Pharmacy, Manmohan Memorial Institute of Health Sciences, Tribhuvan University, Soalteemode, Kathmandu, Nepal; Department of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, Egypt; Department of pharmaceutical sciences, College of Pharmacy & Health Sciences, St. John's University, Queens, NY, United States; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Pharmaceutics, Dattakala Shikshan Sanstha, Dattakala college of pharmacy (Affiliated to Savitribai Phule Pune university, Maharashtra, Pune, India; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia","Thapa R., Department of Pharmacy, Universal college of medical sciences, Tribhuvan University, Rupendehi, Bhairahawa, Nepal; Magar A.T., Department of Medicine, Kathmandu Medical College Teaching Hospital, Sinamangal, Kathmandu, Nepal; Shrestha J., School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia; Panth N., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Idrees S., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Sadaf T., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Bashyal S., Department of Pharmacy, Manmohan Memorial Institute of Health Sciences, Tribhuvan University, Soalteemode, Kathmandu, Nepal; Elwakil B.H., Department of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, Egypt; Sugandhi V.V., Department of pharmaceutical sciences, College of Pharmacy & Health Sciences, St. John's University, Queens, NY, United States; Rojekar S., Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Nikhate R., Department of Pharmaceutics, Dattakala Shikshan Sanstha, Dattakala college of pharmacy (Affiliated to Savitribai Phule Pune university, Maharashtra, Pune, India; Gupta G., Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Dua K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia",dysbiosis; gut microbiome; lung cancer; lung microbiome; probiotics,,Review,Final,All Open Access; Gold Open Access,Scopus,2-s2.0-85210083119
Wang Y.; Thaler M.; Salgado-Benvindo C.; Ly N.; Leijs A.A.; Ninaber D.K.; Hansbro P.M.; Boedijono F.; van Hemert M.J.; Hiemstra P.S.; van der Does A.M.; Faiz A.,"Wang, Ying (57207735283); Thaler, Melissa (57214907832); Salgado-Benvindo, Clarisse (57218287254); Ly, Nathan (58987320700); Leijs, Anouk A (57866861400); Ninaber, Dennis K (8666163400); Hansbro, Philip M (6603119390); Boedijono, Fia (58852659100); van Hemert, Martijn J (55291601300); Hiemstra, Pieter S (7004364809); van der Does, Anne M (23669741800); Faiz, Alen (55601365200)",57207735283; 57214907832; 57218287254; 58987320700; 57866861400; 8666163400; 6603119390; 58852659100; 55291601300; 7004364809; 23669741800; 55601365200,SARS-CoV-2-infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses,2024,Clinical and Translational Immunology,13,4,e1503,,,,1,10.1002/cti2.1503,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190446869&doi=10.1002%2fcti2.1503&partnerID=40&md5=f41113cefd3dbdd185b64a0461e6ea89,"PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands; Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia","Wang Y., PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Thaler M., Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands; Salgado-Benvindo C., Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands; Ly N., Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Leijs A.A., Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands; Ninaber D.K., PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Boedijono F., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; van Hemert M.J., Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands; Hiemstra P.S., PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; van der Does A.M., PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Faiz A., Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia",coronavirus; immediate early genes; primary airway epithelial cells; RNA sequencing; SARS-CoV-2,interferon; nuclear receptor Nur77; protein fos; transcription factor FosB; transcriptome; airway epithelium cell; Article; bronchus epithelium; Calu-3 cell line; comparative study; controlled study; coronavirus disease 2019; down regulation; gene expression profiling; gene induction; genetic transcription; host resistance; human; human cell; Human coronavirus 229E; Human coronavirus OC43; immediate early gene; immune response; lung epithelium; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; nonhuman; pathophysiology; RNA sequencing; SARS coronavirus; severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; signal transduction; upregulation; virus cell interaction; virus replication,Article,Final,All Open Access; Gold Open Access,Scopus,2-s2.0-85190446869
Sahu P.; Donovan C.; Paudel K.R.; Pickles S.; Chimankar V.; Kim R.Y.; Horvart J.C.; Dua K.; Ieni A.; Nucera F.; Bielefeldt-Ohmann H.; Mazilli S.; Caramori G.; Lyons J.G.; Hansbro P.M.,"Sahu, Priyanka (57216189414); Donovan, Chantal (55357105200); Paudel, Keshav Raj (56539588400); Pickles, Sophie (57216189104); Chimankar, Vrushali (57191957166); Kim, Richard Y. (35810406900); Horvart, Jay C. (58640135400); Dua, Kamal (15759138700); Ieni, Antonio (26021273500); Nucera, Francesco (57202946185); Bielefeldt-Ohmann, Helle (7005067985); Mazilli, Sarah (58639706300); Caramori, Gaetano (7003847659); Lyons, J. Guy (7202033263); Hansbro, Philip M. (6603119390)",57216189414; 55357105200; 56539588400; 57216189104; 57191957166; 35810406900; 58640135400; 15759138700; 26021273500; 57202946185; 7005067985; 58639706300; 7003847659; 7202033263; 6603119390,Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions,2023,Frontiers in Oncology,13,,1260411,,,,7,10.3389/fonc.2023.1260411,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85173739384&doi=10.3389%2ffonc.2023.1260411&partnerID=40&md5=55b7a8b73f26ef2b1d18de0c704a4fe4,"Immune Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, Messina, Italy; Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università degli Studi di Messina, Messina, Italy; Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD, Australia; Department of Medicine, Boston University School of Medicine, Boston, MA, United States; Department of Dermatology, The University of Sydney at Royal Prince Alfred Hospital, Sydney, Australia; Centenary Institute, The University of Sydney, Sydney, NSW, Australia","Sahu P., Immune Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Donovan C., Immune Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Pickles S., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Chimankar V., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Kim R.Y., Immune Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Horvart J.C., Immune Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Ieni A., Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, Messina, Italy; Nucera F., Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università degli Studi di Messina, Messina, Italy; Bielefeldt-Ohmann H., Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD, Australia; Mazilli S., Department of Medicine, Boston University School of Medicine, Boston, MA, United States; Caramori G., Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università degli Studi di Messina, Messina, Italy; Lyons J.G., Department of Dermatology, The University of Sydney at Royal Prince Alfred Hospital, Sydney, Australia, Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Hansbro P.M., Immune Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia",animal models; genetic and epigenetic alterations; lung cancer; risk factors; squamous cell carcinoma,"achaete Scute family BHLH transcription factor 4; B Raf kinase; biological marker; carcinogen; epidermal growth factor receptor; fibroblast growth factor receptor 1; Forkhead box protein P1; gastric inhibitory polypeptide; kelch like ECH associated protein 1; microRNA; mitogen activated protein kinase 14; Notch1 receptor; Notch2 receptor; phosphatidylinositol 4,5 bisphosphate 3 kinase; protein p53; protein p63; transcription factor Sox2; unclassified drug; vasculotropin; adenocarcinoma; advanced cancer; animal cell; animal experiment; animal model; animal tissue; cancer growth; cancer staging; cancer survival; carcinogenesis; controlled study; epigenetics; gene amplification; gene expression; gene overexpression; genetic association; genetic marker; genetic susceptibility; glycolysis; intervention study; lung cancer; mouse; non small cell lung cancer; nonhuman; nuclear reprogramming; oncogene c H ras; oxidative phosphorylation; oxidative stress; randomized controlled trial (topic); Review; risk factor; spinal muscular atrophy; squamous cell carcinoma; squamous cell lung carcinoma; transgene; tumor xenograft",Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85173739384
Ryan T.A.J.; Hooftman A.; Rehill A.M.; Johansen M.D.; O’ Brien E.C.; Toller-Kawahisa J.E.; Wilk M.M.; Day E.A.; Weiss H.J.; Sarvari P.; Vozza E.G.; Schramm F.; Peace C.G.; Zotta A.; Miemczyk S.; Nalkurthi C.; Hansbro N.G.; McManus G.; O’Doherty L.; Gargan S.; Long A.; Dunne J.; Cheallaigh C.N.; Conlon N.; Carty M.; Fallon P.G.; Mills K.H.G.; Creagh E.M.; O’ Donnell J.S.; Hertzog P.J.; Hansbro P.M.; McLoughlin R.M.; Wygrecka M.; Preston R.J.S.; Zasłona Z.; O’Neill L.A.J.,"Ryan, Tristram A. J. (57200624032); Hooftman, Alexander (57209197802); Rehill, Aisling M. (57195917648); Johansen, Matt D. (57202983408); O’ Brien, Eóin C. (58498967200); Toller-Kawahisa, Juliana E. (55953840700); Wilk, Mieszko M. (54940750200); Day, Emily A. (57210100829); Weiss, Hauke J. (57218411615); Sarvari, Pourya (58905572100); Vozza, Emilio G. (57220069631); Schramm, Fabian (58709183000); Peace, Christian G. (57416409900); Zotta, Alessia (57211206269); Miemczyk, Stefan (57773070000); Nalkurthi, Christina (57359864400); Hansbro, Nicole G. (15055862300); McManus, Gavin (36739432100); O’Doherty, Laura (57219535631); Gargan, Siobhan (37037334400); Long, Aideen (34881912800); Dunne, Jean (7101823120); Cheallaigh, Clíona Ní (46062251900); Conlon, Niall (49761224700); Carty, Michael (57206532654); Fallon, Padraic G. (7102455344); Mills, Kingston H. G. (7202875495); Creagh, Emma M. (6602453432); O’ Donnell, James S. (57217838376); Hertzog, Paul J. (7005991492); Hansbro, Philip M. (6603119390); McLoughlin, Rachel M. (7005136911); Wygrecka, Małgorzata (16417736600); Preston, Roger J. S. (12774078500); Zasłona, Zbigniew (26221484200); O’Neill, Luke A. J. (7103393094)",57200624032; 57209197802; 57195917648; 57202983408; 58498967200; 55953840700; 54940750200; 57210100829; 57218411615; 58905572100; 57220069631; 58709183000; 57416409900; 57211206269; 57773070000; 57359864400; 15055862300; 36739432100; 57219535631; 37037334400; 34881912800; 7101823120; 46062251900; 49761224700; 57206532654; 7102455344; 7202875495; 6602453432; 57217838376; 7005991492; 6603119390; 7005136911; 16417736600; 12774078500; 26221484200; 7103393094,"Publisher Correction: Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon (Nature Communications, (2023), 14, 1, (3513), 10.1038/s41467-023-39174-1)",2023,Nature Communications,14,1,4374,,,,1,10.1038/s41467-023-40034-1,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85165319409&doi=10.1038%2fs41467-023-40034-1&partnerID=40&md5=7f838c471fc3113eca65f77e079a4f9c,"School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Host Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland; Center for Infection and Genomics of the Lung, German Center for Lung Research (DZL), Faculty of Medicine, Justus Liebig University, Giessen, Germany; Department of Infectious Diseases, St. James’s Hospital, Dublin, Ireland; Clinical Research Facility, St. James’s Hospital, Dublin, Ireland; Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Department of Immunology, St James’s Hospital, Dublin, Ireland; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin 2, Ireland; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia","Ryan T.A.J., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Hooftman A., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Rehill A.M., Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland; Johansen M.D., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; O’ Brien E.C., Host Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Toller-Kawahisa J.E., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Wilk M.M., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland, Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland; Day E.A., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Weiss H.J., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Sarvari P., Center for Infection and Genomics of the Lung, German Center for Lung Research (DZL), Faculty of Medicine, Justus Liebig University, Giessen, Germany; Vozza E.G., Host Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Schramm F., Center for Infection and Genomics of the Lung, German Center for Lung Research (DZL), Faculty of Medicine, Justus Liebig University, Giessen, Germany; Peace C.G., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Zotta A., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Miemczyk S., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Nalkurthi C., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; McManus G., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; O’Doherty L., Department of Infectious Diseases, St. James’s Hospital, Dublin, Ireland, Clinical Research Facility, St. James’s Hospital, Dublin, Ireland, Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Gargan S., Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Long A., Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Dunne J., Department of Immunology, St James’s Hospital, Dublin, Ireland; Cheallaigh C.N., Department of Infectious Diseases, St. James’s Hospital, Dublin, Ireland, Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Conlon N., Clinical Research Facility, St. James’s Hospital, Dublin, Ireland, Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland, Department of Immunology, St James’s Hospital, Dublin, Ireland; Carty M., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Fallon P.G., Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin 2, Ireland; Mills K.H.G., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Creagh E.M., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; O’ Donnell J.S., Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland; Hertzog P.J., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; McLoughlin R.M., Host Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Wygrecka M., Center for Infection and Genomics of the Lung, German Center for Lung Research (DZL), Faculty of Medicine, Justus Liebig University, Giessen, Germany; Preston R.J.S., Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland; Zasłona Z., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; O’Neill L.A.J., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland",,erratum,Erratum,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85165319409
Alamil J.M.R.; Xenaki D.; Manandhar B.; Paudel K.R.; Hansbro P.M.; Oliver B.G.; Chellappan D.K.; Dua K.,"Alamil, Juman Mohammed Rasmi (57687310600); Xenaki, Dikaia (6507411538); Manandhar, Bikash (57204448260); Paudel, Keshav Raj (56539588400); Hansbro, Philip Michael (6603119390); Oliver, Brian Gregory (15919869900); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",57687310600; 6507411538; 57204448260; 56539588400; 6603119390; 15919869900; 35811890500; 15759138700,"AGARWOOD OIL NANOEMULSION ATTENUATES PRODUCTION OF LIPOPOLYSACCHARIDE (LPS)-INDUCED PROINFLAMMATORY CYTOKINES, IL-6 AND IL-8 IN HUMAN BRONCHIAL EPITHELIAL CELLS",2023,EXCLI Journal,22,,,681,685,4,5,10.17179/excli2023-6282,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85166106144&doi=10.17179%2fexcli2023-6282&partnerID=40&md5=e90ff8f6b472a67f5dca8a8e326fbcb9,"School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Woolcock Institute of Medical Research, Macquarie University, Sydney, 2137, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Australian Research Center in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Center for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India","Alamil J.M.R., School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Xenaki D., Woolcock Institute of Medical Research, Macquarie University, Sydney, 2137, NSW, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Center in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Center for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2050, NSW, Australia; Hansbro P.M., Center for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2050, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, Macquarie University, Sydney, 2137, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Center in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India",,agarwood oil; interleukin 6; interleukin 8; lipopolysaccharide; tea tree oil; unclassified drug; vegetable oil; agarwood; antiinflammatory activity; asthma; BEAS-2B cell line; bioavailability; bronchus epithelium; cell viability assay; chronic obstructive lung disease; controlled study; cytokine production; disease exacerbation; drug safety; epithelium cell; herbal medicine; human; human cell; in vitro study; Letter; nanoemulsion; nonhuman; RAW 264.7 cell line; solubility; tree; ultrasound assisted extraction,Letter,Final,,Scopus,2-s2.0-85166106144
Rathnayake S.N.H.; Ditz B.; van Nijnatten J.; Sadaf T.; Hansbro P.M.; Brandsma C.A.; Timens W.; van Schadewijk A.; Hiemstra P.S.; ten Hacken N.H.T.; Oliver B.; Kerstjens H.A.M.; van den Berge M.; Faiz A.,"Rathnayake, Senani N. H. (57208151699); Ditz, Benedikt (57214760701); van Nijnatten, Jos (57326522900); Sadaf, Tayyaba (58669468700); Hansbro, Philip M. (6603119390); Brandsma, Corry A. (22833246900); Timens, Wim (7005755132); van Schadewijk, Annemarie (6602768021); Hiemstra, Peter S. (7004364809); ten Hacken, Nick H. T. (6603712916); Oliver, Brian (15919869900); Kerstjens, Huib A. M. (7005932406); van den Berge, Maarten (56412674600); Faiz, Alen (55601365200)",57208151699; 57214760701; 57326522900; 58669468700; 6603119390; 22833246900; 7005755132; 6602768021; 7004364809; 6603712916; 15919869900; 7005932406; 56412674600; 55601365200,Smoking induces shifts in cellular composition and transcriptome within the bronchial mucus barrier,2023,Respirology,28,2,,132,142,10,4,10.1111/resp.14401,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85142482218&doi=10.1111%2fresp.14401&partnerID=40&md5=e7668b3fc6dd6e801fe34e76c9ac1415,"University of Technology Sydney, Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, Sydney, NSW, Australia; The University of Sydney, Respiratory Cellular and Molecular Biology (RCMB), Woolcock Institute of Medical Research, Sydney, NSW, Australia; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands; Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Centre for Inflammation, Centenary Institute, and the University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands","Rathnayake S.N.H., University of Technology Sydney, Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, Sydney, NSW, Australia, The University of Sydney, Respiratory Cellular and Molecular Biology (RCMB), Woolcock Institute of Medical Research, Sydney, NSW, Australia; Ditz B., Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands; van Nijnatten J., University of Technology Sydney, Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, Sydney, NSW, Australia, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Sadaf T., University of Technology Sydney, Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, and the University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, and the University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Brandsma C.A., University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Timens W., University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; van Schadewijk A., Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Hiemstra P.S., Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; ten Hacken N.H.T., Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands; Oliver B., The University of Sydney, Respiratory Cellular and Molecular Biology (RCMB), Woolcock Institute of Medical Research, Sydney, NSW, Australia; Kerstjens H.A.M., Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands; van den Berge M., Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, Netherlands; Faiz A., University of Technology Sydney, Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, Sydney, NSW, Australia, The University of Sydney, Respiratory Cellular and Molecular Biology (RCMB), Woolcock Institute of Medical Research, Sydney, NSW, Australia, Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands",bronchial mucus barrier; cellular deconvolution; gene expression; goblet cell; smoking,"Biopsy; Humans; Mucus; Pulmonary Disease, Chronic Obstructive; Smoking; Transcriptome; chloride channel; cigarette smoke; mucin; sodium channel; transcriptome; transcriptome; adult; Article; basal cell; bronchus biopsy; bronchus mucus; cell composition; cell transformation; chronic obstructive lung disease; ciliated epithelium cell; cohort analysis; comparative study; controlled study; correlation analysis; deconvolution; differential gene expression; ex-smoker; female; gene expression; gene expression level; genetic modification; goblet cell; human; major clinical study; male; people by smoking status; prediction; single cell RNA seq; smoking; smoking cessation; adverse event; biopsy; chronic obstructive lung disease; genetics; metabolism; mucus; smoking",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85142482218
Pathinayake P.S.; Hsu A.C.-Y.; Nichol K.S.; Horvat J.C.; Hansbro P.M.; Wark P.A.B.,"Pathinayake, Prabuddha S. (55877978000); Hsu, Alan C.-Y. (49861516600); Nichol, Kristy S. (57195914143); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Wark, Peter A.B. (58166423200)",55877978000; 49861516600; 57195914143; 9942405300; 6603119390; 58166423200,Endoplasmic reticulum stress enhances the expression of TLR3-induced TSLP by airway epithelium,2024,American Journal of Physiology - Lung Cellular and Molecular Physiology,326,5,,L618,L626,8,1,10.1152/ajplung.00378.2023,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192113373&doi=10.1152%2fajplung.00378.2023&partnerID=40&md5=42a3792ab09ab9093733ac53d0f26e82,"Immune Health Program, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Immune Health Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; School of Medicine, Monash University, Melbourne, VIC, Australia; AIRMED Alfred Health, Melbourne, VIC, Australia; Signature Research Program in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Graduate Medical School, Singapore, Singapore","Pathinayake P.S., Immune Health Program, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Hsu A.C.-Y., Immune Health Program, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Signature Research Program in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Graduate Medical School, Singapore, Singapore; Nichol K.S., Immune Health Program, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Immune Health Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Immune Health Program, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Wark P.A.B., Immune Health Program, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia, School of Medicine, Monash University, Melbourne, VIC, Australia, AIRMED Alfred Health, Melbourne, VIC, Australia",ER stress; severe neutrophilic asthma; TSLP; unfolded protein response,"Asthma; Bronchi; Cells, Cultured; Cytokines; eIF-2 Kinase; Endoplasmic Reticulum Stress; Epithelial Cells; Female; Humans; Respiratory Mucosa; RNA, Messenger; Signal Transduction; Thymic Stromal Lymphopoietin; Toll-Like Receptor 3; Transcription Factor CHOP; Unfolded Protein Response; budesonide; complementary DNA; corticosteroid; heterodimer; messenger RNA; polyinosinic polycytidylic acid; small interfering RNA; thymic stromal lymphopoietin; toll like receptor 3; tunicamycin; cytokine; growth arrest and DNA damage inducible protein 153; protein kinase R; thymic stromal lymphopoietin; TLR3 protein, human; TSLP protein, human; adult; analysis of variance; Article; asthma; Asthma Control Questionnaire; bronchus biopsy; clinical article; consensus sequence; controlled study; correlation analysis; demographics; endoplasmic reticulum; endoplasmic reticulum stress; eosinophilic asthma; epithelium basal cell; female; forced expiratory volume; forced vital capacity; gene expression; gene induction; gene knockdown; human; human cell; male; nucleotide sequence; protein secretion; real time polymerase chain reaction; respiratory epithelium; severe asthma; unfolded protein response; asthma; bronchus; cell culture; epithelium cell; genetics; metabolism; pathology; respiratory mucosa; signal transduction; unfolded protein response",Article,Final,,Scopus,2-s2.0-85192113373
Malik R.; Paudel K.R.; Manandhar B.; De Rubis G.; Shen J.; Mujwar S.; Singh T.G.; Singh S.K.; Gupta G.; Adams J.; MacLoughlin R.; Oliver B.G.G.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Malik, Raniya (57687045700); Paudel, Keshav Raj (56539588400); Manandhar, Bikash (57204448260); De Rubis, Gabriele (57196257973); Shen, Jessie (58117423800); Mujwar, Somdutt (56449140000); Singh, Thakur Gurjeet (27667828700); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Adams, Jon (35584313300); MacLoughlin, Ronan (57212263206); Oliver, Brian Gregory George (15919869900); Hansbro, Philip Michael (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",57687045700; 56539588400; 57204448260; 57196257973; 58117423800; 56449140000; 27667828700; 57206711834; 15047988400; 35584313300; 57212263206; 15919869900; 6603119390; 35811890500; 15759138700,Agarwood oil nanoemulsion counteracts LPS-induced inflammation and oxidative stress in RAW264.7 mouse macrophages,2023,Pathology Research and Practice,251,,154895,,,,5,10.1016/j.prp.2023.154895,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85176133747&doi=10.1016%2fj.prp.2023.154895&partnerID=40&md5=25ec4c9baae503d5687f5ea9f60f65da,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De'Aurora Pty Ltd., Dean, 3363, VIC, Australia; Chitkara College of Pharmacy, Chitkara University, Punjab, Rajpura, 140401, India; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Department of Pharmacology, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College, Saveetha University, Tamil Nadu, Chennai, 602105, India; School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, 302017, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Uttarakhand, Dehradun, 248007, India; IDA Business Park, Connacht, Galway, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Leinster, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Leinster, Dublin, D02 PN40, Ireland; School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia","Malik R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Shen J., De'Aurora Pty Ltd., Dean, 3363, VIC, Australia; Mujwar S., Chitkara College of Pharmacy, Chitkara University, Punjab, Rajpura, 140401, India; Singh T.G., Chitkara College of Pharmacy, Chitkara University, Punjab, Rajpura, 140401, India; Singh S.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Gupta G., Department of Pharmacology, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College, Saveetha University, Tamil Nadu, Chennai, 602105, India, School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, 302017, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Uttarakhand, Dehradun, 248007, India; Adams J., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; MacLoughlin R., IDA Business Park, Connacht, Galway, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Leinster, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Leinster, Dublin, D02 PN40, Ireland; Oliver B.G.G., School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Agarwood oil; Inflammation; Lipopolysaccharide; Nanoemulsion; Oxidative stress,Animals; Anti-Inflammatory Agents; Antioxidants; Inflammation; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Agarwood oil; essential oil; lipopolysaccharide; nitric oxide; reactive oxygen metabolite; unclassified drug; antiinflammatory agent; antioxidant; immunoglobulin enhancer binding protein; interleukin 6; lipopolysaccharide; nitric oxide; reactive oxygen metabolite; tumor necrosis factor; animal cell; antiinflammatory activity; antioxidant activity; Article; bioassay; cell stimulation; controlled study; gene; gene expression; in vitro study; inflammation; mouse; nanoemulsion; nonhuman; oxidative stress; physical chemistry; polymerase chain reaction; prediction; RAW 264.7 cell line; upregulation; animal; inflammation; macrophage; metabolism; oxidative stress,Article,Final,,Scopus,2-s2.0-85176133747
Awatade N.T.; Wark P.A.B.; Chan A.S.L.; Mamun S.M.A.A.; Mohd Esa N.Y.; Matsunaga K.; Rhee C.K.; Hansbro P.M.; Sohal S.S.,"Awatade, Nikhil T. (56554140500); Wark, Peter A. B. (7003559516); Chan, Andrew S. L. (55430673200); Mamun, SM Abdullah Al (57221831263); Mohd Esa, Nurul Yaqeen (57216922333); Matsunaga, Kazuto (8731434800); Rhee, Chin Kook (35202293000); Hansbro, Philip M. (6603119390); Sohal, Sukhwinder Singh (36449981500)",56554140500; 7003559516; 55430673200; 57221831263; 57216922333; 8731434800; 35202293000; 6603119390; 36449981500,The Complex Association between COPD and COVID-19,2023,Journal of Clinical Medicine,12,11,3791,,,,20,10.3390/jcm12113791,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163062400&doi=10.3390%2fjcm12113791&partnerID=40&md5=7eb22d5940bdac6af7dea6719e14ff3f,"Immune Health Program, Hunter Medical Research Institute and University of Newcastle, Newcastle, 2305, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, 2305, Australia; Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, St. Leonards, 2065, Australia; Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, Australia; Department of Respiratory Medicine & Sleep Medicine, Evercare Hospitals Dhaka, Dhaka, 1229, Bangladesh; Sunway Medical Centre Velocity, Kuala Lumpur, 55100, Malaysia; Department of Respiratory Medicine and Infectious Disease Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, 755-8505, Japan; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, South Korea; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2050, Australia; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, Australia","Awatade N.T., Immune Health Program, Hunter Medical Research Institute and University of Newcastle, Newcastle, 2305, Australia; Wark P.A.B., Immune Health Program, Hunter Medical Research Institute and University of Newcastle, Newcastle, 2305, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, 2305, Australia; Chan A.S.L., Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, St. Leonards, 2065, Australia, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, Australia; Mamun S.M.A.A., Department of Respiratory Medicine & Sleep Medicine, Evercare Hospitals Dhaka, Dhaka, 1229, Bangladesh; Mohd Esa N.Y., Sunway Medical Centre Velocity, Kuala Lumpur, 55100, Malaysia; Matsunaga K., Department of Respiratory Medicine and Infectious Disease Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, 755-8505, Japan; Rhee C.K., Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, South Korea; Hansbro P.M., Immune Health Program, Hunter Medical Research Institute and University of Newcastle, Newcastle, 2305, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2050, Australia; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, Australia",ACE2; COPD; COVID-19,cigarette smoke; corticosteroid; chronic obstructive lung disease; cigarette smoking; coronavirus disease 2019; disease association; disease exacerbation; disease predisposition; disease severity; heredity; human; long COVID; pneumonia; public health service; Review; socioeconomics; vaccination; vaping,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85163062400
Paudel K.R.; Clarence D.D.; Panth N.; Manandhar B.; De Rubis G.; Devkota H.P.; Gupta G.; Zacconi F.C.; Williams K.A.; Pont L.G.; Singh S.K.; Warkiani M.E.; Adams J.; MacLoughlin R.; Oliver B.G.; Chellappan D.K.; Hansbro P.M.; Dua K.,"Paudel, Keshav Raj (56539588400); Clarence, Dvya Delilaa (57897135900); Panth, Nisha (57094240100); Manandhar, Bikash (57204448260); De Rubis, Gabriele (57196257973); Devkota, Hari Prasad (24775939500); Gupta, Gaurav (15047988400); Zacconi, Flavia C. (33667991400); Williams, Kylie A. (7404142756); Pont, Lisa G. (6602612624); Singh, Sachin Kumar (57206711834); Warkiani, Majid Ebrahimi (36138999000); Adams, Jon (35584313300); MacLoughlin, Ronan (57212263206); Oliver, Brian G. (15919869900); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",56539588400; 57897135900; 57094240100; 57204448260; 57196257973; 24775939500; 15047988400; 33667991400; 7404142756; 6602612624; 57206711834; 36138999000; 35584313300; 57212263206; 15919869900; 35811890500; 6603119390; 15759138700,"Zerumbone liquid crystalline nanoparticles protect against oxidative stress, inflammation and senescence induced by cigarette smoke extract in vitro",2024,Naunyn-Schmiedeberg's Archives of Pharmacology,397,4,,2465,2483,18,9,10.1007/s00210-023-02760-7,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85174414946&doi=10.1007%2fs00210-023-02760-7&partnerID=40&md5=949b745dfde3e0e519c3eebcf26b398e,"Centre of Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, Kumamoto City, 862-0973, Japan; Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan; Center for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Tamil Nadu, Chennai, 602105, India; School of Pharmacy, Graphic Era Hill University, Uttarakhand, Dehradun, 248007, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; Departamento de Química Orgánica, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Macul, Santiago, 7820436, Chile; Centro de Investigación en Nanotecnología y Materiales Avanzados, CIEN-UC, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Macul, Santiago, 7820436, Chile; Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Paudel K.R., Centre of Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Clarence D.D., School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Panth N., Centre of Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, Kumamoto City, 862-0973, Japan, Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan; Gupta G., Center for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Tamil Nadu, Chennai, 602105, India, School of Pharmacy, Graphic Era Hill University, Uttarakhand, Dehradun, 248007, India, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; Zacconi F.C., Departamento de Química Orgánica, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Macul, Santiago, 7820436, Chile, Centro de Investigación en Nanotecnología y Materiales Avanzados, CIEN-UC, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Macul, Santiago, 7820436, Chile, Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Williams K.A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Pont L.G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; Warkiani M.E., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Adams J., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; MacLoughlin R., Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., Centre of Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Anti-inflammatory; Antioxidant; Liquid crystalline nanoparticles; Monoolein; P407; Zerumbone,Animals; Anti-Inflammatory Agents; Antioxidants; Cigarette Smoking; Humans; Inflammation; Mice; Nanoparticles; NF-kappa B; Nicotiana; Oxidative Stress; Sesquiterpenes; cigarette smoke; cyclin dependent kinase inhibitor 1A; cyclooxygenase 2; interleukin 1beta; interleukin 6; nanoparticle; nitric oxide; reactive oxygen metabolite; tumor necrosis factor; zerumbone; antiinflammatory agent; antioxidant; immunoglobulin enhancer binding protein; nanoparticle; sesquiterpene; zerumbone; animal cell; antiinflammatory activity; antioxidant activity; Article; asthma; cell viability; chronic obstructive lung disease; cigarette smoking; controlled study; drug effect; drug formulation; drug structure; epithelial cell line; epithelium basal cell; fluorescence imaging; fluorescence intensity; gene expression; granulocyte; human; human cell; immunocytochemistry; immunofluorescence; in vitro study; inflammation; liquid crystal; lung alveolus macrophage; mouse; mRNA expression level; nonhuman; oxidative stress; protein expression; protein expression level; RAW 264.7 cell line; respiratory burst; senescence; upregulation; animal; cigarette smoking; inflammation; metabolism; Nicotiana; oxidative stress,Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85174414946
Yeung S.; Paudel K.R.; Rubis G.D.; Williams K.A.; Hansbro P.M.; Dua K.,"Yeung, Stewart (58822848100); Paudel, Keshav Raj (56539588400); Rubis, Gabriele De (58120540100); Williams, Kylie A. (7404142756); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",58822848100; 56539588400; 58120540100; 7404142756; 6603119390; 15759138700,Exploring the current advancements of quercetin nanoformulations alleviating respiratory diseases,2024,Future Medicinal Chemistry,16,10,,925,928,3,0,10.1080/17568919.2024.2347067,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85193341150&doi=10.1080%2f17568919.2024.2347067&partnerID=40&md5=f5f784cae6a03ff79a0d8009b5e2ad2d,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Centre for Inflammation, Centenary Institute & University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia","Yeung S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute & University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Rubis G.D., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Williams K.A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute & University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, Australia",nanoformulations; nanoparticles; quercetin; respiratory diseases,Antioxidants; Humans; Nanoparticles; Quercetin; Respiratory Tract Diseases; chitosan nanoparticle; hydrogen peroxide; interleukin 1beta; interleukin 6; interleukin 8; lipopolysaccharide; liquid crystalline nanoparticle; nanogel; nanoparticle; oil; polymer; polyvinyl alcohol; quercetin; reactive nitrogen species; reactive oxygen metabolite; superoxide dismutase; tumor necrosis factor; unclassified drug; water; antioxidant; quercetin; A-549 cell line; aerosol; allergenicity; antimicrobial activity; antineoplastic activity; antioxidant activity; antiviral activity; apoptosis; asthma; autophagy (cellular); BCi cell line; BEAS-2B cell line; biocompatibility; biodegradability; cancer inhibition; carbonization; cell culture; cell viability; chronic obstructive lung disease; comparative study; cytotoxicity; down regulation; drug delivery system; Editorial; enzyme activity; gelation; HBEC cell line (bronchial epithelium); high temperature; human; IC30; IC50; in vitro study; in vivo study; inflammation; influenza A (H1N1); inhibitory concentration; internalization (cell); lung adenocarcinoma; lung cancer; lung interstitium; lung parenchyma; molecular weight; MRC-5 cell line; nanoemulsion; nebulization; nonhuman; NS1.1 cell line; oxidative stress; protein blood level; protein expression; pyrolysis; respiratory tract disease; tumor volume; tumor xenograft; chemistry; drug therapy; respiratory tract disease,Editorial,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85193341150
Budden K.F.; Shukla S.D.; Bowerman K.L.; Vaughan A.; Gellatly S.L.; Wood D.L.A.; Lachner N.; Idrees S.; Rehman S.F.; Faiz A.; Patel V.K.; Donovan C.; Alemao C.A.; Shen S.; Amorim N.; Majumder R.; Vanka K.S.; Mason J.; Haw T.J.; Tillet B.; Fricker M.; Keely S.; Hansbro N.; Belz G.T.; Horvat J.; Ashhurst T.; van Vreden C.; McGuire H.; de St Groth B.F.; King N.J.C.; Crossett B.; Cordwell S.J.; Bonaguro L.; Schultze J.L.; Hamilton‐Williams E.E.; Mann E.; Forster S.C.; Cooper M.A.; Segal L.N.; Chotirmall S.H.; Collins P.; Bowman R.; Fong K.M.; Yang I.A.; Wark P.A.B.; Dennis P.G.; Hugenholtz P.; Hansbro P.M.,"Budden, Kurtis F. (57191417986); Shukla, Shakti D. (56367620800); Bowerman, Kate L. (58719708900); Vaughan, Annalicia (55935627600); Gellatly, Shaan L. (26430804400); Wood, David L.A. (55723732300); Lachner, Nancy (55625753600); Idrees, Sobia (55429771900); Rehman, Saima Firdous (57211047721); Faiz, Alen (55601365200); Patel, Vyoma K. (57193533009); Donovan, Chantal (55357105200); Alemao, Charlotte A. (57200821652); Shen, Sj (56707946900); Amorim, Nadia (57221385895); Majumder, Rajib (56825461200); Vanka, Kanth S. (57095767500); Mason, Jazz (58719254000); Haw, Tatt Jhong (56625918900); Tillet, Bree (58139780100); Fricker, Michael (26638839800); Keely, Simon (9739611200); Hansbro, Nicole (15055862300); Belz, Gabrielle T. (7102682937); Horvat, Jay (9942405300); Ashhurst, Thomas (55432845900); van Vreden, Caryn (55247300900); McGuire, Helen (36794271900); de St Groth, Barbara Fazekas (56874664200); King, Nicholas J.C. (7201762862); Crossett, Ben (57204219477); Cordwell, Stuart J. (6701490362); Bonaguro, Lorenzo (57194605623); Schultze, Joachim L. (7103037653); Hamilton‐Williams, Emma E. (6507464326); Mann, Elizabeth (37034567100); Forster, Samuel C. (7101707502); Cooper, Matthew A. (58888732500); Segal, Leopoldo N. (35184010000); Chotirmall, Sanjay H. (15757175700); Collins, Peter (7402501370); Bowman, Rayleen (8576061200); Fong, Kwun M. (57880022900); Yang, Ian A. (7101797862); Wark, Peter A.B. (58166423200); Dennis, Paul G. (57197279960); Hugenholtz, Philip (55811879700); Hansbro, Philip M. (6603119390)",57191417986; 56367620800; 58719708900; 55935627600; 26430804400; 55723732300; 55625753600; 55429771900; 57211047721; 55601365200; 57193533009; 55357105200; 57200821652; 56707946900; 57221385895; 56825461200; 57095767500; 58719254000; 56625918900; 58139780100; 26638839800; 9739611200; 15055862300; 7102682937; 9942405300; 55432845900; 55247300900; 36794271900; 56874664200; 7201762862; 57204219477; 6701490362; 57194605623; 7103037653; 6507464326; 37034567100; 7101707502; 58888732500; 35184010000; 15757175700; 7402501370; 8576061200; 57880022900; 7101797862; 58166423200; 57197279960; 55811879700; 6603119390,Faecal microbial transfer and complex carbohydrates mediate protection against COPD,2024,Gut,73,5,,751,769,18,8,10.1136/gutjnl-2023-330521,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185165030&doi=10.1136%2fgutjnl-2023-330521&partnerID=40&md5=d8c9e4cdaf71ff03c967cec627aed1df,"Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics, The University of Queensland, Brisbane, QLD, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD, Australia; Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Frazer Institute, University of Queensland, Woolloongabba, QLD, Australia; Sydney Cytometry, Charles Perkins Centre, Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, NSW, Australia; Ramaciotti Facility for Human Systems Biology, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Discipline of Pathology, Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia; Sydney Mass Spectrometry, The University of Sydney, Sydney, NSW, Australia; School of Life and Environmental Sciences, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), The University of Bonn, Bonn, Germany; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom; Centre for Innate Immunity and Infectious Diseases, Department of Molecular and Translational Science, Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia; Division of Pulmonary and Critical Care Medicine, Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, United States; Lee Kong Chian School of Medicine, Translational Respiratory Research Laboratory, Singapore; Mater Research Institute, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia; Department of Dietetics, Food Services Mater Hospital, Brisbane, QLD, Australia; School of Earth and Environmental Sciences, The University of Queensland, Brisbane, QLD, Australia","Budden K.F., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Bowerman K.L., School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics, The University of Queensland, Brisbane, QLD, Australia; Vaughan A., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia, UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia, Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD, Australia; Gellatly S.L., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Wood D.L.A., School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics, The University of Queensland, Brisbane, QLD, Australia; Lachner N., School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics, The University of Queensland, Brisbane, QLD, Australia; Idrees S., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Rehman S.F., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Faiz A., Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Patel V.K., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Donovan C., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Alemao C.A., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Shen S., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Amorim N., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Majumder R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Vanka K.S., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Mason J., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Haw T.J., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Tillet B., Frazer Institute, University of Queensland, Woolloongabba, QLD, Australia; Fricker M., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Keely S., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro N., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Belz G.T., Frazer Institute, University of Queensland, Woolloongabba, QLD, Australia; Horvat J., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Ashhurst T., Sydney Cytometry, Charles Perkins Centre, Centenary Institute, The University of Sydney, Sydney, NSW, Australia, Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, NSW, Australia; van Vreden C., Sydney Cytometry, Charles Perkins Centre, Centenary Institute, The University of Sydney, Sydney, NSW, Australia, Ramaciotti Facility for Human Systems Biology, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; McGuire H., Ramaciotti Facility for Human Systems Biology, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; de St Groth B.F., Ramaciotti Facility for Human Systems Biology, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; King N.J.C., Sydney Cytometry, Charles Perkins Centre, Centenary Institute, The University of Sydney, Sydney, NSW, Australia, Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, NSW, Australia, Ramaciotti Facility for Human Systems Biology, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia, Discipline of Pathology, Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia; Crossett B., Sydney Mass Spectrometry, The University of Sydney, Sydney, NSW, Australia; Cordwell S.J., Sydney Mass Spectrometry, The University of Sydney, Sydney, NSW, Australia, School of Life and Environmental Sciences, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Bonaguro L., Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany, Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany; Schultze J.L., Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany, Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany, PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), The University of Bonn, Bonn, Germany; Hamilton‐Williams E.E., Frazer Institute, University of Queensland, Woolloongabba, QLD, Australia; Mann E., Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom; Forster S.C., Centre for Innate Immunity and Infectious Diseases, Department of Molecular and Translational Science, Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia; Cooper M.A., Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia; Segal L.N., Division of Pulmonary and Critical Care Medicine, Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, United States; Chotirmall S.H., Lee Kong Chian School of Medicine, Translational Respiratory Research Laboratory, Singapore; Collins P., Mater Research Institute, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia, Department of Dietetics, Food Services Mater Hospital, Brisbane, QLD, Australia; Bowman R., UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia, Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD, Australia; Fong K.M., UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia, Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD, Australia; Yang I.A., UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia, Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Dennis P.G., School of Earth and Environmental Sciences, The University of Queensland, Brisbane, QLD, Australia; Hugenholtz P., School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics, The University of Queensland, Brisbane, QLD, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia",,"Animals; Carbohydrates; Humans; Inflammation; Lung; Mice; Pneumonia; Pulmonary Disease, Chronic Obstructive; ampicillin; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; beta adrenergic receptor stimulating agent; cigarette smoke; corticosteroid; dipeptidyl carboxypeptidase inhibitor; gentamicin; glucose; hydroxymethylglutaryl coenzyme A reductase inhibitor; inulin; long acting muscarinic antagonist; metronidazole; muscarinic receptor blocking agent; neomycin; placebo; proton pump inhibitor; resistant starch; serotonin noradrenalin reuptake inhibitor; serotonin uptake inhibitor; toll like receptor 4; unclassified drug; vancomycin; carbohydrate; aged; animal cell; animal experiment; animal model; animal tissue; Article; bacterium; chronic obstructive lung disease; clinical article; clinical feature; clinical outcome; cohort analysis; controlled study; correlation analysis; Desulfovibrionaceae; diet supplementation; double blind procedure; down regulation; dysbiosis; exposure; fecal microbiota transplantation; feces microflora; female; glucose metabolism; histopathology; human; immunity; immunocompetent cell; in vivo study; intestine; intestine flora; Lachnospiraceae; lung alveolus; lung function; lung parenchyma; male; metabolomics; metagenomics; mouse; mouse model; Muribaculaceae; nonhuman; pathogenesis; pilot study; population abundance; protection; proteomics; randomized controlled trial; respiratory tract inflammation; smoking cessation; animal; chronic obstructive lung disease; inflammation; lung; metabolism; pathology; pneumonia",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85185165030
Kapellos T.S.; Baßler K.; Fujii W.; Nalkurthi C.; Schaar A.C.; Bonaguro L.; Pecht T.; Galvao I.; Agrawal S.; Saglam A.; Dudkin E.; Frishberg A.; de Domenico E.; Horne A.; Donovan C.; Kim R.Y.; Gallego-Ortega D.; Gillett T.E.; Ansari M.; Schulte-Schrepping J.; Offermann N.; Antignano I.; Sivri B.; Lu W.; Eapen M.S.; van Uelft M.; Osei-Sarpong C.; van den Berge M.; Donker H.C.; Groen H.J.M.; Sohal S.S.; Klein J.; Schreiber T.; Feißt A.; Yildirim A.Ö.; Schiller H.B.; Nawijn M.C.; Becker M.; Händler K.; Beyer M.; Capasso M.; Ulas T.; Hasenauer J.; Pizarro C.; Theis F.J.; Hansbro P.M.; Skowasch D.; Schultze J.L.,"Kapellos, Theodore S. (55624127100); Baßler, Kevin (57209042382); Fujii, Wataru (57078377300); Nalkurthi, Christina (57359864400); Schaar, Anna C. (57223905604); Bonaguro, Lorenzo (57194605623); Pecht, Tal (55620062800); Galvao, Izabela (56656390800); Agrawal, Shobhit (24467256100); Saglam, Adem (57210962672); Dudkin, Erica (57219688218); Frishberg, Amit (56556796200); de Domenico, Elena (57193968923); Horne, Arik (57214892602); Donovan, Chantal (55357105200); Kim, Richard Y. (35810406900); Gallego-Ortega, David (57202352450); Gillett, Tessa E. (57209568057); Ansari, Meshal (57207300757); Schulte-Schrepping, Jonas (57191276382); Offermann, Nina (57191505626); Antignano, Ignazio (57221330394); Sivri, Burcu (58292716300); Lu, Wenying (57202573402); Eapen, Mathew S. (56625716100); van Uelft, Martina (55650317500); Osei-Sarpong, Collins (57208749869); van den Berge, Maarten (56412674600); Donker, Hylke C. (56326951400); Groen, Harry J.M. (35462538800); Sohal, Sukhwinder S. (36449981500); Klein, Johanna (57201257738); Schreiber, Tina (57201332501); Feißt, Andreas (56089211800); Yildirim, Ali Önder (21935550600); Schiller, Herbert B. (15037181200); Nawijn, Martijn C. (6506545287); Becker, Matthias (57199798916); Händler, Kristian (47761155400); Beyer, Marc (34568412000); Capasso, Melania (14035087400); Ulas, Thomas (57207907279); Hasenauer, Jan (36097795200); Pizarro, Carmen (54420968300); Theis, Fabian J. (6701364934); Hansbro, Philip M. (6603119390); Skowasch, Dirk (6603928258); Schultze, Joachim L. (7103037653)",55624127100; 57209042382; 57078377300; 57359864400; 57223905604; 57194605623; 55620062800; 56656390800; 24467256100; 57210962672; 57219688218; 56556796200; 57193968923; 57214892602; 55357105200; 35810406900; 57202352450; 57209568057; 57207300757; 57191276382; 57191505626; 57221330394; 58292716300; 57202573402; 56625716100; 55650317500; 57208749869; 56412674600; 56326951400; 35462538800; 36449981500; 57201257738; 57201332501; 56089211800; 21935550600; 15037181200; 6506545287; 57199798916; 47761155400; 34568412000; 14035087400; 57207907279; 36097795200; 54420968300; 6701364934; 6603119390; 6603928258; 7103037653,Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease,2023,Cell Reports,42,6,112525,,,,19,10.1016/j.celrep.2023.112525,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85160438331&doi=10.1016%2fj.celrep.2023.112525&partnerID=40&md5=88aefcd927d98b55a75b96f1d2c5f488,"Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity (LHI), Member of the German Center for Lung Research (DZL), Helmholtz Zentrum München, Neuherberg, 85764, Germany; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, 85764, Germany; Department of Mathematics, Technische Universität München, Garching, 85748, Germany; Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, 53127, Germany; Computational Life Sciences, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Immune Health, Hunter Medical Research Institute, New Lambton and The University of Newcastle, Newcastle, 2305, NSW, Australia; School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Garvan Institute of Medical Research, and St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, 2010, NSW, Australia; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, 9700 AB, Netherlands; GRIAC Research Institute, University Medical Center Groningen, Groningen, 9700 RB, Netherlands; Immunregulation, German Center for Neurodegenerative Diseases (DZNE), Bonn, 53127, Germany; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; Immunogenomics & Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, 53127, Germany; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, 9713 GZ, Netherlands; Department of Internal Medicine II, Pneumology, University Hospital Bonn, Bonn, 53127, Germany; University Clinics for Radiology, University Hospital Bonn, Bonn, 53127, Germany; Modular HPC and AI, German Center for Neurodegenerative Diseases (DZNE), Bonn, 53127, Germany; Institute of Human Genetics, University of Lübeck, Lübeck, 23562, Germany","Kapellos T.S., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany, Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity (LHI), Member of the German Center for Lung Research (DZL), Helmholtz Zentrum München, Neuherberg, 85764, Germany; Baßler K., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Fujii W., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Nalkurthi C., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Schaar A.C., Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, 85764, Germany, Department of Mathematics, Technische Universität München, Garching, 85748, Germany; Bonaguro L., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany, Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, 53127, Germany; Pecht T., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Galvao I., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Agrawal S., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Saglam A., Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, 53127, Germany; Dudkin E., Computational Life Sciences, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Frishberg A., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany, Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, 85764, Germany; de Domenico E., Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, 53127, Germany; Horne A., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Donovan C., University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia, Immune Health, Hunter Medical Research Institute, New Lambton and The University of Newcastle, Newcastle, 2305, NSW, Australia; Kim R.Y., University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia, Immune Health, Hunter Medical Research Institute, New Lambton and The University of Newcastle, Newcastle, 2305, NSW, Australia; Gallego-Ortega D., School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Garvan Institute of Medical Research, and St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, 2010, NSW, Australia; Gillett T.E., Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, 9700 AB, Netherlands, GRIAC Research Institute, University Medical Center Groningen, Groningen, 9700 RB, Netherlands; Ansari M., Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity (LHI), Member of the German Center for Lung Research (DZL), Helmholtz Zentrum München, Neuherberg, 85764, Germany, Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, 85764, Germany; Schulte-Schrepping J., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Offermann N., Immunregulation, German Center for Neurodegenerative Diseases (DZNE), Bonn, 53127, Germany; Antignano I., Immunregulation, German Center for Neurodegenerative Diseases (DZNE), Bonn, 53127, Germany; Sivri B., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Lu W., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; van Uelft M., Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Osei-Sarpong C., Immunogenomics & Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, 53127, Germany; van den Berge M., Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, 9700 AB, Netherlands, Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, 9713 GZ, Netherlands; Donker H.C., Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, 9700 AB, Netherlands, Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, 9713 GZ, Netherlands; Groen H.J.M., Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, 9700 AB, Netherlands, Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, 9713 GZ, Netherlands; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; Klein J., Department of Internal Medicine II, Pneumology, University Hospital Bonn, Bonn, 53127, Germany; Schreiber T., Department of Internal Medicine II, Pneumology, University Hospital Bonn, Bonn, 53127, Germany; Feißt A., University Clinics for Radiology, University Hospital Bonn, Bonn, 53127, Germany; Yildirim A.Ö., Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity (LHI), Member of the German Center for Lung Research (DZL), Helmholtz Zentrum München, Neuherberg, 85764, Germany; Schiller H.B., Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity (LHI), Member of the German Center for Lung Research (DZL), Helmholtz Zentrum München, Neuherberg, 85764, Germany; Nawijn M.C., Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, 9700 AB, Netherlands, GRIAC Research Institute, University Medical Center Groningen, Groningen, 9700 RB, Netherlands; Becker M., Modular HPC and AI, German Center for Neurodegenerative Diseases (DZNE), Bonn, 53127, Germany; Händler K., Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, 53127, Germany, Institute of Human Genetics, University of Lübeck, Lübeck, 23562, Germany; Beyer M., Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, 53127, Germany, Immunogenomics & Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, 53127, Germany; Capasso M., Immunregulation, German Center for Neurodegenerative Diseases (DZNE), Bonn, 53127, Germany; Ulas T., Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, 53127, Germany; Hasenauer J., Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, 85764, Germany, Department of Mathematics, Technische Universität München, Garching, 85748, Germany, Computational Life Sciences, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, 53115, Germany; Pizarro C., Department of Internal Medicine II, Pneumology, University Hospital Bonn, Bonn, 53127, Germany; Theis F.J., Institute of Computational Biology (ICB), Helmholtz Zentrum München, Neuherberg, 85764, Germany, Department of Mathematics, Technische Universität München, Garching, 85748, Germany; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Skowasch D., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; Schultze J.L., Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity (LHI), Member of the German Center for Lung Research (DZL), Helmholtz Zentrum München, Neuherberg, 85764, Germany, Department of Mathematics, Technische Universität München, Garching, 85748, Germany",blood; bone marrow; chronic obstructive pulmonary disease; CP: Immunology; granulopoiesis; neutrophil; single-cell transcriptomics,"Animals; Humans; Inflammation; Lung; Mice; Neutrophils; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; animal cell; animal experiment; animal model; antigen presentation; Article; bone marrow; bronchoalveolar lavage fluid; CD4+ T lymphocyte; cell activation; cell count; chronic obstructive lung disease; cigarette smoking; DE gene; disease exacerbation; down regulation; forced expiratory volume; forced vital capacity; gene; granulocyte; granulopoiesis; immunocompetent cell; lung function; lymphocyte activation; neutrophil; nonhuman; phenotype; single cell analysis; single cell RNA seq; animal; chronic obstructive lung disease; human; inflammation; lung; lung emphysema; mouse; neutrophil",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85160438331
Aogáin M.M.; Ivan F.X.; Jaggi T.K.; Richardson H.; Shoemark A.; Narayana J.K.; Dicker A.J.; Koh M.S.; Lee K.C.H.; How O.T.; Poh M.E.; Chin K.K.; Hou A.L.Y.; Hon P.S.; Low T.B.; Abisheganaden J.A.; Dimakou K.; Digalaki A.; Kosti C.; Gkousiou A.; Hansbro P.M.; Blasi F.; Aliberti S.; Chalmers J.D.; Chotirmall S.H.,"Aogáin, Micheál Mac (57219192429); Ivan, Fransiskus Xaverius (48461321400); Jaggi, Tavleen Kaur (57204228946); Richardson, Hollian (57201496028); Shoemark, Amelia (16246385000); Narayana, Jayanth Kumar (57217280956); Dicker, Alison J. (15044064400); Koh, Mariko Siyue (34570960000); Lee, Ken Cheah Hooi (38162969500); How, Ong Thun (57218194388); Poh, Mau Ern (56118048700); Chin, Ka Kiat (57210900557); Hou, Albert Lim Yick (57218775027); Hon, Puah Ser (59205794500); Low, Teck Boon (10043911000); Abisheganaden, John Arputhan (6701696370); Dimakou, Katerina (6506811930); Digalaki, Antonia (57764959100); Kosti, Chrysavgi (57217190915); Gkousiou, Anna (57697540900); Hansbro, Philip M. (6603119390); Blasi, Francesco (41761074200); Aliberti, Stefano (9247687000); Chalmers, James D. (56648999600); Chotirmall, Sanjay H. (15757175700)",57219192429; 48461321400; 57204228946; 57201496028; 16246385000; 57217280956; 15044064400; 34570960000; 38162969500; 57218194388; 56118048700; 57210900557; 57218775027; 59205794500; 10043911000; 6701696370; 6506811930; 57764959100; 57217190915; 57697540900; 6603119390; 41761074200; 9247687000; 56648999600; 15757175700,Airway “Resistotypes” and Clinical Outcomes in Bronchiectasis,2024,American Journal of Respiratory and Critical Care Medicine,210,1,,47,62,15,11,10.1164/rccm.202306-1059OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195684775&doi=10.1164%2frccm.202306-1059OC&partnerID=40&md5=1652d91dc420f97e63f02841c2c106bc,"Biochemical Genetics Laboratory, Department of Biochemistry, St. James’s Hospital, Dublin, Ireland; Clinical Biochemistry Unit, School of Medicine, Trinity College Dublin, Dublin, Ireland; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom; Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore; Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia; Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore; Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore; 5th Respiratory Medicine Department, General Hospital for Chest Diseases of Athens “Sotiria”, Athens, Greece; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Respiratory Unit and Cystic Fibrosis Center, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Respiratory Unit, Rozzano, Milan, Italy","Aogáin M.M., Biochemical Genetics Laboratory, Department of Biochemistry, St. James’s Hospital, Dublin, Ireland, Clinical Biochemistry Unit, School of Medicine, Trinity College Dublin, Dublin, Ireland, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Ivan F.X., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Jaggi T.K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Richardson H., University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom; Shoemark A., University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom; Narayana J.K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Dicker A.J., University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom; Koh M.S., Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore; Lee K.C.H., Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore; How O.T., Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore; Poh M.E., Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia; Chin K.K., Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia; Hou A.L.Y., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore; Hon P.S., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore; Low T.B., Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore; Abisheganaden J.A., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore; Dimakou K., 5th Respiratory Medicine Department, General Hospital for Chest Diseases of Athens “Sotiria”, Athens, Greece; Digalaki A., 5th Respiratory Medicine Department, General Hospital for Chest Diseases of Athens “Sotiria”, Athens, Greece; Kosti C., 5th Respiratory Medicine Department, General Hospital for Chest Diseases of Athens “Sotiria”, Athens, Greece; Gkousiou A., 5th Respiratory Medicine Department, General Hospital for Chest Diseases of Athens “Sotiria”, Athens, Greece; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Blasi F., Respiratory Unit and Cystic Fibrosis Center, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Aliberti S., Department of Biomedical Sciences, Humanitas University, Milan, Italy, IRCCS Humanitas Research Hospital, Respiratory Unit, Rozzano, Milan, Italy; Chalmers J.D., University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom; Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore",bronchiectasis; metagenomics; microbiome; resistome; resistotype,Adult; Aged; Anti-Bacterial Agents; Bronchiectasis; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Metagenomics; Microbiota; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; aminoglycoside antibiotic agent; antibiotic agent; bacterial DNA; bicozamycin; bronchodilating agent; chloramphenicol; colistin; corticosteroid; fosfomycin; triclosan; antiinfective agent; adult; antibiotic resistance; antibiotic resistome; Article; bacterial clearance; bacterial colonization; bronchiectasis; clinical outcome; cohort analysis; controlled study; cross-sectional study; female; forced expiratory volume; genetic profile; geographic origin; Haemophilus influenzae; hospital admission; human; Klebsiella pneumoniae; longitudinal study; lung function; major clinical study; male; metagenomics; microbiome; Neisseria; nonhuman; Prevotella; Pseudomonas aeruginosa; recurrent infection; Rothia; Rothia mucilaginosa; Serratia marcescens; sputum; Streptococcus; Veillonella; whole genome sequencing; aged; bronchiectasis; clinical trial; complication; drug therapy; genetics; microbiology; microflora; middle aged; multicenter study; pathophysiology; procedures; prospective study; Pseudomonas infection,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85195684775
Shrestha J.; Paudel K.R.; Nazari H.; Dharwal V.; Bazaz S.R.; Johansen M.D.; Dua K.; Hansbro P.M.; Warkiani M.E.,"Shrestha, Jesus (57214237167); Paudel, Keshav Raj (56539588400); Nazari, Hojjatollah (57203750457); Dharwal, Vivek (57195758477); Bazaz, Sajad Razavi (57200006380); Johansen, Matt D. (57202983408); Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390); Warkiani, Majid Ebrahimi (36138999000)",57214237167; 56539588400; 57203750457; 57195758477; 57200006380; 57202983408; 15759138700; 6603119390; 36138999000,Advanced models for respiratory disease and drug studies,2023,Medicinal Research Reviews,43,5,,1470,1503,33,9,10.1002/med.21956,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85156269174&doi=10.1002%2fmed.21956&partnerID=40&md5=de78cf143ab003c357f979c9914c682a,"School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia","Shrestha J., School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Nazari H., School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia; Dharwal V., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Bazaz S.R., School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia; Johansen M.D., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Warkiani M.E., School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia",animal models; drug discovery; lung-on-a-chip; medicinal research; respiratory diseases,Animals; COVID-19; Drug Development; Humans; Pandemics; toxin; air pollution; asthma; cell culture; chronic obstructive lung disease; clinical evaluation; coronavirus disease 2019; drug screening; health care cost; human; lung biopsy; lung cancer; lung fibrosis; lung parenchyma; medical research; nonhuman; organoid; pandemic; pharmacokinetic parameters; phenotype; preclinical study; respiratory tract disease; respiratory tract infection; Review; stem cell; wildfire; animal; coronavirus disease 2019; drug development; pandemic,Review,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85156269174
Mishra N.; Bhatt S.; Paudel K.R.; Hansbro P.M.; Dua K.,"Mishra, Neeraj (23027996000); Bhatt, Shvetank (57197493015); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",23027996000; 57197493015; 56539588400; 6603119390; 15759138700,Preface,2023,Synbiotics for the Management of Cancer,,,,v,vi,,0,,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85171521927&partnerID=40&md5=8b820b22188fea3b1b189332d65b9d90,"Department of Pharmaceutics Amity Institute of Pharmacy, Amity University Madhya Pradesh, Madhya Pradesh, Gwalior, India; School of Pharmacy, Dr.Vishwanath Karad MIT World Peace University, Maharashtra, Pune, India; Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, NSW, Sydney, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia","Mishra N., Department of Pharmaceutics Amity Institute of Pharmacy, Amity University Madhya Pradesh, Madhya Pradesh, Gwalior, India; Bhatt S., School of Pharmacy, Dr.Vishwanath Karad MIT World Peace University, Maharashtra, Pune, India; Paudel K.R., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, NSW, Sydney, Australia; Hansbro P.M., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, NSW, Sydney, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia",,,Editorial,Final,,Scopus,2-s2.0-85171521927
Patel M.N.; Patel A.J.; Nandpal M.N.; Raval M.A.; Patel R.J.; Patel A.A.; Paudel K.R.; Hansbro P.M.; Singh S.K.; Gupta G.; Dua K.; Patel S.G.,"Patel, Meghana N. (57213987452); Patel, Archita J. (55449668200); Nandpal, Manish N. (58490582300); Raval, Manan A. (59068097100); Patel, Ravish J. (57190756102); Patel, Amit A. (15843949000); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Dua, Kamal (15759138700); Patel, Samir G. (57198335014)",57213987452; 55449668200; 58490582300; 59068097100; 57190756102; 15843949000; 56539588400; 6603119390; 57206711834; 15047988400; 15759138700; 57198335014,"Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape",2024,Naunyn-Schmiedeberg's Archives of Pharmacology,,,,,,,0,10.1007/s00210-024-03466-0,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85205887672&doi=10.1007%2fs00210-024-03466-0&partnerID=40&md5=b4452f2ada1e5d1cbdafeab4613b6f4d,"Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, At. & Post:-Changa, Tal.:- Petlad, Dist.:- Anand, Gujarat, 388421, India; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India; Centre for Research Impact & amp; Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, 140401, India; Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia","Patel M.N., Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, At. & Post:-Changa, Tal.:- Petlad, Dist.:- Anand, Gujarat, 388421, India; Patel A.J., Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, At. & Post:-Changa, Tal.:- Petlad, Dist.:- Anand, Gujarat, 388421, India; Nandpal M.N., Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, At. & Post:-Changa, Tal.:- Petlad, Dist.:- Anand, Gujarat, 388421, India; Raval M.A., Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, At. & Post:-Changa, Tal.:- Petlad, Dist.:- Anand, Gujarat, 388421, India; Patel R.J., Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, At. & Post:-Changa, Tal.:- Petlad, Dist.:- Anand, Gujarat, 388421, India; Patel A.A., Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, At. & Post:-Changa, Tal.:- Petlad, Dist.:- Anand, Gujarat, 388421, India; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India; Gupta G., Centre for Research Impact & amp; Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, 140401, India, Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; Patel S.G., Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, CHARUSAT Campus, At. & Post:-Changa, Tal.:- Petlad, Dist.:- Anand, Gujarat, 388421, India",AI-Based Approaches; DR-TB Management; Drug-Resistant; Novel Techniques; Patent Analysis; Tuberculosis,,Review,Article in press,,Scopus,2-s2.0-85205887672
De Rubis G.; Paudel K.R.; Liu G.; Agarwal V.; MacLoughlin R.; de Jesus Andreoli Pinto T.; Singh S.K.; Adams J.; Nammi S.; Chellappan D.K.; Oliver B.G.G.; Hansbro P.M.; Dua K.,"De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Liu, Gang (57189061134); Agarwal, Vipul (53981137700); MacLoughlin, Ronan (57212263206); de Jesus Andreoli Pinto, Terezinha (7003263019); Singh, Sachin Kumar (57206711834); Adams, Jon (35584313300); Nammi, Srinivas (6602547699); Chellappan, Dinesh Kumar (35811890500); Oliver, Brian Gregory George (15919869900); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",57196257973; 56539588400; 57189061134; 53981137700; 57212263206; 7003263019; 57206711834; 35584313300; 6602547699; 35811890500; 15919869900; 6603119390; 15759138700,Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells,2023,Toxicology in Vitro,92,,105660,,,,8,10.1016/j.tiv.2023.105660,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85168479307&doi=10.1016%2fj.tiv.2023.105660&partnerID=40&md5=a11b00874854003a8b998ee5ef169660,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Cluster for Advanced Macromolecular Design (CAMD), School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Aerogen, IDA Business Park, Connacht, Galway, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Leinster, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Leinster, Dublin, D02 PN40, Ireland; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; School of Science, Western Sydney University, Penrith, 2751, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India","De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Liu G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Agarwal V., Cluster for Advanced Macromolecular Design (CAMD), School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; MacLoughlin R., Aerogen, IDA Business Park, Connacht, Galway, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Leinster, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Leinster, Dublin, D02 PN40, Ireland; de Jesus Andreoli Pinto T., Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Adams J., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Nammi S., School of Science, Western Sydney University, Penrith, 2751, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Oliver B.G.G., Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India",Airway remodelling; Asthma; Berberine; COPD; Liquid crystalline nanoparticles; Lung cancer; Phytoceuticals; TGF-β,Airway Remodeling; Antioxidants; Berberine; Cell Proliferation; Epithelial Cells; Humans; berberine; cystatin C; endoglin; fibroblast growth factor 2; glycerol oleate; myeloperoxidase; nanoparticle; thrombospondin 1; transforming growth factor beta; vasculotropin; antioxidant; airway remodeling; Article; BEAS-2B cell line; bronchus epithelium; cell migration; cell viability; chronic respiratory tract disease; concentration response; controlled study; down regulation; drug delivery system; drug efficacy; drug mechanism; epithelium cell; human; human cell; protein expression; upregulation; wound closure; cell proliferation; epithelium cell,Article,Final,,Scopus,2-s2.0-85168479307
Scaramuzzo G.; Nucera F.; Asmundo A.; Messina R.; Mari M.; Montanaro F.; Johansen M.D.; Monaco F.; Fadda G.; Tuccari G.; Hansbro N.G.; Hansbro P.M.; Hansel T.T.; Adcock I.M.; David A.; Kirkham P.; Caramori G.; Volta C.A.; Spadaro S.,"Scaramuzzo, Gaetano (57200518480); Nucera, Francesco (57202946185); Asmundo, Alessio (6603302421); Messina, Roberto (35170676000); Mari, Matilde (57423818400); Montanaro, Federica (57226554006); Johansen, Matt D. (57202983408); Monaco, Francesco (56941491100); Fadda, Guido (35299028100); Tuccari, Giovanni (7004479946); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Hansel, Trevor T. (7006490149); Adcock, Ian M. (7007066538); David, Antonio (7402606823); Kirkham, Paul (7003632920); Caramori, Gaetano (7003847659); Volta, Carlo Alberto (7003816053); Spadaro, Savino (55503307600)",57200518480; 57202946185; 6603302421; 35170676000; 57423818400; 57226554006; 57202983408; 56941491100; 35299028100; 7004479946; 15055862300; 6603119390; 7006490149; 7007066538; 7402606823; 7003632920; 7003847659; 7003816053; 55503307600,Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance,2023,Journal of Inflammation (United Kingdom),20,1,11,,,,7,10.1186/s12950-023-00333-2,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150416788&doi=10.1186%2fs12950-023-00333-2&partnerID=40&md5=851dc8fcaa98faadf4fdbb1995c07907,"Department of Translational Medicine, University of Ferrara, Ferrara, Italy; Department of Emergency, Section of Intensive Care and Anesthesia, Azienda Ospedaliera-Universitaria Sant’Anna, Ferrara, Italy; Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Medicina Legale, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Intensive Care Unit, Dipartimento di Patologia Umana e dell’Età Evolutiva Gaetano Barresi, Università di Messina, Messina, Italy; Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Chirurgia Toracica, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Section of Pathological Anatomy, Department of Human Pathology of Adult and Developmental Age “Gaetano Barresi”, University of Messina, Messina, Italy; Medical Research Council and Asthma, UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom; Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Biomedical Sciences, Faculty of Sciences and Engineering, University of Wolverhampton, West Midlands, Wolverhampton, United Kingdom","Scaramuzzo G., Department of Translational Medicine, University of Ferrara, Ferrara, Italy, Department of Emergency, Section of Intensive Care and Anesthesia, Azienda Ospedaliera-Universitaria Sant’Anna, Ferrara, Italy; Nucera F., Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Asmundo A., Medicina Legale, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Messina R., Intensive Care Unit, Dipartimento di Patologia Umana e dell’Età Evolutiva Gaetano Barresi, Università di Messina, Messina, Italy; Mari M., Department of Translational Medicine, University of Ferrara, Ferrara, Italy, Department of Emergency, Section of Intensive Care and Anesthesia, Azienda Ospedaliera-Universitaria Sant’Anna, Ferrara, Italy; Montanaro F., Department of Translational Medicine, University of Ferrara, Ferrara, Italy, Department of Emergency, Section of Intensive Care and Anesthesia, Azienda Ospedaliera-Universitaria Sant’Anna, Ferrara, Italy; Johansen M.D., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Monaco F., Chirurgia Toracica, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Fadda G., Section of Pathological Anatomy, Department of Human Pathology of Adult and Developmental Age “Gaetano Barresi”, University of Messina, Messina, Italy; Tuccari G., Section of Pathological Anatomy, Department of Human Pathology of Adult and Developmental Age “Gaetano Barresi”, University of Messina, Messina, Italy; Hansbro N.G., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Hansel T.T., Medical Research Council and Asthma, UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom; Adcock I.M., Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; David A., Intensive Care Unit, Dipartimento di Patologia Umana e dell’Età Evolutiva Gaetano Barresi, Università di Messina, Messina, Italy; Kirkham P., Department of Biomedical Sciences, Faculty of Sciences and Engineering, University of Wolverhampton, West Midlands, Wolverhampton, United Kingdom; Caramori G., Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Volta C.A., Department of Translational Medicine, University of Ferrara, Ferrara, Italy, Department of Emergency, Section of Intensive Care and Anesthesia, Azienda Ospedaliera-Universitaria Sant’Anna, Ferrara, Italy; Spadaro S., Department of Translational Medicine, University of Ferrara, Ferrara, Italy, Department of Emergency, Section of Intensive Care and Anesthesia, Azienda Ospedaliera-Universitaria Sant’Anna, Ferrara, Italy",ARDS; Biomarkers; Chemokines; COVID-19; Cytokines; SARS-CoV-2,advanced glycation end product receptor; alpha interferon; angiotensin converting enzyme 2; club cell secretory protein 16; endothelial leukocyte adhesion molecule 1; epithelial cell adhesion molecule; gamma interferon; gamma interferon inducible protein 10; glucocorticoid; granulocyte macrophage colony stimulating factor; HLA antigen; immunoglobulin G antibody; intercellular adhesion molecule 1; interleukin 2; interleukin 6; Janus kinase; krebs von den lungen 6 protein; macrophage inflammatory protein 1alpha; membrane protein; monocyte chemotactic protein 1; PADGEM protein; plasminogen activator inhibitor 1; secretory protein; surfactant associated protein; toll like receptor; transmembrane protease serine 2; tumor necrosis factor; unclassified drug; vascular cell adhesion molecule 1; von Willebrand factor; ACE2 gene; adult respiratory distress syndrome; aging; airway cell; allele; B lymphocyte; blood group ABO system; blood level; cell function; chronic kidney failure; chronic obstructive lung disease; cigarette smoking; coronavirus disease 2019; cytokine storm; diabetes mellitus; diffuse alveolar damage; disease association; disease course; disease severity; fibrosing alveolitis; gender; genetic association; genetic damage; genetic susceptibility; human; hypertension; IL 1 signaling; IL 6 signaling; immune system; immunomodulation; lung alveolus cell; lung alveolus macrophage; lung epithelium; lung lavage; lung parenchyma; molecular pathology; neutrophil; nonhuman; obesity; protein analysis; protein blood level; protein function; protein targeting; Review; risk factor; Severe acute respiratory syndrome coronavirus 2; signal transduction; single nucleotide polymorphism; Spaniard; virus entry; virus replication,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85150416788
Yin M.; Wadhwa R.; Marshall J.E.; Gillis C.M.; Kim R.Y.; Dua K.; Palsson-McDermott E.M.; Fallon P.G.; Hansbro P.M.; O’Neill L.A.J.,"Yin, Maureen (57364749800); Wadhwa, Ridhima (57159091700); Marshall, Jacqueline E. (57218547927); Gillis, Caitlin M. (55780837800); Kim, Richard Y. (35810406900); Dua, Kamal (15759138700); Palsson-McDermott, Eva M. (8744784400); Fallon, Padraic G. (7102455344); Hansbro, Philip M. (6603119390); O’Neill, Luke A.J. (7103393094)",57364749800; 57159091700; 57218547927; 55780837800; 35810406900; 15759138700; 8744784400; 7102455344; 6603119390; 7103393094,4-Octyl Itaconate Alleviates Airway Eosinophilic Inflammation by Suppressing Chemokines and Eosinophil Development,2024,Journal of Immunology,212,1,,13,23,10,3,10.4049/jimmunol.2300155,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85180543494&doi=10.4049%2fjimmunol.2300155&partnerID=40&md5=a4e9a14ff6ba68a0d899ceae83822f13,"School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Priority Research Centre for Immune Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Yin M., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Wadhwa R., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Marshall J.E., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Gillis C.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Kim R.Y., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Palsson-McDermott E.M., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Fallon P.G., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia, Priority Research Centre for Immune Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; O’Neill L.A.J., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland",,Animals; Chemokines; Eosinophils; Inflammation; Mice; Pulmonary Eosinophilia; 4 octyl itaconate; chemokine; interleukin 1beta; interleukin 4; interleukin 5; itaconic acid; transcription factor Nrf2; unclassified drug; 4-octyl itaconate; chemokine; itaconic acid; A-549 cell line; airway epithelium cell; airway resistance; animal cell; animal experiment; animal model; Article; Bagg albino mouse; bone marrow derived macrophage; cell differentiation; cell maturation; controlled study; cytokine production; dose response; enzyme linked immunosorbent assay; eosinophil; eosinophilic asthma; female; human; IL 5 signaling; M1 macrophage; M2 macrophage; mouse; nonhuman; Nrf2 signaling; ovalbumin-induced airway inflammation; pulmonary eosinophilia; Th2 cell; animal; inflammation; pulmonary eosinophilia,Article,Final,,Scopus,2-s2.0-85180543494
Patel V.K.; Vishwas S.; Kumar R.; De Rubis G.; Shukla S.D.; Paudel K.R.; Manandhar B.; Singh T.G.; Chellappan D.K.; Gulati M.; Kaur I.P.; Allam V.S.R.R.; Hansbro P.M.; Oliver B.G.; MacLoughlin R.; Singh S.K.; Dua K.,"Patel, Vyoma K. (57193533009); Vishwas, Sukriti (57216932631); Kumar, Rajan (57200984997); De Rubis, Gabriele (57196257973); Shukla, Shakti D. (56367620800); Paudel, Keshav Raj (56539588400); Manandhar, Bikash (57204448260); Singh, Thakur Gurjeet (27667828700); Chellappan, Dinesh Kumar (35811890500); Gulati, Monica (7006677671); Kaur, Indu Pal (55409565600); Allam, Venkata Sita Rama Raju (57200203739); Hansbro, Philip M. (6603119390); Oliver, Brian G. (15919869900); MacLoughlin, Ronan (57212263206); Singh, Sachin Kumar (57206711834); Dua, Kamal (15759138700)",57193533009; 57216932631; 57200984997; 57196257973; 56367620800; 56539588400; 57204448260; 27667828700; 35811890500; 7006677671; 55409565600; 57200203739; 6603119390; 15919869900; 57212263206; 57206711834; 15759138700,Tackling the cytokine storm using advanced drug delivery in allergic airway disease,2023,Journal of Drug Delivery Science and Technology,82,,104366,,,,2,10.1016/j.jddst.2023.104366,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150758325&doi=10.1016%2fj.jddst.2023.104366&partnerID=40&md5=354618dfe7067b764d3662cbbfde68f0,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123 Broadway, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, 2052, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Chitkara College of Pharmacy, Chitkara University, Punjab, 140401, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Aerogen Ltd., IDA Business Park, Dangan, Galway, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India","Patel V.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123 Broadway, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, 2052, NSW, Australia; Vishwas S., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Kumar R., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123 Broadway, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Shukla S.D., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123 Broadway, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123 Broadway, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh T.G., Chitkara College of Pharmacy, Chitkara University, Punjab, 140401, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Gulati M., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Kaur I.P., University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India; Allam V.S.R.R., Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Oliver B.G., School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; MacLoughlin R., Aerogen Ltd., IDA Business Park, Dangan, Galway, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123 Broadway, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India",Asthma; Clinical trials; Cytokines; Drug delivery systems,antiasthmatic agent; chitosan nanoparticle; cytokine; dendrimer; inorganic compound; lipid nanoparticle; liposome; metal nanoparticle; microsphere; nanocarrier; polymer nanoparticle; solid lipid nanoparticle; asthma; clinical trial (topic); cytokine storm; drug delivery system; exosome; gene therapy; human; inflammation; liposomal delivery; lung injury; micelle; nanopharmaceutics; nonhuman; pathophysiology; polymerization; Review,Review,Final,,Scopus,2-s2.0-85150758325
Mendes de Almeida V.; Engel D.F.; Ricci M.F.; Cruz C.S.; Lopes Í.S.; Alves D.A.; d’ Auriol M.; Magalhães J.; Machado E.C.; Rocha V.M.; Carvalho T.G.; Lacerda L.S.B.; Pimenta J.C.; Aganetti M.; Zuccoli G.S.; Smith B.J.; Carregari V.C.; da Silva Rosa E.; Galvão I.; Dantas Cassali G.; Garcia C.C.; Teixeira M.M.; André L.C.; Ribeiro F.M.; Martins F.S.; Saia R.S.; Costa V.V.; Martins-de-Souza D.; Hansbro P.M.; Marques J.T.; Aguiar E.R.G.R.; Vieira A.T.,"Mendes de Almeida, Viviani (57194703396); Engel, Daiane F. (49061029800); Ricci, Mayra F. (57212555195); Cruz, Clênio Silva (57267561900); Lopes, Ícaro Santos (57820273600); Alves, Daniele Almeida (57801475900); d’ Auriol, Mirna (57819758400); Magalhães, João (58377802100); Machado, Elayne C. (57203525645); Rocha, Victor M. (57169859500); Carvalho, Toniana G. (55992812200); Lacerda, Larisse S. B. (57371265700); Pimenta, Jordane C. (57225181841); Aganetti, Mariana (57222397532); Zuccoli, Giuliana S. (57191903903); Smith, Bradley J. (57193832250); Carregari, Victor C. (37664726500); da Silva Rosa, Erika (58287891800); Galvão, Izabela (56656390800); Dantas Cassali, Geovanni (56233128000); Garcia, Cristiana C. (25937253900); Teixeira, Mauro Martins (7202391189); André, Leiliane C. (55983010000); Ribeiro, Fabiola Mara (7102417800); Martins, Flaviano S. (57216004873); Saia, Rafael Simone (14069143500); Costa, Vivian Vasconcelos (23984393400); Martins-de-Souza, Daniel (25621529400); Hansbro, Philip M. (6603119390); Marques, João Trindade (7203033370); Aguiar, Eric R. G. R. (55842956500); Vieira, Angélica T. (8614414900)",57194703396; 49061029800; 57212555195; 57267561900; 57820273600; 57801475900; 57819758400; 58377802100; 57203525645; 57169859500; 55992812200; 57371265700; 57225181841; 57222397532; 57191903903; 57193832250; 37664726500; 58287891800; 56656390800; 56233128000; 25937253900; 7202391189; 55983010000; 7102417800; 57216004873; 14069143500; 23984393400; 25621529400; 6603119390; 7203033370; 55842956500; 8614414900,Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms,2023,Gut Microbes,15,2,2249146,,,,18,10.1080/19490976.2023.2249146,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85169664105&doi=10.1080%2f19490976.2023.2249146&partnerID=40&md5=d6aa090ae0c5832ddeca3752cd657816,"Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Department of Clinical Analysis, School of Pharmacy, Universidade Federal de Ouro Preto - UFOP, Ouro Preto, Brazil; Laboratory of Virus Bioinformatics, Department of Biological Science, Center of Biotechnology and Genetics, Universidade Estadual de Santa Cruz - UESC, Ilhéus, Brazil; Laboratory of RNA Interference and Antiviral Immunity, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Laboratory of Toxicology, Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Laboratory of Neurobiochemistry, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Center for Research and Development of Drugs, Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, Universidade do Estado de Campinas - UNICAMP, Campinas, Brazil; Laboratory of Comparative Pathology, Department of Pathology, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Laboratory of Respiratory Viruses and Measles, Instituto Oswaldo Cruz - Fiocruz, Rio de Janeiro, Brazil; Laboratory of Biotherapeutic Agents, Department of Microbiology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Laboratory of Intestinal Physiology, Department of Physiology, Ribeirão Preto Medical School, Universidade de São Paulo, Ribeirão Preto, Brazil; D’Or Institute for Research and Education, São Paulo, Brazil; Experimental Medicine Research Cluster, Universidade do Estado de Campinas - UNICAMP, Campinas, Brazil; National Institute of Biomarkers in Neuropsychiatry, National Council for Scientific and Technological Development, São Paulo, Brazil; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; CNRS UPR9022, University of Strasbourg, Strasbourg, France","Mendes de Almeida V., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Engel D.F., Department of Clinical Analysis, School of Pharmacy, Universidade Federal de Ouro Preto - UFOP, Ouro Preto, Brazil; Ricci M.F., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Cruz C.S., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Lopes Í.S., Laboratory of Virus Bioinformatics, Department of Biological Science, Center of Biotechnology and Genetics, Universidade Estadual de Santa Cruz - UESC, Ilhéus, Brazil; Alves D.A., Laboratory of RNA Interference and Antiviral Immunity, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; d’ Auriol M., Laboratory of Toxicology, Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Magalhães J., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Machado E.C., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Rocha V.M., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Carvalho T.G., Laboratory of Neurobiochemistry, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Lacerda L.S.B., Center for Research and Development of Drugs, Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Pimenta J.C., Center for Research and Development of Drugs, Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Aganetti M., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Zuccoli G.S., Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, Universidade do Estado de Campinas - UNICAMP, Campinas, Brazil; Smith B.J., Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, Universidade do Estado de Campinas - UNICAMP, Campinas, Brazil; Carregari V.C., Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, Universidade do Estado de Campinas - UNICAMP, Campinas, Brazil; da Silva Rosa E., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Galvão I., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Dantas Cassali G., Laboratory of Comparative Pathology, Department of Pathology, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Garcia C.C., Laboratory of Respiratory Viruses and Measles, Instituto Oswaldo Cruz - Fiocruz, Rio de Janeiro, Brazil; Teixeira M.M., Center for Research and Development of Drugs, Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; André L.C., Laboratory of Toxicology, Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Ribeiro F.M., Laboratory of Neurobiochemistry, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Martins F.S., Laboratory of Biotherapeutic Agents, Department of Microbiology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Saia R.S., Laboratory of Intestinal Physiology, Department of Physiology, Ribeirão Preto Medical School, Universidade de São Paulo, Ribeirão Preto, Brazil; Costa V.V., Center for Research and Development of Drugs, Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil; Martins-de-Souza D., Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, Universidade do Estado de Campinas - UNICAMP, Campinas, Brazil, D’Or Institute for Research and Education, São Paulo, Brazil, Experimental Medicine Research Cluster, Universidade do Estado de Campinas - UNICAMP, Campinas, Brazil, National Institute of Biomarkers in Neuropsychiatry, National Council for Scientific and Technological Development, São Paulo, Brazil; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Marques J.T., Laboratory of RNA Interference and Antiviral Immunity, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil, CNRS UPR9022, University of Strasbourg, Strasbourg, France; Aguiar E.R.G.R., Laboratory of Virus Bioinformatics, Department of Biological Science, Center of Biotechnology and Genetics, Universidade Estadual de Santa Cruz - UESC, Ilhéus, Brazil; Vieira A.T., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, Brazil",antimicrobial-resistance; COVID-19; inflammation; microbiota; post-COVID; SARS-CoV-2,Animals; Anti-Bacterial Agents; COVID-19; Disease Progression; Gastrointestinal Microbiome; Mice; SARS-CoV-2; alpha smooth muscle actin; antibiotic agent; fatty acid binding protein 2; RNA 16S; short chain fatty acid; antiinfective agent; adult; animal experiment; animal tissue; antibiotic resistance; antibiotic sensitivity; Article; Bayesian learning; behavioral test parameters; clinical outcome; cognition; colony forming unit; comorbidity; controlled study; coronavirus disease 2019; cross-sectional study; diet; disease severity; DNA extraction; Enterobacteriaceae; environmental factor; enzyme linked immunosorbent assay; epithelium cell; experimental design; exposure; fecal microbiota transplantation; feeding behavior; female; flow rate; gastrointestinal symptom; gene amplification; goblet cell; Gram negative bacterium; high performance liquid chromatography; histology; histopathology; homeostasis; human; immunohistochemistry; infant; inflammation; inflammatory cell; inflammatory infiltrate; intestine flora; Klebsiella pneumoniae infection; lifestyle; long COVID; lung infection; lung lavage; male; matrix assisted laser desorption ionization time of flight mass spectrometry; memory disorder; microbial diversity; microbiology; microflora; morphometry; mouse; mRNA expression level; multidrug resistant Klebsiella pneumoniae; nervous system inflammation; nonhuman; operational taxonomic unit; phenotype; pneumonia; prevalence; principal component analysis; real time polymerase chain reaction; RNA extraction; RNA sequencing; sampling; sequence analysis; serology; Severe acute respiratory syndrome coronavirus 2; Shannon index; Simpson index; species diversity; workflow; animal; disease exacerbation,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85169664105
Solanki N.; Gupta G.; Chellappan D.K.; Singh S.K.; Gulati M.; Paudel K.R.; Hansbro P.M.; Dua K.; Bhan S.; Saini M.; Dureja H.,"Solanki, Neeta (57219934315); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Singh, Sachin Kumar (57206711834); Gulati, Monica (7006677671); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Bhan, Suraj (58810120800); Saini, Manisha (57201463253); Dureja, Harish (6507566948)",57219934315; 15047988400; 35811890500; 57206711834; 7006677671; 56539588400; 6603119390; 15759138700; 58810120800; 57201463253; 6507566948,Boswellic Acids: A Critical Appraisal of their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases,2024,"Endocrine, Metabolic and Immune Disorders - Drug Targets",24,1,,116,129,13,8,10.2174/1871530323666230512154634,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85182216719&doi=10.2174%2f1871530323666230512154634&partnerID=40&md5=7359c357caf9944a952ed2044c67f84d,"Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Department of Life Sciences, School of Pharmacy, International Medical Univer-sity, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Centre for Inflammation, Centenary Institute, Sydney, 2050, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, New South Wales, Australia; World College of Medical Science & Research, Jhajjar, India; School of Medical and Allied Sciences, G.D. Goenka University, Gurugram, India","Solanki N., Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical Univer-sity, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, New South Wales, Australia; Bhan S., World College of Medical Science & Research, Jhajjar, India; Saini M., School of Medical and Allied Sciences, G.D. Goenka University, Gurugram, India; Dureja H., Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India",anti-inflammatory; boswellic acids; chronic inflammatory diseases; immune system; Inflammation; mediators,Anti-Inflammatory Agents; Humans; Immune System; Immunologic Factors; Inflammation; Plant Extracts; boswellic acid; gamma interferon; histamine; immunoglobulin E; interleukin 10; interleukin 12; interleukin 13; interleukin 23; interleukin 6; leukotriene; prostaglandin; toll like receptor; transcription factor Nrf2; transforming growth factor beta; tumor necrosis factor; antiinflammatory agent; immunologic factor; plant extract; antiarthritic activity; antiasthmatic activity; antidiarrheal activity; antiinflammatory activity; antimicrobial activity; antineoplastic activity; antirheumatic activity; asthma; Boswellia; chemical structure; drug safety; endoscopy; histopathology; human; hypolipidemic activity; immune response; inflammatory bowel disease; nonhuman; nutrition; regulatory T lymphocyte; Review; rheumatoid arthritis; Th1 cell; Th2 cell; ulcerative colitis; immune system; inflammation,Review,Final,,Scopus,2-s2.0-85182216719
Idrees S.; Paudel K.R.; Sadaf T.; Hansbro P.M.,"Idrees, Sobia (55429771900); Paudel, Keshav Raj (56539588400); Sadaf, Tayyaba (58669468700); Hansbro, Philip M. (6603119390)",55429771900; 56539588400; 58669468700; 6603119390,HOW DIFFERENT VIRUSES PERTURB HOST CELLULAR MACHINERY VIA SHORT LINEAR MOTIFS,2023,EXCLI Journal,22,,,1113,1128,15,6,10.17179/excli2023-6328,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85175165081&doi=10.17179%2fexcli2023-6328&partnerID=40&md5=5182890199f11a21615f1d4c6a4368b7,"School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute and the University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia","Idrees S., School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute and the University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and the University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia; Sadaf T., Centre for Inflammation, Centenary Institute and the University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and the University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia",mimicry; protein-protein interactions; short linear motifs; Virus,double-stranded DNA virus; double-stranded RNA virus; human; molecular mimicry; nonhuman; protein motif; protein protein interaction; Review; short linear motif; single-stranded DNA virus; single-stranded RNA virus; virus cell interaction,Review,Final,,Scopus,2-s2.0-85175165081
Ullah T.R.; Johansen M.D.; Balka K.R.; Ambrose R.L.; Gearing L.J.; Roest J.; Vivian J.P.; Sapkota S.; Jayasekara W.S.N.; Wenholz D.S.; Aldilla V.R.; Zeng J.; Miemczyk S.; Nguyen D.H.; Hansbro N.G.; Venkatraman R.; Kang J.H.; Pang E.S.; Thomas B.J.; Alharbi A.S.; Rezwan R.; O’Keeffe M.; Donald W.A.; Ellyard J.I.; Wong W.; Kumar N.; Kile B.T.; Vinuesa C.G.; Kelly G.E.; Laczka O.F.; Hansbro P.M.; De Nardo D.; Gantier M.P.,"Ullah, Tomalika R. (57210438051); Johansen, Matt D. (57202983408); Balka, Katherine R. (57202868120); Ambrose, Rebecca L. (34976333100); Gearing, Linden J. (24467836000); Roest, James (57953563600); Vivian, Julian P. (7005333787); Sapkota, Sunil (58345034400); Jayasekara, W. Samantha N. (55634537300); Wenholz, Daniel S. (57195515398); Aldilla, Vina R. (57195354654); Zeng, Jun (57805088500); Miemczyk, Stefan (57773070000); Nguyen, Duc H. (54886138200); Hansbro, Nicole G. (15055862300); Venkatraman, Rajan (57803784100); Kang, Jung Hee (57578399700); Pang, Ee Shan (57200031099); Thomas, Belinda J. (14120315000); Alharbi, Arwaf S. (57218261276); Rezwan, Refaya (57195260643); O’Keeffe, Meredith (7102551239); Donald, William A. (16241197000); Ellyard, Julia I. (6508009461); Wong, Wilson (57202277673); Kumar, Naresh (57806585000); Kile, Benjamin T. (6602986924); Vinuesa, Carola G. (6602533471); Kelly, Graham E. (57214751515); Laczka, Olivier F. (23485708300); Hansbro, Philip M. (6603119390); De Nardo, Dominic (8254619000); Gantier, Michael P. (19639930300)",57210438051; 57202983408; 57202868120; 34976333100; 24467836000; 57953563600; 7005333787; 58345034400; 55634537300; 57195515398; 57195354654; 57805088500; 57773070000; 54886138200; 15055862300; 57803784100; 57578399700; 57200031099; 14120315000; 57218261276; 57195260643; 7102551239; 16241197000; 6508009461; 57202277673; 57806585000; 6602986924; 6602533471; 57214751515; 23485708300; 6603119390; 8254619000; 19639930300,Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection,2023,Nature Communications,14,1,5666,,,,7,10.1038/s41467-023-41381-9,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85171546738&doi=10.1038%2fs41467-023-41381-9&partnerID=40&md5=4c2f571c188dea45cb5af94f6c43ec95,"Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia; St. Vincent’s Institute of Medical Research, Fitzroy, VIC, Australia; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Noxopharm Limited, Chatswood, NSW, Australia; School of Chemistry, UNSW Sydney, Kensington, NSW, Australia; MedChemSoft Solutions, Ferntree Gully, VIC, Australia; Monash Lung and Sleep, Monash Medical Centre, Clayton, VIC, Australia; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Turabah, Saudi Arabia; Department of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia; Francis Crick Institute, London, United Kingdom","Ullah T.R., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; Johansen M.D., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Balka K.R., Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia; Ambrose R.L., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; Gearing L.J., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; Roest J., St. Vincent’s Institute of Medical Research, Fitzroy, VIC, Australia; Vivian J.P., St. Vincent’s Institute of Medical Research, Fitzroy, VIC, Australia, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Sapkota S., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; Jayasekara W.S.N., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; Wenholz D.S., Noxopharm Limited, Chatswood, NSW, Australia, School of Chemistry, UNSW Sydney, Kensington, NSW, Australia; Aldilla V.R., School of Chemistry, UNSW Sydney, Kensington, NSW, Australia; Zeng J., MedChemSoft Solutions, Ferntree Gully, VIC, Australia; Miemczyk S., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Nguyen D.H., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Venkatraman R., Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia; Kang J.H., Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia; Pang E.S., Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia; Thomas B.J., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia, Monash Lung and Sleep, Monash Medical Centre, Clayton, VIC, Australia; Alharbi A.S., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Turabah, Saudi Arabia; Rezwan R., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; O’Keeffe M., Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia; Donald W.A., School of Chemistry, UNSW Sydney, Kensington, NSW, Australia; Ellyard J.I., Department of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia, Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia; Wong W., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia, Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia; Kumar N., School of Chemistry, UNSW Sydney, Kensington, NSW, Australia; Kile B.T., Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia; Vinuesa C.G., Department of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia, Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia, Francis Crick Institute, London, United Kingdom; Kelly G.E., Noxopharm Limited, Chatswood, NSW, Australia; Laczka O.F., Noxopharm Limited, Chatswood, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; De Nardo D., Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia; Gantier M.P., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia",,"Animals; COVID-19; Disease Models, Animal; I-kappa B Kinase; Inflammation; Interferon Type I; Mice; SARS-CoV-2; cytokine; I kappa B kinase epsilon; idronoxil; imidazole; phosphotransferase; tank biding kinase 1; toll like receptor 3; unclassified drug; I kappa B kinase; interferon; gene expression; immunocompetence; inhibition; molecular analysis; numerical model; pathology; severe acute respiratory syndrome; animal cell; animal experiment; animal model; Article; bone marrow derived macrophage; C57BL 6 mouse; cell culture; controlled study; coronavirus disease 2019; Giemsa stain; HEK293T cell line; hyperinflammation; immunoblotting; immunopathology; immunoprecipitation; in vitro study; luciferase assay; mouse; murine model; NCTC clone 929 cell line; nonhuman; plasmacytoid dendritic cell; real time polymerase chain reaction; RNA sequencing; size exclusion chromatography; surface plasmon resonance; THP-1 cell line; animal; disease model; inflammation; Severe acute respiratory syndrome coronavirus 2",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85171546738
Martino D.J.; Bui D.S.; Li S.; Idrose S.; Perret J.; Lowe A.J.; Lodge C.J.; Bowatte G.; Moodley Y.; Thomas P.S.; Zosky G.; Hansbro P.M.; Holloway J.W.; Svanes C.; Faner R.; Walters E.H.; Dharmage S.C.,"Martino, David J. (23009178200); Bui, Dinh S. (56376159800); Li, Shuai (56941241200); Idrose, Sabrina (57214213825); Perret, Jennifer (55546380400); Lowe, Adrian J. (57215492176); Lodge, Caroline J. (25637487300); Bowatte, Gayan (57209843687); Moodley, Yuben (6602358911); Thomas, Paul S. (7404889769); Zosky, Graeme (6506459703); Hansbro, Philip M. (6603119390); Holloway, John W. (57221220827); Svanes, Cecilie (7003653338); Faner, Rosa (6507910788); Walters, Eugene H. (7102865814); Dharmage, Shaymali C. (57208540237)",23009178200; 56376159800; 56941241200; 57214213825; 55546380400; 57215492176; 25637487300; 57209843687; 6602358911; 7404889769; 6506459703; 6603119390; 57221220827; 7003653338; 6507910788; 7102865814; 57208540237,Genetic and Epigenetic Associations with Pre–Chronic Obstructive Pulmonary Disease Lung Function Trajectories,2023,American Journal of Respiratory and Critical Care Medicine,208,10,,1135,1137,2,4,10.1164/rccm.202306-1025LE,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85184992818&doi=10.1164%2frccm.202306-1025LE&partnerID=40&md5=70f2672ef138ff1233dbdf96a0693137,"Wal-yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, West Perth, WA, Australia; Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia; Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia; Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, WA, Australia; Respiratory Medicine, Prince of Wales Hospital, Prince of Wales Clinical School, University of New South Wales, Randwick, NSW, Australia; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway; Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway; Immunology Unit, Biomedicine Department, University of Barcelona, Barcelona, Spain; Institut d’Investigacions Biomediques August Pi i Sunyer–Fundació Clinic Recerca, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain; School of Medicine, University of Tasmania, Hobart, TAS, Australia; School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Wal-yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, P.O. Box 855, West Perth, 6872, WA, Australia","Martino D.J., Wal-yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, West Perth, WA, Australia; Bui D.S., Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Li S., Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom, Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia; Idrose S., Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Perret J., Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Lowe A.J., Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia; Lodge C.J., Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia; Bowatte G., Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Moodley Y., Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, WA, Australia; Thomas P.S., Respiratory Medicine, Prince of Wales Hospital, Prince of Wales Clinical School, University of New South Wales, Randwick, NSW, Australia; Zosky G., Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Holloway J.W., Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Svanes C., Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway, Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway; Faner R., Immunology Unit, Biomedicine Department, University of Barcelona, Barcelona, Spain, Institut d’Investigacions Biomediques August Pi i Sunyer–Fundació Clinic Recerca, Barcelona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain; Walters E.H., Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia, School of Medicine, University of Tasmania, Hobart, TAS, Australia, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia, Wal-yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, P.O. Box 855, West Perth, 6872, WA, Australia; Dharmage S.C., Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia",,"Epigenesis, Genetic; Humans; Lung; Pulmonary Disease, Chronic Obstructive; cytosine; HLA DQA1 antigen; HLA DQB1 antigen; HLA DRB1 antigen; Hox protein; mucin 4; acceleration; Article; chronic obstructive lung disease; comparative study; controlled study; DNA methylation; epigenetics; female; follow up; genome-wide association study; high risk population; human; lung function; male; pathogenesis; pilot study; spirometry; chronic obstructive lung disease; genetic epigenesis; lung",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85184992818
De Rubis G.; Paudel K.R.; Yeung S.; Mohamad S.; Sudhakar S.; Singh S.K.; Gupta G.; Hansbro P.M.; Chellappan D.K.; Oliver B.G.G.; Dua K.,"De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Yeung, Stewart (58822848100); Mohamad, Siddiq (58979414800); Sudhakar, Swathi (57194115158); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Hansbro, Philip Michael (6603119390); Chellappan, Dinesh Kumar (35811890500); Oliver, Brian Gregory George (15919869900); Dua, Kamal (15759138700)",57196257973; 56539588400; 58822848100; 58979414800; 57194115158; 57206711834; 15047988400; 6603119390; 35811890500; 15919869900; 15759138700,18-β-glycyrrhetinic acid-loaded polymeric nanoparticles attenuate cigarette smoke-induced markers of impaired antiviral response in vitro,2024,Pathology Research and Practice,257,,155295,,,,1,10.1016/j.prp.2024.155295,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85189978262&doi=10.1016%2fj.prp.2024.155295&partnerID=40&md5=46d81bb58d49a88cbfbd797af9bf6469,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Department of Applied Mechanics and Biomedical Engineering, Indian Institute of Technology-Madras, Tamil Nadu, Chennai, 600036, India; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India; School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India; School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India; School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia","De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Yeung S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Mohamad S., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Sudhakar S., Department of Applied Mechanics and Biomedical Engineering, Indian Institute of Technology-Madras, Tamil Nadu, Chennai, 600036, India; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Gupta G., Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India, School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India, School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Oliver B.G.G., School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",18-β-glycyrrhetinic acid; Advanced drug delivery; Antiviral response; Cigarette smoke; COPD; Phytoceuticals,"Antiviral Agents; Cell Line; Cigarette Smoking; Epithelial Cells; Glycyrrhetinic Acid; Humans; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Pulmonary Disease, Chronic Obstructive; Smoke; cigarette smoke; cigarette smoke extract; CXCL11 chemokine; gamma interferon inducible protein 10; glycyrrhetinic acid; macrophage inflammatory protein 1alpha; macrophage inflammatory protein 1beta; nanocarrier; polyglactin; polymer nanoparticle; unclassified drug; 18alpha-glycyrrhetinic acid; antivirus agent; glycyrrhetinic acid; nanoparticle; antiviral immunity; Article; BCi-NS1.1 cell line; bronchial cell line; chronic obstructive lung disease; controlled study; drug delivery system; epithelial cell line; human; human cell; immune response; immunity; in vitro study; nanoencapsulation; protein expression; pulmonary antiviral immune response; smoking; cell line; chemistry; chronic obstructive lung disease; cigarette smoking; drug effect; epithelium cell; immunology; smoke; virology",Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85189978262
Girkin J.L.N.; Sokulsky L.A.; Starkey M.R.; Hansbro P.M.; Foster P.S.; Collison A.M.; Mattes J.,"Girkin, Jason L. N. (55978746600); Sokulsky, Leon A. (56638608200); Starkey, Malcolm R. (35811293400); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569); Collison, Adam M. (23995251200); Mattes, Joerg (7005999915)",55978746600; 56638608200; 35811293400; 6603119390; 7201517569; 23995251200; 7005999915,A unique role for IL-13 in inducing esophageal eosinophilia through MID-1 and STAT6,2023,Frontiers in Allergy,4,,1248432,,,,0,10.3389/falgy.2023.1248432,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85177461199&doi=10.3389%2ffalgy.2023.1248432&partnerID=40&md5=b3818e1157d8d36f6d2b8b74c5896dc0,"The Priority Research Centre for Healthy Lungs and The Asthma and Breathing Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; The Priority Research Centre,  and The Asthma and Breathing Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; The Department of Respiratory and Sleep Medicine, John Hunter Children's Hospital, NewcastleNSW, NSW, Australia","Girkin J.L.N., The Priority Research Centre for Healthy Lungs and The Asthma and Breathing Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Sokulsky L.A., The Priority Research Centre,  and The Asthma and Breathing Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Starkey M.R., Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Hansbro P.M., The Priority Research Centre,  and The Asthma and Breathing Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Foster P.S., The Priority Research Centre,  and The Asthma and Breathing Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Collison A.M., The Priority Research Centre for Healthy Lungs and The Asthma and Breathing Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Mattes J., The Priority Research Centre for Healthy Lungs and The Asthma and Breathing Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, The Department of Respiratory and Sleep Medicine, John Hunter Children's Hospital, NewcastleNSW, NSW, Australia",allergy; eosinophilic esophagitis; eosinophils; interleukin 13 (IL-13); midline 1 (Mid1),,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85177461199
Faiz A.; Mahbub R.M.; Boedijono F.S.; Tomassen M.I.; Kooistra W.; Timens W.; Nawijn M.; Hansbro P.M.; Johansen M.D.; Pouwels S.D.; Heijink I.H.; Massip F.; Biase M.S.D.; Schwarz R.F.; Adcock I.M.; Chung K.F.; van der Does A.; Hiemstra P.S.; Goulaouic H.; Xing H.; Abdulai R.; Rinaldis E.D.; Cunoosamy D.; Harel S.; Lederer D.; Nivens M.C.; Wark P.A.; Kerstjens H.A.M.; Hylkema M.N.; Brandsma C.-A.; Berge M.V.D.,"Faiz, Alen (55601365200); Mahbub, Rashad M. (57872243500); Boedijono, Fia Sabrina (58852659100); Tomassen, Milan I. (58852115500); Kooistra, Wierd (36458562800); Timens, Wim (7005755132); Nawijn, Martijn (6506545287); Hansbro, Philip M. (6603119390); Johansen, Matt D. (57202983408); Pouwels, Simon D. (55173550600); Heijink, Irene H. (8593569200); Massip, Florian (55646400800); Biase, Maria Stella de (58852006300); Schwarz, Roland F. (8937694100); Adcock, Ian M. (57201387004); Chung, Kian F. (57208201733); van der Does, Anne (23669741800); Hiemstra, Pieter S. (7004364809); Goulaouic, Helene (6602634972); Xing, Heming (58852220500); Abdulai, Raolat (54960831100); Rinaldis, Emanuele de (25723665400); Cunoosamy, Danen (56008677800); Harel, Sivan (57211027926); Lederer, David (57195118696); Nivens, Michael C. (6506827347); Wark, Peter A. (58166423200); Kerstjens, Huib A.M. (7005932406); Hylkema, Machteld N. (35518936700); Brandsma, Corry-Anke (22833246900); Berge, Maarten van den (56412674600)",55601365200; 57872243500; 58852659100; 58852115500; 36458562800; 7005755132; 6506545287; 6603119390; 57202983408; 55173550600; 8593569200; 55646400800; 58852006300; 8937694100; 57201387004; 57208201733; 23669741800; 7004364809; 6602634972; 58852220500; 54960831100; 25723665400; 56008677800; 57211027926; 57195118696; 6506827347; 58166423200; 7005932406; 35518936700; 22833246900; 56412674600,IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels,2023,American Journal of Respiratory and Critical Care Medicine,208,10,,1075,1087,12,6,10.1164/RCCM.202210-1881OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85179796947&doi=10.1164%2fRCCM.202210-1881OC&partnerID=40&md5=a76cb8938d7ac4fbdfa34e181c4662b4,"Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Groningen Research Institute for Asthma and COPD, Netherlands; Department of Pulmonary Diseases, Netherlands; Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; Centre for Inflammation Faculty of Science Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Centre for Computational Biology, Mines ParisTech, Paris Sciences et Lettres Research University, Paris, France; Cancer and Genome: Bioinformatics, Biostatistics and Epidemiology of Complex Systems Institut Curie, Paris, France; Institut Nationale de la Santeet de la Recherche Medicale U900, Paris, France; Berlin Institute for Medical Systems Biology, Max Delbruck € Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; Institute for Computational Cancer Biology, Center for Integrated Oncology, Cancer Research Center Cologne Essen, Faculty of Medicine, University Hospital Cologne, University of Cologne, Germany; Berlin Institute for the Foundations of Learning and Data, Berlin, Germany; National Heart & Lung Institute, Imperial College London, London, United Kingdom; Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Sanofi Chilly-Mazarin, France; Sanofi, Cambridge, MA, United States; Regeneron Pharmaceuticals, Tarrytown, NY, United States; Centre for Asthma & Respiratory Disease The University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Vaccines, Infection, Viruses & Asthma, Newcastle, NSW, Australia","Faiz A., Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Groningen Research Institute for Asthma and COPD, Netherlands, Department of Pulmonary Diseases, Netherlands, Berlin Institute for the Foundations of Learning and Data, Berlin, Germany, National Heart & Lung Institute, Imperial College London, London, United Kingdom, Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Mahbub R.M., Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Berlin Institute for the Foundations of Learning and Data, Berlin, Germany; Boedijono F.S., Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation Faculty of Science Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia, Berlin Institute for the Foundations of Learning and Data, Berlin, Germany; Tomassen M.I., Groningen Research Institute for Asthma and COPD, Netherlands, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Kooistra W., Groningen Research Institute for Asthma and COPD, Netherlands, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Timens W., Groningen Research Institute for Asthma and COPD, Netherlands, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Nawijn M., Groningen Research Institute for Asthma and COPD, Netherlands, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Hansbro P.M., Centre for Inflammation Faculty of Science Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Johansen M.D., Centre for Inflammation Faculty of Science Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Pouwels S.D., Groningen Research Institute for Asthma and COPD, Netherlands, Department of Pulmonary Diseases, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom, Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Heijink I.H., Groningen Research Institute for Asthma and COPD, Netherlands, Department of Pulmonary Diseases, Netherlands, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom, Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Massip F., Centre for Computational Biology, Mines ParisTech, Paris Sciences et Lettres Research University, Paris, France, Cancer and Genome: Bioinformatics, Biostatistics and Epidemiology of Complex Systems Institut Curie, Paris, France, Institut Nationale de la Santeet de la Recherche Medicale U900, Paris, France; Biase M.S.D., Berlin Institute for Medical Systems Biology, Max Delbruck € Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; Schwarz R.F., Berlin Institute for Medical Systems Biology, Max Delbruck € Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany, Institute for Computational Cancer Biology, Center for Integrated Oncology, Cancer Research Center Cologne Essen, Faculty of Medicine, University Hospital Cologne, University of Cologne, Germany; Adcock I.M.; Chung K.F.; van der Does A.; Hiemstra P.S.; Goulaouic H., Sanofi Chilly-Mazarin, France; Xing H., Sanofi Chilly-Mazarin, France; Abdulai R., Sanofi, Cambridge, MA, United States; Rinaldis E.D., Sanofi, Cambridge, MA, United States; Cunoosamy D., Sanofi, Cambridge, MA, United States; Harel S., Regeneron Pharmaceuticals, Tarrytown, NY, United States; Lederer D., Regeneron Pharmaceuticals, Tarrytown, NY, United States; Nivens M.C., Regeneron Pharmaceuticals, Tarrytown, NY, United States; Wark P.A., Centre for Asthma & Respiratory Disease The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Vaccines, Infection, Viruses & Asthma, Newcastle, NSW, Australia; Kerstjens H.A.M., Groningen Research Institute for Asthma and COPD, Netherlands, Department of Pulmonary Diseases, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom, Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands; Hylkema M.N., Groningen Research Institute for Asthma and COPD, Netherlands, Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Brandsma C.-A., Groningen Research Institute for Asthma and COPD, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Berge M.V.D., Groningen Research Institute for Asthma and COPD, Netherlands, National Heart & Lung Institute, Imperial College London, London, United Kingdom",basal cell; cigarette smoke; COPD; gene expression; IL-33,"Gene Expression Profiling; Humans; Interleukin-33; Pulmonary Disease, Chronic Obstructive; Smokers; Smoking; interleukin 1 receptor like 1 protein; interleukin 33; interleukin 33; adult; aged; airway dynamics; Article; bronchus biopsy; cell differentiation; cell subpopulation; clinical assessment; controlled study; current smoker; environmental exposure; epithelium basal cell; ex-smoker; female; gene expression level; genetic analysis; genetic variability; human; human cell; human tissue; immunohistochemistry; in vitro study; in vivo study; lung parenchyma; male; middle aged; never smoker; phenotype; RNA splicing; signal transduction; single cell RNA seq; smoking cessation; transcriptomics; Western blotting; chronic obstructive lung disease; gene expression profiling; genetics; pathology; smoking",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85179796947
Allam V.S.R.R.; Patel V.K.; De Rubis G.; Paudel K.R.; Gupta G.; Chellappan D.K.; Singh S.K.; Hansbro P.M.; Oliver B.G.G.; Dua K.,"Allam, Venkata Sita Rama Raju (57200203739); Patel, Vyoma K. (57193533009); De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Singh, Sachin Kumar (57206711834); Hansbro, Philip M. (6603119390); Oliver, Brian Gregory George (15919869900); Dua, Kamal (15759138700)",57200203739; 57193533009; 57196257973; 56539588400; 15047988400; 35811890500; 57206711834; 6603119390; 15919869900; 15759138700,Exploring the role of the ocular surface in the lung-eye axis: Insights into respiratory disease pathogenesis,2024,Life Sciences,349,,122730,,,,0,10.1016/j.lfs.2024.122730,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85193618744&doi=10.1016%2fj.lfs.2024.122730&partnerID=40&md5=c6d6ba217ad49bad03371890fcc6c118,"Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123, Broadway, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, 2052, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India; School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia; School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Allam V.S.R.R., Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden, Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden; Patel V.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123, Broadway, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, 2052, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123, Broadway, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Gupta G., Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India, School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Oliver B.G.G., Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia, School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box 123, Broadway, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Environmental pollutants; Inflammation; Lung-eye axis; Microbiome,Animals; Eye; Eye Diseases; Humans; Lung; Microbiota; Respiratory Tract Diseases; anti-SARS-CoV-2 agent; eye drops; glycoprotein; immunoglobulin A; interleukin 10; tumor necrosis factor; Bifidobacterium; brain dysfunction; conjunctivitis; coronavirus disease 2019; Corynebacterium; coughing; dendritic cell; dysbiosis; endothelium cell; epithelium cell; eye; human; Human adenovirus D; hypersensitivity; immunocompetent cell; immunology; inflammation; lacrimal duct; lung; macrophage; microbiome; optic nerve; pathogenesis; Pneumovirus; respiratory tract disease; reverse transcription polymerase chain reaction; Review; Staphylococcus; stem cell mobilization; Streptococcus; animal; etiology; eye disease; lung; microbiology; microflora; pathophysiology; physiology; respiratory tract disease; virology,Review,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85193618744
Martins Costa Gomes G.; Da Silva Sena C.R.; Murphy V.E.; Hansbro P.M.; Starkey M.R.; Gibson P.G.; Mattes J.; Collison A.M.,"Martins Costa Gomes, Gabriela (57222158030); Da Silva Sena, Carla Rebeca (57215826825); Murphy, Vanessa E (7006804832); Hansbro, Philip M (6603119390); Starkey, Malcolm R (35811293400); Gibson, Peter G (7202414199); Mattes, Joerg (7005999915); Collison, Adam M (23995251200)",57222158030; 57215826825; 7006804832; 6603119390; 35811293400; 7202414199; 7005999915; 23995251200,Cord blood granulocyte levels are associated with severe bronchiolitis in the first year of life,2024,Clinical and Translational Immunology,13,9,e70004,,,,0,10.1002/cti2.70004,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85204894821&doi=10.1002%2fcti2.70004&partnerID=40&md5=283287ff0b6242c9e6ec9d38fe5d93c4,"Asthma and Breathing Program, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Paediatric Respiratory & Sleep Medicine Department, John Hunter Children's Hospital, Newcastle, NSW, Australia","Martins Costa Gomes G., Asthma and Breathing Program, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia; Da Silva Sena C.R., Asthma and Breathing Program, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia; Murphy V.E., Asthma and Breathing Program, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Starkey M.R., Department of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC, Australia; Gibson P.G., Asthma and Breathing Program, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Mattes J., Asthma and Breathing Program, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia, Paediatric Respiratory & Sleep Medicine Department, John Hunter Children's Hospital, Newcastle, NSW, Australia; Collison A.M., Asthma and Breathing Program, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, School of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, Australia",bronchiolitis; cord blood; eosinophil; neutrophil,CD16 antigen; chemokine receptor CCR3; receptor type tyrosine protein phosphatase C; salbutamol; adult; Article; asthma; bronchiolitis; cesarean section; cohort analysis; controlled study; disease association; eosinophil; eosinophil count; female; fetus heart; fetus heart rate; gestational age; granulocyte; high flow nasal cannula therapy; hospitalization; human; infant; labor; major clinical study; male; maternal smoking; neutrophil; pregnancy; season; umbilical cord blood,Article,Final,,Scopus,2-s2.0-85204894821
McDonald V.M.; Archbold G.; Beyene T.; Brew B.K.; Franklin P.; Gibson P.G.; Harrington J.; Hansbro P.M.; Johnston F.H.; Robinson P.D.; Sutherland M.; Yates D.; Zosky G.R.; Abramson M.J.,"McDonald, Vanessa M. (12242373300); Archbold, Gregory (58575714400); Beyene, Tesfalidet (56721378300); Brew, Bronwyn K. (56431298400); Franklin, Peter (7006044422); Gibson, Peter G. (7202414199); Harrington, John (57216912539); Hansbro, Philip M. (6603119390); Johnston, Fay H. (7101845773); Robinson, Paul D. (12794088900); Sutherland, Michael (25925391000); Yates, Deborah (7103213555); Zosky, Graeme R. (6506459703); Abramson, Michael J. (57200582849)",12242373300; 58575714400; 56721378300; 56431298400; 7006044422; 7202414199; 57216912539; 6603119390; 7101845773; 12794088900; 25925391000; 7103213555; 6506459703; 57200582849,Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement,2023,Respirology,28,11,,1023,1035,12,4,10.1111/resp.14593,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85171193836&doi=10.1111%2fresp.14593&partnerID=40&md5=c98178ce8868f3df56a83ca45f3ac26c,"College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia; Asthma and Breathing Research Program, The Hunter Medical Research Institute (HMRI), New Lambton, NSW, Australia; Department of Sleep and Respiratory Medicine, Hunter New England Local Health District, Newcastle, NSW, Australia; National Perinatal Epidemiology and Biostatistics Unit, Centre for Big Data Research in Health, Discipline of Women's Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia; School of Population and Global Health, The University of Western Australia, Perth, WA, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia; Immune Health, Hunter Medical Research Institute and The University of Newcastle, Callaghan, NSW, Australia; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, QLD, Australia; Children's Health and Environment Program, Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia; Epworth Richmond, Richmond, VIC, Australia; Department of Thoracic Medicine, St Vincent's Hospital, Darlinghurst, NSW, Australia; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia; Tasmanian School of Medicine, University of Tasmania, Hobart, TAS, Australia; School of Public Health & Preventive Medicine, Monash University, Melbourne, VIC, Australia","McDonald V.M., College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia, Asthma and Breathing Research Program, The Hunter Medical Research Institute (HMRI), New Lambton, NSW, Australia, Department of Sleep and Respiratory Medicine, Hunter New England Local Health District, Newcastle, NSW, Australia; Archbold G., Asthma and Breathing Research Program, The Hunter Medical Research Institute (HMRI), New Lambton, NSW, Australia; Beyene T., College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia, Asthma and Breathing Research Program, The Hunter Medical Research Institute (HMRI), New Lambton, NSW, Australia; Brew B.K., National Perinatal Epidemiology and Biostatistics Unit, Centre for Big Data Research in Health, Discipline of Women's Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia; Franklin P., School of Population and Global Health, The University of Western Australia, Perth, WA, Australia; Gibson P.G., College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia, Asthma and Breathing Research Program, The Hunter Medical Research Institute (HMRI), New Lambton, NSW, Australia, Department of Sleep and Respiratory Medicine, Hunter New England Local Health District, Newcastle, NSW, Australia; Harrington J., Asthma and Breathing Research Program, The Hunter Medical Research Institute (HMRI), New Lambton, NSW, Australia, Department of Sleep and Respiratory Medicine, Hunter New England Local Health District, Newcastle, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia, Immune Health, Hunter Medical Research Institute and The University of Newcastle, Callaghan, NSW, Australia; Johnston F.H., Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; Robinson P.D., Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, QLD, Australia, Children's Health and Environment Program, Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia; Sutherland M., Epworth Richmond, Richmond, VIC, Australia; Yates D., Department of Thoracic Medicine, St Vincent's Hospital, Darlinghurst, NSW, Australia, School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia; Zosky G.R., Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia, Tasmanian School of Medicine, University of Tasmania, Hobart, TAS, Australia; Abramson M.J., School of Public Health & Preventive Medicine, Monash University, Melbourne, VIC, Australia",asthma; exacerbation; impacts risk; landscape fire smoke; management; mitigation; pathogenesis,Adult; Aged; Asthma; Australia; Australian Aboriginal and Torres Strait Islander Peoples; Child; Female; Humans; New Zealand; Pregnancy; Smoke; air quality; Article; asthma; Australia and New Zealand; awareness; clinical feature; disease severity; environmental exposure; fire smoke; human; medical society; prevalence; risk factor; smoke; adult; aged; asthma; Australia; child; female; New Zealand; Oceanic ancestry group; pregnancy,Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85171193836
Kannaujiya V.K.; De Rubis G.; Paudel K.R.; Manandhar B.; Chellappan D.K.; Singh S.K.; MacLoughlin R.; Gupta G.; Xenaki D.; Kumar P.; Hansbro P.M.; Oliver B.G.G.; Wich P.R.; Dua K.,"Kannaujiya, Vinod Kumar (57219713766); De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Manandhar, Bikash (57204448260); Chellappan, Dinesh Kumar (35811890500); Singh, Sachin Kumar (57206711834); MacLoughlin, Ronan (57212263206); Gupta, Gaurav (15047988400); Xenaki, Dikaia (6507411538); Kumar, Pradeep (7403960277); Hansbro, Philip Michael (6603119390); Oliver, Brian Gregory George (15919869900); Wich, Peter Richard (7801599835); Dua, Kamal (15759138700)",57219713766; 57196257973; 56539588400; 57204448260; 35811890500; 57206711834; 57212263206; 15047988400; 6507411538; 7403960277; 6603119390; 15919869900; 7801599835; 15759138700,Anticancer activity of NFκB decoy oligonucleotide-loaded nanoparticles against human lung cancer,2023,Journal of Drug Delivery Science and Technology,82,,104328,,,,16,10.1016/j.jddst.2023.104328,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150921263&doi=10.1016%2fj.jddst.2023.104328&partnerID=40&md5=840a9bdf7ef45baacdb8078795bed25f,"School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Australian Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; Research and Development, Aerogen, IDA Business Park, Dangan, Galway, H91HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Leinster, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Leinster, Dublin, D02 PN40, Ireland; School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, 302017, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Uttarakhand, Dehradun, 248007, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical & Technical Sciences, Saveetha University, Chennai, 602105, India; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Kannaujiya V.K., School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia, Australian Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; MacLoughlin R., Research and Development, Aerogen, IDA Business Park, Dangan, Galway, H91HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Leinster, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Leinster, Dublin, D02 PN40, Ireland; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, 302017, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Uttarakhand, Dehradun, 248007, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical & Technical Sciences, Saveetha University, Chennai, 602105, India; Xenaki D., Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Kumar P., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Oliver B.G.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Wich P.R., School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia, Australian Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",AcDex nanoparticles; Decoy oligodeoxynucleotides; Lung cancer; Migration; NFκB; NSCLC; Proliferation; Pulmonary delivery,crystal violet; decoy oligodeoxynucleotide; dextran; immunoglobulin enhancer binding protein; mixed lineage kinase; mixed lineage kinase domain like; nanoparticle; oligodeoxynucleotide; receptor interacting protein serine threonine kinase; receptor interacting protein serine threonine kinase 2; receptor interacting protein serine threonine kinase 3; tumor necrosis factor; unclassified drug; A-549 cell line; anti colony formation activity; antineoplastic activity; antiproliferative activity; apoptosis; Article; BEAS-2B cell line; cell proliferation; cell viability; centrifugation; colony formation; controlled study; drug activity; human; human cell; hydrophilicity; migration inhibition; mRNA expression level; MTT assay; nanoencapsulation; necroptosis; non small cell lung cancer; particle size; pH; photon correlation spectroscopy; proof of concept; real time polymerase chain reaction; scanning electron microscopy; static electricity; transwell assay; wound healing assay; zeta potential,Article,Final,,Scopus,2-s2.0-85150921263
Idrees S.; Paudel K.R.; Sadaf T.; Hansbro P.M.,"Idrees, Sobia (55429771900); Paudel, Keshav Raj (56539588400); Sadaf, Tayyaba (58669468700); Hansbro, Philip M. (6603119390)",55429771900; 56539588400; 58669468700; 6603119390,Uncovering domain motif interactions using high-throughput protein–protein interaction detection methods,2024,FEBS Letters,598,7,,725,742,17,1,10.1002/1873-3468.14841,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85186909933&doi=10.1002%2f1873-3468.14841&partnerID=40&md5=88633a025d51fa2c4edca71f8daa52cc,"School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia; Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia","Idrees S., School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia, Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia; Sadaf T., Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology Sydney, Australia",domain–motif interactions; high-throughput methods; PPI databases; protein–protein interactions,"Databases, Protein; Protein Interaction Domains and Motifs; Protein Interaction Mapping; Proteins; protein; affinity purification; amino acid sequence; bioinformatics; complex formation; domain motif interaction; fractionation; high throughput sequencing; human; mass spectrometry; nonhuman; prediction; protein assembly; protein binding; protein database; protein domain; protein protein interaction; proteomics; Review; short linear motif; yeast cell; metabolism; protein domain",Review,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85186909933
Kokkinis S.; Singh M.; Paudel K.R.; De Rubis G.; Bani Saeid A.; Jessamine V.; Datsyuk J.; Singh S.K.; Vishwas S.; Adams J.; Hansbro P.M.; Oliver B.; Gupta G.; Dureja H.; Dua K.,"Kokkinis, Sofia (58631105400); Singh, Manisha (57214312793); Paudel, Keshav Raj (56539588400); De Rubis, Gabriele (57196257973); Bani Saeid, Ayeh (58635250800); Jessamine, Victoria (58868227200); Datsyuk, Jessica (58631184200); Singh, Sachin Kumar (57206711834); Vishwas, Sukriti (57216932631); Adams, Jon (35584313300); Hansbro, Philip M. (6603119390); Oliver, Brian (15919869900); Gupta, Gaurav (15047988400); Dureja, Harish (6507566948); Dua, Kamal (15759138700)",58631105400; 57214312793; 56539588400; 57196257973; 58635250800; 58868227200; 58631184200; 57206711834; 57216932631; 35584313300; 6603119390; 15919869900; 15047988400; 6507566948; 15759138700,Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges,2024,Food Bioscience,58,,103761,,,,3,10.1016/j.fbio.2024.103761,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185572425&doi=10.1016%2fj.fbio.2024.103761&partnerID=40&md5=99bdd92291789caf7d124aaad147f0b5,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Haryana, Rohtak, 124001, India","Kokkinis S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Bani Saeid A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Jessamine V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Datsyuk J., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; Vishwas S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; Adams J., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Oliver B., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India, School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India, Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Haryana, Rohtak, 124001, India; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Antioxidants; Drug delivery; Inflammation; Lung cancer; Nanoparticles; Pulmonary disorders,,Review,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85185572425
Cooper G.E.; Mayall J.; Donovan C.; Haw T.J.; Budden K.F.; Hansbro N.G.; Blomme E.E.; Maes T.; Kong C.W.; Horvat J.C.; Khakoo S.I.; Wilkinson T.M.A.; Hansbro P.M.; Staples K.J.,"Cooper, Grace E. (57191612804); Mayall, Jemma (55607222700); Donovan, Chantal (55357105200); Haw, Tatt J. (56625918900); Budden, Kurtis F. (57191417986); Hansbro, Nicole G. (15055862300); Blomme, Evy E. (57194550217); Maes, Tania (6603579162); Kong, Chia Wei (57242449200); Horvat, Jay C. (9942405300); Khakoo, Salim I. (6602868240); Wilkinson, Tom M A (7202351234); Hansbro, Philip M. (6603119390); Staples, Karl J. (6701613987)",57191612804; 55607222700; 55357105200; 56625918900; 57191417986; 15055862300; 57194550217; 6603579162; 57242449200; 9942405300; 6602868240; 7202351234; 6603119390; 6701613987,Antiviral Responses of Tissue-resident CD49a+ Lung Natural Killer Cells Are Dysregulated in Chronic Obstructive Pulmonary Disease,2023,American journal of respiratory and critical care medicine,207,5,,553,565,12,10,10.1164/rccm.202205-0848OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85145997245&doi=10.1164%2frccm.202205-0848OC&partnerID=40&md5=742fb9076b5c4d6d850c91d2b375465f,"Clinical & Experimental Sciences, Southampton General Hospital, Southampton, United Kingdom; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; NIHR Southampton Biomedical Research Centre; Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom","Cooper G.E., Clinical & Experimental Sciences, Southampton General Hospital, Southampton, United Kingdom; Mayall J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Haw T.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Budden K.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Blomme E.E., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Maes T., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Kong C.W., Clinical & Experimental Sciences, Southampton General Hospital, Southampton, United Kingdom; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Khakoo S.I., Clinical & Experimental Sciences, Southampton General Hospital, Southampton, United Kingdom; Wilkinson T.M.A., Clinical & Experimental Sciences, Southampton General Hospital, Southampton, United Kingdom, NIHR Southampton Biomedical Research Centre, Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Staples K.J., Clinical & Experimental Sciences, Southampton General Hospital, Southampton, United Kingdom, NIHR Southampton Biomedical Research Centre, Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom",COPD; human influenza; innate immunity; mucosal immunity,"Animals; Antiviral Agents; Humans; Influenza, Human; Integrin alpha1; Integrin alpha2; Killer Cells, Natural; Lung; Lung Diseases; Mice; Pulmonary Disease, Chronic Obstructive; alpha1 integrin; alpha2 integrin; antivirus agent; animal; chronic obstructive lung disease; genetics; human; influenza; lung; lung disease; metabolism; mouse; natural killer cell",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85145997245
Narayana J.K.; Mac Aogáin M.; Hansbro P.M.; Chotirmall S.H.,"Narayana, Jayanth Kumar (57217280956); Mac Aogáin, Micheál (33667783800); Hansbro, Philip M. (6603119390); Chotirmall, Sanjay H. (15757175700)",57217280956; 33667783800; 6603119390; 15757175700,The bronchiectasis microbiome: current understanding and treatment implications,2024,Current Opinion in Pulmonary Medicine,,,10.1097/MCP.0000000000001131,,,,0,10.1097/MCP.0000000000001131,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85208973512&doi=10.1097%2fMCP.0000000000001131&partnerID=40&md5=d21d68ee5fa84191154c61b9e15f4617,"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Department of Biochemistry, St. James's Hospital, Dublin, Ireland; School of Medicine, Trinity College, Dublin, Ireland; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore, Singapore","Narayana J.K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Mac Aogáin M., Department of Biochemistry, St. James's Hospital, Dublin, Ireland, School of Medicine, Trinity College, Dublin, Ireland; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore, Singapore",endotyping; host-microbiome interactions; inflammation; microbiome; multiomics,adult; bronchiectasis; commensal; diagnosis; DNA sequencing; drug therapy; Haemophilus influenzae; host microbe interaction; human; inflammation; microbiome; multiomics; mycobiome; nonhuman; phenotype; Pseudomonas aeruginosa; review; therapy; treatment outcome; treatment response; virome,Review,Article in press,,Scopus,2-s2.0-85208973512
Farrell L.A.; O’Rourke M.B.; Padula M.P.; Souza-Fonseca-Guimaraes F.; Caramori G.; Wark P.A.B.; Dharmage S.C.; Hansbro P.M.,"Farrell, Luke A. (59344721400); O’Rourke, Matthew B. (56735635000); Padula, Matthew P. (24462195700); Souza-Fonseca-Guimaraes, Fernando (52564361600); Caramori, Gaetano (7003847659); Wark, Peter A. B. (58166423200); Dharmage, Shymali C. (57208540237); Hansbro, Phillip M. (6603119390)",59344721400; 56735635000; 24462195700; 52564361600; 7003847659; 58166423200; 57208540237; 6603119390,The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment,2024,Proteomes,12,3,23,,,,0,10.3390/proteomes12030023,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85205034165&doi=10.3390%2fproteomes12030023&partnerID=40&md5=22b7dd945f3e9cfd8dd19d3e47633f80,"School of Life Sciences, Faculty of Science, University of Technology Sydney, Centre for Inflammation, Ultimo, 2007, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, 4102, QLD, Australia; Department of Medicine and Surgery, University of Parma, Parma, 43126, Italy; School of Translational Medicine, Monash University, Melbourne, 3000, VIC, Australia; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, 3000, VIC, Australia","Farrell L.A., School of Life Sciences, Faculty of Science, University of Technology Sydney, Centre for Inflammation, Ultimo, 2007, NSW, Australia; O’Rourke M.B., School of Life Sciences, Faculty of Science, University of Technology Sydney, Centre for Inflammation, Ultimo, 2007, NSW, Australia; Padula M.P., School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Souza-Fonseca-Guimaraes F., Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, 4102, QLD, Australia; Caramori G., Department of Medicine and Surgery, University of Parma, Parma, 43126, Italy; Wark P.A.B., School of Translational Medicine, Monash University, Melbourne, 3000, VIC, Australia; Dharmage S.C., Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, 3000, VIC, Australia; Hansbro P.M., School of Life Sciences, Faculty of Science, University of Technology Sydney, Centre for Inflammation, Ultimo, 2007, NSW, Australia",COPD; emphysema; pathogenesis; proteomics; treatment discovery and development,,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85205034165
Colarusso C.; Terlizzi M.; Falanga A.; Stathopoulos G.; De Lucia L.; Hansbro P.M.; Pinto A.; Sorrentino R.,"Colarusso, Chiara (57191250457); Terlizzi, Michela (55605037100); Falanga, Anna (58249782700); Stathopoulos, Georgious (57210856789); De Lucia, Luigi (58648497400); Hansbro, Phillip M. (6603119390); Pinto, Aldo (7402306499); Sorrentino, Rosalinda (14065472200)",57191250457; 55605037100; 58249782700; 57210856789; 58648497400; 6603119390; 7402306499; 14065472200,Absent in melanoma 2 (AIM2) positive profile identifies a poor prognosis of lung adenocarcinoma patients,2023,International Immunopharmacology,124,,110990,,,,4,10.1016/j.intimp.2023.110990,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85174182942&doi=10.1016%2fj.intimp.2023.110990&partnerID=40&md5=3a2149c52ca9ec7b1bcdfe1c7820dc33,"Department of Pharmacy, University of Salerno, Italy; Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Patras, Greece; Centre for Inflammation, Centenary Institute and University of Technology Sydney (UTS), School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia","Colarusso C., Department of Pharmacy, University of Salerno, Italy; Terlizzi M., Department of Pharmacy, University of Salerno, Italy; Falanga A., Department of Pharmacy, University of Salerno, Italy; Stathopoulos G., Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Patras, Greece; De Lucia L., Department of Pharmacy, University of Salerno, Italy; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney (UTS), School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Pinto A., Department of Pharmacy, University of Salerno, Italy; Sorrentino R., Department of Pharmacy, University of Salerno, Italy",AIM2 inflammasome; Lung adenocarcinoma; Smoke; Smoking habit; Transcriptomic signature,"Adenocarcinoma of Lung; Animals; DNA-Binding Proteins; Humans; Inflammasomes; Lung Neoplasms; Melanoma; Mice; Prognosis; Tumor Microenvironment; absent in melanoma 2 protein; inflammasome; messenger RNA; unclassified drug; AIM2 protein, human; DNA binding protein; inflammasome; adult; aged; animal experiment; animal model; animal tissue; Article; cancer patient; cancer prognosis; cancer staging; controlled study; dendritic cell; ex-smoker; female; human; human cell; human tissue; lung adenocarcinoma; male; middle aged; mouse; mRNA expression level; non-smoker; nonhuman; protein expression level; regulatory T lymphocyte; smoking; smoking cessation; transcriptomics; upregulation; very elderly; animal; genetics; lung adenocarcinoma; lung tumor; melanoma; metabolism; prognosis; tumor microenvironment",Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85174182942
Imran M.; Insaf A.; Hasan N.; Sugandhi V.V.; Shrestha D.; Paudel K.R.; Jha S.K.; Hansbro P.M.; Dua K.; Devkota H.P.; Mohammed Y.,"Imran, Mohammad (57209466043); Insaf, Areeba (57211627631); Hasan, Nazeer (58494592400); Sugandhi, Vrushabh V. (57475497600); Shrestha, Deumaya (58238297200); Paudel, Keshav Raj (56539588400); Jha, Saurav Kumar (57210712565); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Devkota, Hari Prasad (24775939500); Mohammed, Yousuf (56116912300)",57209466043; 57211627631; 58494592400; 57475497600; 58238297200; 56539588400; 57210712565; 6603119390; 15759138700; 24775939500; 56116912300,Exploring the Remarkable Chemotherapeutic Potential of Polyphenolic Antioxidants in Battling Various Forms of Cancer,2023,Molecules,28,8,3475,,,,22,10.3390/molecules28083475,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85158140032&doi=10.3390%2fmolecules28083475&partnerID=40&md5=6218fff6ee6494dc017f47dabc22fa69,"Therapeutics Research Group, Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, QLD, Australia; Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Department of Pharmaceutics, Y.B. Chavan College of Pharmacy, Aurangabad, 431001, India; Department of Bioscience, Mokp o National University, Muna, 58554, South Korea; Centre of Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Biomedicine, Health & Life Convergence Sciences, Mokpo National University, Muna, 58554, South Korea; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto, 862-0973, Japan; Pharmacy Program, Gandaki University, Pokhara, 33700, Nepal; School of Pharmacy, The University of Queensland, Brisbane, 4102, QLD, Australia","Imran M., Therapeutics Research Group, Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, QLD, Australia; Insaf A., Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Hasan N., Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Sugandhi V.V., Department of Pharmaceutics, Y.B. Chavan College of Pharmacy, Aurangabad, 431001, India; Shrestha D., Department of Bioscience, Mokp o National University, Muna, 58554, South Korea; Paudel K.R., Centre of Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Jha S.K., Department of Biomedicine, Health & Life Convergence Sciences, Mokpo National University, Muna, 58554, South Korea; Hansbro P.M., Centre of Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto, 862-0973, Japan, Pharmacy Program, Gandaki University, Pokhara, 33700, Nepal; Mohammed Y., Therapeutics Research Group, Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, QLD, Australia, School of Pharmacy, The University of Queensland, Brisbane, 4102, QLD, Australia",anticancer; antioxidant; combination therapy; flavonoids; nanotechnology,Antioxidants; Flavonoids; Humans; Lipids; Neoplasms; Phytochemicals; antioxidant; flavonoid; lipid; phytochemical; human; neoplasm,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85158140032
Nucera F.; Bonina L.; Cipolla A.; Pirina P.; Hansbro P.M.; Adcock I.M.; Caramori G.,"Nucera, Francesco (57202946185); Bonina, Letterio (7003804356); Cipolla, Antonino (58120729700); Pirina, Pietro (57189226636); Hansbro, Philip M. (6603119390); Adcock, Ian M. (7007066538); Caramori, Gaetano (7003847659)",57202946185; 7003804356; 58120729700; 57189226636; 6603119390; 7007066538; 7003847659,Poxviridae Pneumonia,2024,Advances in Experimental Medicine and Biology,1451,,,183,204,21,1,10.1007/978-3-031-57165-7_12,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85194352628&doi=10.1007%2f978-3-031-57165-7_12&partnerID=40&md5=3086c2372193d267b6472d5b2471dfb7,"Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università degli Studi di Messina, Messina, Italy; Dipartimento di Patologia delle Malattie Umane “G. Barresi”, Università degli Studi di Messina, Messina, Italy; Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Catania, Catania, Italy; Dipartimento di Medicina, Chirurgia e Farmacia, Università degli Studi di Sassari, Sassari, Italy; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Medicine and Surgery, University of Parma, Parma, Italy","Nucera F., Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università degli Studi di Messina, Messina, Italy; Bonina L., Dipartimento di Patologia delle Malattie Umane “G. Barresi”, Università degli Studi di Messina, Messina, Italy; Cipolla A., Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Catania, Catania, Italy; Pirina P., Dipartimento di Medicina, Chirurgia e Farmacia, Università degli Studi di Sassari, Sassari, Italy; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Adcock I.M., Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Caramori G., Department of Medicine and Surgery, University of Parma, Parma, Italy",Cowpox; MPXV; Smallpox; Vaccinia; Variola,"Animals; Antiviral Agents; Humans; Pneumonia, Viral; Poxviridae; Poxviridae Infections; Smallpox; Vaccinia virus; Variola virus; brincidofovir; cidofovir; dexamethasone; smallpox vaccine; tecovirimat; antivirus agent; adult respiratory distress syndrome; anemia; Chlamydia trachomatis; dyspnea; fever; human; immune evasion; immunofluorescence; immunoglobulin deficiency; immunosuppressive treatment; leukocytosis; Monkeypox virus; Orthopoxvirus; pneumonia; Poxviridae; skin defect; Smallpox virus; thrombocytopenia; Treponema pallidum; vaccination; Vaccinia virus; animal; complication; drug therapy; genetics; immunology; pathogenicity; physiology; Poxviridae; poxvirus infection; prevention and control; smallpox; virology; virus pneumonia",Book chapter,Final,,Scopus,2-s2.0-85194352628
Idrees S.; Paudel K.R.; Hansbro P.M.,"Idrees, Sobia (55429771900); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390)",55429771900; 56539588400; 6603119390,Prediction of motif-mediated viral mimicry through the integration of host–pathogen interactions,2024,Archives of Microbiology,206,3,94,,,,2,10.1007/s00203-024-03832-9,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85184794450&doi=10.1007%2fs00203-024-03832-9&partnerID=40&md5=d4fb8ea6d1f5ac0a287366afadf35c25,"School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia; Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and the University of Technology Sydney, Sydney, NSW, Australia","Idrees S., School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia, Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and the University of Technology Sydney, Sydney, NSW, Australia; Paudel K.R., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and the University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and the University of Technology Sydney, Sydney, NSW, Australia",Bioinformatics; Short linear motifs; Viral mimicry; Virus-host interactions,cell protein; epidermal growth factor receptor 4; viral protein; affinity purification; Article; bioinformatics; Bluetongue orbivirus; controlled study; down regulation; Epstein Barr virus; gene ontology; high throughput screening; Human coronavirus HKU1; Human coronavirus OC43; Human cytomegalovirus; Human herpesvirus 8; Human immunodeficiency virus 1; Human immunodeficiency virus 2; Human papillomavirus type 16; Human papillomavirus type 18; Human papillomavirus type 3; Human papillomavirus type 31; Human papillomavirus type 33; Human T-lymphotropic virus 1; Influenza A virus; Influenza A virus (H1N1); mass spectrometry; molecular mimicry; nonhuman; prediction; protein domain; protein motif; protein protein interaction; Rous sarcoma virus; Semliki Forest virus; Severe acute respiratory syndrome coronavirus 2; signal transduction; Simian foamy virus; two hybrid system; virus cell interaction; Zika virus,Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85184794450
Gadhave D.G.; Sugandhi V.V.; Jha S.K.; Nangare S.N.; Gupta G.; Singh S.K.; Dua K.; Cho H.; Hansbro P.M.; Paudel K.R.,"Gadhave, Dnyandev G. (57205302325); Sugandhi, Vrashabh V. (57475497600); Jha, Saurav Kumar (57210712565); Nangare, Sopan N. (57208781039); Gupta, Gaurav (15047988400); Singh, Sachin Kumar (57206711834); Dua, Kamal (15759138700); Cho, Hyunah (47961004600); Hansbro, Philip M. (6603119390); Paudel, Keshav Raj (56539588400)",57205302325; 57475497600; 57210712565; 57208781039; 15047988400; 57206711834; 15759138700; 47961004600; 6603119390; 56539588400,Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance,2024,Ageing Research Reviews,99,,102357,,,,9,10.1016/j.arr.2024.102357,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195401929&doi=10.1016%2fj.arr.2024.102357&partnerID=40&md5=101687dbcbf94c8f1e36c1fec7b9ed0d,"Department of Pharmaceutics, Dattakala Shikshan Sanstha's, Dattakala College of Pharmacy (Affiliated to Savitribai Phule Pune University), Swami Chincholi, Daund, Maharashtra, Pune, 413130, India; College of Pharmacy & Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, 11439, NY, United States; Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Department of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra, Dhule, 425405, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Chitkara College of Pharmacy, Chitkara University, Punjab, Rajpura, 140401, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, Australia","Gadhave D.G., Department of Pharmaceutics, Dattakala Shikshan Sanstha's, Dattakala College of Pharmacy (Affiliated to Savitribai Phule Pune University), Swami Chincholi, Daund, Maharashtra, Pune, 413130, India, College of Pharmacy & Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, 11439, NY, United States; Sugandhi V.V., Department of Pharmaceutics, Dattakala Shikshan Sanstha's, Dattakala College of Pharmacy (Affiliated to Savitribai Phule Pune University), Swami Chincholi, Daund, Maharashtra, Pune, 413130, India, College of Pharmacy & Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, 11439, NY, United States; Jha S.K., Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Nangare S.N., Department of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra, Dhule, 425405, India; Gupta G., Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates, Chitkara College of Pharmacy, Chitkara University, Punjab, Rajpura, 140401, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Dua K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Cho H., College of Pharmacy & Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, 11439, NY, United States; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, Australia; Paudel K.R., Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India, Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, Australia",Biomaterials; Blood-brain barrier; Cellular mechanisms of neurodegeneration; Neurodegenerative disorders; Novel therapeutic approaches,Animals; Blood-Brain Barrier; Clinical Relevance; Humans; Neurodegenerative Diseases; biomaterial; gene therapy agent; monoclonal antibody; neuroprotective agent; protein; Alzheimer disease; amyotrophic lateral sclerosis; blood brain barrier; blood cerebrospinal fluid barrier; brain mitochondrion; brain tumor; cell activation; clinical significance; degenerative disease; disorders of mitochondrial functions; drug delivery system; gene therapy; human; Huntington chorea; immunotherapy; microglia; molecular pathology; multiple sclerosis; nervous system inflammation; nonhuman; oxidative stress; Parkinson disease; protein aggregation; protein misfolding; Review; animal; degenerative disease; drug effect; drug therapy; metabolism; pathology; therapy,Review,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85195401929
De Rubis G.; Paudel K.R.; Yeung S.; Agarwal V.; Hansbro P.M.; Oliver B.G.G.; Dua K.,"De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Yeung, Stewart (58822848100); Agarwal, Vipul (53981137700); Hansbro, Philip Michael (6603119390); Oliver, Brian Gregory George (15919869900); Dua, Kamal (15759138700)",57196257973; 56539588400; 58822848100; 53981137700; 6603119390; 15919869900; 15759138700,Ribavirin attenuates carcinogenesis by downregulating IL-6 and IL-8 in vitro in human lung adenocarcinoma,2024,Pathology Research and Practice,253,,155038,,,,6,10.1016/j.prp.2023.155038,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85179812535&doi=10.1016%2fj.prp.2023.155038&partnerID=40&md5=a33ef1e80f4874cfe5d49e8c429aa6eb,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Cluster for Advanced Macromolecular Design (CAMD), School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia","De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Yeung S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Agarwal V., Cluster for Advanced Macromolecular Design (CAMD), School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Oliver B.G.G., School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",Drug repurposing; IL-6; IL-8; Interleukins; Lung cancer; Ribavirin,Adenocarcinoma of Lung; Carcinogenesis; Humans; Interleukin-6; Interleukin-8; Lung Neoplasms; Ribavirin; interleukin 6; interleukin 8; ribavirin; interleukin 6; interleukin 8; ribavirin; A-549 cell line; antineoplastic activity; Article; cancer therapy; carcinogenesis; controlled study; down regulation; drug repositioning; drug use; human; human cell; in vitro study; lung adenocarcinoma; protein expression; carcinogenesis; lung tumor; pathology,Article,Final,,Scopus,2-s2.0-85179812535
Tu J.; Li W.; Hansbro P.M.; Yan Q.; Bai X.; Donovan C.; Kim R.Y.; Galvao I.; Das A.; Yang C.; Zou J.; Diwan A.,"Tu, Ji (57191420626); Li, Wentian (57219289722); Hansbro, Philip M. (6603119390); Yan, Qi (36464568800); Bai, Xupeng (56496091100); Donovan, Chantal (55357105200); Kim, Richard Y. (35810406900); Galvao, Izabela (56656390800); Das, Abhirup (57211301247); Yang, Cao (7407030349); Zou, Jun (35274067800); Diwan, Ashish (35510380300)",57191420626; 57219289722; 6603119390; 36464568800; 56496091100; 55357105200; 35810406900; 56656390800; 57211301247; 7407030349; 35274067800; 35510380300,Smoking and tetramer tryptase accelerate intervertebral disc degeneration by inducing METTL14-mediated DIXDC1 m6 modification,2023,Molecular Therapy,31,8,,2524,2542,18,13,10.1016/j.ymthe.2023.06.010,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85164689653&doi=10.1016%2fj.ymthe.2023.06.010&partnerID=40&md5=ac20e726677bf22c2a5f9737dd04f7ff,"Spine Labs, St. George & Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Orthopedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China; Center for Innovation and Translational Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China; Department of Orthopedic Surgery, Wuhan Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China; Spine Service, Department of Orthopedic Surgery, St. George Hospital, Kogarah, NSW, Australia","Tu J., Spine Labs, St. George & Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; Li W., Spine Labs, St. George & Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; Hansbro P.M., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Yan Q., Department of Orthopedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China; Bai X., Center for Innovation and Translational Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China; Donovan C., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Kim R.Y., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Galvao I., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Das A., Spine Labs, St. George & Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; Yang C., Department of Orthopedic Surgery, Wuhan Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China; Zou J., Department of Orthopedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China; Diwan A., Spine Labs, St. George & Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia, Spine Service, Department of Orthopedic Surgery, St. George Hospital, Kogarah, NSW, Australia",intervertebral disc; low back pain; mast cells; smoking; spine,"Animals; Intervertebral Disc Degeneration; Intracellular Signaling Peptides and Proteins; Mice; Nucleus Pulposus; Smoking; Tryptases; Wnt Signaling Pathway; 6 n methyladenosine; messenger RNA; methyltransferase; methyltransferase 14; tetramer tryptase; tryptase; unclassified drug; Dixdc1 protein, mouse; signal peptide; tryptase; 3' untranslated region; animal experiment; animal model; animal tissue; Article; C57BL 6 mouse; cell aging; controlled study; DIXDC1 gene; epigenetics; female; gene; genetic modification; intervertebral disk degeneration; mouse; nonhuman; nucleus pulposus; promoter region; protein expression; RNA methylation; RNA stability; signal transduction; smoking; upregulation; animal; genetics; metabolism; nucleus pulposus; smoking; Wnt signaling",Article,Final,,Scopus,2-s2.0-85164689653
Malyla V.; Paudel K.R.; De Rubis G.; Hansbro N.G.; Hansbro P.M.; Dua K.,"Malyla, Vamshikrishna (57205128961); Paudel, Keshav Raj (56539588400); De Rubis, Gabriele (57196257973); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57205128961; 56539588400; 57196257973; 15055862300; 6603119390; 15759138700,Cigarette smoking induces lung cancer tumorigenesis via upregulation of the WNT/β-catenin signaling pathway,2023,Life Sciences,326,,121787,,,,14,10.1016/j.lfs.2023.121787,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85159649400&doi=10.1016%2fj.lfs.2023.121787&partnerID=40&md5=66cff57461238fd861da5a1b06a5931a,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro N.G., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Cigarette smoke; Extracellular vesicles; Lung cancer; Tumorigenesis; WNT/β-catenin signaling,"beta Catenin; Cell Transformation, Neoplastic; Cigarette Smoking; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; RNA; Tobacco; Up-Regulation; Wnt Signaling Pathway; AXL receptor tyrosine kinase; catenin; dickkopf 1 protein; endoglin; epidermal growth factor receptor; fibroblast growth factor 2; heme oxygenase 1; hypoxia inducible factor; intercellular adhesion molecule 1; oncoprotein; serine protease inhibitor E1; transcription factor Snail; unclassified drug; Wnt protein; beta catenin; RNA; 16HBE14o- cell line; Article; AXIN gene; beta catenin gene; cell migration; cigarette smoking; controlled study; DLV3 gene; down regulation; epithelial mesenchymal transition; exosome; gene; human; human cell; lung cancer; protein targeting; signal transduction; upregulation; WNT3 gene; genetics; lung tumor; metabolism; neoplastic cell transformation; tobacco; Wnt signaling",Article,Final,,Scopus,2-s2.0-85159649400
Liu G.; Haw T.J.; Starkey M.R.; Philp A.M.; Pavlidis S.; Nalkurthi C.; Nair P.M.; Gomez H.M.; Hanish I.; Hsu A.C.; Hortle E.; Pickles S.; Rojas-Quintero J.; Estepar R.S.J.; Marshall J.E.; Kim R.Y.; Collison A.M.; Mattes J.; Idrees S.; Faiz A.; Hansbro N.G.; Fukui R.; Murakami Y.; Cheng H.S.; Tan N.S.; Chotirmall S.H.; Horvat J.C.; Foster P.S.; Oliver B.G.; Polverino F.; Ieni A.; Monaco F.; Caramori G.; Sohal S.S.; Bracke K.R.; Wark P.A.; Adcock I.M.; Miyake K.; Sin D.D.; Hansbro P.M.,"Liu, Gang (57189061134); Haw, Tatt Jhong (56625918900); Starkey, Malcolm R. (35811293400); Philp, Ashleigh M. (57311488900); Pavlidis, Stelios (56642790400); Nalkurthi, Christina (57359864400); Nair, Prema M. (55749131000); Gomez, Henry M. (57191960363); Hanish, Irwan (55572056100); Hsu, Alan Cy. (49861516600); Hortle, Elinor (57204193930); Pickles, Sophie (57216189104); Rojas-Quintero, Joselyn (25621617700); Estepar, Raul San Jose (57865245400); Marshall, Jacqueline E. (57218547927); Kim, Richard Y. (35810406900); Collison, Adam M. (23995251200); Mattes, Joerg (7005999915); Idrees, Sobia (55429771900); Faiz, Alen (55601365200); Hansbro, Nicole G. (15055862300); Fukui, Ryutaro (23018681500); Murakami, Yusuke (56415576400); Cheng, Hong Sheng (56565817700); Tan, Nguan Soon (57195418278); Chotirmall, Sanjay H. (15757175700); Horvat, Jay C. (9942405300); Foster, Paul S. (7201517569); Oliver, Brian Gg. (15919869900); Polverino, Francesca (23989412600); Ieni, Antonio (26021273500); Monaco, Francesco (56941491100); Caramori, Gaetano (7003847659); Sohal, Sukhwinder S. (36449981500); Bracke, Ken R. (8338303000); Wark, Peter A. (58166423200); Adcock, Ian M. (7007066538); Miyake, Kensuke (7401759553); Sin, Don D. (57917591300); Hansbro, Philip M. (6603119390)",57189061134; 56625918900; 35811293400; 57311488900; 56642790400; 57359864400; 55749131000; 57191960363; 55572056100; 49861516600; 57204193930; 57216189104; 25621617700; 57865245400; 57218547927; 35810406900; 23995251200; 7005999915; 55429771900; 55601365200; 15055862300; 23018681500; 56415576400; 56565817700; 57195418278; 15757175700; 9942405300; 7201517569; 15919869900; 23989412600; 26021273500; 56941491100; 7003847659; 36449981500; 8338303000; 58166423200; 7007066538; 7401759553; 57917591300; 6603119390,TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase,2023,Nature Communications,14,1,7349,,,,6,10.1038/s41467-023-42913-z,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85176384352&doi=10.1038%2fs41467-023-42913-z&partnerID=40&md5=a331a1cbefdafc0290c788e33d85cca6,"Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia; Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Depatrment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; School of Clinical Medicine, UNSW Medicine and Health, St Vincent’s Healthcare clinical campus, UNSW, Sydney, Australia; The Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Selangor, Serdang, Malaysia; Department of Medicine, Baylor College of Medicine, Houston, TX, United States; Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; Division of Innate Immunity, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Shirokanedai, Minatoku, Tokyo, Japan; Faculty of Pharmacy, Department of Pharmaceutical Sciences, Musashino University, Nishitokyo-shi, Tokyo, Japan; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore; Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Woolcock Institute of Medical Research, University of Sydney & School of Life Sciences, University of Technology, Sydney, Australia; Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, Università di Messina, Messina, Italy; Thoracic Surgery, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Pneumologia, Dipartimento BIOMORF and Dipartimento di Medicina e Chirurgia, Universities of Messina and Parma, Messina, Italy; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Australia; Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; The University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital & Respiratory Division, Dept of Medicine, University of British Columbia, Vancouver, BC, Canada","Liu G., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia; Haw T.J., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Starkey M.R., Depatrment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Philp A.M., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia, School of Clinical Medicine, UNSW Medicine and Health, St Vincent’s Healthcare clinical campus, UNSW, Sydney, Australia; Pavlidis S., The Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Nalkurthi C., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia; Nair P.M., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Gomez H.M., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Hanish I., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia, Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Selangor, Serdang, Malaysia; Hsu A.C., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Hortle E., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia; Pickles S., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia; Rojas-Quintero J., Department of Medicine, Baylor College of Medicine, Houston, TX, United States; Estepar R.S.J., Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States; Marshall J.E., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia; Kim R.Y., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; Collison A.M., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Mattes J., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Idrees S., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia; Faiz A., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia; Fukui R., Division of Innate Immunity, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Shirokanedai, Minatoku, Tokyo, Japan; Murakami Y., Faculty of Pharmacy, Department of Pharmaceutical Sciences, Musashino University, Nishitokyo-shi, Tokyo, Japan; Cheng H.S., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Tan N.S., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, School of Biological Sciences, Nanyang Technological University, Singapore, Singapore; Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Horvat J.C., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Foster P.S., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney & School of Life Sciences, University of Technology, Sydney, Australia; Polverino F., Department of Medicine, Baylor College of Medicine, Houston, TX, United States; Ieni A., Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, Università di Messina, Messina, Italy; Monaco F., Thoracic Surgery, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Caramori G., Pneumologia, Dipartimento BIOMORF and Dipartimento di Medicina e Chirurgia, Universities of Messina and Parma, Messina, Italy; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Australia; Bracke K.R., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Wark P.A., Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Adcock I.M., School of Clinical Medicine, UNSW Medicine and Health, St Vincent’s Healthcare clinical campus, UNSW, Sydney, Australia; Miyake K., Division of Innate Immunity, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Shirokanedai, Minatoku, Tokyo, Japan; Sin D.D., The University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital & Respiratory Division, Dept of Medicine, University of British Columbia, Vancouver, BC, Canada; Hansbro P.M., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Camperdown, NSW, Australia, Immune Healthy &/or Grow Up Well, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia",,"Animals; Emphysema; Humans; Imiquimod; Lung; Mice; Mice, Inbred C57BL; Nicotiana; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Toll-Like Receptor 7; Tryptases; cigarette smoke; cromoglycate disodium; imiquimod; isoflurane; messenger RNA; monoclonal antibody; myeloid differentiation factor 88; protease 6; proteinase; toll like receptor 7; tryptase; unclassified drug; imiquimod; TLR7 protein, human; toll like receptor 7; tryptase; cell; chronic obstructive pulmonary disease; disease prevalence; experimental study; immunity; induced response; smoke; airway epithelium cell; airway remodeling; animal cell; animal experiment; animal model; animal tissue; antiinflammatory activity; apoptosis; Article; chronic obstructive lung disease; cigarette smoke-induced emphysema; clinical article; controlled study; differential gene expression; disease severity; enzyme activity; experimental lung injury; female; human; human cell; human tissue; immune response; in vitro study; in vivo study; mast cell; mouse; nonhuman; respiratory tract inflammation; wild type mouse; animal; C57BL mouse; chronic obstructive lung disease; emphysema; genetics; lung; lung emphysema; Nicotiana",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85176384352
Malyla V.; Paudel K.R.; Rubis G.D.; Hansbro N.G.; Hansbro P.M.; Dua K.,"Malyla, Vamshikrishna (57205128961); Paudel, Keshav Raj (56539588400); Rubis, Gabriele De (58120540100); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57205128961; 56539588400; 58120540100; 15055862300; 6603119390; 15759138700,Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling,2023,International Journal of Molecular Sciences,24,4,3500,,,,5,10.3390/ijms24043500,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85148996845&doi=10.3390%2fijms24043500&partnerID=40&md5=2a70684daac5f5994978a13cac5f3a0a,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Rubis G.D., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro N.G., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia",biomarkers; EMT; extracellular vesicles; lung cancer; tumorigenesis; β-catenin signaling,beta catenin; carcinoembryonic antigen related cell adhesion molecule 5; CD63 antigen; cell adhesion molecule; dickkopf 1 protein; endostatin; epithelial cell adhesion molecule; fibroblast growth factor 2; galectin 3; intercellular adhesion molecule 1; oncoprotein; progranulin; transcription factor Snail; unclassified drug; uvomorulin; vascular cell adhesion molecule 1; vimentin; 16HBE14o- cell line; A-549 cell line; Article; bronchiole cell; cancer cell; carcinogenesis; cell migration; cell proliferation; controlled study; down regulation; epithelial mesenchymal transition; exosome; gene expression; human; human cell; protein expression; signal transduction; tumor invasion; upregulation,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85148996845
Paudel K.R.; Mohamad M.S.B.; De Rubis G.; Reyes R.-J.; Panth N.; Dureja H.; Gupta G.; Singh S.K.; Madheswaran T.; Collet T.; Hansbro P.M.; Dua K.; Chellappan D.K.,"Paudel, Keshav Raj (56539588400); Mohamad, Mohamad Siddiq Bin (58095765400); De Rubis, Gabriele (57196257973); Reyes, Ruby-Jean (57941713800); Panth, Nisha (57094240100); Dureja, Harish (6507566948); Gupta, Gaurav (15047988400); Singh, Sachin Kumar (57206711834); Madheswaran, Thiagarajan (55505311000); Collet, Trudi (36898251800); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",56539588400; 58095765400; 57196257973; 57941713800; 57094240100; 6507566948; 15047988400; 57206711834; 55505311000; 36898251800; 6603119390; 15759138700; 35811890500,18-β-Glycyrrhetinic acid encapsulated PLGA nanoparticles attenuate lung cancer proliferation and migration,2024,Journal of Drug Delivery Science and Technology,95,,105523,,,,8,10.1016/j.jddst.2024.105523,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85187983675&doi=10.1016%2fj.jddst.2024.105523&partnerID=40&md5=e337cb845dd233f0cdebb74209440621,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; School of Postgraduate Studies, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Haryana, Rohtak, 124001, India; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Innovative Medicines Group, Faculty of Health, Queensland University of Technology, Kelvin Grove, 4059, QLD, Australia; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Mohamad M.S.B., School of Postgraduate Studies, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; De Rubis G., Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Reyes R.-J., Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Panth N., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Haryana, Rohtak, 124001, India; Gupta G., Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India, Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Singh S.K., Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Collet T., Innovative Medicines Group, Faculty of Health, Queensland University of Technology, Kelvin Grove, 4059, QLD, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Dua K., Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia",18-β-Glycyrrhetinic acid; A549 lung cancer cells; mRNA expression; Non-small-cell lung cancer; PLGA nanoparticle; Protein expression,B Raf kinase; baculoviral IAP repeat containing protein 5; colony stimulating factor 1; epidermal growth factor receptor; epidermal growth factor receptor 2; glycyrrhetinic acid; K ras protein; mesothelin; nanoparticle; polyglycolic acid; water; A-549 cell line; angiogenesis; antineoplastic activity; Article; cancer growth; cell migration; cell proliferation; clinical practice; concentration (parameter); controlled study; down regulation; drug bioavailability; drug delivery system; drug release; Glycyrrhiza glabra; human; human cell; in vitro study; lung cancer; metastasis; nanoencapsulation; oncogene; physical chemistry; water solubility,Article,Final,,Scopus,2-s2.0-85187983675
Rouet R.; Henry J.Y.; Johansen M.D.; Sobti M.; Balachandran H.; Langley D.B.; Walker G.J.; Lenthall H.; Jackson J.; Ubiparipovic S.; Mazigi O.; Schofield P.; Burnett D.L.; Brown S.H.J.; Martinello M.; Hudson B.; Gilroy N.; Post J.J.; Kelleher A.; Jäck H.-M.; Goodnow C.C.; Turville S.G.; Rawlinson W.D.; Bull R.A.; Stewart A.G.; Hansbro P.M.; Christ D.,"Rouet, Romain (47962460700); Henry, Jake Y. (59283461600); Johansen, Matt D. (57202983408); Sobti, Meghna (35084356300); Balachandran, Harikrishnan (26634808400); Langley, David B. (7006461904); Walker, Gregory J. (57203590121); Lenthall, Helen (57191628440); Jackson, Jennifer (57190133673); Ubiparipovic, Stephanie (57221697547); Mazigi, Ohan (57193925875); Schofield, Peter (57219821496); Burnett, Deborah L. (57196194699); Brown, Simon H. J. (35081788500); Martinello, Marianne (57919154500); Hudson, Bernard (55730035500); Gilroy, Nicole (6602838365); Post, Jeffrey J. (7202174742); Kelleher, Anthony (57219637519); Jäck, Hans-Martin (7005855616); Goodnow, Christopher C. (7005003390); Turville, Stuart G. (6507720820); Rawlinson, William D. (7005245886); Bull, Rowena A. (8564636600); Stewart, Alastair G. (57191808595); Hansbro, Philip M. (6603119390); Christ, Daniel (7005298324)",47962460700; 59283461600; 57202983408; 35084356300; 26634808400; 7006461904; 57203590121; 57191628440; 57190133673; 57221697547; 57193925875; 57219821496; 57196194699; 35081788500; 57919154500; 55730035500; 6602838365; 7202174742; 57219637519; 7005855616; 7005003390; 6507720820; 7005245886; 8564636600; 57191808595; 6603119390; 7005298324,Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients,2023,Nature Communications,14,1,687,,,,20,10.1038/s41467-023-36295-5,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147724688&doi=10.1038%2fs41467-023-36295-5&partnerID=40&md5=f2635f309ade33d4040a4836bc44321e,"Garvan Institute of Medical Research, Sydney, NSW, Australia; UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Center for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; UNSW Sydney, School of Medical Sciences, Faculty of Medicine, Sydney, NSW, Australia; Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Prince of Wales Hospital, Sydney, NSW, Australia; Molecular Horizons, University of Wollongong, Wollongong, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia; Westmead Hospital, Sydney, NSW, Australia; Division of Molecular Immunology, Friedrich-Alexander University Erlangen-Nürnberg and University Hospital Erlangen, Erlangen-Nürnberg, Germany","Rouet R., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Henry J.Y., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Johansen M.D., Center for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Sobti M., UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia, Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; Balachandran H., UNSW Sydney, School of Medical Sciences, Faculty of Medicine, Sydney, NSW, Australia, Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Langley D.B., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Walker G.J., UNSW Sydney, School of Medical Sciences, Faculty of Medicine, Sydney, NSW, Australia, Kirby Institute, UNSW Sydney, Sydney, NSW, Australia, Prince of Wales Hospital, Sydney, NSW, Australia; Lenthall H., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Jackson J., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Ubiparipovic S., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Mazigi O., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Schofield P., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Burnett D.L., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Brown S.H.J., Molecular Horizons, University of Wollongong, Wollongong, NSW, Australia; Martinello M., UNSW Sydney, School of Medical Sciences, Faculty of Medicine, Sydney, NSW, Australia, Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Hudson B., Royal North Shore Hospital, Sydney, NSW, Australia; Gilroy N., Westmead Hospital, Sydney, NSW, Australia; Post J.J., Prince of Wales Hospital, Sydney, NSW, Australia; Kelleher A., UNSW Sydney, School of Medical Sciences, Faculty of Medicine, Sydney, NSW, Australia, Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Jäck H.-M., Division of Molecular Immunology, Friedrich-Alexander University Erlangen-Nürnberg and University Hospital Erlangen, Erlangen-Nürnberg, Germany; Goodnow C.C., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia; Turville S.G., UNSW Sydney, School of Medical Sciences, Faculty of Medicine, Sydney, NSW, Australia, Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Rawlinson W.D., UNSW Sydney, School of Medical Sciences, Faculty of Medicine, Sydney, NSW, Australia, Prince of Wales Hospital, Sydney, NSW, Australia; Bull R.A., UNSW Sydney, School of Medical Sciences, Faculty of Medicine, Sydney, NSW, Australia, Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Stewart A.G., UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia, Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; Hansbro P.M., Prince of Wales Hospital, Sydney, NSW, Australia; Christ D., Garvan Institute of Medical Research, Sydney, NSW, Australia, UNSW Sydney, St Vincent’s Clinical School, Faculty of Medicine, Sydney, NSW, Australia",,"Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; Epitopes; Female; Humans; Leukocytes, Mononuclear; Mice; Neutralization Tests; SARS-CoV-2; Spike Glycoprotein, Coronavirus; angiotensin converting enzyme 2; broadly neutralizing antibody; broadly neutralizing antibody gar05; broadly neutralizing antibody gar12; broadly neutralizing antibody gar20; CD19 antigen; CD20 antigen; CD3 antigen; cross reacting antibody; epitope; immunoglobulin G1; s 309; SARS-CoV-2 antibody; sotrovimab; unclassified drug; coronavirus spike glycoprotein; epitope; monoclonal antibody; neutralizing antibody; spike protein, SARS-CoV-2; virus antibody; antibody; blood; mutation; neutralization; severe acute respiratory syndrome; vaccine; adult; aged; animal experiment; animal model; antibody response; Article; biolayer interferometry; body weight loss; carboxy terminal sequence; cell isolation; cohort analysis; controlled study; convalescence; coronavirus disease 2019; cryoelectron microscopy; drug potency; electron microscopy; enzyme linked immunosorbent assay; expression vector; eyelid closure; female; fluorescence intensity; HEK293T cell line; human; human cell; IC50; interferometry; lung lavage fluid; lung lobe; macrophage; male; memory B lymphocyte; mouse; mouse model; neutrophil; nonhuman; peripheral blood mononuclear cell; polyacrylamide gel electrophoresis; prophylaxis; protein analysis; real time polymerase chain reaction; receptor binding; SARS-CoV-2 Delta; SARS-CoV-2 Omicron; Severe acute respiratory syndrome coronavirus 2; structure analysis; trimerization; variant of concern; virus load; virus neutralization; virus pathogenesis; X ray crystallography; animal; genetics; mononuclear cell; serodiagnosis",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85147724688
Mayall J.R.; Horvat J.C.; Mangan N.E.; Chevalier A.; McCarthy H.; Hampsey D.; Donovan C.; Brown A.C.; Matthews A.Y.; de Weerd N.A.; de Geus E.D.; Starkey M.R.; Kim R.Y.; Daly K.; Goggins B.J.; Keely S.; Maltby S.; Baldwin R.; Foster P.S.; Boyle M.J.; Tanwar P.S.; Huntington N.D.; Hertzog P.J.; Hansbro P.M.,"Mayall, Jemma R (55607222700); Horvat, Jay C (9942405300); Mangan, Niamh E (6506688263); Chevalier, Anne (57196690888); McCarthy, Huw (57217073584); Hampsey, Daniel (55383350800); Donovan, Chantal (55357105200); Brown, Alexandra C (55637745000); Matthews, Antony Y (9632535100); de Weerd, Nicole A (6508220812); de Geus, Eveline D (26655439000); Starkey, Malcolm R (35811293400); Kim, Richard Y (35810406900); Daly, Katie (57221387938); Goggins, Bridie J (55894233100); Keely, Simon (9739611200); Maltby, Steven (6507446799); Baldwin, Rennay (58889953300); Foster, Paul S (7201517569); Boyle, Michael J (7202761793); Tanwar, Pradeep S (23570291100); Huntington, Nicholas D (55922608600); Hertzog, Paul J (7005991492); Hansbro, Philip M (6603119390)",55607222700; 9942405300; 6506688263; 57196690888; 57217073584; 55383350800; 55357105200; 55637745000; 9632535100; 6508220812; 26655439000; 35811293400; 35810406900; 57221387938; 55894233100; 9739611200; 6507446799; 58889953300; 7201517569; 7202761793; 23570291100; 55922608600; 7005991492; 6603119390,Interferon-epsilon is a novel regulator of NK cell responses in the uterus,2024,EMBO Molecular Medicine,16,2,,267,293,26,1,10.1038/s44321-023-00018-6,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185216988&doi=10.1038%2fs44321-023-00018-6&partnerID=40&md5=d144c0bd16c6dbca651add231b727fc4,"Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research and Departments of Molecular and Translational Sciences, Monash University, Clayton, 3168, VIC, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2000, NSW, Australia; Immunology and Pathology, Central Clinical School, Monash University, Clayton, 3168, VIC, Australia; Immunology and Infectious Diseases Unit, John Hunter Hospital, Newcastle, 2305, NSW, Australia; Gynecology Oncology Research Group, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308, NSW, Australia; Monash Biomedicine Discovery Institute, Monash University, Clayton, 3168, VIC, Australia","Mayall J.R., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Horvat J.C., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Mangan N.E., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research and Departments of Molecular and Translational Sciences, Monash University, Clayton, 3168, VIC, Australia; Chevalier A., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; McCarthy H., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Hampsey D., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Donovan C., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2000, NSW, Australia; Brown A.C., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Matthews A.Y., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research and Departments of Molecular and Translational Sciences, Monash University, Clayton, 3168, VIC, Australia; de Weerd N.A., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research and Departments of Molecular and Translational Sciences, Monash University, Clayton, 3168, VIC, Australia; de Geus E.D., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research and Departments of Molecular and Translational Sciences, Monash University, Clayton, 3168, VIC, Australia; Starkey M.R., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia, Immunology and Pathology, Central Clinical School, Monash University, Clayton, 3168, VIC, Australia; Kim R.Y., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2000, NSW, Australia; Daly K., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Goggins B.J., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Keely S., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Maltby S., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Baldwin R., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Foster P.S., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Boyle M.J., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia, Immunology and Infectious Diseases Unit, John Hunter Hospital, Newcastle, 2305, NSW, Australia; Tanwar P.S., Gynecology Oncology Research Group, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308, NSW, Australia; Huntington N.D., Monash Biomedicine Discovery Institute, Monash University, Clayton, 3168, VIC, Australia; Hertzog P.J., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research and Departments of Molecular and Translational Sciences, Monash University, Clayton, 3168, VIC, Australia; Hansbro P.M., Immune Health Program, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2000, NSW, Australia",Chlamydia Infection; Female Reproductive Tract; Interferon-Epsilon; Natural Killer Cell; Type I Interferon,"Female; Fetus; Humans; Interferons; Killer Cells, Natural; Uterus; epsilon interferon; gamma interferon; interleukin 15; interferon; animal cell; animal experiment; animal model; animal tissue; Article; cell protection; cellular distribution; Chlamydia infection; controlled study; cytokine production; human; human tissue; immunocompetent cell; lymphocyte activation; lymphocyte count; lymphocyte subpopulation; mouse; natural killer cell; nonhuman; protein expression; protein function; uterus; female; fetus",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85185216988
Mishra N.; Bhatt S.; Paudel K.R.; Hansbro P.M.; Dua K.,"Mishra, Neeraj (23027996000); Bhatt, Shvetank (57197493015); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",23027996000; 57197493015; 56539588400; 6603119390; 15759138700,Synbiotics for the Management of Cancer,2023,Synbiotics for the Management of Cancer,,,,1,340,339,3,10.1007/978-981-19-7550-9,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85171498746&doi=10.1007%2f978-981-19-7550-9&partnerID=40&md5=3ed6f47d182e4140b04e9cc697d60ef6,"Department of Pharmaceutics Amity Institute of Pharmacy, Amity University Madhya Pradesh, Madhya Pradesh, Gwalior, India; School of Pharmacy, Dr.Vishwanath Karad MIT World Peace University, Maharashtra, Pune, India; Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, NSW, Sydney, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia","Mishra N., Department of Pharmaceutics Amity Institute of Pharmacy, Amity University Madhya Pradesh, Madhya Pradesh, Gwalior, India; Bhatt S., School of Pharmacy, Dr.Vishwanath Karad MIT World Peace University, Maharashtra, Pune, India; Paudel K.R., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, NSW, Sydney, Australia; Hansbro P.M., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, NSW, Sydney, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia",Cervical Cancer; Colon Cancer; Prebiotics; Probiotics; Reactive oxygen species; Synbiotics,,Book,Final,,Scopus,2-s2.0-85171498746
Chen L.; A. Hoefel G.; Pathinayake P.S.; Reid A.; Pillar A.L.; Kelly C.; Tan H.; Ali A.; Kim R.Y.; Hansbro P.M.; Brody S.L.; Foster P.S.; Horvat J.C.; Riveros C.; Awatade N.; Wark P.A.B.; Kaiko G.E.,"Chen, Ling (56424151100); A. Hoefel, Gabriela (59352714600); Pathinayake, Prabuddha S. (55877978000); Reid, Andrew (39561518600); Pillar, Amber L. (57216038374); Kelly, Coady (57704015800); Tan, HuiYing (59352851900); Ali, Ayesha (57192694030); Kim, Richard Y. (35810406900); Hansbro, Philip M. (6603119390); Brody, Steven L. (7102026527); Foster, Paul S. (7201517569); Horvat, Jay C. (9942405300); Riveros, Carlos (35765762800); Awatade, Nikhil (56554140500); Wark, Peter A. B. (58166423200); Kaiko, Gerard E. (21739529400)",56424151100; 59352714600; 55877978000; 39561518600; 57216038374; 57704015800; 59352851900; 57192694030; 35810406900; 6603119390; 7102026527; 7201517569; 9942405300; 35765762800; 56554140500; 58166423200; 21739529400,Inflammation-induced loss of CFTR-expressing airway ionocytes in non-eosinophilic asthma,2025,Respirology,30,1,,25,40,15,1,10.1111/resp.14833,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85205548892&doi=10.1111%2fresp.14833&partnerID=40&md5=299a642c7d7e0512c8134d6b1ef47e50,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Department of Medicine, Washington University School of Medicine in St Louis, St Louis, MO, United States; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia; Department of Respiratory Medicine, Alfred Health, Melbourne, VIC, Australia","Chen L., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; A. Hoefel G., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Pathinayake P.S., Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Reid A., Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Pillar A.L., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Kelly C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Tan H., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Ali A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Kim R.Y., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Brody S.L., Department of Medicine, Washington University School of Medicine in St Louis, St Louis, MO, United States; Foster P.S., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Horvat J.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Riveros C., Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Awatade N., Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Wark P.A.B., Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia, Department of Respiratory Medicine, Alfred Health, Melbourne, VIC, Australia; Kaiko G.E., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia",airway epithelium; CFTR; ionocytes; mucous; neutrophils; severe asthma; single cell RNA-sequencing,"Animals; Asthma; Bronchi; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Eosinophils; Epithelial Cells; Female; Humans; Inflammation; Male; Mice; Neutrophils; Respiratory Mucosa; cystic fibrosis transmembrane conductance regulator; elexacaftor plus ivacaftor plus tezacaftor; interleukin 13; interleukin 17; interleukin 22; tumor necrosis factor; CFTR protein, human; adult; airway epithelium cell; Alternaria alternata; animal experiment; animal model; animal tissue; Article; asthma; bronchoscopy; bronchus epithelium; Chlamydia muridarum; chronic obstructive lung disease; controlled study; differential expression analysis; eosinophil; eosinophilic asthma; forced expiratory volume; genotype; human; human cell; human tissue; immunofluorescence assay; inflammation; microscopy; mouse; neutrophil; non eosinophilic asthma; nonhuman; protein expression; protein folding; RNA isolation; signal transduction; single cell RNA seq; spirometry; transepithelial resistance; animal; asthma; bronchus; disease model; epithelium cell; female; genetics; inflammation; male; metabolism; pathology; respiratory mucosa",Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85205548892
Imran M.; Jin X.; Ali M.; Tapfumaneyi P.; Lelasseur P.; Carlo L.; Jude A.; Bourg A.L.; Panchal B.; Dick A.; Paudel K.R.; Hansbro P.M.; Mohammed Y.,"Imran, Mohammad (57209466043); Jin, Xuping (58117276000); Ali, Masood (57199279317); Tapfumaneyi, Pronalis (57817953500); Lelasseur, Pauline (58117276100); Carlo, Laure (58117276200); Jude, Axelle (58117445000); Bourg, Alice Le (58117445100); Panchal, Bhavesh (57194406324); Dick, Arianna (57207349155); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Mohammed, Yousuf (56116912300)",57209466043; 58117276000; 57199279317; 57817953500; 58117276100; 58117276200; 58117445000; 58117445100; 57194406324; 57207349155; 56539588400; 6603119390; 56116912300,The Pandemic and Your Skin—Direct and Indirect Impact of COVID-19,2023,Cosmetics,10,1,34,,,,9,10.3390/cosmetics10010034,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85148861446&doi=10.3390%2fcosmetics10010034&partnerID=40&md5=7580701cb5426b4560dd94ad353b9def,"Therapeutics Research Group, Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, QLD, Australia; School of Pharmacy, University of Queensland, Brisbane, 4102, QLD, Australia; School of Pharmacy, Rhodes University, Makhanda, Grahamstown, 6139, South Africa; Faculty of Pharmacy, The University of Rennes, Rennes, 35000, France; Biosciences and Food Technology, School of Science, RMIT University, Melbourne, 3000, VIC, Australia; Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, Australia","Imran M., Therapeutics Research Group, Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, QLD, Australia; Jin X., Therapeutics Research Group, Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, QLD, Australia, School of Pharmacy, University of Queensland, Brisbane, 4102, QLD, Australia; Ali M., Therapeutics Research Group, Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, QLD, Australia; Tapfumaneyi P., School of Pharmacy, Rhodes University, Makhanda, Grahamstown, 6139, South Africa; Lelasseur P., Faculty of Pharmacy, The University of Rennes, Rennes, 35000, France; Carlo L., Faculty of Pharmacy, The University of Rennes, Rennes, 35000, France; Jude A., Faculty of Pharmacy, The University of Rennes, Rennes, 35000, France; Bourg A.L., Faculty of Pharmacy, The University of Rennes, Rennes, 35000, France; Panchal B., Therapeutics Research Group, Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, QLD, Australia; Dick A., Therapeutics Research Group, Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, QLD, Australia, Biosciences and Food Technology, School of Science, RMIT University, Melbourne, 3000, VIC, Australia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, Australia; Mohammed Y., Therapeutics Research Group, Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, QLD, Australia, School of Pharmacy, University of Queensland, Brisbane, 4102, QLD, Australia",COVID-19; immunological response; PPEs; skin manifestations,,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85148861446
Datsyuk J.K.; Paudel K.R.; Rajput R.; Kokkinis S.; El Sherkawi T.; Singh S.K.; Gupta G.; Chellappan D.K.; Yeung S.; Hansbro P.M.; Oliver B.G.G.; Santos H.A.; Dua K.; De Rubis G.,"Datsyuk, Jessica Katrine (58631184200); Paudel, Keshav Raj (56539588400); Rajput, Rashi (58196313700); Kokkinis, Sofia (58631105400); El Sherkawi, Tammam (58631184300); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Yeung, Stewart (58822848100); Hansbro, Philip Michael (6603119390); Oliver, Brian Gregory George (15919869900); Santos, Hélder A. (9239103400); Dua, Kamal (15759138700); De Rubis, Gabriele (57196257973)",58631184200; 56539588400; 58196313700; 58631105400; 58631184300; 57206711834; 15047988400; 35811890500; 58822848100; 6603119390; 15919869900; 9239103400; 15759138700; 57196257973,Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases,2023,Chemico-Biological Interactions,385,,110737,,,,5,10.1016/j.cbi.2023.110737,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85173133275&doi=10.1016%2fj.cbi.2023.110737&partnerID=40&md5=cd335dc7b366863c5d9388991823d7c0,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India; School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, Netherlands; W.J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, Netherlands; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India","Datsyuk J.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Rajput R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Kokkinis S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; El Sherkawi T., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Gupta G., Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India, School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Yeung S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Oliver B.G.G., Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Santos H.A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, Netherlands, W.J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, Netherlands; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Asthma; COPD; Decoy oligodeoxynucleotides; Inflammation; Nanoparticles; NFκB,immunoglobulin enhancer binding protein; mepolizumab; nanoparticle; oligodeoxynucleotide; omalizumab; roflumilast; asthma; binding site; bronchoconstriction; chronic obstructive lung disease; cigarette smoking; human; pathophysiology; protein targeting; respiratory tract allergy; Review; tissue specificity,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85173133275
Manandhar B.; Paudel K.R.; Clarence D.D.; De Rubis G.; Madheswaran T.; Panneerselvam J.; Zacconi F.C.; Williams K.A.; Pont L.G.; Warkiani M.E.; MacLoughlin R.; Oliver B.G.; Gupta G.; Singh S.K.; Chellappan D.K.; Hansbro P.M.; Dua K.,"Manandhar, Bikash (57204448260); Paudel, Keshav Raj (56539588400); Clarence, Dvya Delilaa (57897135900); De Rubis, Gabriele (57196257973); Madheswaran, Thiagarajan (55505311000); Panneerselvam, Jithendra (57201993010); Zacconi, Flavia C. (33667991400); Williams, Kylie A. (7404142756); Pont, Lisa G. (6602612624); Warkiani, Majid Ebrahimi (36138999000); MacLoughlin, Ronan (57212263206); Oliver, Brian Gregory (15919869900); Gupta, Gaurav (15047988400); Singh, Sachin Kumar (57206711834); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57204448260; 56539588400; 57897135900; 57196257973; 55505311000; 57201993010; 33667991400; 7404142756; 6602612624; 36138999000; 57212263206; 15919869900; 15047988400; 57206711834; 35811890500; 6603119390; 15759138700,Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro,2024,Naunyn-Schmiedeberg's Archives of Pharmacology,397,1,,343,356,13,7,10.1007/s00210-023-02603-5,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85164839832&doi=10.1007%2fs00210-023-02603-5&partnerID=40&md5=79bc32841d798f60084e90e3dcbd84fc,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2050, Australia; School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Departamento de Química Orgánica, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Santiago, Macul, 7820436, Chile; Centro de Investigación en Nanotecnología y Materiales Avanzados, CIEN-UC, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Santiago, Macul, 7820436, Chile; Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Research and Development, Aerogen Limited, IDA Business Park, Galway, Connacht, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Leinster, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, Leinster, D02 PN40, Ireland; Woolcock Institute of Medical Research, Macquarie University, Sydney, 2137, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, India; Center for Transdisciplinary Research, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, India; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, 144411, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia","Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2050, Australia; Clarence D.D., School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Zacconi F.C., Departamento de Química Orgánica, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Santiago, Macul, 7820436, Chile, Centro de Investigación en Nanotecnología y Materiales Avanzados, CIEN-UC, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4860, Santiago, Macul, 7820436, Chile, Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Williams K.A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Pont L.G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Warkiani M.E., School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; MacLoughlin R., Research and Development, Aerogen Limited, IDA Business Park, Galway, Connacht, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Leinster, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, Leinster, D02 PN40, Ireland; Oliver B.G., Woolcock Institute of Medical Research, Macquarie University, Sydney, 2137, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, India, Center for Transdisciplinary Research, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, India; Singh S.K., Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, 144411, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2050, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia",A549 lung cancer cells; Cell migration; Cell proliferation; Liquid crystalline nanoparticles; Non-small-cell lung cancer; Zerumbone,"Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Nanoparticles; Sesquiterpenes; baculoviral IAP repeat containing protein 5; cytokeratin 18; dickkopf 1 protein; epidermal growth factor receptor; nanoparticle; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; protein p53; zerumbone; nanoparticle; sesquiterpene; zerumbone; A-549 cell line; antineoplastic activity; Article; cell migration; cell proliferation; controlled study; down regulation; drug bioavailability; drug delivery system; genetic susceptibility; genetic transcription; human; human cell; in vitro study; liquid crystal; metastasis; non small cell lung cancer; protein microarray; tumor suppressor gene; water solubility; apoptosis; cell proliferation; lung tumor; tumor cell line",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85164839832
Van Eeckhoutte H.P.; Donovan C.; Kim R.Y.; Conlon T.M.; Ansari M.; Khan H.; Jayaraman R.; Hansbro N.G.; Dondelinger Y.; Delanghe T.; Beal A.M.; Geddes B.; Bertin J.; Berghe T.V.; De Volder J.; Maes T.; Vandenabeele P.; Vanaudenaerde B.M.; Deforce D.; Škevin S.; Van Nieuwerburgh F.; Verhamme F.M.; Joos G.F.; Idrees S.; Schiller H.B.; Yildirim A.Ö.; Faiz A.; Bertrand M.J.M.; Brusselle G.G.; Hansbro P.M.; Bracke K.R.,"Van Eeckhoutte, Hannelore P. (57212378504); Donovan, Chantal (55357105200); Kim, Richard Y. (35810406900); Conlon, Thomas M. (40261075700); Ansari, Meshal (57207300757); Khan, Haroon (57204287630); Jayaraman, Ranjith (57225458602); Hansbro, Nicole G. (15055862300); Dondelinger, Yves (55201208200); Delanghe, Tom (57196121132); Beal, Allison M. (54785868300); Geddes, Brad (7004170615); Bertin, John (7004563508); Berghe, Tom Vanden (6603179568); De Volder, Joyceline (57211133328); Maes, Tania (6603579162); Vandenabeele, Peter (7005733218); Vanaudenaerde, Bart M. (7801354724); Deforce, Dieter (6602167794); Škevin, Sonja (57325194100); Van Nieuwerburgh, Filip (12345200700); Verhamme, Fien M. (56008794900); Joos, Guy F. (7102353943); Idrees, Sobia (55429771900); Schiller, Herbert B. (15037181200); Yildirim, Ali Önder (21935550600); Faiz, Alen (55601365200); Bertrand, Mathieu J.M. (56404042800); Brusselle, Guy G. (57197253407); Hansbro, Philip M. (6603119390); Bracke, Ken R. (8338303000)",57212378504; 55357105200; 35810406900; 40261075700; 57207300757; 57204287630; 57225458602; 15055862300; 55201208200; 57196121132; 54785868300; 7004170615; 7004563508; 6603179568; 57211133328; 6603579162; 7005733218; 7801354724; 6602167794; 57325194100; 12345200700; 56008794900; 7102353943; 55429771900; 15037181200; 21935550600; 55601365200; 56404042800; 57197253407; 6603119390; 8338303000,RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD,2023,European Respiratory Journal,61,4,2201506,,,,25,10.1183/13993003.01506-2022,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85151575111&doi=10.1183%2f13993003.01506-2022&partnerID=40&md5=3b287e9fd6d049f135c2e95e6b3c414e,"Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center for Lung Research (DZL), Munich, Germany; Institute of Computational Biology, Helmholtz Munich, Munich, Germany; Centre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; VIB-UGent Center for Inflammation Research, Department for Biomedical Molecular Biology, Cell Death and Inflammation Unit, Ghent University, Ghent, Belgium; Immunology Research Unit, GlaxoSmithKline, Collegeville, PA, United States; Prime Medicine Inc., Cambridge, MA, United States; Immunology and Inflammation Research Therapeutic Area, Sanofi, Cambridge, MA, United States; Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium; BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium; NXTGNT, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; Laboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium","Van Eeckhoutte H.P., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium; Donovan C., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia, Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kim R.Y., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia, Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Conlon T.M., Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center for Lung Research (DZL), Munich, Germany; Ansari M., Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center for Lung Research (DZL), Munich, Germany, Institute of Computational Biology, Helmholtz Munich, Munich, Germany; Khan H., Centre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; Jayaraman R., Centre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; Hansbro N.G., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia, Centre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; Dondelinger Y., VIB-UGent Center for Inflammation Research, Department for Biomedical Molecular Biology, Cell Death and Inflammation Unit, Ghent University, Ghent, Belgium; Delanghe T., VIB-UGent Center for Inflammation Research, Department for Biomedical Molecular Biology, Cell Death and Inflammation Unit, Ghent University, Ghent, Belgium; Beal A.M., Immunology Research Unit, GlaxoSmithKline, Collegeville, PA, United States; Geddes B., Prime Medicine Inc., Cambridge, MA, United States; Bertin J., Immunology and Inflammation Research Therapeutic Area, Sanofi, Cambridge, MA, United States; Berghe T.V., VIB-UGent Center for Inflammation Research, Department for Biomedical Molecular Biology, Cell Death and Inflammation Unit, Ghent University, Ghent, Belgium, Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium; De Volder J., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium; Maes T., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium; Vandenabeele P., VIB-UGent Center for Inflammation Research, Department for Biomedical Molecular Biology, Cell Death and Inflammation Unit, Ghent University, Ghent, Belgium; Vanaudenaerde B.M., BREATHE, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium; Deforce D., NXTGNT, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; Škevin S., NXTGNT, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium, Laboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; Van Nieuwerburgh F., NXTGNT, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium, Laboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; Verhamme F.M., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium; Joos G.F., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium; Idrees S., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia, Centre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; Schiller H.B., Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center for Lung Research (DZL), Munich, Germany; Yildirim A.Ö., Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center for Lung Research (DZL), Munich, Germany; Faiz A., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia, Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center for Lung Research (DZL), Munich, Germany, Centre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; Bertrand M.J.M., VIB-UGent Center for Inflammation Research, Department for Biomedical Molecular Biology, Cell Death and Inflammation Unit, Ghent University, Ghent, Belgium; Brusselle G.G., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium; Hansbro P.M., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia, Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia; Bracke K.R., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium",,"Animals; Cell Death; Emphysema; Humans; Inflammation; Lung; Mice; Mice, Inbred C57BL; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Receptor-Interacting Protein Serine-Threonine Kinases; cigarette smoke; elastase; protein kinase; receptor interacting protein kinase 1; unclassified drug; receptor interacting protein serine threonine kinase; RIPK1 protein, human; Ripk1 protein, mouse; adult; aged; airway remodeling; animal experiment; animal model; animal tissue; apoptosis; Article; cell death; chronic obstructive lung disease; cigarette smoking; ciliated epithelium cell; controlled study; down regulation; enzyme inhibition; female; human; human tissue; immunohistochemistry; infant; inflammation; lung alveolus cell type 1; lung alveolus cell type 2; lung alveolus macrophage; lung emphysema; lung function; lung parenchyma; male; mouse; necroptosis; neurosecretory cell; never smoker; nonhuman; pathogenesis; respiratory epithelium; single cell RNA seq; smoking; T lymphocyte; animal; C57BL mouse; cell death; chronic obstructive lung disease; emphysema; genetics; inflammation; lung; lung emphysema; metabolism",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85151575111
Hansbro P.,"Hansbro, Philip (6603119390)",6603119390,Omics technologies to study virus infection and chronic lung diseases,2023,Respirology,28,4,,403,,,2,10.1111/resp.14480,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85149870898&doi=10.1111%2fresp.14480&partnerID=40&md5=c401e95b96b81611f7b3f0936b568abf,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia","Hansbro P., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia",chronic lung disease; omics; virus infection,Genomics; Humans; Lung Diseases; Virus Diseases; messenger RNA; bioinformatics; chronic lung disease; epigenetics; gene expression; human; infection risk; mass spectrometry; metabolite; metagenomics; metatranscriptomics; nonhuman; Note; omics; pathogenesis; protein function; proteomics; RNA sequencing; RNA transcription; RNA translation; signal transduction; single cell RNA seq; viral respiratory tract infection; genetics; genomics; lung disease; virus infection,Note,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85149870898
De Rubis G.; Paudel K.R.; Corrie L.; Mehndiratta S.; Patel V.K.; Kumbhar P.S.; Manjappa A.S.; Disouza J.; Patravale V.; Gupta G.; Manandhar B.; Rajput R.; Robinson A.K.; Reyes R.-J.; Chakraborty A.; Chellappan D.K.; Singh S.K.; Oliver B.G.G.; Hansbro P.M.; Dua K.,"De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Corrie, Leander (57214724523); Mehndiratta, Samir (58708275900); Patel, Vyoma K. (57193533009); Kumbhar, Popat S. (57202303372); Manjappa, Arehalli Sidramappa (20734589700); Disouza, John (6506849197); Patravale, Vandana (57207504972); Gupta, Gaurav (15047988400); Manandhar, Bikash (57204448260); Rajput, Rashi (58196313700); Robinson, Alexandra Kailie (58706228800); Reyes, Ruby-Jean (57941713800); Chakraborty, Amlan (56714779500); Chellappan, Dinesh Kumar (35811890500); Singh, Sachin Kumar (57206711834); Oliver, Brian Gregory George (15919869900); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",57196257973; 56539588400; 57214724523; 58708275900; 57193533009; 57202303372; 20734589700; 6506849197; 57207504972; 15047988400; 57204448260; 58196313700; 58706228800; 57941713800; 56714779500; 35811890500; 57206711834; 15919869900; 6603119390; 15759138700,Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease,2024,Naunyn-Schmiedeberg's Archives of Pharmacology,397,5,,2793,2833,40,12,10.1007/s00210-023-02830-w,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85177593205&doi=10.1007%2fs00210-023-02830-w&partnerID=40&md5=18bb5d1ddae4abfc0b7746935d15f3f8,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Dist: Kolhapur, Maharashtra, Warananagar, Tal: Panhala, 416113, India; Department of Pharmaceutics, Vasantidevi Patil Institute of Pharmacy, Kodoli, Maharashtra, Kolkapur, 416114, India; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Maharashtra, Mumbai, 400019, India; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India, Chennai, India; School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; Division of Immunology, Immunity to Infection and Respiratory Medicine (DIIIRM), School of Biological Sciences I Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom; School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia","De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Corrie L., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Mehndiratta S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Patel V.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; Kumbhar P.S., Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Dist: Kolhapur, Maharashtra, Warananagar, Tal: Panhala, 416113, India; Manjappa A.S., Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Dist: Kolhapur, Maharashtra, Warananagar, Tal: Panhala, 416113, India, Department of Pharmaceutics, Vasantidevi Patil Institute of Pharmacy, Kodoli, Maharashtra, Kolkapur, 416114, India; Disouza J., Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Dist: Kolhapur, Maharashtra, Warananagar, Tal: Panhala, 416113, India; Patravale V., Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Maharashtra, Mumbai, 400019, India; Gupta G., Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India, Chennai, India, School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Rajput R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Robinson A.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Reyes R.-J., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Chakraborty A., Division of Immunology, Immunity to Infection and Respiratory Medicine (DIIIRM), School of Biological Sciences I Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom; Chellappan D.K., School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Singh S.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Oliver B.G.G., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW, Australia; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",Chronic obstructive pulmonary disease; Drug delivery; Lung cancer; miRNA; Nanoparticles; Nucleic acid therapeutics; Phytoceuticals,"Animals; Drug Delivery Systems; Humans; Lung Neoplasms; Nanoparticle Drug Delivery System; Nanoparticles; Nucleic Acids; Pulmonary Disease, Chronic Obstructive; 1,1 diphenyl 2 picrylhydrazyl; agarwood oil; berberine; biological product; cigarette smoke; cyclin dependent kinase inhibitor; dendrimer; isoquercetin; liposome; macrogol; microRNA; mouse double minute 2 homolog; nanocrystal; nanoparticle; nucleic acid; nucleic acid base; oil; phytoceutical; plant medicinal product; polymer nanoparticle; quercetin; small interfering RNA; tocofersolan; unclassified drug; zerumbone; nanocarrier; nanoparticle; nucleic acid; airway remodeling; charge density; chronic obstructive lung disease; cigarette smoking; clinical trial (topic); diet supplementation; drug delivery system; EC50; enzymatic degradation; epithelium basal cell; exosome; gene knockdown; gene silencing; human; inflammation; inflammatory disease; lung cancer; macrophage cell line; micelle; nanoemulsion; nonhuman; oxidative stress; particle size; permeability; phase 1 clinical trial (topic); phase 2 clinical trial (topic); polymerization; Review; signal transduction; wood; animal; chemistry; chronic obstructive lung disease; drug delivery system; lung tumor",Review,Final,,Scopus,2-s2.0-85177593205
Salvato I.; Ricciardi L.; Dal Col J.; Nigro A.; Giurato G.; Memoli D.; Sellitto A.; Lamparelli E.P.; Crescenzi M.A.; Vitale M.; Vatrella A.; Nucera F.; Brun P.; Caicci F.; Dama P.; Stiff T.; Castellano L.; Idrees S.; Johansen M.D.; Faiz A.; Wark P.A.; Hansbro P.M.; Adcock I.M.; Caramori G.; Stellato C.,"Salvato, Ilaria (57094150200); Ricciardi, Luca (57196007340); Dal Col, Jessica (57220091891); Nigro, Annunziata (57200701277); Giurato, Giorgio (36773300600); Memoli, Domenico (37063512400); Sellitto, Assunta (57190859944); Lamparelli, Erwin Pavel (57216362380); Crescenzi, Maria Assunta (57214914829); Vitale, Monica (58367088700); Vatrella, Alessandro (6701595368); Nucera, Francesco (57202946185); Brun, Paola (55093824900); Caicci, Federico (8734744600); Dama, Paola (54392647700); Stiff, Thomas (6506264568); Castellano, Leandro (24467486900); Idrees, Sobia (55429771900); Johansen, Matt D. (57202983408); Faiz, Alen (55601365200); Wark, Peter A. (7003559516); Hansbro, Philip M. (6603119390); Adcock, Ian M. (7007066538); Caramori, Gaetano (7003847659); Stellato, Cristiana (6701383040)",57094150200; 57196007340; 57220091891; 57200701277; 36773300600; 37063512400; 57190859944; 57216362380; 57214914829; 58367088700; 6701595368; 57202946185; 55093824900; 8734744600; 54392647700; 6506264568; 24467486900; 55429771900; 57202983408; 55601365200; 7003559516; 6603119390; 7007066538; 7003847659; 6701383040,Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation,2023,Frontiers in Immunology,14,,1192028,,,,4,10.3389/fimmu.2023.1192028,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85165307581&doi=10.3389%2ffimmu.2023.1192028&partnerID=40&md5=d633b8a0ff1cc6a29120b2cf5ee18dd6,"Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Respiratory Medicine Unit, Department of Biomedical Sciences, Dentistry and Morphological and Functional Imaging (BIOMORF), University of Messina, Messina, Italy; Department of Molecular Medicine, University of Padua, Padua, Italy; Department of Biology, University of Padua, Padua, Italy; Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, United Kingdom; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Immune Health, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; National Heart and Lung Institute, Imperial College London and the National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre, London, United Kingdom","Salvato I., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy, Respiratory Medicine Unit, Department of Biomedical Sciences, Dentistry and Morphological and Functional Imaging (BIOMORF), University of Messina, Messina, Italy; Ricciardi L., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy, Respiratory Medicine Unit, Department of Biomedical Sciences, Dentistry and Morphological and Functional Imaging (BIOMORF), University of Messina, Messina, Italy; Dal Col J., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Nigro A., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Giurato G., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Memoli D., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Sellitto A., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Lamparelli E.P., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Crescenzi M.A., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Vitale M., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Vatrella A., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy; Nucera F., Respiratory Medicine Unit, Department of Biomedical Sciences, Dentistry and Morphological and Functional Imaging (BIOMORF), University of Messina, Messina, Italy; Brun P., Department of Molecular Medicine, University of Padua, Padua, Italy; Caicci F., Department of Biology, University of Padua, Padua, Italy; Dama P., Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, United Kingdom; Stiff T., Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, United Kingdom; Castellano L., Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, United Kingdom; Idrees S., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Johansen M.D., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Faiz A., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Wark P.A., Immune Health, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia, Immune Health, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Adcock I.M., National Heart and Lung Institute, Imperial College London and the National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre, London, United Kingdom; Caramori G., Respiratory Medicine Unit, Department of Biomedical Sciences, Dentistry and Morphological and Functional Imaging (BIOMORF), University of Messina, Messina, Italy; Stellato C., Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Salerno, Italy",airway epithelium; AU-rich element factor 1 (AUF-1); cell senescence; chronic inflammation; chronic obstructive pulmonary disease; inflammaging; oxidative stress; RNA-binding proteins,"Cellular Senescence; Epithelial Cells; Epithelium; Humans; Inflammation; Pulmonary Disease, Chronic Obstructive; RNA; RNA-Binding Proteins; biotin; CD63 antigen; CD9 antigen; cigarette smoke; early growth response factor 1; gamma interferon; glutaraldehyde; histone deacetylase 2; interleukin 1beta; interleukin 6; messenger RNA; mucin 1; nanoparticle; phycoerythrin; protein p21; protein p53; RNA binding protein; small interfering RNA; transforming growth factor beta1; tristetraprolin; tumor necrosis factor; uranyl acetate; RNA; RNA binding protein; 3' untranslated region; aging; airway epithelium cell; amino acid sequence; Article; AU rich element; BEAS-2B cell line; bronchiole epithelium; cell cycle arrest; cell viability; chronic obstructive lung disease; down regulation; electrocardiogram; epithelial cell line; epithelium; exosome; gene control; gene expression; gene ontology; gene set variation analysis; genetic transcription; human; human cell; human tissue; immunoblotting; immunoprecipitation; inflammaging; inflammation; lung biopsy; lung cancer; lung function test; lysosome; mRNA expression assay; ontology; oxidative stress; particle size; photon correlation spectroscopy; prediction; principal component analysis; protein analysis; protein expression; protein function; protein synthesis; real time polymerase chain reaction; respiratory epithelium; RNA extraction; RNA immunoprecipitation; RNA sequence; senescence; senescence-associated secretory phenotype; single cell RNA seq; smoking; steady state; thorax radiography; transcription initiation; transcriptomics; transmission electron microscopy; cell aging; chronic obstructive lung disease; epithelium cell; genetics; inflammation; metabolism; pathology",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85165307581
Shahdab N.; Ward C.; Hansbro P.M.; Cummings S.; Young J.S.; Moheimani F.,"Shahdab, Nafeesa (57910209600); Ward, Christopher (57196516302); Hansbro, Philip M. (6603119390); Cummings, Stephen (7201936559); Young, John S. (35081530600); Moheimani, Fatemeh (36157216000)",57910209600; 57196516302; 6603119390; 7201936559; 35081530600; 36157216000,"Distinct Effects of Respiratory Viral Infection Models on miR-149-5p, IL-6 and p63 Expression in BEAS-2B and A549 Epithelial Cells",2024,Cells,13,11,919,,,,0,10.3390/cells13110919,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195845317&doi=10.3390%2fcells13110919&partnerID=40&md5=6246c5de6e82953b90db3e909f471155,"National Horizons Centre, School of Health and Life Sciences, Teesside University, Middlesbrough, TS1 3BX, United Kingdom; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Department of Life Sciences, Manchester Metropolitan University, Manchester, M15 6BH, United Kingdom","Shahdab N., National Horizons Centre, School of Health and Life Sciences, Teesside University, Middlesbrough, TS1 3BX, United Kingdom; Ward C., Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Cummings S., National Horizons Centre, School of Health and Life Sciences, Teesside University, Middlesbrough, TS1 3BX, United Kingdom; Young J.S., National Horizons Centre, School of Health and Life Sciences, Teesside University, Middlesbrough, TS1 3BX, United Kingdom; Moheimani F., Department of Life Sciences, Manchester Metropolitan University, Manchester, M15 6BH, United Kingdom",epithelial cells; IL-6; miR-149-5p; p63; poly (I:C); SARS-CoV-2 spike protein,"A549 Cells; COVID-19; Epithelial Cells; Gene Expression Regulation; Humans; Interleukin-6; MicroRNAs; Poly I-C; SARS-CoV-2; Transcription Factors; Tumor Suppressor Proteins; interleukin 6; lactate dehydrogenase; microRNA; microRNA 149 5p; protein p63; toll like receptor 2; toll like receptor 3; unclassified drug; viral protein; IL6 protein, human; interleukin 6; microRNA; MIRN149 microRNA, human; polyinosinic polycytidylic acid; TP63 protein, human; transcription factor; tumor suppressor protein; A-549 cell line; Article; BEAS-2B cell line; cell viability assay; controlled study; down regulation; enzyme linked immunosorbent assay; epithelium cell; fluorescence microscopy; gene expression; genetic transfection; human; human cell; immunoblotting; real time polymerase chain reaction; respiratory tract inflammation; reverse transcription polymerase chain reaction; upregulation; viral respiratory tract infection; A-549 cell line; coronavirus disease 2019; drug effect; gene expression regulation; genetics; metabolism; Severe acute respiratory syndrome coronavirus 2; virology",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85195845317
Jessamine V.; Mehndiratta S.; De Rubis G.; Paudel K.R.; Shetty S.; Suares D.; Chellappan D.K.; Oliver B.G.; Hansbro P.M.; Dua K.,"Jessamine, Victoria (58868227200); Mehndiratta, Samir (58708275900); De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Shetty, Saritha (57201969043); Suares, Divya (37122863300); Chellappan, Dinesh Kumar (35811890500); Oliver, Brian G. (15919869900); Hansbro, Phillip M. (6603119390); Dua, Kamal (15759138700)",58868227200; 58708275900; 57196257973; 56539588400; 57201969043; 37122863300; 35811890500; 15919869900; 6603119390; 15759138700,The application of nanoparticles as advanced drug delivery systems in Attenuating COPD,2024,Heliyon,10,3,e25393,,,,8,10.1016/j.heliyon.2024.e25393,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85184309970&doi=10.1016%2fj.heliyon.2024.e25393&partnerID=40&md5=7b765030661658afa6ea18573ed78d84,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute and University of technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's, NMIMS Deemed to Be University, Maharashtra, Mumbai, 400056, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 578000, Malaysia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia","Jessamine V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Mehndiratta S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute and University of technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Shetty S., Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's, NMIMS Deemed to Be University, Maharashtra, Mumbai, 400056, India; Suares D., Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's, NMIMS Deemed to Be University, Maharashtra, Mumbai, 400056, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 578000, Malaysia; Oliver B.G., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Clinical trials; COPD; Drug delivery; Inhaled corticosteroids; miRNA nanotherapeutics; Nanoparticles; Polymeric nanoparticles,,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85184309970
Mohamad M.S.B.; Reyes R.-J.; De Rubis G.; Paudel K.R.; Hansbro P.M.; Dua K.; Chellappan D.K.,"Mohamad, Mohamad Siddiq Bin (58095765400); Reyes, Ruby-Jean (57941713800); De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",58095765400; 57941713800; 57196257973; 56539588400; 6603119390; 15759138700; 35811890500,THE VERSATILITY OF 18Β-GLYCYRRHETINIC ACID IN ATTENUATING PULMONARY INFLAMMATORY DISORDERS,2023,EXCLI Journal,22,,,188,190,2,6,10.17179/excli2023-5845,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147693912&doi=10.17179%2fexcli2023-5845&partnerID=40&md5=d0468caa9c82a0953e6743369e7a905f,"School of Postgraduate Studies, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Center of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Mohamad M.S.B., School of Postgraduate Studies, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia, Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Reyes R.-J., Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; De Rubis G., Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Paudel K.R., Center of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Hansbro P.M., Center of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Dua K., Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia",,glycyrrhetinic acid; heme oxygenase 1; immunoglobulin E; immunoglobulin enhancer binding protein; interleukin 13; interleukin 5; mitogen activated protein kinase; ovalbumin; reactive oxygen metabolite; retinoid related orphan receptor gamma; STAT6 protein; thromboxane synthase; transcription factor FOXP3; transcription factor GATA 3; transcription factor Nrf2; A-549 cell line; antiinflammatory activity; antineoplastic activity; asthma; B lymphocyte; cell activation; cell proliferation; clinical practice; cytotoxicity; enzyme inhibition; Foxp3 gene; G2 phase cell cycle checkpoint; GATA 3 gene; gene expression; HO 1 gene; human; IgE gene; IL 13 gene; IL 5 gene; in vivo study; Letter; lung alveolus macrophage; lung function; nanotechnology; NF kB gene; NF kB signaling; nonhuman; Nrf2 gene; oxidative stress; physical chemistry; pneumonia; protein phosphorylation; RORy gene; STAT6 gene,Letter,Final,,Scopus,2-s2.0-85147693912
Patel V.K.; Kokkinis S.; De Rubis G.; Hansbro P.M.; Paudel K.R.; Dua K.,"Patel, Vyoma K. (57193533009); Kokkinis, Sofia (58631105400); De Rubis, Gabriele (57196257973); Hansbro, Philip Michael (6603119390); Paudel, Keshav Raj (56539588400); Dua, Kamal (15759138700)",57193533009; 58631105400; 57196257973; 6603119390; 56539588400; 15759138700,CURCUMIN LIPOSOMES ATTENUATE THE EXPRESSION OF CIGARETTE SMOKE EXTRACT-INDUCED INFLAMMATORY MARKERS IL-8 AND IL-24 IN VITRO,2024,EXCLI Journal,23,,,904,907,3,2,10.17179/excli2024-7467,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85206078888&doi=10.17179%2fexcli2024-7467&partnerID=40&md5=c096157ba0716c8cae37779421aa1b1c,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Faculty of Health and Medicine, School of Clinical Medicine, University of New South Wales, 2052, NSW, Australia; Pharmako Biotechnologies, Frenchs Forest, 2086, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia","Patel V.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia, Faculty of Health and Medicine, School of Clinical Medicine, University of New South Wales, 2052, NSW, Australia; Kokkinis S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia, Pharmako Biotechnologies, Frenchs Forest, 2086, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",airway inflammation; cigarette smoke; COPD; curcumin; IL-24; IL-8; liposomes,cigarette smoke; curcumin; interleukin 24; interleukin 8; liposome; plexozome; antiinflammatory activity; antioxidant activity; cell infiltration; chronic obstructive lung disease; cigarette smoking; concentration response; human; immune signaling; in vitro study; inflammatory cell; Letter; lung injury; outcome assessment; protein expression,Letter,Final,,Scopus,2-s2.0-85206078888
Bani Saeid A.; Patel V.K.; Mehndiratta S.; Rajput R.; Kundu R.K.; Singh S.K.; Chellappan D.K.; Kokkinis S.; De Rubis G.; Collet T.; Paudel K.R.; Hansbro P.M.; Dua K.,"Bani Saeid, Ayeh (58635250800); Patel, Vyoma K. (57193533009); Mehndiratta, Samir (58708275900); Rajput, Rashi (58196313700); Kundu, Ramesh Kumar (58635486700); Singh, Sachin Kumar (57206711834); Chellappan, Dinesh Kumar (35811890500); Kokkinis, Sofia (58631105400); De Rubis, Gabriele (57196257973); Collet, Trudi (36898251800); Paudel, Keshav Raj (56539588400); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",58635250800; 57193533009; 58708275900; 58196313700; 58635486700; 57206711834; 35811890500; 58631105400; 57196257973; 36898251800; 56539588400; 6603119390; 15759138700,Dissecting the in vitro fate of plant-derived bioactive encapsulated nanoparticles in lung diseases,2023,Food Bioscience,56,,103205,,,,6,10.1016/j.fbio.2023.103205,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85173461790&doi=10.1016%2fj.fbio.2023.103205&partnerID=40&md5=b828d8975baef24424ef90f494572852,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, 144411, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Innovative Medicines Group, Faculty of Health, Queensland University of Technology, Brisbane City, 4000, QLD, Australia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Uttaranchal Institute of Pharmaceutical Sciences, he endo Uttaranchal University, Dehradun, India","Bani Saeid A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Patel V.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; Mehndiratta S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Rajput R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Kundu R.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, 144411, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Kokkinis S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Collet T., Innovative Medicines Group, Faculty of Health, Queensland University of Technology, Brisbane City, 4000, QLD, Australia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, he endo Uttaranchal University, Dehradun, India",Anti-Inflammation; Encapsulated nanoparticles; Herbal medicine; Lung disease; Natural products; Novel drug delivery,,Review,Final,,Scopus,2-s2.0-85173461790
Eapen M.S.; Lu W.; Dey S.; Chia C.; Hardikar A.; Hassan M.I.; Bhattarai P.; Gaikwad A.V.; Das S.; Hansbro P.M.; Singhera G.K.; Hackett T.-L.; Sohal S.S.,"Eapen, Mathew Suji (56625716100); Lu, Wenying (57202573402); Dey, Surajit (57218127423); Chia, Collin (57204561315); Hardikar, Ashutosh (6602989972); Hassan, Md Imtaiyaz (7401625549); Bhattarai, Prem (57219521404); Gaikwad, Archana Vijay (57209282002); Das, Shatarupa (57223007601); Hansbro, Philip M. (6603119390); Singhera, Gurpreet Kaur (14032461100); Hackett, Tillie-Louise (15765031200); Sohal, Sukhwinder Singh (36449981500)",56625716100; 57202573402; 57218127423; 57204561315; 6602989972; 7401625549; 57219521404; 57209282002; 57223007601; 6603119390; 14032461100; 15765031200; 36449981500,Differential expression of mast cells in the small airways and alveolar septa of current smokers and patients with small airway disease and COPD,2024,ERJ Open Research,10,2,00579-2023,,,,1,10.1183/23120541.00579-2023,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85189550779&doi=10.1183%2f23120541.00579-2023&partnerID=40&md5=2ec2ed9604120a60bf05b767feb0a112,"Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Launceston Respiratory and Sleep Centre, Launceston, Australia; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia; Department of Cardiothoracic Surgery, Royal Hobart Hospital, Hobart, Australia; Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India; Faculty of Science, Centre for Inflammation, Centenary Institute and University of Technology Sydney School of Life Sciences, Sydney, Australia; Department of Anaesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, BC, Canada","Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Lu W., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia, Launceston Respiratory and Sleep Centre, Launceston, Australia; Dey S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Chia C., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia, Launceston Respiratory and Sleep Centre, Launceston, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia; Hardikar A., Department of Cardiothoracic Surgery, Royal Hobart Hospital, Hobart, Australia; Hassan M.I., Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India; Bhattarai P., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Gaikwad A.V., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Das S., Faculty of Science, Centre for Inflammation, Centenary Institute and University of Technology Sydney School of Life Sciences, Sydney, Australia; Hansbro P.M., Faculty of Science, Centre for Inflammation, Centenary Institute and University of Technology Sydney School of Life Sciences, Sydney, Australia; Singhera G.K., Department of Anaesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada, Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, BC, Canada; Hackett T.-L., Department of Anaesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada, Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, BC, Canada; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia, Launceston Respiratory and Sleep Centre, Launceston, Australia",,alkaline phosphatase; lysosome associated membrane protein; tryptase; adult; Article; chronic obstructive lung disease; clinical article; collagen 1 index; controlled study; current smoker; diffusing capacity for carbon monoxide; female; fibronectin index; forced expiratory flow; forced expiratory volume; forced vital capacity; human; human tissue; image analysis; immunohistochemistry; lung alveolus wall; lung epithelium; lung function; lung parenchyma; male; mast cell; mast cell degranulation; non small cell lung cancer; protein expression; respiratory tract parameters; small airway disease; small airway wall thickness; smoking; smoking cessation; smooth muscle thickness,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85189550779
Tu X.; Gomez H.M.; Kim R.Y.; Brown A.C.; de Jong E.; Galvao I.; Faiz A.; Bosco A.; Horvat J.C.; Hansbro P.; Donovan C.,"Tu, Xiaofan (57222147245); Gomez, Henry M. (57191960363); Kim, Richard Y. (35810406900); Brown, Alexandra C. (55637745000); de Jong, Emma (56878432200); Galvao, Izabela (56656390800); Faiz, Alen (55601365200); Bosco, Anthony (7006356547); Horvat, Jay C. (9942405300); Hansbro, Philip (6603119390); Donovan, Chantal (55357105200)",57222147245; 57191960363; 35810406900; 55637745000; 56878432200; 56656390800; 55601365200; 7006356547; 9942405300; 6603119390; 55357105200,Airway and parenchyma transcriptomics in a house dust mite model of experimental asthma,2023,Respiratory Research,24,1,32,,,,3,10.1186/s12931-022-02298-x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85146812242&doi=10.1186%2fs12931-022-02298-x&partnerID=40&md5=2fa6bcefb709f5d896fd1d763339d672,"Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Centre for Health Research, Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Asthma and Airway Disease Research Center, University of Arizona, AZ, United States","Tu X., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Gomez H.M., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Kim R.Y., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Brown A.C., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; de Jong E., Centre for Health Research, Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia; Galvao I., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Faiz A., Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Bosco A., Asthma and Airway Disease Research Center, University of Arizona, AZ, United States; Horvat J.C., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Donovan C., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia",AHR; Asthma; House dust mite; Remodeling; SPI1; Transcriptomics,"Animals; Asthma; Collagen; Disease Models, Animal; Humans; Lung; Pyroglyphidae; Transcription Factors; Transcriptome; collagen; DB1976; DB2313; E74 like factor 4; metal response element binding transcription factor 1; transcription factor; transcription factor EC; transcription factor PU 1; unclassified drug; transcription factor; transcriptome; airway; animal experiment; animal model; animal tissue; Article; bronchoalveolar lavage fluid; controlled study; Dermatophagoides; differential gene expression; down regulation; experimental asthma; female; homeobox; immune response; lung function; lung parenchyma; mouse; mucous cell; network analysis; nonhuman; parenchyma; principal component analysis; real time reverse transcription polymerase chain reaction; respiratory tract inflammation; RNA extraction; RNA sequence; transcriptomics; upregulation; animal; asthma; disease model; human; lung; metabolism; Pyroglyphidae",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85146812242
Chakraborty A.; Paudel K.R.; Wang C.; De Rubis G.; Chellappan D.K.; Hansbro P.M.; Samuel C.S.; Dua K.,"Chakraborty, Amlan (56714779500); Paudel, Keshav Raj (56539588400); Wang, Chao (57189270455); De Rubis, Gabriele (57196257973); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip Michael (6603119390); Samuel, Chrishan S. (7101923680); Dua, Kamal (15759138700)",56714779500; 56539588400; 57189270455; 57196257973; 35811890500; 6603119390; 7101923680; 15759138700,ANTI-INFLAMMATORY AND ANTI-FIBROTIC EFFECTS OF BERBERINE-LOADED LIQUID CRYSTALLINE NANOPARTICLES,2023,EXCLI Journal,22,,,1104,1108,4,4,10.17179/excli2023-6467,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85175048058&doi=10.17179%2fexcli2023-6467&partnerID=40&md5=1c3a2168e091a23cbfecc89b79abb7cf,"Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom; Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, 3800, VIC, Australia; Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2050, NSW, Australia; Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Chakraborty A., Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom, Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, 3800, VIC, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2050, NSW, Australia, Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Wang C., Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, 3800, VIC, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2050, NSW, Australia, Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Samuel C.S., Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, 3800, VIC, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",,alpha smooth muscle actin; berberine; collagen type 1; liquid crystalline nanoparticle; nanoparticle; transforming growth factor beta; unclassified drug; antifibrotic activity; antiinflammatory activity; human; human cell; Letter; protein expression; skin fibroblast,Letter,Final,,Scopus,2-s2.0-85175048058
De Rubis G.; Paudel K.R.; Allam V.S.R.R.; Malyla V.; Subramaniyan V.; Singh S.K.; Panth N.; Gupta G.; Hansbro P.M.; Chellappan D.K.; Dua K.,"De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Allam, Venkata Sita Rama Raju (57200203739); Malyla, Vamshikrishna (57205128961); Subramaniyan, Vetriselvan (56721233900); Singh, Sachin Kumar (57206711834); Panth, Nisha (57094240100); Gupta, Gaurav (15047988400); Hansbro, Philip Michael (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",57196257973; 56539588400; 57200203739; 57205128961; 56721233900; 57206711834; 57094240100; 15047988400; 6603119390; 35811890500; 15759138700,"Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles",2024,Pathology Research and Practice,253,,154971,,,,11,10.1016/j.prp.2023.154971,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85178382261&doi=10.1016%2fj.prp.2023.154971&partnerID=40&md5=5f5503ca1b0509d83baf27f8ce9c7d3d,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Pharmacology Unit, Jeffrey Cheah School of Medicineand Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Selangor Darul Ehsan, Bandar Sunway, 47500, Malaysia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar‑Delhi G.T Road, Punjab, Phagwara, India; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India; School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Allam V.S.R.R., Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia, Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Subramaniyan V., Pharmacology Unit, Jeffrey Cheah School of Medicineand Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Selangor Darul Ehsan, Bandar Sunway, 47500, Malaysia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar‑Delhi G.T Road, Punjab, Phagwara, India; Panth N., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Gupta G., Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India, School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",Advanced drug delivery systems; Berberine; Lung cancer; Nanoparticles; Phytoceuticals,"Antigens, Neoplasm; Berberine; Carbonic Anhydrase IX; Epithelial Cell Adhesion Molecule; Humans; Lung Neoplasms; Nanoparticles; Neoplasms; Osteopontin; Receptors, Estrogen; berberine; carbonate dehydratase IX; epithelial cell adhesion molecule; estrogen receptor alpha; liquid crystalline nanoparticle; nanoparticle; osteopontin; unclassified drug; berberine; carbonate dehydratase IX; epithelial cell adhesion molecule; estrogen receptor; osteopontin; tumor antigen; A-549 cell line; antineoplastic activity; Article; cell survival; concentration (parameter); controlled study; drug delivery system; drug penetration; drug solubility; human; human cell; in vitro study; lung alveolus epithelium cell; lung cancer; nanoencapsulation; non small cell lung cancer; protein expression; protein function; lung tumor; metabolism; neoplasm",Article,Final,,Scopus,2-s2.0-85178382261
Paudel K.R.; Singh M.; De Rubis G.; Kumbhar P.; Mehndiratta S.; Kokkinis S.; El-Sherkawi T.; Gupta G.; Singh S.K.; Malik M.Z.; Mohammed Y.; Oliver B.G.; Disouza J.; Patravale V.; Hansbro P.M.; Dua K.,"Paudel, Keshav Raj (56539588400); Singh, Manisha (57214312793); De Rubis, Gabriele (57196257973); Kumbhar, Popat (57202303372); Mehndiratta, Samir (58708275900); Kokkinis, Sofia (58631105400); El-Sherkawi, Tammam (58631184300); Gupta, Gaurav (15047988400); Singh, Sachin Kumar (57206711834); Malik, Md. Zubbair (55640514700); Mohammed, Yousuf (56116912300); Oliver, Brian G. (15919869900); Disouza, John (6506849197); Patravale, Vandana (57207504972); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",56539588400; 57214312793; 57196257973; 57202303372; 58708275900; 58631105400; 58631184300; 15047988400; 57206711834; 55640514700; 56116912300; 15919869900; 6506849197; 57207504972; 6603119390; 15759138700,Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies,2024,Life Sciences,352,,122859,,,,0,10.1016/j.lfs.2024.122859,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196955063&doi=10.1016%2fj.lfs.2024.122859&partnerID=40&md5=5649356df6de97d071d6b479e9867698,"Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Department of Biotechnology, Jaypee Institute of Information Technology (JIIT), Uttar Pradesh, Noida, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Warananagar, Tal: Panhala, Maharashtra, Dist: Kolhapur, 416113, India; Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Punjab, Rajpura, 140401, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman, Kuwait city, 15462, Kuwait; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, QLD, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Maharashtra, Mumbai, 400019, India","Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Singh M., Department of Biotechnology, Jaypee Institute of Information Technology (JIIT), Uttar Pradesh, Noida, India, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Kumbhar P., Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Warananagar, Tal: Panhala, Maharashtra, Dist: Kolhapur, 416113, India; Mehndiratta S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Kokkinis S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; El-Sherkawi T., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Gupta G., Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Punjab, Rajpura, 140401, India, Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; Malik M.Z., Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman, Kuwait city, 15462, Kuwait; Mohammed Y., Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, QLD, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Disouza J., Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Warananagar, Tal: Panhala, Maharashtra, Dist: Kolhapur, 416113, India; Patravale V., Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Maharashtra, Mumbai, 400019, India; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Computational biology; Docking; Drug repurposing; Lung cancer; Molecular dynamics; Ribavirin,A549 Cells; Adenocarcinoma of Lung; Antineoplastic Agents; Antiviral Agents; Apoptosis; Cell Movement; Cell Proliferation; Computational Biology; Drug Repositioning; Humans; Lung Neoplasms; Molecular Docking Simulation; Ribavirin; ribavirin; antineoplastic agent; antivirus agent; A-549 cell line; acute myeloid leukemia; angiogenesis; antineoplastic activity; antitumorigenic activity; apoptosis; Article; bioinformatics; cell migration; cell proliferation; colony formation; controlled study; glioblastoma; hepatitis C; human; human cell; in vitro study; lung adenocarcinoma; lung cancer; molecular docking; molecular dynamics; nasopharynx carcinoma; protein expression; protein protein interaction; reverse transcription polymerase chain reaction; RNA extraction; transwell assay; turnaround time; wound healing assay; cell motion; cell proliferation; drug effect; drug repositioning; drug therapy; genetics; lung tumor; metabolism; pathology; procedures,Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85196955063
Paudel K.R.; Rajput R.; De Rubis G.; Raju Allam V.S.R.; Williams K.A.; Singh S.K.; Gupta G.; Salunke P.; Hansbro P.M.; Gerlach J.; Dua K.,"Paudel, Keshav Raj (56539588400); Rajput, Rashi (58196313700); De Rubis, Gabriele (57196257973); Raju Allam, Venkata Sita Rama (57200203739); Williams, Kylie Anne (7404142756); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Salunke, Prakash (57918359000); Hansbro, Philip Michael (6603119390); Gerlach, Joachim (58713053300); Dua, Kamal (15759138700)",56539588400; 58196313700; 57196257973; 57200203739; 7404142756; 57206711834; 15047988400; 57918359000; 6603119390; 58713053300; 15759138700,"In vitro anti-cancer activity of a polyherbal preparation, VEDICINALS®9, against A549 human lung adenocarcinoma cells",2023,Pathology Research and Practice,250,,154832,,,,14,10.1016/j.prp.2023.154832,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85172234304&doi=10.1016%2fj.prp.2023.154832&partnerID=40&md5=7cc72d3c20061c2183085a958eb5e30f,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Medical Biochemistry and Microbiology, Biomedical Centre (BMC), Uppsala University, Uppsala, Sweden; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, India; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Vedicinals India Private Limited, Maharashtra, Pune, India; School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India","Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Rajput R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Raju Allam V.S.R., Department of Medical Biochemistry and Microbiology, Biomedical Centre (BMC), Uppsala University, Uppsala, Sweden; Williams K.A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, India, Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India; Salunke P., Vedicinals India Private Limited, Maharashtra, Pune, India; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Gerlach J., Vedicinals India Private Limited, Maharashtra, Pune, India; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Angiogenesis; Lung cancer; Migration; Proliferation; VEDICINALS®9,amphiregulin; antineoplastic agent; AXL receptor tyrosine kinase; baculoviral IAP repeat containing protein 5; cathepsin B; cathepsin D; dickkopf 1 protein; endostatin; enolase; enolase 2; fibroblast growth factor 2; herbaceous agent; progranulin; protein bcl x; protein p53; unclassified drug; urokinase; vedicinal 9; A-549 cell line; antiproliferative activity; Article; human; human cell; in vitro study; migration inhibition; protein expression,Article,Final,,Scopus,2-s2.0-85172234304
Idrees S.; Chen H.; Panth N.; Paudel K.R.; Hansbro P.M.,"Idrees, Sobia (55429771900); Chen, Hao (57223198715); Panth, Nisha (57094240100); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390)",55429771900; 57223198715; 57094240100; 56539588400; 6603119390,Exploring Viral–Host Protein Interactions as Antiviral Therapies: A Computational Perspective,2024,Microorganisms,12,3,630,,,,2,10.3390/microorganisms12030630,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85189084839&doi=10.3390%2fmicroorganisms12030630&partnerID=40&md5=491555260597fbbec94bfca7de3c508e,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia","Idrees S., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Chen H., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Panth N., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia",antiviral therapies; protein–protein interactions; viral–host interactions,,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85189084839
Malyla V.; De Rubis G.; Paudel K.R.; Chellappan D.K.; Hansbro N.G.; Hansbro P.M.; Dua K.,"Malyla, Vamshikrishna (57205128961); De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Chellappan, Dinesh Kumar (35811890500); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57205128961; 57196257973; 56539588400; 35811890500; 15055862300; 6603119390; 15759138700,"Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition in lung adenocarcinoma",2023,Naunyn-Schmiedeberg's Archives of Pharmacology,396,12,,3595,3603,8,13,10.1007/s00210-023-02553-y,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85160814870&doi=10.1007%2fs00210-023-02553-y&partnerID=40&md5=24dbc1ad442738268f58309fed0607fd,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, Sydney, 2050, NSW, Australia; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia","Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, Sydney, 2050, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Hansbro N.G., Centre for Inflammation, Centenary Institute, Sydney, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, Sydney, 2050, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Berberine; Lung cancer; Molecular simulation; Nano-formulations; WNT/ß-catenin signalling pathway,"Adenocarcinoma of Lung; Berberine; beta Catenin; Catenins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Nanostructures; Wnt Signaling Pathway; antineoplastic agent; berberine; beta catenin; isoquinoline alkaloid; nanomaterial; berberine; beta catenin; catenin; A-549 cell line; antiinflammatory activity; antineoplastic activity; Article; cancer growth; controlled study; drug bioavailability; drug solubility; epithelial mesenchymal transition; human; human cell; liquid crystal; lung adenocarcinoma; lung adenocarcinoma cell line; molecular docking; physical chemistry; protein expression; Wnt signaling; cell motion; cell proliferation; epithelial mesenchymal transition; lung adenocarcinoma; lung tumor; metabolism; tumor cell line",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85160814870
Horvat J.C.; Kim R.Y.; Weaver N.; Augood C.; Brown A.C.; Donovan C.; Dupre P.; Gunawardhana L.; Mayall J.R.; Hansbro N.G.; Robertson A.A.B.; O’Neill L.A.J.; Cooper M.A.; Holliday E.G.; Hansbro P.M.; Gibson P.G.,"Horvat, Jay C. (9942405300); Kim, Richard Y. (35810406900); Weaver, Natasha (35304314700); Augood, Christopher (58740269600); Brown, Alexandra C. (55637745000); Donovan, Chantal (55357105200); Dupre, Pierrick (59266001200); Gunawardhana, Lakshitha (54895678200); Mayall, Jemma R. (55607222700); Hansbro, Nicole G. (15055862300); Robertson, Avril A. B. (15519764900); O’Neill, Luke A. J. (7103393094); Cooper, Matthew A. (7404411451); Holliday, Elizabeth G. (8879831700); Hansbro, Philip M. (6603119390); Gibson, Peter G. (7202414199)",9942405300; 35810406900; 35304314700; 58740269600; 55637745000; 55357105200; 59266001200; 54895678200; 55607222700; 15055862300; 15519764900; 7103393094; 7404411451; 8879831700; 6603119390; 7202414199,Characterization and inhibition of inflammasome responses in severe and non-severe asthma,2023,Respiratory Research,24,1,303,,,,4,10.1186/s12931-023-02603-2,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85178428589&doi=10.1186%2fs12931-023-02603-2&partnerID=40&md5=516e99d194445823a5fe15a78e7e484a,"University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Centenary Institute, Centre for Inflammation, and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; University of Montpellier, Montpellier Cancer Research Institute (IRCM), Montpellier, France; The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, Australia; Trinity College Dublin, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Dublin, Ireland; Sitala Bio Ltd., Cambridge, United Kingdom","Horvat J.C., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Kim R.Y., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Weaver N., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Augood C., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Centenary Institute, Centre for Inflammation, and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Brown A.C., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Donovan C., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Dupre P., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, University of Montpellier, Montpellier Cancer Research Institute (IRCM), Montpellier, France; Gunawardhana L., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Mayall J.R., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Hansbro N.G., Centenary Institute, Centre for Inflammation, and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Robertson A.A.B., The University of Queensland, School of Chemistry and Molecular Biosciences, Brisbane, Australia; O’Neill L.A.J., Trinity College Dublin, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Dublin, Ireland; Cooper M.A., Sitala Bio Ltd., Cambridge, United Kingdom; Holliday E.G., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Hansbro P.M., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Centenary Institute, Centre for Inflammation, and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Gibson P.G., University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia",Asthma; IL-1β; Inflammasome inhibition; NLRP3 inflammasome; Severe asthma,"Asthma; Female; Humans; Inflammasomes; Interleukin-1beta; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Sulfonamides; inflammasome; interleukin 1beta; nigericin; cryopyrin; interleukin 1beta; lipopolysaccharide; nigericin; sulfonamide; adult; Article; asthma; cell isolation; controlled study; eosinophil count; female; human; immunocompetent cell; major clinical study; male; neutrophil count; peripheral blood mononuclear cell; asthma; mononuclear cell",Article,Final,All Open Access; Gold Open Access,Scopus,2-s2.0-85178428589
Jha S.K.; De Rubis G.; Devkota S.R.; Zhang Y.; Adhikari R.; Jha L.A.; Bhattacharya K.; Mehndiratta S.; Gupta G.; Singh S.K.; Panth N.; Dua K.; Hansbro P.M.; Paudel K.R.,"Jha, Saurav Kumar (57210712565); De Rubis, Gabriele (57196257973); Devkota, Shankar Raj (57226007392); Zhang, Yali (57221502965); Adhikari, Radhika (57605938300); Jha, Laxmi Akhileshwar (57668775700); Bhattacharya, Kunal (57293082600); Mehndiratta, Samir (58708275900); Gupta, Gaurav (15047988400); Singh, Sachin Kumar (57206711834); Panth, Nisha (57094240100); Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390); Paudel, Keshav Raj (56539588400)",57210712565; 57196257973; 57226007392; 57221502965; 57605938300; 57668775700; 57293082600; 58708275900; 15047988400; 57206711834; 57094240100; 15759138700; 6603119390; 56539588400,Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions,2024,Ageing Research Reviews,97,,102315,,,,18,10.1016/j.arr.2024.102315,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85191996869&doi=10.1016%2fj.arr.2024.102315&partnerID=40&md5=1591e22a16222f54aca1e94805914ec8,"Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Monash Biomedicine Discovery Institute, and Department of Biochemistry and Molecular Biology, Monash University, Clayton, 3800, VIC, Australia; School of Chemical Engineering, University of Adelaide, Adelaide, 5005, Australia; College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Jeonnam, 58554, South Korea; Naraina Vidya Peeth Group of Institutions, Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam Technical University, Uttar Pradesh, Lucknow, 0208020, India; Pratiksha Institute of Pharmaceutical Sciences, Assam, Guwahati, 781026, India; Royal School of Pharmacy, The Assam Royal Global University, Assam, Guwahati, 781035, India; Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia","Jha S.K., Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Devkota S.R., Monash Biomedicine Discovery Institute, and Department of Biochemistry and Molecular Biology, Monash University, Clayton, 3800, VIC, Australia; Zhang Y., School of Chemical Engineering, University of Adelaide, Adelaide, 5005, Australia; Adhikari R., College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Jeonnam, 58554, South Korea; Jha L.A., Naraina Vidya Peeth Group of Institutions, Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam Technical University, Uttar Pradesh, Lucknow, 0208020, India; Bhattacharya K., Pratiksha Institute of Pharmaceutical Sciences, Assam, Guwahati, 781026, India, Royal School of Pharmacy, The Assam Royal Global University, Assam, Guwahati, 781035, India; Mehndiratta S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Gupta G., Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India; Panth N., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia",Cellular senescence; Lung cancer; Senescence-associated secretory phenotype; Senescence-targeting therapies; Tumor,"Animals; Carcinoma, Non-Small-Cell Lung; Cellular Senescence; Humans; Lung Neoplasms; antineoplastic agent; galactose; immune checkpoint inhibitor; nanocarrier; prodrug; proteolysis targeting chimera; senolytic agent; senomorphic agent; senotherapeutic agent; unclassified drug; cancer chemotherapy; cancer growth; cancer immunotherapy; cancer radiotherapy; cancer stem cell; cell aging; cell cycle arrest; clinical practice; clinical trial (topic); exosome; human; lung cancer; nonhuman; regulatory mechanism; Review; senescence-associated secretory phenotype; target cell; animal; genetics; lung tumor; non small cell lung cancer; pathology; physiology",Review,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85191996869
Budden K.F.; Gellatly S.L.; Vaughan A.; Amorim N.; Horvat J.C.; Hansbro N.G.; Wood D.L.A.; Hugenholtz P.; Dennis P.G.; Wark P.A.B.; Hansbro P.M.,"Budden, Kurtis F. (57191417986); Gellatly, Shaan L. (26430804400); Vaughan, Annalicia (55935627600); Amorim, Nadia (57221385895); Horvat, Jay C. (9942405300); Hansbro, Nicole G. (15055862300); Wood, David L. A. (55723732300); Hugenholtz, Philip (55811879700); Dennis, Paul G. (57197279960); Wark, Peter A. B. (7003559516); Hansbro, Philip M. (6603119390)",57191417986; 26430804400; 55935627600; 57221385895; 9942405300; 15055862300; 55723732300; 55811879700; 57197279960; 7003559516; 6603119390,Probiotic Bifidobacterium longum subsp. longum Protects against Cigarette Smoke-Induced Inflammation in Mice,2023,International Journal of Molecular Sciences,24,1,252,,,,12,10.3390/ijms24010252,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85145980322&doi=10.3390%2fijms24010252&partnerID=40&md5=b89bf12e98cb4e894ee5704d6d0fa197,"Priority Research Centre for Healthy Lungs and Immune Health Research Program, Hunter Medical Research Institute and The University of Newcastle, Callaghan, 2308, NSW, Australia; Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4102, QLD, Australia; School of Earth and Environmental Sciences, The University of Queensland, Brisbane, 4072, QLD, Australia","Budden K.F., Priority Research Centre for Healthy Lungs and Immune Health Research Program, Hunter Medical Research Institute and The University of Newcastle, Callaghan, 2308, NSW, Australia; Gellatly S.L., Priority Research Centre for Healthy Lungs and Immune Health Research Program, Hunter Medical Research Institute and The University of Newcastle, Callaghan, 2308, NSW, Australia; Vaughan A., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Amorim N., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs and Immune Health Research Program, Hunter Medical Research Institute and The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro N.G., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Wood D.L.A., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4102, QLD, Australia; Hugenholtz P., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4102, QLD, Australia; Dennis P.G., School of Earth and Environmental Sciences, The University of Queensland, Brisbane, 4072, QLD, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs and Immune Health Research Program, Hunter Medical Research Institute and The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs and Immune Health Research Program, Hunter Medical Research Institute and The University of Newcastle, Callaghan, 2308, NSW, Australia, Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia",acetate; Bifidobacterium; cigarette smoke; COPD; inflammation; probiotic; SCFA,Acetates; Animals; Bifidobacterium; Butyrates; Cigarette Smoking; Inflammation; Mice; Probiotics; acetic acid; alpha chemokine; beta chemokine; butyric acid; cigarette smoke; monocyte chemotactic protein 1; probiotic agent; tumor necrosis factor; butyric acid derivative; probiotic agent; animal experiment; animal model; animal tissue; Article; bacterial mutation; bacterial strain; Bifidobacterium longum subsp. longum; cecum; controlled study; female; mouse; nonhuman; pneumonia; protein expression; respiratory tract inflammation; animal; Bifidobacterium; cigarette smoking; inflammation,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85145980322
Kumar B.; Jha L.A.; Pandey P.; Iqbal S.F.; Thaleshwari S.; Banerjee K.; Imran M.; Anwaar S.; Subedi L.; Dubey V.; Mohammed Y.; Panth N.; Hansbro P.M.; Paudel K.R.; Jha S.K.; Bandyopadhyay A.,"Kumar, Bhupendra (58725608600); Jha, Laxmi Akhileshwar (57668775700); Pandey, Prashant (57424006500); Iqbal, Sayeda Fauzia (57219485491); Thaleshwari, Saahiba (57343449700); Banerjee, Kaushani (57297171200); Imran, Mohammad (57209466043); Anwaar, Shoaib (59197345800); Subedi, Laxman (57218826603); Dubey, Vishal (57823290600); Mohammed, Yousuf (56116912300); Panth, Nisha (57094240100); Hansbro, Philip M. (6603119390); Paudel, Keshav Raj (56539588400); Jha, Saurav Kumar (57210712565); Bandyopadhyay, Amitabha (58065362600)",58725608600; 57668775700; 57424006500; 57219485491; 57343449700; 57297171200; 57209466043; 59197345800; 57218826603; 57823290600; 56116912300; 57094240100; 6603119390; 56539588400; 57210712565; 58065362600,Unlocking the future of osteoarthritis: Material engineering and drug delivery confluence for advanced therapeutic approaches,2024,Journal of Drug Delivery Science and Technology,101,,106264,,,,0,10.1016/j.jddst.2024.106264,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85206080811&doi=10.1016%2fj.jddst.2024.106264&partnerID=40&md5=ecc4f0a3e978b92c56cd0e0df232c220,"Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Naraina Vidya Peeth Group of Institutions, Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam Technical University, Uttar Pradesh, Kanpur, 0208020, India; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, 38677-1848, United States; Department of Genetic Engineering, SRM Institute of Science and Technology (SRMIST), Tamil Nadu, Kattankulathur, 603203, India; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, QLD, Australia; Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Mokpo National University, Muan-gun, 58554, South Korea; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia","Kumar B., Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Jha L.A., Naraina Vidya Peeth Group of Institutions, Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam Technical University, Uttar Pradesh, Kanpur, 0208020, India; Pandey P., Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, 38677-1848, United States; Iqbal S.F., Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Thaleshwari S., Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Banerjee K., Department of Genetic Engineering, SRM Institute of Science and Technology (SRMIST), Tamil Nadu, Kattankulathur, 603203, India; Imran M., Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, QLD, Australia; Anwaar S., Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, QLD, Australia; Subedi L., Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Mokpo National University, Muan-gun, 58554, South Korea; Dubey V., Naraina Vidya Peeth Group of Institutions, Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam Technical University, Uttar Pradesh, Kanpur, 0208020, India; Mohammed Y., Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, QLD, Australia; Panth N., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Jha S.K., Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Bandyopadhyay A., Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India",Articular cartilage; Bone morphogenetic protein; Drug delivery; Matrix metalloproteinases; Nanomedicines; Osteoarthritis,beta catenin; bone morphogenetic protein; collagen; collagen type 10; collagen type 2; matrix metalloproteinase; proteoglycan; alkaline phosphatase level; articular cartilage; chondrocyte; drug delivery system; enchondral ossification; endoplasmic reticulum; gene expression; Golgi complex; joint mobility; nanomedicine; nonhuman; osteoarthritis; pharmaceutics; phenotype; physical chemistry; review; signal transduction; tenosynovitis; tissue engineering; vascularization,Review,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85206080811
Awatade N.T.; Reid A.T.; Nichol K.S.; Budden K.F.; Veerati P.C.; Pathinayake P.S.; Grainge C.L.; Hansbro P.M.; Wark P.A.B.,"Awatade, Nikhil T. (56554140500); Reid, Andrew T. (39561518600); Nichol, Kristy S. (57195914143); Budden, Kurtis F. (57191417986); Veerati, Punnam Chander (57200127768); Pathinayake, Prabuddha S. (55877978000); Grainge, Christopher L. (57192248350); Hansbro, Philip M. (6603119390); Wark, Peter A. B. (7003559516)",56554140500; 39561518600; 57195914143; 57191417986; 57200127768; 55877978000; 57192248350; 6603119390; 7003559516,"Comparison of commercially available differentiation media on cell morphology, function, and anti-viral responses in conditionally reprogrammed human bronchial epithelial cells",2023,Scientific Reports,13,1,11200,,,,7,10.1038/s41598-023-37828-0,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85164409424&doi=10.1038%2fs41598-023-37828-0&partnerID=40&md5=525c2aed9b42730b5671dd349a5d55ef,"School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Asthma and Breathing Research Program, Hunter Medical Research Institute University of Newcastle, New Lambton Heights, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Dept of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia","Awatade N.T., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Reid A.T., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Asthma and Breathing Research Program, Hunter Medical Research Institute University of Newcastle, New Lambton Heights, NSW, Australia; Nichol K.S., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Budden K.F., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Veerati P.C., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Asthma and Breathing Research Program, Hunter Medical Research Institute University of Newcastle, New Lambton Heights, NSW, Australia; Pathinayake P.S., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Grainge C.L., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Asthma and Breathing Research Program, Hunter Medical Research Institute University of Newcastle, New Lambton Heights, NSW, Australia, Dept of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia; Hansbro P.M., Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Wark P.A.B., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia, Asthma and Breathing Research Program, Hunter Medical Research Institute University of Newcastle, New Lambton Heights, NSW, Australia, Dept of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia",,Bronchi; Cell Differentiation; Chloride Channels; Cilia; Culture Media; Enterovirus Infections; Epithelial Cells; Humans; chloride channel; bronchus; cell differentiation; cilium; Enterovirus infection; epithelium cell; human,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85164409424
Attia J.; Horvat J.C.; Hunter T.; Hansbro P.M.; Hure A.; Peel R.; Ren S.; Dizon J.; Chiu S.; Srikusalanukul W.; Greenough R.; Abhayaratna W.P.; Newby D.; D'Este C.; Tonkin A.; Hopper I.; Levi C.; Sturm J.; Durrheim D.; Hung J.; Briffa T.; Chew D.; Anderson P.; Moon L.; McEvoy M.,"Attia, John (7003299759); Horvat, Jay C. (9942405300); Hunter, Tegan (57158691000); Hansbro, Philip M. (6603119390); Hure, Alexis (24070975100); Peel, Roseanne (55207142000); Ren, Shu (57189216570); Dizon, Joshua (58085115000); Chiu, Simon (57194409460); Srikusalanukul, Wichat (9246684000); Greenough, Robert (57195406569); Abhayaratna, Walter P. (12759938700); Newby, David (7006580756); D'Este, Catherine (6602084604); Tonkin, Andrew (34572757300); Hopper, Ingrid (57208096319); Levi, Christopher (57250209900); Sturm, Jonathan (7202194795); Durrheim, David (35551260900); Hung, Joseph (35409388600); Briffa, Tom (6507675518); Chew, Derek (7102026332); Anderson, Phil (24503016000); Moon, Lynelle (26641374700); McEvoy, Mark (8911690100)",7003299759; 9942405300; 57158691000; 6603119390; 24070975100; 55207142000; 57189216570; 58085115000; 57194409460; 9246684000; 57195406569; 12759938700; 7006580756; 6602084604; 34572757300; 57208096319; 57250209900; 7202194795; 35551260900; 35409388600; 6507675518; 7102026332; 24503016000; 26641374700; 8911690100,Persistence of Detectable Anti-Pneumococcal Antibodies 4 Years After Pneumococcal Polysaccharide Vaccination in a Randomised Controlled Trial: The Australian Study for the Prevention through Immunisation of Cardiovascular Events (AUSPICE),2023,Heart Lung and Circulation,32,11,,1378,1385,7,1,10.1016/j.hlc.2023.09.006,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85175318785&doi=10.1016%2fj.hlc.2023.09.006&partnerID=40&md5=b70cce9e82627e5de3ec8b73e6896714,"School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia; Department of Medicine, John Hunter Hospital, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Centenary UTS Centre for Inflammation, Sydney, NSW, Australia; Australian National University Medical School, Canberra Hospital, Canberra, ACT, Australia; I-MED Radiology Network, Canberra, ACT, Australia","Attia J., School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia, Department of Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Horvat J.C., Hunter Medical Research Institute, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Hunter T., Hunter Medical Research Institute, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Hunter Medical Research Institute, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Centenary UTS Centre for Inflammation, Sydney, NSW, Australia; Hure A., School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Peel R., School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Ren S., School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Dizon J., Hunter Medical Research Institute, Newcastle, NSW, Australia; Chiu S., Hunter Medical Research Institute, Newcastle, NSW, Australia; Srikusalanukul W., Australian National University Medical School, Canberra Hospital, Canberra, ACT, Australia; Greenough R., I-MED Radiology Network, Canberra, ACT, Australia; Abhayaratna W.P., Australian National University Medical School, Canberra Hospital, Canberra, ACT, Australia; Newby D.; D'Este C.; Tonkin A.; Hopper I.; Levi C.; Sturm J.; Durrheim D.; Hung J.; Briffa T.; Chew D.; Anderson P.; Moon L.; McEvoy M.",Anti-pneumococcal antibodies; Pneumococcal polysaccharide vaccination,Animals; Australia; Cardiovascular Diseases; Carotid Intima-Media Thickness; Humans; Immunoglobulin G; Immunoglobulin M; Mice; Pneumococcal Vaccines; Pulse Wave Analysis; Streptococcus pneumoniae; Vaccination; bacterium antibody; biological marker; C reactive protein; glucose; hemoglobin A1c; immunoglobulin G antibody; immunoglobulin M antibody; insulin; placebo; Pneumococcus antibody; Pneumococcus vaccine; unclassified drug; immunoglobulin G; immunoglobulin M; Pneumococcus vaccine; adult; antibody detection; antibody titer; Article; Australia; cardiovascular disease; carotid intima-media thickness; clinical outcome; controlled study; correlation analysis; disease marker; double blind procedure; fasting blood glucose level; fatality; female; follow up; heart protection; hemoglobin blood level; hepatorenal index; human; immunization; insulin blood level; major clinical study; male; middle aged; molecular mimicry; multicenter study; pneumococcal infection; pulse wave velocity; randomized controlled trial; statistical significance; urogenital system parameters; vaccination; animal; carotid intima-media thickness; epidemiology; mouse; pulse wave; Streptococcus pneumoniae; vaccination,Article,Final,,Scopus,2-s2.0-85175318785
Hardy S.A.; Liesinger L.; Patrick R.; Poettler M.; Rech L.; Gindlhuber J.; Mabotuwana N.S.; Ashour D.; Stangl V.; Bigland M.; Murtha L.A.; Starkey M.R.; Scherr D.; Hansbro P.M.; Hoefler G.; Campos Ramos G.; Cochain C.; Harvey R.P.; Birner-Gruenberger R.; Boyle A.J.; Rainer P.P.,"Hardy, Sean A. (57196034731); Liesinger, Laura (57188825489); Patrick, Ralph (55243324200); Poettler, Maria (58639183200); Rech, Lavinia (57220160698); Gindlhuber, Juergen (57201479231); Mabotuwana, Nishani S. (57196033700); Ashour, DiyaaEldin (57222272984); Stangl, Verena (58823994200); Bigland, Mark (55897105600); Murtha, Lucy A. (55210289700); Starkey, Malcolm R. (35811293400); Scherr, Daniel (22986579300); Hansbro, Philip M. (6603119390); Hoefler, Gerald (7004589408); Campos Ramos, Gustavo (15725998000); Cochain, Clement (24329110900); Harvey, Richard P. (7401535307); Birner-Gruenberger, Ruth (8964790100); Boyle, Andrew J. (35568329400); Rainer, Peter P. (35590576100)",57196034731; 57188825489; 55243324200; 58639183200; 57220160698; 57201479231; 57196033700; 57222272984; 58823994200; 55897105600; 55210289700; 35811293400; 22986579300; 6603119390; 7004589408; 15725998000; 24329110900; 7401535307; 8964790100; 35568329400; 35590576100,Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction,2023,JACC: Basic to Translational Science,8,12,,1539,1554,15,3,10.1016/j.jacbts.2023.05.010,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85173661172&doi=10.1016%2fj.jacbts.2023.05.010&partnerID=40&md5=d25c5408f35972a54373e5103a197525,"Department of Internal Medicine and University Heart Center, Division of Cardiology, Medical University of Graz, Graz, Austria; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria; Institute of Chemical Technologies and Analytical Chemistry, Technische Universität Wien, Vienna, Austria; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia; Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States; Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria; Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany; Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Centre for Inflammation, Centenary Institute, and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Department of Internal Medicine 1, University Hospital of Würzburg, Würzburg, Germany; Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany; School of Biotechnology and Biomolecular Sciences, Faculty of Science, UNSW Sydney, Sydney, Australia; BioTechMed Graz, Austria; Department of Cardiovascular Medicine, John Hunter Hospital, New Lambton Heights, Australia; Department of Medicine, St. Johann in Tirol General Hospital, St. Johann in Tirol, Austria","Hardy S.A., Department of Internal Medicine and University Heart Center, Division of Cardiology, Medical University of Graz, Graz, Austria, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Liesinger L., Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria, Institute of Chemical Technologies and Analytical Chemistry, Technische Universität Wien, Vienna, Austria; Patrick R., School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia, St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia; Poettler M., Department of Internal Medicine and University Heart Center, Division of Cardiology, Medical University of Graz, Graz, Austria; Rech L., Department of Internal Medicine and University Heart Center, Division of Cardiology, Medical University of Graz, Graz, Austria, Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States; Gindlhuber J., Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria; Mabotuwana N.S., Department of Internal Medicine and University Heart Center, Division of Cardiology, Medical University of Graz, Graz, Austria, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Ashour D., Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany; Stangl V., Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria; Bigland M., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Murtha L.A., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Starkey M.R., Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Scherr D., Department of Internal Medicine and University Heart Center, Division of Cardiology, Medical University of Graz, Graz, Austria; Hansbro P.M., Centre for Inflammation, Centenary Institute, and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Hoefler G., Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria; Campos Ramos G., Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany, Department of Internal Medicine 1, University Hospital of Würzburg, Würzburg, Germany; Cochain C., Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany, Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany; Harvey R.P., School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia, St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia, School of Biotechnology and Biomolecular Sciences, Faculty of Science, UNSW Sydney, Sydney, Australia; Birner-Gruenberger R., Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria, Institute of Chemical Technologies and Analytical Chemistry, Technische Universität Wien, Vienna, Austria, BioTechMed Graz, Austria; Boyle A.J., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Department of Cardiovascular Medicine, John Hunter Hospital, New Lambton Heights, Australia; Rainer P.P., Department of Internal Medicine and University Heart Center, Division of Cardiology, Medical University of Graz, Graz, Austria, BioTechMed Graz, Austria, Department of Medicine, St. Johann in Tirol General Hospital, St. Johann in Tirol, Austria",extracellular matrix; fibroblasts; fibrosis; heart; inflammation; myocardial infarction,cell surface receptor; extracellular matrix protein 1; nuclear RNA; scleroprotein; unclassified drug; adult; aged; animal cell; animal experiment; animal model; Article; cell migration; cell transformation; clinical article; controlled study; dilated cardiomyopathy; fibrogenesis; heart failure; heart fibroblast; heart infarction; heart muscle fibrosis; human; human cell; human tissue; inflammation; ischemic cardiomyopathy; M1 macrophage; M2 macrophage; male; mediator release; middle aged; mouse; myofibroblast; nonhuman; pericyte; protein binding; protein expression level; single cell RNA seq; upregulation,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85173661172
Olvera N.; Sanchez-Valle J.; Núñez-Carpintero I.; Rojas-Quintero J.; Noell G.; Casas-Recasens S.; Faiz A.; Hansbro P.; Guirao A.; Lepore R.; Cirillo D.; Agustí A.; Polverino F.; Valencia A.; Faner R.,"Olvera, Nuria (57388657700); Sanchez-Valle, Jon (57194690303); Núñez-Carpintero, Iker (57222038340); Rojas-Quintero, Joselyn (25621617700); Noell, Guillaume (57191334859); Casas-Recasens, Sandra (57191629497); Faiz, Alen (55601365200); Hansbro, Philip (6603119390); Guirao, Angela (57201648715); Lepore, Rosalba (54779981300); Cirillo, Davide (55257048700); Agustí, Alvar (57200597227); Polverino, Francesca (23989412600); Valencia, Alfonso (16308427600); Faner, Rosa (6507910788)",57388657700; 57194690303; 57222038340; 25621617700; 57191334859; 57191629497; 55601365200; 6603119390; 57201648715; 54779981300; 55257048700; 57200597227; 23989412600; 16308427600; 6507910788,Lung Tissue Multilayer Network Analysis Uncovers the Molecular Heterogeneity of Chronic Obstructive Pulmonary Disease,2024,American Journal of Respiratory and Critical Care Medicine,210,10,,1219,1229,10,4,10.1164/rccm.202303-0500OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85208555911&doi=10.1164%2frccm.202303-0500OC&partnerID=40&md5=4002bcd75dede8337c532d36b89caed4,"Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; Barcelona Supercomputing Center, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Barcelona, Spain; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, United States; Respiratory Bioinformatics and Molecular Biology Group, University of Technology, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia; Respiratory Institute, Hospital Clinic, Barcelona, Spain; Department of Biomedicine, Basel University Hospital, University of Basel, Basel, Switzerland; Medicine Department, University of Barcelona, Barcelona, Spain; Biomedicine Department, University of Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain","Olvera N., Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain, Barcelona Supercomputing Center, Barcelona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Barcelona, Spain; Sanchez-Valle J., Barcelona Supercomputing Center, Barcelona, Spain; Núñez-Carpintero I., Barcelona Supercomputing Center, Barcelona, Spain; Rojas-Quintero J., Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, United States; Noell G., Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Barcelona, Spain; Casas-Recasens S., Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Barcelona, Spain; Faiz A., Respiratory Bioinformatics and Molecular Biology Group, University of Technology, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P., Respiratory Bioinformatics and Molecular Biology Group, University of Technology, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia; Guirao A., Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Barcelona, Spain, Respiratory Institute, Hospital Clinic, Barcelona, Spain; Lepore R., Barcelona Supercomputing Center, Barcelona, Spain, Department of Biomedicine, Basel University Hospital, University of Basel, Basel, Switzerland; Cirillo D., Barcelona Supercomputing Center, Barcelona, Spain; Agustí A., Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Barcelona, Spain, Respiratory Institute, Hospital Clinic, Barcelona, Spain, Medicine Department, University of Barcelona, Barcelona, Spain; Polverino F., Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, United States; Valencia A., Barcelona Supercomputing Center, Barcelona, Spain, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain; Faner R., Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Barcelona, Spain, Biomedicine Department, University of Barcelona, Barcelona, Spain",chronic bronchitis; emphysema; endotypes; multiomics; networks,"Aged; Female; Humans; Lung; Male; MicroRNAs; Middle Aged; Pulmonary Disease, Chronic Obstructive; RNA, Messenger; adenylate cyclase; c9orf24 protein; chemokine; corticosteroid; dnah12 protein; efcab1 protein; fbxo15 protein; messenger RNA; microRNA; microRNA 127 3p; microRNA 149 5p; microRNA 323a 3p; microRNA 378c; microRNA 490 3p; protein; scgb1a1 protein; scgb3a1 protein; slc44a4 protein; tmem231 protein; unclassified drug; messenger RNA; microRNA; aged; Article; B lymphocyte; chronic obstructive lung disease; clinical feature; cohort analysis; community; computer assisted tomography; controlled study; CpG island; differential expression analysis; DNA extraction; DNA methylation; down regulation; eosinophil; ex-smoker; female; forced expiratory volume; hematocrit; human; human cell; human tissue; leukocyte count; lung emphysema; lung parenchyma; lymphocyte homing; machine learning; major clinical study; male; methylome; morphogenesis; multilayer network analysis; network analysis; platelet count; RNA transcription; T lymphocyte; transcriptomics; upregulation; very elderly; chronic obstructive lung disease; genetics; lung; metabolism; middle aged; pathophysiology",Article,Final,,Scopus,2-s2.0-85208555911
Kokkinis S.; De Rubis G.; Paudel K.R.; Patel V.K.; Yeung S.; Jessamine V.; MacLoughlin R.; Hansbro P.M.; Oliver B.; Dua K.,"Kokkinis, Sofia (58631105400); De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Patel, Vyoma K. (57193533009); Yeung, Stewart (58822848100); Jessamine, Victoria (58868227200); MacLoughlin, Ronan (57212263206); Hansbro, Philip M. (6603119390); Oliver, Brian (15919869900); Dua, Kamal (15759138700)",58631105400; 57196257973; 56539588400; 57193533009; 58822848100; 58868227200; 57212263206; 6603119390; 15919869900; 15759138700,Liposomal curcumin inhibits cigarette smoke induced senescence and inflammation in human bronchial epithelial cells,2024,Pathology Research and Practice,260,,155423,,,,1,10.1016/j.prp.2024.155423,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196651878&doi=10.1016%2fj.prp.2024.155423&partnerID=40&md5=30994a3af40beb57cdb545bb4511b121,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Pharmako Biotechnologies, Frenchs Forest, 2086, NSW, Australia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health and Medicine, School of Clinical Medicine, University of New South Wales, 2031, NSW, Australia; Research and Development, Science and Emerging Technologies, Aerogen Ltd., Galway Business Park, Galway, H91 HE94, Ireland; School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, Dublin, D02YN77, Ireland; School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02PN40, Ireland; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia","Kokkinis S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Pharmako Biotechnologies, Frenchs Forest, 2086, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Patel V.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health and Medicine, School of Clinical Medicine, University of New South Wales, 2031, NSW, Australia; Yeung S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Jessamine V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; MacLoughlin R., Research and Development, Science and Emerging Technologies, Aerogen Ltd., Galway Business Park, Galway, H91 HE94, Ireland, School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, Dublin, D02YN77, Ireland, School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02PN40, Ireland; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Oliver B., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Chronic Obstructive Pulmonary Disease; Curcumin; Liposomes; Nanoparticles; Phytoceuticals; PlexoZome®,"Anti-Inflammatory Agents; Bronchi; Cell Line; Cellular Senescence; Curcumin; Epithelial Cells; Humans; Inflammation; Liposomes; Pulmonary Disease, Chronic Obstructive; Smoke; cigarette smoke; curcumin; liposome; nanoparticle; antiinflammatory agent; curcumin; Article; BCiNS1.1; chronic obstructive lung disease; epithelium cell; HBEC cell line (bronchial epithelium); human bronchial epithelial cell; human cell; immunofluorescence microscopy; MTT assay; protein microarray; senescence; tuberculosis; adverse event; bronchus; cell aging; cell line; drug effect; drug therapy; human; inflammation; metabolism; pathology; smoke",Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85196651878
Mac Aogáin M.; Tiew P.Y.; Jaggi T.K.; Narayana J.K.; Singh S.; Hansbro P.M.; Segal L.N.; Chotirmall S.H.,"Mac Aogáin, Micheál (33667783800); Tiew, Pei Yee (57118125600); Jaggi, Tavleen Kaur (57204228946); Narayana, Jayanth Kumar (57217280956); Singh, Shivani (57723804000); Hansbro, Philip M. (6603119390); Segal, Leopoldo N. (35184010000); Chotirmall, Sanjay H. (15757175700)",33667783800; 57118125600; 57204228946; 57217280956; 57723804000; 6603119390; 35184010000; 15757175700,Targeting respiratory microbiomes in COPD and bronchiectasis,2024,Expert Review of Respiratory Medicine,18,03-Apr,,111,125,14,2,10.1080/17476348.2024.2355155,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195658221&doi=10.1080%2f17476348.2024.2355155&partnerID=40&md5=3256cc686c64a561270906265ef8c977,"Department of Biochemistry, St. James’s Hospital, Dublin, Ireland; School of Medicine, Trinity College Dublin, Dublin, Ireland; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Division of Pulmonary Critical Care & Sleep Medicine, Department of Medicine, New York University School of Medicine, New York, NY, United States; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore","Mac Aogáin M., Department of Biochemistry, St. James’s Hospital, Dublin, Ireland, School of Medicine, Trinity College Dublin, Dublin, Ireland; Tiew P.Y., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore, Duke-NUS Medical School, Singapore, Singapore; Jaggi T.K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Narayana J.K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Singh S., Division of Pulmonary Critical Care & Sleep Medicine, Department of Medicine, New York University School of Medicine, New York, NY, United States; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Segal L.N., Division of Pulmonary Critical Care & Sleep Medicine, Department of Medicine, New York University School of Medicine, New York, NY, United States; Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore",bronchiectasis; COPD; immunopathology; metagenomics; Microbiome,"Animals; Bronchiectasis; Disease Progression; Humans; Immunotherapy; Microbiota; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; antiinfective agent; antiinflammatory agent; antiinflammatory activity; antimicrobial activity; bronchiectasis; chronic obstructive lung disease; clinical practice; commensal; correlation analysis; human; immune response; immunopathology; immunotherapy; Medline; metagenomics; microbial community; microbiome; nonhuman; Review; treatment outcome; animal; bronchiectasis; chronic obstructive lung disease; disease exacerbation; immunology; microbiology; microflora; pathophysiology; therapy",Review,Final,,Scopus,2-s2.0-85195658221
Sulaiman I.; Wu B.G.; Chung M.; Isaacs B.; Tsay J.-C.J.; Holub M.; Barnett C.R.; Kwok B.; Kugler M.C.; Natalini J.G.; Singh S.; Li Y.; Schluger R.; Carpenito J.; Collazo D.; Perez L.; Kyeremateng Y.; Chang M.; Campbell C.D.; Hansbro P.M.; Oppenheimer B.W.; Berger K.I.; Goldring R.M.; Koralov S.B.; Weiden M.D.; Xiao R.; D’Armiento J.; Clemente J.C.; Ghedin E.; Segal L.N.,"Sulaiman, Imran (36009968200); Wu, Benjamin G. (57203348968); Chung, Matthew (57202940383); Isaacs, Bradley (57223136188); Tsay, Jun-Chieh J. (55305617500); Holub, Meredith (58644701100); Barnett, Clea R. (57222621511); Kwok, Benjamin (57211439357); Kugler, Matthias C. (7003824805); Natalini, Jake G. (57193901236); Singh, Shivani (57723804000); Li, Yonghua (37080590000); Schluger, Rosemary (57221948786); Carpenito, Joseph (57204457382); Collazo, Destiny (37065888100); Perez, Luisanny (57221954147); Kyeremateng, Yaa (57219793405); Chang, Miao (57205237549); Campbell, Christina D. (58590603500); Hansbro, Philip M. (6603119390); Oppenheimer, Beno W. (7004652941); Berger, Kenneth I. (7103356417); Goldring, Roberta M. (7005770108); Koralov, Sergei B. (6508010274); Weiden, Michael D. (7005725007); Xiao, Rui (53983393200); D’Armiento, Jeanine (57209404967); Clemente, Jose C. (36602436000); Ghedin, Elodie (55711597200); Segal, Leopoldo N. (35184010000)",36009968200; 57203348968; 57202940383; 57223136188; 55305617500; 58644701100; 57222621511; 57211439357; 7003824805; 57193901236; 57723804000; 37080590000; 57221948786; 57204457382; 37065888100; 57221954147; 57219793405; 57205237549; 58590603500; 6603119390; 7004652941; 7103356417; 7005770108; 6508010274; 7005725007; 53983393200; 57209404967; 36602436000; 55711597200; 35184010000,Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate Chronic Obstructive Pulmonary Disease,2023,American Journal of Respiratory and Critical Care Medicine,208,10,,1101,1114,13,10,10.1164/rccm.202210-1865OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85173878588&doi=10.1164%2frccm.202210-1865OC&partnerID=40&md5=5a66d30863c6edb0bf84b7dc3e1347c7,"Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Department of Pathology, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Department of Respiratory Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland; Department of Respiratory Medicine, Beaumont Hospital, Dublin, Ireland; Systems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States; Division of Pulmonary and Critical Care Medicine, Veterans Affairs (VA) New York Harbor Healthcare System, New York, NY, United States; Division of Pulmonary and Critical Care Medicine, Hartford Health Care, Hartford, CT, United States; Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Sydney, NSW, Australia; Department of Physiology and Cellular Biophysics, Columbia University School of Medicine, New York, NY, United States; Department of Genetics and Genomic Sciences and Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States","Sulaiman I., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Respiratory Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland, Department of Respiratory Medicine, Beaumont Hospital, Dublin, Ireland; Wu B.G., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Division of Pulmonary and Critical Care Medicine, Veterans Affairs (VA) New York Harbor Healthcare System, New York, NY, United States; Chung M., Systems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States; Isaacs B., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Tsay J.-C.J., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Division of Pulmonary and Critical Care Medicine, Veterans Affairs (VA) New York Harbor Healthcare System, New York, NY, United States; Holub M., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Division of Pulmonary and Critical Care Medicine, Hartford Health Care, Hartford, CT, United States; Barnett C.R., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Kwok B., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Kugler M.C., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Natalini J.G., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Singh S., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Li Y., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Schluger R., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Carpenito J., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Collazo D., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Perez L., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Kyeremateng Y., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Chang M., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Campbell C.D., Department of Respiratory Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland, Department of Respiratory Medicine, Beaumont Hospital, Dublin, Ireland; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Sydney, NSW, Australia; Oppenheimer B.W., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Berger K.I., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Goldring R.M., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Koralov S.B., Department of Pathology, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Weiden M.D., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States; Xiao R., Department of Physiology and Cellular Biophysics, Columbia University School of Medicine, New York, NY, United States; D’Armiento J., Department of Physiology and Cellular Biophysics, Columbia University School of Medicine, New York, NY, United States; Clemente J.C., Department of Genetics and Genomic Sciences and Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Ghedin E., Systems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States; Segal L.N., Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Department of Medicine, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States, Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, New York University (NYU) Langone Health, New York, NY, United States",COPD; lung inflammation; metatranscriptomics; microbiome; transcriptomics,"Animals; Dysbiosis; Humans; Inflammation; Lung; Lung Injury; Mice; Pulmonary Disease, Chronic Obstructive; RNA, Ribosomal, 16S; beta adrenergic receptor stimulating agent; cigarette smoke; corticosteroid; interleukin 17; interleukin 6; mitogen activated protein kinase kinase; mucin 1; mucin 4; phosphatidylinositol 3 kinase; RNA; RNA 16S; transcriptome; RNA 16S; adult; aged; animal experiment; animal model; Article; bronchoscopy; carcinogenesis; chronic obstructive lung disease; cohort analysis; commensal; controlled study; female; genome; host; human; lower airway dysbiosis; lower respiratory tract; lung microbiota; major clinical study; male; middle aged; mouse; nonhuman; pathogenesis; pneumonia; respiratory tract disease; RNA sequencing; smoking; transcriptomics; upper respiratory tract; upregulation; animal; chronic obstructive lung disease; complication; dysbiosis; genetics; inflammation; lung; lung injury; pathology",Article,Final,,Scopus,2-s2.0-85173878588
Bani Saeid A.; De Rubis G.; Williams K.A.; Yeung S.; Chellappan D.K.; Singh S.K.; Gupta G.; Hansbro P.M.; Shahbazi M.-A.; Gulati M.; Kaur I.P.; Santos H.A.; Paudel K.R.; Dua K.,"Bani Saeid, Ayeh (58635250800); De Rubis, Gabriele (57196257973); Williams, Kylie A. (7404142756); Yeung, Stewart (58822848100); Chellappan, Dinesh Kumar (35811890500); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Hansbro, Philip M. (6603119390); Shahbazi, Mohammad-Ali (54891654100); Gulati, Monica (7006677671); Kaur, Indu Pal (55409565600); Santos, Hélder A. (9239103400); Paudel, Keshav Raj (56539588400); Dua, Kamal (15759138700)",58635250800; 57196257973; 7404142756; 58822848100; 35811890500; 57206711834; 15047988400; 6603119390; 54891654100; 7006677671; 55409565600; 9239103400; 56539588400; 15759138700,Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases,2024,Chemico-Biological Interactions,395,,111009,,,,4,10.1016/j.cbi.2024.111009,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190857934&doi=10.1016%2fj.cbi.2024.111009&partnerID=40&md5=8fce0b765315f0d2ec0da4bb3515a487,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, 144411, India; School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India; Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, AV, Groningen, 9713, Netherlands; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; University Institute of Pharmaceutical Sciences, Punjab University Chandigarh, India; Drug Research Program Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India","Bani Saeid A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Williams K.A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Yeung S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, 144411, India; Gupta G., School of Pharmacy, Graphic Era Hill University, Dehradun, 248007, India, Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Shahbazi M.-A., Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, AV, Groningen, 9713, Netherlands; Gulati M., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Kaur I.P., University Institute of Pharmaceutical Sciences, Punjab University Chandigarh, India; Santos H.A., Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, AV, Groningen, 9713, Netherlands, Drug Research Program Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India",Lung disease; Nanoencapsulation; Nutraceuticals; Prebiotic; Probiotic; Synbiotic,Animals; Humans; Lung; Lung Diseases; Nanoparticles; Nanostructures; Synbiotics; chitosan nanoparticle; magnesium oxide nanoparticle; metal oxide nanoparticle; nanocellulose; nanoparticle; nutraceutical; phthalyl pullulan nanoparticle; prebiotic agent; probiotic agent; starch nanoparticle; synbiotic agent; titanium dioxide nanoparticle; unclassified drug; nanomaterial; synbiotic agent; antibacterial activity; antiinflammatory activity; antineoplastic activity; antioxidant activity; Bifidobacterium breve; chronic obstructive lung disease; drug design; drug efficacy; drug formulation; drug quality; drug research; drug safety; drug structure; drug targeting; human; Lactobacillus rhamnosus; lung cancer; lung disease; nanoencapsulation; nanomedicine; nonhuman; oxidative stress; respiratory tract infection; Review; treatment planning; animal; chemistry; drug effect; drug therapy; lung; lung disease; pathology,Review,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85190857934
Paudel K.R.; Manandhar B.; Singh S.K.; Gupta G.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Paudel, Keshav Raj (56539588400); Manandhar, Bikash (57204448260); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Hansbro, Philip Michael (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",56539588400; 57204448260; 57206711834; 15047988400; 6603119390; 35811890500; 15759138700,CYTOTOXIC MECHANISMS OF BERBERINE-PHYTANTRIOL LIQUID CRYSTALLINE NANOPARTICLES AGAINST NON-SMALL-CELL LUNG CANCER,2023,EXCLI Journal,22,,,516,519,3,12,10.17179/excli2023-6156,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163351071&doi=10.17179%2fexcli2023-6156&partnerID=40&md5=0f7801c16d33324d4ab2727b53e7dd94,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2050, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; Center for Transdisciplinary Research, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2050, NSW, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India, Center for Transdisciplinary Research, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2050, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",,baculoviral IAP repeat containing protein 5; berberine; cyclin dependent kinase inhibitor 1B; drug additive; hypoxia inducible factor 1alpha; liquid crystalline nanoparticle; nanoparticle; phytantriol; unclassified drug; A-549 cell line; antiproliferative activity; controlled study; cytotoxicity test; drug formulation; human; human cell; in vitro study; Letter; non small cell lung cancer; proapoptotic activity; protein expression,Letter,Final,,Scopus,2-s2.0-85163351071
Panthi V.K.; Dua K.; Singh S.K.; Gupta G.; Hansbro P.M.; Paudel K.R.,"Panthi, Vijay Kumar (57200221032); Dua, Kamal (15759138700); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Hansbro, Philip M. (6603119390); Paudel, Keshav Raj (56539588400)",57200221032; 15759138700; 57206711834; 15047988400; 6603119390; 56539588400,"Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives",2023,Pharmaceutics,15,4,1192,,,,14,10.3390/pharmaceutics15041192,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85154578633&doi=10.3390%2fpharmaceutics15041192&partnerID=40&md5=efd637eb6edc7ba241a498d88a7b3530,"Department of Pharmacy, College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Jeonnam, 58554, South Korea; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India; School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, 302017, India; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia","Panthi V.K., Department of Pharmacy, College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Jeonnam, 58554, South Korea; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, 302017, India; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia",cancers; clinical study; metronomic chemotherapy; nanoformulations,capecitabine; cyclophosphamide; dexamethasone; docetaxel; etoposide; fibroblast growth factor; fluorouracil; irinotecan; methotrexate; oxaliplatin; paclitaxel; prednisolone; thrombospondin 1; trofosfamide; vasculotropin; vinorelbine tartrate; angiogenesis; antineoplastic activity; breast cancer; cancer chemotherapy; cancer immunotherapy; cancer radiotherapy; cancer stem cell; cancer therapy; circulating endothelial cell; clinical practice; colorectal cancer; cytotoxicity; drug formulation; endothelial progenitor cell; esophagus cancer; human; immunity; middle income country; middle income group; nanoemulsion; nanoformulation; nanotechnology; non small cell lung cancer; nonhuman; pancreas cancer; prostate cancer; regulatory T lymphocyte; Review; tumor growth; tumor immunity; tumor regression; tumor volume; X ray,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85154578633
Boedijono F.S.; Bood V.; Eichhorn I.A.; Hansbro P.M.; Slebos D.-J.; van den Berge M.; Faiz A.; Pouwels S.D.,"Boedijono, Fia Sabrina (58852659100); Bood, Verena (59226033100); Eichhorn, Ilse A. (58502076300); Hansbro, Philip M. (6603119390); Slebos, Dirk-Jan (6602200135); van den Berge, Maarten (56412674600); Faiz, Alen (55601365200); Pouwels, Simon D. (55173550600)",58852659100; 59226033100; 58502076300; 6603119390; 6602200135; 56412674600; 55601365200; 55173550600,Identification of Genetic Factors Associated With DAMP Release in COPD Patients,2024,Archivos de Bronconeumologia,60,11,,714,717,3,0,10.1016/j.arbres.2024.06.020,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85199053866&doi=10.1016%2fj.arbres.2024.06.020&partnerID=40&md5=c159c312d235fdc5b469b265575a436d,"Respiratory Bioinformatics and Molecular Biology Group, University of Technology Sydney, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Department of Pulmonary Diseases, University Medical Center Groningen, Netherlands; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands; GRIAC Research Institute, University of Groningen, Groningen, Netherlands","Boedijono F.S., Respiratory Bioinformatics and Molecular Biology Group, University of Technology Sydney, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Bood V., Department of Pulmonary Diseases, University Medical Center Groningen, Netherlands, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands, GRIAC Research Institute, University of Groningen, Groningen, Netherlands; Eichhorn I.A., Department of Pulmonary Diseases, University Medical Center Groningen, Netherlands, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands, GRIAC Research Institute, University of Groningen, Groningen, Netherlands; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Slebos D.-J., Department of Pulmonary Diseases, University Medical Center Groningen, Netherlands, GRIAC Research Institute, University of Groningen, Groningen, Netherlands; van den Berge M., Department of Pulmonary Diseases, University Medical Center Groningen, Netherlands, GRIAC Research Institute, University of Groningen, Groningen, Netherlands; Faiz A., Respiratory Bioinformatics and Molecular Biology Group, University of Technology Sydney, Australia; Pouwels S.D., Department of Pulmonary Diseases, University Medical Center Groningen, Netherlands, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands, GRIAC Research Institute, University of Groningen, Groningen, Netherlands",,advanced glycation end product receptor; alpha defensin; biological factor; double stranded DNA; ecalectin; kinesin; adult; aged; air pollution; ANKRD22 gene; apoptosis; Article; artificial intelligence; bronchoalveolar lavage fluid; C8B gene; cell death; cell proliferation; cell survival; chronic obstructive lung disease; controlled study; enzyme linked immunosorbent assay; epithelial lining fluid; female; gene; gene expression; gene frequency; gene mutation; gene ontology; genetic analysis; genetic association; genetic variability; genome-wide association study; GJB4 gene; HAPLN3 gene; HEATR6 gene; heredity; HHLA2 gene; human; IGLV545 gene; immunocompetent cell; KIF18A gene; lung emphysema; lung function; lung lavage; LYZ gene; major clinical study; male; missense mutation; mitosis; MROH6 gene; necroptosis; OR2V2 gene; OR5H6  gene; ORM1 gene; PDE11A gene; PLEK2 gene; RGS9 gene; SEMA6C gene; single nucleotide polymorphism; SLC4A4 gene; smoke; smoking; SOAT2 gene; SYT7 gene; TF gene; TRAPPC2L gene; VAV1 gene; whole exome sequencing; ZBTB32 gene,Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85199053866
Singh M.; De Rubis G.; Kokkinis S.; Paudel K.R.; Yeung S.; Hansbro P.M.; Oliver B.G.G.; Dua K.,"Singh, Manisha (57214312793); De Rubis, Gabriele (57196257973); Kokkinis, Sofia (58631105400); Paudel, Keshav Raj (56539588400); Yeung, Stewart (58822848100); Hansbro, Philip Michael (6603119390); Oliver, Brian Gregory George (15919869900); Dua, Kamal (15759138700)",57214312793; 57196257973; 58631105400; 56539588400; 58822848100; 6603119390; 15919869900; 15759138700,Curcumin-loaded liposomes modulating the synergistic role of EpCAM and estrogen receptor alpha in lung cancer management,2024,Pathology Research and Practice,257,,155317,,,,3,10.1016/j.prp.2024.155317,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190874378&doi=10.1016%2fj.prp.2024.155317&partnerID=40&md5=4497aa13678b010c1c2bdcef923c502c,"Department of Biotechnology, Jaypee Institute of Information Technology (JIIT) Noida, Uttar Pradesh, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Woolcock Institute of Medical Research, Macquarie University, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Pharmako Biotechnologies, Sydney, 2086, NSW, Australia","Singh M., Department of Biotechnology, Jaypee Institute of Information Technology (JIIT) Noida, Uttar Pradesh, India, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Kokkinis S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Pharmako Biotechnologies, Sydney, 2086, NSW, Australia; Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Yeung S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Oliver B.G.G., Woolcock Institute of Medical Research, Macquarie University, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Curcumin; Liposomes; Lung Cancer; Phytoceuticals; Respiratory Diseases,"A549 Cells; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Curcumin; Epithelial Cell Adhesion Molecule; Estrogen Receptor alpha; Humans; Liposomes; Lung Neoplasms; curcumin; epithelial cell adhesion molecule; estrogen receptor alpha; liposome; phosphatidylcholine; plexozome; tumor marker; antineoplastic agent; curcumin; EPCAM protein, human; epithelial cell adhesion molecule; ESR1 protein, human; estrogen receptor alpha; A-549 cell line; Article; cancer prognosis; cell invasion; cell survival; clinical indicator; concentration response; controlled study; drug delivery system; drug formulation; drug synthesis; drug targeting; effective dose (pharmacology); human; human cell; in vitro study; lung cancer; metastasis; non small cell lung cancer; patient care; protein expression; protein function; signal transduction; lung tumor; metabolism; non small cell lung cancer; pathology",Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85190874378
Ho J.S.S.; Ping T.L.; Paudel K.R.; El Sherkawi T.; De Rubis G.; Yeung S.; Hansbro P.M.; Oliver B.G.G.; Chellappan D.K.; Sin K.P.; Dua K.,"Ho, Joyce Siaw Syuen (59358380400); Ping, Teh Li (59357796100); Paudel, Keshav Raj (56539588400); El Sherkawi, Tammam (58631184300); De Rubis, Gabriele (57196257973); Yeung, Stewart (58822848100); Hansbro, Philip M. (6603119390); Oliver, Brian Gregory George (15919869900); Chellappan, Dinesh Kumar (35811890500); Sin, Keng Pei (59358779000); Dua, Kamal (15759138700)",59358380400; 59357796100; 56539588400; 58631184300; 57196257973; 58822848100; 6603119390; 15919869900; 35811890500; 59358779000; 15759138700,Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects,2024,Phytotherapy Research,38,12,,5840,5872,32,0,10.1002/ptr.8334,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85205776796&doi=10.1002%2fptr.8334&partnerID=40&md5=81d9abfedee787cefd9cb779e4607c3b,"Department of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and the University of Technology Sydney, Sydney, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, Australia; School of Life Science, University of Technology Sydney, Ultimo, Australia; Woolcock Institute of Medical Research, Macquarie University, Sydney, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia","Ho J.S.S., Department of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Ping T.L., Department of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Paudel K.R., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and the University of Technology Sydney, Sydney, Australia; El Sherkawi T., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, Australia; Yeung S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; Hansbro P.M., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and the University of Technology Sydney, Sydney, Australia; Oliver B.G.G., School of Life Science, University of Technology Sydney, Ultimo, Australia, Woolcock Institute of Medical Research, Macquarie University, Sydney, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Sin K.P., Department of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, Australia",COVID-19; influenza; medicinal plants; pneumonia; pulmonary infection; tuberculosis,"Animals; COVID-19; COVID-19 Drug Treatment; Humans; Influenza, Human; Phytochemicals; Phytotherapy; Plant Extracts; Plants, Medicinal; SARS-CoV-2; biological marker; phytochemical; plant extract; clinical practice; coronavirus disease 2019; drug delivery system; drug therapy; herbal medicine; human; in vitro study; influenza; influenza A; lung infection; medicinal plant; mortality rate; nonhuman; pathophysiology; phytotherapy; pneumonia; review; tuberculosis; virus pneumonia; animal; chemistry; coronavirus disease 2019; COVID-19 pharmacotherapy; drug effect; influenza; Severe acute respiratory syndrome coronavirus 2",Review,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85205776796
De Rubis G.; Paudel K.R.; Manandhar B.; Singh S.K.; Gupta G.; Malik R.; Shen J.; Chami A.; MacLoughlin R.; Chellappan D.K.; Oliver B.G.G.; Hansbro P.M.; Dua K.,"De Rubis, Gabriele (57196257973); Paudel, Keshav Raj (56539588400); Manandhar, Bikash (57204448260); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Malik, Raniya (57687045700); Shen, Jessie (58117423800); Chami, Aniss (58117090600); MacLoughlin, Ronan (57212263206); Chellappan, Dinesh Kumar (35811890500); Oliver, Brian Gregory George (15919869900); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",57196257973; 56539588400; 57204448260; 57206711834; 15047988400; 57687045700; 58117423800; 58117090600; 57212263206; 35811890500; 15919869900; 6603119390; 15759138700,Agarwood Oil Nanoemulsion Attenuates Cigarette Smoke-Induced Inflammation and Oxidative Stress Markers in BCi-NS1.1 Airway Epithelial Cells,2023,Nutrients,15,4,1019,,,,23,10.3390/nu15041019,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85148903720&doi=10.3390%2fnu15041019&partnerID=40&md5=a7280aed55d699f10eae21aa824cec7c,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, 302017, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Uttarakhand, Dehradun, 248007, India; Department of Pharmacology, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College, Saveetha University, Tamil Nadu, Chennai, 602105, India; DeÁurora Pty Ltd, Dean, 3363, VIC, Australia; Vitex Pharmaceuticals, Eastern Creek, 2766, NSW, Australia; IDA Business Park, Galway, Aerogen, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia","De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, 302017, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Uttarakhand, Dehradun, 248007, India, Department of Pharmacology, Saveetha Institute of Medical and Technical Sciences, Saveetha Dental College, Saveetha University, Tamil Nadu, Chennai, 602105, India; Malik R., DeÁurora Pty Ltd, Dean, 3363, VIC, Australia; Shen J., DeÁurora Pty Ltd, Dean, 3363, VIC, Australia; Chami A., Vitex Pharmaceuticals, Eastern Creek, 2766, NSW, Australia; MacLoughlin R., IDA Business Park, Galway, Aerogen, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Oliver B.G.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",agarwood; chronic obstructive pulmonary disease; cigarette smoke; drug delivery; inflammation; inflammation; nanoemulsion; nutraceuticals; phytoceuticals,"Anti-Inflammatory Agents; Antioxidants; Cigarette Smoking; Epithelial Cells; Inflammation; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Tobacco; agarwood oil; antioxidant; Aquilaria crassna extract; biological marker; cigarette smoke; cytokine; essential oil; gamma interferon; glutamate cysteine ligase; glutathione transferase P1; growth differentiation factor 15; growth hormone; interleukin 10; interleukin 18 binding protein; interleukin 1alpha; interleukin 1beta; interleukin 8; messenger RNA; phosphatidylinositol 3 kinase; phytochemical; plant extract; platelet derived growth factor; polymer; serelaxin; trefoil factor 3; unclassified drug; vitamin D binding protein; antiinflammatory agent; antioxidant; agarwood; airway epithelium cell; antiinflammatory activity; antioxidant activity; Aquilaria; Aquilaria crassna; Article; BCi NS1 1 cell line; biological activity; chronic obstructive lung disease; concentration response; controlled study; drug delivery system; drug formulation; drug potency; enzyme activity; epithelial cell line; epithelium basal cell; gene expression; human; human cell; in vitro study; inflammation; medicinal plant; mRNA expression level; nanoemulsion; oxidative stress; protein expression level; signal transduction; transcription regulation; chronic obstructive lung disease; cigarette smoking; epithelium cell; inflammation; metabolism; oxidative stress; tobacco",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85148903720
Allam V.S.R.R.; Pavlidis S.; Liu G.; Kermani N.Z.; Simpson J.; To J.; Donnelly S.; Guo Y.-K.; Hansbro P.M.; Phipps S.; Morand E.F.; Djukanovic R.; Sterk P.; Chung K.F.; Adcock I.; Harris J.; Sukkar M.B.,"Allam, Venkata Sita Rama Raju (57200203739); Pavlidis, Stelios (56642790400); Liu, Gang (57189061134); Kermani, Nazanin Zounemat (57195464650); Simpson, Jennifer (56606596900); To, Joyce (16069833900); Donnelly, Sheila (7101661431); Guo, Yi-Ke (12765868000); Hansbro, Philip M. (6603119390); Phipps, Simon (7005395199); Morand, Eric F. (7006125364); Djukanovic, Ratko (57210653671); Sterk, Peter (7102794272); Chung, Kian Fan (57208201733); Adcock, Ian (7007066538); Harris, James (36079095200); Sukkar, Maria B. (7003439011)",57200203739; 56642790400; 57189061134; 57195464650; 56606596900; 16069833900; 7101661431; 12765868000; 6603119390; 7005395199; 7006125364; 57210653671; 7102794272; 57208201733; 7007066538; 36079095200; 7003439011,Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma,2023,Thorax,78,7,,661,673,12,10,10.1136/thorax-2021-218555,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163913781&doi=10.1136%2fthorax-2021-218555&partnerID=40&md5=41a519a85e2ac7f36a0985bed404e8db,"Graduate School of Health, Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia; Department of Medical Biochemistry and Microbiology, Biomedical Centre, Uppsala University, Uppsala, Sweden; Data Science Institute, Imperial College London, London, United Kingdom; Computational Sciences, Janssen Research and Development, High Wycombe, United Kingdom; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Respiratory Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia; NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Department of Respiratory Medicine, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands; Airways Disease, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom","Allam V.S.R.R., Graduate School of Health, Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia, Department of Medical Biochemistry and Microbiology, Biomedical Centre, Uppsala University, Uppsala, Sweden; Pavlidis S., Data Science Institute, Imperial College London, London, United Kingdom, Computational Sciences, Janssen Research and Development, High Wycombe, United Kingdom; Liu G., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Kermani N.Z., Data Science Institute, Imperial College London, London, United Kingdom; Simpson J., Respiratory Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; To J., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Donnelly S., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Guo Y.-K., Data Science Institute, Imperial College London, London, United Kingdom; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Phipps S., Respiratory Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Morand E.F., Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia; Djukanovic R., NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Sterk P., Department of Respiratory Medicine, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands; Chung K.F., Airways Disease, National Heart & Lung Institute, Imperial College London, London, United Kingdom, Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom; Adcock I., Airways Disease, National Heart & Lung Institute, Imperial College London, London, United Kingdom, Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom; Harris J., Centre for Inflammatory Diseases, Monash University, Melbourne, VIC, Australia; Sukkar M.B., Graduate School of Health, Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia",asthma; asthma mechanisms; cytokine biology,"Animals; Annexins; Asthma; Disease Models, Animal; Glucocorticoid Receptor Deficiency; Glucocorticoids; Humans; Inflammation; Macrophage Migration-Inhibitory Factors; Mice; Neutrophils; cryopyrin; cytokine receptor antagonist; dexamethasone; fluticasone propionate; glucocorticoid; inflammasome; interleukin 1beta; iso 1; lipocortin 1; macrophage migration inhibition factor; unclassified drug; annexin; glucocorticoid; macrophage migration inhibition factor; adult; animal experiment; animal model; animal tissue; Article; asthma; biological activity; clinical feature; cohort analysis; coimmunoprecipitation; controlled study; correlation analysis; cytokine release; disease exacerbation; disease severity; drug response; female; human; major clinical study; mouse; murine model; neutrophil; neutrophilia; neutrophilic inflammation; nonhuman; phenotype; protein blood level; protein expression; protein function; sputum; transcriptomics; animal; asthma; disease model; inflammation; metabolism",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85163913781
De Rubis G.; Chakraborty A.; Paudel K.R.; Wang C.; Kannaujiya V.; Wich P.; Hansbro P.M.; Samuel C.S.; Oliver B.; Dua K.,"De Rubis, Gabriele (57196257973); Chakraborty, Amlan (56714779500); Paudel, Keshav Raj (56539588400); Wang, Chao (57189270455); Kannaujiya, Vinod (57219713766); Wich, Peter (7801599835); Hansbro, Philip Michael (6603119390); Samuel, Chrishan S. (58045142900); Oliver, Brian (15919869900); Dua, Kamal (15759138700)",57196257973; 56714779500; 56539588400; 57189270455; 57219713766; 7801599835; 6603119390; 58045142900; 15919869900; 15759138700,Exploring the anti-inflammatory and anti-fibrotic activity of NFκB decoy oligodeoxynucleotide-loaded spermine-functionalized acetalated nanoparticles,2024,Chemico-Biological Interactions,396,,111059,,,,2,10.1016/j.cbi.2024.111059,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85193424588&doi=10.1016%2fj.cbi.2024.111059&partnerID=40&md5=3965ca9551f40c1dac011741b865ad68,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, United Kingdom; Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, 3800, VIC, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Australian Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia","De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Chakraborty A., Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, United Kingdom, Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, 3800, VIC, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Wang C., Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, 3800, VIC, Australia; Kannaujiya V., School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia, Australian Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia; Wich P., School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia, Australian Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Samuel C.S., Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, 3800, VIC, Australia; Oliver B., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",Chronic respiratory disorders; Decoy oligodeoxynucleotide; Fibrosis; Inflammation; Nanoparticles; NFκB,Anti-Inflammatory Agents; Fibroblasts; Fibrosis; Humans; Lipopolysaccharides; Nanoparticles; NF-kappa B; Oligodeoxyribonucleotides; Spermine; Transforming Growth Factor beta; alpha smooth muscle actin; CD40 antigen; collagen type 1; granulocyte macrophage colony stimulating factor; immunoglobulin enhancer binding protein; lipopolysaccharide; nanoparticle; oligodeoxynucleotide; spermine; spermine functionalized acetalated nanoparticle; toll like receptor 4; transcription factor; transforming growth factor beta; unclassified drug; antiinflammatory agent; immunoglobulin enhancer binding protein; lipopolysaccharide; NF-kappaB decoy; oligodeoxyribonucleotide; spermine; transforming growth factor beta; airway remodeling; animal cell; animal experiment; animal model; antifibrotic activity; antigen presenting cell; antiinflammatory activity; Article; bone marrow cell; bone marrow derived dendritic cell; cell differentiation; cell population; chronic respiratory tract disease; controlled study; dendritic cell; densitometry; endocytosis; Escherichia coli; female; fibroblast; fluorescence activated cell sorting; fluorescence intensity; human; human cell; in vitro study; inflammation; lung fibrosis; M1 macrophage; macrophage; mouse; myofibroblast; nonhuman; oxidative stress; phagocytosis; pneumonia; polarization; protein expression; radioimmunoprecipitation; skin fibroblast; upregulation; Western blotting; chemistry; drug effect; drug therapy; fibrosis; metabolism,Article,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85193424588
Jha S.K.; Imran M.; Anwaar S.; Hansbro P.M.; Paudel K.R.; Mohammed Y.,"Jha, Saurav Kumar (57210712565); Imran, Mohammad (57209466043); Anwaar, Shoaib (59197345800); Hansbro, Philip M (6603119390); Paudel, Keshav Raj (56539588400); Mohammed, Yousuf (56116912300)",57210712565; 57209466043; 59197345800; 6603119390; 56539588400; 56116912300,Mesenchymal stem cell membrane-coated nanoconstructs: why have they not yet found a home in clinical practice?,2024,Nanomedicine,19,17,,1507,1510,3,2,10.1080/17435889.2024.2369495,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85197247687&doi=10.1080%2f17435889.2024.2369495&partnerID=40&md5=b4c2a1f4878b39c42cff0b8c4cb73fb0,"Department of Biological Sciences & Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, Australia; Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute & University of Technology Sydney, Sydney, 2007, Australia; School of Pharmacy, The University of Queensland, Brisbane, 4102, Australia","Jha S.K., Department of Biological Sciences & Bioengineering (BSBE), Indian Institute of Technology, Uttar Pradesh, Kanpur, 208016, India; Imran M., Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, Australia; Anwaar S., Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute & University of Technology Sydney, Sydney, 2007, Australia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute & University of Technology Sydney, Sydney, 2007, Australia; Mohammed Y., Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, 4102, Australia, School of Pharmacy, The University of Queensland, Brisbane, 4102, Australia",bioavailability; biodistribution; biomimetic; clinical translation; mesenchymal stem cell membrane; mesenchymal stem cells; MSCM-nanoconstructs; nanodecoys; nanoparticles; scalability; toxicological study,Animals; Cell Membrane; Humans; Mesenchymal Stem Cells; Nanomedicine; Nanoparticles; Nanostructures; liposome; macrogol; nano ghost; nanocomposite; nanodecoy; nanoparticle; peptide; polymer nanoparticle; unclassified drug; nanomaterial; nanoparticle; Article; biocompatibility; biodegradability; cell membrane; coating (procedure); drug delivery system; enzymatic degradation; human; immune evasion; immune response; mesenchymal stem cell membrane; micelle; nanoencapsulation; nonhuman; osteoarthritis; oxidative stress; particle size; physical chemistry; Severe acute respiratory syndrome coronavirus 2; spheroid cell; virus attachment; virus neutralization; zeta potential; animal; chemistry; cytology; mesenchymal stem cell; nanomedicine; procedures,Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85197247687
Vanders R.L.; Gomez H.M.; Daly K.; Wark P.A.; Horvat J.C.; Hansbro P.M.,"Vanders, Rebecca L. (55773360100); Gomez, Henry M. (57191960363); Daly, Katie (57221387938); Wark, Peter A. (58166423200); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",55773360100; 57191960363; 57221387938; 58166423200; 9942405300; 6603119390,Immune checkpoints are suppressed during pregnancy following influenza A virus infection,2024,American Journal of Physiology - Lung Cellular and Molecular Physiology,327,6,,L890,L904,14,0,10.1152/ajplung.00391.2023,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85210046313&doi=10.1152%2fajplung.00391.2023&partnerID=40&md5=3dde268e4a4a82a14cc4dae14e4d2bc1,"Immune Health, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia","Vanders R.L., Immune Health, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Gomez H.M., Immune Health, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Daly K., Immune Health, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Wark P.A., Immune Health, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Immune Health, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia",antiviral; influenza; innate checkpoint proteins (ICPs); PDL1; pregnancy,"Animals; B7-H1 Antigen; CTLA-4 Antigen; Female; Immune Checkpoint Inhibitors; Immune Checkpoint Proteins; Influenza A virus; Lung; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Pregnancy; Pregnancy Complications, Infectious; Programmed Cell Death 1 Receptor; antivirus agent; CXCL1 chemokine; cytotoxic T lymphocyte antigen 4; immune checkpoint protein; interleukin 6; messenger RNA; programmed death 1 ligand 1; toll like receptor 3; toll like receptor 7; toll like receptor 9; Cd274 protein, mouse; Ctla4 protein, mouse; cytotoxic T lymphocyte antigen 4; immune checkpoint inhibitor; immune checkpoint protein; Pdcd1 protein, mouse; programmed death 1 ligand 1; programmed death 1 receptor; adverse outcome; animal experiment; animal model; animal tissue; antiviral activity; apoptosis; Article; bronchiole; bronchoalveolar lavage fluid; CD4+ T lymphocyte; CD8+ T lymphocyte; comparative study; controlled study; cytotoxic T lymphocyte; enzyme linked immunosorbent assay; female; flow cytometry; gene expression; histology; immunocompetent cell; infectious pregnancy complication; influenza A; Influenza A virus; lung alveolus cell; lung function; lung homogenate; monocyte; mouse; mRNA expression level; nonhuman; plaque forming unit; pregnancy; upregulation; vaccination; virus load; animal; C57BL mouse; genetics; immunology; infectious pregnancy complication; Influenza A virus; lung; metabolism; orthomyxovirus infection; pathology; virology",Article,Final,,Scopus,2-s2.0-85210046313
Shrestha J.; Limbu K.R.; Chhetri R.B.; Paudel K.R.; Hansbro P.M.; Oh Y.S.; Baek D.J.; Ki S.-H.; Park E.-Y.,"Shrestha, Jitendra (57200500479); Limbu, Khem Raj (57203713494); Chhetri, Rashmi Bhandari (57997927100); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Oh, Yoon Sin (34467778200); Baek, Dong Jae (57200593717); Ki, Sung-Hwan (8346836500); Park, Eun-Young (56680548000)",57200500479; 57203713494; 57997927100; 56539588400; 6603119390; 34467778200; 57200593717; 8346836500; 56680548000,"Antioxidant genes in cancer and metabolic diseases: Focusing on Nrf2, Sestrin, and heme oxygenase 1",2024,International Journal of Biological Sciences,20,12,,4888,4907,19,2,10.7150/ijbs.98846,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85204755525&doi=10.7150%2fijbs.98846&partnerID=40&md5=dcbc7a5d376d6022de6603662e46bb81,"College of Pharmacy, Mokpo National University, Jeonnam, 58554, South Korea; Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, 02114, MA, United States; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sci, Sydney, 2007, NSW, Australia; Department of Food and Nutrition, Eulji University, Seongnam, 13135, South Korea; College of Pharmacy, Chosun University, Gwangju, 61451, South Korea","Shrestha J., College of Pharmacy, Mokpo National University, Jeonnam, 58554, South Korea, Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, 02114, MA, United States; Limbu K.R., College of Pharmacy, Mokpo National University, Jeonnam, 58554, South Korea; Chhetri R.B., College of Pharmacy, Mokpo National University, Jeonnam, 58554, South Korea; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sci, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sci, Sydney, 2007, NSW, Australia; Oh Y.S., Department of Food and Nutrition, Eulji University, Seongnam, 13135, South Korea; Baek D.J., College of Pharmacy, Mokpo National University, Jeonnam, 58554, South Korea; Ki S.-H., College of Pharmacy, Chosun University, Gwangju, 61451, South Korea; Park E.-Y., College of Pharmacy, Mokpo National University, Jeonnam, 58554, South Korea",cancer; heme oxygenase 1; metabolic diseases; nuclear factor (erythroid-derived 2)-like 2; Sestrin,"Animals; Antioxidants; Heme Oxygenase-1; Humans; Metabolic Diseases; Neoplasms; NF-E2-Related Factor 2; Nuclear Proteins; Oxidative Stress; Reactive Oxygen Species; antioxidant; heme oxygenase 1; NFE2L2 protein, human; nuclear protein; reactive oxygen metabolite; transcription factor Nrf2; animal; genetics; human; metabolic disorder; metabolism; neoplasm; oxidative stress",Review,Final,All Open Access; Gold Open Access,Scopus,2-s2.0-85204755525
Ryan T.A.J.; Hooftman A.; Rehill A.M.; Johansen M.D.; Brien E.C.O.; Toller-Kawahisa J.E.; Wilk M.M.; Day E.A.; Weiss H.J.; Sarvari P.; Vozza E.G.; Schramm F.; Peace C.G.; Zotta A.; Miemczyk S.; Nalkurthi C.; Hansbro N.G.; McManus G.; O’Doherty L.; Gargan S.; Long A.; Dunne J.; Cheallaigh C.N.; Conlon N.; Carty M.; Fallon P.G.; Mills K.H.G.; Creagh E.M.; Donnell J.S.O.; Hertzog P.J.; Hansbro P.M.; McLoughlin R.M.; Wygrecka M.; Preston R.J.S.; Zasłona Z.; Neill L.A.J.O.,"Ryan, Tristram A. J. (57200624032); Hooftman, Alexander (57209197802); Rehill, Aisling M. (57195917648); Johansen, Matt D. (57202983408); Brien, Eóin C. O’ (58313303100); Toller-Kawahisa, Juliana E. (55953840700); Wilk, Mieszko M. (54940750200); Day, Emily A. (57210100829); Weiss, Hauke J. (57218411615); Sarvari, Pourya (58905572100); Vozza, Emilio G. (57220069631); Schramm, Fabian (58709183000); Peace, Christian G. (57416409900); Zotta, Alessia (57211206269); Miemczyk, Stefan (57773070000); Nalkurthi, Christina (57359864400); Hansbro, Nicole G. (15055862300); McManus, Gavin (36739432100); O’Doherty, Laura (57219535631); Gargan, Siobhan (37037334400); Long, Aideen (34881912800); Dunne, Jean (7101823120); Cheallaigh, Clíona Ní (46062251900); Conlon, Niall (49761224700); Carty, Michael (57206532654); Fallon, Padraic G. (7102455344); Mills, Kingston H. G. (7202875495); Creagh, Emma M. (6602453432); Donnell, James S. O’ (57217838376); Hertzog, Paul J. (7005991492); Hansbro, Philip M. (6603119390); McLoughlin, Rachel M. (7005136911); Wygrecka, Małgorzata (16417736600); Preston, Roger J. S. (12774078500); Zasłona, Zbigniew (26221484200); Neill, Luke A. J. O’ (58313501200)",57200624032; 57209197802; 57195917648; 57202983408; 58313303100; 55953840700; 54940750200; 57210100829; 57218411615; 58905572100; 57220069631; 58709183000; 57416409900; 57211206269; 57773070000; 57359864400; 15055862300; 36739432100; 57219535631; 37037334400; 34881912800; 7101823120; 46062251900; 49761224700; 57206532654; 7102455344; 7202875495; 6602453432; 57217838376; 7005991492; 6603119390; 7005136911; 16417736600; 12774078500; 26221484200; 58313501200,Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon,2023,Nature Communications,14,1,3513,,,,21,10.1038/s41467-023-39174-1,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85161813514&doi=10.1038%2fs41467-023-39174-1&partnerID=40&md5=ca21ab1902d0e4e179466b4d5555858b,"School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Host Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland; Center for Infection and Genomics of the Lung, German Center for Lung Research (DZL), Faculty of Medicine, Justus Liebig University, Giessen, Germany; Department of Infectious Diseases, St. James’s Hospital, Dublin, Ireland; Clinical Research Facility, St. James’s Hospital, Dublin, Ireland; Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Department of Immunology, St James’s Hospital, Dublin, Ireland; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin 2, Ireland; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia","Ryan T.A.J., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Hooftman A., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Rehill A.M., Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland; Johansen M.D., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Brien E.C.O., Host Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Toller-Kawahisa J.E., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Wilk M.M., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland, Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland; Day E.A., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Weiss H.J., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Sarvari P., Center for Infection and Genomics of the Lung, German Center for Lung Research (DZL), Faculty of Medicine, Justus Liebig University, Giessen, Germany; Vozza E.G., Host Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Schramm F., Center for Infection and Genomics of the Lung, German Center for Lung Research (DZL), Faculty of Medicine, Justus Liebig University, Giessen, Germany; Peace C.G., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Zotta A., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Miemczyk S., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Nalkurthi C., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; McManus G., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; O’Doherty L., Department of Infectious Diseases, St. James’s Hospital, Dublin, Ireland, Clinical Research Facility, St. James’s Hospital, Dublin, Ireland, Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Gargan S., Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Long A., Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Dunne J., Department of Immunology, St James’s Hospital, Dublin, Ireland; Cheallaigh C.N., Department of Infectious Diseases, St. James’s Hospital, Dublin, Ireland, Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland; Conlon N., Clinical Research Facility, St. James’s Hospital, Dublin, Ireland, Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland, Department of Immunology, St James’s Hospital, Dublin, Ireland; Carty M., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Fallon P.G., Department of Clinical Medicine, School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin 2, Ireland; Mills K.H.G., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Creagh E.M., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Donnell J.S.O., Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland; Hertzog P.J., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; McLoughlin R.M., Host Pathogen Interactions Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Wygrecka M., Center for Infection and Genomics of the Lung, German Center for Lung Research (DZL), Faculty of Medicine, Justus Liebig University, Giessen, Germany; Preston R.J.S., Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland; Zasłona Z., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Neill L.A.J.O., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland",,Anticoagulants; Caspases; COVID-19; Dimethyl Fumarate; Escherichia coli; Humans; Inflammation; Interferon Type I; Lipopolysaccharides; Macrophages; SARS-CoV-2; Staphylococcus aureus; Thrombin; Thromboplastin; Thrombosis; antiinflammatory agent; beta interferon; caspase 11; dimethyl fumarate; interferon; itaconic acid; lipopolysaccharide; thrombin; thromboplastin; 4-octyl itaconate; anticoagulant agent; caspase; dimethyl fumarate; interferon; lipopolysaccharide; thrombin; thromboplastin; cause of death; coagulation; COVID-19; drug; gene expression; immunity; infectious disease; inhibition; animal cell; animal experiment; animal model; anticoagulation; antiviral activity; Article; cell lysate; controlled study; differential gene expression; enzyme linked immunosorbent assay; Escherichia coli; eyelid closure; gene expression; Gram positive bacterium; in vitro study; inhibition kinetics; innate immunity; interferon signaling; JAK-STAT signaling; lung homogenate; macrophage; nonhuman; preclinical study; promoter region; protein expression; pyroptosis; RNA sequencing; Staphylococcus aureus; thrombocyte poor plasma; tissue repair; type I interferon signaling; Western blotting; coronavirus disease 2019; human; inflammation; macrophage; Severe acute respiratory syndrome coronavirus 2; thrombosis,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85161813514
Vanders R.L.; Gomez H.M.; Hsu A.C.; Daly K.; Wark P.A.B.; Horvat J.C.; Hansbro P.M.,"Vanders, Rebecca L. (55773360100); Gomez, Henry M. (57191960363); Hsu, Alan C. (49861516600); Daly, Katie (57221387938); Wark, Peter A.B. (58166423200); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",55773360100; 57191960363; 49861516600; 57221387938; 58166423200; 9942405300; 6603119390,Inflammatory and antiviral responses to influenza A virus infection are dysregulated in pregnant mice with allergic airway disease,2023,American Journal of Physiology - Lung Cellular and Molecular Physiology,325,3,,L385,L398,13,1,10.1152/ajplung.00232.2022,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85169294907&doi=10.1152%2fajplung.00232.2022&partnerID=40&md5=b68fcf75382bcddf928fe8ebcc098988,"Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia; Vaccines, Infection Viruses and Asthma Research Program Hunter Medical Research Institute, Newcastle, NSW, Australia; Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia","Vanders R.L., Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia, Vaccines, Infection Viruses and Asthma Research Program Hunter Medical Research Institute, Newcastle, NSW, Australia; Gomez H.M., Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia, Vaccines, Infection Viruses and Asthma Research Program Hunter Medical Research Institute, Newcastle, NSW, Australia; Hsu A.C., Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia, Vaccines, Infection Viruses and Asthma Research Program Hunter Medical Research Institute, Newcastle, NSW, Australia; Daly K., Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia, Vaccines, Infection Viruses and Asthma Research Program Hunter Medical Research Institute, Newcastle, NSW, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia, Vaccines, Infection Viruses and Asthma Research Program Hunter Medical Research Institute, Newcastle, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia, Vaccines, Infection Viruses and Asthma Research Program Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia, Vaccines, Infection Viruses and Asthma Research Program Hunter Medical Research Institute, Newcastle, NSW, Australia, Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia",allergic airway disease; asthma; infection; influenza; pregnancy,"Animals; Antiviral Agents; Asthma; beta-Defensins; Cytokines; Disease Models, Animal; Female; Humans; Hyperplasia; Influenza A virus; Influenza, Human; Lung; Mice; Pregnancy; Pyroglyphidae; Respiration Disorders; Respiratory Hypersensitivity; RNA, Messenger; alpha interferon; beta defensin 1; beta defensin 2; beta interferon; gamma interferon inducible protein 10; interleukin 13; interleukin 17; isoflurane; keratinocyte derived chemokine; lambda interferon; messenger RNA; methacholine; microRNA; microRNA 1187; microRNA 155; microRNA 223; microRNA 574; Myxovirus resistance protein; myxovirus resistant 1; protein kinase; surfactant protein D; toll like receptor 3; toll like receptor 9; unclassified drug; antivirus agent; beta defensin; cytokine; messenger RNA; animal cell; animal experiment; animal model; animal tissue; Article; asthma; cell infiltration; controlled study; cytokine response; disease severity; eosinophil; female; hyperplasia; in vitro study; in vivo study; infection sensitivity; influenza A; mouse; mRNA expression level; neutrophil chemotaxis; nonhuman; pregnancy; respiratory tract allergy; respiratory tract inflammation; virus load; animal; asthma; breathing disorder; disease model; human; influenza; Influenza A virus; lung; metabolism; pathology; pregnancy; Pyroglyphidae",Article,Final,,Scopus,2-s2.0-85169294907
Fairley L.H.; Das S.; Dharwal V.; Amorim N.; Hegarty K.J.; Wadhwa R.; Mounika G.; Hansbro P.M.,"Fairley, Lauren H. (57222363646); Das, Shatarupa (57223007601); Dharwal, Vivek (57195758477); Amorim, Nadia (57221385895); Hegarty, Karl J. (57217020672); Wadhwa, Ridhima (57159091700); Mounika, Guntipally (58222471300); Hansbro, Philip M. (6603119390)",57222363646; 57223007601; 57195758477; 57221385895; 57217020672; 57159091700; 58222471300; 6603119390,Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease,2023,Antioxidants,12,4,973,,,,13,10.3390/antiox12040973,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85156187747&doi=10.3390%2fantiox12040973&partnerID=40&md5=aa8c90202861302c8b21904b24f45ae1,"Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Fairley L.H., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Das S., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Dharwal V., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Amorim N., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Hegarty K.J., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Wadhwa R., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Mounika G., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Hansbro P.M., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia",antioxidants; COPD; lung; mitochondria; pulmonary disease; ROS,,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85156187747
Colarusso C.; Terlizzi M.; Maglio A.; Molino A.; Candia C.; Vitale C.; Hansbro P.M.; Vatrella A.; Pinto A.; Sorrentino R.,"Colarusso, Chiara (57191250457); Terlizzi, Michela (55605037100); Maglio, Angelantonio (56385860200); Molino, Antonio (7005073386); Candia, Claudio (57802945800); Vitale, Carolina (56058191400); Hansbro, Philip M. (6603119390); Vatrella, Alessandro (6701595368); Pinto, Aldo (7402306499); Sorrentino, Rosalinda (14065472200)",57191250457; 55605037100; 56385860200; 7005073386; 57802945800; 56058191400; 6603119390; 6701595368; 7402306499; 14065472200,"Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β",2022,Frontiers in Immunology,13,,934264,,,,14,10.3389/fimmu.2022.934264,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134169128&doi=10.3389%2ffimmu.2022.934264&partnerID=40&md5=bbf3f7f86958c608d5779a0066b519f4,"Department of Pharmacy, University of Salerno, Fisciano, Italy; Department of Medicine and Surgery, University of Salerno, Baronissi, Italy; Department of Respiratory Medicine, Respiratory Division, University of Naples Federico II, Naples, Italy; Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia","Colarusso C., Department of Pharmacy, University of Salerno, Fisciano, Italy; Terlizzi M., Department of Pharmacy, University of Salerno, Fisciano, Italy; Maglio A., Department of Medicine and Surgery, University of Salerno, Baronissi, Italy; Molino A., Department of Respiratory Medicine, Respiratory Division, University of Naples Federico II, Naples, Italy; Candia C., Department of Respiratory Medicine, Respiratory Division, University of Naples Federico II, Naples, Italy; Vitale C., Department of Medicine and Surgery, University of Salerno, Baronissi, Italy; Hansbro P.M., Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Vatrella A., Department of Medicine and Surgery, University of Salerno, Baronissi, Italy; Pinto A., Department of Pharmacy, University of Salerno, Fisciano, Italy; Sorrentino R., Department of Pharmacy, University of Salerno, Fisciano, Italy",AIM2 inflammasome; cytokines; post-COVID-19; post-COVID-19 lung fibrosis; SARS–CoV–2,"Carrier Proteins; Caspase 1; COVID-19; DNA-Binding Proteins; Humans; Inflammasomes; Interferon-alpha; Leukocytes, Mononuclear; Melanoma; Pulmonary Fibrosis; SARS-CoV-2; Transforming Growth Factor beta; alpha interferon; beta interferon; caspase 4; cytokine; inflammasome; interleukin 1alpha; interleukin 1beta; interleukin 1beta converting enzyme; transforming growth factor beta; AIM2 protein, human; alpha interferon; carrier protein; DNA binding protein; inflammasome; interleukin 1beta converting enzyme; transforming growth factor beta; Article; blood sampling; cell culture; cell isolation; enzyme linked immunosorbent assay; flow cytometry; fluorescence activated cell sorting; high resolution computer tomography; human; long COVID; lung fibrosis; peripheral blood mononuclear cell; real time polymerase chain reaction; RNA isolation; Severe acute respiratory syndrome coronavirus 2; x-ray computed tomography; complication; melanoma; metabolism; mononuclear cell",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85134169128
Verma N.; Arora V.; Awasthi R.; Chan Y.; Jha N.K.; Thapa K.; Jawaid T.; Kamal M.; Gupta G.; Liu G.; Paudel K.R.; Hansbro P.M.; George Oliver B.G.; Singh S.K.; Chellappan D.K.; Dureja H.; Dua K.,"Verma, Nitin (58160492500); Arora, Vimal (23472175800); Awasthi, Rajendra (36866066100); Chan, Yinghan (57204707263); Jha, Niraj Kumar (55109018100); Thapa, Komal (57216364355); Jawaid, Talha (26326847900); Kamal, Mehnaz (58139792400); Gupta, Gaurav (15047988400); Liu, Gang (57189061134); Paudel, Keshav Raj (56539588400); Hansbro, Philip Michael (6603119390); George Oliver, Brian Gregory (15919869900); Singh, Sachin Kumar (57206711834); Chellappan, Dinesh Kumar (35811890500); Dureja, Harish (6507566948); Dua, Kamal (15759138700)",58160492500; 23472175800; 36866066100; 57204707263; 55109018100; 57216364355; 26326847900; 58139792400; 15047988400; 57189061134; 56539588400; 6603119390; 15919869900; 57206711834; 35811890500; 6507566948; 15759138700,"Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis",2022,Journal of Drug Delivery Science and Technology,75,,103690,,,,13,10.1016/j.jddst.2022.103690,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136713149&doi=10.1016%2fj.jddst.2022.103690&partnerID=40&md5=19c490aadb87f99b36bfb5402eeab757,"Chitkara University School of Pharmacy, Chitkara University, Himachal Pradesh, 174103, India; University Institute of Pharma Sciences, Chandigarh University, Gharuan, Punjab, Mohali, India; Department of Pharmaceutical Sciences, School of Health Sciences & Technology, University of Petroleum and Energy Studies (UPES), Energy Acres, P.O. Bidholi, Via-Prem Nagar, Uttarakhand, Dehradun, 248 007, India; School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34 Knowledge Park III Greater, Uttar Pradesh, Noida, 201310, India; Department of Pharmacology, College of Medicine, Dar Al Uloom University, Al Mizan St, Al Falah, Riyadh, 13314, Saudi Arabia; Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia; School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, India; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia","Verma N., Chitkara University School of Pharmacy, Chitkara University, Himachal Pradesh, 174103, India; Arora V., University Institute of Pharma Sciences, Chandigarh University, Gharuan, Punjab, Mohali, India; Awasthi R., Department of Pharmaceutical Sciences, School of Health Sciences & Technology, University of Petroleum and Energy Studies (UPES), Energy Acres, P.O. Bidholi, Via-Prem Nagar, Uttarakhand, Dehradun, 248 007, India; Chan Y., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34 Knowledge Park III Greater, Uttar Pradesh, Noida, 201310, India; Thapa K., Chitkara University School of Pharmacy, Chitkara University, Himachal Pradesh, 174103, India; Jawaid T., Department of Pharmacology, College of Medicine, Dar Al Uloom University, Al Mizan St, Al Falah, Riyadh, 13314, Saudi Arabia; Kamal M., Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, India; Liu G., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; George Oliver B.G., School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Dureja H., Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",Drug delivery; Multi drug resistance; Nanotechnology; Tuberculosis,BCG vaccine; bedaquiline; clofazimine; delamanid; immunological adjuvant; inactivated vaccine; linezolid; lipid nanoparticle; liposome; live vaccine; macozinone; magnetic nanoparticle; monoclonal antibody; moxifloxacin; n (2 adamantyl) n' geranylethylenediamine; nanocarrier; niosome; pretomanid; quinoline derived antiinfective agent; recombinant vaccine; solid lipid nanoparticle; subunit vaccine; sutezolid; telacebec; tuberculostatic agent; clinical trial (topic); drug delivery system; drug mechanism; human; in vitro study; in vivo study; liposomal delivery; micelle; nanoemulsion; nanopharmaceutics; nonhuman; physical chemistry; Review; tuberculosis,Review,Final,,Scopus,2-s2.0-85136713149
Shrestha J.; Ryan S.T.; Mills O.; Zhand S.; Razavi Bazaz S.; Hansbro P.M.; Ghadiri M.; Ebrahimi Warkiani M.,"Shrestha, Jesus (57214237167); Ryan, Sean Thomas (58323643100); Mills, Oliver (57223241307); Zhand, Sareh (54905091500); Razavi Bazaz, Sajad (57200006380); Hansbro, Philip Michael (6603119390); Ghadiri, Maliheh (57190856835); Ebrahimi Warkiani, Majid (36138999000)",57214237167; 58323643100; 57223241307; 54905091500; 57200006380; 6603119390; 57190856835; 36138999000,A 3D-printed microfluidic platform for simulating the effects of CPAP on the nasal epithelium,2021,Biofabrication,13,3,035028,,,,15,10.1088/1758-5090/abe4c1,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105255455&doi=10.1088%2f1758-5090%2fabe4c1&partnerID=40&md5=f472933b99c90c9ad7d1f9f6d892e376,"School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Woolcock Institute of Medical Research, Respiratory Technology Group, University of Sydney, Sydney, 2037, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2050 and 2007, NSW, Australia; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Institute of Molecular Medicine, Sechenov First Moscow State University, Moscow, 119991, Russian Federation","Shrestha J., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, Respiratory Technology Group, University of Sydney, Sydney, 2037, NSW, Australia; Ryan S.T., Woolcock Institute of Medical Research, Respiratory Technology Group, University of Sydney, Sydney, 2037, NSW, Australia; Mills O., Woolcock Institute of Medical Research, Respiratory Technology Group, University of Sydney, Sydney, 2037, NSW, Australia; Zhand S., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Razavi Bazaz S., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2050 and 2007, NSW, Australia; Ghadiri M., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, Respiratory Technology Group, University of Sydney, Sydney, 2037, NSW, Australia; Ebrahimi Warkiani M., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia, Institute of Molecular Medicine, Sechenov First Moscow State University, Moscow, 119991, Russian Federation",3D printing; Continuous positive airway pressure; microfluidics; nasal epithelium; nose-on-a-chip; obstructive sleep apnea,"Continuous Positive Airway Pressure; Microfluidics; Nasal Mucosa; Printing, Three-Dimensional; Quality of Life; Cell culture; Cell death; Microfluidics; Phase interfaces; Respiratory system; Sleep research; Air liquid interfaces; Chronic disorders; Continuous positive airway pressures; Lactate dehydrogenase; Medical conditions; Micro-fluidic devices; Microfluidic platforms; Obstructive sleep apnea; microfluidics; nose mucosa; positive end expiratory pressure ventilation; quality of life; three dimensional printing; 3D printers",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85105255455
Augustine R.; S A.; Nayeem A.; Salam S.A.; Augustine P.; Dan P.; Maureira P.; Mraiche F.; Gentile C.; Hansbro P.M.; McClements L.; Hasan A.,"Augustine, Robin (55351626400); S, Abhilash (57327773800); Nayeem, Ajisha (57221615950); Salam, Shaheen Abdul (57224567960); Augustine, Priya (57246718200); Dan, Pan (56735988100); Maureira, Pablo (14056454000); Mraiche, Fatima (17135525400); Gentile, Carmine (25821678600); Hansbro, Philip M. (6603119390); McClements, Lana (55600912900); Hasan, Anwarul (55765018700)",55351626400; 57327773800; 57221615950; 57224567960; 57246718200; 56735988100; 14056454000; 17135525400; 25821678600; 6603119390; 55600912900; 55765018700,Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation,2022,Chemico-Biological Interactions,351,,109738,,,,31,10.1016/j.cbi.2021.109738,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118862588&doi=10.1016%2fj.cbi.2021.109738&partnerID=40&md5=5324f4dc92fa4515f1cbde6c7a4f5a81,"Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, Doha, 2713, Qatar; Biomedical Research Center (BRC), Qatar University, PO Box 2713, Doha, Qatar; Department of Microbiology, Majlis Arts and Science College, Puramannur, Malappuram, 676552, Kerala, India; Department of Biotechnology, St. Mary's College, Thrissur, 680020, Kerala, India; Department of Biosciences, MES College Marampally, Aluva, Ernakulam, 683107, Kerala, India; Department of Zoology, Kongunadu Arts and Science College, Coimbatore, 641029, Tamil Nadu, India; Department of Cardiovascular and Transplantation Surgery, Regional Central Hospital of Nancy, Lorraine University, France; Department of Thoracic and Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China; College of Pharmacy, QU-Health, Qatar University, PO Box 2713, Doha, Qatar; School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, NSW, Australia; School of Medicine, Faculty of Medicine and Health, University of Sydney, NSW, Australia; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Centre for Inflammation, Centenary Institute and University of Technology Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia","Augustine R., Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, Doha, 2713, Qatar, Biomedical Research Center (BRC), Qatar University, PO Box 2713, Doha, Qatar; S A., Department of Microbiology, Majlis Arts and Science College, Puramannur, Malappuram, 676552, Kerala, India; Nayeem A., Department of Biotechnology, St. Mary's College, Thrissur, 680020, Kerala, India; Salam S.A., Department of Biosciences, MES College Marampally, Aluva, Ernakulam, 683107, Kerala, India; Augustine P., Department of Zoology, Kongunadu Arts and Science College, Coimbatore, 641029, Tamil Nadu, India; Dan P., Department of Cardiovascular and Transplantation Surgery, Regional Central Hospital of Nancy, Lorraine University, France, Department of Thoracic and Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China; Maureira P., Department of Cardiovascular and Transplantation Surgery, Regional Central Hospital of Nancy, Lorraine University, France; Mraiche F., College of Pharmacy, QU-Health, Qatar University, PO Box 2713, Doha, Qatar; Gentile C., School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, NSW, Australia, School of Medicine, Faculty of Medicine and Health, University of Sydney, NSW, Australia, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia; McClements L., School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia; Hasan A., Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, Doha, 2713, Qatar, Biomedical Research Center (BRC), Qatar University, PO Box 2713, Doha, Qatar",ACE2; Cardiovascular diseases; Coronavirus; COVID-19; RAAS; SARS-CoV-2,"Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; COVID-19; Humans; Receptors, Coronavirus; Renin-Angiotensin System; Risk Factors; SARS-CoV-2; amino terminal pro brain natriuretic peptide; angiotensin converting enzyme 2; angiotensin II; angiotensin[1-7]; creatine kinase MB; dipeptidyl carboxypeptidase; ferritin; interleukin 6; lactate dehydrogenase; myoglobin; troponin I; ACE2 protein, human; angiotensin receptor antagonist; dipeptidyl carboxypeptidase inhibitor; age; cardiogenic shock; cardiomyopathy; cardiovascular disease; cardiovascular risk factor; cerebrovascular disease; coronavirus disease 2019; heart arrhythmia; heart failure; heart infarction; heart injury; heart muscle injury; human; infection risk; ischemic heart disease; nonhuman; renin angiotensin aldosterone system; Review; risk assessment; sample size; tachycardia; virus entry; cardiovascular disease; complication; drug effect; drug therapy; metabolism; pathophysiology; physiology; renin angiotensin aldosterone system; risk factor",Review,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85118862588
Munoz M.A.; Fletcher E.K.; Skinner O.P.; Jurczyluk J.; Kristianto E.; Hodson M.P.; Sun S.; Ebetino F.H.; Croucher D.R.; Hansbro P.M.; Center J.R.; Rogers M.J.,"Munoz, Marcia A. (7402191110); Fletcher, Emma K. (57268030400); Skinner, Oliver P. (57188563681); Jurczyluk, Julie (6504736209); Kristianto, Esther (57222896152); Hodson, Mark P. (7102746746); Sun, Shuting (36629414700); Ebetino, Frank H. (57201775847); Croucher, David R. (13805216800); Hansbro, Philip M. (6603119390); Center, Jacqueline R. (7004173206); Rogers, Michael J. (55481881300)",7402191110; 57268030400; 57188563681; 6504736209; 57222896152; 7102746746; 36629414700; 57201775847; 13805216800; 6603119390; 7004173206; 55481881300,Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophages,2021,eLife,10,,e72430,,,,11,10.7554/eLife.72430,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121997537&doi=10.7554%2feLife.72430&partnerID=40&md5=b5f0e0eb87d7b64f9713dae4d232304e,"Garvan Institute of Medical Research and St Vincent’s Clinical School, UNSW Sydney, Sydney, Australia; Victor Chang Cardiac Research Institute Innovation Centre, Sydney, Australia; School of Pharmacy, University of Queensland, Woolloongabba, Australia; BioVinc, Pasadena, United States; University of Southern California, Los Angeles, United States; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia","Munoz M.A., Garvan Institute of Medical Research and St Vincent’s Clinical School, UNSW Sydney, Sydney, Australia; Fletcher E.K., Garvan Institute of Medical Research and St Vincent’s Clinical School, UNSW Sydney, Sydney, Australia; Skinner O.P., Garvan Institute of Medical Research and St Vincent’s Clinical School, UNSW Sydney, Sydney, Australia; Jurczyluk J., Garvan Institute of Medical Research and St Vincent’s Clinical School, UNSW Sydney, Sydney, Australia; Kristianto E., Victor Chang Cardiac Research Institute Innovation Centre, Sydney, Australia; Hodson M.P., Victor Chang Cardiac Research Institute Innovation Centre, Sydney, Australia, School of Pharmacy, University of Queensland, Woolloongabba, Australia; Sun S., BioVinc, Pasadena, United States, University of Southern California, Los Angeles, United States; Ebetino F.H., BioVinc, Pasadena, United States; Croucher D.R., Garvan Institute of Medical Research and St Vincent’s Clinical School, UNSW Sydney, Sydney, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Center J.R., Garvan Institute of Medical Research and St Vincent’s Clinical School, UNSW Sydney, Sydney, Australia; Rogers M.J., Garvan Institute of Medical Research and St Vincent’s Clinical School, UNSW Sydney, Sydney, Australia",,"Animals; Bone Density Conservation Agents; Chemokines; Cytokines; Female; Lipopolysaccharides; Lung; Macrophages, Alveolar; Macrophages, Peritoneal; Mevalonic Acid; Mice, Inbred C57BL; Protein Prenylation; Zoledronic Acid; bisphosphonic acid derivative; chemokine; cytokine; interleukin 1beta; mevalonic acid; monoclonal antibody; bone density conservation agent; lipopolysaccharide; mevalonic acid; zoledronic acid; adult; animal experiment; animal model; animal tissue; Article; bone disease; chromatography; controlled study; female; flow cytometry; immune response; lung alveolus macrophage; mouse; nonhuman; peritoneum lavage; pneumonia; skeleton; Western blotting; animal; C57BL mouse; drug effect; lung; lung alveolus macrophage; metabolism; peritoneum macrophage; protein prenylation",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85121997537
Stewart E.L.; Counoupas C.; Johansen M.D.; Nguyen D.H.; Miemczyk S.; Hansbro N.G.; Ferrell K.C.; Ashhurst A.; Alca S.; Ashley C.; Steain M.; Britton W.J.; Hansbro P.M.; Petrovsky N.; Triccas J.A.,"Stewart, Erica L. (57211535483); Counoupas, Claudio (24070034400); Johansen, Matt D. (57202983408); Nguyen, Duc H. (54886138200); Miemczyk, Stefan (57773070000); Hansbro, Nicole G. (15055862300); Ferrell, Kia C. (57219892182); Ashhurst, Anneliese (57192872471); Alca, Sibel (57972002900); Ashley, Caroline (57195268120); Steain, Megan (8740991600); Britton, Warwick J. (7102477888); Hansbro, Philip M. (6603119390); Petrovsky, Nikolai (7004919225); Triccas, James A. (7003601814)",57211535483; 24070034400; 57202983408; 54886138200; 57773070000; 15055862300; 57219892182; 57192872471; 57972002900; 57195268120; 8740991600; 7102477888; 6603119390; 7004919225; 7003601814,Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2,2022,Mucosal Immunology,15,6,,1405,1415,10,11,10.1038/s41385-022-00578-9,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85142293616&doi=10.1038%2fs41385-022-00578-9&partnerID=40&md5=e6d7ced01164e548133edfee50631c69,"School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Sydney Institute for Infectious Diseases and the Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia; Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Vaxine Pty Ltd., Bedford Park, Adelaide, 5042, SA, Australia","Stewart E.L., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Counoupas C., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia, Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases and the Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia; Johansen M.D., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Nguyen D.H., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Miemczyk S., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Hansbro N.G., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Ferrell K.C., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Ashhurst A., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia, Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases and the Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia; Alca S., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Ashley C., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Steain M., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases and the Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia; Britton W.J., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia, Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Hansbro P.M., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Petrovsky N., Vaxine Pty Ltd., Bedford Park, Adelaide, 5042, SA, Australia; Triccas J.A., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases and the Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia",,"Adjuvants, Immunologic; Animals; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Gastric Mucosa; Humans; Immunization; Immunologic Memory; Inulin; Lung; Mice; Pandemics; SARS-CoV-2; Vaccination; Vaccines, Synthetic; coronavirus spike glycoprotein; delta inulin adjuvant; inulin; SARS-CoV-2 antibody; SARS-CoV-2 vaccine; unclassified drug; vaccine adjuvant; immunological adjuvant; inulin; recombinant vaccine; animal cell; animal experiment; animal model; antibody response; antibody titer; Article; bronchoalveolar lavage fluid; CD4+ T lymphocyte; CD8+ T lymphocyte; cellular immunity; controlled study; coronavirus disease 2019; drug formulation; embryo; human; human cell; immunization; immunological memory; inducible bronchus associated lymphoid tissue; lung alveolus macrophage; male; mouse; mucosa associated lymphoid tissue; mucosal immunization; nonhuman; Severe acute respiratory syndrome coronavirus 2; sterilizing immunity; vaccine development; animal; CD8+ T lymphocyte; immunization; immunological memory; lung; pandemic; prevention and control; stomach mucosa; vaccination",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85142293616
Wang Y.; Xu X.; Marshall J.E.; Gong M.; Zhao Y.; Dua K.; Hansbro P.M.; Xu J.; Liu G.,"Wang, Yao (57387563900); Xu, Xiaoyue (56524795700); Marshall, Jacqueline E. (57218547927); Gong, Muxue (57387375200); Zhao, Yang (58844328000); Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390); Xu, Jincheng (36239605800); Liu, Gang (57189061134)",57387563900; 56524795700; 57218547927; 57387375200; 58844328000; 15759138700; 6603119390; 36239605800; 57189061134,Loss of Hyaluronan and Proteoglycan Link Protein-1 Induces Tumorigenesis in Colorectal Cancer,2021,Frontiers in Oncology,11,,754240,,,,13,10.3389/fonc.2021.754240,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121783081&doi=10.3389%2ffonc.2021.754240&partnerID=40&md5=265260117806dffe8bba61f5e983df13,"College of Biology and Food Engineering, Anyang Institute of Technology, Anyang, China; Hangzhou Xunyao Biotechnology Pty. Ltd, Hangzhou, China; School of Population Health, University of New South Wales, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology, Sydney, NSW, Australia; School of Clinical Medicine, Bengbu Medicine College, Bengbu, China; Department of Biochemistry and Molecular Biology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Stomatology Department, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China; School of Dental Medicine, Bengbu Medical College, Bengbu, China","Wang Y., College of Biology and Food Engineering, Anyang Institute of Technology, Anyang, China, Hangzhou Xunyao Biotechnology Pty. Ltd, Hangzhou, China; Xu X., School of Population Health, University of New South Wales, Sydney, NSW, Australia; Marshall J.E., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology, Sydney, NSW, Australia; Gong M., School of Clinical Medicine, Bengbu Medicine College, Bengbu, China; Zhao Y., Department of Biochemistry and Molecular Biology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; Dua K., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology, Sydney, NSW, Australia; Xu J., Stomatology Department, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China, School of Dental Medicine, Bengbu Medical College, Bengbu, China; Liu G., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology, Sydney, NSW, Australia",CRC; extracellular matrix protein; HAPLN1; microenvironment; TGF-β,collagen type I alpha 1; hyaluronan and proteoglycan link protein 1; kanamycin; protein; proteoglycan; scleroprotein; Smad2 protein; Smad3 protein; Smad4 protein; transforming growth factor beta; unclassified drug; adult; aged; Article; carcinogenesis; cell migration; cell proliferation; colony formation; colorectal cancer; DNA microarray; extracellular matrix; female; fetal bovine serum; gene expression; gene overexpression; human; human cell; human tissue; immunoblotting; immunofluorescence; immunohistochemistry; Kaplan Meier method; major clinical study; male; microarray analysis; myofibroblast; normal human; protein expression; signal transduction; TGF beta signaling; tissue microarray; upregulation,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85121783081
Prasher P.; Sharma M.; Mehta M.; Satija S.; Aljabali A.A.; Tambuwala M.M.; Anand K.; Sharma N.; Dureja H.; Jha N.K.; Gupta G.; Gulati M.; Singh S.K.; Chellappan D.K.; Paudel K.R.; Hansbro P.M.; Dua K.,"Prasher, Parteek (56079914500); Sharma, Mousmee (57214452304); Mehta, Meenu (7203024234); Satija, Saurabh (54581608400); Aljabali, Alaa A. (35306626800); Tambuwala, Murtaza M. (36657816300); Anand, Krishnan (57488883300); Sharma, Nitin (57830916800); Dureja, Harish (6507566948); Jha, Niraj Kumar (55109018100); Gupta, Gaurav (15047988400); Gulati, Monica (7006677671); Singh, Sachin Kumar (57206711834); Chellappan, Dinesh K. (35811890500); Paudel, Keshav R. (56539588400); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",56079914500; 57214452304; 7203024234; 54581608400; 35306626800; 36657816300; 57488883300; 57830916800; 6507566948; 55109018100; 15047988400; 7006677671; 57206711834; 35811890500; 56539588400; 6603119390; 15759138700,Current-status and applications of polysaccharides in drug delivery systems,2021,Colloids and Interface Science Communications,42,,100418,,,,101,10.1016/j.colcom.2021.100418,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104999025&doi=10.1016%2fj.colcom.2021.100418&partnerID=40&md5=cccde44be720b0bb80aa2e7400866272,"Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Department of Chemistry, Uttaranchal University, Dehradun, 248007, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Yarmouk University, Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Irbid, 566, Jordan; School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, County Londonderry, BT52 1SA, Northern Ireland, United Kingdom; Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences and National Health Laboratory Service, University of the Free State, Bloemfontein, South Africa; Department of Pharmacy, Merrut Institute of Engineering and Technology, 250005, UP, India; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India; Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, 201310, UP, India; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Prasher P., Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Sharma M., Department of Chemistry, Uttaranchal University, Dehradun, 248007, India; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Aljabali A.A., Yarmouk University, Faculty of Pharmacy, Department of Pharmaceutics and Pharmaceutical Technology, Irbid, 566, Jordan; Tambuwala M.M., School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, County Londonderry, BT52 1SA, Northern Ireland, United Kingdom; Anand K., Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences and National Health Laboratory Service, University of the Free State, Bloemfontein, South Africa; Sharma N., Department of Pharmacy, Merrut Institute of Engineering and Technology, 250005, UP, India; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India; Jha N.K., Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, 201310, UP, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia",Biocompatible; Drug delivery; Polysaccharides,,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85104999025
Imran M.; Paudel K.R.; Jha S.K.; Hansbro P.M.; Dua K.; Mohammed Y.,"Imran, Mohammad (57209466043); Paudel, Keshav Raj (56539588400); Jha, Saurav Kumar (57210712565); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Mohammed, Yousuf (56116912300)",57209466043; 56539588400; 57210712565; 6603119390; 15759138700; 56116912300,Dressing multifunctional nanoparticles with natural cell-derived membranes for superior chemotherapy,2022,Nanomedicine,17,10,,665,670,5,13,10.2217/nnm-2022-0051,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129480351&doi=10.2217%2fnnm-2022-0051&partnerID=40&md5=fd7660ee76e062c8bd5f846fec6494d5,"Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Sydney, 2007, NSW, Australia; Department of Biomedicine, Health & Life Convergence Sciences, Mokpo National University, Jeonnam, 58554, South Korea; Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Therapeutics Research Group, University of Queensland Diamantina Institute, University of Queensland, Brisbane, 4102, QLD, Australia","Imran M., Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Paudel K.R., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Sydney, 2007, NSW, Australia; Jha S.K., Department of Biomedicine, Health & Life Convergence Sciences, Mokpo National University, Jeonnam, 58554, South Korea; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Mohammed Y., Therapeutics Research Group, University of Queensland Diamantina Institute, University of Queensland, Brisbane, 4102, QLD, Australia",biomimetic; camouflage; chemotherapy; drug delivery; nanodecoys,Bandages; Biomimetic Materials; Cell Membrane; Drug Delivery Systems; Multifunctional Nanoparticles; Nanoparticles; antineoplastic agent; cytokine; nanocarrier; biomimetic material; nanoparticle; biological mimicry; biomimetics; cancer cell; cancer chemotherapy; cancer diagnosis; cell membrane; controlled drug release; drug delivery system; drug research; drug response; encapsulation; human; immune evasion; malignant neoplasm; metabolic engineering; metronomic drug administration; nonhuman; Note; preclinical study; bandage; cell membrane,Note,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85129480351
Allam V.S.R.R.; Paudel K.R.; Gupta G.; Singh S.K.; Vishwas S.; Gulati M.; Gupta S.; Chaitanya M.V.N.L.; Jha N.K.; Gupta P.K.; Patel V.K.; Liu G.; Kamal M.A.; Hansbro P.M.; Oliver B.G.G.; Chellappan D.K.; Dua K.,"Allam, Venkata Sita Rama Raju (57200203739); Paudel, Keshav Raj (56539588400); Gupta, Gaurav (15047988400); Singh, Sachin Kumar (57206711834); Vishwas, Sukriti (57216932631); Gulati, Monica (7006677671); Gupta, Saurabh (57214718590); Chaitanya, M.V.N.L. (56702930800); Jha, Niraj Kumar (55109018100); Gupta, Piyush Kumar (57220905930); Patel, Vyoma K. (57193533009); Liu, Gang (57189061134); Kamal, Mohammad Amjad (56340070000); Hansbro, Philip M. (6603119390); Oliver, Brian Gregory George (15919869900); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",57200203739; 56539588400; 15047988400; 57206711834; 57216932631; 7006677671; 57214718590; 56702930800; 55109018100; 57220905930; 57193533009; 57189061134; 56340070000; 6603119390; 15919869900; 35811890500; 15759138700,Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma,2022,Environmental Science and Pollution Research,29,42,,62733,62754,21,18,10.1007/s11356-022-21454-w,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133592359&doi=10.1007%2fs11356-022-21454-w&partnerID=40&md5=c2da28551bd1198a1e16c6967f42ed0f,"Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Chitkara College of Pharmacy, Chitkara University, Punjab, India; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Uttar Pradesh, Greater Noida, India; Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, 248007, India; Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Uttar Pradesh, Greater Noida, Australia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, 2052, NSW, Australia; King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah, 21589, Saudi Arabia; Institutes for Systems Genetics, Frontiers Science Center for Disease related Molecular Network, West China Hospital, Sichuan University, Chengdu, China; Enzymoics, Novel Global Community Educational Foundation, 7 Peterlee Place, Hebersham, 2770, NSW, Australia; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, 1207, Bangladesh; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box: 123 Broadway, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Allam V.S.R.R., Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box: 123 Broadway, Ultimo, 2007, NSW, Australia; Vishwas S., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box: 123 Broadway, Ultimo, 2007, NSW, Australia; Gupta S., Chitkara College of Pharmacy, Chitkara University, Punjab, India; Chaitanya M.V.N.L., Chitkara College of Pharmacy, Chitkara University, Punjab, India; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Uttar Pradesh, Greater Noida, India, Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, 248007, India; Gupta P.K., Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Uttar Pradesh, Greater Noida, Australia; Patel V.K., School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, 2052, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Liu G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Kamal M.A., King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah, 21589, Saudi Arabia, Institutes for Systems Genetics, Frontiers Science Center for Disease related Molecular Network, West China Hospital, Sichuan University, Chengdu, China, Enzymoics, Novel Global Community Educational Foundation, 7 Peterlee Place, Hebersham, 2770, NSW, Australia, Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, 1207, Bangladesh; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Oliver B.G.G., School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box: 123 Broadway, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Asthma; Inflammation; Mitochondria; Nutraceuticals; Oxidative stress; Therapeutics,Asthma; Bronchodilator Agents; Dietary Supplements; Humans; Oxidation-Reduction; Oxidative Stress; Diseases; Oxidative stress; Pathology; bronchodilating agent; Anti-inflammatory agents; Asthma; Bronchial asthma; Bronchoconstriction; Chronic inflammatory disease; Current treatments; Inflammation; Mitochondrias; Nutraceuticals; Therapeutic; asthma; morbidity; mortality; oxidative stress; pathology; research work; scavenging (chemistry); asthma; dietary supplement; human; oxidation reduction reaction; oxidative stress; Mitochondria,Review,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85133592359
Darmarajan T.; Paudel K.R.; Candasamy M.; Chellian J.; Madheswaran T.; Sakthivel L.P.; Goh B.H.; Gupta P.K.; Jha N.K.; Devkota H.P.; Gupta G.; Gulati M.; Singh S.K.; Hansbro P.M.; Oliver B.G.G.; Dua K.; Chellappan D.K.,"Darmarajan, Thiviya (57224502805); Paudel, Keshav Raj (56539588400); Candasamy, Mayuren (56190844000); Chellian, Jestin (56993705500); Madheswaran, Thiagarajan (55505311000); Sakthivel, Lakshmana Prabu (57450925800); Goh, Bey Hing (36441148500); Gupta, Piyush Kumar (57220905930); Jha, Niraj Kumar (55109018100); Devkota, Hari Prasad (24775939500); Gupta, Gaurav (15047988400); Gulati, Monica (7006677671); Singh, Sachin Kumar (57206711834); Hansbro, Philip Michael (6603119390); Oliver, Brian Gregory George (15919869900); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",57224502805; 56539588400; 56190844000; 56993705500; 55505311000; 57450925800; 36441148500; 57220905930; 55109018100; 24775939500; 15047988400; 7006677671; 57206711834; 6603119390; 15919869900; 15759138700; 35811890500,Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation,2022,Environmental Science and Pollution Research,29,36,,54072,54087,15,12,10.1007/s11356-022-20984-7,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85131310901&doi=10.1007%2fs11356-022-20984-7&partnerID=40&md5=a6a64bce472e11e37e79d5f1e814a473,"School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Subang Jaya, Selangor, Bandar Sunway, Malaysia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Department of Pharmaceutical Technology, University College of Engineering (BIT Campus), Anna University, Tiruchirappalli, 620024, India; Biofunctional Molecule Exploratory Research Group, School of Pharmacy, Monash University Malaysia, Selangor Darul Ehsan, Bandar Sunway, 47500, Malaysia; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China; Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Department of Biotechnology, School of Engineering & Technology, Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali, 140413, India; Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, 248007, India; Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, Kumamoto City, 862-0973, Japan; Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Kumamoto, Chuo-ku, 862-0973, Japan; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Jagatpura, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Sydney, 2007, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia","Darmarajan T., School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Subang Jaya, Selangor, Bandar Sunway, Malaysia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Candasamy M., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Sakthivel L.P., Department of Pharmaceutical Technology, University College of Engineering (BIT Campus), Anna University, Tiruchirappalli, 620024, India; Goh B.H., Biofunctional Molecule Exploratory Research Group, School of Pharmacy, Monash University Malaysia, Selangor Darul Ehsan, Bandar Sunway, 47500, Malaysia, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China; Gupta P.K., Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Jha N.K., Department of Biotechnology, School of Engineering & Technology, Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India, Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali, 140413, India, Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, 248007, India; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, Kumamoto City, 862-0973, Japan, Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Kumamoto, Chuo-ku, 862-0973, Japan; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Jagatpura, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Sydney, 2007, NSW, Australia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Oliver B.G.G., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Dua K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Sydney, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia",Active immunity; Autoantibodies; Autoimmunity; COVID-19; Passive immunity; SARS-CoV-2,Autoantibodies; Autoimmune Diseases; COVID-19; Humans; SARS-CoV-2; Virulence; autoantibody; COVID-19; immune response; immunity; infectious disease; pathogenicity; autoimmune disease; human; virulence,Review,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85131310901
Ashique S.; De Rubis G.; Sirohi E.; Mishra N.; Rihan M.; Garg A.; Reyes R.-J.; Manandhar B.; Bhatt S.; Jha N.K.; Singh T.G.; Gupta G.; Singh S.K.; Chellappan D.K.; Paudel K.R.; Hansbro P.M.; Oliver B.G.; Dua K.,"Ashique, Sumel (57219283396); De Rubis, Gabriele (57196257973); Sirohi, Ekta (57941713700); Mishra, Neeraj (23027996000); Rihan, Mohd (57211445955); Garg, Ashish (57198487236); Reyes, Ruby-Jean (57941713800); Manandhar, Bikash (57204448260); Bhatt, Shvetank (57197493015); Jha, Niraj Kumar (55109018100); Singh, Thakur Gurjeet (27667828700); Gupta, Gaurav (15047988400); Singh, Sachin Kumar (57206711834); Chellappan, Dinesh Kumar (35811890500); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Oliver, Brian G. (15919869900); Dua, Kamal (15759138700)",57219283396; 57196257973; 57941713700; 23027996000; 57211445955; 57198487236; 57941713800; 57204448260; 57197493015; 55109018100; 27667828700; 15047988400; 57206711834; 35811890500; 56539588400; 6603119390; 15919869900; 15759138700,Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases,2022,Chemico-Biological Interactions,368,,110231,,,,39,10.1016/j.cbi.2022.110231,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85140620116&doi=10.1016%2fj.cbi.2022.110231&partnerID=40&md5=e4a8d5f7604a101e938467e06a450796,"Department of Pharmacy, Bharat Institute of Technology (BIT), School of Pharmacy, UP, Meerut, 250103, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), MP, Gwalior, 474005, India; Department of Pharmacology, National Institute of Pharmaceutical Education andResearch (NIPER), S.A.S. Nagar, Punjab, 160062, India; Department of P.G. Studies and Research in Chemistry and Pharmacy, Rani Durgavati University, MP, Jabalpur, 482001, India; Faculty of Health, University of Technology Sydney, Ultimo, Australia; School of Pharmacy, Dr. Vishwanath Karad MIT World Peace University, Maharashtra, Pune, 411038, India; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Uttar Pradesh, Greater Noida, 201310, India; Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, 248007, India; Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali, 140413, India; Chitkara College of Pharmacy, Chitkara University, Punjab, 140401, India; School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; School of Pharmacy and Pharmaceutical Science, Lovely Professional University, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia","Ashique S., Department of Pharmacy, Bharat Institute of Technology (BIT), School of Pharmacy, UP, Meerut, 250103, India; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Sirohi E., Department of Pharmacy, Bharat Institute of Technology (BIT), School of Pharmacy, UP, Meerut, 250103, India; Mishra N., Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), MP, Gwalior, 474005, India; Rihan M., Department of Pharmacology, National Institute of Pharmaceutical Education andResearch (NIPER), S.A.S. Nagar, Punjab, 160062, India; Garg A., Department of P.G. Studies and Research in Chemistry and Pharmacy, Rani Durgavati University, MP, Jabalpur, 482001, India; Reyes R.-J., Faculty of Health, University of Technology Sydney, Ultimo, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Bhatt S., School of Pharmacy, Dr. Vishwanath Karad MIT World Peace University, Maharashtra, Pune, 411038, India; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Uttar Pradesh, Greater Noida, 201310, India, Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, 248007, India, Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali, 140413, India; Singh T.G., Chitkara College of Pharmacy, Chitkara University, Punjab, 140401, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Singh S.K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, School of Pharmacy and Pharmaceutical Science, Lovely Professional University, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Oliver B.G., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",Gut microbiota metabolites; Gut-lung axis; Potential therapeutics; Respiratory diseases; Short-chain fatty acids,"Asthma; Dysbiosis; Fatty Acids, Volatile; Gastrointestinal Microbiome; Humans; Lung; acetic acid; butyric acid; propionic acid; short chain fatty acid; volatile fatty acid; anaerobic fermentation; asthma; bone marrow progenitor cell; chronic obstructive lung disease; coronavirus disease 2019; cystic fibrosis; dietary fiber; dysbiosis; embryo development; gastrointestinal tract; homeostasis; host pathogen interaction; human; immune signaling; immunocompetent cell; immunomodulation; influenza; intestine; intestine flora; lung; lung cancer; lung disease; lung function; mediator; metabolite; nonhuman; respiratory system; respiratory tract disease; Review; tuberculosis; asthma; intestine flora; lung; metabolism",Review,Final,,Scopus,2-s2.0-85140620116
Khursheed R.; Paudel K.R.; Gulati M.; Vishwas S.; Jha N.K.; Hansbro P.M.; Oliver B.G.; Dua K.; Singh S.K.,"Khursheed, Rubiya (57203173043); Paudel, Keshav R. (56539588400); Gulati, Monica (7006677671); Vishwas, Sukriti (57216932631); Jha, Niraj Kumar (55109018100); Hansbro, Philip M. (6603119390); Oliver, Brian G. (15919869900); Dua, Kamal (15759138700); Singh, Sachin Kumar (57206711834)",57203173043; 56539588400; 7006677671; 57216932631; 55109018100; 6603119390; 15919869900; 15759138700; 57206711834,Expanding the arsenal against pulmonary diseases using surface-functionalized polymeric micelles: breakthroughs and bottlenecks,2022,Nanomedicine,17,12,,881,911,30,22,10.2217/nnm-2021-0451,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128266745&doi=10.2217%2fnnm-2021-0451&partnerID=40&md5=6bbfbd80c6a5d1c8545a8d6ec78ae8d7,"School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Centre of Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34 Knowledge Park III Greater Noida, 201310, India; Woolcock Institute of Medical Research, University of Sydney, Sydney, 2007, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Khursheed R., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Paudel K.R., Centre of Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Vishwas S., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34 Knowledge Park III Greater Noida, 201310, India; Hansbro P.M., Centre of Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, 2007, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Dua K., Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",drug targeting; lung diseases; polymeric micelles; pulmonary delivery,Antineoplastic Agents; Drug Carriers; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Lung Diseases; Micelles; Polymers; copolymer; drug carrier; hydrophobic drug; respiratory tract agent; unclassified drug; antineoplastic agent; drug carrier; polymer; acute lung injury; adverse drug reaction; asthma; chemical parameters; chemical procedures; dialysis; dissolution; drug delivery system; drug dosage form comparison; drug efficacy; drug formulation; drug penetration; drug targeting; emulsion; encapsulation; evaporation; freeze drying; human; lung blood vessel; lung cancer; lung disease; lung fibrosis; lung tuberculosis; micelle; mucoadhesion; mucus; nonhuman; oil in water emulsification; pulmonary hypertension; Review; solvent evaporation; surface functionalized polymeric micelle; thin film hydration; worm micelle; chemical phenomena; chemistry; drug delivery system; micelle; procedures,Review,Final,,Scopus,2-s2.0-85128266745
Devkota H.P.; Gaire B.P.; Hori K.; Subedi L.; Adhikari-Devkota A.; Belwal T.; Paudel K.R.; Jha N.K.; Singh S.K.; Chellappan D.K.; Hansbro P.M.; Dua K.; Kurauchi Y.,"Devkota, Hari Prasad (24775939500); Gaire, Bhakta Prasad (37461314800); Hori, Kengo (57193771015); Subedi, Latita (6507443364); Adhikari-Devkota, Anjana (57200393104); Belwal, Tarun (56548880000); Paudel, Keshav Raj (56539588400); Jha, Niraj Kumar (55109018100); Singh, Sachin Kumar (57206711834); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Kurauchi, Yuki (57191567937)",24775939500; 37461314800; 57193771015; 6507443364; 57200393104; 56548880000; 56539588400; 55109018100; 57206711834; 35811890500; 6603119390; 15759138700; 57191567937,"The science of matcha: Bioactive compounds, analytical techniques and biological properties",2021,Trends in Food Science and Technology,118,,,735,743,8,32,10.1016/j.tifs.2021.10.021,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118546516&doi=10.1016%2fj.tifs.2021.10.021&partnerID=40&md5=6d82962532bb836d169d82970907a391,"Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe Honmachi, Kumamoto, 862-0973, Japan; Program for Leading Graduate Schools “HIGO (Health Life Science: Interdisciplinary and Global Oriented) Program”, Kumamoto University, Kumamoto, 862-0973, Japan; Department of Anesthesiology and Neurology, Shock Trauma and Anesthesiology Research Center, University of Maryland, School of Medicine, Baltimore, MD, United States; Analytical Research Laboratories, Pharmaceutical Technology, Astellas Pharma Inc., 160-2, Akahama, Takahagi-shi, Ibaraki, 318-0001, Japan; College of Biosystems Engineering and Food Science, Key Laboratory for Agro-Products Postharvest Handling of Ministry of Agriculture and Rural Affairs, Zhejiang Key Laboratory for Agro-Food Processing, Zhejiang University, Hangzhou, 310058, China; School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Nioda, 201310, UP, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia","Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe Honmachi, Kumamoto, 862-0973, Japan, Program for Leading Graduate Schools “HIGO (Health Life Science: Interdisciplinary and Global Oriented) Program”, Kumamoto University, Kumamoto, 862-0973, Japan; Gaire B.P., Department of Anesthesiology and Neurology, Shock Trauma and Anesthesiology Research Center, University of Maryland, School of Medicine, Baltimore, MD, United States; Hori K., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe Honmachi, Kumamoto, 862-0973, Japan, Analytical Research Laboratories, Pharmaceutical Technology, Astellas Pharma Inc., 160-2, Akahama, Takahagi-shi, Ibaraki, 318-0001, Japan; Subedi L., Department of Anesthesiology and Neurology, Shock Trauma and Anesthesiology Research Center, University of Maryland, School of Medicine, Baltimore, MD, United States; Adhikari-Devkota A., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe Honmachi, Kumamoto, 862-0973, Japan; Belwal T., College of Biosystems Engineering and Food Science, Key Laboratory for Agro-Products Postharvest Handling of Ministry of Agriculture and Rural Affairs, Zhejiang Key Laboratory for Agro-Food Processing, Zhejiang University, Hangzhou, 310058, China; Paudel K.R., School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Nioda, 201310, UP, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., School of Life Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Kurauchi Y., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe Honmachi, Kumamoto, 862-0973, Japan",Camellia sinensis; Functional foods; Green tea; Market; Matcha,Bioactivity; Chemical analysis; Commerce; Plants (botany); Quality control; Bioactive compounds; Biological properties; Camellia sinensis; Food supplements; Green tea; Healthy foods; Market; Matchum; Nutraceuticals; Product formulation; Functional food,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85118546516
O’Rourke M.B.; Roediger B.R.; Jolly C.J.; Crossett B.; Padula M.P.; Hansbro P.M.,"O’Rourke, Matthew B. (56735635000); Roediger, Ben R. (6507386530); Jolly, Christopher J. (7101662916); Crossett, Ben (57204219477); Padula, Matthew P. (24462195700); Hansbro, Phillip M. (6603119390)",56735635000; 6507386530; 7101662916; 57204219477; 24462195700; 6603119390,Viral Biomarker Detection and Validation Using MALDI Mass Spectrometry Imaging (MSI),2022,Proteomes,10,3,33,,,,1,10.3390/proteomes10030033,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138676976&doi=10.3390%2fproteomes10030033&partnerID=40&md5=68ee861d71a07cd51b3a62d446606962,"Centenary UTS Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Camperdown, 2006, NSW, Australia; Novartis Institutes for Biomedical Research-Autoimmunity, Transplantation and Inflammation, Basel, 9656, Switzerland; Lowy Cancer Research Centre, School of Medical Sciences, UNSW Sydney, Sydney, 2007, NSW, Australia; Sydney Mass Spectrometry, University of Sydney, Camperdown, 2006, NSW, Australia; Metabolomics and Lipidomics Core Facility, Faculty of Science, School of Life Sciences and Proteomics, University of Technology Sydney, Ultimo, 2007, NSW, Australia","O’Rourke M.B., Centenary UTS Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Roediger B.R., Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Camperdown, 2006, NSW, Australia, Novartis Institutes for Biomedical Research-Autoimmunity, Transplantation and Inflammation, Basel, 9656, Switzerland; Jolly C.J., Centenary Institute, Faculty of Medicine and Health, The University of Sydney, Camperdown, 2006, NSW, Australia, Lowy Cancer Research Centre, School of Medical Sciences, UNSW Sydney, Sydney, 2007, NSW, Australia; Crossett B., Sydney Mass Spectrometry, University of Sydney, Camperdown, 2006, NSW, Australia; Padula M.P., Metabolomics and Lipidomics Core Facility, Faculty of Science, School of Life Sciences and Proteomics, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centenary UTS Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia",MALDI; mass spectrometry imaging; peptide identification,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85138676976
Shastri M.D.; Allam V.S.R.R.; Shukla S.D.; Jha N.K.; Paudel K.R.; Peterson G.M.; Patel R.P.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Shastri, Madhur D. (56007290800); Allam, Venkata Sita Rama Raju (57200203739); Shukla, Shakti D. (56367620800); Jha, Niraj Kumar (55109018100); Paudel, Keshav Raj (56539588400); Peterson, Gregory M. (7402563175); Patel, Rahul P. (36849078400); Hansbro, Philip M. (6603119390); Chellappan, Dinesh K. (35811890500); Dua, Kamal (15759138700)",56007290800; 57200203739; 56367620800; 55109018100; 56539588400; 7402563175; 36849078400; 6603119390; 35811890500; 15759138700,Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases,2021,Life Sciences,283,,119871,,,,18,10.1016/j.lfs.2021.119871,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112482736&doi=10.1016%2fj.lfs.2021.119871&partnerID=40&md5=5c61152a3767f52cda1d50843359cce1,"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, 7005, Australia; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, UP, India; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Shastri M.D., School of Pharmacy and Pharmacology, University of Tasmania, Hobart, 7005, Australia; Allam V.S.R.R., Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Shukla S.D., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, UP, India; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Peterson G.M., School of Pharmacy and Pharmacology, University of Tasmania, Hobart, 7005, Australia; Patel R.P., School of Pharmacy and Pharmacology, University of Tasmania, Hobart, 7005, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Asthma; Chronic respiratory diseases (CRDs); COPD; COVID; Cystic fibrosis; Eosinophils; IL-13; IL-33; Innate lymphoid cells (ILC2s),"Chronic Disease; Humans; Inflammation; Influenza, Human; Interleukin-13; Lung Diseases; Mucus; interleukin 13; chronic disease; human; immunology; inflammation; influenza; lung disease; mucus; pathology",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85112482736
Pacitti D.; Scotton C.J.; Kumar V.; Khan H.; Wark P.A.B.; Torregrossa R.; Hansbro P.M.; Whiteman M.,"Pacitti, Dario (57204035498); Scotton, Chris J. (8766774500); Kumar, Vinod (57212900967); Khan, Haroon (57204287630); Wark, Peter A.B. (7003559516); Torregrossa, Roberta (56176911400); Hansbro, Philip M. (6603119390); Whiteman, Matthew (55675121300)",57204035498; 8766774500; 57212900967; 57204287630; 7003559516; 56176911400; 6603119390; 55675121300,Gasping for sulfide: A critical appraisal of hydrogen sulfide in lung disease and accelerated aging,2021,Antioxidants and Redox Signaling,35,7,,551,579,28,17,10.1089/ars.2021.0039,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112738808&doi=10.1089%2fars.2021.0039&partnerID=40&md5=9ed25d4f9b38f9ae0b23d8570bc8d864,"Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, University of Exeter, St. Luke’s Campus, Magdalen Road, Exeter, EX1 2LU, United Kingdom; Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, The University of Newcastle, Newcastle, Australia; Faculty of Science, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, 2050, Australia","Pacitti D., Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, University of Exeter, St. Luke’s Campus, Magdalen Road, Exeter, EX1 2LU, United Kingdom; Scotton C.J., Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, University of Exeter, St. Luke’s Campus, Magdalen Road, Exeter, EX1 2LU, United Kingdom; Kumar V., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, The University of Newcastle, Newcastle, Australia; Khan H., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, The University of Newcastle, Newcastle, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, The University of Newcastle, Newcastle, Australia; Torregrossa R., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, The University of Newcastle, Newcastle, Australia; Hansbro P.M., Faculty of Science, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, 2050, Australia; Whiteman M., Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, University of Exeter, St. Luke’s Campus, Magdalen Road, Exeter, EX1 2LU, United Kingdom",3-MST; Aging; AP123; AP39; CBS; CGL; CSE; GYY4137; H<sub>2</sub>S ELISA; Inflammation; Mitochondria; Therapeutics,Aging; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Lung Diseases; Sulfides; biological marker; hydrogen sulfide; cystathionine beta synthase; cystathionine gamma lyase; hydrogen sulfide; sulfide; acute lung injury; aging; allergic rhinitis; asthma; chronic obstructive lung disease; cystic fibrosis; drug activity; drug combination; human; interstitial lung disease; lung cancer; lung development; lung disease; lung transplantation; mitochondrion; pathophysiology; physiology; protein expression level; respiratory tract disease; Review; synergistic effect; viral respiratory tract infection; aging; lung disease; metabolism,Review,Final,,Scopus,2-s2.0-85112738808
Lao J.C.; Bui C.B.; Pang M.A.; Cho S.X.; Rudloff I.; Elgass K.; Schröder J.; Maksimenko A.; Mangan N.E.; Starkey M.R.; Skuza E.M.; Sun Y.B.Y.; Beker F.; Collins C.L.; Kamlin O.F.; König K.; Malhotra A.; Tan K.; Theda C.; Young M.J.; McLean C.A.; Wilson N.J.; Sehgal A.; Hansbro P.M.; Pearson J.T.; Polo J.M.; Veldman A.; Berger P.J.; Nold-Petry C.A.; Nold M.F.,"Lao, Jason C. (56533484300); Bui, Christine B. (57192265741); Pang, Merrin A. (57196033835); Cho, Steven X. (56004381800); Rudloff, Ina (36931070700); Elgass, Kirstin (24479337600); Schröder, Jan (25723678000); Maksimenko, Anton (56189915400); Mangan, Niamh E. (6506688263); Starkey, Malcolm R. (35811293400); Skuza, Elisabeth M. (6507816656); Sun, Yu B.Y. (55569489100); Beker, Friederike (6507012587); Collins, Clare L. (7401739836); Kamlin, Omar F. (8866718400); König, Kai (14324919600); Malhotra, Atul (36131954500); Tan, Kenneth (57001973600); Theda, Christiane (6602577322); Young, Morag J. (7404192903); McLean, Catriona A. (7103396821); Wilson, Nicholas J. (7402218386); Sehgal, Arvind (7102296059); Hansbro, Philip M. (6603119390); Pearson, James T. (7401927924); Polo, Jose M. (7101663943); Veldman, Alex (7005093531); Berger, Philip J. (7402866100); Nold-Petry, Claudia A. (22981220300); Nold, Marcel F. (6603550703)",56533484300; 57192265741; 57196033835; 56004381800; 36931070700; 24479337600; 25723678000; 56189915400; 6506688263; 35811293400; 6507816656; 55569489100; 6507012587; 7401739836; 8866718400; 14324919600; 36131954500; 57001973600; 6602577322; 7404192903; 7103396821; 7402218386; 7102296059; 6603119390; 7401927924; 7101663943; 7005093531; 7402866100; 22981220300; 6603550703,Type 2 immune polarization is associated with cardiopulmonary disease in preterm infants,2022,Science Translational Medicine,14,639,eaaz8454,,,,18,10.1126/scitranslmed.aaz8454,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85127645599&doi=10.1126%2fscitranslmed.aaz8454&partnerID=40&md5=14099955bc5d35d2a5ed6ffaad4dbc84,"Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia; Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Monash Micro Imaging, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Department of Anatomy and Developmental Biology, Monash University, Melbourne, 3800, VIC, Australia; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, 3800, VIC, Australia; Australian Regenerative Medicine Institute, Monash University, Melbourne, 3800, VIC, Australia; Imaging and Medical Beamline, Australian Synchrotron, Melbourne, 3168, VIC, Australia; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Department of Molecular and Translational Science, Monash University, Melbourne, 3168, VIC, Australia; Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Department of Immunology and Pathology, Monash University, Melbourne, 3004, VIC, Australia; Mater Research Institute, University of Queensland, Brisbane, 4101, QLD, Australia; Neonatal Services, Mercy Hospital for Women, Melbourne, 3084, VIC, Australia; Department of Newborn Research, Royal Women’s Hospital, Melbourne, 3052, VIC, Australia; University of Melbourne, Melbourne, 3010, VIC, Australia; Murdoch Children’s Research Institute, Melbourne, 3052, VIC, Australia; Department of Paediatrics, Medicum Wesemlin, Lucerne, 6006, Switzerland; Monash Newborn, Monash Children’s Hospital, Melbourne, 3168, VIC, Australia; Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Baker Heart and Diabetes Institute, Melbourne, 3004, VIC, Australia; Department of Anatomical Pathology, Alfred Health, Melbourne, 3004, VIC, Australia; Department of Medicine, Central Clinical School, Monash University, Melbourne, 3800, VIC, Australia; CSL Limited, Bio21 Institute, Parkville, Melbourne, 3052, VIC, Australia; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Ultimo, Sydney, 2007, NSW, Australia; Cardiovascular Disease Program, Monash Biomedicine Discovery Institute, Department of Physiology, Monash University, Melbourne, 3800, VIC, Australia; Department of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Suita, 564-8565, Japan; Victorian Heart Institute, Melbourne, 3168, VIC, Australia; Adelaide Centre for Epigenetics, University of Adelaide, Adelaide, 5005, SA, Australia; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, 5005, SA, Australia; Department of Pediatrics, Helios HSK, Wiesbaden, 65199, Germany; Department of Pediatric Cardiology, J. Liebig University, Gießen, 35392, Germany","Lao J.C., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Bui C.B., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Pang M.A., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Cho S.X., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Rudloff I., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Elgass K., Monash Micro Imaging, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Schröder J., Department of Anatomy and Developmental Biology, Monash University, Melbourne, 3800, VIC, Australia, Development and Stem Cells Program, Monash Biomedicine Discovery Institute, 3800, VIC, Australia, Australian Regenerative Medicine Institute, Monash University, Melbourne, 3800, VIC, Australia; Maksimenko A., Imaging and Medical Beamline, Australian Synchrotron, Melbourne, 3168, VIC, Australia; Mangan N.E., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia, Department of Molecular and Translational Science, Monash University, Melbourne, 3168, VIC, Australia; Starkey M.R., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia, Department of Immunology and Pathology, Monash University, Melbourne, 3004, VIC, Australia; Skuza E.M., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Sun Y.B.Y., Department of Anatomy and Developmental Biology, Monash University, Melbourne, 3800, VIC, Australia, Development and Stem Cells Program, Monash Biomedicine Discovery Institute, 3800, VIC, Australia, Australian Regenerative Medicine Institute, Monash University, Melbourne, 3800, VIC, Australia; Beker F., Mater Research Institute, University of Queensland, Brisbane, 4101, QLD, Australia, Neonatal Services, Mercy Hospital for Women, Melbourne, 3084, VIC, Australia; Collins C.L., Neonatal Services, Mercy Hospital for Women, Melbourne, 3084, VIC, Australia; Kamlin O.F., Department of Newborn Research, Royal Women’s Hospital, Melbourne, 3052, VIC, Australia, University of Melbourne, Melbourne, 3010, VIC, Australia, Murdoch Children’s Research Institute, Melbourne, 3052, VIC, Australia; König K., Department of Paediatrics, Medicum Wesemlin, Lucerne, 6006, Switzerland; Malhotra A., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia, Monash Newborn, Monash Children’s Hospital, Melbourne, 3168, VIC, Australia; Tan K., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Monash Newborn, Monash Children’s Hospital, Melbourne, 3168, VIC, Australia; Theda C., Department of Newborn Research, Royal Women’s Hospital, Melbourne, 3052, VIC, Australia, University of Melbourne, Melbourne, 3010, VIC, Australia, Murdoch Children’s Research Institute, Melbourne, 3052, VIC, Australia; Young M.J., Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia, Baker Heart and Diabetes Institute, Melbourne, 3004, VIC, Australia; McLean C.A., Department of Anatomical Pathology, Alfred Health, Melbourne, 3004, VIC, Australia, Department of Medicine, Central Clinical School, Monash University, Melbourne, 3800, VIC, Australia; Wilson N.J., CSL Limited, Bio21 Institute, Parkville, Melbourne, 3052, VIC, Australia; Sehgal A., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Monash Newborn, Monash Children’s Hospital, Melbourne, 3168, VIC, Australia; Hansbro P.M., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Ultimo, Sydney, 2007, NSW, Australia; Pearson J.T., Cardiovascular Disease Program, Monash Biomedicine Discovery Institute, Department of Physiology, Monash University, Melbourne, 3800, VIC, Australia, Department of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Suita, 564-8565, Japan, Victorian Heart Institute, Melbourne, 3168, VIC, Australia; Polo J.M., Department of Anatomy and Developmental Biology, Monash University, Melbourne, 3800, VIC, Australia, Development and Stem Cells Program, Monash Biomedicine Discovery Institute, 3800, VIC, Australia, Australian Regenerative Medicine Institute, Monash University, Melbourne, 3800, VIC, Australia, Adelaide Centre for Epigenetics, University of Adelaide, Adelaide, 5005, SA, Australia, South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, 5005, SA, Australia; Veldman A., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia, Department of Pediatrics, Helios HSK, Wiesbaden, 65199, Germany, Department of Pediatric Cardiology, J. Liebig University, Gießen, 35392, Germany; Berger P.J., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Nold-Petry C.A., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Nold M.F., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia, Monash Newborn, Monash Children’s Hospital, Melbourne, 3168, VIC, Australia",,"Animals; Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Infant, Premature; Inflammation; Interleukin-13; Lung; Mice; Pregnancy; eotaxin; gamma interferon; interleukin 13; interleukin 17; interleukin 1beta; interleukin 4; interleukin 5; magnesium sulfate; RANTES; STAT6 protein; transcription factor GATA 3; interleukin 13; adaptive immunity; adult; animal cell; animal tissue; Article; artificial ventilation; brain hemorrhage; cardiopulmonary arrest; cardiopulmonary disease; CD3+ T lymphocyte; CD4+ T lymphocyte; CD8+ T lymphocyte; chorioamnionitis; cytokine production; enzyme linked immunosorbent assay; flow cytometry; hepatitis B; immune system; in vivo study; infant; lung dysplasia; mouse; natural killer cell; nonhuman; polarization; pulmonary hypertension; regulatory T lymphocyte; single cell RNA seq; T lymphocyte; T lymphocyte activation; transcriptomics; vaccination; animal; complication; female; human; inflammation; lung; lung dysplasia; newborn; pathology; pregnancy; prematurity",Article,Final,,Scopus,2-s2.0-85127645599
Paudel K.R.; Mehta M.; Yin G.H.S.; Yen L.L.; Malyla V.; Patel V.K.; Panneerselvam J.; Madheswaran T.; MacLoughlin R.; Jha N.K.; Gupta P.K.; Singh S.K.; Gupta G.; Kumar P.; Oliver B.G.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Paudel, Keshav R. (56539588400); Mehta, Meenu (7203024234); Yin, Geena Hew Suet (57457446400); Yen, Lee Li (57457722500); Malyla, Vamshikrishna (57205128961); Patel, Vyoma K. (57193533009); Panneerselvam, Jithendra (57201993010); Madheswaran, Thiagarajan (55505311000); MacLoughlin, Ronan (57212263206); Jha, Niraj Kumar (55109018100); Gupta, Piyush Kumar (57220905930); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Kumar, Pradeep (7403960277); Oliver, Brian G. (15919869900); Hansbro, Philip M. (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",56539588400; 7203024234; 57457446400; 57457722500; 57205128961; 57193533009; 57201993010; 55505311000; 57212263206; 55109018100; 57220905930; 57206711834; 15047988400; 7403960277; 15919869900; 6603119390; 35811890500; 15759138700,Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro,2022,Environmental Science and Pollution Research,29,31,,46830,46847,17,57,10.1007/s11356-022-19158-2,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124839906&doi=10.1007%2fs11356-022-19158-2&partnerID=40&md5=1840529b7ca99f5869dff4cccf5a8a86,"School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; IDA Business Park, Galway, Dangan, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Uttar Pradesh, Greater Noida, 201310, India; Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Mahal Road, Jaipur, India; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa; Woolcock Institute of Medical Research, University of Sydney, Sydney, 2006, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Paudel K.R., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Mehta M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Yin G.H.S., School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Yen L.L., School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Malyla V., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Patel V.K., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; MacLoughlin R., IDA Business Park, Galway, Dangan, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Uttar Pradesh, Greater Noida, 201310, India; Gupta P.K., Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Mahal Road, Jaipur, India; Kumar P., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa; Oliver B.G., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2006, NSW, Australia; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2006, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Berberine; Liquid crystalline nanoparticles; Lung cancer; Migration; Proliferation, Epithelial mesenchymal transition","Berberine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Nanoparticles; berberine; nanoparticle; assay; bioavailability; bromide; cancer; nanoparticle; particle size; solubility; cell proliferation; chemistry; human; lung tumor; non small cell lung cancer; tumor cell line",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85124839906
Paudel K.R.; Jha S.K.; Allam V.S.R.R.; Prasher P.; Gupta P.K.; Bhattacharjee R.; Jha N.K.; Vishwas S.; Singh S.K.; Shrestha J.; Imran M.; Panth N.; Chellappan D.K.; Warkiani M.E.; Hansbro P.M.; Dua K.,"Paudel, Keshav Raj (56539588400); Jha, Saurav Kumar (57210712565); Allam, Venkata Sita Rama Raju (57200203739); Prasher, Parteek (56079914500); Gupta, Piyush Kumar (57220905930); Bhattacharjee, Rahul (57366154500); Jha, Niraj Kumar (55109018100); Vishwas, Sukriti (57216932631); Singh, Sachin K. (57206711834); Shrestha, Jesus (57214237167); Imran, Mohammad (57209466043); Panth, Nisha (57094240100); Chellappan, Dinesh Kumar (35811890500); Warkiani, Majid Ebrahimi (36138999000); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",56539588400; 57210712565; 57200203739; 56079914500; 57220905930; 57366154500; 55109018100; 57216932631; 57206711834; 57214237167; 57209466043; 57094240100; 35811890500; 36138999000; 6603119390; 15759138700,Recent advances in chronotherapy targeting respiratory diseases,2021,Pharmaceutics,13,12,2008,,,,24,10.3390/pharmaceutics13122008,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120791280&doi=10.3390%2fpharmaceutics13122008&partnerID=40&md5=de4cc5aecd018309752c06f50c13c6fa,"Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Biomedicine, Health and Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Muan, 58554, South Korea; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, 75237, Sweden; Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, Uttarakhand, 248007, India; Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh, 201310, India; Kalinga Institute of Industrial Technology (KIIT-DU), KIIT School of Biotechnology, Bhubaneswar, Odisha, 751024, India; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34, Knowledge Park III, Greater Noida, Uttar Pradesh, 201310, India; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi Grand Trunk Road, Phagwara, Punjab, 144411, India; School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, Delhi, 110062, India; School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia","Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Jha S.K., Department of Biomedicine, Health and Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Muan, 58554, South Korea; Allam V.S.R.R., Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, 75237, Sweden; Prasher P., Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, Uttarakhand, 248007, India; Gupta P.K., Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh, 201310, India; Bhattacharjee R., Kalinga Institute of Industrial Technology (KIIT-DU), KIIT School of Biotechnology, Bhubaneswar, Odisha, 751024, India; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34, Knowledge Park III, Greater Noida, Uttar Pradesh, 201310, India; Vishwas S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi Grand Trunk Road, Phagwara, Punjab, 144411, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi Grand Trunk Road, Phagwara, Punjab, 144411, India; Shrestha J., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Imran M., Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, Delhi, 110062, India; Panth N., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Chellappan D.K., School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Warkiani M.E., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia",Asthma; Chronic obstructive pulmonary disease; Chronotherapy; Circadian rhythm; Lung cancer; Pulmonary fibrosis,adrenergic receptor stimulating agent; cholinergic receptor blocking agent; corticosteroid; transcription factor ARNTL; transcription factor CLOCK; asthma; BMAL1 gene; chronic obstructive lung disease; chronotherapy; circadian rhythm; clinical study; CLOCK gene; coronavirus disease 2019; drug efficacy; human; lung cancer; lung fibrosis; nonhuman; respiratory tract disease; Review,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85120791280
Jacquelot N.; Seillet C.; Wang M.; Pizzolla A.; Liao Y.; Hediyeh-zadeh S.; Grisaru-Tal S.; Louis C.; Huang Q.; Schreuder J.; Souza-Fonseca-Guimaraes F.; de Graaf C.A.; Thia K.; Macdonald S.; Camilleri M.; Luong K.; Zhang S.; Chopin M.; Molden-Hauer T.; Nutt S.L.; Umansky V.; Ciric B.; Groom J.R.; Foster P.S.; Hansbro P.M.; McKenzie A.N.J.; Gray D.H.D.; Behren A.; Cebon J.; Vivier E.; Wicks I.P.; Trapani J.A.; Munitz A.; Davis M.J.; Shi W.; Neeson P.J.; Belz G.T.,"Jacquelot, Nicolas (12789586500); Seillet, Cyril (24342395600); Wang, Minyu (57190385139); Pizzolla, Angela (21934793100); Liao, Yang (55756054100); Hediyeh-zadeh, Soroor (57194010119); Grisaru-Tal, Sharon (57218128028); Louis, Cynthia (56694021100); Huang, Qiutong (57208895756); Schreuder, Jaring (56677525400); Souza-Fonseca-Guimaraes, Fernando (52564361600); de Graaf, Carolyn A. (18633797200); Thia, Kevin (6602898130); Macdonald, Sean (57222463701); Camilleri, Mary (51763262000); Luong, Kylie (57205124565); Zhang, Shengbo (57215605298); Chopin, Michael (24066484800); Molden-Hauer, Tristan (57193258831); Nutt, Stephen L. (7004301216); Umansky, Viktor (7005982509); Ciric, Bogoljub (7003303523); Groom, Joanna R. (6603812738); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390); McKenzie, Andrew N. J. (7101774635); Gray, Daniel H. D. (7403493916); Behren, Andreas (10142723000); Cebon, Jonathan (26643442700); Vivier, Eric (7006036977); Wicks, Ian P. (35557081000); Trapani, Joseph A. (7005668641); Munitz, Ariel (7003439665); Davis, Melissa J. (35419216300); Shi, Wei (56420990900); Neeson, Paul J. (57211720743); Belz, Gabrielle T. (7102682937)",12789586500; 24342395600; 57190385139; 21934793100; 55756054100; 57194010119; 57218128028; 56694021100; 57208895756; 56677525400; 52564361600; 18633797200; 6602898130; 57222463701; 51763262000; 57205124565; 57215605298; 24066484800; 57193258831; 7004301216; 7005982509; 7003303523; 6603812738; 7201517569; 6603119390; 7101774635; 7403493916; 10142723000; 26643442700; 7006036977; 35557081000; 7005668641; 7003439665; 35419216300; 56420990900; 57211720743; 7102682937,Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma,2021,Nature Immunology,22,7,,851,864,13,118,10.1038/s41590-021-00943-z,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107501086&doi=10.1038%2fs41590-021-00943-z&partnerID=40&md5=5156f2297480faf021e2ef10dea5b014,"The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia; School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia; Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; The University of Queensland Diamantina Institute, University of Queensland, Brisbane, QLD, Australia; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States; Priority Research Centres for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Ludwig Institute for Cancer Research, Melbourne-Austin Branch, Melbourne, VIC, Australia; Innate Pharma Research Labs, Marseille, France; Aix Marseille University, CNRS, INSERM, CIML, Marseille, France; Service d’Immunologie, Marseille Immunopole, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France; Rheumatology Unit, Royal Melbourne Hospital, Melbourne, Australia; Department of Computing and Information Systems, University of Melbourne, Melbourne, VIC, Australia; Princess Margaret Cancer Centre, Toronto, ON, Canada","Jacquelot N., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia, Princess Margaret Cancer Centre, Toronto, ON, Canada; Seillet C., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Wang M., Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Pizzolla A., Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Liao Y., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia, School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia; Hediyeh-zadeh S., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Grisaru-Tal S., Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Louis C., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Huang Q., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia, The University of Queensland Diamantina Institute, University of Queensland, Brisbane, QLD, Australia; Schreuder J., The University of Queensland Diamantina Institute, University of Queensland, Brisbane, QLD, Australia; Souza-Fonseca-Guimaraes F., The University of Queensland Diamantina Institute, University of Queensland, Brisbane, QLD, Australia; de Graaf C.A., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Thia K., Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Macdonald S., Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Camilleri M., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Luong K., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Zhang S., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Chopin M., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Molden-Hauer T., Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Nutt S.L., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Umansky V., Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany, Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany; Ciric B., Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States; Groom J.R., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Foster P.S., Priority Research Centres for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centres for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; McKenzie A.N.J., Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom; Gray D.H.D., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Behren A., Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia, School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Cebon J., Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia, School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia, Ludwig Institute for Cancer Research, Melbourne-Austin Branch, Melbourne, VIC, Australia; Vivier E., Innate Pharma Research Labs, Marseille, France, Aix Marseille University, CNRS, INSERM, CIML, Marseille, France, Service d’Immunologie, Marseille Immunopole, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France; Wicks I.P., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia, Rheumatology Unit, Royal Melbourne Hospital, Melbourne, Australia; Trapani J.A., Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Munitz A., Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Davis M.J., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Computing and Information Systems, University of Melbourne, Melbourne, VIC, Australia; Shi W., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia, School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia, Department of Computing and Information Systems, University of Melbourne, Melbourne, VIC, Australia; Neeson P.J., Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Belz G.T., The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia, The University of Queensland Diamantina Institute, University of Queensland, Brisbane, QLD, Australia",,"Animals; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chemotaxis, Leukocyte; Cytotoxicity, Immunologic; Eosinophils; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immune Checkpoint Inhibitors; Interleukin-33; Lymphocytes; Male; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Programmed Cell Death 1 Receptor; Skin Neoplasms; granulocyte macrophage colony stimulating factor; interleukin 33; programmed death 1 receptor; antibody; antineoplastic agent; granulocyte macrophage colony stimulating factor; interleukin 33; PDCD1 protein, human; Pdcd1 protein, mouse; programmed death 1 receptor; animal cell; animal experiment; animal model; animal tissue; Article; cell proliferation; eosinophil; group 2 innate lymphoid cell; human; human cell; immunocompetent cell; in vivo study; lymphoid cell; melanoma; mouse; nonhuman; protein expression; tumor immunity; animal; C57BL mouse; cytotoxicity; drug effect; experimental melanoma; female; genetics; immunology; knockout mouse; lymphocyte; male; metabolism; neutrophil chemotaxis; pharmacology; phenotype; skin tumor; tumor cell line",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85107501086
Prasher P.; Sharma M.; Singh S.K.; Gulati M.; Jha N.K.; Gupta P.K.; Gupta G.; Chellappan D.K.; Zacconi F.; de Jesus Andreoli Pinto T.; Chan Y.; Liu G.; Paudel K.R.; Hansbro P.M.; George Oliver B.G.; Dua K.,"Prasher, Parteek (56079914500); Sharma, Mousmee (57214452304); Singh, Sachin Kumar (57206711834); Gulati, Monica (7006677671); Jha, Niraj Kumar (55109018100); Gupta, Piyush Kumar (57220905930); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Zacconi, Flavia (33667991400); de Jesus Andreoli Pinto, Terezinha (7003263019); Chan, Yinghan (57204707263); Liu, Gang (57189061134); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); George Oliver, Brian Gregory (15919869900); Dua, Kamal (15759138700)",56079914500; 57214452304; 57206711834; 7006677671; 55109018100; 57220905930; 15047988400; 35811890500; 33667991400; 7003263019; 57204707263; 57189061134; 56539588400; 6603119390; 15919869900; 15759138700,Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems,2022,Chemico-Biological Interactions,365,,110048,,,,23,10.1016/j.cbi.2022.110048,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135700303&doi=10.1016%2fj.cbi.2022.110048&partnerID=40&md5=2df337535641a48b1ca06662d413f070,"Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Department of Chemistry, Uttaranchal University, Dehradun, 248007, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, 201310, UP, India; Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida, 201310, Uttar Pradesh, India; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile; Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, 7820436, Chile; The Research Center for Nanotechnology and Advanced Materials, CIEN-UC, Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Professor Lineu Prestes Street, São Paulo, 05508-000, Brazil; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India","Prasher P., Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Sharma M., Department of Chemistry, Uttaranchal University, Dehradun, 248007, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Jha N.K., Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, 201310, UP, India; Gupta P.K., Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida, 201310, Uttar Pradesh, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Zacconi F., Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile, Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, 7820436, Chile, The Research Center for Nanotechnology and Advanced Materials, CIEN-UC, Pontificia Universidad Católica de Chile, Santiago, Chile; de Jesus Andreoli Pinto T., Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Professor Lineu Prestes Street, São Paulo, 05508-000, Brazil; Chan Y., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Liu G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; George Oliver B.G., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",Chronic respiratory diseases; Mucoadhesive; Mucus penetration; Nanoparticles,"Biological Transport; Delayed-Action Preparations; Drug Delivery Systems; Female; Humans; Mucus; Nanoparticles; alginic acid; budesonide; chitosan; cholesterol; ciprofloxacin; colchicine; cyclosporine; dipalmitoyloglycerophosphatidylcholine; dipalmitoylphosphatidylcholine; dipalmitoylphosphatidylethanolamine; distearoyloglycerophosphatidylcholine; etofylline; formoterol fumarate; gel; gemcitabine; glucocorticoid; hyaluronic acid; levofloxacin; lipid core nanocapsule; liposome; macrogol; mucus gel; n [(2 hydroxyl)propyl 3 trimethylammonium] chitosan chloride; n,n,n trimethylchitosan nanoparticle; nanoparticle; paclitaxel; phosphatidylcholine; pluronic mixed micelle; polyglactin; polylactide; polymer; rifampicin; salbutamol; solid lipid nanoparticle; stearic acid; unclassified drug; nanoparticle; aerodynamics; aerosol; asthma; biocompatibility; bronchoalveolar lavage fluid; bronchospasm; bronchus mucus; CFTR gene; chemical modification; chemical structure; chronic obstructive lung disease; clinical effectiveness; clinical study; cystic fibrosis; drug delivery system; drug efficacy; drug formulation; drug solubility; dynamics; eye disease; fibrosing alveolitis; hydrophilicity; hydrophobicity; irritable colon; lung cancer; lung clearance; mannosylation; minimum inhibitory concentration; molecular weight; mucoadhesion; mucosal surface; mucus fiber; mucus penetration; mucus permeation; mucus secretion; nonhuman; particle size; pulmonary hypertension; respiratory mucus barrier; respiratory system; respiratory tract disease; retention time; Review; sexually transmitted disease; sustained release preparation; chemistry; delayed release formulation; drug delivery system; female; human; mucus; transport at the cellular level",Review,Final,,Scopus,2-s2.0-85135700303
Khursheed R.; Dua K.; Vishwas S.; Gulati M.; Jha N.K.; Aldhafeeri G.M.; Alanazi F.G.; Goh B.H.; Gupta G.; Paudel K.R.; Hansbro P.M.; Chellappan D.K.; Singh S.K.,"Khursheed, Rubiya (57203173043); Dua, Kamal (15759138700); Vishwas, Sukriti (57216932631); Gulati, Monica (7006677671); Jha, Niraj Kumar (55109018100); Aldhafeeri, Ghalib Mohammed (57578516600); Alanazi, Fayez Ghadeer (57577845900); Goh, Bey Hing (36441148500); Gupta, Gaurav (15047988400); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Chellappan, Dinesh Kumar (35811890500); Singh, Sachin Kumar (57206711834)",57203173043; 15759138700; 57216932631; 7006677671; 55109018100; 57578516600; 57577845900; 36441148500; 15047988400; 56539588400; 6603119390; 35811890500; 57206711834,Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives,2022,Biomedicine and Pharmacotherapy,150,,112951,,,,133,10.1016/j.biopha.2022.112951,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128267023&doi=10.1016%2fj.biopha.2022.112951&partnerID=40&md5=80740ffb212d47db5e461847b14456e3,"School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No.32–34 Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Al-dawaa Medical Services, Eastern Region, Kingdom of Saudi Arabia, Hafr Al Batin, 39513, Saudi Arabia; Lemon Pharmacies, Eastern region, Kingdom of Saudi Arabia, Hafr Al Batin, 39957, Saudi Arabia; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Selangor Darul Ehsan, Bandar Sunway, 47500, Malaysia; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China; School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Khursheed R., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Vishwas S., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No.32–34 Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Aldhafeeri G.M., Al-dawaa Medical Services, Eastern Region, Kingdom of Saudi Arabia, Hafr Al Batin, 39513, Saudi Arabia; Alanazi F.G., Lemon Pharmacies, Eastern region, Kingdom of Saudi Arabia, Hafr Al Batin, 39957, Saudi Arabia; Goh B.H., School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Selangor Darul Ehsan, Bandar Sunway, 47500, Malaysia, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Cancer; Drug delivery; Metallic nanoparticles; Nanotechnology,Drug Delivery Systems; Humans; Metal Nanoparticles; Nanoparticles; Nanotechnology; Neoplasms; Surface Plasmon Resonance; antineoplastic agent; copper nanoparticle; graphene oxide; iron oxide nanoparticle; metal nanoparticle; nanomaterial; plant extract; polymer; silica nanoparticle; silver nanoparticle; zinc oxide nanoparticle; metal nanoparticle; nanoparticle; Brust Schiffrin method; cancer diagnosis; cancer risk; carcinogenesis; drug delivery system; drug targeting; green chemistry; human; hyperthermia; malignant neoplasm; molecular imaging; molecular pathology; nanomedicine; nonhuman; photoablation therapy; phototherapy; Review; seed growth method; synthesis; tumor ablation; Turkevich method; chemistry; nanotechnology; neoplasm; surface plasmon resonance,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85128267023
Afrose D.; Chen H.; Ranashinghe A.; Liu C.-C.; Henessy A.; Hansbro P.M.; McClements L.,"Afrose, Dinara (57222390772); Chen, Hao (57223198715); Ranashinghe, Amali (57733757700); Liu, Chia-chi (26537733500); Henessy, Annemarie (57733930300); Hansbro, Philip M. (6603119390); McClements, Lana (55600912900)",57222390772; 57223198715; 57733757700; 26537733500; 57733930300; 6603119390; 55600912900,The diagnostic potential of oxidative stress biomarkers for preeclampsia: systematic review and meta-analysis,2022,Biology of Sex Differences,13,1,26,,,,19,10.1186/s13293-022-00436-0,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85131628330&doi=10.1186%2fs13293-022-00436-0&partnerID=40&md5=b244b227b7c422642373ef0abe6519ec,"School of Life Sciences & Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, and University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia; Faculty of Science, University of Colombo, Colombo 03, Sri Lanka; The Heart Research Institute, University of Sydney, Newtown, NSW, Australia; School of Medicine, Western Sydney University, Campbelltown, Australia; Campbelltown Hospital, South Western Sydney Local Health District, Warwick Farm, Australia","Afrose D., School of Life Sciences & Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chen H., School of Life Sciences & Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, and University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia; Ranashinghe A., Faculty of Science, University of Colombo, Colombo 03, Sri Lanka; Liu C.-C., The Heart Research Institute, University of Sydney, Newtown, NSW, Australia, School of Medicine, Western Sydney University, Campbelltown, Australia; Henessy A., The Heart Research Institute, University of Sydney, Newtown, NSW, Australia, School of Medicine, Western Sydney University, Campbelltown, Australia, Campbelltown Hospital, South Western Sydney Local Health District, Warwick Farm, Australia; Hansbro P.M., School of Life Sciences & Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, and University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia; McClements L., School of Life Sciences & Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Biomarkers; Heavy metals; IMA; MDA; Oxidative stress; Preeclampsia; Uric acid,Biomarkers; Female; Humans; Oxidative Stress; Pre-Eclampsia; Pregnancy; Serum Albumin; Uric Acid; biological marker; serum albumin; uric acid; female; human; meta analysis; oxidative stress; preeclampsia; pregnancy,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85131628330
Tu X.; Kim R.Y.; Brown A.C.; de Jong E.; Jones-Freeman B.; Ali M.K.; Gomez H.M.; Budden K.F.; Starkey M.R.; Cameron G.J.M.; Loering S.; Nguyen D.H.; Nair P.M.; Haw T.J.; Alemao C.A.; Faiz A.; Tay H.L.; Wark P.A.B.; Knight D.A.; Foster P.S.; Bosco A.; Horvat J.C.; Hansbro P.M.; Donovan C.,"Tu, Xiaofan (57222147245); Kim, Richard Y. (35810406900); Brown, Alexandra C. (55637745000); de Jong, Emma (56878432200); Jones-Freeman, Bernadette (56215070300); Ali, Md Khadem (57194408422); Gomez, Henry M. (57191960363); Budden, Kurtis F. (57191417986); Starkey, Malcolm R. (35811293400); Cameron, Guy J.M. (57203977896); Loering, Svenja (57205469740); Nguyen, Duc H. (54886138200); Nair, Prema Mono (55749131000); Haw, Tatt Jhong (56625918900); Alemao, Charlotte A. (57200821652); Faiz, Alen (55601365200); Tay, Hock L. (55639898100); Wark, Peter A.B. (7003559516); Knight, Darryl A. (7402350036); Foster, Paul S. (7201517569); Bosco, Anthony (7006356547); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Donovan, Chantal (55357105200)",57222147245; 35810406900; 55637745000; 56878432200; 56215070300; 57194408422; 57191960363; 57191417986; 35811293400; 57203977896; 57205469740; 54886138200; 55749131000; 56625918900; 57200821652; 55601365200; 55639898100; 7003559516; 7402350036; 7201517569; 7006356547; 9942405300; 6603119390; 55357105200,Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlap,2022,Journal of Allergy and Clinical Immunology,150,4,,817,829.e6,,13,10.1016/j.jaci.2022.04.032,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132221796&doi=10.1016%2fj.jaci.2022.04.032&partnerID=40&md5=2c4f61db63e3537bd5fb00d790f7c3b6,"Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, Australia; Telethon Kids Institute, Centre for Health Research, The University of Western Australia, Nedlands, Australia; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia; Providence Health Care Research Institute, Vancouver, BC, Canada; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, Australia","Tu X., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Kim R.Y., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, Australia; Brown A.C., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; de Jong E., Telethon Kids Institute, Centre for Health Research, The University of Western Australia, Nedlands, Australia; Jones-Freeman B., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia, Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia; Ali M.K., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Gomez H.M., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Budden K.F., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Starkey M.R., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia, Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia; Cameron G.J.M., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Loering S., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Nguyen D.H., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Nair P.M., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Haw T.J., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Alemao C.A., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Faiz A., Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, Australia; Tay H.L., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Wark P.A.B., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Knight D.A., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia, Providence Health Care Research Institute, Vancouver, BC, Canada; Foster P.S., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Bosco A., Telethon Kids Institute, Centre for Health Research, The University of Western Australia, Nedlands, Australia; Horvat J.C., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, Australia; Donovan C., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, Australia",Asthma COPD overlap; cigarette smoke; house dust mite; SPI1; transcriptomics,"Animals; Asthma; Eosinophilia; Female; Mice; Pulmonary Disease, Chronic Obstructive; Respiratory Hypersensitivity; RNA; Transcription Factors; Transcriptome; antiasthmatic agent; biological marker; cigarette smoke; db 2313; dexamethasone; dust mite extract; gamma interferon; interleukin 13; interleukin 17; interleukin 17F; interleukin 21; STAT1 protein; transcription factor; transcription factor SPI1; unclassified drug; RNA; transcription factor; transcriptome; airway; airway remodeling; animal cell; animal experiment; animal model; animal tissue; Article; B lymphocyte; BCR signaling; CD4+ T lymphocyte; CD8+ T lymphocyte; chronic obstructive lung disease; clinical feature; controlled study; corticosteroid therapy; Dermatophagoides pteronyssinus; differential expression analysis; differential gene expression; down regulation; eosinophil count; eosinophilia; experimental asthma; extracellular matrix; female; fuzzy clustering; gamma delta T lymphocyte; gene ontology; innate immunity; KEGG; leukocyte count; lung parenchyma; macrophage count; mouse; neutrophil chemotaxis; neutrophil count; neutrophilic inflammation; nonhuman; phenotype; pleiotropy; pneumonia; RNA sequencing; Th1 cell; Th17 cell; Th2 cell; transcriptomics; upregulation; animal; asthma; chronic obstructive lung disease; eosinophilia; respiratory tract allergy",Article,Final,,Scopus,2-s2.0-85132221796
Devkota H.P.; Paudel K.R.; Khanal S.; Baral A.; Panth N.; Adhikari-Devkota A.; Jha N.K.; Das N.; Singh S.K.; Chellappan D.K.; Dua K.; Hansbro P.M.,"Devkota, Hari Prasad (24775939500); Paudel, Keshav Raj (56539588400); Khanal, Shristi (57570960000); Baral, Ananda (57347023000); Panth, Nisha (57094240100); Adhikari-Devkota, Anjana (57200393104); Jha, Niraj Kumar (55109018100); Das, Niranjan (54935333000); Singh, Sachin Kumar (57206711834); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390)",24775939500; 56539588400; 57570960000; 57347023000; 57094240100; 57200393104; 55109018100; 54935333000; 57206711834; 35811890500; 15759138700; 6603119390,"Stinging Nettle (Urtica dioica L.): Nutritional Composition, Bioactive Compounds, and Food Functional Properties",2022,Molecules,27,16,5219,,,,51,10.3390/molecules27165219,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137125122&doi=10.3390%2fmolecules27165219&partnerID=40&md5=0cc68a5f74ad875868fa7210cf20a555,"Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan; Headquarters for Admissions and Education, Kumamoto University, Kurokami, 2-39-1, Chuo-ku, Kumamoto, 860-8555, Japan; Pharmacy Program, Gandaki University, Pokhara, 33700, Nepal; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; College of Pharmacy, Yeungnam University, 280 Daehak-ro, Gyeongsan, 38541, South Korea; Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, 201310, India; Department of Chemistry, Ramthakur College, Badharghat, Agartala, 799003, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India","Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan, Headquarters for Admissions and Education, Kumamoto University, Kurokami, 2-39-1, Chuo-ku, Kumamoto, 860-8555, Japan, Pharmacy Program, Gandaki University, Pokhara, 33700, Nepal; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Khanal S., College of Pharmacy, Yeungnam University, 280 Daehak-ro, Gyeongsan, 38541, South Korea; Baral A., College of Pharmacy, Yeungnam University, 280 Daehak-ro, Gyeongsan, 38541, South Korea; Panth N., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Adhikari-Devkota A., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan; Jha N.K., Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, 201310, India; Das N., Department of Chemistry, Ramthakur College, Badharghat, Agartala, 799003, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia",anti-bacterial; anti-inflammatory; anti-ulcer; antioxidant; nettle; nutraceuticals; stinging nettle; Urtica dioica,Anti-Inflammatory Agents; Plant Extracts; Plant Leaves; Urtica dioica; Urticaceae; antiinflammatory agent; plant extract; chemistry; plant leaf; Urtica dioica; Urticaceae,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85137125122
Johansen M.D.; Shalini; Kumar S.; Raynaud C.; Quan D.H.; Britton W.J.; Hansbro P.M.; Kumar V.; Kremer L.,"Johansen, Matt D. (57202983408); Shalini (57201200153); Kumar, Sumit (57211400244); Raynaud, Clément (57210704430); Quan, Diana H. (57159060300); Britton, Warwick J. (7102477888); Hansbro, Philip M. (6603119390); Kumar, Vipan (55323563900); Kremer, Laurent (7005620040)",57202983408; 57201200153; 57211400244; 57210704430; 57159060300; 7102477888; 6603119390; 55323563900; 7005620040,Biological and biochemical evaluation of isatin-isoniazid hybrids as bactericidal candidates against mycobacterium tuberculosis,2021,Antimicrobial Agents and Chemotherapy,65,8,e00011-21,,,,13,10.1128/AAC.00011-21,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110349825&doi=10.1128%2fAAC.00011-21&partnerID=40&md5=6e8d23e2f7907d6188224640bb829d6c,"Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Department of Chemistry, Guru Nanak Dev University, Punjab, India; Tuberculosis Research Program, Centenary Institute, The University of Sydney, Camperdown, NSW, Australia; Centenary Institute, The University of Sydney, Camperdown, NSW, Australia; Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; INSERM, IRIM, Montpellier, France","Johansen M.D., Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Shalini, Department of Chemistry, Guru Nanak Dev University, Punjab, India; Kumar S., Department of Chemistry, Guru Nanak Dev University, Punjab, India; Raynaud C., Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France; Quan D.H., Tuberculosis Research Program, Centenary Institute, The University of Sydney, Camperdown, NSW, Australia; Britton W.J., Centenary Institute, The University of Sydney, Camperdown, NSW, Australia, Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Kumar V., Department of Chemistry, Guru Nanak Dev University, Punjab, India; Kremer L., Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France, INSERM, IRIM, Montpellier, France",Bactericidal activity; Drug resistance; InhA; Isatin-isoniazid hybrids; KatG; Mycobacterium tuberculosis; Mycolic acids,Antitubercular Agents; Bacterial Proteins; Catalase; Humans; Isatin; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; isatin; isoniazid; mycolic acid; bacterial protein; catalase; isatin; isoniazid; tuberculostatic agent; Article; bacterial strain; bactericidal activity; biochemical analysis; biological activity; biosynthesis; cross resistance; drug design; drug structure; drug synthesis; drug tolerability; kidney cell; macrophage; minimum inhibitory concentration; Mycobacterium tuberculosis; nonhuman; structure activity relation; THP-1 cell line; Vero cell line; genetics; human; microbial sensitivity test; mutation,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85110349825
Burnett D.L.; Jackson K.J.L.; Langley D.B.; Aggrawal A.; Stella A.O.; Johansen M.D.; Balachandran H.; Lenthall H.; Rouet R.; Walker G.; Saunders B.M.; Singh M.; Li H.; Henry J.Y.; Jackson J.; Stewart A.G.; Witthauer F.; Spence M.A.; Hansbro N.G.; Jackson C.; Schofield P.; Milthorpe C.; Martinello M.; Schulz S.R.; Roth E.; Kelleher A.; Emery S.; Britton W.J.; Rawlinson W.D.; Karl R.; Schäfer S.; Winkler T.H.; Brink R.; Bull R.A.; Hansbro P.M.; Jäck H.-M.; Turville S.; Christ D.; Goodnow C.C.,"Burnett, Deborah L. (57196194699); Jackson, Katherine J.L. (55766972300); Langley, David B. (7006461904); Aggrawal, Anupria (26431741800); Stella, Alberto Ospina (57200605815); Johansen, Matt D. (57202983408); Balachandran, Harikrishnan (26634808400); Lenthall, Helen (57191628440); Rouet, Romain (47962460700); Walker, Gregory (57203590121); Saunders, Bernadette M. (7102328746); Singh, Mandeep (57221974709); Li, Hui (57208714519); Henry, Jake Y. (59283461600); Jackson, Jennifer (57190133673); Stewart, Alastair G. (57191808595); Witthauer, Franka (57345501700); Spence, Matthew A. (57206937030); Hansbro, Nicole G. (15055862300); Jackson, Colin (35546487200); Schofield, Peter (57219821496); Milthorpe, Claire (57344587600); Martinello, Marianne (57919154500); Schulz, Sebastian R. (57191440585); Roth, Edith (7202767893); Kelleher, Anthony (7006091312); Emery, Sean (57188785246); Britton, Warwick J. (7102477888); Rawlinson, William D. (7005245886); Karl, Rudolfo (57344737900); Schäfer, Simon (57345038400); Winkler, Thomas H. (51162311100); Brink, Robert (7004647792); Bull, Rowena A. (8564636600); Hansbro, Philip M. (6603119390); Jäck, Hans-Martin (7005855616); Turville, Stuart (6507720820); Christ, Daniel (7005298324); Goodnow, Christopher C. (7005003390)",57196194699; 55766972300; 7006461904; 26431741800; 57200605815; 57202983408; 26634808400; 57191628440; 47962460700; 57203590121; 7102328746; 57221974709; 57208714519; 59283461600; 57190133673; 57191808595; 57345501700; 57206937030; 15055862300; 35546487200; 57219821496; 57344587600; 57919154500; 57191440585; 7202767893; 7006091312; 57188785246; 7102477888; 7005245886; 57344737900; 57345038400; 51162311100; 7004647792; 8564636600; 6603119390; 7005855616; 6507720820; 7005298324; 7005003390,Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability,2021,Immunity,54,12,,2908,2921.e6,,34,10.1016/j.immuni.2021.10.019,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119369946&doi=10.1016%2fj.immuni.2021.10.019&partnerID=40&md5=54db94550ed9b89544a8bd6b1e2ff293,"Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia; UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia; Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Center for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2006, NSW, Australia; Victor Chang Cardiac Research Institute, Sydney, 2010, NSW, Australia; Serology and Virology Division (SAViD), NSW Health Pathology, SEALS Randwick, Sydney, 2031, NSW, Australia; Division of Molecular Immunology, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, 91054, Germany; Research School of Chemistry, Australian National University, Canberra, 2601, ACT, Australia; Division of Genetics, Department Biology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, 91054, Germany; Centenary Institute, The University of Sydney, Sydney, 2006, NSW, Australia; Cellular Genomics Futures Institute, UNSW Sydney, Sydney, 2052, NSW, Australia","Burnett D.L., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia, UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia; Jackson K.J.L., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia; Langley D.B., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia; Aggrawal A., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Stella A.O., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Johansen M.D., Center for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2006, NSW, Australia; Balachandran H., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Lenthall H., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia; Rouet R., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia, UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia; Walker G., UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia; Saunders B.M., Center for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2006, NSW, Australia; Singh M., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia, UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia; Li H., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Henry J.Y., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia; Jackson J., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia; Stewart A.G., UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia, Victor Chang Cardiac Research Institute, Sydney, 2010, NSW, Australia; Witthauer F., Division of Molecular Immunology, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, 91054, Germany; Spence M.A., Research School of Chemistry, Australian National University, Canberra, 2601, ACT, Australia; Hansbro N.G., Center for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2006, NSW, Australia; Jackson C., Research School of Chemistry, Australian National University, Canberra, 2601, ACT, Australia; Schofield P., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia, UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia; Milthorpe C., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia; Martinello M., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Schulz S.R., Division of Molecular Immunology, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, 91054, Germany; Roth E., Division of Molecular Immunology, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, 91054, Germany; Kelleher A., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Emery S., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Britton W.J., Centenary Institute, The University of Sydney, Sydney, 2006, NSW, Australia; Rawlinson W.D., UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia, Serology and Virology Division (SAViD), NSW Health Pathology, SEALS Randwick, Sydney, 2031, NSW, Australia; Karl R., Division of Genetics, Department Biology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, 91054, Germany; Schäfer S., Division of Genetics, Department Biology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, 91054, Germany; Winkler T.H., Division of Genetics, Department Biology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, 91054, Germany; Brink R., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia, UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia; Bull R.A., UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia, Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Hansbro P.M., Center for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2006, NSW, Australia; Jäck H.-M., Division of Molecular Immunology, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, 91054, Germany; Turville S., UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia, Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Christ D., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia, UNSW Sydney, Faculty of Medicine, Sydney, 2010, NSW, Australia; Goodnow C.C., Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia, Cellular Genomics Futures Institute, UNSW Sydney, Sydney, 2052, NSW, Australia",antigenic variation; class 4 epitope site; cross-reactivity; epitope conservation; escape mutations; human antibodies; mouse model; neutralization; next generation vaccines; SARS-CoV-2; variants of concern,"Animals; Antibodies, Neutralizing; Antibodies, Viral; Betacoronavirus; Conserved Sequence; Coronavirus Infections; COVID-19 Vaccines; Evolution, Molecular; Humans; Immunization; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Protein Binding; Protein Domains; SARS Virus; Spike Glycoprotein, Coronavirus; Vaccine Development; angiotensin converting enzyme 2; cross reacting antibody; epitope; neutralizing antibody; recombinant antibody; SARS-CoV-2 antibody; coronavirus spike glycoprotein; neutralizing antibody; protein binding; spike protein, SARS-CoV-2; virus antibody; adult; aged; animal cell; animal experiment; animal model; animal tissue; Article; beta sheet; cladistics; controlled study; Coronavirinae; coronavirus disease 2019; embryo; female; human; human cell; immunization; light chain; male; mouse; nonhuman; protein domain; protein interaction; receptor binding; Sarbecovirus; structure analysis; variant of concern; virus neutralization; animal; Bagg albino mouse; Betacoronavirus; C57BL mouse; conserved sequence; Coronavirus infection; genetics; immunization; immunology; metabolism; molecular evolution; physiology; protein domain; SARS coronavirus",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85119369946
Prasher P.; Sharma M.; Singh S.K.; Haghi M.; MacLoughlin R.; Chellappan D.K.; Gupta G.; Paudel K.R.; Hansbro P.M.; George Oliver B.G.; Wich P.R.; Dua K.,"Prasher, Parteek (56079914500); Sharma, Mousmee (57214452304); Singh, Sachin Kumar (57206711834); Haghi, Mehra (37033934800); MacLoughlin, Ronan (57212263206); Chellappan, Dinesh Kumar (35811890500); Gupta, Gaurav (15047988400); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); George Oliver, Brian Gregory (15919869900); Wich, Peter Richard (7801599835); Dua, Kamal (15759138700)",56079914500; 57214452304; 57206711834; 37033934800; 57212263206; 35811890500; 15047988400; 56539588400; 6603119390; 15919869900; 7801599835; 15759138700,Advances and applications of dextran-based nanomaterials targeting inflammatory respiratory diseases,2022,Journal of Drug Delivery Science and Technology,74,,103598,,,,18,10.1016/j.jddst.2022.103598,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134744329&doi=10.1016%2fj.jddst.2022.103598&partnerID=40&md5=5c150ac0e232f42615e73aa47ed6f587,"Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Department of Chemistry, Uttaranchal University, Dehradun, 248007, India; School of Pharmacy and Pharmaceutical Science, Lovely Professional University, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Jaipur, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Australian Centre for NanoMedicine and Centre for Advanced Macromolecular Design, University of New South Wales, Sydney, 2052, NSW, Australia","Prasher P., Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Sharma M., Department of Chemistry, Uttaranchal University, Dehradun, 248007, India; Singh S.K., School of Pharmacy and Pharmaceutical Science, Lovely Professional University, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Haghi M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; MacLoughlin R., Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Jaipur, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; George Oliver B.G., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Wich P.R., School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia, Australian Centre for NanoMedicine and Centre for Advanced Macromolecular Design, University of New South Wales, Sydney, 2052, NSW, Australia; Dua K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia",Airways; Asthma; Bronchitis; Chemical modification; COPD; COVID-19 pandemic; Dextran-based nanomaterials; Drug delivery; Inflammatory lung disease; Lymphangioleiomyomatosis; Pneumonia; Tularemia,cation; dextran; dextran sulfate; fluorescent dye; magnetic nanoparticle; nanogel; nanomaterial; acetalation; amination; chemical modification; drug delivery system; esterification; fluorescence; human; nonhuman; pneumonia; respiratory tract inflammation; Review,Review,Final,,Scopus,2-s2.0-85134744329
Majumder R.; Alam M.B.; Paudel K.R.; Ahmed K.A.; Devkota H.P.; Lee S.-H.; Hansbro P.M.; Park Y.-H.,"Majumder, Rajib (56825461200); Alam, Md Badrul (56706777100); Paudel, Keshav Raj (56539588400); Ahmed, Khandaker Asif (57409049800); Devkota, Hari Prasad (24775939500); Lee, Sang-Han (57221453703); Hansbro, Philip M. (6603119390); Park, Yong-Ha (7405370415)",56825461200; 56706777100; 56539588400; 57409049800; 24775939500; 57221453703; 6603119390; 7405370415,Anti-Influenza Virus Potential of Probiotic Strain Lactoplantibacillus plantarum YML015 Isolated from Korean Fermented Vegetable,2022,Fermentation,8,11,572,,,,4,10.3390/fermentation8110572,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85141583248&doi=10.3390%2ffermentation8110572&partnerID=40&md5=51228f539559ca6c8269fcb097e98799,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Applied Biosciences, Macquarie University, Sydney, 2109, NSW, Australia; Department of Applied Microbiology and Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea; Department of Food Science and Biotechnology, Graduate School, Kyunpook National University, Daegu, 37224, South Korea; Australian Centre for Disease Preparedness (ACDP), CSIRO, Geelong, 3220, VIC, Australia; Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan; Headquarters for Admissions and Education, Kumamoto University, Kurokami, 2-39-1, Chuo-ku, Kumamoto, 860-8555, Japan; Pharmacy Program, Gandaki University, Pokhara, 33700, Nepal","Majumder R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia, Applied Biosciences, Macquarie University, Sydney, 2109, NSW, Australia, Department of Applied Microbiology and Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea; Alam M.B., Department of Food Science and Biotechnology, Graduate School, Kyunpook National University, Daegu, 37224, South Korea; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Ahmed K.A., Applied Biosciences, Macquarie University, Sydney, 2109, NSW, Australia, Australian Centre for Disease Preparedness (ACDP), CSIRO, Geelong, 3220, VIC, Australia; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan, Headquarters for Admissions and Education, Kumamoto University, Kurokami, 2-39-1, Chuo-ku, Kumamoto, 860-8555, Japan, Pharmacy Program, Gandaki University, Pokhara, 33700, Nepal; Lee S.-H., Department of Food Science and Biotechnology, Graduate School, Kyunpook National University, Daegu, 37224, South Korea; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Park Y.-H., Department of Applied Microbiology and Biotechnology, Yeungnam University, Gyeongsan, 38541, South Korea",antiviral activity; L. plantarum YML015; probiotic,,Article,Final,All Open Access; Gold Open Access,Scopus,2-s2.0-85141583248
Devkota H.P.; Paudel K.R.; Jha N.K.; Gupta P.K.; Singh S.K.; Chellappan D.K.; Hansbro P.M.; Dua K.,"Devkota, Hari P. (24775939500); Paudel, Keshav R. (56539588400); Jha, Niraj K. (55109018100); Gupta, Piyush K. (57220905930); Singh, Sachin K. (57206711834); Chellappan, Dinesh K. (35811890500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",24775939500; 56539588400; 55109018100; 57220905930; 57206711834; 35811890500; 6603119390; 15759138700,Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases,2021,Nanomedicine,16,27,,2407,2410,3,11,10.2217/nnm-2021-0275,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120006719&doi=10.2217%2fnnm-2021-0275&partnerID=40&md5=f69990b9c9203861fdc53c72d239336d,"Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chou-ku Kumamoto City Kumamoto, 862-0973, Japan; School of Life Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil Kuala Lumpur, 57000, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia","Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chou-ku Kumamoto City Kumamoto, 862-0973, Japan; Paudel K.R., School of Life Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Jha N.K., Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Gupta P.K., Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil Kuala Lumpur, 57000, Malaysia; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia",drug delivery; inflammasomes; pulmonary,"Drug Delivery Systems; Humans; Inflammasomes; Inflammation; Lung Diseases; NLR Family, Pyrin Domain-Containing 3 Protein; 3 hydroxybutyric acid; belnacasan; cryopyrin; immunoglobulin enhancer binding protein; interleukin 1; interleukin 1beta; interleukin 1beta converting enzyme; interleukin 8; mesoporous silica nanoparticle; toll like receptor 4; cryopyrin; inflammasome; asthma; chronic obstructive lung disease; coronavirus disease 2019; drug delivery system; human; in vitro study; in vivo study; lung disease; macrophage; NF kB signaling; nonhuman; protein blood level; protein function; protein targeting; Review; THP-1 cell line; TLR signaling; upregulation; drug delivery system; inflammation; lung disease",Review,Final,,Scopus,2-s2.0-85120006719
Ashique S.; Gupta K.; Gupta G.; Mishra N.; Singh S.; Wadhwa S.; Gulati M.; Dureja H.; Zacconi F.; Oliver B.G.; Paudel K.R.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Ashique, Sumel (57219283396); Gupta, Kirti (57215607107); Gupta, Gaurav (15047988400); Mishra, Neeraj (23027996000); Singh, Sachin Kumar (57206711834); Wadhwa, Sheetu (55575798400); Gulati, Monica (7006677671); Dureja, Harish (6507566948); Zacconi, Flavia (33667991400); Oliver, Brian G. (15919869900); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",57219283396; 57215607107; 15047988400; 23027996000; 57206711834; 55575798400; 7006677671; 6507566948; 33667991400; 15919869900; 56539588400; 6603119390; 35811890500; 15759138700,Vitamin D—A prominent immunomodulator to prevent COVID-19 infection,2023,International Journal of Rheumatic Diseases,26,1,,13,30,17,19,10.1111/1756-185X.14477,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85141404295&doi=10.1111%2f1756-185X.14477&partnerID=40&md5=7daf72a65d3ea3b487d453e2f81dfc81,"Department of Pharmaceutics, Bharat Institute of Technology (BIT), School of Pharmacy, Meerut, India; Department of Pharmacology, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be) University, Ambala, India; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Gwalior, India; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India; Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile; Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia","Ashique S., Department of Pharmaceutics, Bharat Institute of Technology (BIT), School of Pharmacy, Meerut, India; Gupta K., Department of Pharmacology, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be) University, Ambala, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Mishra N., Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Gwalior, India; Singh S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Wadhwa S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, India; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India; Zacconi F., Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile, Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Dua K., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia",doses; immune system; mechanism; severe acute respiratory syndrome coronavirus 2; vitamin D,"Adjuvants, Immunologic; COVID-19; COVID-19 Drug Treatment; Dietary Supplements; Humans; Immunologic Factors; SARS-CoV-2; Vitamin D; angiotensin converting enzyme 2; azithromycin; calcifediol; hydroxychloroquine; placebo; vitamin D; immunologic factor; immunological adjuvant; vitamin D; adaptive immunity; age; antiviral activity; autophagy (cellular); cellular immunity; clinical research; coronavirus disease 2019; down regulation; drug efficacy; drug megadose; drug protein binding; exercise; hospitalization; human; humoral immunity; immune response; immunomodulation; immunotherapy; infection prevention; inflammation; innate immunity; lung parenchyma; meta analysis; mortality rate; neutrophil; nitrative stress; nonhuman; oxidative stress; practice guideline; recommended drug dose; respiratory tract infection; Review; risk reduction; systematic review; virus inhibition; virus transmission; vitamin D deficiency; vitamin supplementation; adverse event; dietary supplement; prevention and control",Review,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85141404295
Wadhwa R.; Raj Paudel K.; Shukla S.; Shastri M.; Gupta G.; Devkota H.P.; Bebawy M.; Kumar Chellappan D.; Hansbro P.M.; Dua K.,"Wadhwa, Ridhima (57159091700); Raj Paudel, Keshav (56539588400); Shukla, Shakti (56367620800); Shastri, Madhur (56007290800); Gupta, Gaurav (15047988400); Devkota, Hari Prasad (24775939500); Bebawy, Mary (6506211522); Kumar Chellappan, Dinesh (57216736092); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",57159091700; 56539588400; 56367620800; 56007290800; 15047988400; 24775939500; 6506211522; 57216736092; 6603119390; 15759138700,Epigenetic Therapy as a Potential Approach for Targeting Oxidative Stress-Induced Non-small-Cell Lung Cancer,2022,Handbook of Oxidative Stress in Cancer: Mechanistic Aspects,2,,,1545,1560,15,4,10.1007/978-981-15-9411-3_106,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85159480178&doi=10.1007%2f978-981-15-9411-3_106&partnerID=40&md5=863563fa29b636a85a408583aada0114,"Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia","Wadhwa R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Raj Paudel K., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Shukla S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Shastri M., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Kumar Chellappan D., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia",DNA methylation; Epigenetic therapy; Histone modification; Non-small-cell lung cancer; Oxidative stress,,Book chapter,Final,,Scopus,2-s2.0-85159480178
Kaur J.; Gulati M.; Famta P.; Corrie L.; Awasthi A.; Saini S.; Khatik G.L.; Bettada V.G.; Madhunapantula S.V.; Paudel K.R.; Gupta G.; Chellappan D.K.; Arshad M.F.; Adams J.; Gowthamarajan K.; Dua K.; Hansbro P.M.; Singh S.K.,"Kaur, Jaskiran (57215605892); Gulati, Monica (7006677671); Famta, Paras (57215067618); Corrie, Leander (57214724523); Awasthi, Ankit (57210919438); Saini, Sumant (56375267600); Khatik, Gopal L. (14031691500); Bettada, Vidya G. (57221284682); Madhunapantula, SubbaRao V. (6507978628); Paudel, Keshav Raj (56539588400); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Arshad, Mohammed F. (57471657200); Adams, Jon (35584313300); Gowthamarajan, Kuppusamy (8452710300); Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390); Singh, Sachin Kumar (57206711834)",57215605892; 7006677671; 57215067618; 57214724523; 57210919438; 56375267600; 14031691500; 57221284682; 6507978628; 56539588400; 15047988400; 35811890500; 57471657200; 35584313300; 8452710300; 15759138700; 6603119390; 57206711834,"Polymeric micelles loaded with glyburide and vanillic acid: I. Formulation development, in-vitro characterization and bioavailability studies",2022,International Journal of Pharmaceutics,624,,121987,,,,25,10.1016/j.ijpharm.2022.121987,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135123112&doi=10.1016%2fj.ijpharm.2022.121987&partnerID=40&md5=74223d5e433bb1b592f7a75f7fbd9de3,"School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad, India; National Institute of Pharmaceutical Education and Research, Bijnor-Sisendi Road, Sarojini Nagar, Lucknow, 226301, Uttar Pradesh, India; Center of Excellence in Molecular Biology and Regenerative Medicine Laboratory (A DST-FIST Supported Center), Department of Biochemistry (A DST-FIST Supported Department), JSS Medical College, JSS Academy of Higher Education and Research, Bannimantapa, Sri Shivarathreeshwara Nagar, Mysore, 570 015, Karnataka, India; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jaipur, Jagatpura, India; Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Research and Scientific Communications, Isthmus Research and Publishing House, New Delhi, 110044, India; Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India","Kaur J., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Famta P., Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad, India; Corrie L., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India; Awasthi A., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India; Saini S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India; Khatik G.L., National Institute of Pharmaceutical Education and Research, Bijnor-Sisendi Road, Sarojini Nagar, Lucknow, 226301, Uttar Pradesh, India; Bettada V.G., Center of Excellence in Molecular Biology and Regenerative Medicine Laboratory (A DST-FIST Supported Center), Department of Biochemistry (A DST-FIST Supported Department), JSS Medical College, JSS Academy of Higher Education and Research, Bannimantapa, Sri Shivarathreeshwara Nagar, Mysore, 570 015, Karnataka, India; Madhunapantula S.V., Center of Excellence in Molecular Biology and Regenerative Medicine Laboratory (A DST-FIST Supported Center), Department of Biochemistry (A DST-FIST Supported Department), JSS Medical College, JSS Academy of Higher Education and Research, Bannimantapa, Sri Shivarathreeshwara Nagar, Mysore, 570 015, Karnataka, India; Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jaipur, Jagatpura, India, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Chellappan D.K., School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Arshad M.F., Department of Research and Scientific Communications, Isthmus Research and Publishing House, New Delhi, 110044, India; Adams J., Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Gowthamarajan K., Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India; Dua K., Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Bioavailability; Glyburide; Insulin resistance; Micelles; mPEG-b-PCL; Vanillic acid,"Biological Availability; Caco-2 Cells; Diabetes Mellitus, Type 2; Drug Carriers; Glucose; Glyburide; Humans; Micelles; Polyethylene Glycols; Polymers; Vanillic Acid; amphophile; cetrimide; copolymer; gallic acid; glibenclamide; glucose; insulin; nanocarrier; polymer; solvent; surfactant; vanillic acid; drug carrier; glibenclamide; macrogol; polymer; vanillic acid; animal experiment; Article; Box Behnken design; Caco-2 cell line; cell viability; concentration response; controlled study; critical micelle concentration; cytotoxicity assay; drug bioavailability; drug formulation; drug solubility; glucose transport; Hep-G2 cell line; human; human cell; hydrophobicity; in vitro study; limit of detection; limit of quantitation; micelle; nonhuman; particle size; pharmacokinetic parameters; precipitation; rat; sustained drug release; zeta potential; bioavailability; chemistry; non insulin dependent diabetes mellitus",Article,Final,,Scopus,2-s2.0-85135123112
Wark P.A.B.; Pathinayake P.S.; Kaiko G.; Nichol K.; Ali A.; Chen L.; Sutanto E.N.; Garratt L.W.; Sohal S.S.; Lu W.; Eapen M.S.; Oldmeadow C.; Bartlett N.; Reid A.; Veerati P.; Hsu A.C.Y.; Looi K.; Iosifidis T.; Stick S.M.; Hansbro P.M.; Kicic A.,"Wark, Peter A.B. (7003559516); Pathinayake, Prabuddha S. (55877978000); Kaiko, Gerard (21739529400); Nichol, Kristy (57195914143); Ali, Ayesha (57192694030); Chen, Ling (56424151100); Sutanto, Erika N. (6602674065); Garratt, Luke W. (35291683300); Sohal, Sukhwinder S. (36449981500); Lu, Wenying (57202573402); Eapen, Mathew S. (56625716100); Oldmeadow, Christopher (24471011800); Bartlett, Nathan (7005608564); Reid, Andrew (39561518600); Veerati, Punnam (57200127768); Hsu, Alan C.-Y. (49861516600); Looi, Kevin (37034521600); Iosifidis, Thomas (56069997800); Stick, Stephen M. (35373713500); Hansbro, Philip M. (6603119390); Kicic, Anthony (6507472922)",7003559516; 55877978000; 21739529400; 57195914143; 57192694030; 56424151100; 6602674065; 35291683300; 36449981500; 57202573402; 56625716100; 24471011800; 7005608564; 39561518600; 57200127768; 49861516600; 37034521600; 56069997800; 35373713500; 6603119390; 6507472922,ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma,2021,Respirology,26,5,,442,451,9,62,10.1111/resp.14003,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099405817&doi=10.1111%2fresp.14003&partnerID=40&md5=efa7150b47789602c264b059b0b5f28e,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Telethon Kids Institute, University of Western Australia, Perth, WA, Australia; School of Public Health, Curtin University, Perth, WA, Australia; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia; Clinical Research Design and Statistics, Hunter Medical Research Institute, Newcastle, NSW, Australia; Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Department of Respiratory and Sleep Medicine, Perth Children's Hospital, Perth, WA, Australia; Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia","Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Pathinayake P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Kaiko G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Nichol K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Ali A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Chen L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Sutanto E.N., Telethon Kids Institute, University of Western Australia, Perth, WA, Australia, School of Public Health, Curtin University, Perth, WA, Australia; Garratt L.W., Telethon Kids Institute, University of Western Australia, Perth, WA, Australia; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia; Lu W., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia; Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia; Oldmeadow C., Clinical Research Design and Statistics, Hunter Medical Research Institute, Newcastle, NSW, Australia; Bartlett N., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Reid A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Veerati P., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Hsu A.C.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Looi K., Telethon Kids Institute, University of Western Australia, Perth, WA, Australia, School of Public Health, Curtin University, Perth, WA, Australia; Iosifidis T., Telethon Kids Institute, University of Western Australia, Perth, WA, Australia, School of Public Health, Curtin University, Perth, WA, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Stick S.M., Telethon Kids Institute, University of Western Australia, Perth, WA, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia, Department of Respiratory and Sleep Medicine, Perth Children's Hospital, Perth, WA, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, and Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Kicic A., Telethon Kids Institute, University of Western Australia, Perth, WA, Australia, School of Public Health, Curtin University, Perth, WA, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia, Department of Respiratory and Sleep Medicine, Perth Children's Hospital, Perth, WA, Australia",bronchial asthma; chronic obstructive pulmonary disease; coronavirus disease; COVID-19; pandemic; SARS-CoV-2; viral infections,Asthma; Australia; Comorbidity; COVID-19; Epithelial Cells; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; SARS-CoV-2; angiotensin converting enzyme 2; angiotensin receptor antagonist; beclomethasone dipropionate; corticosteroid; dipeptidyl carboxypeptidase inhibitor; furin; prednisone; proton pump inhibitor; tumor necrosis factor alpha converting enzyme; dipeptidyl carboxypeptidase; adult; age; aged; airway epithelium cell; Article; asthma; Australia; bronchus biopsy; child; chronic obstructive lung disease; controlled study; female; gene expression; human; human cell; human tissue; immunohistochemistry; major clinical study; male; middle aged; priority journal; protein expression; real time polymerase chain reaction; respiratory epithelium; sex difference; virus entry; asthma; biosynthesis; comorbidity; epithelium cell; gene expression regulation; genetics; metabolism,Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85099405817
Quan D.H.; Kwong A.J.; Hansbro P.M.; Britton W.J.,"Quan, Diana H. (57159060300); Kwong, Alexander J. (57733553300); Hansbro, Philip M. (6603119390); Britton, Warwick J. (7102477888)",57159060300; 57733553300; 6603119390; 7102477888,No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis,2022,European Respiratory Review,31,164,210252,,,,20,10.1183/16000617.0252-2021,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85131657160&doi=10.1183%2f16000617.0252-2021&partnerID=40&md5=c7bcd69d85575c509156722013b92735,"Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, Australia; NSW Dept of Education and Training, Parramatta, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Dept of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, Australia","Quan D.H., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, Australia; Kwong A.J., NSW Dept of Education and Training, Parramatta, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Britton W.J., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, Australia, Dept of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, Australia",,Cigarette Smoking; Humans; Latent Tuberculosis; Neutrophils; Tobacco; Tuberculosis; cigarette smoke; adaptive immunity; bacterial transmission; cigarette smoking; dendritic cell; exposure; geographic distribution; human; immunopathology; in vivo study; innate immunity; latent tuberculosis; lung alveolus macrophage; lung tuberculosis; lymphocyte function; macrophage function; mortality; Mycobacterium tuberculosis; neutrophil; nonhuman; oxidative stress; Review; risk factor; systematic review; T lymphocyte; tuberculosis; adverse event; epidemiology; latent tuberculosis; tobacco,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85131657160
Mehta M.; Paudel K.R.; Shukla S.D.; Allam V.S.R.R.; Kannaujiya V.K.; Panth N.; Das A.; Parihar V.K.; Chakraborty A.; Ali M.K.; Jha N.K.; Xenaki D.; Su Q.P.; Wich P.R.; Adams J.; Hansbro P.M.; Chellappan D.K.; Oliver B.G.G.; Dua K.,"Mehta, Meenu (7203024234); Paudel, Keshav Raj (56539588400); Shukla, Shakti Dhar (56367620800); Allam, Venkata Sita Rama Raju (57200203739); Kannaujiya, Vinod Kumar (57219713766); Panth, Nisha (57094240100); Das, Amlan (55257158800); Parihar, Vipan Kumar (15069887300); Chakraborty, Amlan (56714779500); Ali, Md Khadem (57194408422); Jha, Niraj Kumar (55109018100); Xenaki, Dikaia (6507411538); Su, Qian Peter (56734072700); Wich, Peter Richard (7801599835); Adams, Jon (35584313300); Hansbro, Philip Michael (6603119390); Chellappan, Dinesh Kumar (35811890500); Oliver, Brian Gregory George (15919869900); Dua, Kamal (15759138700)",7203024234; 56539588400; 56367620800; 57200203739; 57219713766; 57094240100; 55257158800; 15069887300; 56714779500; 57194408422; 55109018100; 6507411538; 56734072700; 7801599835; 35584313300; 6603119390; 35811890500; 15919869900; 15759138700,Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases,2021,Journal of Controlled Release,337,,,629,644,15,25,10.1016/j.jconrel.2021.08.010,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112352735&doi=10.1016%2fj.jconrel.2021.08.010&partnerID=40&md5=3f6d8efe83ca5ba84945129f48c1f704,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Medical Biochemistry and Microbiology, Uppsala University, 75237, Sweden; School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; National Institute of Biomedical Genomics, Kalyani, Nadia, 741235, WB, India; Department of Radiation Oncology, NASA Specialized Center of Research, University of California, Irvine, 92697, United States; Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Melbourne, 3800, VIC, Australia; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, CA, United States; Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, Stanford, CA, United States; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, 201310, Uttar Pradesh, India; Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia; School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, 2007, NSW, Australia; Australian Centre for NanoMedicine and Centre for Advanced Macromolecular Design, University of New South Wales, Sydney, 2052, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Shukla S.D., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Allam V.S.R.R., Department of Medical Biochemistry and Microbiology, Uppsala University, 75237, Sweden; Kannaujiya V.K., School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Panth N., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Das A., National Institute of Biomedical Genomics, Kalyani, Nadia, 741235, WB, India; Parihar V.K., Department of Radiation Oncology, NASA Specialized Center of Research, University of California, Irvine, 92697, United States; Chakraborty A., Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Melbourne, 3800, VIC, Australia; Ali M.K., Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, CA, United States, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, Stanford, CA, United States; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, 201310, Uttar Pradesh, India; Xenaki D., Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia; Su Q.P., School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, 2007, NSW, Australia; Wich P.R., School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia, Australian Centre for NanoMedicine and Centre for Advanced Macromolecular Design, University of New South Wales, Sydney, 2052, NSW, Australia; Adams J., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Oliver B.G.G., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia",Decoy oligodeoxynucleotide; Novel delivery systems; Nuclear factor kappa B; Respiratory disorder,Cytokines; Humans; NF-kappa B; Oligodeoxyribonucleotides; Pneumonia; Biological organs; Biomolecules; Pathology; Pharmacokinetics; antisense oligonucleotide; immunoglobulin enhancer binding protein; lipid nanoparticle; nanocarrier; nanoparticle; oligodeoxynucleotide; polymer nanoparticle; cytokine; immunoglobulin enhancer binding protein; oligodeoxyribonucleotide; Cellular uptake; Decoy oligodeoxynucleotide; Delivery systems; Novel delivery system; Nuclear factor kappa B; Nuclear factors; Oligodeoxynucleotides; Pharmacokinetic profiles; Recent trends; Respiratory disorders; antisense therapy; asthma; chronic obstructive lung disease; clinical study; cystic fibrosis; drug delivery system; endocytosis; human; inflammatory disease; internalization (cell); lung fibrosis; membrane fusion; molecular biology; nanomedicine; nonhuman; pathogenesis; pulmonary hypertension; respiratory tract disease; Review; pneumonia; Pulmonary diseases,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85112352735
Paudel K.R.; De Rubis G.; Panth N.; Singh S.K.; Chellappan D.K.; Hansbro P.M.; Dua K.,"Paudel, Keshav Raj (56539588400); De Rubis, Gabriele (57196257973); Panth, Nisha (57094240100); Singh, Sachin Kumar (57206711834); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",56539588400; 57196257973; 57094240100; 57206711834; 35811890500; 6603119390; 15759138700,Letter to the editor: NANOMEDICINE AND MEDICINAL PLANTS: EMERGING SYMBIOSIS IN MANAGING LUNG DISEASES AND ASSOCIATED INFECTIONS,2022,EXCLI Journal,21,,,1299,1303,4,8,10.17179/excli2022-5376,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85140454077&doi=10.17179%2fexcli2022-5376&partnerID=40&md5=2c88a1efae4bb1bc6a08f8993ba043ed,"Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; School of Pharmacy and Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Panth N., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, Australia; Singh S.K., School of Pharmacy and Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia",,curcumin; dendrimer; doxorubicin; drug carrier; fluticasone propionate; heme oxygenase 1; interleukin 13; interleukin 1beta; interleukin 4; interleukin 6; interleukin 8; Ki 67 antigen; liposome; macrophage inflammatory protein 1alpha; macrophage inflammatory protein 2; macrophage inflammatory protein 3alpha; malonaldehyde; monocyte chemotactic protein 1; naringenin; ofloxacin; polymer nanoparticle; RANTES; resveratrol; rutoside; solid lipid nanoparticle; superoxide dismutase; tumor necrosis factor; antineoplastic activity; antioxidant activity; cell migration; cell proliferation; clinical effectiveness; down regulation; drug delivery system; drug formulation; human; Letter; lung cancer; lung disease; lung infection; lung injury; lung lavage; medicinal plant; micelle; nanomedicine; nonhuman; pathophysiology; physical chemistry; phytochemistry; protein expression; signal transduction; symbiosis; upregulation,Letter,Final,,Scopus,2-s2.0-85140454077
Alnuqaydan A.M.; Almutary A.G.; Azam M.; Manandhar B.; De Rubis G.; Madheswaran T.; Paudel K.R.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Alnuqaydan, Abdullah M. (56400959400); Almutary, Abdulmajeed G. (57190179251); Azam, Mohd (58133354900); Manandhar, Bikash (57204448260); De Rubis, Gabriele (57196257973); Madheswaran, Thiagarajan (55505311000); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",56400959400; 57190179251; 58133354900; 57204448260; 57196257973; 55505311000; 56539588400; 6603119390; 35811890500; 15759138700,Phytantriol-Based Berberine-Loaded Liquid Crystalline Nanoparticles Attenuate Inflammation and Oxidative Stress in Lipopolysaccharide-Induced RAW264.7 Macrophages,2022,Nanomaterials,12,23,4312,,,,21,10.3390/nano12234312,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85143626173&doi=10.3390%2fnano12234312&partnerID=40&md5=ee8bc685dcaf276c0d974a9dcd927d70,"Department of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia","Alnuqaydan A.M., Department of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Almutary A.G., Department of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Azam M., Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; De Rubis G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",advanced drug delivery; berberine; chronic inflammatory diseases; inflammation; liquid crystalline nanoparticles; LPS; macrophages; oxidative stress,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85143626173
Mehta M.; Malyla V.; Paudel K.R.; Chellappan D.K.; Hansbro P.M.; Oliver B.G.; Dua K.,"Mehta, Meenu (7203024234); Malyla, Vamshikrishna (57205128961); Paudel, Keshav R. (56539588400); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip M. (6603119390); Oliver, Brian G. (15919869900); Dua, Kamal (15759138700)",7203024234; 57205128961; 56539588400; 35811890500; 6603119390; 15919869900; 15759138700,Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro,2021,Journal of Food Biochemistry,45,11,e13954,,,,31,10.1111/jfbc.13954,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116360679&doi=10.1111%2fjfbc.13954&partnerID=40&md5=c27582feb0361473a89d057754caee3c,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Oliver B.G., School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia",berberine; inflammation; interleukins; liquid crystalline nanoparticles; lung cancer,A549 Cells; Anti-Inflammatory Agents; Berberine; Cell Proliferation; Humans; Nanoparticles; Neoplasms; Alkaloids; Biological organs; Cell proliferation; Diseases; Liquids; Nanoparticles; Pathology; Proteins; antiinflammatory agent; berberine; nanoparticle; Berberine; Cancer progression; Chemokine ligands; Heme oxygenase-1; Interleukin; Isoquinolines; Liquid crystalline; Liquid crystalline nanoparticles; Lung Cancer; Monoolein; A-549 cell line; cell proliferation; human; neoplasm; Ligands,Article,Final,All Open Access; Gold Open Access,Scopus,2-s2.0-85116360679
Kar R.; Jha S.K.; Ojha S.; Sharma A.; Dholpuria S.; Raju V.S.R.; Prasher P.; Chellappan D.K.; Gupta G.; Kumar Singh S.; Paudel K.R.; Hansbro P.M.; Kumar Singh S.; Ruokolainen J.; Kesari K.K.; Dua K.; Jha N.K.,"Kar, Rohan (57193338860); Jha, Saurabh Kumar (56425051500); Ojha, Shreesh (8710432200); Sharma, Ankur (57225853834); Dholpuria, Sunny (57193092220); Raju, Venkata Sita Rama (57222631589); Prasher, Parteek (56079914500); Chellappan, Dinesh Kumar (35811890500); Gupta, Gaurav (15047988400); Kumar Singh, Sachin (55788283600); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Kumar Singh, Sandeep (57222640819); Ruokolainen, Janne (7004601530); Kesari, Kavindra Kumar (24332073300); Dua, Kamal (15759138700); Jha, Niraj Kumar (55109018100)",57193338860; 56425051500; 8710432200; 57225853834; 57193092220; 57222631589; 56079914500; 35811890500; 15047988400; 55788283600; 56539588400; 6603119390; 57222640819; 7004601530; 24332073300; 15759138700; 55109018100,The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues,2021,Cancer Reports,4,4,e1369,,,,19,10.1002/cnr2.1369,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103557988&doi=10.1002%2fcnr2.1369&partnerID=40&md5=9969d3ea728296b14054a2b4ab37b15e,"Indian Institute of Management Ahmedabad (IIMA), Ahmedabad, 380015, Gujarat, India; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, 201310, Uttar Pradesh, India; Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 17666, United Arab Emirates; Department of Life sciences, School of Basic Science & Research (SBSR), Sharda University, Greater Noida, 201310, Uttar Pradesh, India; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Centre for Inflammation, Centenary Institute, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, 2308, NSW, Australia; Indian Scientific Education and Technology Foundation, Lucknow, 226002, Uttar Pradesh, India; Department of Applied Physics, School of Science, Aalto University, Espoo, Finland; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia","Kar R., Indian Institute of Management Ahmedabad (IIMA), Ahmedabad, 380015, Gujarat, India; Jha S.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, 201310, Uttar Pradesh, India; Ojha S., Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 17666, United Arab Emirates; Sharma A., Department of Life sciences, School of Basic Science & Research (SBSR), Sharda University, Greater Noida, 201310, Uttar Pradesh, India; Dholpuria S., Department of Life sciences, School of Basic Science & Research (SBSR), Sharda University, Greater Noida, 201310, Uttar Pradesh, India; Raju V.S.R., Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Prasher P., Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Kumar Singh S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Paudel K.R., Centre for Inflammation, Centenary Institute, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, 2308, NSW, Australia; Kumar Singh S., Indian Scientific Education and Technology Foundation, Lucknow, 226002, Uttar Pradesh, India; Ruokolainen J., Department of Applied Physics, School of Science, Aalto University, Espoo, Finland; Kesari K.K., Department of Applied Physics, School of Science, Aalto University, Espoo, Finland; Dua K., Centre for Inflammation, Centenary Institute, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, 201310, Uttar Pradesh, India",cancer; diagnostic markers; E3 ligase; FBXW7; mutation; NOTCH; SCF; therapeutics,F box/WD repeat containing protein 7; Notch receptor; numb protein; peptidylprolyl isomerase; phosphatase; phosphotransferase; presenilin; protein; protein Jagged 1; transcription factor HES 1; transcription factor HES 5; unclassified drug; acute lymphoblastic leukemia; adenoid cystic carcinoma; apoptosis; cancer diagnosis; cancer prognosis; cancer resistance; carcinogenesis; cell cycle regulation; cell differentiation; cell proliferation; enzyme phosphorylation; esophageal squamous cell carcinoma; gene mutation; head and neck squamous cell carcinoma; human; melanoma; metastasis; multidrug resistance; nonhuman; Notch signaling; osteochondroma; protein phosphorylation; protein protein interaction; Review; Sezary syndrome; T cell leukemia,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85103557988
Moecking J.; Laohamonthonkul P.; Chalker K.; White M.J.; Harapas C.R.; Yu C.-H.; Davidson S.; Hrovat-Schaale K.; Hu D.; Eng C.; Huntsman S.; Calleja D.J.; Horvat J.C.; Hansbro P.M.; O'Donoghue R.J.J.; Ting J.P.; Burchard E.G.; Geyer M.; Gerlic M.; Masters S.L.,"Moecking, Jonas (56225442800); Laohamonthonkul, Pawat (57203792136); Chalker, Katelyn (57221843179); White, Marquitta J. (36052196500); Harapas, Cassandra R. (57202334614); Yu, Chien-Hsiung (57195201573); Davidson, Sophia (55937925700); Hrovat-Schaale, Katja (57221841077); Hu, Donglei (7402585007); Eng, Celeste (57208041356); Huntsman, Scott (16202774500); Calleja, Dale J. (57204236811); Horvat, Jay C. (9942405300); Hansbro, Phil M. (6603119390); O'Donoghue, Robert J.J. (26656139900); Ting, Jenny P. (58586161300); Burchard, Esteban G. (57203216533); Geyer, Matthias (7101696391); Gerlic, Motti (6504685113); Masters, Seth L. (8618391900)",56225442800; 57203792136; 57221843179; 36052196500; 57202334614; 57195201573; 55937925700; 57221841077; 7402585007; 57208041356; 16202774500; 57204236811; 9942405300; 6603119390; 26656139900; 58586161300; 57203216533; 7101696391; 6504685113; 8618391900,NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity,2021,Journal of Allergy and Clinical Immunology,147,6,,2134,2145.e20,,14,10.1016/j.jaci.2020.12.636,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100439372&doi=10.1016%2fj.jaci.2020.12.636&partnerID=40&md5=068e541f83d78209724b75573e1308e4,"Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; Department of Medical Biology, University of Melbourne, Parkville, Australia; the Institute of Structural Biology, University of Bonn, Venusberg-Campus 1, Bonn, Germany; Department of Medicine, University of California, San Francisco, Calif, United States; the Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Australia; University of Newcastle, Callaghan, Australia; Centre for Inflammation, Centenary Institute, Sydney, Australia; Faculty of Science, University of Technology Sydney, Ultimo, Australia; Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, Australia; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, United States; Department of Bioengineering & Therapeutic Sciences, University of California, San Francisco, San Francisco, Calif, United States; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel","Moecking J., Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia, the Institute of Structural Biology, University of Bonn, Venusberg-Campus 1, Bonn, Germany; Laohamonthonkul P., Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Chalker K., Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; White M.J., Department of Medicine, University of California, San Francisco, Calif, United States; Harapas C.R., Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Yu C.-H., Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Davidson S., Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Hrovat-Schaale K., Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Hu D., Department of Medicine, University of California, San Francisco, Calif, United States; Eng C., Department of Medicine, University of California, San Francisco, Calif, United States; Huntsman S., Department of Medicine, University of California, San Francisco, Calif, United States; Calleja D.J., Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Horvat J.C., the Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Australia, University of Newcastle, Callaghan, Australia; Hansbro P.M., the Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Australia, University of Newcastle, Callaghan, Australia, Centre for Inflammation, Centenary Institute, Sydney, Australia, Faculty of Science, University of Technology Sydney, Ultimo, Australia; O'Donoghue R.J.J., Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, Australia; Ting J.P., Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, United States; Burchard E.G., Department of Medicine, University of California, San Francisco, Calif, United States, Department of Bioengineering & Therapeutic Sciences, University of California, San Francisco, San Francisco, Calif, United States; Geyer M., the Institute of Structural Biology, University of Bonn, Venusberg-Campus 1, Bonn, Germany; Gerlic M., Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Masters S.L., Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia",asthma; DPP9; inflammasome; NLRP1; SNP,"Alleles; Amino Acid Sequence; Amino Acid Substitution; Animals; Asthma; Cell Line; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Disease Models, Animal; Disease Susceptibility; Eosinophils; Genetic Predisposition to Disease; Humans; Inflammasomes; Mice; Mice, Knockout; Mutation; NLR Proteins; Polymorphism, Single Nucleotide; Structure-Activity Relationship; Trauma Severity Indices; dipeptidyl peptidase; dipeptidyl peptidase 9; inflammasome; NLRP1 protein; unclassified drug; dipeptidyl peptidase; DPP9 protein, human; inflammasome; NLRP1 protein, human; nucleotide binding oligomerization domain like receptor; adolescent; animal experiment; animal model; animal tissue; Article; asthma; controlled study; disease severity; enzyme inhibition; eosinophilia; gene mutation; genetic manipulation; haplotype; human; human cell; in vitro study; in vivo study; major clinical study; male; Mexican American; molecular pathology; mouse; nonhuman; priority journal; protein protein interaction; respiratory tract inflammation; single nucleotide polymorphism; allele; amino acid sequence; amino acid substitution; animal; asthma; cell line; chemistry; disease model; disease predisposition; eosinophil; genetic predisposition; genetics; immunology; injury scale; knockout mouse; metabolism; mutation; pathology; single nucleotide polymorphism; structure activity relation",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85100439372
Clarence D.D.; Paudel K.R.; Manandhar B.; Singh S.K.; Devkota H.P.; Panneerselvam J.; Gupta V.; Chitranshi N.; Verma N.; Saad S.; Gupta G.; Hansbro P.M.; Oliver B.G.; Madheswaran T.; Dua K.; Chellappan D.K.,"Clarence, Dvya Delilaa (57897135900); Paudel, Keshav Raj (56539588400); Manandhar, Bikash (57204448260); Singh, Sachin Kumar (57206711834); Devkota, Hari Prasad (24775939500); Panneerselvam, Jithendra (57201993010); Gupta, Vivek (35073936800); Chitranshi, Nitin (15029905100); Verma, Nitin (58160492500); Saad, Sonia (9734266500); Gupta, Gaurav (15047988400); Hansbro, Philip Michael (6603119390); Oliver, Brian Gregory (15919869900); Madheswaran, Thiagarajan (55505311000); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",57897135900; 56539588400; 57204448260; 57206711834; 24775939500; 57201993010; 35073936800; 15029905100; 58160492500; 9734266500; 15047988400; 6603119390; 15919869900; 55505311000; 15759138700; 35811890500,Unravelling the Therapeutic Potential of Nano-Delivered Functional Foods in Chronic Respiratory Diseases,2022,Nutrients,14,18,3828,,,,17,10.3390/nu14183828,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138323176&doi=10.3390%2fnu14183828&partnerID=40&md5=b874986c4686dcfc86b03ce68b531b5d,"School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road, Phagwara, 144411, India; Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan; Pharmacy Program, Gandaki University, Pokhara, 33700, Nepal; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, 2109, NSW, Australia; Chitkara School of Pharmacy, Chitkara University, Atal Nagar, 174103, India; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2006, NSW, Australia; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, 302017, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 600077, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Woolcock Institute of Medical Research, University of Sydney, Sydney, 2006, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia","Clarence D.D., School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Singh S.K., Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road, Phagwara, 144411, India; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan, Pharmacy Program, Gandaki University, Pokhara, 33700, Nepal; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Gupta V., Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, 2109, NSW, Australia; Chitranshi N., Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, 2109, NSW, Australia; Verma N., Chitkara School of Pharmacy, Chitkara University, Atal Nagar, 174103, India; Saad S., Faculty of Medicine and Health, The University of Sydney, Camperdown, 2006, NSW, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, 302017, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 600077, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, 2006, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia",functional foods; inflammation; nanoparticles; pulmonary; respiratory diseases,"Anti-Inflammatory Agents; Antioxidants; Curcumin; Functional Food; Humans; Hypoglycemic Agents; Inflammation; Pulmonary Disease, Chronic Obstructive; Rutin; Azadirachta indica extract; boswellic acid; capsaicin; cinnamaldehyde; curcumin; eugenol; herbaceous agent; nanocarrier; nanoparticle; naringenin; nutraceutical; rutoside; zerumbone; antidiabetic agent; antiinflammatory agent; antioxidant; curcumin; rutoside; antiinflammatory activity; Azadirachta indica; chronic inflammation; chronic respiratory tract disease; clinical trial (topic); disease exacerbation; drug delivery system; drug mechanism; drug penetration; functional food; human; nanotechnology; nonhuman; pneumonia; Review; signal transduction; chronic obstructive lung disease; functional food; inflammation",Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85138323176
Kim R.Y.; Sunkara K.P.; Bracke K.R.; Jarnicki A.G.; Donovan C.; Hsu A.C.; Ieni A.; Beckett E.L.; Galvão I.; Wijnant S.; Ricciardolo F.L.M.; Di Stefano A.; Haw T.J.; Liu G.; Ferguson A.L.; Palendira U.; Wark P.A.; Conickx G.; Mestdagh P.; Brusselle G.G.; Caramori G.; Foster P.S.; Horvat J.C.; Hansbro P.M.,"Kim, Richard Y. (35810406900); Sunkara, Krishna P. (57190382716); Bracke, Ken R. (8338303000); Jarnicki, Andrew G. (6603137164); Donovan, Chantal (55357105200); Hsu, Alan C. (49861516600); Ieni, Antonio (26021273500); Beckett, Emma L. (36620958500); Galvão, Izabela (56656390800); Wijnant, Sara (57189070322); Ricciardolo, Fabio L.M. (7004516912); Di Stefano, Antonino (36003195400); Haw, Tatt Jhong (56625918900); Liu, Gang (57189061134); Ferguson, Angela L. (57201723429); Palendira, Umamainthan (6508349658); Wark, Peter A. (7003559516); Conickx, Griet (56712859600); Mestdagh, Pieter (25724578400); Brusselle, Guy G. (57197253407); Caramori, Gaetano (7003847659); Foster, Paul S. (7201517569); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",35810406900; 57190382716; 8338303000; 6603137164; 55357105200; 49861516600; 26021273500; 36620958500; 56656390800; 57189070322; 7004516912; 36003195400; 56625918900; 57189061134; 57201723429; 6508349658; 7003559516; 56712859600; 25724578400; 57197253407; 7003847659; 7201517569; 9942405300; 6603119390,A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis,2021,Science Translational Medicine,13,621,aav7223,,,,63,10.1126/scitranslmed.aav7223,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122029765&doi=10.1126%2fscitranslmed.aav7223&partnerID=40&md5=a8d9d1a1cc05f0f3a627a0af50ed5a69,"Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Graduate School of Health Discipline of Pharmacy, University of Technology Sydney, Sydney, 2007, NSW, Australia; Intensive Care Unit, John Hunter Hospital, Newcastle, 2308, NSW, Australia; Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, 9000, Belgium; Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, 3010, VIC, Australia; Department of Human Pathology in Adult and Developmental Age 'Gaetano Barresi', Section of Anatomic Pathology, University of Messina, Messina, 98100, Italy; Rare Lung Disease Unit, Department of Clinical and Biological Sciences, University of Torino, San Luigi Gonzaga University Hospital Orbassano, Torino, 10043, Italy; Istituti Clinici Scientifici Maugeri, IRCCS, SpA Societa Benefit, Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell'Apparato Cardio Respiratorio, Veruno, Novara, 28100, Italy; Charles Perkins Centre, University of Sydney, Sydney, 2006, NSW, Australia; Centenary Institute, University of Technology Sydney, Sydney, 2006, NSW, Australia; Ablynx N.V., a Sanofi company, Ghent, 9052, Belgium; Center for Medical Genetics, Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, 9000, Belgium; Pneumologia, Dipartimento di Scienze Biomediche Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Universita di Messina, Messina, 98100, Italy","Kim R.Y., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Sunkara K.P., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia, Graduate School of Health Discipline of Pharmacy, University of Technology Sydney, Sydney, 2007, NSW, Australia, Intensive Care Unit, John Hunter Hospital, Newcastle, 2308, NSW, Australia; Bracke K.R., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, 9000, Belgium; Jarnicki A.G., Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, 3010, VIC, Australia; Donovan C., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Hsu A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Ieni A., Department of Human Pathology in Adult and Developmental Age 'Gaetano Barresi', Section of Anatomic Pathology, University of Messina, Messina, 98100, Italy; Beckett E.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Galvão I., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, 2007, NSW, Australia; Wijnant S., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, 9000, Belgium; Ricciardolo F.L.M., Rare Lung Disease Unit, Department of Clinical and Biological Sciences, University of Torino, San Luigi Gonzaga University Hospital Orbassano, Torino, 10043, Italy; Di Stefano A., Istituti Clinici Scientifici Maugeri, IRCCS, SpA Societa Benefit, Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell'Apparato Cardio Respiratorio, Veruno, Novara, 28100, Italy; Haw T.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Liu G., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, 2007, NSW, Australia; Ferguson A.L., Charles Perkins Centre, University of Sydney, Sydney, 2006, NSW, Australia, Centenary Institute, University of Technology Sydney, Sydney, 2006, NSW, Australia; Palendira U., Charles Perkins Centre, University of Sydney, Sydney, 2006, NSW, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Conickx G., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, 9000, Belgium, Ablynx N.V., a Sanofi company, Ghent, 9052, Belgium; Mestdagh P., Center for Medical Genetics, Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, 9000, Belgium; Brusselle G.G., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, 9000, Belgium; Caramori G., Pneumologia, Dipartimento di Scienze Biomediche Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Universita di Messina, Messina, 98100, Italy; Foster P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia",,"Animals; Lung; Matrix Attachment Region Binding Proteins; Mice; MicroRNAs; NF-kappa B; Pulmonary Disease, Chronic Obstructive; ant 21; calgranulin B; immunoglobulin enhancer binding protein; microRNA 21; respiratory tract agent; RNA binding protein; sequence binding protein 1; small interfering RNA; unclassified drug; immunoglobulin enhancer binding protein; matrix attachment region binding protein; microRNA; animal cell; Article; cell culture; chronic obstructive lung disease; cigarette smoking; clinical article; cohort analysis; computer simulation; controlled study; disease severity; female; gene expression; genetic identification; human; human tissue; hysteresis; lung alveolus macrophage; lung fibrosis; lung function; lung parenchyma; lung resistance; lymphocyte; mouse; neutrophil; nonhuman; pathogenesis; pathogenicity; pilot study; population structure; protein expression; protein function; real time polymerase chain reaction; respiratory epithelium; respiratory tract inflammation; RNA microarray; upregulation; animal; chronic obstructive lung disease; genetics; lung; metabolism; pathology",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85122029765
Counoupas C.; Johansen M.D.; Stella A.O.; Nguyen D.H.; Ferguson A.L.; Aggarwal A.; Bhattacharyya N.D.; Grey A.; Hutchings O.; Patel K.; Siddiquee R.; Stewart E.L.; Feng C.G.; Hansbro N.G.; Palendira U.; Steain M.C.; Saunders B.M.; Low J.K.K.; Mackay J.P.; Kelleher A.D.; Britton W.J.; Turville S.G.; Hansbro P.M.; Triccas J.A.,"Counoupas, Claudio (24070034400); Johansen, Matt D. (57202983408); Stella, Alberto O. (57200605815); Nguyen, Duc H. (54886138200); Ferguson, Angela L. (57201723429); Aggarwal, Anupriya (26431741800); Bhattacharyya, Nayan D. (57091257200); Grey, Alice (57209476071); Hutchings, Owen (57221539494); Patel, Karishma (57216038426); Siddiquee, Rezwan (57214806700); Stewart, Erica L. (57211535483); Feng, Carl G. (7402911663); Hansbro, Nicole G. (15055862300); Palendira, Umaimainthan (6508349658); Steain, Megan C. (8740991600); Saunders, Bernadette M. (7102328746); Low, Jason K. K. (34877135200); Mackay, Joel P. (7201377458); Kelleher, Anthony D. (7006091312); Britton, Warwick J. (7102477888); Turville, Stuart G. (6507720820); Hansbro, Philip M. (6603119390); Triccas, James A. (7003601814)",24070034400; 57202983408; 57200605815; 54886138200; 57201723429; 26431741800; 57091257200; 57209476071; 57221539494; 57216038426; 57214806700; 57211535483; 7402911663; 15055862300; 6508349658; 8740991600; 7102328746; 34877135200; 7201377458; 7006091312; 7102477888; 6507720820; 6603119390; 7003601814,"A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection",2021,npj Vaccines,6,1,143,,,,44,10.1038/s41541-021-00406-4,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120166235&doi=10.1038%2fs41541-021-00406-4&partnerID=40&md5=2ca0ba283661efbaa183752b3a050e9f,"School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia; Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; RPA Virtual Hospital, Sydney Local Health District, Sydney, NSW, Australia; School of Life and Environmental Sciences, The University of Sydney, Sydney, 2006, NSW, Australia; Sydney Institute for Infectious Diseases and Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia","Counoupas C., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia, Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Johansen M.D., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Stella A.O., Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Nguyen D.H., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Ferguson A.L., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia, Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Aggarwal A., Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Bhattacharyya N.D., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Grey A., Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Hutchings O., RPA Virtual Hospital, Sydney Local Health District, Sydney, NSW, Australia; Patel K., School of Life and Environmental Sciences, The University of Sydney, Sydney, 2006, NSW, Australia; Siddiquee R., School of Life and Environmental Sciences, The University of Sydney, Sydney, 2006, NSW, Australia; Stewart E.L., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia; Feng C.G., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Palendira U., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia; Steain M.C., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Saunders B.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Low J.K.K., School of Life and Environmental Sciences, The University of Sydney, Sydney, 2006, NSW, Australia; Mackay J.P., School of Life and Environmental Sciences, The University of Sydney, Sydney, 2006, NSW, Australia; Kelleher A.D., Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Britton W.J., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Sydney, NSW, Australia, Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Turville S.G., Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Triccas J.A., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia, Sydney Institute for Infectious Diseases and Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia",,aluminum potassium sulfate; bcg covac; BCG vaccine; coronavirus spike glycoprotein; immunoglobulin G antibody; neutralizing antibody; SARS-CoV-2 antibody; SARS-CoV-2 vaccine; unclassified drug; vaccine adjuvant; virus antigen; adult; animal cell; animal experiment; animal model; animal tissue; antibody response; antigen specificity; Article; asymptomatic infection; BCG vaccination; controlled study; coronavirus disease 2019; cytokine release; drug formulation; experimental coronavirus disease 2019; female; human; immunostimulation; local lymph node assay; male; mouse; Mycobacterium bovis BCG; nonhuman; nose smear; popliteal lymph node; single drug dose; sterilizing immunity; Tfh cell; Th1 cell; trimerization; Vero C1008 cell line,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85120166235
Alamil J.M.R.; Paudel K.R.; Chan Y.; Xenaki D.; Panneerselvam J.; Singh S.K.; Gulati M.; Jha N.K.; Kumar D.; Prasher P.; Gupta G.; Malik R.; Oliver B.G.; Hansbro P.M.; Dua K.; Chellappan D.K.,"Alamil, Juman Mohammed Rasmi (57687310600); Paudel, Keshav Raj (56539588400); Chan, Yinghan (57204707263); Xenaki, Dikaia (6507411538); Panneerselvam, Jithendra (57201993010); Singh, Sachin Kumar (57206711834); Gulati, Monica (7006677671); Jha, Niraj Kumar (55109018100); Kumar, Deepak (55534141182); Prasher, Parteek (56079914500); Gupta, Gaurav (15047988400); Malik, Raniya (57687045700); Oliver, Brian George (15919869900); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",57687310600; 56539588400; 57204707263; 6507411538; 57201993010; 57206711834; 7006677671; 55109018100; 55534141182; 56079914500; 15047988400; 57687045700; 15919869900; 6603119390; 15759138700; 35811890500,Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases,2022,Molecules,27,9,3038,,,,25,10.3390/molecules27093038,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130009581&doi=10.3390%2fmolecules27093038&partnerID=40&md5=203efcb212245bf089400e58ab55ade9,"School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; School of Pharmacy, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Woolcock Institute of Medical Research, University of Sydney, Sydney, 2006, NSW, Australia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, 201310, India; Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, India; Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 602105, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; DeÁurora Pty Ltd., Dean, 3363, VIC, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia","Alamil J.M.R., School of Postgraduate Studies, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Chan Y., School of Pharmacy, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Xenaki D., Woolcock Institute of Medical Research, University of Sydney, Sydney, 2006, NSW, Australia; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, 201310, India; Kumar D., Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, India; Prasher P., Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 602105, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Malik R., DeÁurora Pty Ltd., Dean, 3363, VIC, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, 2006, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Woolcock Institute of Medical Research, University of Sydney, Sydney, 2006, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, 57000, Malaysia",agarwood; agarwood oil; anti-inflammatory; herbs; inflammation; therapeutics,Anti-Inflammatory Agents; Humans; Inflammation; Plant Extracts; Quality of Life; Thymelaeaceae; Wood; antiinflammatory agent; plant extract; human; inflammation; quality of life; Thymelaeaceae; wood,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85130009581
Paudel K.R.; Mehta M.; Shukla S.D.; Panth N.; Chellappan D.K.; Dua K.; Hansbro P.,"Paudel, Keshav Raj (56539588400); Mehta, Meenu (7203024234); Shukla, Shakti Dhar (56367620800); Panth, Nisha (57094240100); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700); Hansbro, Philip (6603119390)",56539588400; 7203024234; 56367620800; 57094240100; 35811890500; 15759138700; 6603119390,Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease,2022,Nanomedicine,17,23,,1757,1760,3,10,10.2217/nnm-2021-0373,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85148307443&doi=10.2217%2fnnm-2021-0373&partnerID=40&md5=04dcb5c8728d140068431bcdee5ba910,"Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Paudel K.R., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Shukla S.D., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Panth N., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2007, NSW, Australia",chronic obstructive pulmonary disease; drug delivery; nanotherapeutics; pulmonary; senescence,"Humans; Pulmonary Disease, Chronic Obstructive; magnetic nanoparticle; metformin; protein p16; protein p21; protein p53; reactive oxygen metabolite; senotherapeutic agent; sirolimus; sirtuin; Akt signaling; cell aging; chronic obstructive lung disease; cigarette smoking; disability-adjusted life year; drug delivery system; drug targeting; Editorial; human; nanomedicine; nonhuman; oxidative stress; protein expression",Editorial,Final,,Scopus,2-s2.0-85148307443
Manandhar B.; Paudel K.R.; Panth N.; Hansbro P.; Oliver B.G.; Dua K.,"Manandhar, Bikash (57204448260); Paudel, Keshav Raj (56539588400); Panth, Nisha (57094240100); Hansbro, Philip (6603119390); Oliver, Brian G. (15919869900); Dua, Kamal (15759138700)",57204448260; 56539588400; 57094240100; 6603119390; 15919869900; 15759138700,Applications of extracellular vesicles as a drug-delivery system for chronic respiratory diseases,2022,Nanomedicine,17,12,,817,820,3,7,10.2217/nnm-2021-0384,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133558147&doi=10.2217%2fnnm-2021-0384&partnerID=40&md5=71dd86204e79006299626a2098bdfa40,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia","Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Panth N., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Hansbro P., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Oliver B.G., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",drug delivery; extracellular vesicles; inflammation; lung diseases; respiratory,Drug Delivery Systems; Extracellular Vesicles; drug carrier; liposome; microRNA; nanocarrier; respiratory tract agent; small interfering RNA; antiinflammatory activity; cell infiltration; chronic respiratory tract disease; drug delivery system; encapsulation; exosome; homeostasis; human; immunocompetent cell; inflammation; lung disease; mesenchymal stem cell; molecular stability; nonhuman; reticuloendothelial system; Review; safety; stem cell transplantation; tissue repair; treatment outcome; drug delivery system,Review,Final,,Scopus,2-s2.0-85133558147
Francis I.; Shrestha J.; Paudel K.R.; Hansbro P.M.; Warkiani M.E.; Saha S.C.,"Francis, Isabella (57610241500); Shrestha, Jesus (57214237167); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Warkiani, Majid Ebrahimi (36138999000); Saha, Suvash C. (57524032100)",57610241500; 57214237167; 56539588400; 6603119390; 36138999000; 57524032100,Recent advances in lung-on-a-chip models,2022,Drug Discovery Today,27,9,,2593,2602,9,52,10.1016/j.drudis.2022.06.004,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133223584&doi=10.1016%2fj.drudis.2022.06.004&partnerID=40&md5=4a5ee3829b30298393a865df72884fec,"School of Mechanical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2050 & 2007, NSW, Australia; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia","Francis I., School of Mechanical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Shrestha J., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2050 & 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, 2050 & 2007, NSW, Australia; Warkiani M.E., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Saha S.C., School of Mechanical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia",Lung-on-a-chip; Lungs; Organ-on-a-chip; Respiratory diseases; Respiratory system,Animals; Cell Culture Techniques; Drug Discovery; Lab-On-A-Chip Devices; Lung; Respiratory Tract Diseases; air quality; animal cell; animal experiment; animal model; drug development; nonhuman; respiratory tract disease; Review; three dimensional cell culture; tumor microenvironment; two dimensional cell culture; animal; cell culture technique; drug development; lab on a chip; lung,Review,Final,,Scopus,2-s2.0-85133223584
Dhanjal D.S.; Sharma P.; Mehta M.; Tambuwala M.M.; Prasher P.; Paudel K.R.; Liu G.; Shukla S.D.; Hansbro P.M.; Chellappan D.K.; Dua K.; Satija S.,"Dhanjal, Daljeet Singh (58224756300); Sharma, Parvarish (57225938846); Mehta, Meenu (7203024234); Tambuwala, Murtaza M (36657816300); Prasher, Parteek (56079914500); Paudel, Keshav R (56539588400); Liu, Gang (57189061134); Shukla, Shakti D (56367620800); Hansbro, Philip M (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700); Satija, Saurabh (54581608400)",58224756300; 57225938846; 7203024234; 36657816300; 56079914500; 56539588400; 57189061134; 56367620800; 6603119390; 35811890500; 15759138700; 54581608400,Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases,2022,Future Medicinal Chemistry,14,4,,271,288,17,12,10.4155/fmc-2021-0081,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124173631&doi=10.4155%2ffmc-2021-0081&partnerID=40&md5=64b7e2a987c5f34e163c4227a1364aa4,"School of Bioengineering and Biosciences, Lovely Professional University, Punjab, Phagwara, 144411, India; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County, Londonderry, BT52 1SA, United Kingdom; Department of Chemistry, University of Petroleum and Energy Studies, Dehradun, 248007, India; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Dhanjal D.S., School of Bioengineering and Biosciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Sharma P., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County, Londonderry, BT52 1SA, United Kingdom; Prasher P., Department of Chemistry, University of Petroleum and Energy Studies, Dehradun, 248007, India; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Liu G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Shukla S.D., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India",COPD; NDDS; remodeling; respiratory disorders,"Administration, Inhalation; Airway Remodeling; Asthma; Drug Carriers; Humans; Inflammation; Lung; Medication Adherence; Pulmonary Disease, Chronic Obstructive; alpha actin; carbon nanotube; collagenase 3; eotaxin; epidermal growth factor receptor; epithelial derived neutrophil activating factor 78; fibronectin; gelatinase B; granulocyte macrophage colony stimulating factor; graphene oxide; interleukin 13; interleukin 18; interleukin 4; interleukin 5; interleukin 8; interleukin 9; ivacaftor; pirfenidone; platelet derived growth factor; RANTES; riociguat; roflumilast; STAT1 protein; drug carrier; age distribution; airway remodeling; anatomical concepts; cell function; chronic obstructive lung disease; cystic fibrosis; drug delivery system; extracellular matrix; fibrosing alveolitis; gas exchange; human; inflammation; lung capacity; lung fibroblast; lung function; medication compliance; nonhuman; particle size; phenotype; protein aggregation; pulmonary hypertension; respiratory tract disease; Review; airway remodeling; anatomy and histology; asthma; chemistry; chronic obstructive lung disease; inflammation; inhalational drug administration; lung; metabolism; pathology; physiology",Review,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85124173631
Gomez H.M.; Pillar A.L.; Brown A.C.; Kim R.Y.; Ali M.K.; Essilfie A.-T.; Vanders R.L.; Frazer D.M.; Anderson G.J.; Hansbro P.M.; Collison A.M.; Jensen M.E.; Murphy V.E.; Johnstone D.M.; Reid D.; Milward E.A.; Donovan C.; Horvat J.C.,"Gomez, Henry M. (57191960363); Pillar, Amber L. (57216038374); Brown, Alexandra C. (55637745000); Kim, Richard Y. (35810406900); Ali, Md Khadem (57194408422); Essilfie, Ama-Tawiah (22955585600); Vanders, Rebecca L. (55773360100); Frazer, David M. (7007108349); Anderson, Gregory J. (7404222977); Hansbro, Philip M. (6603119390); Collison, Adam M. (23995251200); Jensen, Megan E. (45060964500); Murphy, Vanessa E. (7006804832); Johnstone, Daniel M. (15829670700); Reid, David (7402154724); Milward, Elizabeth A. (6603563509); Donovan, Chantal (55357105200); Horvat, Jay C. (9942405300)",57191960363; 57216038374; 55637745000; 35810406900; 57194408422; 22955585600; 55773360100; 7007108349; 7404222977; 6603119390; 23995251200; 45060964500; 7006804832; 15829670700; 7402154724; 6603563509; 55357105200; 9942405300,Investigating the links between lower iron status in pregnancy and respiratory disease in offspring using murine models,2021,Nutrients,13,12,4461,,,,4,10.3390/nu13124461,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121340043&doi=10.3390%2fnu13124461&partnerID=40&md5=0e070b228d67a4ca5370f8bc4a38c396,"School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; QIMR Berghofer Medical Research Institute, Herston, 4006, QLD, Australia; School of Biomedical Sciences, The University of Queensland, St Lucia, 4067, QLD, Australia; School of Chemistry and Molecular Bioscience, The University of Queensland, St Lucia, 4067, QLD, Australia; Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, Priority Research Centre for GrowUpWell, The University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; School of Medical Sciences, University of Sydney, Camperdown, 2050, NSW, Australia","Gomez H.M., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Pillar A.L., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Brown A.C., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Kim R.Y., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Ali M.K., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Essilfie A.-T., QIMR Berghofer Medical Research Institute, Herston, 4006, QLD, Australia; Vanders R.L., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Frazer D.M., QIMR Berghofer Medical Research Institute, Herston, 4006, QLD, Australia, School of Biomedical Sciences, The University of Queensland, St Lucia, 4067, QLD, Australia; Anderson G.J., QIMR Berghofer Medical Research Institute, Herston, 4006, QLD, Australia, School of Chemistry and Molecular Bioscience, The University of Queensland, St Lucia, 4067, QLD, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia, Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Collison A.M., School of Medicine and Public Health, College of Health, Medicine and Wellbeing, Priority Research Centre for GrowUpWell, The University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Jensen M.E., School of Medicine and Public Health, College of Health, Medicine and Wellbeing, Priority Research Centre for GrowUpWell, The University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Murphy V.E., School of Medicine and Public Health, College of Health, Medicine and Wellbeing, Priority Research Centre for GrowUpWell, The University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Johnstone D.M., School of Medical Sciences, University of Sydney, Camperdown, 2050, NSW, Australia; Reid D., QIMR Berghofer Medical Research Institute, Herston, 4006, QLD, Australia; Milward E.A., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Donovan C., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Horvat J.C., School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia",Asthma; Iron deficiency; Offspring; Pregnancy; Respiratory disease,"Animals; Collagen; Egg Proteins, Dietary; Female; Inflammation; Iron; Iron Deficiencies; Lung; Maternal Nutritional Physiological Phenomena; Mice; Mice, Inbred BALB C; Pregnancy; Prenatal Exposure Delayed Effects; Prenatal Nutritional Physiological Phenomena; Respiratory Tract Diseases; collagen; iron; collagen; iron; animal experiment; animal model; animal tissue; Article; asthma; controlled study; disease severity; experimental asthma; female; iron deficiency; iron intake; iron restriction; lung function; lung structure; male; murine model; neutrophilic inflammation; nonhuman; pregnant woman; progeny; respiratory tract inflammation; animal; Bagg albino mouse; complication; growth, development and aging; inflammation; lung; maternal nutrition; metabolism; mouse; pathology; pregnancy; prenatal exposure; protein intake; respiratory tract disease",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85121340043
Deng K.; Zhang X.; Liu Y.; Zhang L.; Wang G.; Feng M.; Oliver B.G.; Wang L.; Hansbro P.M.; Qin L.; Xie M.; Chen Z.H.; Simpson J.; Zhang J.; Li W.M.; Gibson P.G.,"Deng, Ke (58587211800); Zhang, Xin (55277957600); Liu, Ying (57200212919); Zhang, Li (57190759919); Wang, Gang (56167771700); Feng, Min (57219892109); Oliver, Brian G. (15919869900); Wang, Lei (57069199100); Hansbro, Philip M. (6603119390); Qin, Lin (57222247845); Xie, Min (56988391000); Chen, Zhi Hong (57196282666); Simpson, Jodie (7404326026); Zhang, Jie (55957803100); Li, Wei Min (55718755500); Gibson, Peter Gerard (7202414199)",58587211800; 55277957600; 57200212919; 57190759919; 56167771700; 57219892109; 15919869900; 57069199100; 6603119390; 57222247845; 56988391000; 57196282666; 7404326026; 55957803100; 55718755500; 7202414199,Heterogeneity of Paucigranulocytic Asthma: A Prospective Cohort Study with Hierarchical Cluster Analysis,2021,Journal of Allergy and Clinical Immunology: In Practice,9,6,,2344,2355,11,16,10.1016/j.jaip.2021.01.004,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102000138&doi=10.1016%2fj.jaip.2021.01.004&partnerID=40&md5=b09d912e6948e938e91bc49ff09d0203,"Department of Respiratory and Critical Care Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China; West China School of Medicine, Sichuan University, Chengdu, Sichuan, China; School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia; Respiratory Cellular and Molecule Biology, Woolcock Institute of Medical Research, the University of Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Department of Pulmonary and Critical and Care Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Respiratory and Critical Care Medicine, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, Hubei, China; Shanghai Institute of Respiratory Disease, Respiratory Division of Zhongshan Hospital, Fudan University, Shanghai, China; Priority Research Center for Healthy Lungs, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Jilin University, Changchun, Jilin, China; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Deng K., Department of Respiratory and Critical Care Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan, China; Zhang X., Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Liu Y., Department of Respiratory and Critical Care Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Zhang L., Department of Respiratory and Critical Care Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Wang G., Department of Respiratory and Critical Care Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China; Feng M., Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China, West China School of Medicine, Sichuan University, Chengdu, Sichuan, China; Oliver B.G., School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia, Respiratory Cellular and Molecule Biology, Woolcock Institute of Medical Research, the University of Sydney, Sydney, NSW, Australia; Wang L., Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Qin L., Department of Pulmonary and Critical and Care Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China; Xie M., Department of Respiratory and Critical Care Medicine, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, Hubei, China; Chen Z.H., Shanghai Institute of Respiratory Disease, Respiratory Division of Zhongshan Hospital, Fudan University, Shanghai, China; Simpson J., Priority Research Center for Healthy Lungs, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia; Zhang J., Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Jilin University, Changchun, Jilin, China; Li W.M., Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Gibson P.G., Priority Research Center for Healthy Lungs, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",Asthma; Cluster analysis; Heterogeneity; Paucigranulocytic asthma; Phenotypes,Asthma; Cluster Analysis; Humans; Phenotype; Prospective Studies; Sputum; gamma interferon; interleukin 13; interleukin 17; interleukin 1beta; interleukin 4; interleukin 5; interleukin 6; interleukin 8; tumor necrosis factor; adult; Article; asthma; Asthma Control Questionnaire; Asthma Control Test; Asthma Quality of Life Questionnaire; atopy; cohort analysis; controlled study; cross-sectional study; demography; disease duration; disease exacerbation; female; follow up; forced expiratory volume; hierarchical clustering; human; major clinical study; male; mental disease; paucigranulocytic asthma; phenotype; population research; post hoc analysis; prospective study; rhinoconjunctivitis; risk factor; smoking; validation study; asthma; cluster analysis; sputum,Article,Final,,Scopus,2-s2.0-85102000138
Dhouib R.; Nasreen M.; Othman D.S.M.P.; Ellis D.; Lee S.; Essilfie A.-T.; Hansbro P.M.; McEwan A.G.; Kappler U.,"Dhouib, Rabeb (15061097600); Nasreen, Marufa (57192541596); Othman, Dk Seti Maimonah Pg (56107298100); Ellis, Daniel (57223921540); Lee, Simon (57226771788); Essilfie, Ama-Tawiah (22955585600); Hansbro, Philip M. (6603119390); McEwan, Alastair G. (7102063435); Kappler, Ulrike (6603150947)",15061097600; 57192541596; 56107298100; 57223921540; 57226771788; 22955585600; 6603119390; 7102063435; 6603150947,The DmsABC Sulfoxide Reductase Supports Virulence in Non-typeable Haemophilus influenzae,2021,Frontiers in Microbiology,12,,686833,,,,6,10.3389/fmicb.2021.686833,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112616247&doi=10.3389%2ffmicb.2021.686833&partnerID=40&md5=d794cab9aed7edc3acb3d9b188c0563e,"School of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; Centre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia","Dhouib R., School of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia; Nasreen M., School of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia; Othman D.S.M.P., School of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia; Ellis D., School of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia; Lee S., School of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia; Essilfie A.-T., QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; McEwan A.G., School of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia; Kappler U., School of Chemistry and Molecular Biosciences, Australian Infectious Disease Research Centre, The University of Queensland, St Lucia, QLD, Australia",anaerobic respiration; energy generation; Haemophilus influenzae; molybdenum enzyme; respiratory pathogen; sulfoxide; sulfoxide reductase,dimethyl sulfoxide reductase; DNA fragment; hypochlorite; oxygen; anaerobic growth; animal cell; animal experiment; animal model; Article; bacterial growth; bacterial load; bacterial strain; bacterial virulence; bacterium adherence; bacterium culture; bioassay; biofilm; bronchoalveolar lavage fluid; colony forming unit; controlled study; drug sensitivity; enzyme activity; female; gene; gene expression; human; human cell; hypochlorite susceptibility assay; immunofluorescence microscopy; lung parenchyma; mouse; neutrophil killing assay; nonhuman; nontypeable Haemophilus influenzae; operon; phenotype; protein expression; real time reverse transcription polymerase chain reaction; RNA isolation; tissue culture,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85112616247
Chan Y.; Raju Allam V.S.R.; Paudel K.R.; Singh S.K.; Gulati M.; Dhanasekaran M.; Gupta P.K.; Jha N.K.; Devkota H.P.; Gupta G.; Hansbro P.M.; Oliver B.G.G.; Chellappan D.K.; Dua K.,"Chan, Yinghan (57204707263); Raju Allam, Venkata Sita Rama (57200203739); Paudel, Keshav Raj (56539588400); Singh, Sachin K. (57206711834); Gulati, Monica (7006677671); Dhanasekaran, Muralikrishnan (8935112400); Gupta, Piyush Kumar (57220905930); Jha, Niraj Kumar (55109018100); Devkota, Hari Prasad (24775939500); Gupta, Gaurav (15047988400); Hansbro, Philip M (6603119390); Oliver, Brian Gregory George (15919869900); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",57204707263; 57200203739; 56539588400; 57206711834; 7006677671; 8935112400; 57220905930; 55109018100; 24775939500; 15047988400; 6603119390; 15919869900; 35811890500; 15759138700,Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases,2023,Critical Reviews in Food Science and Nutrition,63,19,,3302,3332,30,14,10.1080/10408398.2021.1986467,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116488602&doi=10.1080%2f10408398.2021.1986467&partnerID=40&md5=25b6af59726830f83ef1d40e2e80f788,"School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States; Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Uttar Pradesh, Greater Noida, India; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Uttar Pradesh, Greater Noida, India; Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Kumamoto City, Japan; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Jagatpura, India; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia","Chan Y., School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Raju Allam V.S.R., Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Dhanasekaran M., Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States; Gupta P.K., Department of Life Sciences, School of Basic Sciences and Research (SBSR), Sharda University, Uttar Pradesh, Greater Noida, India; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Uttar Pradesh, Greater Noida, India; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Kumamoto City, Japan; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Jagatpura, India; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Oliver B.G.G., School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Dua K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Uttar Pradesh, Greater Noida, India, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia",,Asthma; Dietary Supplements; Humans; Quality of Life; Respiratory Tract Diseases; Disease control; Probiotics; Quality control; Adverse effect; Chronic obstructive pulmonary disease; Clinical application; Health concerns; Low qualities; Nutraceuticals; Pulmonary fibrosis; Respiratory tract; Socio-economics; Therapeutic agents; asthma; dietary supplement; human; quality of life; respiratory tract disease; Pulmonary diseases,Review,Final,,Scopus,2-s2.0-85116488602
Nucera F.; Mumby S.; Paudel K.R.; Dharwal V.; Di Stefano A.; Casolaro V.; Hansbro P.M.; Adcock I.M.; Caramori G.,"Nucera, Francesco (57202946185); Mumby, Sharon (7005804196); Paudel, Keshav R. (56539588400); Dharwal, Vivek (57195758477); Di Stefano, Antonino (36003195400); Casolaro, Vincenzo (7003526446); Hansbro, Philip M. (6603119390); Adcock, Ian M. (7007066538); Caramori, Gaetano (7003847659)",57202946185; 7005804196; 56539588400; 57195758477; 36003195400; 7003526446; 6603119390; 7007066538; 7003847659,Role of oxidative stress in the pathogenesis of COPD,2022,Minerva Medica,113,3,,370,404,34,45,10.23736/S0026-4806.22.07972-1,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133637155&doi=10.23736%2fS0026-4806.22.07972-1&partnerID=40&md5=f7b992fef07e058a0da63e251fdee325,"Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), University of Messina, Messina, Italy; Section of Airways Diseases, Faculty of Medicine, Imperial College London, National Heart and Lung Institute, London, United Kingdom; Center for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Division of Pneumology, Laboratory of Cardiorespiratory System Citoimmunopathology, Istituti Clinici Scientifici Maugeri IRCCS, Veruno, Novara, Italy; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy","Nucera F., Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), University of Messina, Messina, Italy; Mumby S., Section of Airways Diseases, Faculty of Medicine, Imperial College London, National Heart and Lung Institute, London, United Kingdom; Paudel K.R., Center for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Dharwal V., Center for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Di Stefano A., Division of Pneumology, Laboratory of Cardiorespiratory System Citoimmunopathology, Istituti Clinici Scientifici Maugeri IRCCS, Veruno, Novara, Italy; Casolaro V., Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy; Hansbro P.M., Center for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Adcock I.M., Section of Airways Diseases, Faculty of Medicine, Imperial College London, National Heart and Lung Institute, London, United Kingdom; Caramori G., Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), University of Messina, Messina, Italy","Antioxidants; Oxidative stress; Pulmonary disease, chronic obstructive","Animals; Antioxidants; Humans; Oxidants; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Smokers; antioxidant; apocynin; azithromycin; beclomethasone dipropionate; budesonide; budesonide plus formoterol; cadmium; carbocisteine; carotenoid; catalase; cefepime; cigarette smoke; citrulline; clarithromycin; creatine kinase; dexamethasone; eosinophil peroxidase; erdosteine; fluticasone; fluticasone propionate; glucocorticoid receptor; glutathione; glutathione peroxidase; histone deacetylase 2; inducible nitric oxide synthase; interleukin 18; interleukin 1beta; liposome; lipoxygenase; losartan; macrolide; malonaldehyde; mefenamic acid; myeloperoxidase; nitric oxide; nitric oxide synthase; oxidizing agent; oxytetracycline; polyphenol; prednisone; reactive nitrogen species; reactive oxygen metabolite; reduced nicotinamide adenine dinucleotide phosphate; resveratrol; roflumilast; salbutamol; sapropterin; sulforaphane; superoxide dismutase; toll like receptor 2; ubidecarenone; antioxidant; oxidizing agent; autophagy (cellular); bioinformatics; chronic obstructive lung disease; controlled clinical trial (topic); cytotoxicity; dietary intake; disease exacerbation; DNA repair; enzyme activity; extracellular trap; ferroptosis; human; immunocompetent cell; inflammation; length of stay; lipid metabolism; lipid peroxidation; lung cancer; lung function; nonhuman; oxidative stress; pathogenesis; phagocytosis; pyroptosis; Review; smoking cessation; ubiquitination; animal; chronic obstructive lung disease; oxidative stress; pathology; smoking",Review,Final,,Scopus,2-s2.0-85133637155
Moheimani F.; Shahdab N.; Cummings S.; Hansbro P.M.; Ward C.,"Moheimani, Fatemeh (36157216000); Shahdab, Nafeesa (57910209600); Cummings, Stephen (7201936559); Hansbro, Philip M. (6603119390); Ward, Christopher (57196516302)",36157216000; 57910209600; 7201936559; 6603119390; 57196516302,Key role of dysregulated airway epithelium in response to respiratory viral infections in asthma,2022,ERJ Open Research,8,3,00314-2022,,,,0,10.1183/23120541.00314-2022,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138954098&doi=10.1183%2f23120541.00314-2022&partnerID=40&md5=a579a7e5d442877b48bf82f2f1118ae5,"School of Health and Life Sciences, Teesside University, Middlesbrough, United Kingdom; National Horizons Centre, Teesside University, Darlington, United Kingdom; Vice Chancellors’ Office, Teesside University, Middlesbrough, United Kingdom; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom","Moheimani F., School of Health and Life Sciences, Teesside University, Middlesbrough, United Kingdom, National Horizons Centre, Teesside University, Darlington, United Kingdom; Shahdab N., School of Health and Life Sciences, Teesside University, Middlesbrough, United Kingdom, National Horizons Centre, Teesside University, Darlington, United Kingdom; Cummings S., National Horizons Centre, Teesside University, Darlington, United Kingdom, Vice Chancellors’ Office, Teesside University, Middlesbrough, United Kingdom; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Ward C., Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom",,CD147 antigen; collagen type 5; gamma interferon inducible protein 10; gelatinase B; histone deacetylase 4; interleukin 17 antibody; interleukin 6; interleukin 8; microRNA 22; sialidase; toll like receptor; vasculotropin; antiviral activity; asthma; cytolysis; epigenetics; extracellular matrix; gene sequence; goblet cell; HBEC cell line (bronchial epithelium); human; Influenza A virus (H1N1); innate immunity; Letter; phenotype; respiratory epithelium; Rhinovirus infection; viral respiratory tract infection; virus replication,Letter,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85138954098
Devkota H.P.; Paudel K.R.; Hassan M.M.; Dirar A.I.; Das N.; Adhikari-Devkota A.; Echeverría J.; Logesh R.; Jha N.K.; Singh S.K.; Hansbro P.M.; Chan Y.; Chellappan D.K.; Dua K.,"Devkota, Hari Prasad (24775939500); Paudel, Keshav Raj (56539588400); Hassan, Md. Mahadi (57201949982); Dirar, Amina Ibrahim (57189034559); Das, Niranjan (54935333000); Adhikari-Devkota, Anjana (57200393104); Echeverría, Javier (16642183600); Logesh, Rajan (57321157400); Jha, Niraj Kumar (55109018100); Singh, Sachin Kumar (57206711834); Hansbro, Philip M. (6603119390); Chan, Yinghan (57204707263); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",24775939500; 56539588400; 57201949982; 57189034559; 54935333000; 57200393104; 16642183600; 57321157400; 55109018100; 57206711834; 6603119390; 57204707263; 35811890500; 15759138700,Bioactive compounds from zingiber montanum and their pharmacological activities with focus on zerumbone,2021,Applied Sciences (Switzerland),11,21,10205,,,,19,10.3390/app112110205,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118387771&doi=10.3390%2fapp112110205&partnerID=40&md5=52d480b55b79c6c07b81951cda273d4b,"Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo ku, Kumamoto, 862-0973, Japan; School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Department of Chemistry, Iswar Chandra Vidyasagar College, Belonia, Tripura, 799155, India; Departamento de Ciencias del Ambiente, Facultad de Química y Biología, Universidad de Santiago de Chile, Casilla 40, Correo 33, Santiago, 9170022, Chile; TIFAC-CORE in Herbal Drugs, Department of Pharmacognosy and Phytopharmacy, JSS College of Pharmacy (JSS Academy of Higher Education and Research), Ooty Tamil Nadu, 643001, India; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida Uttar Pradesh, 201310, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara Punjab, 144411, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Sydney, 2007, NSW, Australia","Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo ku, Kumamoto, 862-0973, Japan; Paudel K.R., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Hassan M.M., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo ku, Kumamoto, 862-0973, Japan; Dirar A.I., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo ku, Kumamoto, 862-0973, Japan; Das N., Department of Chemistry, Iswar Chandra Vidyasagar College, Belonia, Tripura, 799155, India; Adhikari-Devkota A., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo ku, Kumamoto, 862-0973, Japan; Echeverría J., Departamento de Ciencias del Ambiente, Facultad de Química y Biología, Universidad de Santiago de Chile, Casilla 40, Correo 33, Santiago, 9170022, Chile; Logesh R., TIFAC-CORE in Herbal Drugs, Department of Pharmacognosy and Phytopharmacy, JSS College of Pharmacy (JSS Academy of Higher Education and Research), Ooty Tamil Nadu, 643001, India; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida Uttar Pradesh, 201310, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara Punjab, 144411, India; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Chan Y., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Sydney, 2007, NSW, Australia",Anti-inflammatory; Anticancer; Zerumbone; Zingiber cassumunar; Zingiber montanum,,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85118387771
Gupta M.; Sharma V.; Sharma K.; Kumar A.; Sharma A.; Kazmi I.; Al-Abbasi F.A.; Alzarea S.I.; Afzal O.; Altamimi A.S.A.; Singh S.K.; Gupta G.; Paudel K.R.; Hansbro P.M.; Dua K.,"Gupta, Madhu (57675023400); Sharma, Vikas (57212921166); Sharma, Kalicharan (57202130288); Kumar, Anoop (57211377560); Sharma, Ajay (58689441700); Kazmi, Imran (54796632400); Al-Abbasi, Fahad A. (36338457400); Alzarea, Sami I. (57217185560); Afzal, Obaid (53870994800); Altamimi, Abdulmalik Saleh Alfawaz (57192575796); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57675023400; 57212921166; 57202130288; 57211377560; 58689441700; 54796632400; 36338457400; 57217185560; 53870994800; 57192575796; 57206711834; 15047988400; 56539588400; 6603119390; 15759138700,"A kNGR Peptide-Tethered Lipid–Polymer Hybrid Nanocarrier-Based Synergistic Approach for Effective Tumor Therapy: Development, Characterization, Ex-Vivo, and In-Vivo Assessment",2022,Pharmaceutics,14,7,1401,,,,12,10.3390/pharmaceutics14071401,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133681717&doi=10.3390%2fpharmaceutics14071401&partnerID=40&md5=2004af04737d9ec5e29ba5c55e750146,"Department of Pharmaceutics, Delhi Pharmaceutical Science and Research University, Pushp Vihar Sector-3, MB Road, New Delhi, 110017, India; Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour University (A Central University), Sagar, 470003, India; Divine International Group of Institutions-Pharmacy, Gwalior, 474001, India; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, 72388, Saudi Arabia; Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, 11942, Saudi Arabia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jaipur, 302017, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 602105, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, Australia","Gupta M., Department of Pharmaceutics, Delhi Pharmaceutical Science and Research University, Pushp Vihar Sector-3, MB Road, New Delhi, 110017, India, Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour University (A Central University), Sagar, 470003, India; Sharma V., Divine International Group of Institutions-Pharmacy, Gwalior, 474001, India; Sharma K., Department of Pharmaceutics, Delhi Pharmaceutical Science and Research University, Pushp Vihar Sector-3, MB Road, New Delhi, 110017, India; Kumar A., Department of Pharmaceutics, Delhi Pharmaceutical Science and Research University, Pushp Vihar Sector-3, MB Road, New Delhi, 110017, India; Sharma A., Department of Pharmaceutics, Delhi Pharmaceutical Science and Research University, Pushp Vihar Sector-3, MB Road, New Delhi, 110017, India; Kazmi I., Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; Al-Abbasi F.A., Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; Alzarea S.I., Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, 72388, Saudi Arabia; Afzal O., Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, 11942, Saudi Arabia; Altamimi A.S.A., Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, 11942, Saudi Arabia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, 144411, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jaipur, 302017, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 602105, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Dua K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, Australia",hybrid nanoparticles; intracellular delivery; kNGR peptide; polymer–lipid CD13 receptor; targeted therapy,kNGR peptide; lipid; macrogol; microsomal aminopeptidase; nanocarrier; paclitaxel; phosphatidylcholine; polyglactin; polymer; polypeptide; unclassified drug; animal experiment; animal model; animal tissue; Article; conjugation; controlled study; drug blood level; drug distribution; drug efficacy; drug formulation; drug tissue level; ex vivo study; HT-1080 cell line; human; human cell; IC50; in vivo study; molecularly targeted therapy; mouse; nonhuman; precipitation; proapoptotic activity; solid malignant neoplasm; sustained drug release,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85133681717
Pinkerton J.W.; Kim R.Y.; Brown A.C.; Rae B.E.; Donovan C.; Mayall J.R.; Carroll O.R.; Khadem Ali M.; Scott H.A.; Berthon B.S.; Baines K.J.; Starkey M.R.; Kermani N.Z.; Guo Y.-K.; Robertson A.A.B.; O'Neill L.A.J.; Adcock I.M.; Cooper M.A.; Gibson P.G.; Wood L.G.; Hansbro P.M.; Horvat J.C.,"Pinkerton, James W. (56647761900); Kim, Richard Y. (35810406900); Brown, Alexandra C. (55637745000); Rae, Brittany E. (57336626800); Donovan, Chantal (55357105200); Mayall, Jemma R. (55607222700); Carroll, Olivia R. (57202356826); Khadem Ali, Md. (55820432000); Scott, Hayley A. (7402297708); Berthon, Bronwyn S. (49660949300); Baines, Katherine J. (35078051200); Starkey, Malcolm R. (35811293400); Kermani, Nazanin Z. (57195464650); Guo, Yi-Ke (12765868000); Robertson, Avril A.B. (15519764900); O'Neill, Luke A.J. (7103393094); Adcock, Ian M. (7007066538); Cooper, Matthew A. (7404411451); Gibson, Peter G. (7202414199); Wood, Lisa G. (55859741700); Hansbro, Philip M. (6603119390); Horvat, Jay C. (9942405300)",56647761900; 35810406900; 55637745000; 57336626800; 55357105200; 55607222700; 57202356826; 55820432000; 7402297708; 49660949300; 35078051200; 35811293400; 57195464650; 12765868000; 15519764900; 7103393094; 7007066538; 7404411451; 7202414199; 55859741700; 6603119390; 9942405300,Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma,2022,Journal of Allergy and Clinical Immunology,149,4,,1270,1280,10,34,10.1016/j.jaci.2021.10.003,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119001381&doi=10.1016%2fj.jaci.2021.10.003&partnerID=40&md5=b6e5b0cf2386e25419a8e877799c473c,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Division of Pulmonary and Critical Care Medicine, Stanford University, Calif, Stanford; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia; Priority Research Centre GrowUpWell, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia","Pinkerton J.W., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia, Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Rae B.E., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Mayall J.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Carroll O.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Khadem Ali M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia, Division of Pulmonary and Critical Care Medicine, Stanford University, Calif, Stanford; Scott H.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Berthon B.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Baines K.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia, Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia, Priority Research Centre GrowUpWell, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Kermani N.Z., Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; Guo Y.-K., Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; Robertson A.A.B., School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia; O'Neill L.A.J., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Adcock I.M., Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Cooper M.A., Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia; Gibson P.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia",Asthma; IL-13; IL-5; NLRP3 inflammasomes; obesity,"Asthma; Cytokines; Humans; Inflammasomes; Inflammation; Interleukin-13; Interleukin-1beta; Interleukin-5; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; bronchodilating agent; chemokine receptor CCR3; corticosteroid; cryopyrin; cytokine; cytokine receptor antagonist; dexamethasone; inflammasome; interleukin 13; interleukin 13 antibody; interleukin 1beta; interleukin 5; interleukin 5 antibody; mcc950; ovalbumin; type 2 cytokine; unclassified drug; cryopyrin; cytokine; inflammasome; interleukin 13; interleukin 1beta; interleukin 5; adult; animal experiment; animal model; Article; asthma; body mass; cell count; clinical article; cytokine response; diet therapy; diet-induced obesity; disease severity; eosinophil count; experimental asthma; gene expression; human; mouse; nonhuman; pathogenesis; prick test; protein expression; respiratory tract allergy; respiratory tract inflammation; reverse transcription; RNA extraction; spirometry; sputum induction; asthma; complication; inflammation; metabolism; obesity",Article,Final,,Scopus,2-s2.0-85119001381
Kuchibhotla V.N.S.; Starkey M.R.; Reid A.T.; Heijink I.H.; Nawijn M.C.; Hansbro P.M.; Knight D.A.,"Kuchibhotla, Virinchi N. S. (57203802307); Starkey, Malcolm R. (35811293400); Reid, Andrew T. (39561518600); Heijink, Irene H. (8593569200); Nawijn, Martijn C. (6506545287); Hansbro, Philip M. (6603119390); Knight, Darryl A. (7402350036)",57203802307; 35811293400; 39561518600; 8593569200; 6506545287; 6603119390; 7402350036,Inhibition of β-Catenin/CREB Binding Protein Signaling Attenuates House Dust Mite-Induced Goblet Cell Metaplasia in Mice,2021,Frontiers in Physiology,12,,690531,,,,1,10.3389/fphys.2021.690531,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112227348&doi=10.3389%2ffphys.2021.690531&partnerID=40&md5=2b3f57e5b2b93dd8b33cf7a62fc699ac,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; GRIAC Research Institute, University Medical Center Groningen, Groningen, Netherlands; Department of Pathology and Medical Biology, Laboratory of Experimental Pulmonology and Inflammation Research, University of Groningen, Groningen, Netherlands; Priority Research Centre GrowUpWell and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Newcastle, NSW, Australia; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia; Department of Pulmonology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Providence Health Care Research Institute, Vancouver, BC, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, BC, Canada","Kuchibhotla V.N.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, GRIAC Research Institute, University Medical Center Groningen, Groningen, Netherlands, Department of Pathology and Medical Biology, Laboratory of Experimental Pulmonology and Inflammation Research, University of Groningen, Groningen, Netherlands; Starkey M.R., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre GrowUpWell and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Newcastle, NSW, Australia, Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Reid A.T., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia; Heijink I.H., GRIAC Research Institute, University Medical Center Groningen, Groningen, Netherlands, Department of Pathology and Medical Biology, Laboratory of Experimental Pulmonology and Inflammation Research, University of Groningen, Groningen, Netherlands, Department of Pulmonology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; Nawijn M.C., GRIAC Research Institute, University Medical Center Groningen, Groningen, Netherlands, Department of Pathology and Medical Biology, Laboratory of Experimental Pulmonology and Inflammation Research, University of Groningen, Groningen, Netherlands; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Knight D.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Providence Health Care Research Institute, Vancouver, BC, Canada, Department of Anesthesiology, Pharmacology and Therapeutics, The University of British Columbia, Vancouver, BC, Canada",airway inflammation; asthma; goblet cell metaplasia; ICG-001; β-catenin,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85112227348
Kim R.Y.; Oliver B.G.; Wark P.A.B.; Hansbro P.M.; Donovan C.,"Kim, Richard Y (35810406900); Oliver, Brian G (15919869900); Wark, Peter A B (7003559516); Hansbro, Philip M (6603119390); Donovan, Chantal (55357105200)",35810406900; 15919869900; 7003559516; 6603119390; 55357105200,COPD exacerbations: targeting IL-33 as a new therapy,2021,The Lancet Respiratory Medicine,9,11,,1213,1214,1,11,10.1016/S2213-2600(21)00182-X,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118481271&doi=10.1016%2fS2213-2600%2821%2900182-X&partnerID=40&md5=01d450d8343b64ae31f11a989a8aa522,"Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia; Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia","Kim R.Y., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Wark P.A.B., Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Donovan C., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia",,"Humans; Interleukin-33; Pulmonary Disease, Chronic Obstructive; Sputum; antibiotic agent; corticosteroid; dupilumab; interleukin 1 receptor like 1 protein; interleukin 33; itepekimab; long acting drug; mepolizumab; muscarinic receptor blocking agent; placebo; interleukin 33; allele; antibiotic therapy; asthma; bioavailability; chronic bronchitis; chronic obstructive lung disease; clinical outcome; confounding variable; disease association; disease exacerbation; disease severity; drug effect; drug efficacy; eosinophil count; ex-smoker; forced expiratory volume; gain of function mutation; gene function; gene mutation; gene targeting; genetic analysis; genetic association; genetic risk; genetic variation; human; IL 33 gene; IL1RL1 gene; loss of function mutation; Note; pathogenesis; practice guideline; risk factor; sputum",Note,Final,,Scopus,2-s2.0-85118481271
Jha S.K.; Imran M.; Paudel K.R.; Mohammed Y.; Hansbro P.; Dua K.,"Jha, Saurav Kumar (57210712565); Imran, Mohammad (57209466043); Paudel, Keshav Raj (56539588400); Mohammed, Yousuf (56116912300); Hansbro, Philip (6603119390); Dua, Kamal (15759138700)",57210712565; 57209466043; 56539588400; 56116912300; 6603119390; 15759138700,Treating primary lymphoma of the brain in AIDS patients via multifunctional oral nanoparticulate systems,2022,Nanomedicine,17,7,,425,429,4,8,10.2217/nnm-2021-0444,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125683107&doi=10.2217%2fnnm-2021-0444&partnerID=40&md5=1ef90b0a10b0720238aff7184be45971,"Department of Biomedicine, Health and Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam, 58554, South Korea; Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Centre of Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, 2007, NSW, Australia; Therapeutics Research Group, University of Queensland Diamantina Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, QLD, Australia; Discipline of Pharmacy, School of Health, University of Technology, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia","Jha S.K., Department of Biomedicine, Health and Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam, 58554, South Korea; Imran M., Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, 2007, NSW, Australia; Mohammed Y., Therapeutics Research Group, University of Queensland Diamantina Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, QLD, Australia; Hansbro P., Centre of Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, School of Health, University of Technology, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia",AIDS; bioavailability; brain targeting; chemotherapy; drug delivery; metronomic chemotherapy; oral nanoparticles; primary central nervous system lymphoma,"Acquired Immunodeficiency Syndrome; Administration, Oral; Brain; Drug Delivery Systems; Humans; Lymphoma; Nanoparticles; biotin; cell penetrating peptide; chitosan nanoparticle; cyclophosphamide; cytarabine; deoxycholic acid; diethylene glycol monoethyl ether; doxycycline; etoposide; hydrogel; idelalisib; maleimide; methotrexate; monoclonal antibody; monoclonal antibody MRK 16; monoclonal antibody UIC2; nanoparticle; polylactic acid; polymer; polysorbate 80; prednisone; procarbazine; rivastigmine; temozolomide; temsirolimus; unclassified drug; acquired immune deficiency syndrome; blood brain barrier; cancer chemotherapy; cancer patient; cancer recurrence; cancer regression; cancer survival; central nervous system; drug delivery system; drug formulation; drug targeting; human; maximum tolerated dose; nanoemulsion; nonhuman; overall survival; primary central nervous system lymphoma; Review; acquired immune deficiency syndrome; brain; complication; diagnostic imaging; drug delivery system; lymphoma; oral drug administration",Review,Final,,Scopus,2-s2.0-85125683107
Nucera F.; Caramori G.; Hansbro P.M.; Paudel K.R.; Casolaro V.; Appanna R.; Kirkham P.; Adcock I.M.,"Nucera, Francesco (57202946185); Caramori, Gaetano (7003847659); Hansbro, Phil M. (6603119390); Paudel, Keshav Raj (56539588400); Casolaro, Vincenzo (7003526446); Appanna, Ramapraba (22733797400); Kirkham, Paul (7003632920); Adcock, Ian M. (7007066538)",57202946185; 7003847659; 6603119390; 56539588400; 7003526446; 22733797400; 7003632920; 7007066538,Role of autoimmunity in the pathogenesis of chronic obstructive pulmonary disease and pulmonary emphysema,2022,Translational Autoimmunity: Autoimmune Disease Associated with Different Clinical Features,,,,311,331,20,8,10.1016/B978-0-323-85415-3.00003-9,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137903817&doi=10.1016%2fB978-0-323-85415-3.00003-9&partnerID=40&md5=75720034d1a6634a22863dca0de3779b,"Department of Biomedical Sciences, Dentistry and Morphological and Functional Imaging (BIOMORF), University of Messina, Messina, Italy; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, Salerno, Italy; Department of Biomedical Sciences and Physiology, School of Medicine, University of Wolverhampton, Wolverhampton, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom","Nucera F., Department of Biomedical Sciences, Dentistry and Morphological and Functional Imaging (BIOMORF), University of Messina, Messina, Italy; Caramori G., Department of Biomedical Sciences, Dentistry and Morphological and Functional Imaging (BIOMORF), University of Messina, Messina, Italy; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Casolaro V., Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, Salerno, Italy; Appanna R., Department of Medicine, Surgery and Dentistry ""Scuola Medica Salernitana"", University of Salerno, Salerno, Italy; Kirkham P., Department of Biomedical Sciences and Physiology, School of Medicine, University of Wolverhampton, Wolverhampton, United Kingdom; Adcock I.M., National Heart and Lung Institute, Imperial College London, London, United Kingdom",ADCC; Autoantibody; Autoimmunity; BALT; mAbs,,Book chapter,Final,,Scopus,2-s2.0-85137903817
Tiotiu A.; Badi Y.; Kermani N.Z.; Sanak M.; Kolmert J.; Wheelock C.E.; Hansbro P.M.; Dahlén S.-E.; Sterk P.J.; Djukanovic R.; Guo Y.; Mumby S.; Adcock I.M.; Chung K.F.; Hoda U.; Rossios C.; Bel E.; Rao N.; Myles D.; Compton C.; Van Geest M.; Howarth P.; Roberts G.; Lefaudeux D.; De Meulder B.; Bansal A.T.; Knowles R.; Erzen D.; Wagers S.; Krug N.; Higenbottam T.; Matthews J.; Erpenbeek V.; Carayannopoulos L.; Roberts A.; Supple D.; deBoer P.; Caruso M.; Chanez P.; Horváth I.; Musial J.; Sandström T.,"Tiotiu, Angelica (23499586600); Badi, Yusef (56275233300); Kermani, Nazanin Zounemat (57195464650); Sanak, Marek (7004497201); Kolmert, Johan (23985326600); Wheelock, Craig E. (6602142864); Hansbro, Philip M. (6603119390); Dahlén, Sven-Erik (7006190330); Sterk, Peter J. (7102794272); Djukanovic, Ratko (57210653671); Guo, Yike (12765868000); Mumby, Sharon (7005804196); Adcock, Ian M. (7007066538); Chung, Kian Fan (35403525000); Hoda, Uruj (55902643200); Rossios, Christos (16204205900); Bel, Elisabeth (7003406795); Rao, Navin (56574651000); Myles, David (56950231700); Compton, Chris (7102214061); Van Geest, Marleen (57191635532); Howarth, Peter (7103350375); Roberts, Graham (14047151700); Lefaudeux, Diane (57191863756); De Meulder, Bertrand (35621479600); Bansal, Aruna T. (8583470200); Knowles, Richard (7102146954); Erzen, Damijn (6602770213); Wagers, Scott (6602151433); Krug, Norbert (36618807500); Higenbottam, Tim (7102854255); Matthews, John (57210505325); Erpenbeek, Veit (57221390076); Carayannopoulos, Leon (35582328200); Roberts, Amanda (57213416490); Supple, David (56741231100); deBoer, Pim (57221391415); Caruso, Massimo (57221255824); Chanez, Pascal (7102979861); Horváth, Ildikó (7202508959); Musial, Jacek (7005200528); Sandström, Thomas (7005947478)",23499586600; 56275233300; 57195464650; 7004497201; 23985326600; 6602142864; 6603119390; 7006190330; 7102794272; 57210653671; 12765868000; 7005804196; 7007066538; 35403525000; 55902643200; 16204205900; 7003406795; 56574651000; 56950231700; 7102214061; 57191635532; 7103350375; 14047151700; 57191863756; 35621479600; 8583470200; 7102146954; 6602770213; 6602151433; 36618807500; 7102854255; 57210505325; 57221390076; 35582328200; 57213416490; 56741231100; 57221391415; 57221255824; 7102979861; 7202508959; 7005200528; 7005947478,Association of Differential Mast Cell Activation with Granulocytic Inflammation in Severe Asthma,2022,American Journal of Respiratory and Critical Care Medicine,205,4,,397,411,14,42,10.1164/rccm.202102-0355OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124633452&doi=10.1164%2frccm.202102-0355OC&partnerID=40&md5=13c89463cf79e8e2e4e689640b54fd4f,"National Heart and Lung Institute, Department of Computing, Imperial College London, London, United Kingdom; Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; Department of Pulmonology, University Hospital of Nancy, Nancy, France; Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland; The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden; Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia; Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands; Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Airways Disease, National Heart and Lung Institute, Imperial College London, United Kingdom; Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, United Kingdom; Faculty of Medicine, University of Amsterdam, Amsterdam, Netherlands; Janssen Research and Development, Buckinghamshire, High Wycombe, United Kingdom; Respiratory Therapy Area Unit, GlaxoSmithKline, Stockley Park, United Kingdom; Discovery Medicine, GlaxoSmithKline, Stockley Park, United Kingdom; AstraZeneca R&D, Molndal, Sweden; Faculty of Medicine, Southampton University, Southampton, United Kingdom; NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, United Kingdom; European Institute for Systems Biology and Medicine, CNRS-ENSUCBL, Université de Lyon, Lyon, France; Acclarogen Ltd., St John's Innovation Centre, Cambridge, United Kingdom; Knowles Consulting, Stevenage Bioscience Catalyst, Stevenage, United Kingdom; Boehringer Ingelheim Pharma, Ingelheim am Rhein, Germany; BioSci Consulting, Maasmechelen, Belgium; Immunology, Allergology and Clinical Inhalation, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany; Corporate Clinical Development, Chiesi Pharmaceutics Ltd., Cheadle, United Kingdom; Genentech Inc., South San Francisco, CA, United States; Translational Medicine - Respiratory Profiling, Novartis Institutes for BioMedical Research, Basel, Switzerland; Merck Inc., Kenilworth, NJ, United States; U-BIOPRED Patient Input Platform, ELF, Sheffield, United Kingdom; Department of Clinical and Experimental Medicine Hospital University, University of Catania, Catania, Italy; Département des Maladies Respiratoires, Laboratoire d'Immunologie, Aix Marseille Université, Marseille, France; The Centre for Allergy Research, The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden; Department of Pulmonology, Semmelweis University, Budapest, Hungary; Department of Medicine, Jagiellonian University Medical College, Krakow, Poland; Department of Medicine, Respiratory and Allergy Unit, University Hospital, Umeå, Sweden","Tiotiu A., National Heart and Lung Institute, Department of Computing, Imperial College London, London, United Kingdom, Department of Pulmonology, University Hospital of Nancy, Nancy, France; Badi Y., National Heart and Lung Institute, Department of Computing, Imperial College London, London, United Kingdom, Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; Kermani N.Z., Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; Sanak M., Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland; Kolmert J., The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden, Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden; Wheelock C.E., Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia; Dahlén S.-E., The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden, Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden, The Centre for Allergy Research, The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden; Sterk P.J., Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands; Djukanovic R., Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Guo Y., Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; Mumby S., National Heart and Lung Institute, Department of Computing, Imperial College London, London, United Kingdom; Adcock I.M., National Heart and Lung Institute, Department of Computing, Imperial College London, London, United Kingdom, Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; Chung K.F., National Heart and Lung Institute, Department of Computing, Imperial College London, London, United Kingdom, Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; Hoda U., Airways Disease, National Heart and Lung Institute, Imperial College London, United Kingdom, Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, United Kingdom; Rossios C., Airways Disease, National Heart and Lung Institute, Imperial College London, United Kingdom, Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, United Kingdom; Bel E., Faculty of Medicine, University of Amsterdam, Amsterdam, Netherlands; Rao N., Janssen Research and Development, Buckinghamshire, High Wycombe, United Kingdom; Myles D., Respiratory Therapy Area Unit, GlaxoSmithKline, Stockley Park, United Kingdom; Compton C., Discovery Medicine, GlaxoSmithKline, Stockley Park, United Kingdom; Van Geest M., AstraZeneca R&D, Molndal, Sweden; Howarth P., Faculty of Medicine, Southampton University, Southampton, United Kingdom, NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, United Kingdom; Roberts G., Faculty of Medicine, Southampton University, Southampton, United Kingdom, NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, United Kingdom; Lefaudeux D., European Institute for Systems Biology and Medicine, CNRS-ENSUCBL, Université de Lyon, Lyon, France; De Meulder B., European Institute for Systems Biology and Medicine, CNRS-ENSUCBL, Université de Lyon, Lyon, France; Bansal A.T., Acclarogen Ltd., St John's Innovation Centre, Cambridge, United Kingdom; Knowles R., Knowles Consulting, Stevenage Bioscience Catalyst, Stevenage, United Kingdom; Erzen D., Boehringer Ingelheim Pharma, Ingelheim am Rhein, Germany; Wagers S., BioSci Consulting, Maasmechelen, Belgium; Krug N., Immunology, Allergology and Clinical Inhalation, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany; Higenbottam T., Corporate Clinical Development, Chiesi Pharmaceutics Ltd., Cheadle, United Kingdom; Matthews J., Genentech Inc., South San Francisco, CA, United States; Erpenbeek V., Translational Medicine - Respiratory Profiling, Novartis Institutes for BioMedical Research, Basel, Switzerland; Carayannopoulos L., Merck Inc., Kenilworth, NJ, United States; Roberts A., U-BIOPRED Patient Input Platform, ELF, Sheffield, United Kingdom; Supple D., U-BIOPRED Patient Input Platform, ELF, Sheffield, United Kingdom; deBoer P., U-BIOPRED Patient Input Platform, ELF, Sheffield, United Kingdom; Caruso M., Department of Clinical and Experimental Medicine Hospital University, University of Catania, Catania, Italy; Chanez P., Département des Maladies Respiratoires, Laboratoire d'Immunologie, Aix Marseille Université, Marseille, France; Horváth I., Department of Pulmonology, Semmelweis University, Budapest, Hungary; Musial J., Department of Medicine, Jagiellonian University Medical College, Krakow, Poland; Sandström T., Department of Medicine, Respiratory and Allergy Unit, University Hospital, Umeå, Sweden",Eosinophils; IgE-FceRI; IL-33; Mast cell; Neutrophils,Adult; Aged; Asthma; Biomarkers; Case-Control Studies; Cohort Studies; Female; Granulocytes; Humans; Inflammation; Male; Mast Cells; Middle Aged; Patient Acuity; Phenotype; Sputum; Transcriptome; Fc epsilon receptor 1; gamma interferon; immunoglobulin E receptor; immunoglobulin enhancer binding protein; interleukin 1beta; interleukin 33; lipopolysaccharide; tumor necrosis factor; unclassified drug; biological marker; transcriptome; adult; antibody directed enzyme prodrug therapy; Article; bronchus biopsy; cell activation; cell stimulation; cohort analysis; controlled study; disease severity; eosinophilic asthma; female; gene set variation analysis; granulocyte; human; human cell; inflammation; interleukin signaling; major clinical study; male; mast cell; middle aged; neutrophil; NF kB signaling; phenotype; severe asthma; sputum analysis; sputum induction; TNF signaling; transcriptomics; virus infection; aged; asthma; case control study; genetics; granulocyte; immunology; inflammation; mast cell; metabolism; patient acuity; sputum,Article,Final,,Scopus,2-s2.0-85124633452
Hortle E.; Tran V.L.T.; Wright K.; Fontaine A.R.M.; Pinello N.; O’Rourke M.B.; Wong J.J.-L.; Hansbro P.M.; Britton W.J.; Oehlers S.H.,"Hortle, Elinor (57204193930); Tran, Vi L.T. (57222017545); Wright, Kathryn (58462129200); Fontaine, Angela R.M. (57224131948); Pinello, Natalia (55813012000); O’Rourke, Matthew B. (56735635000); Wong, Justin J.-L. (57216148735); Hansbro, Philip M. (6603119390); Britton, Warwick J. (7102477888); Oehlers, Stefan H. (35811120600)",57204193930; 57222017545; 58462129200; 57224131948; 55813012000; 56735635000; 57216148735; 6603119390; 7102477888; 35811120600,OXSR1 inhibits inflammasome activation by limiting potassium efflux during mycobacterial infection,2022,Life Science Alliance,5,9,e202201476,,,,4,10.26508/lsa.202201476,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129960350&doi=10.26508%2flsa.202201476&partnerID=40&md5=ba9a8f197ee5b2b7c8f3cdfd72ffd6a7,"Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, Australia; The University of Sydney, Discipline of Infectious Diseases and Immunology, Sydney Institute for Infectious Diseases, Camperdown, Australia; Centre for Inflammation, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Centenary Imaging and Sydney Cytometry, The Centenary Institute, The University of Sydney, Camperdown, Australia; Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, Australia; The University of Sydney, Faculty of Medicine and Health, Camperdown, Australia; Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, Australia; A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore","Hortle E., Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, Australia, The University of Sydney, Discipline of Infectious Diseases and Immunology, Sydney Institute for Infectious Diseases, Camperdown, Australia, Centre for Inflammation, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Tran V.L.T., Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, Australia; Wright K., Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, Australia; Fontaine A.R.M., Centenary Imaging and Sydney Cytometry, The Centenary Institute, The University of Sydney, Camperdown, Australia; Pinello N., Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, Australia, The University of Sydney, Faculty of Medicine and Health, Camperdown, Australia; O’Rourke M.B., Centre for Inflammation, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Wong J.J.-L., Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, Australia, The University of Sydney, Faculty of Medicine and Health, Camperdown, Australia; Hansbro P.M., Centre for Inflammation, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Britton W.J., Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, Australia, Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, Australia; Oehlers S.H., Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, Australia, The University of Sydney, Discipline of Infectious Diseases and Immunology, Sydney Institute for Infectious Diseases, Camperdown, Australia, A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore",,"Animals; Inflammasomes; Mycobacterium; NLR Family, Pyrin Domain-Containing 3 Protein; Potassium; Signal Transduction; Zebrafish; cryopyrin; inflammasome; potassium; animal; genetics; metabolism; Mycobacterium; signal transduction; zebra fish",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85129960350
Paudel K.R.; Wadhwa R.; Tew X.N.; Lau N.J.X.; Madheswaran T.; Panneerselvam J.; Zeeshan F.; Kumar P.; Gupta G.; Anand K.; Singh S.K.; Jha N.K.; MacLoughlin R.; Hansbro N.G.; Liu G.; Shukla S.D.; Mehta M.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Paudel, Keshav Raj (56539588400); Wadhwa, Ridhima (57159091700); Tew, Xin Nee (57214071502); Lau, Natalie Jia Xin (57222656519); Madheswaran, Thiagarajan (55505311000); Panneerselvam, Jithendra (57201993010); Zeeshan, Farrukh (26654611200); Kumar, Pradeep (7403960277); Gupta, Gaurav (15047988400); Anand, Krishnan (57488883300); Singh, Sachin K. (57206711834); Jha, Niraj Kumar (55109018100); MacLoughlin, Ronan (57212263206); Hansbro, Nicole G. (15055862300); Liu, Gang (57189061134); Shukla, Shakti D. (56367620800); Mehta, Meenu (7203024234); Hansbro, Philip M. (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",56539588400; 57159091700; 57214071502; 57222656519; 55505311000; 57201993010; 26654611200; 7403960277; 15047988400; 57488883300; 57206711834; 55109018100; 57212263206; 15055862300; 57189061134; 56367620800; 7203024234; 6603119390; 35811890500; 15759138700,Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro,2021,Life Sciences,276,,119436,,,,73,10.1016/j.lfs.2021.119436,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103636592&doi=10.1016%2fj.lfs.2021.119436&partnerID=40&md5=c23767de3a401951169a48f66bc7c9ca,"School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, 302017, India; Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences and National Health Laboratory Service, University of the Free State, Bloemfontein, South Africa; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34, Knowledge Park III, Greater Noida, 201310, Uttar Pradesh, India; Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Paudel K.R., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Wadhwa R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Tew X.N., School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Lau N.J.X., School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Zeeshan F., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Kumar P., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, 302017, India; Anand K., Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences and National Health Laboratory Service, University of the Free State, Bloemfontein, South Africa; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Plot No. 32-34, Knowledge Park III, Greater Noida, 201310, Uttar Pradesh, India; MacLoughlin R., Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Hansbro N.G., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Liu G., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Shukla S.D., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Mehta M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia",Liquid crystalline nanoparticles; Lung cancer; Migration; Proliferation; Rutin,"A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Humans; Liquid Crystals; Lung Neoplasms; Nanoparticles; Rutin; glycerol oleate; liquid crystalline nanoparticle; nanoparticle; rutoside; unclassified drug; nanoparticle; rutoside; A-549 cell line; antineoplastic activity; antiproliferative activity; Article; cell migration; cell proliferation; colony formation; controlled study; drug structure; human; human cell; in vitro study; MTT assay; non small cell lung cancer; trypan blue assay; apoptosis; cell motion; cell proliferation; chemistry; liquid crystal; lung tumor; non small cell lung cancer; pathology",Article,Final,,Scopus,2-s2.0-85103636592
Runtsch M.C.; Angiari S.; Hooftman A.; Wadhwa R.; Zhang Y.; Zheng Y.; Spina J.S.; Ruzek M.C.; Argiriadi M.A.; McGettrick A.F.; Mendez R.S.; Zotta A.; Peace C.G.; Walsh A.; Chirillo R.; Hams E.; Fallon P.G.; Jayamaran R.; Dua K.; Brown A.C.; Kim R.Y.; Horvat J.C.; Hansbro P.M.; Wang C.; O'Neill L.A.J.,"Runtsch, Marah C. (55539310400); Angiari, Stefano (25649000600); Hooftman, Alexander (57209197802); Wadhwa, Ridhima (57159091700); Zhang, Yanling (55898032700); Zheng, Yunan (57467625000); Spina, Joseph S. (57191280886); Ruzek, Melanie C. (59026057200); Argiriadi, Maria A. (6507087358); McGettrick, Anne F. (6701336634); Mendez, Rui Santalla (57466907800); Zotta, Alessia (57211206269); Peace, Christian G. (57416409900); Walsh, Aoife (57466907900); Chirillo, Roberta (57201158140); Hams, Emily (24576674000); Fallon, Padraic G. (7102455344); Jayamaran, Ranjith (57466618400); Dua, Kamal (15759138700); Brown, Alexandra C. (55637745000); Kim, Richard Y. (35810406900); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Wang, Chu (37035300200); O'Neill, Luke A.J. (7103393094)",55539310400; 25649000600; 57209197802; 57159091700; 55898032700; 57467625000; 57191280886; 59026057200; 6507087358; 6701336634; 57466907800; 57211206269; 57416409900; 57466907900; 57201158140; 24576674000; 7102455344; 57466618400; 15759138700; 55637745000; 35810406900; 9942405300; 6603119390; 37035300200; 7103393094,Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages,2022,Cell Metabolism,34,3,,487,501.e8,,157,10.1016/j.cmet.2022.02.002,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125277972&doi=10.1016%2fj.cmet.2022.02.002&partnerID=40&md5=903d2bfa2a408186e869357766f2221b,"School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, 100871, China; Drug Discovery Science & Technology, AbbVie Inc., 1 North Waukegon Road, North Chicago, 60064, IL, United States; AbbVie, Bio Research Center, 100 Research Drive, Worcester, 01608, MA, United States; Department of Experimental and Clinical Medicine, “Magna Græcia” University of Catanzaro, Catanzaro, Italy; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia","Runtsch M.C., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Angiari S., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Hooftman A., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Wadhwa R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Zhang Y., Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, 100871, China; Zheng Y., Drug Discovery Science & Technology, AbbVie Inc., 1 North Waukegon Road, North Chicago, 60064, IL, United States; Spina J.S., AbbVie, Bio Research Center, 100 Research Drive, Worcester, 01608, MA, United States; Ruzek M.C., AbbVie, Bio Research Center, 100 Research Drive, Worcester, 01608, MA, United States; Argiriadi M.A., AbbVie, Bio Research Center, 100 Research Drive, Worcester, 01608, MA, United States; McGettrick A.F., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Mendez R.S., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Zotta A., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Peace C.G., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Walsh A., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Chirillo R., Department of Experimental and Clinical Medicine, “Magna Græcia” University of Catanzaro, Catanzaro, Italy; Hams E., School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Fallon P.G., School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland; Jayamaran R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Kim R.Y., School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Wang C., Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, 100871, China; O'Neill L.A.J., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152–160 Pearse Street, Dublin, D02 R590, Ireland",immunometabolism; itaconate; Jak-STAT; Krebs cycle; M2 macrophage; macrophages,Janus Kinase 1; Macrophage Activation; Macrophages; Signal Transduction; Succinates; 4 octyl itaconate; beta interferon; cysteine; gamma interferon; interleukin 13; interleukin 4; itaconic acid; Janus kinase 1; Janus kinase 1 inhibitor; messenger RNA; ruxolitinib; STAT6 protein; staurosporine; tofacitinib; transcription factor Nrf2; unclassified drug; itaconic acid; Janus kinase 1; succinic acid derivative; animal cell; animal tissue; Article; bone marrow derived macrophage; bronchoalveolar lavage fluid; citric acid cycle; comparative study; controlled study; cytokine signaling; enzyme activity; enzyme inhibition; female; flow cytometry; fluorescence intensity; gene expression; glycolysis; HEK293T cell line; human; human cell; IL 4 signaling; immunoprecipitation; in vitro study; in vivo study; liquid chromatography-mass spectrometry; lung parenchyma; M2 macrophage; macrophage activation; mRNA expression level; nonhuman; oxygen consumption rate; peripheral blood mononuclear cell; protein phosphorylation; Th2 cell; macrophage; metabolism; signal transduction,Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85125277972
Paudel K.R.; Chellappan D.K.; MacLoughlin R.; Pinto T.D.J.A.; Dua K.; Hansbro P.M.,"Paudel, Keshav Raj (56539588400); Chellappan, Dinesh Kumar (35811890500); MacLoughlin, Ronan (57212263206); Pinto, Terezinha de Jesus Andreoli (7003263019); Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390)",56539588400; 35811890500; 57212263206; 7003263019; 15759138700; 6603119390,Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases,2022,Frontiers in Medicine,9,,983583,,,,4,10.3389/fmed.2022.983583,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136588587&doi=10.3389%2ffmed.2022.983583&partnerID=40&md5=76a602bf0b411fd19afe2beb17f9902d,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, NSW, Sydney, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, SGR, Kuala Lumpur, Malaysia; Research and Development, Science and Emerging Technologies, Aerogen Limited, Galway Business Park, Galway, Ireland; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland; School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Sydney, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, NSW, Ultimo, Australia","Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, NSW, Sydney, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, SGR, Kuala Lumpur, Malaysia; MacLoughlin R., Research and Development, Science and Emerging Technologies, Aerogen Limited, Galway Business Park, Galway, Ireland, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland, School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland; Pinto T.D.J.A., Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Sydney, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, NSW, Ultimo, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, NSW, Sydney, Australia",chronic respiratory disease; drug delivery; drug discovery; pulmonary medicine; therapeutic delivery,,Editorial,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85136588587
Barnes J.L.; Plank M.W.; Asquith K.; Maltby S.; Sabino L.R.; Kaiko G.E.; Lochrin A.; Horvat J.C.; Mayall J.R.; Kim R.Y.; Hansbro P.M.; Keely S.; Belz G.T.; Tay H.L.; Foster P.S.,"Barnes, Jessica L. (57193562267); Plank, Maximilian W. (23486258000); Asquith, Kelly (6507212626); Maltby, Steven (6507446799); Sabino, Lorena R. (57224217191); Kaiko, Gerard E. (21739529400); Lochrin, Alyssa (57196031173); Horvat, Jay C. (9942405300); Mayall, Jemma R. (55607222700); Kim, Richard Y. (35810406900); Hansbro, Philip M. (6603119390); Keely, Simon (9739611200); Belz, Gabrielle T. (7102682937); Tay, Hock L. (55639898100); Foster, Paul S. (7201517569)",57193562267; 23486258000; 6507212626; 6507446799; 57224217191; 21739529400; 57196031173; 9942405300; 55607222700; 35810406900; 6603119390; 9739611200; 7102682937; 55639898100; 7201517569,T-helper 22 cells develop as a distinct lineage from Th17 cells during bacterial infection and phenotypic stability is regulated by T-bet,2021,Mucosal Immunology,14,5,,1077,1087,10,14,10.1038/s41385-021-00414-6,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107272467&doi=10.1038%2fs41385-021-00414-6&partnerID=40&md5=483a0ac77bce34f7b2aa26388fd6ec15,"Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Medical Directorate, GSK, Abbotsford, VIC, Australia; Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Digestive Health and Neurogastroenterology, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia; The Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville, Melbourne, VIC, Australia; The University of Queensland Diamantina Institute, University of Queensland, Woolloongabba, QLD, Australia","Barnes J.L., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Plank M.W., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Medical Directorate, GSK, Abbotsford, VIC, Australia; Asquith K., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Maltby S., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Sabino L.R., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Kaiko G.E., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Lochrin A., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Mayall J.R., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Kim R.Y., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Keely S., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia; Belz G.T., The Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, Melbourne, VIC, Australia, The University of Queensland Diamantina Institute, University of Queensland, Woolloongabba, QLD, Australia; Tay H.L., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia",,"Animals; Bacterial Infections; Cell Differentiation; Disease Models, Animal; Disease Susceptibility; Gene Expression Regulation; Host-Pathogen Interactions; Immunophenotyping; Interleukin-17; Interleukins; Mice; Mice, Knockout; Mice, Transgenic; T-Box Domain Proteins; T-Lymphocyte Subsets; Th17 Cells; interleukin 17; interleukin 22; interleukin derivative; interleukin-22; T box transcription factor; T-box transcription factor TBX21; adoptive transfer; adult; animal cell; animal experiment; animal model; Article; bacterial infection; C57BL 6 mouse; CD4+ T lymphocyte; cell culture; cell differentiation assay; cell separation; controlled study; enzyme linked immunosorbent assay; ex vivo study; female; flow cytometry; inflammation; male; mouse; nonhuman; phenotype; randomized controlled trial; real time polymerase chain reaction; spleen cell; Th17 cell; Th22 cell; wild type; animal; bacterial infection; biosynthesis; cell differentiation; cytology; disease model; disease predisposition; gene expression regulation; genetics; host pathogen interaction; immunology; immunophenotyping; knockout mouse; metabolism; physiology; T lymphocyte subpopulation; Th17 cell; transgenic mouse",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85107272467
Ramanunny A.K.; Wadhwa S.; Kumar Singh S.; Kumar B.; Gulati M.; Kumar A.; Almawash S.; Al Saqr A.; Gowthamarajan K.; Dua K.; Singh H.; Vishwas S.; Khursheed R.; Rahana Parveen S.; Venkatesan A.; Paudel K.R.; Hansbro P.M.; Kumar Chellappan D.,"Ramanunny, Arya Kadukkattil (57210970124); Wadhwa, Sheetu (55575798400); Kumar Singh, Sachin (57206711834); Kumar, Bimlesh (55493533700); Gulati, Monica (7006677671); Kumar, Ankit (56585359200); Almawash, Saud (57195565335); Al Saqr, Ahmed (57217130302); Gowthamarajan, Kuppusamy (8452710300); Dua, Kamal (15759138700); Singh, Harpreet (58716695200); Vishwas, Sukriti (57216932631); Khursheed, Rubiya (57203173043); Rahana Parveen, Shaik (57765595700); Venkatesan, Aravindhanathan (57214897681); Paudel, Keshav Raj (56539588400); Hansbro, Philip M (6603119390); Kumar Chellappan, Dinesh (35811890500)",57210970124; 55575798400; 57206711834; 55493533700; 7006677671; 56585359200; 57195565335; 57217130302; 8452710300; 15759138700; 58716695200; 57216932631; 57203173043; 57765595700; 57214897681; 56539588400; 6603119390; 35811890500,Topical non-aqueous nanoemulsion of Alpinia galanga extract for effective treatment in psoriasis: In vitro and in vivo evaluation,2022,International Journal of Pharmaceutics,624,,121882,,,,18,10.1016/j.ijpharm.2022.121882,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132883428&doi=10.1016%2fj.ijpharm.2022.121882&partnerID=40&md5=cfc95a9dd09ae142a55534282c53a5e8,"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia; Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj, 11942, Saudi Arabia; Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, India; Lovely Faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Ramanunny A.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Wadhwa S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Kumar Singh S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Kumar B., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Kumar A., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Almawash S., Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia; Al Saqr A., Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj, 11942, Saudi Arabia; Gowthamarajan K., Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, India; Dua K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh H., Lovely Faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Vishwas S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Khursheed R., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Rahana Parveen S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Venkatesan A., Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Kumar Chellappan D., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia",Alpinia galanga extract; Box-Behnken design; Imiquimod induced mouse model; Non-aqueous nanoemulsion; PASI,"Administration, Cutaneous; Alpinia; Animals; Emulsions; Mice; Nanoparticles; Psoriasis; Skin Absorption; Surface-Active Agents; Swine; Alpinia galanga extract; betamethasone; catalase; cosurfactant; cremophor; glutathione; glycerol; imiquimod; superoxide dismutase; surfactant; thiobarbituric acid reactive substance; nanoparticle; animal experiment; animal model; animal tissue; antioxidant activity; Article; body weight; Box Behnken design; confocal laser scanning microscopy; controlled study; diffusion; drug retention; drug stability; enzyme activity; ex vivo study; female; histopathology; imiquimod-induced psoriasis; in vitro study; in vivo study; lipid peroxidation; male; microemulsion; molecular stability; mouse; nanoemulsion; nonhuman; pH; phase separation; physical appearance; psoriasis; Psoriasis Area and Severity Index; rat; refraction index; shear rate; skin toxicity; spleen weight; static electricity; surface charge; surface property; surface tension; topical treatment; viscosity; zeta potential; Alpinia; animal; cutaneous drug administration; emulsion; pig; skin absorption",Article,Final,,Scopus,2-s2.0-85132883428
Patel V.K.; Paudel K.R.; Shukla S.D.; Liu G.; Oliver B.G.; Hansbro P.M.; Dua K.,"Patel, Vyoma K. (57193533009); Paudel, Keshav R. (56539588400); Shukla, Shakti D. (56367620800); Liu, Gang (57189061134); Oliver, Brian G. (15919869900); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57193533009; 56539588400; 56367620800; 57189061134; 15919869900; 6603119390; 15759138700,"TOLL-LIKE RECEPTORS, INNATE IMMUNE SYSTEM, AND LUNG DISEASES: A VITAL TRILATERAL ASSOCIATION",2022,EXCLI Journal,21,,,519,523,4,8,10.17179/excli2022-4688,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125574982&doi=10.17179%2fexcli2022-4688&partnerID=40&md5=7c8ea7f85cd8a6afd053ba6608e7add0,"Macular Disease Foundation, 2000, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia","Patel V.K., Macular Disease Foundation, 2000, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Paudel K.R., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Shukla S.D., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Liu G., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Oliver B.G., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Dua K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia",,beta defensin; CXCL1 chemokine; cytokeratin 16; gamma interferon; gamma interferon inducible protein 10; interleukin 1beta; interleukin 6; interleukin 8; macrophage inflammatory protein 1alpha; macrophage inflammatory protein 2; myeloid differentiation factor 88; reduced nicotinamide adenine dinucleotide phosphate; toll like receptor; toll like receptor 2; toll like receptor 3; toll like receptor 4; toll like receptor 7; toll like receptor 9; tumor necrosis factor; apoptosis; asthma; chronic obstructive lung disease; coronavirus disease 2019; correlational study; disease exacerbation; disease severity; down regulation; emphysema; gene expression; human; immune response; innate immunity; Letter; lung disease; morbidity; nonhuman; signal transduction; Th1 cell; Th2 cell; upregulation; validation process; virus entry,Letter,Final,,Scopus,2-s2.0-85125574982
AlAjmi M.F.; Khan S.; Choudhury A.; Mohammad T.; Noor S.; Hussain A.; Lu W.; Eapen M.S.; Chimankar V.; Hansbro P.M.; Sohal S.S.; Elasbali A.M.; Hassan M.I.,"AlAjmi, Mohamed F. (6602962722); Khan, Shama (57202026473); Choudhury, Arunabh (57223399613); Mohammad, Taj (57196216261); Noor, Saba (56640963600); Hussain, Afzal (58276508100); Lu, Wenying (57202573402); Eapen, Mathew Suji (56625716100); Chimankar, Vrushali (57191957166); Hansbro, Philip M (6603119390); Sohal, Sukhwinder Singh (36449981500); Elasbali, Abdelbaset Mohamed (12762765800); Hassan, Md. Imtaiyaz (7401625549)",6602962722; 57202026473; 57223399613; 57196216261; 56640963600; 58276508100; 57202573402; 56625716100; 57191957166; 6603119390; 36449981500; 12762765800; 7401625549,"Impact of Deleterious Mutations on Structure, Function and Stability of Serum/Glucocorticoid Regulated Kinase 1: A Gene to Diseases Correlation",2021,Frontiers in Molecular Biosciences,8,,780284,,,,14,10.3389/fmolb.2021.780284,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119443668&doi=10.3389%2ffmolb.2021.780284&partnerID=40&md5=c1bbdc76a392a6579d32356790c1b9d4,"Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; Drug Discovery and Development Centre (H3D), University of Cape Town, Cape Town, South Africa; Department of Computer Science, Jamia Millia Islamia, New Delhi, India; Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Clinical Laboratory Science, College of Applied Medical Sciences-Qurayyat, Jouf University, Sakakah, Saudi Arabia","AlAjmi M.F., Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; Khan S., Drug Discovery and Development Centre (H3D), University of Cape Town, Cape Town, South Africa; Choudhury A., Department of Computer Science, Jamia Millia Islamia, New Delhi, India; Mohammad T., Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India; Noor S., Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India; Hussain A., Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; Lu W., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia; Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia; Chimankar V., Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia; Elasbali A.M., Clinical Laboratory Science, College of Applied Medical Sciences-Qurayyat, Jouf University, Sakakah, Saudi Arabia; Hassan M.I., Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India",deleterious mutations; essential dynamics; molecular dynamics simulation; serum/glucocorticoid regulated kinase 1; single amino acid substitutions,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85119443668
Vanka K.S.; Shukla S.; Gomez H.M.; James C.; Palanisami T.; Williams K.; Chambers D.C.; Britton W.J.; Ilic D.; Hansbro P.M.; Horvat J.C.,"Vanka, Kanth Swaroop (57095767500); Shukla, Shakti (56367620800); Gomez, Henry M. (57191960363); James, Carole (12140370900); Palanisami, Thava (23567398800); Williams, Kenneth (55459225000); Chambers, Daniel C. (26424572400); Britton, Warwick J. (7102477888); Ilic, Dusan (23035096600); Hansbro, Philip Michael (6603119390); Horvat, Jay Christopher (9942405300)",57095767500; 56367620800; 57191960363; 12140370900; 23567398800; 55459225000; 26424572400; 7102477888; 23035096600; 6603119390; 9942405300,Understanding the pathogenesis of occupational coal and silica dust-associated lung disease,2022,European Respiratory Review,31,165,210250,,,,60,10.1183/16000617.0250-2021,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133987271&doi=10.1183%2f16000617.0250-2021&partnerID=40&md5=d63a6c4c041b46c72793c29355b61cd4,"School of Biomedical Sciences and Pharmacy, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Division of Pulmonary, Allergy, and Critical Care Medicine, Dept of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, United States; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; School of Health Sciences, The University of Newcastle, Newcastle, NSW, Australia; Global Innovative Centre for Advanced Nanomaterials, College of Engineering, Science and Environment (CERSE), The University of Newcastle, Newcastle, NSW, Australia; Newcastle Institute for Energy and Resources (NIER), School of Engineering, The University of Newcastle, Newcastle, NSW, Australia; School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia; Queensland Lung Transplant Program, The Prince Charles Hospital, Brisbane, QLD, Australia; Centenary Institute, The University of Sydney, Sydney, NSW, Australia; Dept of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia","Vanka K.S., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Division of Pulmonary, Allergy, and Critical Care Medicine, Dept of Medicine, University of Pennsylvania, Philadelphia, PA, United States, Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, United States; Shukla S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Gomez H.M., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; James C., School of Health Sciences, The University of Newcastle, Newcastle, NSW, Australia; Palanisami T., Global Innovative Centre for Advanced Nanomaterials, College of Engineering, Science and Environment (CERSE), The University of Newcastle, Newcastle, NSW, Australia; Williams K., Newcastle Institute for Energy and Resources (NIER), School of Engineering, The University of Newcastle, Newcastle, NSW, Australia; Chambers D.C., School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia, Queensland Lung Transplant Program, The Prince Charles Hospital, Brisbane, QLD, Australia; Britton W.J., Centenary Institute, The University of Sydney, Sydney, NSW, Australia, Dept of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Ilic D., Newcastle Institute for Energy and Resources (NIER), School of Engineering, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Horvat J.C., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia",,Coal; Dust; Humans; Lung; Lung Diseases; Occupational Diseases; Occupational Exposure; Quality of Life; Silicon Dioxide; coal; growth factor; silicon dioxide; coal; silicon dioxide; classification; cytotoxicity; disease burden; dust control; human; lung disease; nonhuman; occupational disease; occupational exposure; oxidative stress; particulate matter; pathogenesis; pathophysiology; pneumoconiosis; Review; silicosis; adverse event; dust; lung; occupational exposure; quality of life,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85133987271
Gomes G.M.C.; Karmaus W.; Murphy V.E.; Gibson P.G.; Percival E.; Hansbro P.M.; Starkey M.R.; Mattes J.; Collison A.M.,"Gomes, Gabriela Martins Costa (57221872521); Karmaus, Wilfried (55146650400); Murphy, Vanessa E. (7006804832); Gibson, Peter G. (7202414199); Percival, Elizabeth (57190741148); Hansbro, Philip M. (6603119390); Starkey, Malcolm R. (35811293400); Mattes, Joerg (7005999915); Collison, Adam M. (23995251200)",57221872521; 55146650400; 7006804832; 7202414199; 57190741148; 6603119390; 35811293400; 7005999915; 23995251200,Environmental air pollutants inhaled during pregnancy are associated with altered cord blood immune cell profiles,2021,International Journal of Environmental Research and Public Health,18,14,7431,,,,7,10.3390/ijerph18147431,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109767520&doi=10.3390%2fijerph18147431&partnerID=40&md5=aeb200f87236014f5271916ebb04d970,"Priority Research Centre GrowUpWell®, Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia; School of Public Health, University of Memphis, Memphis, 38152, TN, United States; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Sleep Medicine Department, John Hunter Hospital, Newcastle, 2305, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2025, NSW, Australia; Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2050, NSW, Australia; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, 3800, VIC, Australia; Paediatric Respiratory & Sleep Medicine Department, John Hunter Children’s Hospital, Newcastle, 2305, NSW, Australia","Gomes G.M.C., Priority Research Centre GrowUpWell®, Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia; Karmaus W., School of Public Health, University of Memphis, Memphis, 38152, TN, United States; Murphy V.E., Priority Research Centre GrowUpWell®, Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia; Gibson P.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia, Sleep Medicine Department, John Hunter Hospital, Newcastle, 2305, NSW, Australia; Percival E., Priority Research Centre GrowUpWell®, Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2025, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2050, NSW, Australia; Starkey M.R., Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, 3800, VIC, Australia; Mattes J., Priority Research Centre GrowUpWell®, Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia, Paediatric Respiratory & Sleep Medicine Department, John Hunter Children’s Hospital, Newcastle, 2305, NSW, Australia; Collison A.M., Priority Research Centre GrowUpWell®, Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia",Air pollutants; Asthma; Cord blood; Particulate matter; Prenatal risk factors,Air Pollutants; Air Pollution; Environmental Exposure; Female; Fetal Blood; Humans; Nitrogen Dioxide; Ozone; Particulate Matter; Pregnancy; Sulfur Dioxide; nitrogen dioxide; ozone; sulfur dioxide; air quality; ambient air; asthma; atmospheric pollution; blood; child health; environmental factor; health risk; immune response; particulate matter; pollution effect; pollution exposure; pregnancy; respiratory disease; risk factor; adverse event; air pollutant; air pollution; analysis; chemistry; environmental exposure; female; fetus blood; human; particulate matter; pregnancy; toxicity,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85109767520
Chan Y.; Mehta M.; Paudel K.R.; Madheswaran T.; Panneerselvam J.; Gupta G.; Su Q.P.; Hansbro P.M.; Macloughlin R.; Dua K.; Chellappan D.K.,"Chan, Yinghan (57204707263); Mehta, Meenu (7203024234); Paudel, Keshav Raj (56539588400); Madheswaran, Thiagarajan (55505311000); Panneerselvam, Jithendra (57201993010); Gupta, Gaurav (15047988400); Su, Qian Peter (56734072700); Hansbro, Philip Michael (6603119390); Macloughlin, Ronan (57212263206); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",57204707263; 7203024234; 56539588400; 55505311000; 57201993010; 15047988400; 56734072700; 6603119390; 57212263206; 15759138700; 35811890500,Versatility of liquid crystalline nanoparticles in inflammatory lung diseases,2021,Nanomedicine,16,18,,1545,1548,3,27,10.2217/nnm-2021-0114,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111755662&doi=10.2217%2fnnm-2021-0114&partnerID=40&md5=179c433b02b77a440cf9095def8a3f32,"School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, 2007, NSW, Australia; Aerogen, IDA Business Park, Galway, Dangan, H91 HE94, Ireland; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia","Chan Y., School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Su Q.P., School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Macloughlin R., Aerogen, IDA Business Park, Galway, Dangan, H91 HE94, Ireland, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Bukit Jalil, 57000, Malaysia",drug delivery; inflammation; liquid crystalline nanoparticles; lung disease,Humans; Liquid Crystals; Lung Diseases; Nanoparticles; nanoparticle; human; liquid crystal; lung disease,Review,Final,,Scopus,2-s2.0-85111755662
Donovan C.; Kim R.Y.; Galvao I.; Jarnicki A.G.; Brown A.C.; Jones-Freeman B.; Gomez H.M.; Wadhwa R.; Hortle E.; Jayaraman R.; Khan H.; Pickles S.; Sahu P.; Chimankar V.; Tu X.; Ali M.K.; Mayall J.R.; Nguyen D.H.; Budden K.F.; Kumar V.; Schroder K.; Robertson A.A.B.; Cooper M.A.; Wark P.A.B.; Oliver B.G.; Horvat J.C.; Hansbro P.M.,"Donovan, Chantal (55357105200); Kim, Richard Y (35810406900); Galvao, Izabela (56656390800); Jarnicki, Andrew G (6603137164); Brown, Alexandra C (55637745000); Jones-Freeman, Bernadette (56215070300); Gomez, Henry M (57191960363); Wadhwa, Ridhima (57159091700); Hortle, Elinor (57204193930); Jayaraman, Ranjith (57225458602); Khan, Haroon (14521310700); Pickles, Sophie (57216189104); Sahu, Priyanka (57216189414); Chimankar, Vrushali (57191957166); Tu, Xiaofan (57222147245); Ali, Md Khadem (57194408422); Mayall, Jemma R (55607222700); Nguyen, Duc H (54886138200); Budden, Kurtis F (57191417986); Kumar, Vinod (57212900967); Schroder, Kate (8504949200); Robertson, Avril AB (15519764900); Cooper, Matthew A (7404411451); Wark, Peter AB (7003559516); Oliver, Brian G (15919869900); Horvat, Jay C (9942405300); Hansbro, Philip M (6603119390)",55357105200; 35810406900; 56656390800; 6603137164; 55637745000; 56215070300; 57191960363; 57159091700; 57204193930; 57225458602; 14521310700; 57216189104; 57216189414; 57191957166; 57222147245; 57194408422; 55607222700; 54886138200; 57191417986; 57212900967; 8504949200; 15519764900; 7404411451; 7003559516; 15919869900; 9942405300; 6603119390,"Aim2 suppresses cigarette smoke-induced neutrophil recruitment, neutrophil caspase-1 activation and anti-Ly6G-mediated neutrophil depletion",2022,Immunology and Cell Biology,100,4,,235,249,14,11,10.1111/imcb.12537,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126741558&doi=10.1111%2fimcb.12537&partnerID=40&md5=9e205afadd006c2514eebfff3c624674,"Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Department of Biochemistry and Pharmacology, Lung Health Research Centre, University of Melbourne, Parkville, VIC, Australia; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia; School of Chemistry and Molecular Bioscience, The University of Queensland, St Lucia, QLD, Australia","Donovan C., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Kim R.Y., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Galvao I., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Jarnicki A.G., Department of Biochemistry and Pharmacology, Lung Health Research Centre, University of Melbourne, Parkville, VIC, Australia; Brown A.C., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Jones-Freeman B., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Gomez H.M., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Wadhwa R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Hortle E., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Jayaraman R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Khan H., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Pickles S., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Sahu P., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Chimankar V., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Tu X., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Ali M.K., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Mayall J.R., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Nguyen D.H., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Budden K.F., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Kumar V., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Schroder K., Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia; Robertson A.A.B., School of Chemistry and Molecular Bioscience, The University of Queensland, St Lucia, QLD, Australia; Cooper M.A., Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia; Wark P.A.B., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Horvat J.C., Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia, Priority Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia",Aim2; anti-Ly6G; cigarette smoke; inflammasome; lung,"Animals; Caspase 1; Cigarette Smoking; DNA-Binding Proteins; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; cigarette smoke; cryopyrin; inflammasome; interleukin 1beta converting enzyme; Aim2 protein, mouse; DNA binding protein; interleukin 1beta converting enzyme; animal cell; animal experiment; animal model; animal tissue; Article; blood; bone marrow; chronic obstructive lung disease; controlled study; disease course; disease exacerbation; enzyme activation; lung; male; mouse; neutrophil; nonhuman; oligomerization; adverse event; animal; C57BL mouse; cigarette smoking; neutrophil chemotaxis",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85126741558
Tan C.L.; Chan Y.; Candasamy M.; Chellian J.; Madheswaran T.; Sakthivel L.P.; Patel V.K.; Chakraborty A.; MacLoughlin R.; Kumar D.; Verma N.; Malyla V.; Gupta P.K.; Jha N.K.; Thangavelu L.; Devkota H.P.; Bhatt S.; Prasher P.; Gupta G.; Gulati M.; Singh S.K.; Paudel K.R.; Hansbro P.M.; Oliver B.G.; Dua K.; Chellappan D.K.,"Tan, Ching Leng (57451103000); Chan, Yinghan (57204707263); Candasamy, Mayuren (56190844000); Chellian, Jestin (56993705500); Madheswaran, Thiagarajan (55505311000); Sakthivel, Lakshmana Prabu (57450925800); Patel, Vyoma K. (57193533009); Chakraborty, Amlan (56714779500); MacLoughlin, Ronan (57212263206); Kumar, Deepak (55534141182); Verma, Nitin (58160492500); Malyla, Vamshikrishna (57205128961); Gupta, Piyush Kumar (57220905930); Jha, Niraj Kumar (55109018100); Thangavelu, Lakshmi (57221436939); Devkota, Hari Prasad (24775939500); Bhatt, Shvetank (57197493015); Prasher, Parteek (56079914500); Gupta, Gaurav (15047988400); Gulati, Monica (7006677671); Singh, Sachin Kumar (57206711834); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Oliver, Brian G. (15919869900); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",57451103000; 57204707263; 56190844000; 56993705500; 55505311000; 57450925800; 57193533009; 56714779500; 57212263206; 55534141182; 58160492500; 57205128961; 57220905930; 55109018100; 57221436939; 24775939500; 57197493015; 56079914500; 15047988400; 7006677671; 57206711834; 56539588400; 6603119390; 15919869900; 15759138700; 35811890500,Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models,2022,European Journal of Pharmacology,919,,174821,,,,17,10.1016/j.ejphar.2022.174821,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124503920&doi=10.1016%2fj.ejphar.2022.174821&partnerID=40&md5=b3b60fd6620ebc1caa7eb69cb739f6d5,"School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Pharmaceutical Technology, University College of Engineering (BIT Campus), Anna University, Tiruchirappalli, 620024, India; Faculty of Medicine and Health, University of Sydney, Camperdown, 2006, NSW, Australia; Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia; Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Himachal Pradesh, Solan, 173229, India; Chitkara University School of Pharmacy, Chitkara University, Atal Shiksha Kunj, Atal Nagar, Himachal Pradesh, 174103, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Department of Biotechnology, School of Engineering & Technology, Sharda University, Uttar Pradesh, Greater Noida, 201310, India; Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, 862-0973, Kumamoto, Japan; Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan; Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Madhya Pradesh, Gwalior, 474005, India; Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India; School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia","Tan C.L., School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Chan Y., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Candasamy M., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Sakthivel L.P., Department of Pharmaceutical Technology, University College of Engineering (BIT Campus), Anna University, Tiruchirappalli, 620024, India; Patel V.K., Faculty of Medicine and Health, University of Sydney, Camperdown, 2006, NSW, Australia; Chakraborty A., Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia; MacLoughlin R., Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Kumar D., Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Himachal Pradesh, Solan, 173229, India; Verma N., Chitkara University School of Pharmacy, Chitkara University, Atal Shiksha Kunj, Atal Nagar, Himachal Pradesh, 174103, India; Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Gupta P.K., Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Jha N.K., Department of Biotechnology, School of Engineering & Technology, Sharda University, Uttar Pradesh, Greater Noida, 201310, India; Thangavelu L., Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, 862-0973, Kumamoto, Japan, Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Chuo-ku, 862-0973, Kumamoto, Japan; Bhatt S., Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Madhya Pradesh, Gwalior, 474005, India; Prasher P., Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India; Paudel K.R., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Oliver B.G., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia",Asthma; Chronic respiratory diseases; COPD; Cystic fibrosis; In vitro models; Lung cancer,"Biomarkers; Drug Development; Humans; Models, Theoretical; Pulmonary Disease, Chronic Obstructive; acetylcysteine; ADAM protein; ADAM33 protein; antiasthmatic agent; boswellic acid; budesonide; carbocisteine; chemokine receptor CCR3; chemokine receptor CCR4; chemokine receptor CCR8; chitosan nanoparticle; curcumin; cyclooxygenase 2; cystic fibrosis transmembrane conductance regulator; dalteparin; enoxaparin; eotaxin 3; erythromycin; formoterol; gemcitabine; granulocyte macrophage colony stimulating factor; heat shock protein 70; high mobility group B1 protein; hydroxymethylglutaryl coenzyme A reductase inhibitor; indoleamine 2,3 dioxygenase; interleukin 13; interleukin 25; interleukin 27; interleukin 4; interleukin 5; interstitial collagenase; ipratropium bromide; liquid crystalline nanoparticle; long acting muscarinic antagonist; lysosome associated membrane protein 1; metalloproteinase; microRNA; microRNA 29c; mitogen activated protein kinase 1; mitogen activated protein kinase 3; muscarinic receptor blocking agent; myeloperoxidase; nanocarrier; nanoparticle; naringenin; nitric oxide synthase; placental growth factor; pregnancy associated alpha2 glycoprotein; recombinant CC16; recombinant protein; retinoid related orphan receptor gamma; rifampicin; Seonpyejeongcheon tang; STAT1 protein; STAT3 protein; transcription factor FOXP3; transcription factor GATA 3; transforming growth factor beta1; tryptophan hydroxylase; unclassified drug; vasculotropin receptor 2; Wnt4 protein; biological marker; A-549 cell line; air liquid interface culture; Aspergillus; asthma; bacterial colonization; bacterial infection; bacteriophage; bronchiectasis; Burkholderia cenocepacia; Burkholderia multivorans; cell communication; cell culture; cell damage; cell differentiation; cell function; cell population; cell proliferation; cell viability; chronic obstructive lung disease; chronic respiratory tract disease; combination drug therapy; cystic fibrosis; cytokine release; disease exacerbation; disease model; drug delivery system; drug development; enzyme linked immunosorbent assay; epithelial mesenchymal transition; extracellular matrix; fibrosing alveolitis; gene expression regulation; Haemophilus influenzae; Haemophilus parainfluenzae; high throughput sequencing; human; Human respiratory syncytial virus; immune response; in vitro study; Influenza A virus; lung alveolus cell; lung cancer; lung on chip model; Malassezia; nasopharyngeal swab; NCI-H226 cell line; non cystic fibrosis bronchiectasis; nonhuman; organoid; pathogenesis; phenotype; polymerase chain reaction restriction fragment length polymorphism; protein blood level; protein expression; protein function; Pseudomonas aeruginosa; respiratory epithelium; Review; risk factor; Scedosporium; signal transduction; single nucleotide polymorphism; sputum analysis; Staphylococcus aureus; Streptococcus mitis; upregulation; virus infection; chronic obstructive lung disease; drug development; metabolism; theoretical model",Review,Final,,Scopus,2-s2.0-85124503920
Wille M.; Grillo V.; de Gouvea Pedroso S.B.; Burgess G.W.; Crawley A.; Dickason C.; Hansbro P.M.; Hoque Md.A.; Horwood P.F.; Kirkland P.D.; Kung N.Y.-H.; Lynch S.E.; Martin S.; McArthur M.; O’Riley K.; Read A.J.; Warner S.; Hoye B.J.; Lisovski S.; Leen T.; Hurt A.C.; Butler J.; Broz I.; Davies K.R.; Mileto P.; Neave M.J.; Stevens V.; Breed A.C.; Lam T.T.Y.; Holmes E.C.; Klaassen M.; Wong F.Y.K.,"Wille, Michelle (36572831000); Grillo, Victoria (59087888900); de Gouvea Pedroso, Silvia Ban (57216188247); Burgess, Graham W. (7102788039); Crawley, Allison (57431620200); Dickason, Celia (57154099600); Hansbro, Philip M. (6603119390); Hoque, Md. Ahasanul (36082736400); Horwood, Paul F. (24503135900); Kirkland, Peter D. (56243457600); Kung, Nina Yu-Hsin (36977766700); Lynch, Stacey E. (57033569200); Martin, Sue (57432024400); McArthur, Michaela (57431025000); O’Riley, Kim (57223644718); Read, Andrew J. (36553309500); Warner, Simone (23983839400); Hoye, Bethany J. (26632061000); Lisovski, Simeon (30267694200); Leen, Trent (57431225300); Hurt, Aeron C. (6603378203); Butler, Jeff (55633548700); Broz, Ivano (55357901400); Davies, Kelly R. (23969947800); Mileto, Patrick (57225093795); Neave, Matthew J. (53878144300); Stevens, Vicky (57216557103); Breed, Andrew C. (14059643400); Lam, Tommy T.Y. (56549450000); Holmes, Edward C. (55535773400); Klaassen, Marcel (7004383496); Wong, Frank Y.K. (57200643500)",36572831000; 59087888900; 57216188247; 7102788039; 57431620200; 57154099600; 6603119390; 36082736400; 24503135900; 56243457600; 36977766700; 57033569200; 57432024400; 57431025000; 57223644718; 36553309500; 23983839400; 26632061000; 30267694200; 57431225300; 6603378203; 55633548700; 55357901400; 23969947800; 57225093795; 53878144300; 57216557103; 14059643400; 56549450000; 55535773400; 7004383496; 57200643500,Australia as a global sink for the genetic diversity of avian influenza A virus,2022,PLoS Pathogens,18,5,e1010150,,,,14,10.1371/journal.ppat.1010150,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130004933&doi=10.1371%2fjournal.ppat.1010150&partnerID=40&md5=44aad50004558cce6b699b9887e907b9,"WHO Collaborating Centre for Reference and Research on Influenza, the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Sydney Institute for Infectious Diseases, School of Life and Environmental Sciences, School of Medical Sciences, The University of Sydney, Sydney, Australia; Department of Microbiology and Immunology, the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia; Wildlife Health Australia, Mosman, Australia; College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Australia; Primary Industries and Regions, Adelaide, Australia; Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Chattogram (previously Chittagong) Veterinary and Animal Sciences University, Khulshi, Bangladesh; NSW Department of Primary Industries, Elizabeth Macarthur Agricultural Institute, Menangle, Australia; Animal Biosecurity & Welfare, Biosecurity Queensland, Department of Agriculture and Fisheries, Health Food Science Precinct, Coopers Plains, Australia; Agriculture Victoria Research, AgriBio Centre for AgriBioscience, Bundoora, Australia; Department of Primary Industries, Parks, Water and Environment, Hobart, Australia; Department of Primary Industries and Regional Development, Kensington, Australia; Centre for Integrative Ecology, Deakin University, Geelong, Australia; Geelong Field & Game, Geelong, Australia; Wetlands Environmental Taskforce, Field & Game Australia, Seymour, Australia; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness, Geelong, Australia; Department of Agriculture, Water and the Environment, Canberra, Australia; University of Queensland, St. Lucia, Australia; State Key Laboratory of Emerging Infectious Diseases, School of Public Health, The University of Hong Kong, Hong Kong","Wille M., WHO Collaborating Centre for Reference and Research on Influenza, the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia, Sydney Institute for Infectious Diseases, School of Life and Environmental Sciences, School of Medical Sciences, The University of Sydney, Sydney, Australia, Department of Microbiology and Immunology, the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia; Grillo V., Wildlife Health Australia, Mosman, Australia; de Gouvea Pedroso S.B., Wildlife Health Australia, Mosman, Australia; Burgess G.W., College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Australia; Crawley A., Primary Industries and Regions, Adelaide, Australia; Dickason C., Primary Industries and Regions, Adelaide, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Hoque Md.A., Chattogram (previously Chittagong) Veterinary and Animal Sciences University, Khulshi, Bangladesh; Horwood P.F., College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Australia; Kirkland P.D., NSW Department of Primary Industries, Elizabeth Macarthur Agricultural Institute, Menangle, Australia; Kung N.Y.-H., Animal Biosecurity & Welfare, Biosecurity Queensland, Department of Agriculture and Fisheries, Health Food Science Precinct, Coopers Plains, Australia; Lynch S.E., Agriculture Victoria Research, AgriBio Centre for AgriBioscience, Bundoora, Australia; Martin S., Department of Primary Industries, Parks, Water and Environment, Hobart, Australia; McArthur M., Department of Primary Industries and Regional Development, Kensington, Australia; O’Riley K., Agriculture Victoria Research, AgriBio Centre for AgriBioscience, Bundoora, Australia; Read A.J., NSW Department of Primary Industries, Elizabeth Macarthur Agricultural Institute, Menangle, Australia; Warner S., Agriculture Victoria Research, AgriBio Centre for AgriBioscience, Bundoora, Australia; Hoye B.J., Centre for Integrative Ecology, Deakin University, Geelong, Australia; Lisovski S., Centre for Integrative Ecology, Deakin University, Geelong, Australia; Leen T., Geelong Field & Game, Geelong, Australia, Wetlands Environmental Taskforce, Field & Game Australia, Seymour, Australia; Hurt A.C., WHO Collaborating Centre for Reference and Research on Influenza, the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Butler J., Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness, Geelong, Australia; Broz I., Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness, Geelong, Australia; Davies K.R., Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness, Geelong, Australia; Mileto P., Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness, Geelong, Australia; Neave M.J., Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness, Geelong, Australia; Stevens V., Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness, Geelong, Australia; Breed A.C., Department of Agriculture, Water and the Environment, Canberra, Australia, University of Queensland, St. Lucia, Australia; Lam T.T.Y., State Key Laboratory of Emerging Infectious Diseases, School of Public Health, The University of Hong Kong, Hong Kong; Holmes E.C., Sydney Institute for Infectious Diseases, School of Life and Environmental Sciences, School of Medical Sciences, The University of Sydney, Sydney, Australia; Klaassen M., Centre for Integrative Ecology, Deakin University, Geelong, Australia; Wong F.Y.K., Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness, Geelong, Australia",,"Animals; Animals, Wild; Australia; Birds; Ducks; Genetic Variation; Influenza A virus; Influenza in Birds; Phylogeny; hemagglutinin; Influenza virus hemagglutinin; rain; Article; avian influenza virus; bioinformatics; bird; controlled study; duck; Echinococcus granulosus; gene sequence; genetic analysis; genetic reassortment; genetic variability; geographic distribution; influenza; influenza A; Influenza A virus (H5N3); Influenza A virus (H9N2); Influenza virus; Monte Carlo method; nonhuman; phylogenetic tree; phylogeny; phylogeography; pig; population structure; prevalence; RNA isolation; viral diversity; virus gene; virus genome; waterfowl; animal; Australia; avian influenza; genetic variation; genetics; Influenza A virus; wild animal",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85130004933
Ren S.; Hansbro P.M.; Srikusalanukul W.; Horvat J.C.; Hunter T.; Brown A.C.; Peel R.; Faulkner J.; Evans T.-J.; Li S.C.; Newby D.; Hure A.; Abhayaratna W.P.; Tsimikas S.; Gonen A.; Witztum J.L.; Attia J.; Abhayaratna W.; D'Este C.; Tonkin A.; Hopper I.; Thrift A.; Levi C.; Sturm J.; Durrheim D.; Hung J.; Briffa T.; Chew D.; Anderson P.; Moon L.; McEvoy M.,"Ren, Shu (57189216570); Hansbro, Philip M. (6603119390); Srikusalanukul, Wichat (9246684000); Horvat, Jay C. (9942405300); Hunter, Tegan (57158691000); Brown, Alexandra C. (55637745000); Peel, Roseanne (55207142000); Faulkner, Jack (57222474632); Evans, Tiffany-Jane (26634998400); Li, Shu Chuen (7409238460); Newby, David (7006580756); Hure, Alexis (24070975100); Abhayaratna, Walter P. (12759938700); Tsimikas, Sotirios (57203048921); Gonen, Ayelet (8726010500); Witztum, Joseph L. (7102013646); Attia, John (7003299759); Abhayaratna, Walter (6602084604); D'Este, Catherine (34572757300); Tonkin, Andrew (57208096319); Hopper, Ingrid (7004824524); Thrift, Amanda (57250209900); Levi, Christopher (7202194795); Sturm, Jonathan (35551260900); Durrheim, David (35409388600); Hung, Joseph (6507675518); Briffa, Tom (7102026332); Chew, Derek (24503016000); Anderson, Phil (26641374700); Moon, Lynelle (8911690100); McEvoy, Mark (8)",57189216570; 6603119390; 9246684000; 9942405300; 57158691000; 55637745000; 55207142000; 57222474632; 26634998400; 7409238460; 7006580756; 24070975100; 12759938700; 57203048921; 8726010500; 7102013646; 7003299759; 6602084604; 34572757300; 57208096319; 7004824524; 57250209900; 7202194795; 35551260900; 35409388600; 6507675518; 7102026332; 24503016000; 26641374700; 8911690100; 8,Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial,2022,Atherosclerosis,346,,,68,74,6,10,10.1016/j.atherosclerosis.2022.02.011,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126085765&doi=10.1016%2fj.atherosclerosis.2022.02.011&partnerID=40&md5=816874bbc8d27e9bf40de5363179bddd,"School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia; Centenary UTS Centre for Inflammation, Sydney, NSW, Australia; Australian National University Medical School, Canberra Hospital, Canberra, ACT, Australia; Department of Medicine, University of California San Diego, La Jolla, CA, United States; Department of Medicine, John Hunter Hospital, Newcastle, NSW, Australia","Ren S., School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia, Centenary UTS Centre for Inflammation, Sydney, NSW, Australia; Srikusalanukul W., Australian National University Medical School, Canberra Hospital, Canberra, ACT, Australia; Horvat J.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hunter T., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Brown A.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Peel R., School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Faulkner J., Hunter Medical Research Institute, Newcastle, NSW, Australia; Evans T.-J., Hunter Medical Research Institute, Newcastle, NSW, Australia; Li S.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Newby D., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Hure A., School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Abhayaratna W.P., Australian National University Medical School, Canberra Hospital, Canberra, ACT, Australia; Tsimikas S., Department of Medicine, University of California San Diego, La Jolla, CA, United States; Gonen A., Department of Medicine, University of California San Diego, La Jolla, CA, United States; Witztum J.L., Department of Medicine, University of California San Diego, La Jolla, CA, United States; Attia J., School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia, Department of Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Abhayaratna W.; D'Este C.; Tonkin A.; Hopper I.; Thrift A.; Levi C.; Sturm J.; Durrheim D.; Hung J.; Briffa T.; Chew D.; Anderson P.; Moon L.; McEvoy M.",Anti-oxLDL antibodies; Anti-pneumococcal antibodies; Atherosclerosis; Cardiovascular disease; Human clinical trial; Oxidative stress; Pneumococcal vaccine,Atherosclerosis; Australia; Biomarkers; Humans; Immunoglobulin G; Immunoglobulin M; Pneumococcal Vaccines; Streptococcus pneumoniae; antibody; C reactive protein; immunoglobulin G antibody; immunoglobulin G2; immunoglobulin M antibody; oxidized low density lipoprotein antibody; Pneumococcus vaccine; polysaccharide vaccine; biological marker; immunoglobulin G; immunoglobulin M; adult; antibody blood level; antibody response; antibody titer; Article; atherosclerosis; carotid intima-media thickness; cerebrovascular accident; comparative study; controlled study; disease marker; double blind procedure; female; follow up; heart infarction; heart protection; human; immunization; immunoglobulin blood level; major clinical study; male; middle aged; observational study; pulse wave velocity; randomized controlled trial; vaccination; atherosclerosis; Australia; Streptococcus pneumoniae,Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85126085765
Asrani P.; Tiwari K.; Eapen M.S.; McAlinden K.D.; Haug G.; Johansen M.D.; Hansbro P.M.; Flanagan K.L.; Hassan M.I.; Sohal S.S.,"Asrani, Purva (57218386907); Tiwari, Keshav (57340359400); Eapen, Mathew Suji (56625716100); McAlinden, Kielan Darcy (57193794597); Haug, Greg (56560843300); Johansen, Matt D. (57202983408); Hansbro, Philip M. (6603119390); Flanagan, Katie L. (35473319600); Hassan, Md. Imtaiyaz (7401625549); Sohal, Sukhwinder Singh (36449981500)",57218386907; 57340359400; 56625716100; 57193794597; 56560843300; 57202983408; 6603119390; 35473319600; 7401625549; 36449981500,Clinical features and mechanistic insights into drug repurposing for combating COVID-19,2022,International Journal of Biochemistry and Cell Biology,142,,106114,,,,11,10.1016/j.biocel.2021.106114,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119169169&doi=10.1016%2fj.biocel.2021.106114&partnerID=40&md5=f896c7e8ee517b340b11cff38162843d,"Department of Microbiology, University of Delhi, South Campus, New Delhi, India; ICAR – National Institute for Plant Biotechnology, New Delhi, India; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Department of Respiratory Medicine, Launceston General Hospital, Launceston, 7250, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; University of Technology Sydney, Faculty of Science, School of Life Sciences, Ultimo, 2007, NSW, Australia; Clinical School, College of Health and Medicine, University of Tasmania, Launceston, 7250, Tasmania, Australia; School of Health and Biomedical Science, RMIT University, Melbourne, Victoria, Australia; Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia; Tasmania Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, 7250, Tasmania, Australia; Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India","Asrani P., Department of Microbiology, University of Delhi, South Campus, New Delhi, India; Tiwari K., ICAR – National Institute for Plant Biotechnology, New Delhi, India; Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; McAlinden K.D., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Haug G., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, 7250, Australia; Johansen M.D., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Technology Sydney, Faculty of Science, School of Life Sciences, Ultimo, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Technology Sydney, Faculty of Science, School of Life Sciences, Ultimo, 2007, NSW, Australia; Flanagan K.L., Clinical School, College of Health and Medicine, University of Tasmania, Launceston, 7250, Tasmania, Australia, School of Health and Biomedical Science, RMIT University, Melbourne, Victoria, Australia, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia, Tasmania Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, 7250, Tasmania, Australia; Hassan M.I., Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia",Anti-viral compounds; COVID-19; Cytokine storm; SARS-CoV-2; Therapeutic,"Adaptive Immunity; Antibodies, Viral; Antimalarials; Antiparasitic Agents; Antiviral Agents; CD4-Positive T-Lymphocytes; COVID-19; Drug Repositioning; Humans; Immunity, Innate; Immunization, Passive; Probiotics; SARS-CoV-2; antibiotic agent; antiinflammatory agent; antimalarial agent; antiparasitic agent; antiretrovirus agent; antivirus agent; monoclonal antibody; probiotic agent; antimalarial agent; antiparasitic agent; antivirus agent; probiotic agent; virus antibody; antiretroviral therapy; clinical feature; coronavirus disease 2019; drug repositioning; human; Review; traditional medicine; World Health Organization; adaptive immunity; CD4+ T lymphocyte; drug effect; drug therapy; immunology; innate immunity; passive immunization; procedures; therapy",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85119169169
Chellappan D.K.; Dharwal V.; Paudel K.R.; Jha N.K.; MacLoughlin R.; Oliver B.G.; Hansbro P.M.; Dua K.,"Chellappan, DInesh Kumar (35811890500); Dharwal, Vivek (57195758477); Paudel, Keshav Raj (56539588400); Jha, Niraj Kumar (55109018100); MacLoughlin, Ronan (57212263206); Oliver, Brian G (15919869900); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",35811890500; 57195758477; 56539588400; 55109018100; 57212263206; 15919869900; 6603119390; 15759138700,Mitochondrial dysfunctions associated with chronic respiratory diseases and their targeted therapies: An update,2021,Future Medicinal Chemistry,13,15,,1249,1251,2,10,10.4155/fmc-2021-0097,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110334245&doi=10.4155%2ffmc-2021-0097&partnerID=40&md5=bc9aad6102a4b69ceb67667aa7eb076f,"Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Malaysia; School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Plot No. 32-34, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; Aerogen, IDA Business Park, Dangan, H91 HE94, Ireland; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia","Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Malaysia; Dharwal V., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Paudel K.R., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Jha N.K., Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Plot No. 32-34, Knowledge Park III, Uttar Pradesh, Greater Noida, 201310, India; MacLoughlin R., Aerogen, IDA Business Park, Dangan, H91 HE94, Ireland, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Oliver B.G., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia",inflammation; mitochondria; respiratory diseases; targeted therapies,"Adenosine Triphosphate; Benzodiazepines; Glyburide; Humans; Lung Diseases; Mitochondria; Oxidative Stress; Reactive Oxygen Species; 7 chloro 5 (2 chlorophenyl) 1,5 dihydro 4,1 benzothiazepin 2(3h) one; adenosine triphosphate; cell protein; glibenclamide; gramicidin S; mitofusin 1; mitofusin 2; parkin; protein Drp1; protein Fis1; protein Mff; protein Opa1; reactive oxygen metabolite; succinate dehydrogenase (ubiquinone); transforming growth factor beta; ubiquinol cytochrome c reductase; unclassified drug; benzodiazepine derivative; glibenclamide; apoptosis; asthma; bioaccumulation; bioenergy; cell function; cell fusion; cell permeabilization; cell structure; chronic obstructive lung disease; chronic respiratory tract disease; cigarette smoking; disease association; disorders of mitochondrial functions; electron transport; enzyme activity; epithelium cell; gene expression; in vitro study; in vivo study; lipophilicity; lung alveolus macrophage; lung emphysema; lung fibrosis; mitochondrial membrane potential; mitochondrion; Note; oxygen consumption; pathogenesis; protein expression; risk factor; drug effect; human; lung disease; metabolism; oxidative stress; pathology",Note,Final,,Scopus,2-s2.0-85110334245
Paudel K.R.; Dua K.; Panth N.; Hansbro P.M.; Chellappan D.K.,"Paudel, Keshav Raj (56539588400); Dua, Kamal (15759138700); Panth, Nisha (57094240100); Hansbro, Philip Michael (6603119390); Chellappan, Dinesh Kumar (35811890500)",56539588400; 15759138700; 57094240100; 6603119390; 35811890500,Advances in research with rutin-loaded nanoformulations in mitigating lung diseases,2022,Future Medicinal Chemistry,14,18,,1293,1295,2,6,10.4155/fmc-2022-0088,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137136014&doi=10.4155%2ffmc-2022-0088&partnerID=40&md5=2778d5c4526bf15e7ce0b89cb639c047,"Centre for Inflammation, Centenary Institute & University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Paudel K.R., Centre for Inflammation, Centenary Institute & University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Panth N., Centre for Inflammation, Centenary Institute & University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute & University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia",advances; lung diseases; nanoformulations; nanoparticles; rutin,acetylcysteine; chitosan; chitosan nanoparticle; copper oxide nanocomposite; cytokine; ethane; glucose; glutathione; glutathione disulfide; gold nanoparticle; iron oxide; iron oxide nanoparticle; lipopolysaccharide; liquid crystalline nanoparticle; malonaldehyde; nanoparticle; nitric oxide; reactive oxygen metabolite; rutoside; sodium; sodium caseinate; unclassified drug; water; zein; A-549 cell line; ABTS radical scavenging assay; adult respiratory distress syndrome; antiinflammatory activity; antioxidant activity; apoptosis; asthma; BEAS-2B cell line; biological activity; cell migration; cell proliferation; chronic obstructive lung disease; chronic respiratory tract disease; clinical practice; clinical research; colony formation; concentration (parameter); cytotoxicity; down regulation; DPPH radical scavenging assay; drug delivery system; drug formulation; Gclc gene; gene; human; hydrogen peroxide scavenging assay; IC50; in vitro study; lipid peroxidation; lung disease; lung epithelium; nanotechnology; nonhuman; Nox2B gene; Nox4 gene; Nqo 1 gene; oxidative stress; Review; upregulation,Review,Final,,Scopus,2-s2.0-85137136014
Johansen M.D.; Mahbub R.M.; Idrees S.; Nguyen D.H.; Miemczyk S.; Pathinayake P.; Nichol K.; Hansbro N.G.; Gearing L.J.; Hertzog P.J.; Gallego-Ortega D.; Britton W.J.; Saunders B.M.; Wark P.A.; Faiz A.; Hansbro P.M.,"Johansen, Matt D. (57202983408); Mahbub, Rashad M. (57872243500); Idrees, Sobia (55429771900); Nguyen, Duc H. (54886138200); Miemczyk, Stefan (57773070000); Pathinayake, Prabuddha (55877978000); Nichol, Kristy (57195914143); Hansbro, Nicole G. (15055862300); Gearing, Linden J. (24467836000); Hertzog, Paul J. (7005991492); Gallego-Ortega, David (57202352450); Britton, Warwick J. (7102477888); Saunders, Bernadette M. (7102328746); Wark, Peter A. (7003559516); Faiz, Alen (55601365200); Hansbro, Philip M. (6603119390)",57202983408; 57872243500; 55429771900; 54886138200; 57773070000; 55877978000; 57195914143; 15055862300; 24467836000; 7005991492; 57202352450; 7102477888; 7102328746; 7003559516; 55601365200; 6603119390,"Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing",2022,American Journal of Respiratory and Critical Care Medicine,206,6,,712,729,17,31,10.1164/rccm.202108-1901OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138457188&doi=10.1164%2frccm.202108-1901OC&partnerID=40&md5=de043dcaf16fcb73189d150e3cb18d2f,"Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, Clayton, VIC, Australia; Faculty of Engineering and Information Technology, School of Biomedical Engineering, Centre for Single Cell Technology, University of Technology Sydney, Ultimo, NSW, Australia; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia; St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Sydney, Kensington, NSW, Australia; Centenary Institute, University of Sydney, Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia","Johansen M.D., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Mahbub R.M., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Idrees S., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Nguyen D.H., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Miemczyk S., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Pathinayake P., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Nichol K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro N.G., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Gearing L.J., Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, Clayton, VIC, Australia; Hertzog P.J., Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, Clayton, VIC, Australia; Gallego-Ortega D., Faculty of Engineering and Information Technology, School of Biomedical Engineering, Centre for Single Cell Technology, University of Technology Sydney, Ultimo, NSW, Australia, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia, St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales Sydney, Kensington, NSW, Australia; Britton W.J., Centenary Institute, University of Sydney, Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Saunders B.M., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Faiz A., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",COPD; COVID-19; interferon; protease; single-cell RNA sequencing,"COVID-19; Cytokines; Epithelial Cells; Humans; Peptide Hydrolases; Pulmonary Disease, Chronic Obstructive; SARS-CoV-2; Sequence Analysis, RNA; Serpins; cytokine; interferon; proteinase; serine proteinase inhibitor; transmembrane protease serine 2; cytokine; peptide hydrolase; serine proteinase inhibitor; adult; aged; Article; basal cell; bronchiole cell; chronic obstructive lung disease; clinical article; controlled study; coronavirus disease 2019; cytokine response; differential expression analysis; disease exacerbation; disease severity; epithelium cell; ex vivo study; gene expression; goblet cell; human; human cell; immune response; infection sensitivity; inflammation; inoculation; middle aged; network analysis; plaque assay; Severe acute respiratory syndrome coronavirus 2; single cell RNA seq; very elderly; virus load; virus replication; chronic obstructive lung disease; epithelium cell; sequence analysis",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85138457188
Ashhurst A.S.; Johansen M.D.; Maxwell J.W.C.; Stockdale S.; Ashley C.L.; Aggarwal A.; Siddiquee R.; Miemczyk S.; Nguyen D.H.; Mackay J.P.; Counoupas C.; Byrne S.N.; Turville S.; Steain M.; Triccas J.A.; Hansbro P.M.; Payne R.J.; Britton W.J.,"Ashhurst, Anneliese S. (57192872471); Johansen, Matt D. (57202983408); Maxwell, Joshua W. C. (57218386819); Stockdale, Skye (57964032500); Ashley, Caroline L. (57195268120); Aggarwal, Anupriya (26431741800); Siddiquee, Rezwan (57214806700); Miemczyk, Stefan (57773070000); Nguyen, Duc H. (54886138200); Mackay, Joel P. (7201377458); Counoupas, Claudio (24070034400); Byrne, Scott N. (7007066556); Turville, Stuart (6507720820); Steain, Megan (8740991600); Triccas, James A. (7003601814); Hansbro, Philip M. (6603119390); Payne, Richard J. (7201993403); Britton, Warwick J. (7102477888)",57192872471; 57202983408; 57218386819; 57964032500; 57195268120; 26431741800; 57214806700; 57773070000; 54886138200; 7201377458; 24070034400; 7007066556; 6507720820; 8740991600; 7003601814; 6603119390; 7201993403; 7102477888,Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice,2022,Nature Communications,13,1,6972,,,,20,10.1038/s41467-022-34297-3,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85141834495&doi=10.1038%2fs41467-022-34297-3&partnerID=40&md5=b09a7df739b18ae623d85f1eaf7fe6b4,"School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, 2006, NSW, Australia; School of Chemistry, The University of Sydney, Sydney, 2006, NSW, Australia; The University of Sydney Institute for Infectious Diseases, Sydney, 2006, NSW, Australia; Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, 2006, NSW, Australia; Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology, Sydney, 2007, NSW, Australia; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, 2006, NSW, Australia; Kirby Institute, Sydney, 2052, NSW, Australia; School of Life and Environmental Sciences, The University of Sydney, Sydney, 2006, NSW, Australia; Westmead Institute for Medical Research, Centre for Immunology and Allergy Research, Westmead, 2145, NSW, Australia; Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, 2050, NSW, Australia","Ashhurst A.S., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, NSW, Australia, Charles Perkins Centre, The University of Sydney, Sydney, 2006, NSW, Australia, School of Chemistry, The University of Sydney, Sydney, 2006, NSW, Australia, The University of Sydney Institute for Infectious Diseases, Sydney, 2006, NSW, Australia, Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, 2006, NSW, Australia; Johansen M.D., Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology, Sydney, 2007, NSW, Australia; Maxwell J.W.C., School of Chemistry, The University of Sydney, Sydney, 2006, NSW, Australia, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, 2006, NSW, Australia; Stockdale S., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, NSW, Australia, Charles Perkins Centre, The University of Sydney, Sydney, 2006, NSW, Australia; Ashley C.L., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, NSW, Australia, Charles Perkins Centre, The University of Sydney, Sydney, 2006, NSW, Australia; Aggarwal A., Kirby Institute, Sydney, 2052, NSW, Australia; Siddiquee R., School of Life and Environmental Sciences, The University of Sydney, Sydney, 2006, NSW, Australia; Miemczyk S., Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology, Sydney, 2007, NSW, Australia; Nguyen D.H., Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology, Sydney, 2007, NSW, Australia; Mackay J.P., School of Life and Environmental Sciences, The University of Sydney, Sydney, 2006, NSW, Australia; Counoupas C., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, NSW, Australia, Charles Perkins Centre, The University of Sydney, Sydney, 2006, NSW, Australia, The University of Sydney Institute for Infectious Diseases, Sydney, 2006, NSW, Australia, Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, 2006, NSW, Australia; Byrne S.N., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, NSW, Australia, Charles Perkins Centre, The University of Sydney, Sydney, 2006, NSW, Australia, Westmead Institute for Medical Research, Centre for Immunology and Allergy Research, Westmead, 2145, NSW, Australia; Turville S., Kirby Institute, Sydney, 2052, NSW, Australia; Steain M., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, NSW, Australia, Charles Perkins Centre, The University of Sydney, Sydney, 2006, NSW, Australia, The University of Sydney Institute for Infectious Diseases, Sydney, 2006, NSW, Australia; Triccas J.A., School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2006, NSW, Australia, Charles Perkins Centre, The University of Sydney, Sydney, 2006, NSW, Australia, The University of Sydney Institute for Infectious Diseases, Sydney, 2006, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and Faculty of Science, School of Life Sciences, University of Technology, Sydney, 2007, NSW, Australia; Payne R.J., School of Chemistry, The University of Sydney, Sydney, 2006, NSW, Australia, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, 2006, NSW, Australia; Britton W.J., Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, 2006, NSW, Australia, Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, 2050, NSW, Australia",,"Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunity, Mucosal; Lung; Mice; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Toll-Like Receptor 2; Vaccination; Viral Vaccines; adjuvant; immunoglobulin A; neutralizing antibody; subunit vaccine; toll like receptor 2; virus spike protein; coronavirus spike glycoprotein; spike protein, SARS-CoV-2; TLR2 protein, human; Tlr2 protein, mouse; toll like receptor 2; virus antibody; virus vaccine; antibody; immunity; infectious disease; severe acute respiratory syndrome; vaccination; animal cell; animal experiment; animal tissue; Article; CD4+ T lymphocyte; controlled study; epithelium; gene expression; hematopoietic cell; immunocompetent cell; male; mouse; nonhuman; protein expression; respiratory system; respiratory virus; Severe acute respiratory syndrome coronavirus 2; vaccination; animal; human; lung; mucosal immunity; prevention and control; vaccination",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85141834495
Devkota H.P.; Adhikari-Devkota A.; Paudel K.R.; Panth N.; Gupta G.; Chellappan D.K.; Hansbro P.M.; Dua K.,"Devkota, Hari Prasad (24775939500); Adhikari-Devkota, Anjana (57200393104); Paudel, Keshav Raj (56539588400); Panth, Nisha (57094240100); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",24775939500; 57200393104; 56539588400; 57094240100; 15047988400; 35811890500; 6603119390; 15759138700,Phytochemicals and their Nanoformulations Targeted for Pulmonary Diseases,2022,Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases,,,,95,106,11,5,10.1007/978-981-16-4392-7_5,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85166140100&doi=10.1007%2f978-981-16-4392-7_5&partnerID=40&md5=22329f9374e1df18102ce1fbc79eaa10,"Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Program for Leading Graduate Schools, Health life science: Interdisciplinary and Glocal Oriented (HIGO) Program, Kumamoto, Japan; School of Life Science, University of Technology Sydney, Ultimo, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Department of Life Sciences, International Medical University, Kuala Lumpur, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia","Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan, Program for Leading Graduate Schools, Health life science: Interdisciplinary and Glocal Oriented (HIGO) Program, Kumamoto, Japan; Adhikari-Devkota A., Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Paudel K.R., School of Life Science, University of Technology Sydney, Ultimo, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Panth N., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Chellappan D.K., Department of Life Sciences, International Medical University, Kuala Lumpur, Malaysia; Hansbro P.M., School of Life Science, University of Technology Sydney, Ultimo, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia",Bioavailability; Nanoformulations; Phytochemicals; Polyphenols; Respiratory diseases,,Book chapter,Final,,Scopus,2-s2.0-85166140100
Chotirmall S.H.; Bogaert D.; Chalmers J.D.; Cox M.J.; Hansbro P.M.; Huang Y.J.; Molyneaux P.L.; O’Dwyer D.N.; Pragman A.A.; Rogers G.B.; Segal L.N.; Dickson R.P.,"Chotirmall, Sanjay H. (15757175700); Bogaert, Debby (55962909800); Chalmers, James D. (56648999600); Cox, Michael J. (55597087384); Hansbro, Philip M. (6603119390); Huang, Yvonne J. (35519582500); Molyneaux, Philip L. (43661539300); O’Dwyer, David N. (21234106500); Pragman, Alexa A. (6506451959); Rogers, Geraint B. (8888679600); Segal, Leopoldo N. (35184010000); Dickson, Robert P. (15052833100)",15757175700; 55962909800; 56648999600; 55597087384; 6603119390; 35519582500; 43661539300; 21234106500; 6506451959; 8888679600; 35184010000; 15052833100,Therapeutic Targeting of the Respiratory Microbiome,2022,American Journal of Respiratory and Critical Care Medicine,206,5,,535,544,9,42,10.1164/rccm.202112-2704PP,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136527960&doi=10.1164%2frccm.202112-2704PP&partnerID=40&md5=813897e44d842e2523db609ba414722f,"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore; Center for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom; Department of Paediatric Immunology and Infectious Diseases, University Medical Center Utrecht, Utrecht, Netherlands; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom; Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, United States; Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, United States; National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Medicine, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, United States; Department of Medicine, University of Minnesota, Minneapolis, MN, United States; Microbiome and Host Health, South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Infection and Immunity, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia; Division of Pulmonary, Critical Care, and Sleep Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, United States; Weil Institute for Critical Care Research and Innovation, Ann Arbor, MI, United States","Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore; Bogaert D., Center for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom, Department of Paediatric Immunology and Infectious Diseases, University Medical Center Utrecht, Utrecht, Netherlands; Chalmers J.D., Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom; Cox M.J., Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Huang Y.J., Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, United States, Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, United States; Molyneaux P.L., National Heart and Lung Institute, Imperial College London, London, United Kingdom; O’Dwyer D.N., Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, United States; Pragman A.A., Department of Medicine, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, United States, Department of Medicine, University of Minnesota, Minneapolis, MN, United States; Rogers G.B., Microbiome and Host Health, South Australian Health and Medical Research Institute, Adelaide, SA, Australia, Infection and Immunity, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia; Segal L.N., Division of Pulmonary, Critical Care, and Sleep Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, United States; Dickson R.P., Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, United States, Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, United States, Weil Institute for Critical Care Research and Innovation, Ann Arbor, MI, United States",,antibiotic agent; azithromycin; clarithromycin; corticosteroid; cotrimoxazole; doxycycline; erythromycin; probiotic agent; tobramycin; access to information; Article; bacterial immunity; clinician; comprehension; drug exposure; ecology; intestine flora; lung disease; lung microbiota; microbiology; nonhuman; pathogenesis; pathophysiology; phenotype; randomized controlled trial (topic); target organism; therapy effect,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85136527960
Liu G.; Philp A.M.; Corte T.; Travis M.A.; Schilter H.; Hansbro N.G.; Burns C.J.; Eapen M.S.; Sohal S.S.; Burgess J.K.; Hansbro P.M.,"Liu, Gang (57189061134); Philp, Ashleigh M. (57311488900); Corte, Tamera (57220408326); Travis, Mark A. (36797986000); Schilter, Heidi (23480284500); Hansbro, Nicole G. (15055862300); Burns, Chris J. (7201835134); Eapen, Mathew S. (56625716100); Sohal, Sukhwinder S. (36449981500); Burgess, Janette K. (7201650628); Hansbro, Philip M. (6603119390)",57189061134; 57311488900; 57220408326; 36797986000; 23480284500; 15055862300; 7201835134; 56625716100; 36449981500; 7201650628; 6603119390,Therapeutic targets in lung tissue remodelling and fibrosis,2021,Pharmacology and Therapeutics,225,,107839,,,,146,10.1016/j.pharmthera.2021.107839,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103944297&doi=10.1016%2fj.pharmthera.2021.107839&partnerID=40&md5=71a2a449000d3696eeaa5d7949cbaf5d,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; St Vincent's Medical School, UNSW Medicine, UNSW, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre and Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom; Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, NSW, Australia; Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, The University of Melbourne, Melbourne, 3010, VIC, Australia; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, TAS, Australia; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Pathology and Medical Biology, Groningen, Netherlands; Woolcock Institute of Medical Research, Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia","Liu G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Philp A.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia, St Vincent's Medical School, UNSW Medicine, UNSW, Sydney, NSW, Australia; Corte T., Royal Prince Alfred Hospital, Camperdown, NSW, Australia, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Travis M.A., The Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre and Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, United Kingdom; Schilter H., Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Burns C.J., Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, The University of Melbourne, Melbourne, 3010, VIC, Australia; Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, TAS, Australia; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, TAS, Australia; Burgess J.K., University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Pathology and Medical Biology, Groningen, Netherlands, Woolcock Institute of Medical Research, Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia",Asthma; Collagen; COPD; COVID-19; Extracellular matrix; Fibroblasts; Fibrosis; IPF; Remodelling,"Airway Remodeling; Asthma; Calcium-Binding Proteins; Extracellular Matrix; Fibroblasts; Fibrosis; Glycoproteins; Humans; Idiopathic Pulmonary Fibrosis; Lung Diseases; Matrix Metalloproteinases; Pulmonary Disease, Chronic Obstructive; Transforming Growth Factor beta; 66ga cvp 8; aclidinium bromide; alpha interferon; ang 3070; antiasthmatic agent; antiinflammatory agent; arformoterol; avid 200; aviptadil; bbt 877; beclometasone; belumosudil; bemcentinib; benralizumab; bg00011; bld 2660; bms 986020; bms 986262; bms 986278; bot 191; budesonide; cc 90001; ciclesonide; collagen; elastin; famitinib levo malate; fezagepras; fibronectin; fibulin; fluticasone; formoterol; fp 025; fp r 01mg; fresolimumab; gamma1b interferon; glpg 1205; glycoprotein; glycopyrronium; hec 68498; ianalumab; idl 2965; imatinib; indacaterol; ipratropium bromide; iw 001; laminin; lebrikizumab; leukotriene derivative; levalbuterol; matrix metalloproteinase; mepolizumab; methylprednisolone; mg s 2525; midismase; mmi 0100; mometasone furoate; montelukast; mor 107; nintedanib; olodaterol; omalizumab; omipalisib; pamrevlumab; pamufetinib; pbf 1129; pirfenidone; pln 74809; prednisone; proteoglycan; pxs 5338; pxs 5382a; recombinant thrombomodulin; reslizumab; rg6354; roflumilast; romilkimab; rvt 1601; salbutamol; salmeterol; setanaxib; simtuzumab; td139; tenascin; theophylline; tiotropium bromide; tipelukast; tissue inhibitor of metalloproteinase; tralokinumab; transforming growth factor beta; umeclidinium; unclassified drug; vilanterol; vismodegib; vitronectin; zafirlukast; zileution; ziritaxestat; zl 2102; calcium binding protein; fibulin; glycoprotein; matrix metalloproteinase; transforming growth factor beta; airway remodeling; airway smooth muscle cell; asthma; cell activation; cell differentiation; chronic obstructive lung disease; clinical feature; combination chemotherapy; drug mechanism; extracellular matrix; fibroblast; fibrosing alveolitis; human; lung alveolus wall; lung blood vessel; lung fibrosis; lung parenchyma; macromolecule; microvasculature; myofibroblast; priority journal; respiratory epithelium; respiratory tract disease; Review; systematic review; fibrosing alveolitis; fibrosis; lung disease; metabolism; pathophysiology; physiology",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85103944297
Paudel K.R.; Panth N.; Manandhar B.; Singh S.K.; Gupta G.; Wich P.R.; Nammi S.; Macloughlin R.; Adams J.; Warkiani M.E.; Chellappan D.K.; Oliver B.G.; Hansbro P.M.; Dua K.,"Paudel, Keshav Raj (56539588400); Panth, Nisha (57094240100); Manandhar, Bikash (57204448260); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Wich, Peter R. (7801599835); Nammi, Srinivas (6602547699); Macloughlin, Ronan (57212263206); Adams, Jon (35584313300); Warkiani, Majid Ebrahimi (36138999000); Chellappan, Dinesh Kumar (35811890500); Oliver, Brian G. (15919869900); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",56539588400; 57094240100; 57204448260; 57206711834; 15047988400; 7801599835; 6602547699; 57212263206; 35584313300; 36138999000; 35811890500; 15919869900; 6603119390; 15759138700,"Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 Cells",2022,Antioxidants,11,5,873,,,,36,10.3390/antiox11050873,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129137160&doi=10.3390%2fantiox11050873&partnerID=40&md5=6505d7d704113bbc64990169ac083037,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, 302017, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Uttarakhand, Dehradun, 248007, India; School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Australian Centre for NanoMedicine and Centre for Advanced Macromolecular Design, University of New South Wales, Sydney, 2052, NSW, Australia; School of Science, Western Sydney University, Penrith, 2751, NSW, Australia; IDA Business Park, Connacht, Galway, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Leinster, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Leinster, Dublin, D02 PN40, Ireland; School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, SGR, Kuala Lumpur, 57000, Malaysia; Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia","Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Panth N., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi GT Road, Punjab, Phagwara, 144411, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Rajasthan, Jaipur, 302017, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Uttarakhand, Dehradun, 248007, India; Wich P.R., School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia, Australian Centre for NanoMedicine and Centre for Advanced Macromolecular Design, University of New South Wales, Sydney, 2052, NSW, Australia; Nammi S., School of Science, Western Sydney University, Penrith, 2751, NSW, Australia; Macloughlin R., IDA Business Park, Connacht, Galway, H91 HE94, Ireland, School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Leinster, Dublin, D02 YN77, Ireland, School of Pharmacy & Pharmaceutical Sciences, Trinity College, Leinster, Dublin, D02 PN40, Ireland; Adams J., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Warkiani M.E., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, SGR, Kuala Lumpur, 57000, Malaysia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia",airway inflammation; berberine; cigarette smoking; liquid crystalline nanoparticles; oxidative stress; senescence,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85129137160
Lu Z.; van Eeckhoutte H.P.; Liu G.; Nair P.M.; Jones B.; Gillis C.M.; Nalkurthi B.C.; Verhamme F.; Buyle-Huybrecht T.; Vandenabeele P.; Vanden Berghe T.; Brusselle G.G.; Horvat J.C.; Murphy J.M.; Wark P.A.; Bracke K.R.; Fricker M.; Hansbro P.M.,"Lu, Zhe (57267339000); van Eeckhoutte, Hannelore P. (57212378504); Liu, Gang (57189061134); Nair, Prema M. (55749131000); Jones, Bernadette (56215070300); Gillis, Caitlin M. (55780837800); Nalkurthi, B. Christina (57255507700); Verhamme, Fien (56008794900); Buyle-Huybrecht, Tamariche (57267554600); Vandenabeele, Peter (7005733218); Vanden Berghe, Tom (6603179568); Brusselle, Guy G. (57197253407); Horvat, Jay C. (9942405300); Murphy, James M. (56365677400); Wark, Peter A. (7003559516); Bracke, Ken R. (8338303000); Fricker, Michael (26638839800); Hansbro, Philip M. (6603119390)",57267339000; 57212378504; 57189061134; 55749131000; 56215070300; 55780837800; 57255507700; 56008794900; 57267554600; 7005733218; 6603179568; 57197253407; 9942405300; 56365677400; 7003559516; 8338303000; 26638839800; 6603119390,"Necroptosis signaling promotes inflammation, airway remodeling, and emphysema in chronic obstructive pulmonary disease",2021,American Journal of Respiratory and Critical Care Medicine,204,6,,667,681,14,115,10.1164/rccm.202009-3442OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111386814&doi=10.1164%2frccm.202009-3442OC&partnerID=40&md5=5c76ccdd23d3ba6c28479f7d42474f8c,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; VIB Center for Inflammation Research, Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium; Methusalem Program: Cell Death Activity Regulation in Inflammation and Cancer, Ghent University, Ghent, Belgium; Department Biomedical Sciences, University of Antwerp, Antwerp, Belgium; Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Melbourne, VIC, Australia; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia","Lu Z., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; van Eeckhoutte H.P., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Liu G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Nair P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Jones B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Gillis C.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia, VIB Center for Inflammation Research, Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium, Methusalem Program: Cell Death Activity Regulation in Inflammation and Cancer, Ghent University, Ghent, Belgium; Nalkurthi B.C., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Verhamme F., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Buyle-Huybrecht T., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Vandenabeele P., VIB Center for Inflammation Research, Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium, Methusalem Program: Cell Death Activity Regulation in Inflammation and Cancer, Ghent University, Ghent, Belgium; Vanden Berghe T., VIB Center for Inflammation Research, Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium, Methusalem Program: Cell Death Activity Regulation in Inflammation and Cancer, Ghent University, Ghent, Belgium, Department Biomedical Sciences, University of Antwerp, Antwerp, Belgium; Brusselle G.G., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Murphy J.M., Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Melbourne, VIC, Australia, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Bracke K.R., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Fricker M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia",Apoptosis; COPD; Inflammation; Necroptosis; Remodeling,"Airway Remodeling; Animals; Case-Control Studies; Cigarette Smoking; Disease Progression; Humans; Inflammation; Linear Models; Mice; Necroptosis; Protein Kinases; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; caspase 3; CXCL1 chemokine; macrophage elastase; marco protein; messenger RNA; mip1a protein; mlkl protein; neutrophil collagenase; protein; quinoline; ripk1 protein; unclassified drug; ym1 protein; MLKL protein, human; MLKL protein, mouse; protein kinase; receptor interacting protein serine threonine kinase; RIPK3 protein, human; Ripk3 protein, mouse; adult; age; airway remodeling; animal cell; animal experiment; animal model; animal tissue; apoptosis; Article; cell death; cells; chronic obstructive lung disease; controlled study; emphysema; enzyme inhibition; epithelium; human; immunoblotting; immunocompetent cell; immunohistochemistry; inflammation; leukocyte; lung alveolus macrophage; lung resection; macrophage; male; mouse; necroptosis; neutrophil; nonhuman; pathogenesis; people by smoking status; real time polymerase chain reaction; respiratory epithelium; respiratory tract inflammation; RNA sequencing; sex difference; signal transduction; upregulation; adverse event; animal; case control study; chronic obstructive lung disease; cigarette smoking; disease exacerbation; inflammation; lung emphysema; metabolism; pathophysiology; signal transduction; statistical model",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85111386814
Imran M.; Jha S.K.; Hasan N.; Insaf A.; Shrestha J.; Shrestha J.; Devkota H.P.; Khan S.; Panth N.; Warkiani M.E.; Dua K.; Hansbro P.M.; Paudel K.R.; Mohammed Y.,"Imran, Mohammad (57209466043); Jha, Saurav Kumar (57210712565); Hasan, Nazeer (58494592400); Insaf, Areeba (57211627631); Shrestha, Jitendra (57200500479); Shrestha, Jesus (57214237167); Devkota, Hari Prasad (24775939500); Khan, Salman (57490469600); Panth, Nisha (57094240100); Warkiani, Majid Ebrahimi (36138999000); Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390); Paudel, Keshav Raj (56539588400); Mohammed, Yousuf (56116912300)",57209466043; 57210712565; 58494592400; 57211627631; 57200500479; 57214237167; 24775939500; 57490469600; 57094240100; 36138999000; 15759138700; 6603119390; 56539588400; 56116912300,Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems,2022,Pharmaceutics,14,3,586,,,,34,10.3390/pharmaceutics14030586,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126444967&doi=10.3390%2fpharmaceutics14030586&partnerID=40&md5=54ee07989d4e822a1b81ceea42660b46,"Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Department of Biomedicine, Health and Life Convergence Sciences, Mokpo National University, Jeonnam, 58554, South Korea; Department of Pharmacognosy and Phytochemistry, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017, India; College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Jeonnam, 58554, South Korea; School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, Australia; Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo ku, Kumamoto, 862-0973, Japan; Department of Public Health, School of Allied Health Sciences, Noida International University, Greater Noida, 203201, India; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Therapeutics Research Group, The University of Queensland Diamantina Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, Australia","Imran M., Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Jha S.K., Department of Biomedicine, Health and Life Convergence Sciences, Mokpo National University, Jeonnam, 58554, South Korea; Hasan N., Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Insaf A., Department of Pharmacognosy and Phytochemistry, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017, India; Shrestha J., College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Jeonnam, 58554, South Korea; Shrestha J., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, Australia; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo ku, Kumamoto, 862-0973, Japan; Khan S., Department of Public Health, School of Allied Health Sciences, Noida International University, Greater Noida, 203201, India; Panth N., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Warkiani M.E., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, 2007, Australia; Dua K., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, Australia; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, Australia; Mohammed Y., Therapeutics Research Group, The University of Queensland Diamantina Institute, Faculty of Medicine, University of Queensland, Brisbane, 4102, Australia",Antimicrobial resistance; Drug delivery; Lipid-based nanocarriers; Microfluidics; Nanoparticles; Resistance mechanism,antibiotic agent; dendrimer; gold nanoparticle; liposome; nanocarrier; peptidoglycan; polymer nanoparticle; reactive oxygen metabolite; silver nanoparticle; solid lipid nanoparticle; titanium dioxide nanoparticle; zinc oxide nanoparticle; adaptive immunity; antibiotic resistance; antimicrobial therapy; Aspergillus fumigatus; Aspergillus niger; Bacillus subtilis; bacterial cell wall; biofilm; biotransformation; Burkholderia cepacia; Candida albicans; cell wall; DNA damage; drug delivery system; Escherichia coli; gene transfer; immune response; innate immunity; intracellular signaling; Klebsiella pneumoniae; methicillin resistant Staphylococcus aureus; multidrug resistance; nanodelivery system; nanotechnology; nonhuman; oxidative stress; plasmid; protein synthesis; Pseudomonas aeruginosa; Review; Salmonella enterica serovar Abortus equi; Staphylococcus aureus; Staphylococcus epidermidis,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85126444967
Chellappan D.K.; Paudel K.R.; Tan N.W.; Cheong K.S.; Khoo S.S.Q.; Seow S.M.; Chellian J.; Candasamy M.; Patel V.K.; Arora P.; Singh P.K.; Singh S.K.; Gupta G.; Oliver B.G.; Hansbro P.M.; Dua K.,"Chellappan, Dinesh Kumar (35811890500); Paudel, Keshav Raj (56539588400); Tan, Nian Wan (57906998200); Cheong, Ka Seng (57908173800); Khoo, Samantha Sert Qi (57908173900); Seow, Su Min (57907383900); Chellian, Jestin (56993705500); Candasamy, Mayuren (56190844000); Patel, Vyoma K. (57193533009); Arora, Poonam (56450245700); Singh, Pankaj Kumar (57212591654); Singh, Sachin Kumar (57206711834); Gupta, Gaurav (15047988400); Oliver, Brian G. (15919869900); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",35811890500; 56539588400; 57906998200; 57908173800; 57908173900; 57907383900; 56993705500; 56190844000; 57193533009; 56450245700; 57212591654; 57206711834; 15047988400; 15919869900; 6603119390; 15759138700,Targeting the mitochondria in chronic respiratory diseases,2022,Mitochondrion,67,,,15,37,22,24,10.1016/j.mito.2022.09.003,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138826284&doi=10.1016%2fj.mito.2022.09.003&partnerID=40&md5=38af93233718c8e81b43d17b0797a30b,"Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, 2052, NSW, Australia; Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India; Department of Pharmacognosy and Phytochemistry, SGT College of Pharmacy, SGT University, Haryana, Gurugram, India; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Telangana, Hyderabad, 500037, India; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Jagatpura, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia","Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Tan N.W., School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Cheong K.S., School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Khoo S.S.Q., School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Seow S.M., School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Candasamy M., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Patel V.K., School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, 2052, NSW, Australia, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Arora P., Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India, Department of Pharmacognosy and Phytochemistry, SGT College of Pharmacy, SGT University, Haryana, Gurugram, India; Singh P.K., Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Telangana, Hyderabad, 500037, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Punjab, Phagwara, India, Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Jagatpura, India, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Oliver B.G., School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Dua K., Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia",Asthma; COPD; Lung cancer; Mitochondria; Oxidative stress,"Asthma; Humans; Lung; Lung Neoplasms; Mitochondria; Pulmonary Disease, Chronic Obstructive; adenosine triphosphate; alpha tocopherol; antiinflammatory agent; antioxidant; beta adrenergic receptor stimulating agent; calcium ion; corticosteroid; ivacaftor; long acting drug; mitochondrial enzyme; mitochondrial protein; myricetin; nanoparticle; natural product; reactive oxygen metabolite; resveratrol; short acting drug; tobacco smoke; asthma; autophagy (cellular); biosynthesis; calcium balance; calcium cell level; cancer epidemiology; cell aging; cell component; cell shape; chronic obstructive lung disease; chronic respiratory tract disease; cystic fibrosis; cytosol; disorders of mitochondrial functions; drug efficacy; drug targeting; energy yield; environmental factor; gene; gene control; gene function; gene therapy; human; lung cancer; lung carcinogenesis; lung fibrosis; mesenchymal stroma cell; metabolic parameters; mitochondria related gene; mitochondrial respiration; mitophagy; molecular biology; nonhuman; oxidative stress; pathogenesis; pathophysiology; personalized medicine; protein synthesis; respiratory tract infection; respiratory tract inflammation; Review; target cell; asthma; chronic obstructive lung disease; lung; lung tumor; metabolism; mitochondrion; pathology",Review,Final,,Scopus,2-s2.0-85138826284
Liu G.; Jarnicki A.G.; Paudel K.R.; Lu W.; Wadhwa R.; Philp A.M.; Van Eeckhoutte H.; Marshall J.E.; Malyla V.; Katsifis A.; Fricker M.; Hansbro N.G.; Dua K.; Kermani N.Z.; Eapen M.S.; Tiotiu A.; Chung K.F.; Caramori G.; Bracke K.; Adcock I.M.; Sohal S.S.; Wark P.A.; Oliver B.G.; Hansbro P.M.,"Liu, Gang (57189061134); Jarnicki, Andrew G. (6603137164); Paudel, Keshav R. (56539588400); Lu, Wenying (57202573402); Wadhwa, Ridhima (57159091700); Philp, Ashleigh M. (57311488900); Van Eeckhoutte, Hannelore (57212378504); Marshall, Jacqueline E. (57218547927); Malyla, Vamshikrishna (57205128961); Katsifis, Angelica (58025234400); Fricker, Michael (26638839800); Hansbro, Nicole G. (15055862300); Dua, Kamal (15759138700); Kermani, Nazanin Z. (57195464650); Eapen, Mathew S. (56625716100); Tiotiu, Angelica (23499586600); Chung, K. Fan (35403525000); Caramori, Gaetano (7003847659); Bracke, Ken (8338303000); Adcock, Ian M. (7007066538); Sohal, Sukhwinder S. (36449981500); Wark, Peter A. (7003559516); Oliver, Brian G. (15919869900); Hansbro, Philip M. (6603119390)",57189061134; 6603137164; 56539588400; 57202573402; 57159091700; 57311488900; 57212378504; 57218547927; 57205128961; 58025234400; 26638839800; 15055862300; 15759138700; 57195464650; 56625716100; 23499586600; 35403525000; 7003847659; 8338303000; 7007066538; 36449981500; 7003559516; 15919869900; 6603119390,Adverse roles of mast cell chymase-1 in COPD,2022,European Respiratory Journal,60,6,2101431,,,,23,10.1183/13993003.01431-2021,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85144504766&doi=10.1183%2f13993003.01431-2021&partnerID=40&md5=da09a9c1d801d6c3f69f3998fac1cf7d,"Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, Australia; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Australia; St Vincent’s Medical School, University of New South Wales Medicine, University of New South Wales, Sydney, Australia; Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Pulmonology, University Hospital of Nancy, Nancy, France; UOC di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Woolcock Institute, School of Life Science, Faculty of Science Life Science, University of Technology Sydney, Sydney, Australia","Liu G., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Jarnicki A.G., Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Lu W., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Australia; Wadhwa R., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Philp A.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia, St Vincent’s Medical School, University of New South Wales Medicine, University of New South Wales, Sydney, Australia; Van Eeckhoutte H., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Marshall J.E., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Malyla V., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Katsifis A., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Fricker M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Dua K., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; Kermani N.Z., Data Science Institute, Department of Computing, Imperial College London, London, United Kingdom; Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Australia; Tiotiu A., National Heart and Lung Institute, Imperial College London, London, United Kingdom, Department of Pulmonology, University Hospital of Nancy, Nancy, France; Chung K.F., National Heart and Lung Institute, Imperial College London, London, United Kingdom; Caramori G., UOC di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Bracke K., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Adcock I.M., National Heart and Lung Institute, Imperial College London, London, United Kingdom; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, University of Tasmania, Launceston, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Oliver B.G., Woolcock Institute, School of Life Science, Faculty of Science Life Science, University of Technology Sydney, Sydney, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia",,"Airway Remodeling; Animals; Chymases; Emphysema; Humans; Inflammation; Lung; Mast Cells; Mice; Mice, Inbred C57BL; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Tumor Necrosis Factor-alpha; chymase; chymase 1; chymase inhibitor; mast cell protease 5; membrane protein; tumor necrosis factor; unclassified drug; chymase; tumor necrosis factor; airway remodeling; animal cell; animal experiment; animal model; animal tissue; antiinflammatory activity; Article; bioaccumulation; cell activation; chronic obstructive lung disease; controlled study; disease severity; drug potency; drug targeting; enzyme activity; ex vivo study; human; human cell; human tissue; in vitro study; lung alveolus macrophage; lung emphysema; lung fibrosis; lung function; lung parenchyma; mast cell; mast cell degranulation; mouse; nonhuman; protein protein interaction; respiratory tract inflammation; smoking; wild type mouse; animal; C57BL mouse; complication; emphysema; inflammation; lung; lung emphysema; metabolism",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85144504766
Paudel K.R.; Patel V.; Vishwas S.; Gupta S.; Sharma S.; Chan Y.; Jha N.K.; Shrestha J.; Imran M.; Panth N.; Shukla S.D.; Jha S.K.; Devkota H.P.; Warkiani M.E.; Singh S.K.; Ali M.K.; Gupta G.; Chellappan D.K.; Hansbro P.M.; Dua K.,"Paudel, Keshav Raj (56539588400); Patel, Vyoma (57193533009); Vishwas, Sukriti (57216932631); Gupta, Saurabh (57214718590); Sharma, Sumit (55491684400); Chan, Yinghan (57204707263); Jha, Niraj Kumar (55109018100); Shrestha, Jesus (57214237167); Imran, Mohammad (57209466043); Panth, Nisha (57094240100); Shukla, Shakti Dhar (56367620800); Jha, Saurav Kumar (57210712565); Devkota, Hari Prasad (24775939500); Warkiani, Majid Ebrahimi (36138999000); Singh, Sachin Kumar (57206711834); Ali, Md Khadem (57194408422); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",56539588400; 57193533009; 57216932631; 57214718590; 55491684400; 57204707263; 55109018100; 57214237167; 57209466043; 57094240100; 56367620800; 57210712565; 24775939500; 36138999000; 57206711834; 57194408422; 15047988400; 35811890500; 6603119390; 15759138700,Nutraceuticals and COVID-19: A mechanistic approach toward attenuating the disease complications,2022,Journal of Food Biochemistry,46,12,e14445,,,,16,10.1111/jfbc.14445,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85139866493&doi=10.1111%2fjfbc.14445&partnerID=40&md5=44188f0bc88b53752c2021a11681076c,"Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India; Delhi Pharmaceutical Sciences and Research University, New Delhi, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Nioda, India; School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia; Therapeutics Research Group, The University of Queensland Diamantina Institute, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia; Department of Biomedicine, Health and Life Convergence Sciences, Biomedical and Healthcare Research Institute, Mokpo National University, Muan, South Korea; Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, CA, United States; Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, Stanford, CA, United States; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India","Paudel K.R., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Patel V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; Vishwas S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India; Gupta S., Delhi Pharmaceutical Sciences and Research University, New Delhi, India; Sharma S., Delhi Pharmaceutical Sciences and Research University, New Delhi, India; Chan Y., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Jha N.K., Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Nioda, India; Shrestha J., School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia; Imran M., Therapeutics Research Group, The University of Queensland Diamantina Institute, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia; Panth N., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Shukla S.D., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia; Jha S.K., Department of Biomedicine, Health and Life Convergence Sciences, Biomedical and Healthcare Research Institute, Mokpo National University, Muan, South Korea; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Warkiani M.E., School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Singh S.K., Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India; Ali M.K., Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, CA, United States, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, Stanford, CA, United States; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Hansbro P.M., Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia",COVID-19; nutraceuticals; probiotics; vitamins,"COVID-19; Dietary Supplements; Humans; Plants, Medicinal; Probiotics; Vitamins; Additives; Immune system; Polyunsaturated fatty acids; Probiotics; Search engines; Vitamins; probiotic agent; vitamin; 'current; Drug candidates; Large-scales; Mechanistics; Nutraceuticals; Potential drug; Probiotics; Property; Shelf life; Viral infections; dietary supplement; human; medicinal plant; COVID-19",Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85139866493
Alnuqaydan A.M.; Almutary A.G.; Azam M.; Manandhar B.; Yin G.H.S.; Yen L.L.; Madheswaran T.; Paudel K.R.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Alnuqaydan, Abdullah M. (56400959400); Almutary, Abdulmajeed G. (57190179251); Azam, Mohd (58133354900); Manandhar, Bikash (57204448260); Yin, Geena Hew Suet (57457446400); Yen, Lee Li (57457722500); Madheswaran, Thiagarajan (55505311000); Paudel, Keshav Raj (56539588400); Hansbro, Philip M. (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",56400959400; 57190179251; 58133354900; 57204448260; 57457446400; 57457722500; 55505311000; 56539588400; 6603119390; 35811890500; 15759138700,Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine–Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro,2022,Pharmaceutics,14,6,1119,,,,28,10.3390/pharmaceutics14061119,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85131546029&doi=10.3390%2fpharmaceutics14061119&partnerID=40&md5=0bc5f4bb04d0898eee08bc067e6461e8,"Department of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India","Alnuqaydan A.M., Department of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Almutary A.G., Department of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Azam M., Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraidah, 51452, Saudi Arabia; Manandhar B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Yin G.H.S., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Yen L.L., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Paudel K.R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, India",berberine; human lung adenocarcinoma A549 cell; liquid crystalline nanoparticles; migration; mRNA expression; non-small-cell lung cancer; proliferation; protein expression,berberine; messenger RNA; nanoparticle; pytantriol liquid crystalline nanoparticle; unclassified drug; A-549 cell line; antineoplastic activity; antiproliferative activity; Article; colony formation; controlled study; dispersity; down regulation; drug cytotoxicity; drug release; drug screening; drug structure; encapsulation efficiency; gene expression regulation; human; human cell; in vitro study; KRT18 gene; migration inhibition; mitosis inhibition; non small cell lung cancer; particle size; physical chemistry; physical parameters; process optimization; PTEN gene; tumor suppressor gene; tumor-related gene; upregulation; zeta potential,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85131546029
Skerrett-Byrne D.A.; Bromfield E.G.; Murray H.C.; Jamaluddin M.F.B.; Jarnicki A.G.; Fricker M.; Essilfie A.T.; Jones B.; Haw T.J.; Hampsey D.; Anderson A.L.; Nixon B.; Scott R.J.; Wark P.A.B.; Dun M.D.; Hansbro P.M.,"Skerrett-Byrne, David A. (57200648755); Bromfield, Elizabeth G. (55143329400); Murray, Heather C. (55812679200); Jamaluddin, M. Fairuz B. (49061059500); Jarnicki, Andrew G. (6603137164); Fricker, Michael (26638839800); Essilfie, Ama T. (22955585600); Jones, Bernadette (56215070300); Haw, Tatt J. (56625918900); Hampsey, Daniel (55383350800); Anderson, Amanda L. (36055954400); Nixon, Brett (34571659200); Scott, Rodney J. (7404341627); Wark, Peter A. B. (7003559516); Dun, Matthew D. (36547795700); Hansbro, Philip M. (6603119390)",57200648755; 55143329400; 55812679200; 49061059500; 6603137164; 26638839800; 22955585600; 56215070300; 56625918900; 55383350800; 36055954400; 34571659200; 7404341627; 7003559516; 36547795700; 6603119390,Time-resolved proteomic profiling of cigarette smoke-induced experimental chronic obstructive pulmonary disease,2021,Respirology,26,10,,960,973,13,20,10.1111/resp.14111,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109167011&doi=10.1111%2fresp.14111&partnerID=40&md5=7246e291b412aab9f6bfbe83c1b1e3bb,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia; Pregnancy and Reproduction Program, Hunter Medical Research Institute, Newcastle, NSW, Australia; University of Newcastle, Callaghan, NSW, Australia; Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands; Cancer Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia; Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, Australia; Queensland Institute of Medical Research, Herston, QLD, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia","Skerrett-Byrne D.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, Pregnancy and Reproduction Program, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia; Bromfield E.G., Pregnancy and Reproduction Program, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands; Murray H.C., University of Newcastle, Callaghan, NSW, Australia, Cancer Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia; Jamaluddin M.F.B., University of Newcastle, Callaghan, NSW, Australia, Cancer Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia; Jarnicki A.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, Australia; Fricker M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia; Essilfie A.T., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, Queensland Institute of Medical Research, Herston, QLD, Australia; Jones B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia; Haw T.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia; Hampsey D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia; Anderson A.L., Pregnancy and Reproduction Program, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia; Nixon B., Pregnancy and Reproduction Program, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia; Scott R.J., University of Newcastle, Callaghan, NSW, Australia, Cancer Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia; Dun M.D., University of Newcastle, Callaghan, NSW, Australia, Cancer Research Program, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Newcastle, Callaghan, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia",biomarkers; cigarette smoke; emphysema; experimental chronic obstructive pulmonary disease; mouse model; proteomics; therapeutic targets,"Animals; Disease Models, Animal; Lung; Mice; Proteomics; Pulmonary Disease, Chronic Obstructive; Smoke; Smoking; cigarette smoke; heterogeneous nuclear ribonucleoprotein group C; proteome; adult; animal experiment; animal model; animal tissue; Article; bronchus biopsy; chronic obstructive lung disease; clinical article; clinical feature; cohort analysis; controlled study; disease exacerbation; disorders of mitochondrial functions; emphysema; female; human; human tissue; inflammation; lung parenchyma; male; middle aged; mouse; nonhuman; oxidative stress; pathogenesis; protein expression; protein fingerprinting; proteomics; RNA synthesis; validation process; adverse event; animal; disease model; lung; proteomics; smoke; smoking",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85109167011
Flood R.L.; Danzenbaker M.; Hansbro P.M.; Rogers C.; Tanoi H.; Tanoi S.,"Flood, Robert L. (16835953300); Danzenbaker, Mike (57196003807); Hansbro, Philip M. (6603119390); Rogers, Colin (57913277000); Tanoi, Hiroyuki (57913489900); Tanoi, Shoko (57912840500)",16835953300; 57196003807; 6603119390; 57913277000; 57913489900; 57912840500,"More New Zealand Storm Petrels Fregetta maoriana off Gau Island, Fiji, in May 2022",2022,Bulletin of the British Ornithologists' Club,142,3,,380,382,2,2,10.25226/bboc.v142i3.2022.a11,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85139124020&doi=10.25226%2fbboc.v142i3.2022.a11&partnerID=40&md5=fa8467656a21cde0d93237dfe7d9f0e4,"FitzPatrick Institute of African Ornithology, DST-NRF Centre of Excellence, University of Cape Town, Rondebosch, 7701, South Africa; 13164 Diericx Dr., Mountain View, 94040, CA, United States; Centenary UTS Centre for Inflammation, University of Technology Sydney, 15 Broadway, Ultimo, 2007, NSW, Australia; 6 Flavel Avenue, Woodforde, Adelaide, 5072, SA, Australia; Ecoris Inc., 5-3-21 Nakada, Taihaku Miyagi, Sendai, 981-1104, Japan","Flood R.L., FitzPatrick Institute of African Ornithology, DST-NRF Centre of Excellence, University of Cape Town, Rondebosch, 7701, South Africa; Danzenbaker M., 13164 Diericx Dr., Mountain View, 94040, CA, United States; Hansbro P.M., Centenary UTS Centre for Inflammation, University of Technology Sydney, 15 Broadway, Ultimo, 2007, NSW, Australia; Rogers C., 6 Flavel Avenue, Woodforde, Adelaide, 5072, SA, Australia; Tanoi H., Ecoris Inc., 5-3-21 Nakada, Taihaku Miyagi, Sendai, 981-1104, Japan; Tanoi S., Ecoris Inc., 5-3-21 Nakada, Taihaku Miyagi, Sendai, 981-1104, Japan",,,Article,Final,All Open Access; Gold Open Access,Scopus,2-s2.0-85139124020
Pathinayake P.S.; Waters D.W.; Nichol K.S.; Brown A.C.; Reid A.T.; Hsu A.C.-Y.; Horvat J.C.; Wood L.G.; Baines K.J.; Simpson J.L.; Gibson P.G.; Hansbro P.M.; Wark P.A.B.,"Pathinayake, Prabuddha S. (55877978000); Waters, David W. (57194028630); Nichol, Kristy S. (57195914143); Brown, Alexandra C. (55637745000); Reid, Andrew T. (39561518600); Hsu, Alan Chen-Yu (49861516600); Horvat, Jay C. (9942405300); Wood, Lisa G. (55859741700); Baines, Katherine J. (35078051200); Simpson, Jodie L. (7404326026); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390); Wark, Peter A.B. (58166423200)",55877978000; 57194028630; 57195914143; 55637745000; 39561518600; 49861516600; 9942405300; 55859741700; 35078051200; 7404326026; 7202414199; 6603119390; 58166423200,Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma,2022,Thorax,77,5,,443,451,8,24,10.1136/thoraxjnl-2020-215979,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122081542&doi=10.1136%2fthoraxjnl-2020-215979&partnerID=40&md5=7c52bf753cf507d4feb29e9d73fffad9,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia; NHMRC Centre for Clinical Research Excellence in Severe Asthma, New Lambton Heights, NSW, Australia; Centre for Inflammation, Centenary Institute, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia","Pathinayake P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia; Waters D.W., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Nichol K.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Reid A.T., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Hsu A.C.-Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Baines K.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia; Simpson J.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia; Gibson P.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia, NHMRC Centre for Clinical Research Excellence in Severe Asthma, New Lambton Heights, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Centre for Inflammation, Centenary Institute, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, The University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia, NHMRC Centre for Clinical Research Excellence in Severe Asthma, New Lambton Heights, NSW, Australia",,Animals; Asthma; Endoplasmic Reticulum; Humans; Inflammation; Mice; Neutrophils; Signal Transduction; Unfolded Protein Response; chaperone; cryopyrin; CXCL1 chemokine; endoplasmic reticulum chaperone BiP; growth arrest and DNA damage inducible protein 153; interleukin 13; interleukin 17F; interleukin 1beta; interleukin 4; interleukin 8; protein CALR; protein CANX; protein DERL1; protein EDEM1; protein PPP1R15A; tumor necrosis factor; unclassified drug; adult; aged; apoptosis; Article; asthma; biological model; bronchus biopsy; cellular stress signal; clinical article; cohort analysis; controlled study; CXCL1 gene; disease severity; endoplasmic reticulum stress; eosinophilic asthma; female; forced expiratory volume; human; human cell; human tissue; IL 13 gene; IL 17F gene; IL 1b gene; IL 4 gene; IL 8 gene; inflammation; male; neutrophilic asthma; pathogenesis; protein degradation; respiratory tract allergy; signal transduction; sputum analysis; Th17 cell; Th2 cell; TNFalpha gene; tracheobronchial toilet; unfolded protein response; animal; asthma; endoplasmic reticulum; metabolism; mouse; neutrophil; pathology; signal transduction; unfolded protein response,Article,Final,,Scopus,2-s2.0-85122081542
Shrestha J.; Razavi Bazaz S.; Ding L.; Vasilescu S.; Idrees S.; Söderström B.; Hansbro P.M.; Ghadiri M.; Ebrahimi Warkiani M.,"Shrestha, Jesus (57214237167); Razavi Bazaz, Sajad (57200006380); Ding, Lin (57213156078); Vasilescu, Steven (57192809652); Idrees, Sobia (55429771900); Söderström, Bill (54897291600); Hansbro, Philip M. (6603119390); Ghadiri, Maliheh (57190856835); Ebrahimi Warkiani, Majid (36138999000)",57214237167; 57200006380; 57213156078; 57192809652; 55429771900; 54897291600; 6603119390; 57190856835; 36138999000,Rapid separation of bacteria from primary nasal samples using inertial microfluidics,2022,Lab on a Chip,23,1,,146,156,10,14,10.1039/d2lc00794k,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85144180832&doi=10.1039%2fd2lc00794k&partnerID=40&md5=8f9ea0202bb160b664df86396e03ff0a,"School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Woolcock Institute of Medical Research, Respiratory Technology Group, University of Sydney, Sydney, 2037, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, Australia; Australian Institute for Microbiology and Infection, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Institute of Molecular Medicine, Sechenov First Moscow State University, Moscow, 119991, Russian Federation","Shrestha J., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, Respiratory Technology Group, University of Sydney, Sydney, 2037, NSW, Australia; Razavi Bazaz S., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Ding L., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Vasilescu S., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia; Idrees S., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, Australia; Söderström B., Australian Institute for Microbiology and Infection, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, 2007, Australia; Ghadiri M., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, Respiratory Technology Group, University of Sydney, Sydney, 2037, NSW, Australia; Ebrahimi Warkiani M., School of Biomedical Engineering, University of Technology Sydney, Sydney, 2007, NSW, Australia, Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia, Institute of Molecular Medicine, Sechenov First Moscow State University, Moscow, 119991, Russian Federation",,"Bacteria; Cell Separation; Humans; Microfluidics; Sequence Analysis, DNA; Cell culture; Cell proliferation; Cost effectiveness; Debris; Disease control; DNA sequences; Gene encoding; Microfluidics; Molecular biology; RNA 16S; Antibiotics resistance; Bacterial cells; Bacterial diversity; Epithelial cells; Human health; Inertial microfluidics; Microbial populations; Microbiotas; Nasal cavity; Rapid separation; Article; bacterial cell; bacterial growth; bacterium; bioinformatics; cell culture; DNA extraction; DNA sequencing; epithelium cell; gene sequence; human; human cell; microfluidics; microscopy; nasal epithelial cell; nasopharyngeal swab; nonhuman; nose cavity; nose smear; separation technique; cell separation; DNA sequence; procedures; Bacteria",Article,Final,,Scopus,2-s2.0-85144180832
Zhang Y.; Almazi J.G.; Ong H.X.; Johansen M.D.; Ledger S.; Traini D.; Hansbro P.M.; Kelleher A.D.; Ahlenstiel C.L.,"Zhang, Yuan (57463434700); Almazi, Juhura G. (55274161100); Ong, Hui Xin (54391482200); Johansen, Matt D. (57202983408); Ledger, Scott (56233631100); Traini, Daniela (10142464500); Hansbro, Philip M. (6603119390); Kelleher, Anthony D. (7006091312); Ahlenstiel, Chantelle L. (11140750900)",57463434700; 55274161100; 54391482200; 57202983408; 56233631100; 10142464500; 6603119390; 7006091312; 11140750900,Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract,2022,International Journal of Molecular Sciences,23,5,2408,,,,17,10.3390/ijms23052408,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125098605&doi=10.3390%2fijms23052408&partnerID=40&md5=fae04c3a575de9ed7ce069d53f62bd2e,"Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Respiratory Technology, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia; Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Ryde, 2109, NSW, Australia; Centre for Inflammation, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia","Zhang Y., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Almazi J.G., Respiratory Technology, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Ryde, 2109, NSW, Australia; Ong H.X., Respiratory Technology, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Ryde, 2109, NSW, Australia; Johansen M.D., Centre for Inflammation, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Ledger S., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Traini D., Respiratory Technology, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Ryde, 2109, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, 2050, NSW, Australia; Kelleher A.D., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia; Ahlenstiel C.L., Kirby Institute, UNSW, Sydney, 2052, NSW, Australia",COVID-19; Glycogen nanopar-ticles; Inhalation; Lipid nanoparticles; Nanomedicine; Nanoparticle-capsulated drug delivery; Polymer nanoparticles; SiRNA,"Animals; COVID-19; Drug Delivery Systems; Humans; Models, Genetic; Nanoparticles; Pandemics; RNA, Small Interfering; RNAi Therapeutics; SARS-CoV-2; argonaute 1 protein; argonaute 2 protein; cell penetrating peptide; doxorubicin; glucose transporter 3; glycogen; lipid nanoparticle; liposome; nanocarrier; nanomaterial; nanoparticle; polymer nanoparticle; small interfering RNA; variant surface glycoprotein; nanoparticle; small interfering RNA; antiviral therapy; biocompatibility; biodegradability; coronavirus disease 2019; drug delivery system; gene silencing; gene therapy; Human coronavirus 229E; Human coronavirus HKU1; Human coronavirus NL63; Human coronavirus OC43; inhalation; Middle East respiratory syndrome coronavirus; nanomedicine; nonhuman; respiratory tract disease; Review; RNAi therapeutics; SARS coronavirus; Severe acute respiratory syndrome coronavirus 2; animal; biological model; chemistry; drug delivery system; epidemiology; genetics; human; pandemic; physiology; procedures; RNAi therapeutics; therapy; virology",Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85125098605
Sharma K.; Zhang Y.; Paudel K.R.; Kachelmeier A.; Hansbro P.M.; Shi X.,"Sharma, Kushal (57209161792); Zhang, Yunpei (57218560521); Paudel, Keshav Raj (56539588400); Kachelmeier, Allan (24558678600); Hansbro, Philip M. (6603119390); Shi, Xiaorui (7402952928)",57209161792; 57218560521; 56539588400; 24558678600; 6603119390; 7402952928,The Emerging Role of Pericyte-Derived Extracellular Vesicles in Vascular and Neurological Health,2022,Cells,11,19,3108,,,,21,10.3390/cells11193108,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85139787992&doi=10.3390%2fcells11193108&partnerID=40&md5=c7cda8b7df4a3700b67b7f1d9dfef83d,"Oregon Hearing Research Center, Department of Otolaryngology/Head & Neck Surgery, Oregon Health & Science University, Portland, 97239, OR, United States; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia","Sharma K., Oregon Hearing Research Center, Department of Otolaryngology/Head & Neck Surgery, Oregon Health & Science University, Portland, 97239, OR, United States; Zhang Y., Oregon Hearing Research Center, Department of Otolaryngology/Head & Neck Surgery, Oregon Health & Science University, Portland, 97239, OR, United States; Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Kachelmeier A., Oregon Hearing Research Center, Department of Otolaryngology/Head & Neck Surgery, Oregon Health & Science University, Portland, 97239, OR, United States; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, 2007, NSW, Australia; Shi X., Oregon Hearing Research Center, Department of Otolaryngology/Head & Neck Surgery, Oregon Health & Science University, Portland, 97239, OR, United States",angiogenesis; blood–brain barrier; neuroprotection; Parkinson’s disease; PC-derived extracellular vesicle; pericyte; peripheral neuropathy,"Angiopoietin-1; Brain-Derived Neurotrophic Factor; Cytokines; Endothelial Growth Factors; Extracellular Vesicles; Fibroblast Growth Factors; Glial Cell Line-Derived Neurotrophic Factor; Interleukin-10; Interleukin-8; Lipids; MicroRNAs; Nerve Growth Factor; Pericytes; RNA, Circular; Vascular Endothelial Growth Factor A; angiopoietin 1; brain derived neurotrophic factor; CD63 antigen; CD81 antigen; CD9 antigen; circular ribonucleic acid; claudin 5; connective tissue growth factor; cytokine; DNA; endothelial nitric oxide synthase; fibroblast growth factor; growth factor; intercellular adhesion molecule 1; lipid; matrix metalloproteinase; messenger RNA; microRNA; mitogen activated protein kinase; mitogen activated protein kinase 1; mitogen activated protein kinase 3; nerve growth factor; neurotrophin 3; occludin; phosphatidylinositol 3 kinase; placental growth factor; platelet derived growth factor; stress activated protein kinase; tetraspanin; tropomyosin; vascular cell adhesion molecule 1; vasculotropin; angiopoietin 1; brain derived neurotrophic factor; cytokine; endothelial cell growth factor; fibroblast growth factor; glial cell line derived neurotrophic factor; interleukin 10; interleukin 8; lipid; microRNA; nerve growth factor; vasculotropin A; Alzheimer disease; angiogenesis; autophagosome; biogenesis; blood brain barrier; cell membrane; cerebrovascular disease; diabetic retinopathy; endocytosis; endosome; erectile dysfunction; exosome; health; human; infection; lysosome; membrane microparticle; muscle atrophy; neurologic disease; neurology; neuroprotection; nonhuman; Parkinson disease; pericyte; peripheral neuropathy; Review; spinal cord injury; genetics; metabolism; pericyte",Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85139787992
Dua K.; Hansbro P.M.; Wadhwa R.; Haghi M.; Pont L.G.; Williams K.A.,"Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390); Wadhwa, Ridhima (57159091700); Haghi, Mehra (37033934800); Pont, Lisa G. (6602612624); Williams, Kylie A. (7404142756)",15759138700; 6603119390; 57159091700; 37033934800; 6602612624; 7404142756,Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems,2020,Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems,,,,1,587,586,9,10.1016/C2019-0-01427-6,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104472313&doi=10.1016%2fC2019-0-01427-6&partnerID=40&md5=778d128273695da2157f159805a8a8a5,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia","Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Wadhwa R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Haghi M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Pont L.G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Williams K.A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia",,,Book,Final,,Scopus,2-s2.0-85104472313
Shukla S.D.; Walters E.H.; Simpson J.L.; Keely S.; Wark P.A.B.; O'Toole R.F.; Hansbro P.M.,"Shukla, Shakti D. (56367620800); Walters, E. Haydn (7102865814); Simpson, Jodie L. (7404326026); Keely, Simon (9739611200); Wark, Peter A.B. (7003559516); O'Toole, Ronan F. (7005094224); Hansbro, Philip M. (6603119390)",56367620800; 7102865814; 7404326026; 9739611200; 7003559516; 7005094224; 6603119390,Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease,2020,Respirology,25,1,,53,63,10,45,10.1111/resp.13722,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074821257&doi=10.1111%2fresp.13722&partnerID=40&md5=b7d1751d5f3cf372a5e3871cf626cf05,"School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia; Respiratory and Sleep Medicine, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Priority Research Centre for Digestive Health and Neurogastroenterology, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; School of Molecular Sciences, College of Science, Health and Engineering, La Trobe University, Melbourne, VIC, Australia; Centenary Institute and School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia","Shukla S.D., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Walters E.H., School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia; Simpson J.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Respiratory and Sleep Medicine, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Keely S., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Respiratory and Sleep Medicine, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; O'Toole R.F., School of Molecular Sciences, College of Science, Health and Engineering, La Trobe University, Melbourne, VIC, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Centenary Institute and School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia",airway infections; bacterial adhesion; chronic obstructive pulmonary disease; hypoxia-inducible factor; platelet-activating factor receptor,"Animals; Bacterial Infections; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Platelet Membrane Glycoproteins; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Receptors, G-Protein-Coupled; 2 (3 methoxy 5 methylsulfonyl 4 propoxyphenyl) 5 (3,4,5 trimethoxyphenyl)tetrahydrofuran; apafant; foropafant; hydroxymethylglutaryl coenzyme A reductase inhibitor; hypoxia inducible factor 1alpha; placebo; reactive oxygen metabolite; simvastatin; thrombocyte activating factor receptor; fibrinogen receptor; G protein coupled receptor; HIF1A protein, human; hypoxia inducible factor 1alpha; reactive oxygen metabolite; thrombocyte activating factor receptor; antibiotic resistance; asthma; bacterial colonization; bacterial infection; bacterial load; bacterial translocation; bacterium adherence; chronic obstructive lung disease; disease exacerbation; Haemophilus influenzae; human; hypoxemia; hypoxia; immune complex nephritis; lung emphysema; lung fibrosis; nonhuman; oxidative stress; priority journal; Pseudomonas aeruginosa; respiratory tract inflammation; Review; smoking; Streptococcus pneumonia; Streptococcus pneumoniae; animal; bacterial infection; chronic obstructive lung disease; complication; metabolism; microbiology",Review,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85074821257
Paudel K.R.; Dharwal V.; Patel V.K.; Galvao I.; Wadhwa R.; Malyla V.; Shen S.S.; Budden K.F.; Hansbro N.G.; Vaughan A.; Yang I.A.; Kohonen-Corish M.R.J.; Bebawy M.; Dua K.; Hansbro P.M.,"Paudel, Keshav Raj (56539588400); Dharwal, Vivek (57195758477); Patel, Vyoma K. (57193533009); Galvao, Izabela (56656390800); Wadhwa, Ridhima (57159091700); Malyla, Vamshikrishna (57205128961); Shen, Sj Sijie (56707946900); Budden, Kurtis F. (57191417986); Hansbro, Nicole G. (15055862300); Vaughan, Annalicia (55935627600); Yang, Ian A. (7101797862); Kohonen-Corish, Maija R J (6603956915); Bebawy, Mary (6506211522); Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390)",56539588400; 57195758477; 57193533009; 56656390800; 57159091700; 57205128961; 56707946900; 57191417986; 15055862300; 55935627600; 7101797862; 6603956915; 6506211522; 15759138700; 6603119390,Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases,2020,Frontiers in Medicine,7,,554,,,,56,10.3389/fmed.2020.00554,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091907121&doi=10.3389%2ffmed.2020.00554&partnerID=40&md5=2c89280eb349818c7d27424aaaa62a40,"Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Faculty of Medicine, Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia; Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; School of Medicine, Western Sydney University, Sydney, NSW, Australia; St George, Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia","Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Dharwal V., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Patel V.K., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Galvao I., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Wadhwa R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Malyla V., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Shen S.S., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Budden K.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Vaughan A., Faculty of Medicine, Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia, Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia; Yang I.A., Faculty of Medicine, Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia, Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia; Kohonen-Corish M.R.J., Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, School of Medicine, Western Sydney University, Sydney, NSW, Australia, St George, Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia",asthma; chronic obstructive pulmonary disease; lung cancer; lung fibrosis; microbiome,bacterial toxin; adaptive immunity; asthma; Bacteroidetes; chronic obstructive lung disease; cigarette smoking; commensal; Firmicutes; Haemophilus; human; innate immunity; Klebsiella; lung cancer; lung fibrosis; lung microbiome; metabolite; microbiome; nonhuman; pathogenesis; phylum; Prevotella; Pseudomonas; Review; Streptococcus; Veillonella,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85091907121
Mehta M.; Satija S.; Paudel K.R.; Malyla V.; Kannaujiya V.K.; Chellappan D.K.; Bebawy M.; Hansbro P.M.; Wich P.R.; Dua K.,"Mehta, Meenu (7203024234); Satija, Saurabh (54581608400); Paudel, Keshav R (56539588400); Malyla, Vamshikrishna (57205128961); Kannaujiya, Vinod Kumar (57219713766); Chellappan, Dinesh Kumar (35811890500); Bebawy, Mary (6506211522); Hansbro, Philip M (6603119390); Wich, Peter R (7801599835); Dua, Kamal (15759138700)",7203024234; 54581608400; 56539588400; 57205128961; 57219713766; 35811890500; 6506211522; 6603119390; 7801599835; 15759138700,Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives,2021,"Nanomedicine: Nanotechnology, Biology, and Medicine",31,,102303,,,,25,10.1016/j.nano.2020.102303,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092470577&doi=10.1016%2fj.nano.2020.102303&partnerID=40&md5=c9b6a1a9600e0f4fc61f52e45609ce92,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia; School of Chemical Engineering, University of New South Wales, Sydney, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia; Centre for Nanomedicine, University of New South Wales, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia; Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Kannaujiya V.K., School of Chemical Engineering, University of New South Wales, Sydney, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia; Wich P.R., School of Chemical Engineering, University of New South Wales, Sydney, NSW, Australia, Centre for Nanomedicine, University of New South Wales, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India",AntagomiR; Chronic respiratory disorders; Lung cancer; microRNA; Nanotechnology,Animals; Antagomirs; Humans; Lung Neoplasms; MicroRNAs; Nanocapsules; Nanoparticles; Nanotechnology; Polymers; Nanoparticles; Plants (botany); Pulmonary diseases; antagomir; antagomir 155; antagomir 25; antihypertensive agent; antineoplastic agent; chitosan; cobomarsen; dendrimer; gold nanoparticle; graphene oxide; mesoporous silica nanoparticle; microRNA; microRNA 126; microRNA 204; microRNA 205; nanocarrier; polyethyleneimine; respiratory tract agent; rg 125; unclassified drug; antagomir; microRNA; nanocapsule; nanoparticle; polymer; Clinical application; Future perspectives; Inorganic nanoparticle; Intracellular delivery; Lipid nanocapsules; Physiological process; Polymer nanoparticles; Respiratory disorders; Article; asthma; chronic obstructive lung disease; clinical trial (topic); cystic fibrosis; drug delivery system; drug utilization; exosome; human; lung cancer; nonhuman; pulmonary hypertension; T cell lymphoma; animal; chemistry; lung tumor; metabolism; nanotechnology; procedures; RNA,Article,Final,,Scopus,2-s2.0-85092470577
Johansen M.D.; Irving A.; Montagutelli X.; Tate M.D.; Rudloff I.; Nold M.F.; Hansbro N.G.; Kim R.Y.; Donovan C.; Liu G.; Faiz A.; Short K.R.; Lyons J.G.; McCaughan G.W.; Gorrell M.D.; Cole A.; Moreno C.; Couteur D.; Hesselson D.; Triccas J.; Neely G.G.; Gamble J.R.; Simpson S.J.; Saunders B.M.; Oliver B.G.; Britton W.J.; Wark P.A.; Nold-Petry C.A.; Hansbro P.M.,"Johansen, M.D. (57202983408); Irving, A. (8047804900); Montagutelli, X. (7004592288); Tate, M.D. (22939334200); Rudloff, I. (36931070700); Nold, M.F. (6603550703); Hansbro, N.G. (15055862300); Kim, R.Y. (35810406900); Donovan, C. (55357105200); Liu, G. (57189061134); Faiz, A. (55601365200); Short, K.R. (36673861500); Lyons, J.G. (7202033263); McCaughan, G.W. (7103117295); Gorrell, M.D. (7003898943); Cole, A. (57212725675); Moreno, C. (55534864900); Couteur, D. (55965779200); Hesselson, D. (6504344115); Triccas, J. (7003601814); Neely, G.G. (22941514000); Gamble, J.R. (57205935684); Simpson, S.J. (24339260900); Saunders, B.M. (7102328746); Oliver, B.G. (15919869900); Britton, W.J. (7102477888); Wark, P.A. (7003559516); Nold-Petry, C.A. (22981220300); Hansbro, P.M. (6603119390)",57202983408; 8047804900; 7004592288; 22939334200; 36931070700; 6603550703; 15055862300; 35810406900; 55357105200; 57189061134; 55601365200; 36673861500; 7202033263; 7103117295; 7003898943; 57212725675; 55534864900; 55965779200; 6504344115; 7003601814; 22941514000; 57205935684; 24339260900; 7102328746; 15919869900; 7102477888; 7003559516; 22981220300; 6603119390,Animal and translational models of SARS-CoV-2 infection and COVID-19,2020,Mucosal Immunology,13,6,,877,891,14,138,10.1038/s41385-020-00340-z,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089666209&doi=10.1038%2fs41385-020-00340-z&partnerID=40&md5=cb81c2f3da39e183a1e17b7b5b2d1ba0,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia; Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, ZJU International Campus, Haining, China; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Genomes and Genetics, Institut Pasteur, Paris, France; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia; Ritchie Centre, Hudson Institute of Medical Research, Clayton, 3168, VIC, Australia; Department of Paediatrics, Monash University, Clayton, 3168, VIC, Australia; Monash Newborn, Monash Children’s Hospital, Clayton, VIC, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; School of Chemistry and Molecular Biosciences and Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Australia; Centenary Institute and Dermatology, The University of Sydney and Cancer Services, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Centenary Institute and Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Dr. John and Anne Chong Lab for Functional Genomics, Charles Perkins Centre, Centenary Institute, and School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre and School of Life and Environmental Sciences, University of Sydney, and Faculty of Medicine and Health, Concord Clinical School, ANZAC Research Institute and Centre for Education and Research on Ageing, Sydney, Australia; Discipline of Infectious Diseases and Immunology, Central Clinical School, Faculty of Medicine and Health and the Charles Perkins Centre, The University of Sydney, Camperdown, Sydney, Australia; Woolcock Institute of Medical Research, Sydney, Australia; Centenary Institute, The University of Sydney and Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia","Johansen M.D., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia; Irving A., Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, ZJU International Campus, Haining, China, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Montagutelli X., Department of Genomes and Genetics, Institut Pasteur, Paris, France; Tate M.D., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia; Rudloff I., Ritchie Centre, Hudson Institute of Medical Research, Clayton, 3168, VIC, Australia, Department of Paediatrics, Monash University, Clayton, 3168, VIC, Australia; Nold M.F., Ritchie Centre, Hudson Institute of Medical Research, Clayton, 3168, VIC, Australia, Monash Newborn, Monash Children’s Hospital, Clayton, VIC, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Kim R.Y., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Donovan C., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Liu G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Faiz A., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia; Short K.R., School of Chemistry and Molecular Biosciences and Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Australia; Lyons J.G., Centenary Institute and Dermatology, The University of Sydney and Cancer Services, Royal Prince Alfred Hospital, Sydney, NSW, Australia; McCaughan G.W., Centenary Institute and Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Gorrell M.D., Centenary Institute and Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Cole A., Centenary Institute and Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Moreno C., Dr. John and Anne Chong Lab for Functional Genomics, Charles Perkins Centre, Centenary Institute, and School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia; Couteur D., Charles Perkins Centre and School of Life and Environmental Sciences, University of Sydney, and Faculty of Medicine and Health, Concord Clinical School, ANZAC Research Institute and Centre for Education and Research on Ageing, Sydney, Australia; Hesselson D., Centenary Institute and Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Triccas J., Discipline of Infectious Diseases and Immunology, Central Clinical School, Faculty of Medicine and Health and the Charles Perkins Centre, The University of Sydney, Camperdown, Sydney, Australia; Neely G.G., Dr. John and Anne Chong Lab for Functional Genomics, Charles Perkins Centre, Centenary Institute, and School of Life and Environmental Sciences, University of Sydney, Sydney, NSW, Australia; Gamble J.R., Centenary Institute and Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Simpson S.J., Charles Perkins Centre and School of Life and Environmental Sciences, University of Sydney, and Faculty of Medicine and Health, Concord Clinical School, ANZAC Research Institute and Centre for Education and Research on Ageing, Sydney, Australia; Saunders B.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia; Oliver B.G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia, Woolcock Institute of Medical Research, Sydney, Australia; Britton W.J., Centenary Institute, The University of Sydney and Department of Clinical Immunology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Nold-Petry C.A., Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Clayton, 3168, VIC, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia",,"Animals; Animals, Genetically Modified; Antibodies, Viral; Antiviral Agents; Betacoronavirus; Cats; Chiroptera; Coronavirus Infections; Cricetulus; Disease Models, Animal; Female; Ferrets; Haplorhini; Humans; Male; Mice; Organoids; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Severity of Illness Index; Species Specificity; Spike Glycoprotein, Coronavirus; Viral Vaccines; adenovirus vector; angiotensin converting enzyme 2; remdesivir; SARS-CoV-2 vaccine; angiotensin converting enzyme 2; antivirus agent; coronavirus spike glycoprotein; COVID-19 vaccine; dipeptidyl carboxypeptidase; spike protein, SARS-CoV-2; virus antibody; virus vaccine; age; age related susceptibility; antiviral activity; cardiovascular disease; cell model; cells; chicken; chronic respiratory tract disease; clinical feature; clustered regularly interspaced short palindromic repeat; coronavirus disease 2019; diabetes mellitus; disease model; dog; drug development; experimental coronavirus disease 2019; explant; human; infection prevention; infection sensitivity; mouse adapted virus; mouse model; Mustela putorius furo; nonhuman; obesity; organoid; phylogeny; pig; pneumonia; primate; priority journal; Review; risk factor; Severe acute respiratory syndrome coronavirus 2; small animal model; Syrian hamster; tissue model; tissues; translational research; Tupaiidae; wild animal; animal; bat; Betacoronavirus; biosynthesis; cat; Coronavirus infection; Cricetulus; drug effect; female; genetics; Haplorhini; immunology; male; mouse; pandemic; pathogenicity; physiology; severity of illness index; species difference; synthesis; transgenic animal; virology; virus pneumonia",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85089666209
Nucera F.; Bello F.L.; Shen S.S.; Ruggeri P.; Coppolino I.; Stefano A.D.; Stellato C.; Casolaro V.; Hansbro P.M.; Adcock I.M.; Caramori G.,"Nucera, Francesco (57202946185); Bello, Federica Lo (57202941930); Shen, Sj S. (56707946900); Ruggeri, Paolo (15923794000); Coppolino, Irene (57205402564); Stefano, Antonino Di (36003195400); Stellato, Cristiana (6701383040); Casolaro, Vincenzo (7003526446); Hansbro, Phil M. (6603119390); Adcock, Ian M. (7007066538); Caramori, Gaetano (7003847659)",57202946185; 57202941930; 56707946900; 15923794000; 57205402564; 36003195400; 6701383040; 7003526446; 6603119390; 7007066538; 7003847659,Role of atypical chemokines and chemokine receptors pathways in the pathogenesis of copd,2021,Current Medicinal Chemistry,28,13,,2577,2653,76,14,10.2174/0929867327999200819145327,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098476788&doi=10.2174%2f0929867327999200819145327&partnerID=40&md5=c223c20a14974925110afa8519c6eda3,"Department of Biomedical, Dental, Morphological and Functional Imaging Sciences (BIOMORF), University of Messina, Pugliatti Square 1, Messina, 98122, Italy; Faculty of Science, Centre for Inflammation, Centenary Institute, University of Technology, Ultimo, Sydney, Australia; Division of Pneumology, CytoImmunopathology Laboratory of the Cardio-Respiratory System, Clinical Scientific Institutes Maugeri IRCCS, Veruno, Italy; Department of Medicine, Surgery and Dentistry, Salerno Medical School, University of Salerno, Salerno, Italy; Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom","Nucera F., Department of Biomedical, Dental, Morphological and Functional Imaging Sciences (BIOMORF), University of Messina, Pugliatti Square 1, Messina, 98122, Italy; Bello F.L., Department of Biomedical, Dental, Morphological and Functional Imaging Sciences (BIOMORF), University of Messina, Pugliatti Square 1, Messina, 98122, Italy; Shen S.S., Faculty of Science, Centre for Inflammation, Centenary Institute, University of Technology, Ultimo, Sydney, Australia; Ruggeri P., Department of Biomedical, Dental, Morphological and Functional Imaging Sciences (BIOMORF), University of Messina, Pugliatti Square 1, Messina, 98122, Italy; Coppolino I., Department of Biomedical, Dental, Morphological and Functional Imaging Sciences (BIOMORF), University of Messina, Pugliatti Square 1, Messina, 98122, Italy; Stefano A.D., Division of Pneumology, CytoImmunopathology Laboratory of the Cardio-Respiratory System, Clinical Scientific Institutes Maugeri IRCCS, Veruno, Italy; Stellato C., Department of Medicine, Surgery and Dentistry, Salerno Medical School, University of Salerno, Salerno, Italy; Casolaro V., Department of Medicine, Surgery and Dentistry, Salerno Medical School, University of Salerno, Salerno, Italy; Hansbro P.M., Faculty of Science, Centre for Inflammation, Centenary Institute, University of Technology, Ultimo, Sydney, Australia; Adcock I.M., Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom; Caramori G., Department of Biomedical, Dental, Morphological and Functional Imaging Sciences (BIOMORF), University of Messina, Pugliatti Square 1, Messina, 98122, Italy",Airway inflammation; Alveolar macrophages; Atypical chemokine receptors; Atypical chemokines; Chronic obstructive pulmonary disease; Lymphocytes; Small airways,"Animals; Chemokines; HMGB1 Protein; Lung; Pulmonary Disease, Chronic Obstructive; Receptors, Chemokine; adrenomedullin; advanced glycation end product receptor; alpha intermedin; atypical chemokine receptor 1; atypical chemokine receptor 2; atypical chemokine receptor 3; atypical chemokine receptor 4; calcitonin gene related peptide; cathelicidin; chemerin; chemokine; chemokine receptor; defensin; hepcidin; high mobility group B1 protein; lactoferricin; lactoferrin; lysozyme; macrophage migration inhibition factor; neuropeptide; neuropeptide Y; polypeptide antibiotic agent; prostaglandin D2; ribonuclease; substance P; toll like receptor; unclassified drug; chemokine; chemokine receptor; high mobility group B1 protein; chronic obstructive lung disease; human; internalization (cell); intracellular signaling; microbiome; molecular interaction; nonhuman; pathogenesis; protein structure; Review; animal; chronic obstructive lung disease; lung",Review,Final,,Scopus,2-s2.0-85098476788
Shastri M.D.; Chong W.C.; Dua K.; Peterson G.M.; Patel R.P.; Mahmood M.Q.; Tambuwala M.; Chellappan D.K.; Hansbro N.G.; Shukla S.D.; Hansbro P.M.,"Shastri, Madhur D. (56007290800); Chong, Wai Chin (57192809246); Dua, Kamal (15759138700); Peterson, Gregory M. (7402563175); Patel, Rahul P. (36849078400); Mahmood, Malik Q. (56368609600); Tambuwala, Murtaza (36657816300); Chellappan, Dinesh K. (35811890500); Hansbro, Nicole G. (15055862300); Shukla, Shakti D. (56367620800); Hansbro, Philip M. (6603119390)",56007290800; 57192809246; 15759138700; 7402563175; 36849078400; 56368609600; 36657816300; 35811890500; 15055862300; 56367620800; 6603119390,Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators,2021,Inflammopharmacology,29,1,,15,33,18,13,10.1007/s10787-020-00770-y,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095593337&doi=10.1007%2fs10787-020-00770-y&partnerID=40&md5=ce49e0d7f1b9b7fc7484c073fc6629c0,"School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Faculty of Health, School of Medicine, Deakin University, Melbourne, Australia; School of Pharmacy and Pharmaceutical Science, Ulster University, Belfast, United Kingdom; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Priority Research Centre for Healthy Lungs, School of Medicine and Public Health, The University of Newcastle, Callaghan, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Shastri M.D., School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia; Chong W.C., Department of Molecular and Translational Science, Monash University, Clayton, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia, Priority Research Centre for Healthy Lungs, School of Medicine and Public Health, The University of Newcastle, Callaghan, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Peterson G.M., School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia; Patel R.P., School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia; Mahmood M.Q., Faculty of Health, School of Medicine, Deakin University, Melbourne, Australia; Tambuwala M., School of Pharmacy and Pharmaceutical Science, Ulster University, Belfast, United Kingdom; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Hansbro N.G., Priority Research Centre for Healthy Lungs, School of Medicine and Public Health, The University of Newcastle, Callaghan, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, School of Medicine and Public Health, The University of Newcastle, Callaghan, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, School of Medicine and Public Health, The University of Newcastle, Callaghan, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Asthma; microRNA; Molecular mechanisms; Novel drug candidates; Targeted drug delivery; Vascularisation,Airway Remodeling; Allergens; Animals; Anti-Asthmatic Agents; Asthma; Drug Delivery Systems; Humans; Medication Adherence; MicroRNAs; antihistaminic agent; immunoglobulin E antibody; interleukin 13 antibody; interleukin 17 antibody; interleukin 33; interleukin 4 antibody; interleukin 4 receptor alpha antibody; interleukin 5 antibody; liposome; macrolide; microRNA; phosphodiesterase inhibitor; protein antibody; thymic stromal lymphopoietin; unclassified drug; vasculotropin inhibitor; allergen; antiasthmatic agent; microRNA; airway obstruction; asthma; drug delivery system; gene targeting; human; nonhuman; patient compliance; priority journal; respiratory tract inflammation; Review; vascularization; airway remodeling; animal; asthma; genetics; immunology; medication compliance,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85095593337
Dharwal V.; Paudel K.R.; Hansbro P.M.,"Dharwal, Vivek (57195758477); Paudel, Keshav R (56539588400); Hansbro, Philip M (6603119390)",57195758477; 56539588400; 6603119390,Impact of bushfire smoke on respiratory health,2020,Medical Journal of Australia,213,6,,284,284.e1,,12,10.5694/mja2.50754,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089968257&doi=10.5694%2fmja2.50754&partnerID=40&md5=c8da1de31f564ac5b1e822c2d7a563f5,"Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; University of Technology Sydney, Sydney, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia","Dharwal V., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, University of Technology Sydney, Sydney, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, University of Technology Sydney, Sydney, NSW, Australia, University of Newcastle, Newcastle, NSW, Australia",Air pollutants; Environmental pollution; Public health,Air Pollutants; Air Pollution; Humans; Respiratory Tract Diseases; Smoke; cigarette smoke; airway remodeling; asthma; autophagy (cellular); bronchoepithelial cell; chronic obstructive lung disease; disease exacerbation; disease predisposition; epigenetics; epithelium cell; fibroblast; groups by age; health; human; innate immunity; Letter; lung function; mouse model; nonhuman; oxidative stress; particulate matter 10; particulate matter 2.5; pathogenesis; PM10 exposure; PM2.5 exposure; pneumonia; proteomics; respiratory health; smoke; wildfire; adverse event; air pollutant; air pollution; respiratory tract disease; smoke,Letter,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85089968257
Ng P.Q.; Ling L.S.C.; Chellian J.; Madheswaran T.; Panneersel-Vam J.; Kunnath A.P.; Gupta G.; Satija S.; Mehta M.; Hansbro P.M.; Collet T.; Dua K.; Chellappan D.K.,"Ng, Phui Qi (57205271584); Ling, Laura Soon Cheau (57218934586); Chellian, Jestin (56993705500); Madheswaran, Thiagarajan (55505311000); Panneersel-Vam, Jithendra (57218934224); Kunnath, Anil Philip (28567859800); Gupta, Gaurav (15047988400); Satija, Saurabh (54581608400); Mehta, Meenu (7203024234); Hansbro, Philip Michael (6603119390); Collet, Trudi (36898251800); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",57205271584; 57218934586; 56993705500; 55505311000; 57218934224; 28567859800; 15047988400; 54581608400; 7203024234; 6603119390; 36898251800; 15759138700; 35811890500,Applications of nanocarriers as drug delivery vehicles for active phytoconstituents,2020,Current Pharmaceutical Design,26,36,,4580,4590,10,38,10.2174/1381612826666200610111013,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089267900&doi=10.2174%2f1381612826666200610111013&partnerID=40&md5=25101e94c9b3a9c66211182d7c6b80c2,"School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Life Sciences, Faculty of Sci-ence, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centenary Institute, Royal Prince Alfred Hospital, Camper-down, 2050, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Innovative Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, 4059, QLD, Australia","Ng P.Q., School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Ling L.S.C., School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Panneersel-Vam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Kunnath A.P., Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., School of Life Sciences, Faculty of Sci-ence, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centenary Institute, Royal Prince Alfred Hospital, Camper-down, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Collet T., Innovative Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, 4059, QLD, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centenary Institute, Royal Prince Alfred Hospital, Camper-down, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia",Bioavailability; Chronic diseases; Nanocarriers; Nanomedicine; Nanoparticles; Phytoconstituents,Biological Availability; Drug Carriers; Drug Delivery Systems; Nanoparticles; Pharmaceutical Preparations; Solubility; atorvastatin; baicalin; berberine; boswellic acid; capsaicin; curcumin; emodin; Ficus Benjamina extract; garlic oil; grapefruit extract; gum arabic; hesperidin; lycopene; magnetic nanoparticle; nanocarrier; nanocrystal; noscapine; piperine; plant extract; polyglactin; polymer; quantum dot; quercetin; resveratrol; silver nanoparticle; silymarin; solid lipid nanoparticle; Tagetes erecta extract; unclassified drug; vinca extract; drug; drug carrier; nanoparticle; antiarthritic activity; antidiabetic activity; antineoplastic activity; area under the curve; breast cancer; Ca Ski cell line; cardiotoxicity; chronic disease; drug activity; drug bioavailability; drug delivery system; drug efficacy; drug formulation; drug mechanism; dyslipidemia; glioblastoma; glioblastoma cell line; heart protection; human; hypertension; IC50; liver cell carcinoma; liver protection; MCF-7 cell line; nanoemulsion; non insulin dependent diabetes mellitus; nonhuman; osteoarthritis; priority journal; Review; rheumatoid arthritis; SiHa cell line; Tagetes erecta; uterine cervix cancer; Vinca; bioavailability; drug delivery system; solubility,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85089267900
Tiotiu A.; Zounemat Kermani N.; Badi Y.; Pavlidis S.; Hansbro P.M.; Guo Y.-K.; Chung K.F.; Adcock I.M.,"Tiotiu, Angelica (23499586600); Zounemat Kermani, Nazanin (57218534288); Badi, Yusef (56275233300); Pavlidis, Stelios (56642790400); Hansbro, Philip M. (6603119390); Guo, Yi-Ke (12765868000); Chung, Kian Fan (35403525000); Adcock, Ian M. (7007066538)",23499586600; 57218534288; 56275233300; 56642790400; 6603119390; 12765868000; 35403525000; 7007066538,Sputum macrophage diversity and activation in asthma: Role of severity and inflammatory phenotype,2021,Allergy: European Journal of Allergy and Clinical Immunology,76,3,,775,788,13,28,10.1111/all.14535,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089447364&doi=10.1111%2fall.14535&partnerID=40&md5=273de3234f549ac4d62ef7d6576e85ce,"National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Pulmonology, University Hospital of Nancy, Nancy, France; Department of Computing, Data Science Institute, Imperial College London, London, United Kingdom; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia","Tiotiu A., National Heart and Lung Institute, Imperial College London, London, United Kingdom, Department of Pulmonology, University Hospital of Nancy, Nancy, France; Zounemat Kermani N., Department of Computing, Data Science Institute, Imperial College London, London, United Kingdom; Badi Y., National Heart and Lung Institute, Imperial College London, London, United Kingdom, Department of Computing, Data Science Institute, Imperial College London, London, United Kingdom; Pavlidis S., National Heart and Lung Institute, Imperial College London, London, United Kingdom, Department of Computing, Data Science Institute, Imperial College London, London, United Kingdom; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Guo Y.-K., Department of Computing, Data Science Institute, Imperial College London, London, United Kingdom; Chung K.F., National Heart and Lung Institute, Imperial College London, London, United Kingdom; Adcock I.M., National Heart and Lung Institute, Imperial College London, London, United Kingdom, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia",asthma; gene set variation analysis; macrophage subtypes; sputum; tissue-resident,Asthma; Humans; Macrophage Activation; Macrophages; Phenotype; Sputum; C reactive protein; corticosteroid; eotaxin; gamma interferon; high density lipoprotein; interleukin 10; interleukin 13; interleukin 2; interleukin 4; interleukin 6; lipoxygenase; prostaglandin E2; toll like receptor; transcription factor RUNX2; tumor necrosis factor receptor; adult; airway obstruction; Akt signaling; arachidonic acid metabolism; Article; asthma; biosynthesis; cohort analysis; controlled study; disease exacerbation; disease severity; female; fibrosing alveolitis; genetic variation; granulocyte; human; human cell; inflammation; innate immunity; interferon signaling; lung alveolus macrophage; lung parenchyma; M1 macrophage; M2 macrophage; macrophage activation; major clinical study; male; microarray analysis; middle aged; phenotype; priority journal; sputum analysis; asthma; genetics; macrophage; macrophage activation; phenotype; sputum,Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85089447364
Khatak S.; Mehta M.; Awasthi R.; Paudel K.R.; Singh S.K.; Gulati M.; Hansbro N.G.; Hansbro P.M.; Dua K.; Dureja H.,"Khatak, Sunil (37261353700); Mehta, Meenu (7203024234); Awasthi, Rajendra (36866066100); Paudel, Keshav Raj (56539588400); Singh, Sachin Kumar (57206711834); Gulati, Monica (7006677671); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Dureja, Harish (6507566948)",37261353700; 7203024234; 36866066100; 56539588400; 57206711834; 7006677671; 15055862300; 6603119390; 15759138700; 6507566948,Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection,2020,Tuberculosis,125,,102008,,,,49,10.1016/j.tube.2020.102008,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092537485&doi=10.1016%2fj.tube.2020.102008&partnerID=40&md5=3fa1a7820a41a8c8973e8186a5b84ff5,"Raj Kumar Goel Institute of Technology (Pharmacy), Ghaziabad, Uttar Pradesh, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Amity Institute of Pharmacy, Amity University, Noida, 201313, Uttar Pradesh, India; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, Himachal Pradesh, India; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India","Khatak S., Raj Kumar Goel Institute of Technology (Pharmacy), Ghaziabad, Uttar Pradesh, India, Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Awasthi R., Amity Institute of Pharmacy, Amity University, Noida, 201313, Uttar Pradesh, India; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Hansbro N.G., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, Himachal Pradesh, India; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India",Antitubercular drugs; Isoniazid; Pyrazinamide; Rifampicin; Solid lipid nanoparticles; Tuberculosis,"Animals; Antitubercular Agents; Disease Models, Animal; Mice; Microscopy, Electron, Scanning; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Nanoparticles; Particle Size; glycerol behenate; isoniazid; poloxamer; pyrazinamide; rifampicin; solid lipid nanoparticle; stearic acid; taurocholic acid; nanoparticle; tuberculostatic agent; animal cell; Article; cell viability; controlled study; cytotoxicity; cytotoxicity assay; drug release; drug solubility; drug stability; encapsulation; Fourier transform infrared spectroscopy; growth inhibition; IC50; in vitro study; macrophage cell line; mathematical model; microemulsion; minimum inhibitory concentration; MTT assay; mycobacteriosis; Mycobacterium marinum; nonhuman; particle size; priority journal; scanning electron microscopy; tablet formulation; thermal analysis; X ray diffraction; zeta potential; animal; atypical mycobacteriosis; disease model; drug effect; isolation and purification; microbiology; mouse; Mycobacterium marinum; pathology; ultrastructure",Article,Final,,Scopus,2-s2.0-85092537485
Starkey M.R.; Plank M.W.; Casolari P.; Papi A.; Pavlidis S.; Guo Y.; Cameron G.J.M.; Haw T.J.; Tam A.; Obiedat M.; Donovan C.; Hansbro N.G.; Nguyen D.H.; Nair P.M.; Kim R.Y.; Horvat J.C.; Kaiko G.E.; Durum S.K.; Wark P.A.; Sin D.D.; Caramori G.; Adcock I.M.; Foster P.S.; Hansbro P.M.,"Starkey, Malcolm R. (35811293400); Plank, Maximilian W. (23486258000); Casolari, Paolo (8437991500); Papi, Alberto (7006239532); Pavlidis, Stelios (56642790400); Guo, Yike (12765868000); Cameron, Guy J.M. (57203977896); Haw, Tatt Jhong (56625918900); Tam, Anthony (42162059500); Obiedat, Ma'en (57210266264); Donovan, Chantal (55357105200); Hansbro, Nicole G. (15055862300); Nguyen, Duc H. (54886138200); Nair, Prema Mono (55749131000); Kim, Richard Y. (35810406900); Horvat, Jay C. (9942405300); Kaiko, Gerard E. (21739529400); Durum, Scott K. (7005323212); Wark, Peter A. (7003559516); Sin, Don D. (57202594563); Caramori, Gaetano (7003847659); Adcock, Ian M. (7007066538); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",35811293400; 23486258000; 8437991500; 7006239532; 56642790400; 12765868000; 57203977896; 56625918900; 42162059500; 57210266264; 55357105200; 15055862300; 54886138200; 55749131000; 35810406900; 9942405300; 21739529400; 7005323212; 7003559516; 57202594563; 7003847659; 7007066538; 7201517569; 6603119390,IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis,2019,European Respiratory Journal,54,1,1800174,,,,65,10.1183/13993003.00174-2018,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070117306&doi=10.1183%2f13993003.00174-2018&partnerID=40&md5=11446715f1dd9a025515d585dc292638,"Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Interdepartmental Study Center for Inflammatory and Smoke-related Airway Diseases (CEMICEF), Cardiorespiratory and Internal Medicine Section, University of Ferrara, Ferrara, Italy; The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; The University of British Columbia Center for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada; Respiratory Division, Dept of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Inflammation, Centenary Institute, Sydney, Australia; School of Life Sciences, University of Technology, Ultimo, Australia; Laboratory of Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, United States; UOC di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy","Starkey M.R., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Plank M.W., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Casolari P., Interdepartmental Study Center for Inflammatory and Smoke-related Airway Diseases (CEMICEF), Cardiorespiratory and Internal Medicine Section, University of Ferrara, Ferrara, Italy; Papi A., Interdepartmental Study Center for Inflammatory and Smoke-related Airway Diseases (CEMICEF), Cardiorespiratory and Internal Medicine Section, University of Ferrara, Ferrara, Italy; Pavlidis S., The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Guo Y., The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Cameron G.J.M., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Haw T.J., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Tam A., The University of British Columbia Center for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada, Respiratory Division, Dept of Medicine, University of British Columbia, Vancouver, BC, Canada; Obiedat M., The University of British Columbia Center for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada, Respiratory Division, Dept of Medicine, University of British Columbia, Vancouver, BC, Canada; Donovan C., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Hansbro N.G., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia, Centre for Inflammation, Centenary Institute, Sydney, Australia, School of Life Sciences, University of Technology, Ultimo, Australia; Nguyen D.H., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Nair P.M., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Kim R.Y., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Horvat J.C., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Kaiko G.E., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Durum S.K., Laboratory of Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, United States; Wark P.A., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Sin D.D., The University of British Columbia Center for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada, Respiratory Division, Dept of Medicine, University of British Columbia, Vancouver, BC, Canada; Caramori G., UOC di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Adcock I.M., The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Foster P.S., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Hansbro P.M., Priority Research Centres GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia, Centre for Inflammation, Centenary Institute, Sydney, Australia, School of Life Sciences, University of Technology, Ultimo, Australia",,"Airway Remodeling; Airway Resistance; Animals; Emphysema; Female; Humans; Immunity, Innate; Interleukins; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Disease, Chronic Obstructive; Receptors, Interleukin; Smoke; Tobacco Products; cigarette smoke; interleukin 22; messenger RNA; interleukin derivative; interleukin receptor; interleukin-22; interleukin-22 receptor; airway remodeling; airway resistance; animal experiment; animal model; animal tissue; Article; CD4+ T lymphocyte; chronic obstructive lung disease; controlled study; emphysema; female; forced vital capacity; gene expression; gene expression profiling; helper cell; innate lymphoid cell; inspiratory capacity; lung capacity; lung compliance; lung function; mouse; natural killer T cell; neutrophilic inflammation; nonhuman; pathogenesis; pneumonia; protein expression; adverse event; animal; C57BL mouse; chronic obstructive lung disease; emphysema; human; innate immunity; knockout mouse; lymphocyte; metabolism; pathology; physiology; smoke; tobacco",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85070117306
Loering S.; Cameron G.J.M.; Bhatt N.P.; Belz G.T.; Foster P.S.; Hansbro P.M.; Starkey M.R.,"Loering, Svenja (57205469740); Cameron, Guy J.M. (57203977896); Bhatt, Nirmal P (57221500733); Belz, Gabrielle T (7102682937); Foster, Paul S (7201517569); Hansbro, Philip M (6603119390); Starkey, Malcolm R (35811293400)",57205469740; 57203977896; 57221500733; 7102682937; 7201517569; 6603119390; 35811293400,"Differences in pulmonary group 2 innate lymphoid cells are dependent on mouse age, sex and strain",2021,Immunology and Cell Biology,99,5,,542,551,9,15,10.1111/imcb.12430,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099305425&doi=10.1111%2fimcb.12430&partnerID=40&md5=65d32eff2c3e4776223859d54eebe2e6,"Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland Translational Research Institute, Woolloongabba, QLD, Australia; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology, Sydney, NSW, Australia; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia","Loering S., Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Cameron G.J.M., Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Bhatt N.P., Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Belz G.T., The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland Translational Research Institute, Woolloongabba, QLD, Australia, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Foster P.S., Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology, Sydney, NSW, Australia; Starkey M.R., Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia, Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia",group 2 innate lymphoid cells (ILC2); infant; innate lymphoid cells (ILC); lung; neonate; respiratory,"Animals; Female; Immunity, Innate; Lung; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; inducible T cell costimulator; interleukin 1 receptor like 1 protein; interleukin 13; interleukin 5; membrane antigen; receptor type tyrosine protein phosphatase C; Thy 1 membrane glycoprotein; adult; age; animal cell; antigen expression; Article; Bagg albino mouse; controlled study; female; flow cytometry; lung development; lymphoid cell; male; mouse; mouse strain; newborn; nonhuman; protein expression; protein expression level; pulmonary group 2 innate lymphod cell; sex difference; T lymphocyte; animal; C57BL mouse; innate immunity; lung; lymphocyte",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85099305425
Mehta M.; Paudel K.R.; Shukla S.D.; Shastri M.D.; Singh S.K.; Gulati M.; Dureja H.; Gupta G.; Satija S.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Mehta, Meenu (7203024234); Paudel, Keshav R. (56539588400); Shukla, Shakti D. (56367620800); Shastri, Madhur D. (56007290800); Singh, Sachin K. (57206711834); Gulati, Monica (7006677671); Dureja, Harish (6507566948); Gupta, Gaurav (15047988400); Satija, Saurabh (54581608400); Hansbro, Philip M. (6603119390); Chellappan, Dinesh K. (35811890500); Dua, Kamal (15759138700)",7203024234; 56539588400; 56367620800; 56007290800; 57206711834; 7006677671; 6507566948; 15047988400; 54581608400; 6603119390; 35811890500; 15759138700,Letter to the editor: Interferon therapy for preventing copd exacerbations,2020,EXCLI Journal,19,,,1477,1480,3,8,10.17179/excli2020-2997,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098261713&doi=10.17179%2fexcli2020-2997&partnerID=40&md5=b741d6a667bb3e1fba93e2b1f486a2cf,"Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, 2305, NSW, Australia; Shastri M.D., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, 2305, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India",,alpha interferon; beta interferon; beta interferon receptor; cytokine; interferon; interferon beta receptor 1; interferon lambda 3; interleukin 28A; interleukin 29; interleukin 6; Janus kinase; STAT1 protein; toll like receptor 2; toll like receptor 4; toll like receptor adaptor molecule 1; unclassified drug; virus RNA; 2' 5' oligoadenylate synthase 1 gene; airway epithelium cell; chronic obstructive lung disease; disease exacerbation; disease severity; gene; gene expression regulation; human; IFN signaling; IL 17A gene; infection risk; Influenza A virus; ISG MxA gene; Letter; mortality; nonhuman; protein degradation; protein expression; protein function; protein phosphorylation; signal transduction; smoking; ubiquitination; viperin gene,Letter,Final,,Scopus,2-s2.0-85098261713
Mehta M.; Deeksha; Tewari D.; Gupta G.; Awasthi R.; Singh H.; Pandey P.; Chellappan D.K.; Wadhwa R.; Collet T.; Hansbro P.M.; Kumar S.R.; Thangavelu L.; Negi P.; Dua K.; Satija S.,"Mehta, Meenu (7203024234); Deeksha (59019265000); Tewari, Devesh (55850375500); Gupta, Gaurav (15047988400); Awasthi, Rajendra (36866066100); Singh, Harjeet (57211295911); Pandey, Parijat (56583499400); Chellappan, Dinesh Kumar (35811890500); Wadhwa, Ridhima (57159091700); Collet, Trudi (36898251800); Hansbro, Philip M. (6603119390); Kumar, S Rajesh (57206762888); Thangavelu, Lakshmi (57221436939); Negi, Poonam (57971006900); Dua, Kamal (15759138700); Satija, Saurabh (54581608400)",7203024234; 59019265000; 55850375500; 15047988400; 36866066100; 57211295911; 56583499400; 35811890500; 57159091700; 36898251800; 6603119390; 57206762888; 57221436939; 57971006900; 15759138700; 54581608400,Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases,2019,Chemico-Biological Interactions,308,,,206,215,9,356,10.1016/j.cbi.2019.05.028,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066284380&doi=10.1016%2fj.cbi.2019.05.028&partnerID=40&md5=7b654bf88e457b4ddf7284d7c1945c4e,"School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; School of Phamacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India; Amity School of Pharmacy, Amity University, Noida, Uttar Pradesh, India; National Medicinal Plants Board, Ministry of AYUSH, New Delhi, India; Department of Pharmaceutical Sciences, Shri Baba Mastnath University, Rohtak, 124001, Haryana, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Faculty of Life Science and Biotechnology, South Asian University, Akbar Bhawan, Chanakyapuri, New Delhi, 110021, India; Indigenous Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Nanobiomedicine Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, 600077, Tamil Nadu, India; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Mehta M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Deeksha, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Tewari D., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Gupta G., School of Phamacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India; Awasthi R., Amity School of Pharmacy, Amity University, Noida, Uttar Pradesh, India; Singh H., National Medicinal Plants Board, Ministry of AYUSH, New Delhi, India; Pandey P., Department of Pharmaceutical Sciences, Shri Baba Mastnath University, Rohtak, 124001, Haryana, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Wadhwa R., Faculty of Life Science and Biotechnology, South Asian University, Akbar Bhawan, Chanakyapuri, New Delhi, 110021, India; Collet T., Indigenous Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Kumar S.R., Nanobiomedicine Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, 600077, Tamil Nadu, India; Thangavelu L., Nanobiomedicine Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, 600077, Tamil Nadu, India; Negi P., School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India",miRNA; Nano-drug delivery; Novel approaches; Oligonucleotides; Respiratory diseases; siRNA,"Dendrimers; Drug Carriers; Humans; Liposomes; MicroRNAs; Nanoparticles; Oligonucleotides, Antisense; Pulmonary Disease, Chronic Obstructive; RNA Interference; RNA, Small Interfering; ADAM protein; ADAM33 protein; alpha interferon; antisense oligonucleotide; chitosan; CpG oligodeoxynucleotide; decoy oligodeoxynucleotide; gamma interferon; immunoglobulin enhancer binding protein; liposome; mesoporous silica nanoparticle; microRNA 122; microRNA 16; microRNA 192; neuropeptide S; neuropeptide S receptor 1; niosome; oligodeoxynucleotide; quantum dot; single stranded DNA; single stranded RNA; small interfering RNA; solid lipid nanoparticle; toll like receptor 9; unclassified drug; antisense oligonucleotide; dendrimer; drug carrier; microRNA; nanoparticle; small interfering RNA; asthma; bronchitis; chronic obstructive lung disease; cytokine production; cytokine release; down regulation; drug delivery system; drug formulation; enzyme inhibition; gene silencing; gene transfer; human; hydrolysis; intracellular signaling; lung fibrosis; micelle; microarray analysis; nonhuman; plasmacytoid dendritic cell; protein targeting; Review; RNA interference; chemistry; chronic obstructive lung disease",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85066284380
Ashcroft S.P.; Fletcher G.; Philp A.M.; Jenkinson C.; Das S.; Hansbro P.M.; Atherton P.J.; Philp A.,"Ashcroft, Stephen P. (56950258400); Fletcher, Gareth (57221353052); Philp, Ashleigh M. (57311488900); Jenkinson, Carl (55148366600); Das, Shatarupa (57223007601); Hansbro, Philip M. (6603119390); Atherton, Philip J. (14012757400); Philp, Andrew (11739653700)",56950258400; 57221353052; 57311488900; 55148366600; 57223007601; 6603119390; 14012757400; 11739653700,Diet-induced Vitamin D deficiency reduces skeletal muscle mitochondrial respiration,2021,Journal of Endocrinology,249,2,,113,124,11,18,10.1530/JOE-20-0233,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104486273&doi=10.1530%2fJOE-20-0233&partnerID=40&md5=3c872c2d35f7e965fb01e0b6502af91c,"School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom; MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Clinical, Metabolic and Molecular Physiology, University of Nottingham, Royal Derby Hospital Centre, Derby, United Kingdom; Mitochondrial Metabolism and Ageing Laboratory, Garvan Institute of Medical Research, Sydney, NSW, Australia; St Vincent’s Clinical School, UNSW Medicine, UNSW, Sydney, NSW, Australia; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom; ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia; Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; UTS Centenary Centre for Inflammation, University Technology Sydney, NSW, Australia","Ashcroft S.P., School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom, MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Clinical, Metabolic and Molecular Physiology, University of Nottingham, Royal Derby Hospital Centre, Derby, United Kingdom, Mitochondrial Metabolism and Ageing Laboratory, Garvan Institute of Medical Research, Sydney, NSW, Australia; Fletcher G., Mitochondrial Metabolism and Ageing Laboratory, Garvan Institute of Medical Research, Sydney, NSW, Australia; Philp A.M., Mitochondrial Metabolism and Ageing Laboratory, Garvan Institute of Medical Research, Sydney, NSW, Australia, St Vincent’s Clinical School, UNSW Medicine, UNSW, Sydney, NSW, Australia; Jenkinson C., Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia; Das S., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia, UTS Centenary Centre for Inflammation, University Technology Sydney, NSW, Australia; Hansbro P.M., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia, UTS Centenary Centre for Inflammation, University Technology Sydney, NSW, Australia; Atherton P.J., MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Clinical, Metabolic and Molecular Physiology, University of Nottingham, Royal Derby Hospital Centre, Derby, United Kingdom; Philp A., Mitochondrial Metabolism and Ageing Laboratory, Garvan Institute of Medical Research, Sydney, NSW, Australia, St Vincent’s Clinical School, UNSW Medicine, UNSW, Sydney, NSW, Australia",Mitochondria; Skeletal muscle; Vitamin D,"Animals; Body Composition; Calcium; Diet; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mitochondria, Muscle; Mitochondrial Proteins; Muscle, Skeletal; Oxygen Consumption; Vitamin D; Vitamin D Deficiency; adenosine diphosphate; calcium; citrate synthase; colecalciferol; hydroxymethylglutaryl coenzyme A reductase kinase; mitochondrial protein; mitofilin; OPA1 protein; phosphorus; reduced nicotinamide adenine dinucleotide dehydrogenase (ubiquinone); succinate dehydrogenase (ubiquinone); unclassified drug; vitamin D; mitochondrial protein; vitamin D; animal cell; animal experiment; animal model; animal tissue; Article; controlled study; data analysis software; diet; diet therapy; enzyme activity; enzyme phosphorylation; gastrocnemius muscle; immunoblotting; in vivo study; male; mitochondrial respiration; mouse; muscle mitochondrion; myopathy; nonhuman; priority journal; protein content; respiratory chain; respirometry; skeletal muscle; vitamin D deficiency; adverse event; animal; blood; body composition; C57BL mouse; drug effect; gene expression regulation; genetics; metabolism; muscle mitochondrion; oxygen consumption; skeletal muscle; vitamin D deficiency",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85104486273
Li J.; Xu X.; Jiang Y.; Hansbro N.G.; Hansbro P.M.; Xu J.; Liu G.,"Li, Jinzhi (57204911435); Xu, Xiaoyue (56524795700); Jiang, Yanyan (57215780307); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Xu, Jincheng (36239605800); Liu, Gang (57189061134)",57204911435; 56524795700; 57215780307; 15055862300; 6603119390; 36239605800; 57189061134,Elastin is a key factor of tumor development in colorectal cancer,2020,BMC Cancer,20,1,217,,,,43,10.1186/s12885-020-6686-x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081935153&doi=10.1186%2fs12885-020-6686-x&partnerID=40&md5=90a4f881cd67b57c07f78dca48555027,"School of Nursing, Bengbu Medical College, Bengbu, Anhui, China; Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia; School of Anatomy, Bengbu Medical College, Bengbu, Anhui, China; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia; Priority Research Centre for Health Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Stomatology Department, First Affiliated Hospital, Bengbu Medical College, Bengbu, Anhui, China; School of Dental Medicine, Bengbu Medical College, Bengbu, Anhui, China","Li J., School of Nursing, Bengbu Medical College, Bengbu, Anhui, China; Xu X., Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia; Jiang Y., School of Anatomy, Bengbu Medical College, Bengbu, Anhui, China; Hansbro N.G., School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia, Priority Research Centre for Health Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Hansbro P.M., School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia, Priority Research Centre for Health Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia; Xu J., Stomatology Department, First Affiliated Hospital, Bengbu Medical College, Bengbu, Anhui, China, School of Dental Medicine, Bengbu Medical College, Bengbu, Anhui, China; Liu G., School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia","Colorectal cancer; Elastin, epithelial-mesenchymal transition; Extracellular matrix protein","Animals; Caco-2 Cells; Carcinogenesis; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Elastin; Epithelial-Mesenchymal Transition; Extracellular Matrix; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 12; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Recombinant Proteins; Tissue Inhibitor of Metalloproteinase-3; Tumor Microenvironment; Tumor Necrosis Factor-alpha; alpha smooth muscle actin; elastin; gelatinase B; lipopolysaccharide; macrophage elastase; messenger RNA; phosphate buffered saline; recombinant protein; scleroprotein; tissue inhibitor of metalloproteinase 3; transforming growth factor beta; tumor necrosis factor; uvomorulin; vimentin; elastin; ELN protein, human; gelatinase B; macrophage elastase; MMP12 protein, human; MMP9 protein, human; recombinant protein; TIMP3 protein, human; tissue inhibitor of metalloproteinase 3; tumor necrosis factor; animal cell; Article; bone marrow derived macrophage; cancer tissue; carcinogenesis; cell migration; cell proliferation; clinical article; colon cell; colorectal cancer; controlled study; cytokine release; epithelial mesenchymal transition; female; gene expression; human; human cell; human tissue; intestine epithelium cell; microarray analysis; mouse; nonhuman; protein expression; protein synthesis; tumor microenvironment; wound healing; animal; C57BL mouse; Caco-2 cell line; cell motion; colorectal tumor; drug effect; extracellular matrix; gene expression regulation; genetics; metabolism",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85081935153
Khadem Ali Md.; Kim R.Y.; Brown A.C.; Mayall J.R.; Karim R.; Pinkerton J.W.; Liu G.; Martin K.L.; Starkey M.R.; Pillar A.L.; Donovan C.; Pathinayake P.S.; Carroll O.R.; Trinder D.; Tay H.L.; Badi Y.E.; Kermani N.Z.; Guo Y.-K.; Aryal R.; Mumby S.; Pavlidis S.; Adcock I.M.; Weaver J.; Xenaki D.; Oliver B.G.; Holliday E.G.; Foster P.S.; Wark P.A.; Johnstone D.M.; Milward E.A.; Hansbro P.M.; Horvat J.C.,"Khadem Ali, Md. (55820432000); Kim, Richard Y. (35810406900); Brown, Alexandra C. (55637745000); Mayall, Jemma R. (55607222700); Karim, Rafia (57194419768); Pinkerton, James W. (56647761900); Liu, Gang (57189061134); Martin, Kristy L. (57194415123); Starkey, Malcolm R. (35811293400); Pillar, Amber L. (57216038374); Donovan, Chantal (55357105200); Pathinayake, Prabuddha S. (55877978000); Carroll, Olivia R. (57202356826); Trinder, Debbie (7004242701); Tay, Hock L. (55639898100); Badi, Yusef E. (56275233300); Kermani, Nazanin Z. (57195464650); Guo, Yi-Ke (12765868000); Aryal, Ritambhara (57211585658); Mumby, Sharon (7005804196); Pavlidis, Stelios (56642790400); Adcock, Ian M. (7007066538); Weaver, Jessica (57193562267); Xenaki, Dikaia (6507411538); Oliver, Brian G. (15919869900); Holliday, Elizabeth G. (8879831700); Foster, Paul S. (7201517569); Wark, Peter A. (7003559516); Johnstone, Daniel M. (15829670700); Milward, Elizabeth A. (6603563509); Hansbro, Philip M. (6603119390); Horvat, Jay C. (9942405300)",55820432000; 35810406900; 55637745000; 55607222700; 57194419768; 56647761900; 57189061134; 57194415123; 35811293400; 57216038374; 55357105200; 55877978000; 57202356826; 7004242701; 55639898100; 56275233300; 57195464650; 12765868000; 57211585658; 7005804196; 56642790400; 7007066538; 57193562267; 6507411538; 15919869900; 8879831700; 7201517569; 7003559516; 15829670700; 6603563509; 6603119390; 9942405300,Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma,2020,European Respiratory Journal,55,4,1901340,,,,51,10.1183/13993003.01340-2019,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084025077&doi=10.1183%2f13993003.01340-2019&partnerID=40&md5=0801dabe4be7ed7862d0bbb76da799da,"Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA, United States; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, Australia; Respiratory Pharmacology and Toxicology Group, National Heart and Lung Institute, Imperial College London, London, United Kingdom; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Dept of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, Australia; Medical School, Harry Perkins Medical Research Institute, University of Western Australia, Fiona Stanley Hospital, Perth, Australia; Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Data Science Institute, Dept of Computing, Imperial College London, London, United Kingdom; Woolcock Institute of Medical Research, University of Sydney, School of Life Sciences, University of Technology Sydney, Sydney, Australia; Hunter Medical Research Institute, New Lambton, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, Australia; Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia; Discipline of Physiology and Bosch Institute, University of Sydney, Sydney, Australia","Khadem Ali Md., Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA, United States, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, Australia; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Mayall J.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Karim R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Pinkerton J.W., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia, Respiratory Pharmacology and Toxicology Group, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Liu G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, Australia; Martin K.L., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia, Dept of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia; Pillar A.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, Australia; Pathinayake P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Newcastle, Australia; Carroll O.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Trinder D., Medical School, Harry Perkins Medical Research Institute, University of Western Australia, Fiona Stanley Hospital, Perth, Australia; Tay H.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Badi Y.E., Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Kermani N.Z., Data Science Institute, Dept of Computing, Imperial College London, London, United Kingdom; Guo Y.-K., Data Science Institute, Dept of Computing, Imperial College London, London, United Kingdom; Aryal R., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Mumby S., Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Pavlidis S., Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Adcock I.M., Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Weaver J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Xenaki D., Woolcock Institute of Medical Research, University of Sydney, School of Life Sciences, University of Technology Sydney, Sydney, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, School of Life Sciences, University of Technology Sydney, Sydney, Australia; Holliday E.G., Hunter Medical Research Institute, New Lambton, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia, Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia; Johnstone D.M., Discipline of Physiology and Bosch Institute, University of Sydney, Sydney, Australia; Milward E.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia",,CD71 antigen; interleukin 13; interleukin 6; interleukin 8; iron; natural resistance associated macrophage protein 2; adult; airway smooth muscle cell; animal experiment; animal model; Article; asthma; cell count; clinical article; clinical feature; clinical study; cohort analysis; controlled study; Dermatophagoides; disease association; disease severity; DMT1 gene; ex vivo study; experimental study; extracellular matrix; female; fibroblast; forced expiratory volume; forced vital capacity; gene; gene expression; human; human cell; human tissue; IL 13 gene; iron blood level; lung alveolus macrophage; lung fibrosis; lung function; lung iron level; lung lavage; lung parenchyma; male; middle aged; molecular pathology; mouse; nonhuman; pneumonia; priority journal; protein expression; respiratory tract allergy; respiratory tract parameters; TFR1 gene,Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85084025077
Hadjigol S.; Netto K.G.; Maltby S.; Tay H.L.; Nguyen T.H.; Hansbro N.G.; Eyers F.; Hansbro P.M.; Yang M.; Foster P.S.,"Hadjigol, Sara (56460310100); Netto, Keilah G. (57211477944); Maltby, Steven (6507446799); Tay, Hock L. (55639898100); Nguyen, Thi H. (57209165993); Hansbro, Nicole G. (15055862300); Eyers, Fiona (6506572937); Hansbro, Philip M. (6603119390); Yang, Ming (56857729900); Foster, Paul S. (7201517569)",56460310100; 57211477944; 6507446799; 55639898100; 57209165993; 15055862300; 6506572937; 6603119390; 56857729900; 7201517569,Lipopolysaccharide induces steroid-resistant exacerbations in a mouse model of allergic airway disease collectively through IL-13 and pulmonary macrophage activation,2020,Clinical and Experimental Allergy,50,1,,82,94,12,26,10.1111/cea.13505,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074083631&doi=10.1111%2fcea.13505&partnerID=40&md5=7168286a67ad4dcff87d068b207f6e58,"Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia","Hadjigol S., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Netto K.G., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Maltby S., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Tay H.L., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Nguyen T.H., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Eyers F., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Yang M., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia",airway hyperresponsiveness; asthma exacerbation; IL-13; lipopolysaccharide; Macrophages; steroid resistance,"Airway Resistance; Animals; Asthma; Bacterial Infections; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Cytokines; Dexamethasone; Disease Models, Animal; Disease Progression; Drug Resistance; Glucocorticoids; Interferon-gamma; Interleukin-13; Interleukins; Lipopolysaccharides; Macrophage Activation; Macrophages, Alveolar; Mice; Mucin 5AC; Ovalbumin; Respiratory Hypersensitivity; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; dexamethasone; gamma interferon; interleukin 13; interleukin 27; interleukin 5; lipopolysaccharide; monocyte chemotactic protein 1; tumor necrosis factor; Ccl2 protein, mouse; cytokine; dexamethasone; glucocorticoid; IFNG protein, mouse; Il27 protein, mouse; interleukin 13; interleukin derivative; lipopolysaccharide; Muc5ac protein, mouse; mucin 5AC; ovalbumin; Tnf protein, mouse; animal cell; animal experiment; animal model; animal tissue; Article; disease exacerbation; lung lavage; macrophage activation; male; mouse; neutrophil; nonhuman; priority journal; respiratory tract allergy; airway resistance; animal; asthma; bacterial infection; bronchoalveolar lavage fluid; cytology; disease model; drug effect; drug resistance; immunology; lung alveolus macrophage; macrophage activation; metabolism; respiratory tract allergy; reverse transcription polymerase chain reaction",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85074083631
Paudel K.R.; Wadhwa R.; Mehta M.; Chellappan D.K.; Hansbro P.M.; Dua K.,"Paudel, Keshav Raj (56539588400); Wadhwa, Ridhima (57159091700); Mehta, Meenu (7203024234); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",56539588400; 57159091700; 7203024234; 35811890500; 6603119390; 15759138700,Rutin loaded liquid crystalline nanoparticles inhibit lipopolysaccharide induced oxidative stress and apoptosis in bronchial epithelial cells in vitro,2020,Toxicology in Vitro,68,,104961,,,,48,10.1016/j.tiv.2020.104961,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089277384&doi=10.1016%2fj.tiv.2020.104961&partnerID=40&md5=74c15656e39a201a1684b43b869f8e2e,"School of Life Sciences, Faculty of Science, University of Technology, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia","Paudel K.R., School of Life Sciences, Faculty of Science, University of Technology, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Wadhwa R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Mehta M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., School of Life Sciences, Faculty of Science, University of Technology, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia",Airway inflammation; Lipopolysaccharide; Liquid crystalline nanoparticles; Oxidative stress; Rutin,Apoptosis; Bronchi; Cell Line; Cell Survival; Epithelial Cells; Humans; Lipopolysaccharides; Nanoparticles; Nitric Oxide; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Rutin; dichlorodihydrofluorescein diacetate; fluorescein isothiocyanate; lipocortin 5; lipopolysaccharide; liquid crystalline nanoparticle; nanoparticle; nitric oxide; reactive oxygen metabolite; rutoside; unclassified drug; nanoparticle; protective agent; rutoside; apoptosis; Article; BEAS-2B cell line; cell protection; cell stimulation; controlled study; drug delivery system; drug efficacy; drug screening; enzyme inhibition; human; human cell; immunohistochemistry; in vitro study; oxidative stress; respiratory tract inflammation; apoptosis; bronchus; cell line; cell survival; cytology; drug effect; epithelium cell; metabolism; oxidative stress,Article,Final,,Scopus,2-s2.0-85089277384
Findlay A.D.; Foot J.S.; Buson A.; Deodhar M.; Jarnicki A.G.; Hansbro P.M.; Liu G.; Schilter H.; Turner C.I.; Zhou W.; Jarolimek W.,"Findlay, Alison D. (13905740600); Foot, Jonathan S. (36790740700); Buson, Alberto (6507407930); Deodhar, Mandar (55635622900); Jarnicki, Andrew G. (6603137164); Hansbro, Philip M. (6603119390); Liu, Gang (57189061134); Schilter, Heidi (23480284500); Turner, Craig I. (57198935305); Zhou, Wenbin (55893249200); Jarolimek, Wolfgang (6603814673)",13905740600; 36790740700; 6507407930; 55635622900; 6603137164; 6603119390; 57189061134; 23480284500; 57198935305; 55893249200; 6603814673,Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3,2019,Journal of Medicinal Chemistry,62,21,,9874,9889,15,40,10.1021/acs.jmedchem.9b01283,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073820000&doi=10.1021%2facs.jmedchem.9b01283&partnerID=40&md5=ab9740808fd398c2ff2e47fc60f975b3,"Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, 2086, NSW, Australia; Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, 2300, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Findlay A.D., Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, 2086, NSW, Australia; Foot J.S., Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, 2086, NSW, Australia; Buson A., Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, 2086, NSW, Australia; Deodhar M., Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, 2086, NSW, Australia; Jarnicki A.G., Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, 2300, NSW, Australia; Hansbro P.M., Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, 2300, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Liu G., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Schilter H., Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, 2086, NSW, Australia; Turner C.I., Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, 2086, NSW, Australia; Zhou W., Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, 2086, NSW, Australia; Jarolimek W., Pharmaxis Ltd, 20 Rodborough Road, Frenchs Forest, Sydney, 2086, NSW, Australia",,"Amines; Animals; Drug Design; Enzyme Inhibitors; Humans; Mice; Protein-Lysine 6-Oxidase; Triazoles; (s,z) 4 (4 amino 2 fluorobut 2 enyloxy) n (1 phenyl ethyl) benzenesulfonamide; (z) 1 (4 ((tert butoxycarbonyl)amino) 2 fluorobut 2 en 1 yl) 3 (3 (n,n dimethylsulfamoyl) phenyl) 2 methyl 1h indole 5 carboxylic acid; (z) 1 (4 amino 2 fluorobut 2 en 1 yl) 3 (3 (n,n dimethylsulfamoyl)phenyl) n,n,2 trimethyl 1h indole 5 carboxamide hydrochloride; (z) 3 (1 (4 amino 2 fluorobut 2 en 1 yl) 1h pyrrol 3 yl) n,n dimethylbenzenesulfonamide hydrochloride; (z) 3 (1 (4 amino 2 fluorobut 2 en 1 yl) 2 methyl 1h indol 3 yl) n,n dimethylbenzenesulfonamide hydrochloride; (z) 3 fluoro 4 (4 ((2 (methylsulfonyl)phenoxy)methyl) 1h 1,2,3 triazol 1 yl)but 2 en 1 amine hydrochloride; (z) 3 fluoro 4 (4 ((3 (methylsulfonyl)phenoxy)methyl) 1h 1,2,3 triazol 1 yl)but 2 en 1 amine hydrochloride; (z) 3 fluoro 4 (4 ((4 (methylsulfonyl)phenoxy)methyl) 1h 1,2,3 triazol 1 yl)but 2 en 1 amine hydrochloride; (z) 3 fluoro 4 (4 (phenoxymethyl) 1h 1,2,3 triazol 1 yl)but 2 en 1 amine Hydrochloride; (z) 4 ((1 (4 amino 2 fluorobut 2 en 1 yl) 1h 1,2,3 triazol 4 yl) methyl) n,n dimethylbenzenesulfonamide hydrochloride; (z) 4 ((1 (4 amino 2 fluorobut 2 enyl) 1h 1,2,3 triazol 4 yl) methoxy) 3 chloro n,n dimethylbenzenesulfonamide hydrochloride; (z) 4 ((1 (4 amino 2 fluorobut 2 enyl) 1h 1,2,3 triazol 4 yl) methoxy) n,n dimethylbenzamide hydrochloride; (z) 4 ((1 (4 amino 2 fluorobut 2 enyl) 1h 1,2,3 triazol 4 yl) methoxy) n,n dimethylbenzenesulfonamide hydrochloride; (z) 4 ((1 (4 amino 2 fluorobut 2 enyl) 1h 1,2,3 triazol 4 yl) methylamino) n,n dimethylbenzene sulfonamide hydrochloride; (z) 4 (1 (4 amino 2 fluorobut 2 en 1 yl) 1h 1,2,3 triazol 4 yl) n,n dimethylbenzenesulfonamide hydrochloride; (z) 4 (1 (4 amino 2 fluorobut 2 en 1 yl) 1h pyrrol 3 yl) n,n dimethylbenzenesulfonamide hydrochloride; (z) 4 (1 (4 amino 2 fluorobut 2 en 1 yl) 2 methyl 1h indol 3 yl) n,n dimethylbenzenesulfonamide hydrochloride; (z) 4 (4 ((4 tert butylphenoxy)methyl) 1h 1,2,3 triazol 1 yl) 3 fluorobut 2 en 1 amine hydrochloride; (z) ethyl 1 (4 ((tert butoxycarbonyl)amino) 2 fluorobut 2 en 1 yl) 3 (3 (n,n dimethylsulfamoyl)phenyl) 2 methyl 1h indole 5 carboxylate; (z) tert butyl 3 fluoro 4 hydroxybut 2 enylcarbamate; (z) tert butyl 4 azido 3 fluorobut 2 enylcarbamate; (z) tert butyl 4 bromo 3 fluorobut 2 enylcarbamate; (z) tert butyl(4 (5 (dimethylcarbamoyl) 3 (3 (n,n dimethylsulfamoyl)phenyl) 2 methyl 1h indol 1 yl) 3 fluorobut 2 en 1 yl) carbamate; enzyme inhibitor; fluoroallylamine inhibitor; Lysyl oxidase like 2; n,n dimethyl 4 prop 2 ynoxy benzenesulfonamide; protein lysine 6 oxidase; pxs 5129a; unclassified drug; unindexed drug; amine; enzyme inhibitor; protein lysine 6 oxidase; triazole derivative; animal experiment; animal model; animal tissue; antifibrotic activity; Article; column chromatography; controlled study; dilution; drug identification; drug purity; drug synthesis; enzymatic assay; female; fluorine nuclear magnetic resonance; high performance liquid chromatography; human; human cell; liquid chromatography-mass spectrometry; liver cirrhosis; liver fibrosis; lung fibrosis; male; medicinal chemistry; metabolic stability; mouse; nonhuman; oxidation; proton nuclear magnetic resonance; thin layer chromatography; animal; chemistry; drug design",Article,Final,,Scopus,2-s2.0-85073820000
Tew X.N.; Xin Lau N.J.; Chellappan D.K.; Madheswaran T.; Zeeshan F.; Tambuwala M.M.; Aljabali A.A.; Balusamy S.R.; Perumalsamy H.; Gupta G.; Oliver B.G.; Hsu A.; Wark P.; Reddy K.; Wadhwa R.; Hansbro P.M.; Dua K.,"Tew, Xin Nee (57214071502); Xin Lau, Natalie Jia (57214099305); Chellappan, Dinesh Kumar (35811890500); Madheswaran, Thiagarajan (55505311000); Zeeshan, Farrukh (26654611200); Tambuwala, Murtaza M. (36657816300); Aljabali, Alaa AA. (35306626800); Balusamy, Sri Renukadevi (39261087900); Perumalsamy, Haribalan (35345748600); Gupta, Gaurav (15047988400); Oliver, Brian G. (15919869900); Hsu, Alan (49861516600); Wark, Peter (7003559516); Reddy, Karosham (57214081399); Wadhwa, Ridhima (57159091700); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",57214071502; 57214099305; 35811890500; 55505311000; 26654611200; 36657816300; 35306626800; 39261087900; 35345748600; 15047988400; 15919869900; 49861516600; 7003559516; 57214081399; 57159091700; 6603119390; 15759138700,Immunological axis of berberine in managing inflammation underlying chronic respiratory inflammatory diseases,2020,Chemico-Biological Interactions,317,,108947,,,,41,10.1016/j.cbi.2020.108947,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078137548&doi=10.1016%2fj.cbi.2020.108947&partnerID=40&md5=749cf530ff891a4a13e8561dad1bd35f,"School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County, Londonderry, BT52 1SA, Northern Ireland, United Kingdom; Faculty of Pharmacy, Department of Pharmaceutical Sciences, Yarmouk University, Irbid, 21163, Jordan; Department of Food Science and Biotechnology, Sejong University, Gwangjin-gu, Seoul, 05006, South Korea; Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin, 446–701, South Korea; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, 173 229, Himachal Pradesh, India","Tew X.N., School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Xin Lau N.J., School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Zeeshan F., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County, Londonderry, BT52 1SA, Northern Ireland, United Kingdom; Aljabali A.A., Faculty of Pharmacy, Department of Pharmaceutical Sciences, Yarmouk University, Irbid, 21163, Jordan; Balusamy S.R., Department of Food Science and Biotechnology, Sejong University, Gwangjin-gu, Seoul, 05006, South Korea; Perumalsamy H., Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin, 446–701, South Korea; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; Oliver B.G., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, Australia; Hsu A., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Wark P., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Reddy K., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, Australia; Wadhwa R., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Hansbro P.M., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Dua K., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, 173 229, Himachal Pradesh, India",Asthma; Berberine; COPD; Inflammatory diseases; Lung cancer; Pulmonary fibrosis; Respiratory diseases,Anti-Inflammatory Agents; Berberine; Chronic Disease; Gene Expression Regulation; Humans; Inflammation; Respiratory Tract Diseases; berberine; carboplatin; cisplatin; immunoglobulin enhancer binding protein; mitogen activated protein kinase 1; mitogen activated protein kinase 3; mitogen activated protein kinase p38; nintedanib; pirfenidone; antiinflammatory agent; berberine; antiinflammatory activity; asthma; chronic obstructive lung disease; chronic respiratory tract disease; drug structure; human; lung cancer; lung fibrosis; nonhuman; pathophysiology; respiratory tract inflammation; Review; signal transduction; small cell lung cancer; chronic disease; drug effect; gene expression regulation; inflammation; respiratory tract disease,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85078137548
Hu M.J.; Schulze K.E.; Ghildyal R.; Henstridge D.C.; Kolanowski J.L.; New E.J.; Hong Y.; Hsu A.C.; Hansbro P.M.; Wark P.A.B.; Bogoyevitch M.A.; Jans D.A.,"Hu, Meng Jie (55791386100); Schulze, Keith E. (56355428300); Ghildyal, Reena (6603043249); Henstridge, Darren C. (23568269300); Kolanowski, Jacek L. (55698876100); New, Elizabeth J. (16642962700); Hong, Yuning (14321550500); Hsu, Alan C. (49861516600); Hansbro, Philip M. (6603119390); Wark, Peter A. B. (7003559516); Bogoyevitch, Marie A. (7003978880); Jans, David A. (35598249500)",55791386100; 56355428300; 6603043249; 23568269300; 55698876100; 16642962700; 14321550500; 49861516600; 6603119390; 7003559516; 7003978880; 35598249500,Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production,2019,eLife,8,,e42448,,,,41,10.7554/eLife.42448.001,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069006504&doi=10.7554%2feLife.42448.001&partnerID=40&md5=8c680a54b0c6ba98a517847c98be9cba,"Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Australia; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia; Monash Micro Imaging, Monash University, Melbourne, Australia; Centre for Research in Therapeutic Solutions, Faculty of Science and Technology, University of Canberra, Canberra, Australia; Baker Heart and Diabetes Institute, Melbourne, Australia; School of Chemistry, The University of Sydney, Sydney, Australia; Department of Chemistry and Physics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Institute of Bio-organic Chemistry, Polish Academy of Sciences, Poznan, Poland","Hu M.J., Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Australia, Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia; Schulze K.E., Monash Micro Imaging, Monash University, Melbourne, Australia; Ghildyal R., Centre for Research in Therapeutic Solutions, Faculty of Science and Technology, University of Canberra, Canberra, Australia; Henstridge D.C., Baker Heart and Diabetes Institute, Melbourne, Australia; Kolanowski J.L., School of Chemistry, The University of Sydney, Sydney, Australia, Institute of Bio-organic Chemistry, Polish Academy of Sciences, Poznan, Poland; New E.J., School of Chemistry, The University of Sydney, Sydney, Australia; Hong Y., Department of Chemistry and Physics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia; Hsu A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Bogoyevitch M.A., Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Australia; Jans D.A., Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia",,alpha tubulin; antimycin A1; cytochalasin D; cytoplasmic dynein; dynein adenosine triphosphatase; dynein cytoplasmic 1 heavy chain 1; dynein light chain tctex type 1; flavin rhodamine redox sensor 2; gamma tubulin; ionophore; kinesin light chain 1; lactate dehydrogenase; mitoquinone mesylate; molecular motor; monastrol; nocodazole; nonstructural protein 1; oligomycin; oxidoreductase inhibitor; reactive oxygen metabolite; rotenone; small interfering RNA; unclassified drug; A-549 cell line; animal cell; animal experiment; animal model; Article; bioenergy; bleaching; cell infiltration; cell viability; cell viability assay; confocal laser scanning microscopy; controlled study; depolymerization; energy yield; experimental pneumonia; flow cytometry; genetic transfection; glycolysis; Golgi complex; histology; human; human cell; Human respiratory syncytial virus; immunoblotting; immunofluorescence test; live cell imaging; microtubule integrity; microtubule organizing center; mitochondrial distribution; mitochondrial dynamics; mitochondrial function; mitochondrial membrane potential; mitochondrial organization; mitochondrial redistribution; mitochondrial respiration; mouse; nonhuman; oxidation reduction reaction; oxygen consumption; perinuclear mitochondrial clustering; plaque assay; quantitative analysis; real time polymerase chain reaction; respiratory syncytial virus infection; signal detection; viral plaque assay; virus cell interaction; virus genome; virus load; virus replication,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85069006504
Marshall R.J.; Armart P.; Hulme K.D.; Chew K.Y.; Brown A.C.; Hansbro P.M.; Bloxham C.J.; Flint M.; Ronacher K.; Bielefeldt-Ohmann H.; Gallo L.A.; Short K.R.,"Marshall, Rebecca J. (57215924064); Armart, Pornthida (57215923440); Hulme, Katina D. (57194323710); Chew, Keng Yih (51763251700); Brown, Alexandra C. (55637745000); Hansbro, Philip M. (6603119390); Bloxham, Conor J. (57215923396); Flint, Melanie (57202377050); Ronacher, Katharina (24528688300); Bielefeldt-Ohmann, Helle (7005067985); Gallo, Linda A. (54392954800); Short, Kirsty R. (36673861500)",57215924064; 57215923440; 57194323710; 51763251700; 55637745000; 6603119390; 57215923396; 57202377050; 24528688300; 7005067985; 54392954800; 36673861500,Glycemic variability in diabetes increases the severity of influenza,2020,mBio,11,2,e02841-19,,,,33,10.1128/mBio.02841-19,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082380777&doi=10.1128%2fmBio.02841-19&partnerID=40&md5=546dddbb49d5df2619b90fbf253e2b61,"School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, NSW, Australia; The University of Newcastle, Callaghan, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; University of Technology Sydney, Faculty of Science, Ultimo, NSW, Australia; School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, Australia; Mater Research Institute, Translational Research Institute, The University of Queensland, Woolloongabba, QLD, Australia; Australian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, QLD, Australia","Marshall R.J., School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Armart P., School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Hulme K.D., School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Chew K.Y., School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, NSW, Australia, The University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, NSW, Australia, The University of Newcastle, Callaghan, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, University of Technology Sydney, Faculty of Science, Ultimo, NSW, Australia; Bloxham C.J., School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, Australia; Flint M., School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, Australia; Ronacher K., Mater Research Institute, Translational Research Institute, The University of Queensland, Woolloongabba, QLD, Australia; Bielefeldt-Ohmann H., School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia, Australian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, QLD, Australia; Gallo L.A., School of Biomedical Sciences, The University of Queensland, St. Lucia, QLD, Australia, Mater Research Institute, Translational Research Institute, The University of Queensland, Woolloongabba, QLD, Australia; Short K.R., School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia, Australian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, QLD, Australia",Blood glucose; Diabetes; Influenza,"Animals; Biomarkers; Blood Glucose; Cell Death; Cells, Cultured; Coculture Techniques; Diabetes Mellitus, Type 2; Endothelial Cells; Glycemic Load; Humans; Inflammation; Influenza A virus; Influenza, Human; Male; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Oxidative Stress; Severity of Illness Index; 4 hydroxynonenal; alpha interferon; CXCL1 chemokine; gamma interferon; glucose; hemoglobin A1c; interleukin 10; interleukin 1beta; interleukin 6; interleukin 8; lactate dehydrogenase; monocyte chemotactic protein 1; tumor necrosis factor; biological marker; animal cell; animal experiment; animal model; animal tissue; Article; body weight; capillary endothelial cell; cell death; controlled study; diabetes mellitus; disease severity; human; human cell; in vitro study; in vivo study; influenza; influenza A (H1N1); influenza A (H3N2); Influenza A virus (H1N1); male; mouse; NCI-H441 cell line; nonhuman; oxidative stress; pneumonia; primary infection; priority journal; reinfection; secondary infection; transepithelial resistance; virus replication; animal; blood; C57BL mouse; cell culture; coculture; complication; endothelium cell; glucose blood level; glycemic load; immunology; inflammation; influenza; Influenza A virus; non insulin dependent diabetes mellitus; orthomyxovirus infection; pathogenicity; pathophysiology; severity of illness index; virology",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85082380777
Cherk Yong D.O.; Saker S.R.; Wadhwa R.; Chellappan D.K.; Madheswaran T.; Panneerselvam J.; Tambuwala M.M.; Bakshi H.A.; Kumar P.; Pillay V.; Gupta G.; Oliver B.G.; Wark P.; Hsu A.; Hansbro P.M.; Dua K.; Zeeshan F.,"Cherk Yong, David Ong (57211271109); Saker, Sanggetha Raja (57211271252); Wadhwa, Ridhima (57159091700); Chellappan, Dinesh Kumar (35811890500); Madheswaran, Thiagarajan (55505311000); Panneerselvam, Jithendra (57201993010); Tambuwala, Murtaza M. (36657816300); Bakshi, Hamid A. (36028052300); Kumar, Pradeep (7403960277); Pillay, Viness (56711693300); Gupta, Gaurav (15047988400); Oliver, Brian G. (15919869900); Wark, Peter (7003559516); Hsu, Alan (49861516600); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Zeeshan, Farrukh (26654611200)",57211271109; 57211271252; 57159091700; 35811890500; 55505311000; 57201993010; 36657816300; 36028052300; 7403960277; 56711693300; 15047988400; 15919869900; 7003559516; 49861516600; 6603119390; 15759138700; 26654611200,"Preparation, characterization and in-vitro efficacy of quercetin loaded liquid crystalline nanoparticles for the treatment of asthma",2019,Journal of Drug Delivery Science and Technology,54,,101297,,,,40,10.1016/j.jddst.2019.101297,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073234433&doi=10.1016%2fj.jddst.2019.101297&partnerID=40&md5=f71d75eddf3d16c643f7d87a9419cee6,"School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, London, Northern Ireland, Ireland; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia","Cherk Yong D.O., School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Saker S.R., School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Wadhwa R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, London, Northern Ireland, Ireland; Bakshi H.A., School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, London, Northern Ireland, Ireland; Kumar P., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Pillay V., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, 302017, India; Oliver B.G., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Wark P., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Hsu A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Zeeshan F., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia",Asthma; BCi-NS1.1; Inflammation; Liquid crystalline nanoparticles; Quercetin,dimethyl sulfoxide; fluticasone propionate; interleukin 1beta; interleukin 6; interleukin 8; nanoparticle; quercetin; antiinflammatory activity; Article; asthma; controlled study; cytokine production; dispersity; down regulation; drug delivery system; drug efficacy; drug mechanism; flow cytometry; HBEC cell line (bronchial epithelium); human; human cell; in vitro study; liquid crystal; nanoencapsulation; particle size; photon correlation spectroscopy; zeta potential,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85073234433
Wadhwa R.; Sehgal N.; Naresh G.; Aggarwal T.; Satija S.; Mehta M.; Gupta G.; Chellappan D.K.; Tambuwala M.M.; Oliver B.; Collet T.; Maurya P.K.; Hansbro P.M.; Dua K.,"Wadhwa, Ridhima (57159091700); Sehgal, Nikita (57203322225); Naresh, G. (57215610782); Aggarwal, Taru (57196053981); Satija, Saurabh (54581608400); Mehta, Meenu (7203024234); Gupta, Gaurav (15047988400); Chellappan, Dinesh K. (35811890500); Tambuwala, Murtaza M. (36657816300); Oliver, Brain (15919869900); Collet, Trudi (36898251800); Maurya, Pawan K. (15765644500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57159091700; 57203322225; 57215610782; 57196053981; 54581608400; 7203024234; 15047988400; 35811890500; 36657816300; 15919869900; 36898251800; 15765644500; 6603119390; 15759138700,Oxidative stress and immunological complexities in multidrug-resistant tuberculosis,2020,Role of Oxidative Stress in Pathophysiology of Diseases,,,,107,124,17,5,10.1007/978-981-15-1568-2_7,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089633382&doi=10.1007%2f978-981-15-1568-2_7&partnerID=40&md5=d105d308e071f3702b0c62519d896226,"Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy and Pharmaceutical Science, Ulster University, County Londonderry, United Kingdom; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, NSW, Australia; Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Department of Biochemistry, Central University of Haryana, Mahendragarh, Haryana, India; Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, NSW, Australia","Wadhwa R., Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Sehgal N., Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; Naresh G., Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; Aggarwal T., Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Mehta M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Tambuwala M.M., School of Pharmacy and Pharmaceutical Science, Ulster University, County Londonderry, United Kingdom; Oliver B., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, NSW, Australia; Collet T., Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Maurya P.K., Department of Biochemistry, Central University of Haryana, Mahendragarh, Haryana, India; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, NSW, Australia",Drug-susceptible tuberculosis; Multidrug-resistant tuberculosis; Mycobacterium tuberculosis; Oxidative stress,,Book chapter,Final,,Scopus,2-s2.0-85089633382
Prasher P.; Sharma M.; Mehta M.; Paudel K.R.; Satija S.; Chellappan D.K.; Dureja H.; Gupta G.; Tambuwala M.M.; Negi P.; Wich P.R.; Hansbro N.G.; Hansbro P.M.; Dua K.,"Prasher, Parteek (56079914500); Sharma, Mousmee (57214452304); Mehta, Meenu (7203024234); Paudel, Keshav R. (56539588400); Satija, Saurabh (54581608400); Chellappan, Dinesh K. (35811890500); Dureja, Harish (6507566948); Gupta, Gaurav (15047988400); Tambuwala, Murtaza M. (36657816300); Negi, Poonam (57971006900); Wich, Peter R. (7801599835); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",56079914500; 57214452304; 7203024234; 56539588400; 54581608400; 35811890500; 6507566948; 15047988400; 36657816300; 57971006900; 7801599835; 15055862300; 6603119390; 15759138700,Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective,2020,Chemico-Biological Interactions,325,,109125,,,,44,10.1016/j.cbi.2020.109125,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084200370&doi=10.1016%2fj.cbi.2020.109125&partnerID=40&md5=b013e0b039d3948ca8959045328d99a9,"Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Department of Chemistry, Uttaranchal University, Dehradun, 248007, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, Haryana, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India; School of Pharmacy and Pharmaceutical Sciences, Ulster University, County Londonderry, Northern Ireland, Coleraine, BT52 1SA, United Kingdom; School of Pharmaceutical Sciences, Shoolini University, Bajhol, Solan, Sultanpur, 173229, Himachal Pradesh, India; Australian Centre for Nano Medicine, University of New South Wales, Sydney, 2052, NSW, Australia; School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia","Prasher P., Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Sharma M., Department of Chemistry, Uttaranchal University, Dehradun, 248007, India; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, Haryana, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, County Londonderry, Northern Ireland, Coleraine, BT52 1SA, United Kingdom; Negi P., School of Pharmaceutical Sciences, Shoolini University, Bajhol, Solan, Sultanpur, 173229, Himachal Pradesh, India; Wich P.R., Australian Centre for Nano Medicine, University of New South Wales, Sydney, 2052, NSW, Australia, School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Bajhol, Solan, Sultanpur, 173229, Himachal Pradesh, India, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia",Alkaloids; COPD; Flavonoids; Natural products; Respiratory disorders,Animals; Chronic Disease; Humans; Molecular Targeted Therapy; Plant Extracts; Respiratory Tract Diseases; alkaloid derivative; apigenin; asperuloside; atropine; aurantiin; berberine; boswellic acid; carvacrol; curcumin; epicatechin; Eucalyptus extract; eugenol; eukalyptol; flavonoid; iridoid; kaempferol glycoside; lactiflorin; luteolin; naringenin; picroside II; plant medicinal product; procyanidin; puerarin; quercetin; resveratrol; sulforaphane; terpene derivative; tetramethylpyrazine; theophylline; unclassified drug; unindexed drug; plant extract; chronic respiratory tract disease; drug efficacy; drug mechanism; drug structure; human; nonhuman; pharmacological parameters; phytochemistry; Review; therapy effect; animal; chemistry; chronic disease; immunology; molecularly targeted therapy; procedures; respiratory tract disease,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85084200370
Martins Costa Gomes G.; de Gouveia Belinelo P.; Starkey M.R.; Murphy V.E.; Hansbro P.M.; Sly P.D.; Robinson P.D.; Karmaus W.; Gibson P.G.; Mattes J.; Collison A.M.,"Martins Costa Gomes, Gabriela (57222158030); de Gouveia Belinelo, Patricia (57215831762); Starkey, Malcolm R (35811293400); Murphy, Vanessa E (7006804832); Hansbro, Philip M (6603119390); Sly, Peter D (35371387300); Robinson, Paul D (12794088900); Karmaus, Wilfried (55146650400); Gibson, Peter G (7202414199); Mattes, Joerg (7005999915); Collison, Adam M (23995251200)",57222158030; 57215831762; 35811293400; 7006804832; 6603119390; 35371387300; 12794088900; 55146650400; 7202414199; 7005999915; 23995251200,Cord blood group 2 innate lymphoid cells are associated with lung function at 6 weeks of age,2021,Clinical and Translational Immunology,10,7,e1296,,,,6,10.1002/cti2.1296,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111271957&doi=10.1002%2fcti2.1296&partnerID=40&md5=d6084fe89805c8e5c2df0ec82af2abc0,"Priority Research Centre GrowUpWell® – Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Priority Research Centre for Healthy Lungs - Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Centenary UTS Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia; Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW, Australia; School of Public Health, University of Memphis, Memphis, TN, United States; Sleep Medicine Department, John Hunter Hospital, Newcastle, NSW, Australia; Paediatric Respiratory & Sleep Medicine Department, John Hunter Children's Hospital, Newcastle, NSW, Australia","Martins Costa Gomes G., Priority Research Centre GrowUpWell® – Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; de Gouveia Belinelo P., Priority Research Centre GrowUpWell® – Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Starkey M.R., Priority Research Centre GrowUpWell® – Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Priority Research Centre for Healthy Lungs - Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia; Murphy V.E., Priority Research Centre GrowUpWell® – Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs - Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Centenary UTS Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Sly P.D., Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia; Robinson P.D., Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW, Australia; Karmaus W., School of Public Health, University of Memphis, Memphis, TN, United States; Gibson P.G., Priority Research Centre for Healthy Lungs - Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Sleep Medicine Department, John Hunter Hospital, Newcastle, NSW, Australia; Mattes J., Priority Research Centre GrowUpWell® – Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Paediatric Respiratory & Sleep Medicine Department, John Hunter Children's Hospital, Newcastle, NSW, Australia; Collison A.M., Priority Research Centre GrowUpWell® – Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia",asthma; cord blood; CRTh2 ILC2; multiple breath washout; tidal breathing,chemoattractant; interleukin 10; interleukin 5; adult; Article; asthma; body weight gain; eosinophil; expiratory flow; female; fetus; fetus lung; flow cytometry; fluorescence activated cell sorting; follow up; human; human cell; immunocompetent cell; immunophenotyping; lung clearance; lung function; lymphoid cell; major clinical study; male; pregnancy; umbilical cord blood,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85111271957
Yong D.O.C.; Saker S.R.; Chellappan D.K.; Madheswaran T.; Panneerselvam J.; Choudhury H.; Pandey M.; Chan Y.L.; Collet T.; Gupta G.; Oliver B.G.; Wark P.; Hansbro N.; Hsu A.; Hansbro P.M.; Dua K.; Zeeshan F.,"Yong, David O. C. (57219800832); Saker, Sanggetha R. (57211271252); Chellappan, Dinesh K. (35811890500); Madheswaran, Thiagarajan (55505311000); Panneerselvam, Jithendra (57201993010); Choudhury, Hira (23567794600); Pandey, Manisha (36114663600); Chan, Yik L. (56292121300); Collet, Trudi (36898251800); Gupta, Gaurav (15047988400); Oliver, Brian G. (15919869900); Wark, Peter (7003559516); Hansbro, Nicole (15055862300); Hsu, Alan (49861516600); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Zeeshan, Farrukh (26654611200)",57219800832; 57211271252; 35811890500; 55505311000; 57201993010; 23567794600; 36114663600; 56292121300; 36898251800; 15047988400; 15919869900; 7003559516; 15055862300; 49861516600; 6603119390; 15759138700; 26654611200,"Molecular and immunological mechanisms underlying the various pharmacological properties of the potent bioflavonoid, rutin",2020,"Endocrine, Metabolic and Immune Disorders - Drug Targets",20,10,,1590,1596,6,30,10.2174/1871530320666200503053846,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090212635&doi=10.2174%2f1871530320666200503053846&partnerID=40&md5=f6323b43da4330a52efd7be7278ff6c5,"School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Innovative Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, QLD, Australia; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia","Yong D.O.C., School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Saker S.R., School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Choudhury H., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Pandey M., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Chan Y.L., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Collet T., Innovative Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, QLD, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, India; Oliver B.G., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Wark P., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro N., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Hsu A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Dua K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Zeeshan F., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia",Anti-allergic; Anti-diabetic; Anti-inflammatory; Anticancer; Antioxidant; Molecular mechanisms; Rutin,"Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Humans; Hypoglycemic Agents; Inflammation Mediators; Oxidative Stress; Reactive Oxygen Species; Rutin; Signal Transduction; antioxidant; bioflavonoid; catalase; flavonoid; flavonol; glucose transporter 4; glutathione; immunoglobulin E; immunoglobulin enhancer binding protein; inducible nitric oxide synthase; interleukin 10; interleukin 17; interleukin 1beta; interleukin 23; interleukin 4; interleukin 5; interleukin 6; leukotriene; leukotriene B4; lipoxygenase; myeloperoxidase; nitric oxide; peroxisome proliferator activated receptor gamma; phosphatidylinositol 3 kinase; prostaglandin; prostaglandin synthase; protein kinase B; protein kinase C; quercetin; reactive oxygen metabolite; rutoside; stress activated protein kinase; superoxide dismutase; toll like receptor 2; toll like receptor 4; tumor necrosis factor; vascular cell adhesion molecule 1; vasculotropin; antiallergic agent; antidiabetic agent; antiinflammatory agent; antineoplastic agent; antioxidant; autacoid; reactive oxygen metabolite; rutoside; antiallergic activity; antidiabetic activity; antiinflammatory activity; antineoplastic activity; bleeding; cell infiltration; cell migration; cell proliferation; drug mechanism; free radical scavenging assay; gene expression; hemorrhoid; human; immune response; immunology; MAPK signaling; mouse; nonhuman; oxidative stress; rat; Review; signal transduction; structure activity relation; varicosis; animal; drug effect; metabolism",Review,Final,,Scopus,2-s2.0-85090212635
Galvão I.; Kim R.Y.; Shen S.; Budden K.F.; Vieira A.T.; Hansbro P.M.,"Galvão, Izabela (56656390800); Kim, Richard Y. (35810406900); Shen, Sijie (56707946900); Budden, Kurtis F. (57191417986); Vieira, Angélica T. (8614414900); Hansbro, Philip M. (6603119390)",56656390800; 35810406900; 56707946900; 57191417986; 8614414900; 6603119390,Emerging therapeutic targets and preclinical models for severe asthma,2020,Expert Opinion on Therapeutic Targets,,,,845,857,12,6,10.1080/14728222.2020.1786535,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087622622&doi=10.1080%2f14728222.2020.1786535&partnerID=40&md5=40d48b8030cd76cdf7bb28b1110851ce,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Instituto De Ciências Biológicas, Federal University of Minas Gerais, Belo Horizonte, Brazil","Galvão I., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Kim R.Y., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Shen S., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Budden K.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Vieira A.T., Laboratory of Microbiota and Immunomodulation, Department of Biochemistry and Immunology, Instituto De Ciências Biológicas, Federal University of Minas Gerais, Belo Horizonte, Brazil; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia",Inflammation; novel therapies; preclinical models; severe asthma,"Animals; Asthma; Disease Models, Animal; Humans; Mice; Molecular Targeted Therapy; Severity of Illness Index; allergen; histone; inflammasome; macrolide; microRNA; short chain fatty acid; asthma; bacterial infection; clinical feature; disease severity; epigenetics; exposure; gene control; histone modification; human; intestine flora; Medline; mouse model; mycosis; nonhuman; preclinical study; Review; virus infection; animal; asthma; disease model; immunology; molecularly targeted therapy; mouse; pathophysiology; severity of illness index",Review,Final,,Scopus,2-s2.0-85087622622
Liu G.; Cooley M.A.; Jarnicki A.G.; Borghuis T.; Nair P.M.; Tjin G.; Hsu A.C.; Haw T.J.; Fricker M.; Harrison C.L.; Jones B.; Hansbro N.G.; Wark P.A.; Horvat J.C.; Scott Argraves W.; Oliver B.G.; Knight D.A.; Burgess J.K.; Hansbro P.M.,"Liu, Gang (57189061134); Cooley, Marion A. (21644972000); Jarnicki, Andrew G. (6603137164); Borghuis, Theo (6602699507); Nair, Prema M. (55749131000); Tjin, Gavin (55614885600); Hsu, Alan C. (49861516600); Haw, Tatt Jhong (56625918900); Fricker, Michael (26638839800); Harrison, Celeste L. (57191953268); Jones, Bernadette (56215070300); Hansbro, Nicole G. (15055862300); Wark, Peter A. (7003559516); Horvat, Jay C. (9942405300); Scott Argraves, W. (7006209539); Oliver, Brian G. (15919869900); Knight, Darryl A. (7402350036); Burgess, Janette K. (7201650628); Hansbro, Philip M. (6603119390)",57189061134; 21644972000; 6603137164; 6602699507; 55749131000; 55614885600; 49861516600; 56625918900; 26638839800; 57191953268; 56215070300; 15055862300; 7003559516; 9942405300; 7006209539; 15919869900; 7402350036; 7201650628; 6603119390,Fibulin-1c regulates transforming growth factor–β activation in pulmonary tissue fibrosis,2019,JCI Insight,4,16,e124529,,,,59,10.1172/jci.insight.124529,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071228794&doi=10.1172%2fjci.insight.124529&partnerID=40&md5=e87341f447c743e5c3729616c48b5e6d,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Centenary Institute, Sydney, NSW, Australia; Department of Oral Biology and Diagnostic Sciences, Augusta University, Augusta, GA, United States; Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, Australia; University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Department of Pathology and Medical Biology, Groningen, Netherlands; Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States","Liu G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Centenary Institute, Sydney, NSW, Australia; Cooley M.A., Department of Oral Biology and Diagnostic Sciences, Augusta University, Augusta, GA, United States; Jarnicki A.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, Australia; Borghuis T., University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Department of Pathology and Medical Biology, Groningen, Netherlands; Nair P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Tjin G., Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Hsu A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Haw T.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Fricker M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Harrison C.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Jones B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Centenary Institute, Sydney, NSW, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Scott Argraves W., Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Oliver B.G., School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Knight D.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Burgess J.K., University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Department of Pathology and Medical Biology, Groningen, Netherlands, Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Centenary Institute, Sydney, NSW, Australia",,"Adult; Animals; Bleomycin; Calcium-Binding Proteins; Cells, Cultured; Disease Models, Animal; Female; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Latent TGF-beta Binding Proteins; Lung; Lung Transplantation; Male; Mice; Mice, Knockout; Middle Aged; Primary Cell Culture; Protein Isoforms; Transforming Growth Factor beta; Young Adult; fibronectin; fibulin; fibulin 1c; latent transforming growth factor beta binding protein; latent transforming growth factor beta binding protein 1; Smad3 protein; tenascin; transcription factor RUNX2; unclassified drug; bleomycin; calcium binding protein; fibulin; isoprotein; latent transforming growth factor beta binding protein; LTBP1 protein, human; Ltbp1 protein, mouse; transforming growth factor beta; adult; animal experiment; animal model; animal tissue; Article; cell count; clinical article; controlled study; Fbln1c gene; female; fibrosing alveolitis; gene; human; human tissue; lung function; lung parenchyma; male; mouse; myofibroblast; nonhuman; pathogenesis; protein localization; protein phosphorylation; protein protein interaction; protein targeting; signal transduction; Smad3 signaling; animal; cell culture; cytology; disease model; fibroblast; fibrosing alveolitis; genetics; knockout mouse; lung; lung transplantation; metabolism; middle aged; pathology; primary cell culture; young adult",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85071228794
Lo Bello F.; Hansbro P.M.; Donovan C.; Coppolino I.; Mumby S.; Adcock I.M.; Caramori G.,"Lo Bello, Federica (57202941930); Hansbro, Philip M. (6603119390); Donovan, Chantal (55357105200); Coppolino, Irene (57205402564); Mumby, Sharon (7005804196); Adcock, Ian M. (7007066538); Caramori, Gaetano (7003847659)",57202941930; 6603119390; 55357105200; 57205402564; 7005804196; 7007066538; 7003847659,New drugs under development for COPD,2020,Expert Opinion on Emerging Drugs,25,4,,419,431,12,14,10.1080/14728214.2020.1819982,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091792070&doi=10.1080%2f14728214.2020.1819982&partnerID=40&md5=3da121812c662dcc1b97e080cbb2e89f,"Dipartimento di Scienze Biomediche, Odontoiatriche e Delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Centre for Inflammation, Centenary Institute, Sydney, Australia; Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Airways Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom","Lo Bello F., Dipartimento di Scienze Biomediche, Odontoiatriche e Delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, Australia, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Donovan C., Centre for Inflammation, Centenary Institute, Sydney, Australia, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Coppolino I., Dipartimento di Scienze Biomediche, Odontoiatriche e Delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Mumby S., Airways Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom; Adcock I.M., Airways Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom; Caramori G., Dipartimento di Scienze Biomediche, Odontoiatriche e Delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy",COPD; exacerbation; new drugs; pathogenesis; therapy,"Animals; Bronchodilator Agents; Disease Progression; Drug Design; Drug Development; Humans; Pulmonary Disease, Chronic Obstructive; alpha 1 antitrypsin; antifibrotic agent; antiinflammatory agent; antioxidant; antivirus agent; beta 2 adrenergic receptor stimulating agent; bronchodilating agent; chemokine receptor antagonist; cytokine receptor antagonist; dasatinib; fumaric acid dimethyl ester; glucocorticoid; immunoglobulin enhancer binding protein; Janus kinase inhibitor; leukocyte elastase inhibitor; mitogen activated protein kinase inhibitor; muscarinic receptor blocking agent; navitoclax; new drug; phosphatidylinositol 3 kinase inhibitor; phosphodiesterase III inhibitor; phosphodiesterase IV inhibitor; quercetin; rapamycin; recombinant protein; bronchodilating agent; chronic obstructive lung disease; disease exacerbation; drug mechanism; human; innate immunity; lung parenchyma; nonhuman; pathogenesis; phenotype; randomized controlled trial (topic); Review; tissue regeneration; animal; chronic obstructive lung disease; drug design; drug development; pathophysiology",Review,Final,,Scopus,2-s2.0-85091792070
Pinkerton J.W.; Kim R.Y.; Koeninger L.; Armbruster N.S.; Hansbro N.G.; Brown A.C.; Jayaraman R.; Shen S.; Malek N.; Cooper M.A.; Nordkild P.; Horvat J.C.; Jensen B.A.H.; Wehkamp J.; Hansbro P.M.,"Pinkerton, James W. (56647761900); Kim, Richard Y. (35810406900); Koeninger, Louis (57206842638); Armbruster, Nicole S. (57200984185); Hansbro, Nicole G. (15055862300); Brown, Alexandra C. (55637745000); Jayaraman, Ranjith (57225458602); Shen, Sijie (56707946900); Malek, Nisar (6701536363); Cooper, Matthew A. (7404411451); Nordkild, Peter (57213790760); Horvat, Jay C. (9942405300); Jensen, Benjamin A. H. (55574227682); Wehkamp, Jan (6602650443); Hansbro, Philip M. (6603119390)",56647761900; 35810406900; 57206842638; 57200984185; 15055862300; 55637745000; 57225458602; 56707946900; 6701536363; 7404411451; 57213790760; 9942405300; 55574227682; 6602650443; 6603119390,Human β-defensin-2 suppresses key features of asthma in murine models of allergic airways disease,2021,Clinical and Experimental Allergy,51,1,,120,131,11,21,10.1111/cea.13766,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096634486&doi=10.1111%2fcea.13766&partnerID=40&md5=0f69ccf0baac09a69653bee5f16555ab,"Priority Research Centre for Healthy Lungs, University of Newcastle, & Hunter Medical Research Institute, Newcastle, NSW, Australia; National Heart & Lung Institute, Imperial College London, London, United Kingdom; Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Department of Internal Medicine, University of Tübingen, Tübingen, Germany; Institute for Molecular Bioscience, University of Queensland, Brisbane, Qld, Australia; Department of Biology, University of Copenhagen, Copenhagen, Denmark; Section for Human Genomics and Metagenomics in Metabolism, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark","Pinkerton J.W., Priority Research Centre for Healthy Lungs, University of Newcastle, & Hunter Medical Research Institute, Newcastle, NSW, Australia, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Kim R.Y., Priority Research Centre for Healthy Lungs, University of Newcastle, & Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Koeninger L., Department of Internal Medicine, University of Tübingen, Tübingen, Germany; Armbruster N.S., Department of Internal Medicine, University of Tübingen, Tübingen, Germany; Hansbro N.G., Priority Research Centre for Healthy Lungs, University of Newcastle, & Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Brown A.C., Priority Research Centre for Healthy Lungs, University of Newcastle, & Hunter Medical Research Institute, Newcastle, NSW, Australia; Jayaraman R., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Shen S., Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Malek N., Department of Internal Medicine, University of Tübingen, Tübingen, Germany; Cooper M.A., Institute for Molecular Bioscience, University of Queensland, Brisbane, Qld, Australia; Nordkild P., Department of Biology, University of Copenhagen, Copenhagen, Denmark; Horvat J.C., Priority Research Centre for Healthy Lungs, University of Newcastle, & Hunter Medical Research Institute, Newcastle, NSW, Australia; Jensen B.A.H., Section for Human Genomics and Metagenomics in Metabolism, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Wehkamp J., Department of Internal Medicine, University of Tübingen, Tübingen, Germany; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle, & Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia",asthma; human β-defensin-2; steroid resistant; steroid sensitive,"Airway Resistance; Animals; Asthma; beta-Defensins; Bronchoalveolar Lavage Fluid; Chlamydia Infections; Chlamydia muridarum; Disease Models, Animal; Inflammation; Interleukin-13; Interleukin-9; Lung; Lung Compliance; Mice; Ovalbumin; Pyroglyphidae; Respiratory Hypersensitivity; Respiratory Tract Infections; beta defensin 2; dexamethasone; interleukin 10; interleukin 13; interleukin 4; interleukin 5; interleukin 6; interleukin 9; tumor necrosis factor; beta defensin; DEFB4A protein, human; interleukin 13; interleukin 9; ovalbumin; airway resistance; animal cell; animal experiment; animal model; antiinflammatory activity; Article; asthma; bronchoalveolar lavage fluid; clinical feature; controlled study; disease severity; drug megadose; female; house dust allergy; human; human cell; immunomodulation; inflammatory cell; leukocyte differential count; mouse; nonhuman; ovalbumin-induced airway inflammation; pneumonia; priority journal; steroid therapy; animal; asthma; chemistry; Chlamydia muridarum; chlamydiasis; cytology; disease model; drug effect; inflammation; lung; lung compliance; metabolism; pathophysiology; Pyroglyphidae; respiratory tract allergy; respiratory tract infection",Article,Final,,Scopus,2-s2.0-85096634486
Zhang R.; Wang P.; Yu S.; Hansbro P.; Wang H.,"Zhang, Rui (57214233421); Wang, Pu (57214222133); Yu, Shunbang (57211783362); Hansbro, Philip (6603119390); Wang, He (56842012500)",57214233421; 57214222133; 57211783362; 6603119390; 56842012500,Computerized screening of G-protein coupled receptors to identify and characterize olfactory receptors,2020,Journal of Toxicology and Environmental Health - Part A: Current Issues,83,1,,9,19,10,2,10.1080/15287394.2019.1709305,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079047394&doi=10.1080%2f15287394.2019.1709305&partnerID=40&md5=a277148f3be572aef381cc9571a9c5f2,"Xinjiang Laboratory of Minority Speech and Language Information Processing, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumchi, China; University of Chinese Academy of Sciences, Beijing, China; School of Health Sciences, University of Newcastle, Callaghan, Australia; Faculty of Health and Medicine, HMRI, School of Biomedical Sciences and Pharmacy, Callaghan, Australia","Zhang R., Xinjiang Laboratory of Minority Speech and Language Information Processing, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumchi, China, University of Chinese Academy of Sciences, Beijing, China; Wang P., School of Health Sciences, University of Newcastle, Callaghan, Australia; Yu S., School of Health Sciences, University of Newcastle, Callaghan, Australia; Hansbro P., Faculty of Health and Medicine, HMRI, School of Biomedical Sciences and Pharmacy, Callaghan, Australia; Wang H., School of Health Sciences, University of Newcastle, Callaghan, Australia",Computerized Screening; G Protein Coupled Receptors; Olfactory Receptors,"Computer Simulation; Databases, Factual; Machine Learning; Models, Chemical; Neural Networks, Computer; Receptors, Odorant; Reproducibility of Results; G protein coupled receptor; Article; cell organelle; controlled study; convolutional neural network; human; measurement accuracy; olfactory receptor; priority journal; sensitization; software; chemical model; chemistry; computer simulation; factual database; machine learning; olfactory receptor; reproducibility",Article,Final,,Scopus,2-s2.0-85079047394
Aggarwal T.; Wadhwa R.; Gupta R.; Paudel K.R.; Collet T.; Chellappan D.K.; Gupta G.; Perumalsamy H.; Mehta M.; Satija S.; Hansbro P.M.; Dua K.; Maurya P.K.,"Aggarwal, Taru (57196053981); Wadhwa, Ridhima (57159091700); Gupta, Riya (57694324300); Paudel, Keshav Raj (56539588400); Collet, Trudi (36898251800); Chellappan, Dinesh Kumar (35811890500); Gupta, Gaurav (15047988400); Perumalsamy, Haribalan (35345748600); Mehta, Meenu (7203024234); Satija, Saurabh (54581608400); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Maurya, Pawan Kumar (15765644500)",57196053981; 57159091700; 57694324300; 56539588400; 36898251800; 35811890500; 15047988400; 35345748600; 7203024234; 54581608400; 6603119390; 15759138700; 15765644500,Micrornas as biomarker for breast cancer,2020,"Endocrine, Metabolic and Immune Disorders - Drug Targets",20,10,,1597,1610,13,62,10.2174/1871530320666200428113051,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086507610&doi=10.2174%2f1871530320666200428113051&partnerID=40&md5=6f2f40214f53f42c3dd6139e36c81761,"Amity Institute of Biotechnology, Amity University, Noida, 201303, Uttar Pradesh, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Callaghan, 2308, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Indigenous Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, QLD, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, 302017, Jaipur, India; Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin, 446-701, South Korea; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedi-cal Sciences and Pharmacy, University of Newcastle; Department of Biochemistry, Central University of Haryana, Jant-Pali, Mahendergarh District, 123031, Haryana, India","Aggarwal T., Amity Institute of Biotechnology, Amity University, Noida, 201303, Uttar Pradesh, India; Wadhwa R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Callaghan, 2308, NSW, Australia; Gupta R., Amity Institute of Biotechnology, Amity University, Noida, 201303, Uttar Pradesh, India; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Callaghan, 2308, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Collet T., Indigenous Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, QLD, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, 302017, Jaipur, India; Perumalsamy H., Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin, 446-701, South Korea; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Callaghan, 2308, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Callaghan, 2308, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedi-cal Sciences and Pharmacy, University of Newcastle; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedi-cal Sciences and Pharmacy, University of Newcastle; Maurya P.K., Department of Biochemistry, Central University of Haryana, Jant-Pali, Mahendergarh District, 123031, Haryana, India",Breast cancer; Drug resistance; Drug targeting; Micro-RNA; Oncomirs; Oncosuppressormir,"Animals; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Molecular Targeted Therapy; Signal Transduction; biological marker; cyclophosphamide; cytochrome c; doxorubicin; epidermal growth factor receptor 2; estradiol; estrogen; estrogen receptor; gemcitabine; interleukin 8; microRNA; microRNA 145; microRNA 146a; microRNA 155; microRNA 17; microRNA 182; microRNA 200; microRNA 200b; microRNA 205; microRNA 206; microRNA 21; microRNA 210; microRNA 222; microRNA 26a; microRNA 29b; microRNA 335; microRNA 34a; paclitaxel; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; protein p53; RNA binding protein; sirtuin 1; tamoxifen; testosterone; trastuzumab; unclassified drug; vasculotropin; antineoplastic agent; microRNA; tumor marker; antineoplastic activity; apoptosis; breast cancer; cancer diagnosis; cancer growth; cancer inhibition; cancer resistance; cell differentiation; cell function; cell migration; cell proliferation; cell survival; DNA methylation; DNA sequence; drug delivery system; drug targeting; epithelial mesenchymal transition; gene expression; genome-wide association study; human; MCF-7 cell line; multidrug resistance; pathogenesis; protein expression; Review; tumor growth; tumor microenvironment; tumor suppressor gene; animal; breast tumor; drug resistance; female; gene expression regulation; genetics; metabolism; molecularly targeted therapy; pathology; signal transduction",Review,Final,,Scopus,2-s2.0-85086507610
Mehta M.; Chellappan D.K.; Wich P.R.; Hansbro N.G.; Hansbro P.M.; Dua K.,"Mehta, Meenu (7203024234); Chellappan, Dinesh K. (35811890500); Wich, Peter R. (7801599835); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",7203024234; 35811890500; 7801599835; 15055862300; 6603119390; 15759138700,MiRNA nanotherapeutics: Potential and challenges in respiratory disorders,2020,Future Medicinal Chemistry,12,11,,987,990,3,20,10.4155/fmc-2020-0066,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086574052&doi=10.4155%2ffmc-2020-0066&partnerID=40&md5=b5c1699ed18713cc52c4d4d62828050d,"Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Chellappan D.K., School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Wich P.R., School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia, Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India",antagomirs; drug delivery; miRNA; nanoparticles; respiratory disorders,Animals; Anti-Infective Agents; Chronic Disease; Drug Delivery Systems; Humans; Lung Diseases; MicroRNAs; Nanotechnology; amo 106a; amo 9; antagomir; let 7; lipid nanoparticle; lipoplex; mesoporous silica nanoparticle; microRNA; microRNA 146a; microRNA 34a; miR 660; myricetin; nanomaterial; nanoparticle; paclitaxel; polymer; small interfering RNA; unclassified drug; antiinfective agent; microRNA; asthma; chronic obstructive lung disease; down regulation; drug delivery system; drug half life; drug potentiation; emulsion; gene expression; gene silencing; gene targeting; human; immunotoxicity; lung cancer; nanomedicine; nanotechnology; non small cell lung cancer; nonhuman; Note; particle size; priority journal; respiratory tract disease; animal; chronic disease; lung disease; metabolism; nanotechnology,Note,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85086574052
Alemao C.A.; Budden K.F.; Gomez H.M.; Rehman S.F.; Marshall J.E.; Shukla S.D.; Donovan C.; Forster S.C.; Yang I.A.; Keely S.; Mann E.R.; El Omar E.M.; Belz G.T.; Hansbro P.M.,"Alemao, Charlotte A. (57200821652); Budden, Kurtis F. (57191417986); Gomez, Henry M. (57191960363); Rehman, Saima F. (57211047721); Marshall, Jacqueline E. (57218547927); Shukla, Shakti D. (56367620800); Donovan, Chantal (55357105200); Forster, Samuel C. (7101707502); Yang, Ian A. (7101797862); Keely, Simon (9739611200); Mann, Elizabeth R. (37034567100); El Omar, Emad M. (7004327210); Belz, Gabrielle T. (7102682937); Hansbro, Philip M. (6603119390)",57200821652; 57191417986; 57191960363; 57211047721; 57218547927; 56367620800; 55357105200; 7101707502; 7101797862; 9739611200; 37034567100; 7004327210; 7102682937; 6603119390,Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders,2021,Allergy: European Journal of Allergy and Clinical Immunology,76,3,,714,734,20,71,10.1111/all.14548,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089671412&doi=10.1111%2fall.14548&partnerID=40&md5=a88386f433ab622db7ba637b6cb90ac5,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Newcastle, NSW, Australia; The University of Newcastle, Newcastle, NSW, Australia; Faculty of Science, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Department of Molecular and Translational Sciences, Hudson Institute of Medical Research, Centre for Innate Immunity and Infectious Diseases, Monash University, Clayton, VIC, Australia; Thoracic Program, The Prince Charles Hospital, Metro North Hospital and Health Service, Brisbane, QLD, Australia; Faculty of Medicine, UQ Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia; Hunter Medical Research Institute, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, New Lambton Heights, NSW, Australia; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom; Faculty of Biology Medicine and Health, Manchester Collaborative Centre for Inflammation Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; St George & Sutherland Clinical School, Microbiome Research Centre, University of New South Wales, Sydney, NSW, Australia; Diamantina Institute, University of Queensland, Woolloongabba, QLD, Australia; Department of Medical Biology, Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC, Australia","Alemao C.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Newcastle, NSW, Australia, The University of Newcastle, Newcastle, NSW, Australia; Budden K.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Newcastle, NSW, Australia, The University of Newcastle, Newcastle, NSW, Australia; Gomez H.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Newcastle, NSW, Australia, The University of Newcastle, Newcastle, NSW, Australia; Rehman S.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Newcastle, NSW, Australia, The University of Newcastle, Newcastle, NSW, Australia; Marshall J.E., Faculty of Science, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Newcastle, NSW, Australia, The University of Newcastle, Newcastle, NSW, Australia; Donovan C., Faculty of Science, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia; Forster S.C., Department of Molecular and Translational Sciences, Hudson Institute of Medical Research, Centre for Innate Immunity and Infectious Diseases, Monash University, Clayton, VIC, Australia; Yang I.A., Thoracic Program, The Prince Charles Hospital, Metro North Hospital and Health Service, Brisbane, QLD, Australia, Faculty of Medicine, UQ Thoracic Research Centre, The University of Queensland, Brisbane, QLD, Australia; Keely S., Hunter Medical Research Institute, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, New Lambton Heights, NSW, Australia; Mann E.R., Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom, Faculty of Biology Medicine and Health, Manchester Collaborative Centre for Inflammation Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; El Omar E.M., St George & Sutherland Clinical School, Microbiome Research Centre, University of New South Wales, Sydney, NSW, Australia; Belz G.T., Diamantina Institute, University of Queensland, Woolloongabba, QLD, Australia, Department of Medical Biology, Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, Newcastle, NSW, Australia, The University of Newcastle, Newcastle, NSW, Australia, Faculty of Science, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, NSW, Australia",asthma; chronic obstructive pulmonary disease; diet; disease; exacerbation; induction; inflammation; inflammatory bowel disease; microbiome; mucus; prevention; treatment,Diet; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Immune System Diseases; Microbiota; fat; iron; lipid; protein; vitamin; vitamin B complex; asthma; atopic dermatitis; bacterial microbiome; chronic obstructive lung disease; diabetes mellitus; diet; dietary fiber; disease association; disease exacerbation; dysbiosis; gastrointestinal mucosa; gastrointestinal tract; human; immunopathology; inflammatory bowel disease; intestine; intestine flora; lung; macronutrient; metabolic disorder; microbiome; mucus; nonhuman; obesity; priority journal; psoriasis; respiratory mucosa; respiratory system; Review; rheumatoid arthritis; diet; intestine flora; microflora,Review,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85089671412
Malyla V.; Paudel K.R.; Shukla S.D.; Donovan C.; Wadhwa R.; Pickles S.; Chimankar V.; Sahu P.; Bielefeldt-Ohmann H.; Bebawy M.; Hansbro P.M.; Dua K.,"Malyla, Vamshikrishna (57205128961); Paudel, Keshav Raj (56539588400); Shukla, Shakti D (56367620800); Donovan, Chantal (55357105200); Wadhwa, Ridhima (57159091700); Pickles, Sophie (57216189104); Chimankar, Vrushali (57191957166); Sahu, Priyanka (57216189414); Bielefeldt-Ohmann, Helle (7005067985); Bebawy, Mary (6506211522); Hansbro, Philip M (6603119390); Dua, Kamal (15759138700)",57205128961; 56539588400; 56367620800; 55357105200; 57159091700; 57216189104; 57191957166; 57216189414; 7005067985; 6506211522; 6603119390; 15759138700,Recent advances in experimental animal models of lung cancer,2020,Future Medicinal Chemistry,12,7,,567,570,3,43,10.4155/fmc-2019-0338,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082779750&doi=10.4155%2ffmc-2019-0338&partnerID=40&md5=8ff440edcc4392bd6acbfe2ed1d60fc8,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Chippendale, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, 2305, NSW, Australia; Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, 4072, QLD, Australia","Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Chippendale, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, 2305, NSW, Australia; Donovan C., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, 2305, NSW, Australia; Wadhwa R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Chippendale, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Pickles S., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, 2305, NSW, Australia; Chimankar V., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, 2305, NSW, Australia; Sahu P., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, 2305, NSW, Australia; Bielefeldt-Ohmann H., Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, 4072, QLD, Australia; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Chippendale, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, 2305, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Chippendale, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, 2305, NSW, Australia",4-[methyl(nitroso)amino]-1-(3-pyridinyl)-1-butanone; animal models; cigarette smoking; lung cancer; non-small-cell lung cancer,"Animals; Lung Neoplasms; Models, Animal; carcinogen; transcription factor Nrf2; unclassified drug; [4 [methyl(nitroso)amino] 1 (3 pyridinyl) 1 butanone]; BEAS-2B cell line; biological model; comparative study; computer assisted tomography; CRISPR-CAS9 system; DNA modification; human; lung cancer; lung microbiota; microflora; nonhuman; Note; Nrf2 gene; oncogene K ras; priority journal; reproducibility; tumor microenvironment; tumor suppressor gene; tumor xenograft; animal; animal model; lung tumor; metabolism; pathology",Note,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85082779750
Christie M.J.; Irving A.T.; Forster S.C.; Marsland B.J.; Hansbro P.M.; Hertzog P.J.; Nold-Petry C.A.; Nold M.F.,"Christie, Michael J. (57205235288); Irving, Aaron T. (8047804900); Forster, Samuel C. (7101707502); Marsland, Benjamin J. (6603055652); Hansbro, Philip M. (6603119390); Hertzog, Paul J. (7005991492); Nold-Petry, Claudia A. (22981220300); Nold, Marcel F. (6603550703)",57205235288; 8047804900; 7101707502; 6603055652; 6603119390; 7005991492; 22981220300; 6603550703,Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection,2021,Science Immunology,6,63,eabd0205,,,,28,10.1126/sciimmunol.abd0205,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116941804&doi=10.1126%2fsciimmunol.abd0205&partnerID=40&md5=b5d171598d11ed54b43998676ffaf7dd,"Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia; Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China; Zhejiang University, University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University, Haining, 314400, China; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia; Department of Molecular and Translational Sciences, Monash University, Melbourne, VIC, Australia; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, 3004, VIC, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Centre for Inflammation, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Monash Newborn, Monash Children’s Hospital, Melbourne, VIC, Australia","Christie M.J., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia; Irving A.T., Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China, Zhejiang University, University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University, Haining, 314400, China; Forster S.C., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia, Department of Molecular and Translational Sciences, Monash University, Melbourne, VIC, Australia; Marsland B.J., Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, 3004, VIC, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Centre for Inflammation, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hertzog P.J., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia, Department of Molecular and Translational Sciences, Monash University, Melbourne, VIC, Australia; Nold-Petry C.A., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia; Nold M.F., Department of Paediatrics, Monash University, Melbourne, 3168, VIC, Australia, Ritchie Centre, Hudson Institute of Medical Research, Melbourne, 3168, VIC, Australia, Monash Newborn, Monash Children’s Hospital, Melbourne, VIC, Australia",,"Animals; Antibodies, Neutralizing; Chiroptera; COVID-19; Humans; Immunologic Factors; SARS-CoV-2; anti-SARS-CoV-2 agent; antiinflammatory agent; caspase; chemokine receptor CCR5 antagonist; cytokine receptor antagonist; gamma interferon; granulocyte macrophage colony stimulating factor inhibitor; immunostimulating agent; inflammasome; interleukin 1 inhibitor; interleukin 6 inhibitor; lambda interferon; molecular marker; monoclonal antibody; phosphotransferase inhibitor; SARS-CoV-2 antibody; SARS-CoV-2 convalescent plasma; tumor necrosis factor inhibitor; unclassified drug; immunologic factor; neutralizing antibody; adaptation; antigen presentation; bat; cell composition; cell function; complement system; coronavirus disease 2019; cytokine storm; disease course; disease reservoir; enzyme inhibition; human; immune evasion; immune response; immunocompetent cell; immunopathogenesis; immunopathology; immunotherapy; innate immunity; nonhuman; pattern recognition; Review; Severe acute respiratory syndrome coronavirus 2; virus morphology; virus replication; animal; immunology; virology",Review,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85116941804
Liu G.; Baird A.W.; Parsons M.J.; Fan K.; Skerrett-Byrne D.A.; Nair P.M.; Makanyengo S.; Chen J.; Neal R.; Goggins B.J.; Tay H.; Mathe A.; Soh W.S.; Minahan K.; Hansbro P.M.; Nixon B.; McCaughan G.W.; Holtmann G.; Colgan S.P.; Keely S.,"Liu, Gang (57189061134); Baird, Alan W. (7201433015); Parsons, Marie J. (57205603112); Fan, Kening (57208226178); Skerrett-Byrne, David A. (57200648755); Nair, Prema M. (55749131000); Makanyengo, Samwel (57212604343); Chen, Jinbiao (55875725100); Neal, Rachel (57201587411); Goggins, Bridie J. (55894233100); Tay, Hock (55639898100); Mathe, Andrea (56018778600); Soh, Wai S. (57216408573); Minahan, Kyra (35574254300); Hansbro, Phil M. (6603119390); Nixon, Brett (34571659200); McCaughan, Geoffrey W. (7103117295); Holtmann, Gerald (57204264681); Colgan, Sean P. (7103148070); Keely, Simon (9739611200)",57189061134; 7201433015; 57205603112; 57208226178; 57200648755; 55749131000; 57212604343; 55875725100; 57201587411; 55894233100; 55639898100; 56018778600; 57216408573; 35574254300; 6603119390; 34571659200; 7103117295; 57204264681; 7103148070; 9739611200,Platelet activating factor receptor acts to limit colitis-induced liver inflammation,2020,FASEB Journal,34,6,,7718,7732,14,14,10.1096/fj.201901779R,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083430705&doi=10.1096%2ffj.201901779R&partnerID=40&md5=1098fc906698bbde6f0a2c0cd041fcd4,"Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; School of Life Science, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia; UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland; School of Environmental and Life Sciences, Priority Research Centre for Reproductive Science, The University of Newcastle, Callaghan, NSW, Australia; Liver Injury and Cancer Program, Centenary Research Institute, Camperdown, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia; Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia; University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States","Liu G., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia, School of Life Science, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia; Baird A.W., UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland; Parsons M.J., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; Fan K., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; Skerrett-Byrne D.A., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Environmental and Life Sciences, Priority Research Centre for Reproductive Science, The University of Newcastle, Callaghan, NSW, Australia; Nair P.M., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; Makanyengo S., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; Chen J., Liver Injury and Cancer Program, Centenary Research Institute, Camperdown, NSW, Australia, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Neal R., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; Goggins B.J., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; Tay H., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, The University of Newcastle, Newcastle, NSW, Australia; Mathe A., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; Soh W.S., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; Minahan K., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., School of Life Science, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia; Nixon B., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Environmental and Life Sciences, Priority Research Centre for Reproductive Science, The University of Newcastle, Callaghan, NSW, Australia; McCaughan G.W., Liver Injury and Cancer Program, Centenary Research Institute, Camperdown, NSW, Australia, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Holtmann G., Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia; Colgan S.P., University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States; Keely S., Priority Research Centre for Digestive Health and Neurogastroenterology, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia",extraintestinal manifestations in liver; inflammatory bowel disease; PAFR,"Animals; Caspase 1; Cells, Cultured; Colitis; Colon; Dextran Sulfate; Hepatocytes; Humans; Inflammasomes; Inflammation; Inflammatory Bowel Diseases; Interleukin-1beta; Kupffer Cells; Liver; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Toll-Like Receptor 4; CD40 ligand monoclonal antibody; cryopyrin; dextran sulfate; inflammasome; interleukin 1beta; interleukin 1beta converting enzyme; lipopolysaccharide; sirtuin 1; thrombocyte activating factor receptor; toll like receptor 4; cryopyrin; dextran sulfate; fibrinogen receptor; G protein coupled receptor; inflammasome; interleukin 1beta; interleukin 1beta converting enzyme; thrombocyte activating factor receptor; toll like receptor 4; animal cell; animal experiment; animal model; animal tissue; Article; controlled study; dextran sulfate sodium-induced colitis; female; gene overexpression; hepatitis; human; human cell; Kupffer cell; liver cell; liver level; mouse; nonhuman; priority journal; protein expression; protein expression level; protein localization; animal; C57BL mouse; cell culture; colitis; colon; drug effect; inflammation; inflammatory bowel disease; liver; male; metabolism; pathology",Article,Final,,Scopus,2-s2.0-85083430705
Ali M.K.; Kim R.Y.; Brown A.C.; Donovan C.; Vanka K.S.; Mayall J.R.; Liu G.; Pillar A.L.; Jones-Freeman B.; Xenaki D.; Borghuis T.; Karim R.; Pinkerton J.W.; Aryal R.; Heidari M.; Martin K.L.; Burgess J.K.; Oliver B.G.; Trinder D.; Johnstone D.M.; Milward E.A.; Hansbro P.M.; Horvat J.C.,"Ali, Md Khadem (57194408422); Kim, Richard Y (35810406900); Brown, Alexandra C (55637745000); Donovan, Chantal (55357105200); Vanka, Kanth S (57095767500); Mayall, Jemma R (55607222700); Liu, Gang (57189061134); Pillar, Amber L (57216038374); Jones-Freeman, Bernadette (56215070300); Xenaki, Dikaia (6507411538); Borghuis, Theo (6602699507); Karim, Rafia (57194419768); Pinkerton, James W (56647761900); Aryal, Ritambhara (57211585658); Heidari, Moones (57224744178); Martin, Kristy L (57194415123); Burgess, Janette K (7201650628); Oliver, Brian G (15919869900); Trinder, Debbie (7004242701); Johnstone, Daniel M (15829670700); Milward, Elizabeth A (6603563509); Hansbro, Philip M (6603119390); Horvat, Jay C (9942405300)",57194408422; 35810406900; 55637745000; 55357105200; 57095767500; 55607222700; 57189061134; 57216038374; 56215070300; 6507411538; 6602699507; 57194419768; 56647761900; 57211585658; 57224744178; 57194415123; 7201650628; 15919869900; 7004242701; 15829670700; 6603563509; 6603119390; 9942405300,Critical role for iron accumulation in the pathogenesis of fibrotic lung disease,2020,Journal of Pathology,251,1,,49,62,13,77,10.1002/path.5401,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082530750&doi=10.1002%2fpath.5401&partnerID=40&md5=4514215bfe920aff7ed25146749c4e25,"Division of Pulmonary and Critical Care Medicine, School of Medicine, Stanford University, Stanford, CA, United States; Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, Australia; Department of Pathology and Medical Biology, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands; Respiratory Pharmacology & Toxicology Group, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Priority Research Centre for Brain and Mental Health and School of Biomedical Sciences, University of Newcastle, Newcastle, Australia; Medical School and, Harry Perkins Institute of Medical Research, University of Western Australia, Perth, Australia; Discipline of Physiology and Bosch Institute, University of Sydney, Sydney, Australia","Ali M.K., Division of Pulmonary and Critical Care Medicine, School of Medicine, Stanford University, Stanford, CA, United States, Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kim R.Y., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Brown A.C., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Donovan C., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Vanka K.S., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Mayall J.R., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Liu G., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Pillar A.L., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Jones-Freeman B., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Xenaki D., Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, Australia; Borghuis T., Department of Pathology and Medical Biology, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands; Karim R., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Pinkerton J.W., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Respiratory Pharmacology & Toxicology Group, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Aryal R., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Priority Research Centre for Brain and Mental Health and School of Biomedical Sciences, University of Newcastle, Newcastle, Australia; Heidari M., Priority Research Centre for Brain and Mental Health and School of Biomedical Sciences, University of Newcastle, Newcastle, Australia; Martin K.L., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Priority Research Centre for Brain and Mental Health and School of Biomedical Sciences, University of Newcastle, Newcastle, Australia; Burgess J.K., Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, Australia, Department of Pathology and Medical Biology, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, Australia; Trinder D., Medical School and, Harry Perkins Institute of Medical Research, University of Western Australia, Perth, Australia; Johnstone D.M., Discipline of Physiology and Bosch Institute, University of Sydney, Sydney, Australia; Milward E.A., Priority Research Centre for Brain and Mental Health and School of Biomedical Sciences, University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs and School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia",airway hyperresponsiveness; airway inflammation; airway remodeling; bleomycin; collagen; deferoxamine; IPF; iron; lung function; pulmonary fibrosis,"Airway Remodeling; Animals; Bleomycin; Cell Proliferation; Cells, Cultured; Extracellular Matrix; Fibroblasts; Humans; Idiopathic Pulmonary Fibrosis; Iron; Lung; Macrophages; Mice, Knockout; ceruloplasmin; deferoxamine; gelatinase B; hepcidin; interleukin 1beta; interleukin 6; iron; iron regulatory protein 1; toll like receptor 2; toll like receptor 4; transferrin receptor 2; tumor necrosis factor; bleomycin; iron; airway resistance; animal cell; animal experiment; animal model; Article; basement membrane; bleomycin-induced pulmonary fibrosis; cell proliferation; controlled study; disease association; fibrosing alveolitis; gas exchange; gene expression; human; human cell; human tissue; immune response; iron overload; lung fibroblast; lung fibrosis; lung function; lymphocyte; macrophage; mouse; nonhuman; pathogenesis; phenotype; priority journal; protein expression; smooth muscle contractility; airway remodeling; animal; cell culture; drug effect; extracellular matrix; fibroblast; fibrosing alveolitis; knockout mouse; lung; metabolism; pathology",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85082530750
Idowu O.; Semple K.T.; Ramadass K.; O'Connor W.; Hansbro P.; Thavamani P.,"Idowu, Oluyoye (57205270803); Semple, Kirk T. (56926918800); Ramadass, Kavitha (20436756800); O'Connor, Wayne (23025552100); Hansbro, Phil (6603119390); Thavamani, Palanisami (23567398800)",57205270803; 56926918800; 20436756800; 23025552100; 6603119390; 23567398800,Analysis of polycyclic aromatic hydrocarbons (PAHs) and their polar derivatives in soils of an industrial heritage city of Australia,2020,Science of the Total Environment,699,,134303,,,,68,10.1016/j.scitotenv.2019.134303,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074370521&doi=10.1016%2fj.scitotenv.2019.134303&partnerID=40&md5=b400bd7c36bcc03f173451b278860a3f,"Global Centre for Environmental Remediation (GCER), University of Newcastle, Callaghan, 2308, NSW, Australia; Lancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, United Kingdom; Global Innovative Centre for Advanced Nanomaterials (GICAN), University of Newcastle, Callaghan, 2308, NSW, Australia; Port Stephens Fisheries Institute, NSW Department of Primary Industries, Port Stephens, 2316, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia","Idowu O., Global Centre for Environmental Remediation (GCER), University of Newcastle, Callaghan, 2308, NSW, Australia; Semple K.T., Lancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, United Kingdom; Ramadass K., Global Innovative Centre for Advanced Nanomaterials (GICAN), University of Newcastle, Callaghan, 2308, NSW, Australia; O'Connor W., Port Stephens Fisheries Institute, NSW Department of Primary Industries, Port Stephens, 2316, NSW, Australia; Hansbro P., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia; Thavamani P., Global Centre for Environmental Remediation (GCER), University of Newcastle, Callaghan, 2308, NSW, Australia",Excess lifetime cancer risk; Incidental soil ingestion; Industrial heritage; Polar PAHs; Toxicity,Australia; Diseases; Fossil fuels; Mineral oils; Risk assessment; Soils; Toxicity; 2 nitrofluorene; 9 fluorenone; carbazole; heterocyclic compound; nitrogen; oxygen; polycyclic aromatic hydrocarbon derivative; sulfur; unclassified drug; Cancer risk; Concentration profiles; Environmental concentration; Industrial heritage; Polycyclic aromatic hydrocarbons (PAHS); Positive correlations; Soil ingestions; Spatial associations; cancer; concentration (composition); health risk; PAH; risk assessment; soil pollution; toxicity; Article; Australia; chemical composition; concentration (parameter); correlational study; hydrophobicity; land use; molecular weight; physical chemistry; priority journal; soil pollution; Polycyclic aromatic hydrocarbons,Article,Final,,Scopus,2-s2.0-85074370521
Wadhwa R.; Paudel K.R.; Mehta M.; Shukla S.D.; Sunkara K.; Prasher P.; Panth N.; Goyal R.; Chellappan D.K.; Gupta G.; Aljabali A.A.; Hansbro P.M.; Dua K.,"Wadhwa, Ridhima (57159091700); Paudel, Keshav Raj (56539588400); Mehta, Meenu (7203024234); Shukla, Shakti D. (56367620800); Sunkara, Krishna (57190382716); Prasher, Parteek (56079914500); Panth, Nisha (57094240100); Goyal, Rohit (56035487900); Chellappan, Dinesh Kumar (35811890500); Gupta, Gaurav (15047988400); Aljabali, Alaa Aa. (35306626800); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57159091700; 56539588400; 7203024234; 56367620800; 57190382716; 56079914500; 57094240100; 56035487900; 35811890500; 15047988400; 35306626800; 6603119390; 15759138700,Beyond the obvious: Smoking and respiratory infection implications on alzheimer's disease,2020,CNS and Neurological Disorders - Drug Targets,19,9,,698,708,10,10,10.2174/1871527319999200817112427,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096312182&doi=10.2174%2f1871527319999200817112427&partnerID=40&md5=e5c71cf8709a27fa3cc380b47f205c05,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, 173 229, Himachal Pradesh, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India","Wadhwa R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Sunkara K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Prasher P., Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India; Panth N., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Goyal R., School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, 173 229, Himachal Pradesh, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India; Aljabali A.A., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, 173 229, Himachal Pradesh, India",(Aβ) peptide deposition; Alzheimer’s disease; Infection; Oxidative stress; Pulmonary infections; Smoking,"Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Humans; Neurons; Neurotoxins; Oxidative Stress; Plaque, Amyloid; Respiratory Tract Infections; Risk Factors; Smoking; amyloid beta protein; nicotine; reactive oxygen metabolite; tobacco smoke; amyloid beta protein; amyloid precursor protein; APP protein, human; neurotoxin; Alzheimer disease; amyloid plaque; blood brain barrier; cardiovascular disease; chronic lung disease; chronic obstructive lung disease; forced expiratory volume; forced vital capacity; human; Human respiratory syncytial virus; life expectancy; lung cancer; mouth cancer; nerve cell plasticity; neuroprotection; neurotoxicity; oxidative stress; prevalence; protein aggregation; respiratory tract infection; Review; smoking; Alzheimer disease; animal; brain; metabolism; nerve cell; respiratory tract infection; risk factor; smoking",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85096312182
Mehta M.; Satija S.; Paudel K.R.; Liu G.; Chellappan D.K.; Hansbro P.M.; Dua K.,"Mehta, Meenu (7203024234); Satija, Saurabh (54581608400); Paudel, Keshav R. (56539588400); Liu, Gang (57189061134); Chellappan, Dinesh K. (35811890500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",7203024234; 54581608400; 56539588400; 57189061134; 35811890500; 6603119390; 15759138700,Incipient need of targeting airway remodeling using advanced drug delivery in chronic respiratory diseases,2020,Future Medicinal Chemistry,12,10,,873,875,2,15,10.4155/fmc-2020-0091,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085266168&doi=10.4155%2ffmc-2020-0091&partnerID=40&md5=f485f36d70e8109371669677995e6fdc,"Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia; Center for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Center for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Paudel K.R., Center for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Liu G., Center for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., Center for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Center for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India",COPD; Lung cancer; Remodeling; Respiratory disorders,"Airway Remodeling; Drug Delivery Systems; Humans; Pulmonary Disease, Chronic Obstructive; atropine nanoparticle; cerium oxide nanoparticle; complementary RNA; gold nanoparticle; imatinib; liposome; locked nucleic acid; membrane protein; microRNA; miR 192 5p; miR 21; miR 712; nanoparticle; PV1 protein; titanium dioxide nanoparticle; unclassified drug; airway remodeling; apoptosis; asthma; ATG101 gene; atherosclerosis; autophagy (cellular); chronic obstructive lung disease; chronic respiratory tract disease; drug delivery system; exosome; fibrosing alveolitis; gene; human; inflammation; nerve injury; nonhuman; Note; pathophysiology; priority journal; tissue regeneration; airway remodeling; chronic obstructive lung disease; drug effect",Note,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85085266168
Mehta M.; Paudel K.R.; Shukla S.D.; Shastri M.D.; Satija S.; Singh S.K.; Gulati M.; Dureja H.; Zacconi F.C.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Mehta, Meenu (7203024234); Paudel, Keshav Raj (56539588400); Shukla, Shakti D (56367620800); Shastri, Madhur D (56007290800); Satija, Saurabh (54581608400); Singh, Sachin Kumar (57206711834); Gulati, Monica (7006677671); Dureja, Harish (6507566948); Zacconi, Flavia C (33667991400); Hansbro, Philip M (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",7203024234; 56539588400; 56367620800; 56007290800; 54581608400; 57206711834; 7006677671; 6507566948; 33667991400; 6603119390; 35811890500; 15759138700,Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: A PCR validation,2021,Future Medicinal Chemistry,13,6,,543,549,6,23,10.4155/fmc-2020-0297,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102584150&doi=10.4155%2ffmc-2020-0297&partnerID=40&md5=879e7cf3f9578efaaf8709fd22c08b7c,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, 124001, India; Departamento de Química Orgánica, Facultad de Química y de Farma-cia, Pontificia Universidad Católica DeChile, Av. Vicuña Mackenna 4860, Macul, Santiago, 7820436, Chile; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, 2305, NSW, Australia; Shastri M.D., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, 124001, India; Zacconi F.C., Departamento de Química Orgánica, Facultad de Química y de Farma-cia, Pontificia Universidad Católica DeChile, Av. Vicuña Mackenna 4860, Macul, Santiago, 7820436, Chile; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India",antioxidant; inflammation; lipopolysaccharide; oxidative stress genes; rutin,"Bronchi; Cell Line; Epithelial Cells; Humans; Lipopolysaccharides; Liquid Crystals; NAD(P)H Dehydrogenase (Quinone); NADPH Oxidase 2; Nanoparticles; Oxidative Stress; Polymerase Chain Reaction; Rutin; Up-Regulation; glutamate cysteine ligase; nanoparticle; oxidoreductase; reduced nicotinamide adenine dinucleotide phosphate oxidase; rutoside; lipopolysaccharide; nanoparticle; NQO1 protein, human; reduced nicotinamide adenine dinucleotide (phosphate) dehydrogenase (quinone); reduced nicotinamide adenine dinucleotide phosphate oxidase 2; rutoside; Article; BEAS-2B cell line; bronchus epithelium; controlled study; dose response; epithelium cell; GCLC gene; gene; human; human cell; Nox2B gene; Nox4 gene; NQO1 gene; oxidative stress; polymerase chain reaction; priority journal; protein expression; upregulation; validation process; bronchus; cell line; chemistry; cytology; drug effect; epithelium cell; genetics; liquid crystal; metabolism; oxidative stress",Article,Final,,Scopus,2-s2.0-85102584150
Chong W.C.; Shastri M.D.; Peterson G.M.; Patel R.P.; Pathinayake P.S.; Dua K.; Hansbro N.G.; Hsu A.C.; Wark P.A.; Shukla S.D.; Johansen M.D.; Schroder K.; Hansbro P.M.,"Chong, Wai Chin (57192809246); Shastri, Madhur D (56007290800); Peterson, Gregory M (7402563175); Patel, Rahul P (36849078400); Pathinayake, Prabuddha S (55877978000); Dua, Kamal (15759138700); Hansbro, Nicole G (15055862300); Hsu, Alan C (49861516600); Wark, Peter A (7003559516); Shukla, Shakti Dhar (56367620800); Johansen, Matt D (57202983408); Schroder, Kate (8504949200); Hansbro, Philip M (6603119390)",57192809246; 56007290800; 7402563175; 36849078400; 55877978000; 15759138700; 15055862300; 49861516600; 7003559516; 56367620800; 57202983408; 8504949200; 6603119390,The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders,2021,Clinical and Translational Immunology,10,2,e1247,,,,42,10.1002/cti2.1247,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101415798&doi=10.1002%2fcti2.1247&partnerID=40&md5=ec26eda14282a8cc091d49b2a103227d,"Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia; School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Centre for Inflammation, Centenary Institute, Faculty of Science, School of Life Sciences, University of Technology, Sydney, NSW, Australia; Institute for Molecular Bioscience, University of Queensland, St Lucia, QLD, Australia","Chong W.C., Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia, Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia; Shastri M.D., School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia; Peterson G.M., School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia; Patel R.P., School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia; Pathinayake P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute, Faculty of Science, School of Life Sciences, University of Technology, Sydney, NSW, Australia; Hsu A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Johansen M.D., Centre for Inflammation, Centenary Institute, Faculty of Science, School of Life Sciences, University of Technology, Sydney, NSW, Australia; Schroder K., Institute for Molecular Bioscience, University of Queensland, St Lucia, QLD, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia, Centre for Inflammation, Centenary Institute, Faculty of Science, School of Life Sciences, University of Technology, Sydney, NSW, Australia",endoplasmic reticulum stress; inflammasome; inflammatory disorder; NLRP3,activating transcription factor 6; antiinflammatory agent; cryopyrin; inflammasome; interleukin 1beta; interleukin 1beta converting enzyme; membrane protein; membrane protein perk; phytochemical; protein IRE1; unclassified drug; autophosphorylation; endoplasmic reticulum stress; human; inflammatory disease; pathogenesis; priority journal; protein folding; protein interaction; Review; signal transduction,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85101415798
Griffin A.S.; Brown C.; Woodworth B.K.; Ballard G.-A.; Blanch S.; Campbell H.A.; Crewe T.L.; Hansbro P.M.; Herbert C.A.; Hosking T.; Hoye B.J.; Law B.; Leigh K.; Machovsky-Capuska G.E.; Rasmussen T.; McDonald P.G.; Roderick M.; Slade C.; Mackenzie S.A.; Taylor P.D.,"Griffin, Andrea S. (7202675971); Brown, Culum (7408312006); Woodworth, Bradley K. (56107688700); Ballard, Guy-Anthony (25937120200); Blanch, Stuart (57218891356); Campbell, Hamish A. (10042845400); Crewe, Tara L. (36709457000); Hansbro, Philip M. (6603119390); Herbert, Catherine A. (8542669300); Hosking, Tim (57190073967); Hoye, Bethany J. (26632061000); Law, Brad (55539714300); Leigh, Kellie (6603567702); Machovsky-Capuska, Gabriel E. (37124356200); Rasmussen, Thomas (57218900573); McDonald, Paul G. (7202986698); Roderick, Mick (57556497800); Slade, Chris (7003722627); Mackenzie, Stuart A. (15848730100); Taylor, Philip D. (55127619900)",7202675971; 7408312006; 56107688700; 25937120200; 57218891356; 10042845400; 36709457000; 6603119390; 8542669300; 57190073967; 26632061000; 55539714300; 6603567702; 37124356200; 57218900573; 7202986698; 57556497800; 7003722627; 15848730100; 55127619900,A large-scale automated radio telemetry network for monitoring movements of terrestrial wildlife in Australia,2020,Australian Zoologist,40,3,,379,391,12,10,10.7882/AZ.2019.026,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090615327&doi=10.7882%2fAZ.2019.026&partnerID=40&md5=3153f832fb044804017d3e4f99d396f1,"School of Psychology, University of Newcastle, Callaghan, 2308, NSW, Australia; Department of Biological Sciences, Macquarie University, Australia; School of Biological Sciences, University of Queensland, Brisbane, QLD, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia; Vertebrate Pest Research Unit, NSW Department of Primary Industries, Armidale, 2350, NSW, Australia; WWF-Australia, Ultimo, 2007, NSW, Australia; Research Institute for Environment & Livelihoods, Charles Darwin University, Darwin, 0909, NT, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; School of Life and Environmental Sciences, University of Sydney, 2006, NSW, Australia; Biodiversity and Conservation Division, NSW Department of Planning, Industry and Environment, Dubbo, 2830, NSW, Australia; School of Earth, Atmospheric and Life Sciences, University of Wollongong, 2522, NSW, Australia; Forest Science, NSW Primary Industries, Parramatta, 2124, NSW, Australia; Science for Wildlife Ltd., Cammeray, 2062, NSW, Australia; University of Sydney, Charles Perkins Centre, Sydney, Australia; Biologic Environmental Survey, Office G, Rokeby Rd, Subiaco, 6008, WA, Australia; School of Environmental and Rural Science, University of New England, Armidale, 2351, NSW, Australia; Woodland Birds Program, BirdLife Australia, Shortland, 2307, NSW, Australia; Hardwood Forests, Forestry Corporation of NSW, Wauchope, 2446, NSW, Australia; Bird Studies Canada, Port Rowan, N0E1M0, ON, Canada; Department of Biology, Acadia University, Canada","Griffin A.S., School of Psychology, University of Newcastle, Callaghan, 2308, NSW, Australia; Brown C., Department of Biological Sciences, Macquarie University, Australia; Woodworth B.K., School of Biological Sciences, University of Queensland, Brisbane, QLD, Australia; Ballard G.-A., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia, School of Environmental and Rural Science, University of New England, Armidale, 2351, NSW, Australia; Blanch S., Vertebrate Pest Research Unit, NSW Department of Primary Industries, Armidale, 2350, NSW, Australia; Campbell H.A., WWF-Australia, Ultimo, 2007, NSW, Australia; Crewe T.L., WWF-Australia, Ultimo, 2007, NSW, Australia; Hansbro P.M., Research Institute for Environment & Livelihoods, Charles Darwin University, Darwin, 0909, NT, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Herbert C.A., School of Life and Environmental Sciences, University of Sydney, 2006, NSW, Australia; Hosking T., Biodiversity and Conservation Division, NSW Department of Planning, Industry and Environment, Dubbo, 2830, NSW, Australia; Hoye B.J., School of Earth, Atmospheric and Life Sciences, University of Wollongong, 2522, NSW, Australia; Law B., Forest Science, NSW Primary Industries, Parramatta, 2124, NSW, Australia; Leigh K., Science for Wildlife Ltd., Cammeray, 2062, NSW, Australia; Machovsky-Capuska G.E., University of Sydney, Charles Perkins Centre, Sydney, Australia; Rasmussen T., Biologic Environmental Survey, Office G, Rokeby Rd, Subiaco, 6008, WA, Australia; McDonald P.G., School of Environmental and Rural Science, University of New England, Armidale, 2351, NSW, Australia; Roderick M., Woodland Birds Program, BirdLife Australia, Shortland, 2307, NSW, Australia; Slade C., Hardwood Forests, Forestry Corporation of NSW, Wauchope, 2446, NSW, Australia; Mackenzie S.A., Bird Studies Canada, Port Rowan, N0E1M0, ON, Canada; Taylor P.D., Department of Biology, Acadia University, Canada",Automated telemetry; Bat; Insect; Migration; Motus; Movement ecology; Shorebird; Small animal; Songbird; Telemetry; Tracking technology; Water bird,Australia; Animalia; Aves; Hexapoda; Passeri; conservation status; data set; detection method; monitoring; movement; radiotelemetry; terrestrial ecosystem; tracking; wild population,Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85090615327
Lyall D.; Hansbro P.; Horvat J.; Stanwell P.,"Lyall, David (6603168665); Hansbro, Phil (6603119390); Horvat, Jay (9942405300); Stanwell, Peter (8716032500)",6603168665; 6603119390; 9942405300; 8716032500,Quantitative Nondestructive Assessment of Paenibacillus larvae in Apis mellifera Hives,2020,Advances in Intelligent Systems and Computing,1026,,,579,583,4,2,10.1007/978-3-030-27928-8_88,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071462108&doi=10.1007%2f978-3-030-27928-8_88&partnerID=40&md5=84fa54650a741624523ee413666bce13,"School of Health Sciences, The University of Newcastle, Callaghan, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia","Lyall D., School of Health Sciences, The University of Newcastle, Callaghan, Australia; Hansbro P., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; Horvat J., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; Stanwell P., School of Health Sciences, The University of Newcastle, Callaghan, Australia",AFB; American Foulbrood; Apis Mellifera; Bee; European honeybee; Non-destructive; Paenibacillus larvae; PCR; Polymerase Chain Reaction,Costs; Losses; Systems engineering; American foulbrood; Apis mellifera; European honeybees; Non destructive; Paenibacillus larvae; Polymerase chain reaction,Conference paper,Final,,Scopus,2-s2.0-85071462108
Jin-Ying J.-Y.W.; Yin Ng Z.; Mehta M.; Shukla S.D.; Panneerselvam J.; Madheswaran T.; Gupta G.; Negi P.; Kumar P.; Pillay V.; Hsu A.; Hansbro N.G.; Wark P.; Bebawy M.; Hansbro P.M.; Dua K.; Chellappan D.K.,"Jin-Ying, Wong (57221229183); Yin Ng, Zhao (57221229700); Mehta, Meenu (7203024234); Shukla, Shakti D (56367620800); Panneerselvam, Jithendra (57201993010); Madheswaran, Thiagarajan (55505311000); Gupta, Gaurav (15047988400); Negi, Poonam (57971006900); Kumar, Pradeep (7403960277); Pillay, Viness (56711693300); Hsu, Alan (49861516600); Hansbro, Nicole G (15055862300); Wark, Peter (7003559516); Bebawy, Mary (6506211522); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",57221229183; 57221229700; 7203024234; 56367620800; 57201993010; 55505311000; 15047988400; 57971006900; 7403960277; 56711693300; 49861516600; 15055862300; 7003559516; 6506211522; 6603119390; 15759138700; 35811890500,Curcumin-loaded niosomes downregulate mRNA expression of pro-inflammatory markers involved in asthma: An in vitro study,2020,Nanomedicine,15,30,,2955,2970,15,12,10.2217/nnm-2020-0260,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098590528&doi=10.2217%2fnnm-2020-0260&partnerID=40&md5=41b41f12ee7c4eab34285414101ff22c,"School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Department of Pharmaceutical Technology, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa; School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia","Jin-Ying J.-Y.W., School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Yin Ng Z., School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Panneerselvam J., Department of Pharmaceutical Technology, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Negi P., School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India; Kumar P., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa; Pillay V., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa; Hsu A., Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Hansbro N.G., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia; Wark P., Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia",asthma; curcumin; molecular modeling; niosomes; pro-inflammatory markers,"Asthma; Curcumin; Humans; Liposomes; Particle Size; RNA, Messenger; autacoid; chloroform; cholesterol; curcumin; interleukin 1beta; interleukin 6; interleukin 8; messenger RNA; niosome; salbutamol; sorbitan oleate; tumor necrosis factor; curcumin; liposome; messenger RNA; antiinflammatory activity; Article; asthma; dispersity; down regulation; drug efficacy; drug formulation; drug release; encapsulation; Fourier transform infrared spectroscopy; freeze drying; human; hydrophilicity; hydrophobicity; immortalized cell line; in vitro study; particle size; physical chemistry; priority journal; protein expression; sustained release formulation; ultraviolet spectrophotometry; zeta potential; asthma; genetics",Article,Final,,Scopus,2-s2.0-85098590528
Mehta M.; Dhanjal D.S.; Paudel K.R.; Singh B.; Gupta G.; Rajeshkumar S.; Thangavelu L.; Tambuwala M.M.; Bakshi H.A.; Chellappan D.K.; Pandey P.; Dureja H.; Charbe N.B.; Singh S.K.; Shukla S.D.; Nammi S.; Aljabali A.A.; Wich P.R.; Hansbro P.M.; Satija S.; Dua K.,"Mehta, Meenu (7203024234); Dhanjal, Daljeet S. (58224756300); Paudel, Keshav R. (56539588400); Singh, Bhupender (55361243800); Gupta, Gaurav (15047988400); Rajeshkumar, S. (57195616808); Thangavelu, Lakshmi (57221436939); Tambuwala, Murtaza M. (36657816300); Bakshi, Hamid A. (36028052300); Chellappan, Dinesh K. (35811890500); Pandey, Parijat (56583499400); Dureja, Harish (6507566948); Charbe, Nitin B. (55369803000); Singh, Sachin K. (57206711834); Shukla, Shakti D. (56367620800); Nammi, Srinivas (6602547699); Aljabali, Alaa A. (35306626800); Wich, Peter R. (7801599835); Hansbro, Philip M. (6603119390); Satija, Saurabh (54581608400); Dua, Kamal (15759138700)",7203024234; 58224756300; 56539588400; 55361243800; 15047988400; 57195616808; 57221436939; 36657816300; 36028052300; 35811890500; 56583499400; 6507566948; 55369803000; 57206711834; 56367620800; 6602547699; 35306626800; 7801599835; 6603119390; 54581608400; 15759138700,Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update,2020,Inflammopharmacology,28,4,,795,817,22,295,10.1007/s10787-020-00698-3,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082864597&doi=10.1007%2fs10787-020-00698-3&partnerID=40&md5=5a3118cbfe126617dd59fa92a3a82f27,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Bioengineering and Biosciences, Lovely Professional University, Jalandhar-Delhi, G.T. Road (NH-1), Phagwara, 144411, Punjab, India; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Phamacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India; Saveetha Dental College and Hospitals, Saveetha University, SIMATS, Chennai, Tamilnadu, India; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, BT52 1SA, County Londonderry, United Kingdom; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Shri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak, 124001, India; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 12401, Haryana, India; Departamento de Química Orgánica, Facultad de Química Y de Farmacia, Pontificia Universidad Católica de Chile, Av. Vicuña McKenna 4860, Santiago, 7820436, Macul, Chile; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; School of Science and Health, Western Sydney University, Penrith, 2751, NSW, Australia; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan; Australian Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia; School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Himachal Pradesh, Bajhol, Sultanpur, Solan, 173 229, India","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Dhanjal D.S., School of Bioengineering and Biosciences, Lovely Professional University, Jalandhar-Delhi, G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Paudel K.R., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Singh B., School of Bioengineering and Biosciences, Lovely Professional University, Jalandhar-Delhi, G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Gupta G., School of Phamacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India; Rajeshkumar S., Saveetha Dental College and Hospitals, Saveetha University, SIMATS, Chennai, Tamilnadu, India; Thangavelu L., Saveetha Dental College and Hospitals, Saveetha University, SIMATS, Chennai, Tamilnadu, India; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, BT52 1SA, County Londonderry, United Kingdom; Bakshi H.A., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Pandey P., Shri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak, 124001, India; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 12401, Haryana, India; Charbe N.B., Departamento de Química Orgánica, Facultad de Química Y de Farmacia, Pontificia Universidad Católica de Chile, Av. Vicuña McKenna 4860, Santiago, 7820436, Macul, Chile; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Nammi S., School of Science and Health, Western Sydney University, Penrith, 2751, NSW, Australia; Aljabali A.A., Department of Pharmaceutical Sciences, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan; Wich P.R., Australian Centre for NanoMedicine, University of New South Wales, Sydney, 2052, NSW, Australia, School of Chemical Engineering, University of New South Wales, Sydney, 2052, NSW, Australia; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Himachal Pradesh, Bajhol, Sultanpur, Solan, 173 229, India",Cell signaling; Inflammatory; Respiratory diseases; Wnt pathway,Animals; Chronic Disease; Humans; Inflammation; Respiratory Tract Diseases; Signal Transduction; Akt signaling; asthma; cAMP signaling; chronic bronchitis; chronic inflammation; chronic lung disease; chronic obstructive lung disease; cystic fibrosis; hedgehog signaling; hippo signaling; human; JAK-STAT signaling; lung cancer; lung disease; MAPK signaling; Notch signaling; pathogenesis; pneumonia; priority journal; pulmonary vascular disease; respiratory tract disease; Review; signal transduction; synergistic effect; TGF beta signaling; TLR signaling; VEGF signaling; animal; chronic disease; inflammation; metabolism; pathology; physiology; signal transduction,Review,Final,,Scopus,2-s2.0-85082864597
Caramori G.; Ruggeri P.; Mumby S.; Ieni A.; Lo Bello F.; Chaminka V.; Donovan C.; Andò F.; Nucera F.; Coppolino I.; Tuccari G.; Hansbro P.M.; Adcock I.M.,"Caramori, Gaetano (7003847659); Ruggeri, Paolo (15923794000); Mumby, Sharon (7005804196); Ieni, Antonio (26021273500); Lo Bello, Federica (57202941930); Chaminka, Vrushali (57208754129); Donovan, Chantal (55357105200); Andò, Filippo (7101742673); Nucera, Francesco (57202946185); Coppolino, Irene (57205402564); Tuccari, Giovanni (7004479946); Hansbro, Philip M. (6603119390); Adcock, Ian M. (7007066538)",7003847659; 15923794000; 7005804196; 26021273500; 57202941930; 57208754129; 55357105200; 7101742673; 57202946185; 57205402564; 7004479946; 6603119390; 7007066538,Molecular links between COPD and lung cancer: new targets for drug discovery?,2019,Expert Opinion on Therapeutic Targets,23,6,,539,553,14,64,10.1080/14728222.2019.1615884,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065702706&doi=10.1080%2f14728222.2019.1615884&partnerID=40&md5=30cc02957c5b866a2054ee20f3e60cf4,"Unità Operativa Complessa di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom; Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, Messina, Italy; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Faculty of Science, Ultimo, and Centenary Institute, Centre for Inflammation, University of Technology Sydney, Sydney, Australia","Caramori G., Unità Operativa Complessa di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Ruggeri P., Unità Operativa Complessa di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Mumby S., Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom; Ieni A., Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, Messina, Italy; Lo Bello F., Unità Operativa Complessa di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Chaminka V., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Andò F., Unità Operativa Complessa di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Nucera F., Unità Operativa Complessa di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Coppolino I., Unità Operativa Complessa di Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Tuccari G., Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, Messina, Italy; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia, Faculty of Science, Ultimo, and Centenary Institute, Centre for Inflammation, University of Technology Sydney, Sydney, Australia; Adcock I.M., Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom",COPD; lung cancer; smoking; squamous cell carcinoma,"Animals; Cigarette Smoking; DNA Damage; DNA Repair; Drug Discovery; Humans; Inflammation; Lung Neoplasms; Molecular Targeted Therapy; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; antineoplastic agent; bronchodilating agent; chemokine; corticosteroid derivative; cyclooxygenase 2 inhibitor; heterogeneous nuclear ribonucleoprotein; interleukin derivative; prostaglandin derivative; apoptosis; Article; cancer diagnosis; cell cycle regulation; chronic obstructive lung disease; DNA damage; DNA repair; early diagnosis; epigenetics; epithelial mesenchymal transition; gene expression; high throughput sequencing; human; innate immunity; intracellular signaling; long term exposure; lung cancer; mitochondrion; nonhuman; pathogenesis; smoking; adverse event; animal; chronic obstructive lung disease; cigarette smoking; drug development; inflammation; lung tumor; molecularly targeted therapy; oxidative stress; pathology; physiology",Article,Final,,Scopus,2-s2.0-85065702706
Hardwick J.; Taylor J.; Mehta M.; Satija S.; Paudel K.R.; Hans-Bro P.M.; Chellappan D.K.; Bebawy M.; Dua K.,"Hardwick, Joel (57221982997); Taylor, Jack (57194595107); Mehta, Meenu (7203024234); Satija, Saurabh (54581608400); Paudel, Keshav R. (56539588400); Hans-Bro, Philip M. (6603119390); Chellappan, Dinesh K. (35811890500); Bebawy, Mary (6506211522); Dua, Kamal (15759138700)",57221982997; 57194595107; 7203024234; 54581608400; 56539588400; 6603119390; 35811890500; 6506211522; 15759138700,Targeting cancer using curcumin encapsulated vesicular drug delivery systems,2021,Current Pharmaceutical Design,27,1,,2,14,12,41,10.2174/1381612826666200728151610,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100858487&doi=10.2174%2f1381612826666200728151610&partnerID=40&md5=cf2f5113251396f5cfdcc020b68f3b2c,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Centre for Inflam-mation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; University of Newcastle & The Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, Himachal Pradesh, 173229, India","Hardwick J., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Taylor J., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Centre for Inflam-mation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Paudel K.R., Centre for Inflam-mation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hans-Bro P.M., Centre for Inflam-mation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, University of Newcastle & The Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Centre for Inflam-mation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Newcastle & The Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Callaghan, 2308, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, Himachal Pradesh, 173229, India",Cancer; Curcumin; Exosomes; Liposomes; Nanoformulations; Niosomes; Pro-niosomes; Vesicular,Curcumin; Drug Delivery Systems; Humans; Liposomes; Neoplasms; Solubility; curcumin; dendrimer; liposome; nanocarrier; nanoparticle; niosome; nutraceutical; polymer; proniosome; unclassified drug; curcumin; liposome; biotechnology; breast cancer; cancer chemotherapy; cancer inhibition; clinical trial (topic); colon cancer; controlled drug release; Curcuma longa; drug bioavailability; drug delivery system; drug efficacy; drug formulation; drug industry; drug safety; drug solubility; exosome; food industry; functional food; human; liver cancer; nanoencapsulation; nanopharmaceutics; nonhuman; Review; vesicular drug delivery system; drug delivery system; neoplasm; solubility,Review,Final,,Scopus,2-s2.0-85100858487
Vidaillac C.; Yong V.F.L.; Aschtgen M.-S.; Qu J.; Yang S.; Xu G.; Seng Z.J.; Brown A.C.; Ali M.K.; Jaggi T.K.; Sankaran J.; Foo Y.H.; Righetti F.; Nedumaran A.M.; Aogáin M.M.; Roizman D.; Richard J.-A.; Rogers T.R.; Toyofuku M.; Luo D.; Loh E.; Wohland T.; Czarny B.; Horvat J.C.; Hansbro P.M.; Yang L.; Li L.; Normark S.; Normark B.H.; Chotirmall S.H.,"Vidaillac, Celine (6506892186); Yong, Valerie Fei Lee (57193742992); Aschtgen, Marie-Stephanie (25637259800); Qu, Jing (56673422200); Yang, Shuowei (57219223729); Xu, Guangfu (57219225297); Seng, Zi Jing (57204456291); Brown, Alexandra C. (55637745000); Ali, Md Khadem (57194408422); Jaggi, Tavleen K. (57204228946); Sankaran, Jagadish (24072081500); Foo, Yong Hwee (57219222092); Righetti, Francesco (55216604100); Nedumaran, Anu Maashaa (57194204344); Aogáin, Micheál Mac (33667783800); Roizman, Dan (56479171600); Richard, Jean-Alexandre (36187240400); Rogers, Thomas R. (7202088193); Toyofuku, Masanori (16744680700); Luo, Dahai (14020135800); Loh, Edmund (16646875100); Wohland, Thorsten (6602757972); Czarny, Bertrand (6504149380); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Yang, Liang (55625636600); Li, Liang (56526125500); Normark, Staffan (7102655001); Normark, Birgitta Henriques (57220401931); Chotirmall, Sanjay H. (15757175700)",6506892186; 57193742992; 25637259800; 56673422200; 57219223729; 57219225297; 57204456291; 55637745000; 57194408422; 57204228946; 24072081500; 57219222092; 55216604100; 57194204344; 33667783800; 56479171600; 36187240400; 7202088193; 16744680700; 14020135800; 16646875100; 6602757972; 6504149380; 9942405300; 6603119390; 55625636600; 56526125500; 7102655001; 57220401931; 15757175700,Sex steroids induce membrane stress responses and virulence properties in pseudomonas aeruginosa,2020,mBio,11,5,e01774-20,1,19,18,18,10.1128/mBio.01774-20.,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091785531&doi=10.1128%2fmBio.01774-20.&partnerID=40&md5=906ce888de233953ed39c33834ed445e,"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China; Department of Otolaryngology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, China; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical, Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Department of Biological Sciences, National University of Singapore, Singapore; Centre for Bio-Imaging Sciences, National University of Singapore, Singapore; School of Materials Science and Engineering (MSE), Nanyang Technological University, Singapore; Functional Molecules and Polymers, Institute of Chemical and Engineering Sciences, ICES, Agency for Science, Technology, and Research, A*STAR, Singapore; Department of Clinical Microbiology, Trinity College Dublin, St. James’s Hospital Campus, Dublin, Ireland; Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, NSW, Australia","Vidaillac C., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Yong V.F.L., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Aschtgen M.-S., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Qu J., Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China; Yang S., Department of Otolaryngology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, China; Xu G., Department of Otolaryngology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, China; Seng Z.J., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical, Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Ali M.K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical, Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Jaggi T.K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Sankaran J., Department of Biological Sciences, National University of Singapore, Singapore, Centre for Bio-Imaging Sciences, National University of Singapore, Singapore; Foo Y.H., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Righetti F., Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Nedumaran A.M., School of Materials Science and Engineering (MSE), Nanyang Technological University, Singapore; Aogáin M.M., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Roizman D., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Richard J.-A., Functional Molecules and Polymers, Institute of Chemical and Engineering Sciences, ICES, Agency for Science, Technology, and Research, A*STAR, Singapore; Rogers T.R., Department of Clinical Microbiology, Trinity College Dublin, St. James’s Hospital Campus, Dublin, Ireland; Toyofuku M., Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan; Luo D., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Loh E., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Wohland T., Department of Biological Sciences, National University of Singapore, Singapore, Centre for Bio-Imaging Sciences, National University of Singapore, Singapore; Czarny B., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, School of Materials Science and Engineering (MSE), Nanyang Technological University, Singapore; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical, Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical, Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, NSW, Australia; Yang L., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Li L., Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China; Normark S., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Normark B.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden; Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore",Gender; Hormones; Membrane stress; Pseudomonas aeruginosa; Steroids,"Alginates; Animals; Bacterial Outer Membrane; Biofilms; Cystic Fibrosis; Estradiol; Female; Gonadal Steroid Hormones; Humans; Inflammation; Male; Mice; Mice, Inbred BALB C; Pseudomonas aeruginosa; Sex Factors; Stress, Physiological; Testosterone; Virulence; alginic acid; CXCL3 chemokine; elastase; estradiol; estriol; interleukin 1alpha; interleukin 1beta; interleukin 6; macrophage inflammatory protein 1alpha; macrophage inflammatory protein 1beta; monocyte chemotactic protein 1; RANTES; rhamnolipid; sex hormone; testosterone; tumor necrosis factor; alginic acid; estradiol; sex hormone; testosterone; animal experiment; animal model; animal tissue; Article; bacterial clearance; bacterial count; bacterial outer membrane; bacterial phenomena and functions; bacterial virulence; biofilm; controlled study; cystic fibrosis; diffusion; disease severity; female; gene function; infection sensitivity; inflammation; lung infection; lung injury; membrane fluidity; membrane stress response; membrane vesicle; mouse; nonhuman; operon; prediction; priority journal; Pseudomonas aeruginosa; sex difference; signal transduction; stress; swarming motility; tissue injury; animal; Bagg albino mouse; chemistry; complication; drug effect; genetics; growth, development and aging; human; male; metabolism; microbiology; pathogenicity; physiological stress; Pseudomonas aeruginosa; sex factor; virulence",Article,Final,,Scopus,2-s2.0-85091785531
Blomme E.E.; Provoost S.; De Smet E.G.; De Grove K.C.; Van Eeckhoutte H.P.; De Volder J.; Hansbro P.M.; Bonato M.; Saetta M.; Wijnant S.R.A.; Verhamme F.; Joos G.F.; Bracke K.R.; Brusselle G.G.; Maes T.,"Blomme, Evy E (57194550217); Provoost, Sharen (14424314200); De Smet, Elise G (56689846800); De Grove, Katrien C (57050343100); Van Eeckhoutte, Hannelore P (57212378504); De Volder, Joyceline (57211133328); Hansbro, Philip M (6603119390); Bonato, Matteo (57201476759); Saetta, Marina (7005735937); Wijnant, Sara RA (57189070322); Verhamme, Fien (56008794900); Joos, Guy F (7102353943); Bracke, Ken R (8338303000); Brusselle, Guy G (57197253407); Maes, Tania (6603579162)",57194550217; 14424314200; 56689846800; 57050343100; 57212378504; 57211133328; 6603119390; 57201476759; 7005735937; 57189070322; 56008794900; 7102353943; 8338303000; 57197253407; 6603579162,Quantification and role of innate lymphoid cell subsets in Chronic Obstructive Pulmonary Disease,2021,Clinical and Translational Immunology,10,6,e1287,,,,17,10.1002/cti2.1287,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116454375&doi=10.1002%2fcti2.1287&partnerID=40&md5=421f3d4a26eaf1ec5a706749a6c233bd,"Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy; Department of Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands; Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium","Blomme E.E., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Provoost S., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; De Smet E.G., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; De Grove K.C., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Van Eeckhoutte H.P., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; De Volder J., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Bonato M., Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Saetta M., Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy; Wijnant S.R.A., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium, Department of Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium; Verhamme F., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Joos G.F., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Bracke K.R., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Brusselle G.G., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium; Maes T., Department of Respiratory Medicine, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent University Hospital, Ghent, Belgium",COPD; ILC; innate inflammation; innate lymphoid cells,CXCL1 chemokine; gamma interferon; interleukin 6; tumor necrosis factor; adaptive immunity; adult; aged; animal cell; animal experiment; animal model; Article; chronic obstructive lung disease; clinical article; controlled study; dendritic cell; disease assessment; female; flow cytometry; gene expression; histopathology; human; immunohistochemistry; lung lavage; lymphoid cell; male; mediator release; monocyte; mouse; neutrophil; nonhuman; pathogenesis; Peyer patch; protein expression; quantitative analysis; T lymphocyte,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85116454375
Peneaux C.; Hansbro P.M.; Jobling P.; Holdsworth J.L.; Griffin A.S.,"Peneaux, Chloe (57191878275); Hansbro, Philip M (6603119390); Jobling, Phil (6701842567); Holdsworth, John L (34770869300); Griffin, Andrea S (7202675971)",57191878275; 6603119390; 6701842567; 34770869300; 7202675971,Tissue structure contributes to the production of a coloured skin display in the Common Myna,2020,Avian Biology Research,13,4,,100,107,7,3,10.1177/1758155920962908,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094197825&doi=10.1177%2f1758155920962908&partnerID=40&md5=e472b71506ca0325dffa4ad54a420c6c,"School of Psychology, University of Newcastle, Callaghan, NSW, Australia; Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; School of Mathematical and Physical Sciences, University of Newcastle, Callaghan, NSW, Australia","Peneaux C., School of Psychology, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Camperdown, NSW, Australia, School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia; Jobling P., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Holdsworth J.L., School of Mathematical and Physical Sciences, University of Newcastle, Callaghan, NSW, Australia; Griffin A.S., School of Psychology, University of Newcastle, Callaghan, NSW, Australia",Acridotheres tristis; bird; carotenoid pigments; coloration; sexual signal; tissue nanostructure,beta cryptoxanthin; carotenoid; collagen; nanomaterial; xanthophyll; Acridotheres tristis; agriculture; animal experiment; Article; bird; dermis; flow rate; high performance liquid chromatography; microscopy; nonhuman; optics; skin color; skin pigmentation; tissue structure; transmission electron microscopy,Article,Final,,Scopus,2-s2.0-85094197825
Chan Y.; Ng S.W.; Chellappan D.K.; Madheswaran T.; Zeeshan F.; Kumar P.; Pillay V.; Gupta G.; Wadhwa R.; Mehta M.; Wark P.; Hsu A.; Hansbro N.G.; Hansbro P.M.; Dua K.; Panneerselvam J.,"Chan, Yinghan (57204707263); Ng, Sin Wi (57204711291); Chellappan, Dinesh Kumar (35811890500); Madheswaran, Thiagarajan (55505311000); Zeeshan, Farrukh (26654611200); Kumar, Pradeep (7403960277); Pillay, Viness (56711693300); Gupta, Gaurav (15047988400); Wadhwa, Ridhima (57159091700); Mehta, Meenu (7203024234); Wark, Peter (7003559516); Hsu, Alan (49861516600); Hansbro, Nicole G (15055862300); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Panneerselvam, Jithendra (57201993010)",57204707263; 57204711291; 35811890500; 55505311000; 26654611200; 7403960277; 56711693300; 15047988400; 57159091700; 7203024234; 7003559516; 49861516600; 15055862300; 6603119390; 15759138700; 57201993010,Celastrol-loaded liquid crystalline nanoparticles as an anti-inflammatory intervention for the treatment of asthma,2021,International Journal of Polymeric Materials and Polymeric Biomaterials,70,11,,754,763,9,33,10.1080/00914037.2020.1765350,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086567373&doi=10.1080%2f00914037.2020.1765350&partnerID=40&md5=73c51df0c276cf64e9f40220d06766ee,"School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Department of Pharmaceutical Technology, International Medical University (IMU), Kuala Lumpur, Malaysia; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Centenary Institute, Royal Prince Alfred Hospital, Camperdown, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, Australia; School of Life Sciences, University of Technology Sydney (UTS), Ultimo, Australia","Chan Y., School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Ng S.W., School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, International Medical University (IMU), Kuala Lumpur, Malaysia; Zeeshan F., Department of Pharmaceutical Technology, International Medical University (IMU), Kuala Lumpur, Malaysia; Kumar P., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Pillay V., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Wadhwa R., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, Australia; Mehta M., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, Australia; Wark P., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, Australia; Hsu A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, Australia; Hansbro N.G., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, Australia, School of Life Sciences, University of Technology Sydney (UTS), Ultimo, Australia; Hansbro P.M., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, Australia, School of Life Sciences, University of Technology Sydney (UTS), Ultimo, Australia; Dua K., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, Australia; Panneerselvam J., Department of Pharmaceutical Technology, International Medical University (IMU), Kuala Lumpur, Malaysia",Anti-inflammatory; asthma; celastrol; liquid crystalline nanoparticles,Cell culture; Controlled drug delivery; Diseases; Drug products; Nanoparticles; Particle size; Targeted drug delivery; Anti-inflammatories; High entrapment efficiencies; Human bronchial epithelial cells; Liquid crystalline nanoparticles; Mean particle size; Molecular simulations; Sustained drug release; Therapeutic efficacy; Liquid crystals,Article,Final,,Scopus,2-s2.0-85086567373
Bezerra-Santos C.R.; Bondarenko E.; Essilfie A.T.; Nair P.M.; Horvat J.C.; Barbosa-Filho J.M.; Piuvezam M.R.; Nalivaiko E.; Hansbro P.M.,"Bezerra-Santos, Claudio R. (6507070252); Bondarenko, Evgeny (37664434900); Essilfie, Ama T. (22955585600); Nair, Prema M. (55749131000); Horvat, Jay C. (9942405300); Barbosa-Filho, Jose M. (7004597930); Piuvezam, Marcia R. (6602923872); Nalivaiko, Eugene (7003938644); Hansbro, Phil M. (6603119390)",6507070252; 37664434900; 22955585600; 55749131000; 9942405300; 7004597930; 6602923872; 7003938644; 6603119390,Cissampelos sympodialis and Warifteine Suppress Anxiety-Like Symptoms and Allergic Airway Inflammation in Acute Murine Asthma Model,2020,Revista Brasileira de Farmacognosia,30,2,,224,232,8,4,10.1007/s43450-020-00026-4,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086162947&doi=10.1007%2fs43450-020-00026-4&partnerID=40&md5=3f89a7e1d17f6b360dab385f938c3218,"Laboratório de Imunofarmacologia, Departamento de Fisiologia e Patologia, Universidade Federal da Paraíba, PB, João Pessoa, Brazil; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Priority Research Center for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Departamento de Ciências Farmacêuticas, Universidade Federal da Paraíba, PB, João Pessoa, Brazil","Bezerra-Santos C.R., Laboratório de Imunofarmacologia, Departamento de Fisiologia e Patologia, Universidade Federal da Paraíba, PB, João Pessoa, Brazil; Bondarenko E., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Essilfie A.T., Priority Research Center for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Nair P.M., Priority Research Center for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Priority Research Center for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Barbosa-Filho J.M., Departamento de Ciências Farmacêuticas, Universidade Federal da Paraíba, PB, João Pessoa, Brazil; Piuvezam M.R., Laboratório de Imunofarmacologia, Departamento de Fisiologia e Patologia, Universidade Federal da Paraíba, PB, João Pessoa, Brazil; Nalivaiko E., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Center for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia",Acute airway disease; Alkaloid; Plant extract; Psychological disorder; Respiratory rate,,Article,Final,,Scopus,2-s2.0-85086162947
Paudel K.R.; Panth N.; Pangeni R.; Awasthi R.; Chawla V.; Mehta M.; Tambuwala M.M.; Hansbro P.M.,"Paudel, Keshav Raj (56539588400); Panth, Nisha (57094240100); Pangeni, Rudra (56287822300); Awasthi, Rajendra (36866066100); Chawla, Viney (36240409800); Mehta, Meenu (7203024234); Tambuwala, Murtaza M. (36657816300); Hansbro, Philip M. (6603119390)",56539588400; 57094240100; 56287822300; 36866066100; 36240409800; 7203024234; 36657816300; 6603119390,Targeting lung cancer using advanced drug delivery systems,2020,Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems,,,,493,516,23,19,10.1016/B978-0-12-820658-4.00023-6,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120819987&doi=10.1016%2fB978-0-12-820658-4.00023-6&partnerID=40&md5=6940a995e57ec171cea142902b740f4a,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Ultimo, NSW, Australia; College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, 1666 Youngsan-ro (61 Dorim-ri), Jeonnam, 534-729, Muan-gun, South Korea; Amity Institute of Pharmacy, Amity University Uttar Pradesh, Uttar Pradesh, Noida, India; University Institute of Pharmaceutical Sciences, Baba Farid University of Health Sciences, Sadiq Road, Punjab, Faridkot, 151203, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, Northern Ireland, County Londonderry, United Kingdom","Paudel K.R., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Ultimo, NSW, Australia; Panth N., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Ultimo, NSW, Australia; Pangeni R., College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, 1666 Youngsan-ro (61 Dorim-ri), Jeonnam, 534-729, Muan-gun, South Korea; Awasthi R., Amity Institute of Pharmacy, Amity University Uttar Pradesh, Uttar Pradesh, Noida, India; Chawla V., University Institute of Pharmaceutical Sciences, Baba Farid University of Health Sciences, Sadiq Road, Punjab, Faridkot, 151203, India; Mehta M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Ultimo, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, Northern Ireland, County Londonderry, United Kingdom; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Ultimo, NSW, Australia",Chemotherapy; Combination therapy; Immunotherapy; Lung cancer; Nanomedicine; Targeted therapy,,Book chapter,Final,,Scopus,2-s2.0-85120819987
Mehta M.; Dhanjal D.S.; Satija S.; Wadhwa R.; Paudel K.R.; Chellappan D.K.; Mohammad S.; Haghi M.; Hansbro P.M.; Dua K.,"Mehta, Meenu (7203024234); Dhanjal, Daljeet Singh (58224756300); Satija, Saurabh (54581608400); Wadhwa, Ridhima (57159091700); Paudel, Keshav Raj (56539588400); Chellappan, Dinesh Kumar (35811890500); Mohammad, Shiva (57219441160); Haghi, Mehra (37033934800); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",7203024234; 58224756300; 54581608400; 57159091700; 56539588400; 35811890500; 57219441160; 37033934800; 6603119390; 15759138700,Advancing of cellular signaling pathways in respiratory diseases using nanocarrier based drug delivery systems,2020,Current Pharmaceutical Design,26,42,,5380,5392,12,13,10.2174/1381612826999201116161143,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097552570&doi=10.2174%2f1381612826999201116161143&partnerID=40&md5=8e7c91cfa7f0cea44d33efe1cc84c484,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Biosciences and Bioengineering, Lovely Professional University, Phagwara, 144411, Punjab, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Dhanjal D.S., School of Biosciences and Bioengineering, Lovely Professional University, Phagwara, 144411, Punjab, India; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; Wadhwa R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Paudel K.R., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Mohammad S., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Haghi M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia",Cell signaling; COPD; Drug delivery; Morbidity; Nanotechnology; Respiratory diseases,Asthma; Drug Delivery Systems; Humans; Lung Neoplasms; Tuberculosis; as 1411; carbon nanotube; ciprofloxacin; cisplatin; colistin; dendrimer; fluticasone; immunoglobulin enhancer binding protein; Janus kinase; liposome; mitogen activated protein kinase; nanocarrier; paclitaxel; phosphatidylinositol 3 kinase; protein kinase B; quantum dot; quercetin; rifabutin; rosuvastatin; salbutamol; selumetinib; sonolisib; STAT protein; asthma; chronic obstructive lung disease; drug delivery system; human; interstitial lung disease; lung cancer; lung fibrosis; morbidity; nanotechnology; nonhuman; pathophysiology; prevalence; priority journal; Pseudomonas infection; respiratory tract disease; Review; signal transduction; tuberculosis; asthma; drug delivery system; lung tumor; tuberculosis,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85097552570
Huang Q.; Jacquelot N.; Preaudet A.; Hediyeh‐zadeh S.; Souza‐fonseca‐guimaraes F.; McKenzie A.N.J.; Hansbro P.M.; Davis M.J.; Mielke L.A.; Putoczki T.L.; Belz G.T.,"Huang, Qiutong (57208895756); Jacquelot, Nicolas (12789586500); Preaudet, Adele (55581566100); Hediyeh‐zadeh, Soroor (57194010119); Souza‐fonseca‐guimaraes, Fernando (52564361600); McKenzie, Andrew N. J. (7101774635); Hansbro, Philip M. (6603119390); Davis, Melissa J. (35419216300); Mielke, Lisa A. (7006316016); Putoczki, Tracy L. (6503999142); Belz, Gabrielle T. (7102682937)",57208895756; 12789586500; 55581566100; 57194010119; 52564361600; 7101774635; 6603119390; 35419216300; 7006316016; 6503999142; 7102682937,Type 2 innate lymphoid cells protect against colorectal cancer progression and predict improved patient survival,2021,Cancers,13,3,559,1,16,15,34,10.3390/cancers13030559,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100074260&doi=10.3390%2fcancers13030559&partnerID=40&md5=47c1369784dbdf08851b3114b5b9f5cb,"Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, Melbourne, 3010, Australia; University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, Brisbane, 4102, Australia; Medical Research Council Laboratory of Molecular Biology, Cambridge, CB2 0QH, United Kingdom; Center for Inflammation, Centenary Institute and the School of Life Sciences, University of Technology Sydney, Sydney, 2050, Australia; Department of Clinical Pathology, University of Melbourne, Parkville, Melbourne, 3010, Australia; Olivia Newton‐John Cancer Research Institute, La Trobe University School of Cancer Medicine, Heidelberg, 3084, Australia","Huang Q., Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, 3052, Australia, Department of Medical Biology, University of Melbourne, Parkville, Melbourne, 3010, Australia; Jacquelot N., Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, 3052, Australia, Department of Medical Biology, University of Melbourne, Parkville, Melbourne, 3010, Australia; Preaudet A., Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, 3052, Australia, Department of Medical Biology, University of Melbourne, Parkville, Melbourne, 3010, Australia; Hediyeh‐zadeh S., Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, 3052, Australia, Department of Medical Biology, University of Melbourne, Parkville, Melbourne, 3010, Australia; Souza‐fonseca‐guimaraes F., University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, Brisbane, 4102, Australia; McKenzie A.N.J., Medical Research Council Laboratory of Molecular Biology, Cambridge, CB2 0QH, United Kingdom; Hansbro P.M., Center for Inflammation, Centenary Institute and the School of Life Sciences, University of Technology Sydney, Sydney, 2050, Australia; Davis M.J., Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, 3052, Australia, Department of Medical Biology, University of Melbourne, Parkville, Melbourne, 3010, Australia, Department of Clinical Pathology, University of Melbourne, Parkville, Melbourne, 3010, Australia; Mielke L.A., Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, 3052, Australia, Olivia Newton‐John Cancer Research Institute, La Trobe University School of Cancer Medicine, Heidelberg, 3084, Australia; Putoczki T.L., Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, 3052, Australia, Department of Medical Biology, University of Melbourne, Parkville, Melbourne, 3010, Australia; Belz G.T., Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, 3052, Australia, Department of Medical Biology, University of Melbourne, Parkville, Melbourne, 3010, Australia, University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, Brisbane, 4102, Australia",Colitis‐associated cancer; Colon cancer; ILC2; IL‐13; IL‐5; Inflammation,interleukin 13; interleukin 5; animal experiment; animal model; animal tissue; Article; cancer growth; cancer staging; carcinogenesis; cell function; colorectal cancer; controlled study; cytokine production; female; gene; ILC2 gene; lymphoid cell; machine learning; male; mouse; nonhuman; overall survival; tumor immunity; tumor microenvironment; tumor volume,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85100074260
Kc R.; Hyland I.K.; Smith J.A.; Shukla S.D.; Hansbro P.M.; Zosky G.R.; Karupiah G.; O’Toole R.F.,"Kc, Rajendra (56871074100); Hyland, Isabel K. (57203858680); Smith, Jason A. (7410169481); Shukla, Shakti D. (56367620800); Hansbro, Philip M. (6603119390); Zosky, Graeme R. (6506459703); Karupiah, Gunasegaran (7003361237); O’Toole, Ronan F. (7005094224)",56871074100; 57203858680; 7410169481; 56367620800; 6603119390; 6506459703; 7003361237; 7005094224,Cow Dung Biomass Smoke Exposure Increases Adherence of Respiratory Pathogen Nontypeable Haemophilus influenzae to Human Bronchial Epithelial Cells,2020,Exposure and Health,12,4,,883,895,12,6,10.1007/s12403-020-00351-y,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081684588&doi=10.1007%2fs12403-020-00351-y&partnerID=40&md5=1a5388e2c7a76d052b69a574a49e1d2b,"Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia; School of Natural Sciences, College of Sciences and Engineering, University of Tasmania, Hobart, TAS, Australia; Priority Research Centre for Healthy Lungs and School of Medicine and Public Health, Faculty of Health and Medicine, and Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Centre for Inflammation, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Centenary Institute, Sydney, NSW, Australia; Department of Clinical Microbiology, School of Medicine, Trinity College Dublin, Dublin, Ireland; Department of Pharmacy and Biomedical Sciences, School of Molecular Sciences, College of Science, Health and Engineering, La Trobe University, VIC, Australia","Kc R., Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia; Hyland I.K., School of Natural Sciences, College of Sciences and Engineering, University of Tasmania, Hobart, TAS, Australia; Smith J.A., School of Natural Sciences, College of Sciences and Engineering, University of Tasmania, Hobart, TAS, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs and School of Medicine and Public Health, Faculty of Health and Medicine, and Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., Centre for Inflammation, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia, Centenary Institute, Sydney, NSW, Australia; Zosky G.R., Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia; Karupiah G., Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia; O’Toole R.F., Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia, Department of Clinical Microbiology, School of Medicine, Trinity College Dublin, Dublin, Ireland, Department of Pharmacy and Biomedical Sciences, School of Molecular Sciences, College of Science, Health and Engineering, La Trobe University, VIC, Australia",Biomass smoke; Chronic obstructive pulmonary disease; Cigarette smoke; Cow dung smoke; Nontypeable Haemophilus influenzae,Bacteria (microorganisms); Haemophilus influenzae; biomass; cell component; gene expression; induced response; infectious disease; inhibition; inhibitor; pathogen; respiratory disease; smoke,Article,Final,,Scopus,2-s2.0-85081684588
Mehta M.; Paudel K.R.; Panth N.; Xenaki D.; MacLoughlin R.; Oliver B.G.; Lobenberg R.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Mehta, Meenu (7203024234); Paudel, Keshav Raj (56539588400); Panth, Nisha (57094240100); Xenaki, Dikaia (6507411538); MacLoughlin, Ronan (57212263206); Oliver, Brian G (15919869900); Lobenberg, Raimar (6602898019); Hansbro, Philip M (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",7203024234; 56539588400; 57094240100; 6507411538; 57212263206; 15919869900; 6602898019; 6603119390; 35811890500; 15759138700,Drug delivery advances in mitigating inflammation via matrix metalloproteinases in respiratory diseases,2021,Nanomedicine,16,6,,437,439,2,7,10.2217/nnm-2021-0016,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102527891&doi=10.2217%2fnnm-2021-0016&partnerID=40&md5=513422791983261ea459ad798bbf0a9f,"Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; Ida Business Park, Dangan, Galway, H91 HE94, Ireland; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; University of Alberta, Faculty of Pharmacy and Pharmaceutical Sciences, Edmonton, T6G 2N8, AB, Canada; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India","Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia; Panth N., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Xenaki D., Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; MacLoughlin R., Ida Business Park, Dangan, Galway, H91 HE94, Ireland, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland, School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland; Oliver B.G., School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; Lobenberg R., University of Alberta, Faculty of Pharmacy and Pharmaceutical Sciences, Edmonton, T6G 2N8, AB, Canada; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology, Sydney, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Alberta, Faculty of Pharmacy and Pharmaceutical Sciences, Edmonton, T6G 2N8, AB, Canada, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India",inflammation; matrix metalloproteinase; nanoparticles; novel drug delivery; respiratory diseases,Drug Delivery Systems; Humans; Inflammation; Matrix Metalloproteinases; Pharmaceutical Preparations; albumin; cigarette smoke; collagenase 3; dexamethasone; doxycycline; elastin; gelatinase B; glycylprolylleucylglycylisoleucylalanylglycylglutamine; horseradish peroxidase; hydrogel; macrophage elastase; matrix metalloproteinase; methylene blue; monoclonal antibody; monoclonal antibody 2C5; nanoparticle; neutrophil collagenase; peptide; poloxamer; unclassified drug; drug; matrix metalloproteinase; asthma; carcinogenesis; cell invasion; cell migration; chronic obstructive lung disease; drug delivery system; drug release; drug sensitivity; emphysema; exposure variable; extracellular matrix; Fbln1 gene; gene activity; gene expression; gene function; gene knockout; gene overexpression; gene targeting; inflammation; lung cancer; lung fibrosis; lung metastasis; lung non-small cell carcinoma cell line; micelle; MMP 12 gene; MMP 13 gene; MMP 8 gene; MMP 9 gene; MMP gene; nonhuman; nucleosome; pathogenesis; polymerase chain reaction; respiratory tract disease; respiratory tract inflammation; Review; synthesis; tumor microenvironment; drug delivery system; human; inflammation,Review,Final,,Scopus,2-s2.0-85102527891
Schofield Z.V.; Wu M.C.L.; Hansbro P.M.; Cooper M.A.; Woodruff T.M.,"Schofield, Zoe V. (59237270200); Wu, Mike C. L. (57221206363); Hansbro, Philip M. (6603119390); Cooper, Matthew A. (7404411451); Woodruff, Trent M. (7005693216)",59237270200; 57221206363; 6603119390; 7404411451; 7005693216,Acetate protects against intestinal ischemia-reperfusion injury independent of its cognate free fatty acid 2 receptor,2020,FASEB Journal,34,8,,10418,10430,12,14,10.1096/fj.202000960R,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089276781&doi=10.1096%2ffj.202000960R&partnerID=40&md5=e2020c7a4ded3dce79653494a7ccf884,"School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia; The Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia","Schofield Z.V., School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia, The Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia; Wu M.C.L., School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Cooper M.A., The Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia; Woodruff T.M., School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia",acetate; FFA2; ischemia-reperfusion injury; neutrophils,"Acetates; Animals; Intestines; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; Receptors, G-Protein-Coupled; Reperfusion Injury; acetic acid; fatty acid; free fatty acid 2 receptor; granulocyte macrophage colony stimulating factor; interleukin 10; interleukin 17; interleukin 1alpha; interleukin 1beta; reactive oxygen metabolite; tumor necrosis factor; unclassified drug; vasculotropin; acetic acid; Ffar2 protein, mouse; G protein coupled receptor; animal cell; animal experiment; animal model; antiinflammatory activity; apoptosis index; Article; chemotaxis assay; controlled study; drug potency; intestine ischemia; intestine villus; leukocyte count; male; mouse; neutrophil; nonhuman; priority journal; reperfusion injury; small intestine tissue; superior mesenteric artery; animal; C57BL mouse; intestine; metabolism; neutrophil chemotaxis; physiology; reperfusion injury",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85089276781
Wadhwa R.; Aggarwal T.; Malyla V.; Kumar N.; Gupta G.; Chellappan D.K.; Dureja H.; Mehta M.; Satija S.; Gulati M.; Maurya P.K.; Collet T.; Hansbro P.M.; Dua K.,"Wadhwa, Ridhima (57159091700); Aggarwal, Taru (57196053981); Malyla, Vamshikrishna (57205128961); Kumar, Nitesh (57188637148); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Dureja, Harish (6507566948); Mehta, Meenu (7203024234); Satija, Saurabh (54581608400); Gulati, Monica (7006677671); Maurya, Pawan Kumar (15765644500); Collet, Trudi (36898251800); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",57159091700; 57196053981; 57205128961; 57188637148; 15047988400; 35811890500; 6507566948; 7203024234; 54581608400; 7006677671; 15765644500; 36898251800; 6603119390; 15759138700,Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease,2019,Journal of Cellular Physiology,234,10,,16703,16723,20,39,10.1002/jcp.28482,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063413032&doi=10.1002%2fjcp.28482&partnerID=40&md5=483c50ca14250c76515bc36bd51cced6,"Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India; Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia; Amity Institute for Advanced Research & Studies (M&D), Amity University, Noida, Uttar Pradesh, India; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia; Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, Haryana, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Department of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India; Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia","Wadhwa R., Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India; Aggarwal T., Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Kumar N., Amity Institute for Advanced Research & Studies (M&D), Amity University, Noida, Uttar Pradesh, India; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia; Dureja H., Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, Haryana, India; Mehta M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Maurya P.K., Department of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India; Collet T., Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia",biomarkers; cellular therapy; chronic obstructive pulmonary disease; CRISPR/Cas-9; genome editing; oxidative stress,"Biomarkers; Gene Editing; Genetic Therapy; Humans; Pulmonary Disease, Chronic Obstructive; biological marker; reactive oxygen metabolite; transcription activator like effector nuclease; untranslated RNA; zinc finger nuclease; biological marker; antioxidant activity; chronic obstructive lung disease; clustered regularly interspaced short palindromic repeat; CRISPR-CAS9 system; deacetylation; differential diagnosis; DNA methylation; dyspnea; gene activation; gene editing; gene expression level; gene identification; genetic predisposition; genetic variation; genome-wide association study; histone acetylation; histone methylation; homologous recombination; human; lipid peroxidation; oxidative stress; priority journal; Review; risk factor; smoking; whole exome sequencing; chronic obstructive lung disease; gene therapy; metabolism",Review,Final,,Scopus,2-s2.0-85063413032
Liu L.; Zhang X.; Liu Y.; Zhang L.; Zheng J.; Wang J.; Hansbro P.M.; Wang L.; Wang G.; Hsu A.C.-Y.,"Liu, Lei (57190174032); Zhang, Xin (55277957600); Liu, Ying (57200212919); Zhang, Li (57190759919); Zheng, Jing (57189517281); Wang, Ji (57203118557); Hansbro, Philip M. (6603119390); Wang, Lei (57069199100); Wang, Gang (56167771700); Hsu, Alan Chen-Yu (49861516600)",57190174032; 55277957600; 57200212919; 57190759919; 57189517281; 57203118557; 6603119390; 57069199100; 56167771700; 49861516600,"Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations",2019,Respiratory Research,20,1,95,,,,38,10.1186/s12931-019-1051-9,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066507307&doi=10.1186%2fs12931-019-1051-9&partnerID=40&md5=f64ce4ec9abf785f1fcc0501150257f6,"Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Collaborative Innovation Centre for Biotherapy, Chengdu, Sichuan, 610041, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, 21224, MD, United States; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Department of Integrated Traditional Chinese and Western Medicine, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, 2305, NSW, Australia","Liu L., Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Collaborative Innovation Centre for Biotherapy, Chengdu, Sichuan, 610041, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Zhang X., Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Collaborative Innovation Centre for Biotherapy, Chengdu, Sichuan, 610041, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China, Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, 21224, MD, United States, Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Liu Y., Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Collaborative Innovation Centre for Biotherapy, Chengdu, Sichuan, 610041, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Zhang L., Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Collaborative Innovation Centre for Biotherapy, Chengdu, Sichuan, 610041, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Zheng J., Department of Integrated Traditional Chinese and Western Medicine, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China; Wang J., Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Collaborative Innovation Centre for Biotherapy, Chengdu, Sichuan, 610041, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China, Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, 21224, MD, United States; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, 2305, NSW, Australia; Wang L., Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Collaborative Innovation Centre for Biotherapy, Chengdu, Sichuan, 610041, China, Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Wang G., Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China; Hsu A.C.-Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, 2305, NSW, Australia",Asthma treatment response; Exacerbations; Inflammatory phenotypes; YKL-40,"Adult; Aged; Anti-Asthmatic Agents; Asthma; Biomarkers; Chitinase-3-Like Protein 1; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phenotype; Prospective Studies; glycoprotein; interleukin 1beta; interleukin 5; interleukin 6; interleukin 8; macrophage derived chemokine; tumor necrosis factor; unclassified drug; YKL 40 protein; antiasthmatic agent; biological marker; CHI3L1 protein, human; chitinase 3 like protein 1; adult; Article; asthma; controlled study; correlational study; disease exacerbation; disease severity; enzyme linked immunosorbent assay; eosinophil; female; human; human cell; major clinical study; male; neutrophil; phenotype; prospective study; protein blood level; sputum analysis; aged; asthma; blood; cohort analysis; follow up; middle aged; phenotype",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85066507307
Dirar A.I.; Adhikari-Devkota A.; Kunwar R.M.; Paudel K.R.; Belwal T.; Gupta G.; Chellappan D.K.; Hansbro P.M.; Dua K.; Devkota H.P.,"Dirar, Amina Ibrahim (57189034559); Adhikari-Devkota, Anjana (57200393104); Kunwar, Ripu Mardhan (57203574239); Paudel, Keshav Raj (56539588400); Belwal, Tarun (56548880000); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Devkota, Hari Prasad (24775939500)",57189034559; 57200393104; 57203574239; 56539588400; 56548880000; 15047988400; 35811890500; 6603119390; 15759138700; 24775939500,"Genus Blepharis (Acanthaceae): A review of ethnomedicinally used species, and their phytochemistry and pharmacological activities",2021,Journal of Ethnopharmacology,265,,113255,,,,12,10.1016/j.jep.2020.113255,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090030151&doi=10.1016%2fj.jep.2020.113255&partnerID=40&md5=bb8043dd313da5e629134b43501f7eb6,"Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, 862-0973, Kumamoto, Japan; Medicinal, Aromatic Plants and Traditional Medicine Research Institute (MAPTRI), National Center for Research, P.O. Box 2404, Mek Nimr Street, Khartoum, Sudan; Faculty of Clinical and Industrial Pharmacy, National University-Sudan, P.O. Box 3783, Al-Raki Area, Khartoum, Sudan; Ethnobotanical Society of Nepal, Kathmandu, 44600, Nepal; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Key Laboratory for Agro-Products Postharvest Handling of Ministry of Agriculture and Rural Affairs, Zhejiang Key Laboratory for Agro-Food Processing, College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058, China; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan","Dirar A.I., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, 862-0973, Kumamoto, Japan, Medicinal, Aromatic Plants and Traditional Medicine Research Institute (MAPTRI), National Center for Research, P.O. Box 2404, Mek Nimr Street, Khartoum, Sudan, Faculty of Clinical and Industrial Pharmacy, National University-Sudan, P.O. Box 3783, Al-Raki Area, Khartoum, Sudan; Adhikari-Devkota A., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, 862-0973, Kumamoto, Japan; Kunwar R.M., Ethnobotanical Society of Nepal, Kathmandu, 44600, Nepal; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Belwal T., Key Laboratory for Agro-Products Postharvest Handling of Ministry of Agriculture and Rural Affairs, Zhejiang Key Laboratory for Agro-Food Processing, College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058, China; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, 862-0973, Kumamoto, Japan, Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan",Acanthaceae; Bioactive compounds; Blepharis; Ethnomedicine; Pharmacology,"Acanthaceae; Animals; Ethnobotany; Ethnopharmacology; Humans; Medicine, Traditional; Phytochemicals; Phytotherapy; Plant Preparations; antidiabetic agent; antiinfective agent; antiinflammatory agent; antilipemic agent; antineoplastic agent; antithrombocytic agent; hydroxamic acid; phenol derivative; phytochemical; phytosterol; phytochemical; plant medicinal product; Acanthaceae; antidiabetic activity; antiinflammatory activity; antimicrobial activity; antineoplastic activity; Blepharis; Blepharis ciliaris; Blepharis edulis; Blepharis sindica; chemical composition; drug information; drug mechanism; gastrointestinal disease; geographic distribution; hypolipidemic activity; nonhuman; pharmacological parameters; phytochemistry; phytotoxicity; Review; systematic review; traditional medicine; Acanthaceae; animal; chemistry; ethnobotany; ethnopharmacology; human; phytotherapy",Review,Final,,Scopus,2-s2.0-85090030151
Solanki N.; Mehta M.; Chellappan D.K.; Gupta G.; Hansbro N.G.; Tambuwala M.M.; Aa Aljabali A.; Paudel K.R.; Liu G.; Satija S.; Hansbro P.M.; Dua K.; Dureja H.,"Solanki, Neeta (57219934315); Mehta, Meenu (7203024234); Chellappan, Dinesh Kumar (35811890500); Gupta, Gaurav (15047988400); Hansbro, Nicole G. (15055862300); Tambuwala, Murtaza M. (36657816300); Aa Aljabali, Alaa (35306626800); Paudel, Keshav Raj (56539588400); Liu, Gang (57189061134); Satija, Saurabh (54581608400); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Dureja, Harish (6507566948)",57219934315; 7203024234; 35811890500; 15047988400; 15055862300; 36657816300; 35306626800; 56539588400; 57189061134; 54581608400; 6603119390; 15759138700; 6507566948,Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549,2020,Future Medicinal Chemistry,12,22,,2019,2034,15,55,10.4155/fmc-2020-0083,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096152184&doi=10.4155%2ffmc-2020-0083&partnerID=40&md5=10fd687959fa6f7ebacb2a4fe4dd49b3,"Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, 302017, India; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County, Londonderry, Northern Ireland, BT52 1SA, United Kingdom; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Yarmouk University, Irbid, 21163, Jordan; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, Himachal Pradesh, 173 229, India","Solanki N., Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, 302017, India; Hansbro N.G., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County, Londonderry, Northern Ireland, BT52 1SA, United Kingdom; Aa Aljabali A., Department of Pharmaceutical Sciences, Faculty of Pharmacy, Yarmouk University, Irbid, 21163, Jordan; Paudel K.R., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Liu G., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Hansbro P.M., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, Himachal Pradesh, 173 229, India; Dureja H., Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India",bioavailability; boswellic acids; chitosan; lung cancer; nanoparticles,"A549 Cells; Antineoplastic Agents; Cell Cycle; Cell Proliferation; Cell Survival; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; Nanoparticles; Particle Size; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured; boswellic acid; chitosan nanoparticle; antineoplastic agent; boswellic acid; chitosan; drug carrier; nanoparticle; triterpene; A-549 cell line; antiproliferative activity; apoptosis; Article; cell cycle G0 phase; controlled study; drug cytotoxicity; drug delivery system; drug retention; flow cytometry; gelation; human; human cell; IC50; in vitro study; particle size; priority journal; zeta potential; A-549 cell line; cell cycle; cell proliferation; cell survival; chemistry; conformation; dose response; drug effect; drug screening; structure activity relation; synthesis; tumor cell culture",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85096152184
Liu G.; Mateer S.W.; Hsu A.; Goggins B.J.; Tay H.; Mathe A.; Fan K.; Neal R.; Bruce J.; Burns G.; Minahan K.; Maltby S.; Fricker M.; Foster P.S.; Wark P.A.B.; Hansbro P.M.; Keely S.,"Liu, Gang (57189061134); Mateer, Sean W. (56595055500); Hsu, Alan (49861516600); Goggins, Bridie J. (55894233100); Tay, Hock (55639898100); Mathe, Andrea (56018778600); Fan, Kening (57208226178); Neal, Rachel (57201587411); Bruce, Jessica (7201835540); Burns, Grace (57191080549); Minahan, Kyra (35574254300); Maltby, Steven (6507446799); Fricker, Michael (26638839800); Foster, Paul S. (7201517569); Wark, Peter A. B. (7003559516); Hansbro, Philip M. (6603119390); Keely, Simon (9739611200)",57189061134; 56595055500; 49861516600; 55894233100; 55639898100; 56018778600; 57208226178; 57201587411; 7201835540; 57191080549; 35574254300; 6507446799; 26638839800; 7201517569; 7003559516; 6603119390; 9739611200,Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome,2019,Mucosal Immunology,12,4,,862,873,11,43,10.1038/s41385-019-0163-3,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064171346&doi=10.1038%2fs41385-019-0163-3&partnerID=40&md5=86e692145bf39e60d4f3f74975f0ceec,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; School of Nursing and Midwifery, University of Newcastle, Callaghan, NSW, Australia","Liu G., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; Mateer S.W., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; Hsu A., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Goggins B.J., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; Tay H., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Mathe A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; Fan K., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; Neal R., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; Bruce J., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; Burns G., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; Minahan K., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia; Maltby S., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Nursing and Midwifery, University of Newcastle, Callaghan, NSW, Australia; Fricker M., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Foster P.S., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Wark P.A.B., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Keely S., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia",,"Animals; Biopsy; Colitis; Dextran Sulfate; Disease Models, Animal; Disease Susceptibility; Endoscopy; Immunohistochemistry; Inflammasomes; Inflammatory Bowel Diseases; Mice; Neutrophil Infiltration; NLR Family, Pyrin Domain-Containing 3 Protein; Platelet Membrane Glycoproteins; Pneumonia; Receptors, G-Protein-Coupled; Signal Transduction; amoxicillin; cryopyrin; interleukin 1beta; interleukin 1beta converting enzyme; lipopolysaccharide; phosphorylcholine; thrombocyte activating factor receptor; tumor necrosis factor; cryopyrin; dextran sulfate; fibrinogen receptor; G protein coupled receptor; inflammasome; thrombocyte activating factor receptor; animal cell; animal experiment; animal model; animal tissue; antibiotic therapy; Article; bacteremia; bacterial load; controlled study; cytokine release; dextran sulfate sodium-induced colitis; extracellular trap; female; human; human cell; in vitro study; microbial population dynamics; mouse; mouse model; neutrophilia; NLRP3 signaling pathway; nonhuman; pneumonia; priority journal; protein cleavage; protein expression; protein induction; signal transduction; animal; biopsy; colitis; complication; disease model; disease predisposition; endoscopy; immunohistochemistry; immunology; inflammatory bowel disease; metabolism; neutrophil chemotaxis; pathology; pneumonia",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85064171346
Shukla S.D.; Shastri M.D.; Chong W.C.; Dua K.; Budden K.F.; Mahmood M.Q.; Hansbro N.G.; Keely S.; Eri R.; Patel R.P.; Peterson G.M.; Hansbro P.M.,"Shukla, Shakti D (56367620800); Shastri, Madhur D (56007290800); Chong, Wai Chin (57192809246); Dua, K. (15759138700); Budden, Kurtis F (57191417986); Mahmood, Malik Quasir (56368609600); Hansbro, Nicole G (15055862300); Keely, S. (9739611200); Eri, Rajaraman (57206207449); Patel, Rahul P (36849078400); Peterson, Gregory M (7402563175); Hansbro, Philip M (6603119390)",56367620800; 56007290800; 57192809246; 15759138700; 57191417986; 56368609600; 15055862300; 9739611200; 57206207449; 36849078400; 7402563175; 6603119390,Microbiome-focused asthma management strategies,2019,Current Opinion in Pharmacology,46,,,143,149,6,16,10.1016/j.coph.2019.06.003,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068075346&doi=10.1016%2fj.coph.2019.06.003&partnerID=40&md5=dd49106866f1124d1a9ecd2ead33fb26,"Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Australia; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Medicine, College of Health and Medicine, University of Tasmania, Hobart, Australia; Pharmacy, College of Health and Medicine, University of Tasmania, Hobart, Australia; Centre for inflammation, Centenary Institute, Sydney, and School of Life Sciences, University of Technology, Ultimo, NSW, Australia","Shukla S.D., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Shastri M.D., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Chong W.C., Department of Molecular and Translational Science, Monash University, Clayton, Australia, Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Australia; Dua K., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Budden K.F., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Mahmood M.Q., Medicine, College of Health and Medicine, University of Tasmania, Hobart, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia, Centre for inflammation, Centenary Institute, Sydney, and School of Life Sciences, University of Technology, Ultimo, NSW, Australia; Keely S., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia; Eri R., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Patel R.P., Pharmacy, College of Health and Medicine, University of Tasmania, Hobart, Australia; Peterson G.M., Pharmacy, College of Health and Medicine, University of Tasmania, Hobart, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute & University of Newcastle, Callaghan, NSW, Australia, Centre for inflammation, Centenary Institute, Sydney, and School of Life Sciences, University of Technology, Ultimo, NSW, Australia",,Animals; Asthma; Humans; Intestines; Lung; Microbiota; asthma; clinical feature; disease association; disease exacerbation; human; immune response; microbiome; patient risk; prevalence; priority journal; Review; risk factor; species distribution; species richness; animal; asthma; intestine; lung; microbiology; microflora,Review,Final,,Scopus,2-s2.0-85068075346
Budden K.F.; Shukla S.D.; Rehman S.F.; Bowerman K.L.; Keely S.; Hugenholtz P.; Armstrong-James D.P.H.; Adcock I.M.; Chotirmall S.H.; Chung K.F.; Hansbro P.M.,"Budden, Kurtis F (57191417986); Shukla, Shakti D (56367620800); Rehman, Saima Firdous (57211047721); Bowerman, Kate L (55147965300); Keely, Simon (9739611200); Hugenholtz, Philip (55811879700); Armstrong-James, Darius P H (57200299365); Adcock, Ian M (7007066538); Chotirmall, Sanjay H (15757175700); Chung, Kian Fan (35403525000); Hansbro, Philip M (6603119390)",57191417986; 56367620800; 57211047721; 55147965300; 9739611200; 55811879700; 57200299365; 7007066538; 15757175700; 35403525000; 6603119390,Functional effects of the microbiota in chronic respiratory disease,2019,The Lancet Respiratory Medicine,7,10,,907,920,13,294,10.1016/S2213-2600(18)30510-1,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069637530&doi=10.1016%2fS2213-2600%2818%2930510-1&partnerID=40&md5=178b164c3d253a1360e918a016bc7e4c,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Priority Research Centre for Digestive Health and Neurogastroenterology, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Australian Centre for Ecogenomics, School of Chemistry and Molecular Biology, The University of Queensland, QLD, Australia; National Heart and Lung Institute, Imperial College London, London, United Kingdom; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Centre for Inflammation, Centenary Institute, University of Technology Sydney, NSW, Australia","Budden K.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Rehman S.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Bowerman K.L., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biology, The University of Queensland, QLD, Australia; Keely S., Priority Research Centre for Digestive Health and Neurogastroenterology, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Hugenholtz P., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biology, The University of Queensland, QLD, Australia; Armstrong-James D.P.H., National Heart and Lung Institute, Imperial College London, London, United Kingdom; Adcock I.M., National Heart and Lung Institute, Imperial College London, London, United Kingdom; Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Chung K.F., National Heart and Lung Institute, Imperial College London, London, United Kingdom; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, University of Technology Sydney, NSW, Australia",,Chronic Disease; Humans; Immunity; Lung; Microbiota; Respiration Disorders; Respiratory System; antibiotic agent; corticosteroid; drug metabolite; prebiotic agent; probiotic agent; toll like receptor; toll like receptor 2; toll like receptor 4; asthma; bacterium; bronchiectasis; chronic obstructive lung disease; chronic respiratory tract disease; cystic fibrosis; disease exacerbation; fungus; human; immunity; lung infection; lung microbiome; metabolite; microbial diversity; microbiome; nonhuman; pathogenesis; priority journal; protein structure; Review; virus; breathing disorder; chronic disease; immunology; lung; microbiology; microflora; physiology; respiratory system,Review,Final,,Scopus,2-s2.0-85069637530
Pandey P.; Mehta M.; Shukla S.; Wadhwa R.; Singhvi G.; Chellappan D.K.; Satija S.; Gupta G.; Awasthi R.; Prasher P.; Hansbro P.M.; Dua K.; Dureja H.,"Pandey, Parijat (56583499400); Mehta, Meenu (7203024234); Shukla, Shakti (56367620800); Wadhwa, Ridhima (57159091700); Singhvi, Gautam (51864379500); Chellappan, Dinesh Kumar (35811890500); Satija, Saurabh (54581608400); Gupta, Gaurav (15047988400); Awasthi, Rajendra (36866066100); Prasher, Parteek (56079914500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Dureja, Harish (6507566948)",56583499400; 7203024234; 56367620800; 57159091700; 51864379500; 35811890500; 54581608400; 15047988400; 36866066100; 56079914500; 6603119390; 15759138700; 6507566948,Emerging Nanotechnology in Chronic Respiratory Diseases,2020,Nanoformulations in Human Health: Challenges and Approaches,,,,449,468,19,10,10.1007/978-3-030-41858-8_20,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092459190&doi=10.1007%2f978-3-030-41858-8_20&partnerID=40&md5=0e38ec3ebf3df758bac08afdf4db5eac,"Shri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak, India; Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Faculty of Life Sciences and Biotechnology, South Asian University, Akbar Bhawan, Chanakyapuri, New Delhi, India; Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit, Jalil, Kuala Lumpur, Malaysia; School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Amity Institute of Pharmacy, Amity University, Uttar Pradesh, Noida, India; Department of Chemistry, University of Petroleum and Energy Studies, Dehradun, India; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Himachal Pradesh, Bajhol, Sultanpur, Solan, India; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India","Pandey P., Shri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak, India; Mehta M., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Shukla S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Wadhwa R., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia, Faculty of Life Sciences and Biotechnology, South Asian University, Akbar Bhawan, Chanakyapuri, New Delhi, India; Singhvi G., Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit, Jalil, Kuala Lumpur, Malaysia; Satija S., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Awasthi R., Amity Institute of Pharmacy, Amity University, Uttar Pradesh, Noida, India; Prasher P., Department of Chemistry, University of Petroleum and Energy Studies, Dehradun, India; Hansbro P.M., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Dua K., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Himachal Pradesh, Bajhol, Sultanpur, Solan, India; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India",Asthma; Chronic respiratory disease; Dendrimers; Liposomes; Nanotechnology,,Book chapter,Final,,Scopus,2-s2.0-85092459190
Chellappan D.K.; Sze Ning Q.L.; Su Min S.K.; Bin S.Y.; Chern P.J.; Shi T.P.; Ee Mei S.W.; Yee T.H.; Qi O.J.; Thangavelu L.; Rajeshkumar S.; Negi P.; Chellian J.; Wadhwa R.; Gupta G.; Collet T.; Hansbro P.M.; Dua K.,"Chellappan, Dinesh Kumar (35811890500); Sze Ning, Quinnie Ling (57209713915); Su Min, Sandra Khoo (57209718219); Bin, Saw Yan (57209712999); Chern, Pang Jia (57209717865); Shi, Tan Pei (57209716316); Ee Mei, Sylvia Wong (57209712746); Yee, Tan Hui (57209716041); Qi, Ong Jing (57209719344); Thangavelu, Lakshmi (57221436939); Rajeshkumar, S. (57195616808); Negi, Poonam (57971006900); Chellian, Jestin (56993705500); Wadhwa, Ridhima (57159091700); Gupta, Gaurav (15047988400); Collet, Trudi (36898251800); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",35811890500; 57209713915; 57209718219; 57209712999; 57209717865; 57209716316; 57209712746; 57209716041; 57209719344; 57221436939; 57195616808; 57971006900; 56993705500; 57159091700; 15047988400; 36898251800; 6603119390; 15759138700,Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases,2019,Chemico-Biological Interactions,310,,108732,,,,33,10.1016/j.cbi.2019.108732,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068536961&doi=10.1016%2fj.cbi.2019.108732&partnerID=40&md5=0892ee8ab9e74403930ab739ea270811,"Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Saveetha Dental College and Hospitals, Saveetha University, SIMATS, Chennai, Tamil Nadu, India; School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, India, Solan, 173229, India; Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India; Innovative Medicines Group, School of Clinical Sciences, Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Brisbane, 4059, Australia; Centre for Inflammation, Centenary Institute, Royal Prince Alfred Hospital, Missenden Rd, Sydney, 2050, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia","Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Sze Ning Q.L., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Su Min S.K., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Bin S.Y., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Chern P.J., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Shi T.P., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Ee Mei S.W., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Yee T.H., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Qi O.J., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Thangavelu L., Saveetha Dental College and Hospitals, Saveetha University, SIMATS, Chennai, Tamil Nadu, India; Rajeshkumar S., Saveetha Dental College and Hospitals, Saveetha University, SIMATS, Chennai, Tamil Nadu, India; Negi P., School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, India, Solan, 173229, India; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Wadhwa R., Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India; Collet T., Innovative Medicines Group, School of Clinical Sciences, Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Brisbane, 4059, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Royal Prince Alfred Hospital, Missenden Rd, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Royal Prince Alfred Hospital, Missenden Rd, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia",Drug delivery; Engineered microbiome-derived therapeutics; Gut-lung axis; Microbiome; Respiratory disease,Chronic Disease; Drug Delivery Systems; Humans; Lung; Lung Diseases; Microbiota; adenoiditis; allergic disease; asthma; bioengineering; bronchiectasis; bronchiolitis; chronic obstructive lung disease; chronic respiratory tract disease; cystic fibrosis; data base; disease association; drug delivery system; human; immune response; influenza A; intestine flora; lung; lung cancer; lung fibrosis; lung lavage; lung tuberculosis; microbial community; microbial growth; microbiome; mouth flora; nonhuman; pharynx disease; pneumonia; respiratory tract disease; Review; rhinosinusitis; chronic disease; drug delivery system; lung; lung disease; microbiology; microflora; physiology; procedures,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85068536961
Vidaillac C.; Yong V.F.L.; Aschtgen M.-S.; Qu J.; Yang S.; Xu G.; Seng Z.J.; Brown A.C.; Ali M.K.; Jaggi T.K.; Sankaran J.; Foo Y.H.; Righetti F.; Nedumaran A.M.; Aogáin M.M.; Roizman D.; Richard J.-A.; Rogers T.R.; Toyofuku M.; Luo D.; Loh E.; Wohland T.; Czarny B.; Horvat J.C.; Hansbro P.M.; Yang L.; Li L.; Normark S.; Henriques-Normark B.; Chotirmall S.H.,"Vidaillac, Celine (6506892186); Yong, Valerie Fei Lee (57193742992); Aschtgen, Marie-Stephanie (25637259800); Qu, Jing (56673422200); Yang, Shuowei (57219223729); Xu, Guangfu (57219225297); Seng, Zi Jing (57204456291); Brown, Alexandra C. (55637745000); Ali, Md Khadem (57194408422); Jaggi, Tavleen K. (57204228946); Sankaran, Jagadish (24072081500); Foo, Yong Hwee (57219222092); Righetti, Francesco (55216604100); Nedumaran, Anu Maashaa (57194204344); Aogáin, Micheál Mac (57219192429); Roizman, Dan (56479171600); Richard, Jean-Alexandre (36187240400); Rogers, Thomas R. (57219376712); Toyofuku, Masanori (16744680700); Luo, Dahai (14020135800); Loh, Edmund (16646875100); Wohland, Thorsten (6602757972); Czarny, Bertrand (6504149380); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Yang, Liang (55625636600); Li, Liang (56526125500); Normark, Staffan (7102655001); Henriques-Normark, Birgitta (8693654200); Chotirmall, Sanjay H. (15757175700)",6506892186; 57193742992; 25637259800; 56673422200; 57219223729; 57219225297; 57204456291; 55637745000; 57194408422; 57204228946; 24072081500; 57219222092; 55216604100; 57194204344; 57219192429; 56479171600; 36187240400; 57219376712; 16744680700; 14020135800; 16646875100; 6602757972; 6504149380; 9942405300; 6603119390; 55625636600; 56526125500; 7102655001; 8693654200; 15757175700,"Erratum to: For vidaillac et al. “sex steroids induce membrane stress responses and virulence properties in pseudomonas aeruginosa” (mbio, 11, 5, e01774-20, 2020, 10.1128/mBio.01774-20)",2020,mBio,11,6,e02809-20,1,,,1,10.1128/mBio.02809-20,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095601892&doi=10.1128%2fmBio.02809-20&partnerID=40&md5=8289d9f5006be7c64eb2759a237c5b82,"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital Solna, Stockholm, Sweden; Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China; Department of Otolaryngology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, China; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Department of Biological Sciences, National University of Singapore, Singapore; Centre for Bio-Imaging Sciences, National University of Singapore, Singapore; School of Materials Science and Engineering (MSE), Nanyang Technological University, Singapore; Functional Molecules and Polymers, Institute of Chemical and Engineering Sciences, ICES, Agency for Science,Technology, and Research (A*STAR), Singapore; Department of Clinical Microbiology, Trinity College Dublin, St. James’s Hospital Campus, Dublin, Ireland; Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, NSW, Australia","Vidaillac C., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Yong V.F.L., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Aschtgen M.-S., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden, Karolinska University Hospital Solna, Stockholm, Sweden; Qu J., Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China; Yang S., Department of Otolaryngology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, China; Xu G., Department of Otolaryngology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, China; Seng Z.J., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Ali M.K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Jaggi T.K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Sankaran J., Department of Biological Sciences, National University of Singapore, Singapore, Centre for Bio-Imaging Sciences, National University of Singapore, Singapore; Foo Y.H., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Righetti F., Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden, Karolinska University Hospital Solna, Stockholm, Sweden; Nedumaran A.M., School of Materials Science and Engineering (MSE), Nanyang Technological University, Singapore; Aogáin M.M., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Roizman D., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Richard J.-A., Functional Molecules and Polymers, Institute of Chemical and Engineering Sciences, ICES, Agency for Science,Technology, and Research (A*STAR), Singapore; Rogers T.R., Department of Clinical Microbiology, Trinity College Dublin, St. James’s Hospital Campus, Dublin, Ireland; Toyofuku M., Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan; Luo D., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Loh E., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden, Karolinska University Hospital Solna, Stockholm, Sweden; Wohland T., Department of Biological Sciences, National University of Singapore, Singapore, Centre for Bio-Imaging Sciences, National University of Singapore, Singapore; Czarny B., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, School of Materials Science and Engineering (MSE), Nanyang Technological University, Singapore; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, NSW, Australia; Yang L., Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore; Li L., Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China; Normark S., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden, Karolinska University Hospital Solna, Stockholm, Sweden; Henriques-Normark B., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden, Karolinska University Hospital Solna, Stockholm, Sweden; Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore",,erratum,Erratum,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85095601892
Chin L.H.; Hon C.M.; Chellappan D.K.; Chellian J.; Madheswaran T.; Zeeshan F.; Awasthi R.; Aljabali A.A.; Tambuwala M.M.; Dureja H.; Negi P.; Kapoor D.N.; Goyal R.; Paudel K.R.; Satija S.; Gupta G.; Hsu A.; Wark P.; Mehta M.; Wadhwa R.; Hansbro P.M.; Dua K.,"Chin, Li Hian (57216653248); Hon, Chian Ming (57216653836); Chellappan, Dinesh Kumar (35811890500); Chellian, Jestin (56993705500); Madheswaran, Thiagarajan (55505311000); Zeeshan, Farrukh (26654611200); Awasthi, Rajendra (36866066100); Aljabali, Alaa AA. (35306626800); Tambuwala, Murtaza M. (36657816300); Dureja, Harish (6507566948); Negi, Poonam (57971006900); Kapoor, Deepak N. (57194418811); Goyal, Rohit (56035487900); Paudel, Keshav Raj (56539588400); Satija, Saurabh (54581608400); Gupta, Gaurav (15047988400); Hsu, Alan (49861516600); Wark, Peter (7003559516); Mehta, Meenu (7203024234); Wadhwa, Ridhima (57159091700); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",57216653248; 57216653836; 35811890500; 56993705500; 55505311000; 26654611200; 36866066100; 35306626800; 36657816300; 6507566948; 57971006900; 57194418811; 56035487900; 56539588400; 54581608400; 15047988400; 49861516600; 7003559516; 7203024234; 57159091700; 6603119390; 15759138700,Molecular mechanisms of action of naringenin in chronic airway diseases,2020,European Journal of Pharmacology,879,,173139,,,,52,10.1016/j.ejphar.2020.173139,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084238920&doi=10.1016%2fj.ejphar.2020.173139&partnerID=40&md5=93d8cd58cc7c55e809ad532746e36af4,"School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, 201313, Uttar Pradesh, India; Department of Pharmaceutical Sciences, Yarmouk University—Faculty of Pharmacy, Irbid, 566, Jordan; School of Pharmacy and Pharmaceutical Sciences, Ulster University, County Londonderry, Northern Ireland, Coleraine, United Kingdom; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India; School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, 173 212, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia","Chin L.H., School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Hon C.M., School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Zeeshan F., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Awasthi R., Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, 201313, Uttar Pradesh, India; Aljabali A.A., Department of Pharmaceutical Sciences, Yarmouk University—Faculty of Pharmacy, Irbid, 566, Jordan; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, County Londonderry, Northern Ireland, Coleraine, United Kingdom; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, India; Negi P., School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, 173 212, India; Kapoor D.N., School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, 173 212, India; Goyal R., School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, 173 212, India; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India; Hsu A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Wark P., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Mehta M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Wadhwa R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Dua K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia",Asthma; Chronic airway inflammatory disease; Chronic obstructive pulmonary disease; Lung cancer; Naringenin; Pulmonary fibrosis,Animals; Anti-Inflammatory Agents; Chronic Disease; Drug Delivery Systems; Flavanones; Humans; Respiratory Tract Diseases; immunoglobulin enhancer binding protein; nanocarrier; naringenin; polymeric nanoparticle; solid lipid nanoparticle; unclassified drug; antiinflammatory agent; flavanone derivative; naringenin; antiinflammatory activity; asthma; chronic obstructive lung disease; cystic fibrosis; drug bioavailability; drug delivery system; drug effect; drug formulation; drug mechanism; drug solubility; drug structure; drug use; human; lung cancer; lung fibrosis; nonhuman; priority journal; Review; signal transduction; animal; chronic disease; respiratory tract disease,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85084238920
Reid A.T.; Nichol K.S.; Veerati P.C.; Moheimani F.; Kicic A.; Stick S.M.; Bartlett N.W.; Grainge C.L.; Wark P.A.B.; Hansbro P.M.; Knight D.A.,"Reid, Andrew T. (39561518600); Nichol, Kristy S. (57195914143); Veerati, Punnam Chander (57200127768); Moheimani, Fatemeh (36157216000); Kicic, Anthony (6507472922); Stick, Stephen M. (35373713500); Bartlett, Nathan W. (7005608564); Grainge, Chris L. (57192248350); Wark, Peter A.B. (7003559516); Hansbro, Philip M. (6603119390); Knight, Darryl A. (7402350036)",39561518600; 57195914143; 57200127768; 36157216000; 6507472922; 35373713500; 7005608564; 57192248350; 7003559516; 6603119390; 7402350036,Blocking notch3 signaling abolishes MUC5AC production in airway epithelial cells from individuals with asthma,2020,American Journal of Respiratory Cell and Molecular Biology,62,4,,513,523,10,34,10.1165/rcmb.2019-0069OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082780345&doi=10.1165%2frcmb.2019-0069OC&partnerID=40&md5=282cb26c91c4707aacf0bf945e2a2f18,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; School of Paediatrics and Child Health, University of Western Australia, Nedlands, WA, Australia; Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia; Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, WA, Australia; Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, WA, Australia; Occupation and Environment, School of Public Health, Curtin University, Bentley, WA, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada","Reid A.T., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Nichol K.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Veerati P.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Moheimani F., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Kicic A., School of Paediatrics and Child Health, University of Western Australia, Nedlands, WA, Australia, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia, Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, WA, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, WA, Australia, Occupation and Environment, School of Public Health, Curtin University, Bentley, WA, Australia; Stick S.M., School of Paediatrics and Child Health, University of Western Australia, Nedlands, WA, Australia, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia, Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, WA, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, WA, Australia; Bartlett N.W., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Grainge C.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Knight D.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada",Airway epithelium; MUC5AC; Mucus; Notch signaling; Pharmacological inhibition,"Aged; Asthma; Bronchi; Cell Differentiation; Cells, Cultured; Epithelial Cells; Female; Goblet Cells; Humans; Lung; Male; Middle Aged; Mucin 5AC; Receptor, Notch3; Respiratory Mucosa; RNA, Small Interfering; Signal Transduction; mucin 5AC; Notch3 receptor; small interfering RNA; MUC5AC protein, human; mucin 5AC; NOTCH3 protein, human; Notch3 receptor; adult; airway epithelium cell; Article; asthma; bronchus epithelium; clinical article; controlled study; female; human; human cell; human tissue; immunohistochemistry; lung parenchyma; male; middle aged; Notch signaling; protein expression; real time polymerase chain reaction; tissue section; aged; asthma; bronchus; cell culture; cell differentiation; epithelium cell; goblet cell; lung; metabolism; physiology; respiratory mucosa; signal transduction",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85082780345
Peneaux C.; Hansbro P.M.; Griffin A.S.,"Peneaux, Chloe (57191878275); Hansbro, Philip M. (6603119390); Griffin, Andrea S. (7202675971)",57191878275; 6603119390; 7202675971,The potential utility of carotenoid-based coloration as a biomonitor of environmental change,2021,Ibis,163,1,,20,37,17,18,10.1111/ibi.12866,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088563046&doi=10.1111%2fibi.12866&partnerID=40&md5=16cd5e802214b2abe559bcab447807b6,"School of Psychology, University of Newcastle, Callaghan, 2308, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Peneaux C., School of Psychology, University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Griffin A.S., School of Psychology, University of Newcastle, Callaghan, 2308, NSW, Australia",environmental quality; ornaments; sexual signals; urbanization; wildlife management,biodiversity; biomonitoring; bird; carotenoid; environmental quality; morphology; physiological response; taxonomy,Review,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85088563046
Xu J.; Xu X.; Jiang L.; Dua K.; Hansbro P.M.; Liu G.,"Xu, Jincheng (36239605800); Xu, Xiaoyue (56524795700); Jiang, Lina (59285502600); Dua, Kamal (15759138700); Hansbro, Philip M. (6603119390); Liu, Gang (57189061134)",36239605800; 56524795700; 59285502600; 15759138700; 6603119390; 57189061134,SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis,2020,Respiratory Research,21,1,182,,,,149,10.1186/s12931-020-01445-6,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088021574&doi=10.1186%2fs12931-020-01445-6&partnerID=40&md5=ecb38b364528332fba7b4ad574f006fc,"School of Stomatology, Bengbu Medical College, Bengbu, Anhui, 2033, China; School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Kensington, 233000, NSW, Australia; Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Camperdown, 2050, NSW, Australia; School of Life Science, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Xu J., School of Stomatology, Bengbu Medical College, Bengbu, Anhui, 2033, China; Xu X., School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Kensington, 233000, NSW, Australia, Faculty of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Jiang L., School of Stomatology, Bengbu Medical College, Bengbu, Anhui, 2033, China; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, 2050, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Camperdown, 2050, NSW, Australia, School of Life Science, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Liu G., Centre for Inflammation, Centenary Institute, Camperdown, 2050, NSW, Australia, School of Life Science, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Angiotensin-converting enzyme 2; Coronavirus; Lung fibrosis; SARS-CoV-2,"China; Coronavirus Infections; Disease Progression; Epithelial Cells; Female; Gene Expression Regulation; Humans; Male; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Prevalence; Pulmonary Fibrosis; Receptors, Virus; Respiratory Distress Syndrome, Adult; Risk Assessment; SARS Virus; Survival Analysis; Transcription, Genetic; Transcriptional Activation; angiotensinogen; connective tissue growth factor; dipeptidyl carboxypeptidase; disintegrin; fibronectin; messenger RNA; serine proteinase; tissue inhibitor of metalloproteinase; transforming growth factor beta; tumor necrosis factor alpha converting enzyme; vasculotropin A; angiotensin converting enzyme 2; dipeptidyl carboxypeptidase; virus receptor; acute lung injury; Article; bioinformatics; controlled study; coronavirus disease 2019; early diagnosis; epithelium cell; gene expression; genetic transcription; genotype; host cell; human; human cell; lung epithelium; lung fibrosis; pandemic; protein analysis; protein expression; Severe acute respiratory syndrome coronavirus 2; single cell analysis; virus entry; adult respiratory distress syndrome; China; Coronavirus infection; cytology; disease exacerbation; epithelium cell; female; gene expression regulation; genetics; lung fibrosis; male; metabolism; pandemic; pathophysiology; prevalence; risk assessment; SARS coronavirus; survival analysis; transcription initiation; virus pneumonia",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85088021574
Wadhwa R.; Paudel K.R.; Chin L.H.; Hon C.M.; Madheswaran T.; Gupta G.; Panneerselvam J.; Lakshmi T.; Singh S.K.; Gulati M.; Dureja H.; Hsu A.; Mehta M.; Anand K.; Devkota H.P.; Chellian J.; Chellappan D.K.; Hansbro P.M.; Dua K.,"Wadhwa, Ridhima (57159091700); Paudel, Keshav Raj (56539588400); Chin, Li Hian (57216653248); Hon, Chian Ming (57216653836); Madheswaran, Thiagarajan (55505311000); Gupta, Gaurav (15047988400); Panneerselvam, Jithendra (57201993010); Lakshmi, Thangavelu (57221436939); Singh, Sachin Kumar (57206711834); Gulati, Monica (7006677671); Dureja, Harish (6507566948); Hsu, Alan (49861516600); Mehta, Meenu (7203024234); Anand, Krishnan (57488883300); Devkota, Hari Prasad (24775939500); Chellian, Jestin (56993705500); Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57159091700; 56539588400; 57216653248; 57216653836; 55505311000; 15047988400; 57201993010; 57221436939; 57206711834; 7006677671; 6507566948; 49861516600; 7203024234; 57488883300; 24775939500; 56993705500; 35811890500; 6603119390; 15759138700,Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro,2021,Journal of Food Biochemistry,45,1,e13572,,,,106,10.1111/jfbc.13572,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096845160&doi=10.1111%2fjfbc.13572&partnerID=40&md5=f64328ff88203a30fea7710f9d023882,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences and National Health Laboratory Service, University of the Free State, Bloemfontein, South Africa; Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Japan; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia","Wadhwa R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Paudel K.R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Chin L.H., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Hon C.M., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Lakshmi T., Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India; Dureja H., Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India; Hsu A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Mehta M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Anand K., Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences and National Health Laboratory Service, University of the Free State, Bloemfontein, South Africa; Devkota H.P., Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto City, Japan; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia",anti-inflammatory; liquid crystalline nanoparticles; lung cancer; migration; Naringenin; proliferation,A549 Cells; Anti-Inflammatory Agents; Flavanones; Humans; Nanoparticles; Biological organs; Cell culture; Cell death; Controlled drug delivery; Diseases; Drug products; Liquid crystals; Nanoparticles; Polymerase chain reaction; Respiratory system; Tissue regeneration; antiinflammatory agent; flavanone derivative; nanoparticle; naringenin; Airway inflammation; Anti-inflammatories; Anticancer activities; Fluticasone propionate; Lipopolysaccharides; Liquid crystalline nanoparticles; Potential therapies; Wound healing assays; A-549 cell line; human; Flavonoids,Article,Final,All Open Access; Gold Open Access,Scopus,2-s2.0-85096845160
Hayman T.J.; Hsu A.C.; Kolesnik T.B.; Dagley L.F.; Willemsen J.; Tate M.D.; Baker P.J.; Kershaw N.J.; Kedzierski L.; Webb A.I.; Wark P.A.; Kedzierska K.; Masters S.L.; Belz G.T.; Binder M.; Hansbro P.M.; Nicola N.A.; Nicholson S.E.,"Hayman, Thomas J (58993862000); Hsu, Alan C (49861516600); Kolesnik, Tatiana B (7003402994); Dagley, Laura F (55566188700); Willemsen, Joschka (55960912600); Tate, Michelle D (22939334200); Baker, Paul J (56799769100); Kershaw, Nadia J (6602214665); Kedzierski, Lukasz (6602378121); Webb, Andrew I (57210993119); Wark, Peter A (7003559516); Kedzierska, Katherine (8374461700); Masters, Seth L (8618391900); Belz, Gabrielle T (7102682937); Binder, Marco (8860755300); Hansbro, Philip M (6603119390); Nicola, Nicos A (7102817958); Nicholson, Sandra E (7101734064)",58993862000; 49861516600; 7003402994; 55566188700; 55960912600; 22939334200; 56799769100; 6602214665; 6602378121; 57210993119; 7003559516; 8374461700; 8618391900; 7102682937; 8860755300; 6603119390; 7102817958; 7101734064,"RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses",2019,Immunology and Cell Biology,97,9,,840,852,12,77,10.1111/imcb.12284,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070878493&doi=10.1111%2fimcb.12284&partnerID=40&md5=9f4a5eba9576391285b14ecc9aeed52e,"The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Research Group Dynamics of Early Viral Infection and the Innate Antiviral Response, Division Virus-Associated Carcinogenesis (F170), German Cancer Research Center (DKFZ), Heidelberg, Germany; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Molecular Translational Science, School of Clinical Sciences, Monash University, Clayton, VIC, Australia; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia; Centre for Inflammation, Centenary Institute, The University of Technology Sydney, Sydney, NSW, Australia","Hayman T.J., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Hsu A.C., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Kolesnik T.B., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Dagley L.F., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Willemsen J., Research Group Dynamics of Early Viral Infection and the Innate Antiviral Response, Division Virus-Associated Carcinogenesis (F170), German Cancer Research Center (DKFZ), Heidelberg, Germany; Tate M.D., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia, Department of Molecular Translational Science, School of Clinical Sciences, Monash University, Clayton, VIC, Australia; Baker P.J., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Kershaw N.J., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Kedzierski L., Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia; Webb A.I., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Wark P.A., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, The University of Technology Sydney, Sydney, NSW, Australia; Kedzierska K., Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia; Masters S.L., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Belz G.T., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Binder M., Research Group Dynamics of Early Viral Infection and the Innate Antiviral Response, Division Virus-Associated Carcinogenesis (F170), German Cancer Research Center (DKFZ), Heidelberg, Germany; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, The University of Technology Sydney, Sydney, NSW, Australia; Nicola N.A., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Nicholson S.E., The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia",influenza; RIG-I; Riplet; TRIM25,"A549 Cells; Animals; Antiviral Agents; Cell Line; DEAD Box Protein 58; DNA-Binding Proteins; Epithelial Cells; Gene Deletion; Humans; Ligands; Mice, Inbred C57BL; RNA; Signal Transduction; Transcription Factors; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; interferon; retinoic acid inducible protein I; tripartite motif containing 25; ubiquitin protein ligase E3; unclassified drug; antivirus agent; DDX58 protein, human; Ddx58 protein, mouse; DNA binding protein; ligand; retinoic acid inducible protein I; RNA; RNF135 protein, human; Rnf135 protein, mouse; transcription factor; TRIM25 protein, human; Trim25 protein, mouse; tripartite motif protein; ubiquitin protein ligase; A-549 cell line; animal cell; animal experiment; animal model; animal tissue; Article; controlled study; cytokine response; female; human; human cell; in vivo study; influenza A; Influenza A virus; Influenza B virus; male; mouse; nonhuman; Sendai virus; signal transduction; ubiquitination; animal; C57BL mouse; cell line; epithelium cell; gene deletion; metabolism; microbiology; signal transduction; virology",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85070878493
Donovan C.; Liu G.; Shen S.; Marshall J.E.; Kim R.Y.; Alemao C.A.; Budden K.F.; Choi J.P.; Kohonen-Corish M.; El-Omar E.M.; Yang I.A.; Hansbro P.M.,"Donovan, Chantal (55357105200); Liu, Gang (57189061134); Shen, Sj (56707946900); Marshall, Jacqueline E. (57218547927); Kim, Richard Y. (35810406900); Alemao, Charlotte A. (57200821652); Budden, Kurtis F. (57191417986); Choi, Jaesung P. (56185239300); Kohonen-Corish, Maija (6603956915); El-Omar, Emad M. (7004327210); Yang, Ian A. (7101797862); Hansbro, Philip M. (6603119390)",55357105200; 57189061134; 56707946900; 57218547927; 35810406900; 57200821652; 57191417986; 56185239300; 6603956915; 7004327210; 7101797862; 6603119390,The role of the microbiome and the NLRP3 inflammasome in the gut and lung,2020,Journal of Leukocyte Biology,108,3,,925,935,10,68,10.1002/JLB.3MR0720-472RR,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089528544&doi=10.1002%2fJLB.3MR0720-472RR&partnerID=40&md5=0c4c77154366d87f0d09cf3d369702d6,"Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Woolcock Institute of Medical Research and Faculty of Science, University of Technology Sydney, Garvan Institute of Medical Research and St George and Sutherland Clinical School, University of New South Wales, Kogarah, NSW, Australia; Microbiome Research Centre, St George and Sutherland Clinical School, University of New South Wales, Kogarah, NSW, Australia; The Prince Charles Hospital and The University of Queensland, Brisbane, QLD, Australia","Donovan C., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Liu G., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Shen S., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Marshall J.E., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Kim R.Y., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Alemao C.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Budden K.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Choi J.P., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia; Kohonen-Corish M., Woolcock Institute of Medical Research and Faculty of Science, University of Technology Sydney, Garvan Institute of Medical Research and St George and Sutherland Clinical School, University of New South Wales, Kogarah, NSW, Australia; El-Omar E.M., Microbiome Research Centre, St George and Sutherland Clinical School, University of New South Wales, Kogarah, NSW, Australia; Yang I.A., The Prince Charles Hospital and The University of Queensland, Brisbane, QLD, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",gut; lung; microbiome; microbiota; NLRP3 inflammasome,"Aging; Air Pollutants; Animals; Asthma; Cigarette Smoking; Colitis; Dysbiosis; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Heterocyclic Compounds, 4 or More Rings; Humans; Inflammasomes; Inflammation; Intestines; Lung; Mice; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia, Bacterial; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Specific Pathogen-Free Organisms; Sulfones; Symbiosis; cryopyrin; inflammasome; cryopyrin; fused heterocyclic rings; inflammasome; MCC-950; Nlrp3 protein, mouse; sulfone; air pollution; asthma; bacterial infection; chronic obstructive lung disease; gastrointestinal tissue; human; immune response; inflammatory cell; intestine flora; lung disease; lung parenchyma; particulate matter; pneumonia; priority journal; Review; virus infection; aging; air pollutant; animal; bacterial pneumonia; cigarette smoking; colitis; dysbiosis; fecal microbiota transplantation; germfree animal; immunology; inflammation; intestine; intestine flora; knockout mouse; lung; microbiology; mouse; physiology; symbiosis; toxicity; virus pneumonia",Review,Final,,Scopus,2-s2.0-85089528544
Prihandoko R.; Kaur D.; Wiegman C.H.; Alvarez-Curto E.; Donovan C.; Chachi L.; Ulven T.; Tyas M.R.; Euston E.; Dong Z.; Alharbi A.G.M.; Kim R.Y.; Lowe J.G.; Hansbro P.M.; Chung K.F.; Brightling C.E.; Milligan G.; Tobin A.B.,"Prihandoko, Rudi (37061904100); Kaur, Davinder (8208834700); Wiegman, Coen H. (57063112500); Alvarez-Curto, Elisa (8745696400); Donovan, Chantal (55357105200); Chachi, Latifa (56902672800); Ulven, Trond (6602942508); Tyas, Martha R. (57218607295); Euston, Eloise (57218608051); Dong, Zhaoyang (57218608016); Alharbi, Abdulrahman Ghali M. (57218607370); Kim, Richard Y. (35810406900); Lowe, Jack G. (57218607180); Hansbro, Philip M. (6603119390); Chung, Kian Fan (35403525000); Brightling, Christopher E. (54790515400); Milligan, Graeme (36045003300); Tobin, Andrew B. (7103149620)",37061904100; 8208834700; 57063112500; 8745696400; 55357105200; 56902672800; 6602942508; 57218607295; 57218608051; 57218608016; 57218607370; 35810406900; 57218607180; 6603119390; 35403525000; 54790515400; 36045003300; 7103149620,Pathophysiological regulation of lung function by the free fatty acid receptor FFA4,2020,Science Translational Medicine,12,557,eaaw9009,,,,19,10.1126/SCITRANSLMED.AAW9009,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089769628&doi=10.1126%2fSCITRANSLMED.AAW9009&partnerID=40&md5=16a2e32bf343de73d872f1d773efbf1b,"Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, Scotland, G12 8QQ, United Kingdom; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, LE3 9QP, United Kingdom; Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, SW3 6LY, United Kingdom; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, 2305, NSW, Australia; University of Newcastle, Callaghan, 2208, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia; Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, Copenhagen, DK-2100, Denmark; Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah, 42353, Saudi Arabia","Prihandoko R., Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, Scotland, G12 8QQ, United Kingdom; Kaur D., Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, LE3 9QP, United Kingdom; Wiegman C.H., Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, SW3 6LY, United Kingdom; Alvarez-Curto E., Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, Scotland, G12 8QQ, United Kingdom; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, 2305, NSW, Australia, University of Newcastle, Callaghan, 2208, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia; Chachi L., Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, LE3 9QP, United Kingdom; Ulven T., Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, Copenhagen, DK-2100, Denmark; Tyas M.R., Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, Scotland, G12 8QQ, United Kingdom; Euston E., Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, Scotland, G12 8QQ, United Kingdom; Dong Z., Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, Scotland, G12 8QQ, United Kingdom; Alharbi A.G.M., Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, Scotland, G12 8QQ, United Kingdom, Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah, 42353, Saudi Arabia; Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, 2305, NSW, Australia, University of Newcastle, Callaghan, 2208, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia; Lowe J.G., Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, SW3 6LY, United Kingdom; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, 2305, NSW, Australia, University of Newcastle, Callaghan, 2208, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia; Chung K.F., Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, SW3 6LY, United Kingdom; Brightling C.E., Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, LE3 9QP, United Kingdom; Milligan G., Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, Scotland, G12 8QQ, United Kingdom; Tobin A.B., Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow Glasgow, Scotland, G12 8QQ, United Kingdom",,"Animals; Fatty Acids, Nonesterified; Lung; Mice; Pyroglyphidae; Receptors, G-Protein-Coupled; Signal Transduction; cigarette smoke; free fatty acid receptor 4; G protein coupled receptor; G protein coupled receptor 40; guanine nucleotide binding protein alpha subunit; ozone; prostaglandin E receptor 2; prostaglandin E2; unclassified drug; fatty acid; G protein coupled receptor; adult; air pollution; airway resistance; airway smooth muscle; animal experiment; animal model; animal tissue; Article; asthma; breathing muscle; bronchoconstriction; chronic obstructive lung disease; controlled study; Dermatophagoides; drug targeting; ex vivo study; female; human; human cell; in vivo study; lung disease; lung vascular resistance; male; mouse; nonhuman; pathophysiology; pneumonia; priority journal; prostaglandin release; protein analysis; protein expression; protein function; receptor upregulation; signal transduction; smooth muscle relaxation; animal; lung; Pyroglyphidae",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85089769628
Gosens R.; Hiemstra P.S.; Adcock I.M.; Bracke K.R.; Dickson R.P.; Hansbro P.M.; Krauss-Etschmann S.; Smits H.H.; Stassen F.R.M.; Bartel S.,"Gosens, Reinoud (6602543993); Hiemstra, Pieter S. (7004364809); Adcock, Ian M. (7007066538); Bracke, Ken R. (8338303000); Dickson, Robert P. (15052833100); Hansbro, Philip M. (6603119390); Krauss-Etschmann, Susanne (8248834500); Smits, Hermelijn H. (35475214500); Stassen, Frank R.M. (7003616216); Bartel, Sabine (56250194100)",6602543993; 7004364809; 7007066538; 8338303000; 15052833100; 6603119390; 8248834500; 35475214500; 7003616216; 56250194100,Host-microbe cross-talk in the lung microenvironment: Implications for understanding and treating chronic lung disease,2020,European Respiratory Journal,56,2,02320,,,,17,10.1183/13993003.02320-2019,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089787175&doi=10.1183%2f13993003.02320-2019&partnerID=40&md5=dc411791db0ce011d7432832383d6446,"University of Groningen, Dept of Molecular Pharmacology, GRIAC Research Institute, Groningen, Netherlands; Dept of Pulmonology, Leiden University Medical Center (LUMC), Leiden, Netherlands; Airways Disease, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Division of Pulmonary and Critical Care Medicine, Dept of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States; Michigan Center for Integrative Research in Critical Care, Ann Arbor, MI, United States; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia; Early Life Origins of Chronic Lung Disease, Research Center Borstel, Leibniz Lung Center, Airway Research Center North, German Center for Lung Research (DZL), Borstel, Germany; Institute for Experimental Medicine, Christian-Albrechts-Universitaet zu Kiel, Kiel, Germany; Dept of Parasitology, Leiden University Medical Center, Leiden, Netherlands; Dept of Medical Microbiology, NUTRIM - School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, Netherlands; University of Groningen, University Medical Center Groningen, Dept of Pathology and Medical Biology, GRIAC Research Institute, Groningen, Netherlands","Gosens R., University of Groningen, Dept of Molecular Pharmacology, GRIAC Research Institute, Groningen, Netherlands; Hiemstra P.S., Dept of Pulmonology, Leiden University Medical Center (LUMC), Leiden, Netherlands; Adcock I.M., Airways Disease, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Bracke K.R., Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Dickson R.P., Division of Pulmonary and Critical Care Medicine, Dept of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States, Michigan Center for Integrative Research in Critical Care, Ann Arbor, MI, United States; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, Sydney, Australia; Krauss-Etschmann S., Early Life Origins of Chronic Lung Disease, Research Center Borstel, Leibniz Lung Center, Airway Research Center North, German Center for Lung Research (DZL), Borstel, Germany, Institute for Experimental Medicine, Christian-Albrechts-Universitaet zu Kiel, Kiel, Germany; Smits H.H., Dept of Parasitology, Leiden University Medical Center, Leiden, Netherlands; Stassen F.R.M., Dept of Medical Microbiology, NUTRIM - School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, Netherlands; Bartel S., Early Life Origins of Chronic Lung Disease, Research Center Borstel, Leibniz Lung Center, Airway Research Center North, German Center for Lung Research (DZL), Borstel, Germany, University of Groningen, University Medical Center Groningen, Dept of Pathology and Medical Biology, GRIAC Research Institute, Groningen, Netherlands",,Humans; Lung; Lung Diseases; Microbiota; Respiration Disorders; Respiratory Tract Diseases; bacterium lipopolysaccharide; corticosteroid; macrolide; probiotic agent; proton pump inhibitor; vitamin D; Adenoviridae; allergic airway inflammation; allergic rhinitis; antiinflammatory activity; Article; Aspergillus; asthma; bacterial colonization; bronchiectasis; carcinogenesis; chronic lung disease; chronic obstructive lung disease; Clostridium difficile infection; Coronavirinae; cystic fibrosis; drug efficacy; drug response; fecal microbiota transplantation; Haemophilus influenzae; host pathogen interaction; human; Human respiratory syncytial virus; immunomodulation; infection sensitivity; Influenza virus; lung cancer; lung mucosa; membrane vesicle; microbial community; nonhuman; pathogenesis; priority journal; Pseudomonas aeruginosa; Rhinovirus; Staphylococcus aureus; Streptococcus pneumoniae; breathing disorder; lung; lung disease; microflora; respiratory tract disease,Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85089787175
Idowu O.; Tran T.K.A.; Webster G.; Chapman I.; Baker P.; Farrel H.; Zammit A.; Semple K.T.; Hansbro P.M.; O'Connor W.; Thavamani P.,"Idowu, Oluyoye (57205270803); Tran, Thi Kim Anh (57149755000); Webster, Grant (55432851300); Chapman, Ian (57217586533); Baker, Phil (57200639718); Farrel, Hazel (57216971300); Zammit, Anthony (57052932700); Semple, Kirk T. (56926918800); Hansbro, Phil M. (6603119390); O'Connor, Wayne (23025552100); Thavamani, Palanisami (23567398800)",57205270803; 57149755000; 55432851300; 57217586533; 57200639718; 57216971300; 57052932700; 56926918800; 6603119390; 23025552100; 23567398800,Quantitative biomonitoring of polycyclic aromatic compounds (PACs) using the Sydney rock oyster (Saccostrea glomerata),2020,Science of the Total Environment,742,,140497,,,,5,10.1016/j.scitotenv.2020.140497,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085571205&doi=10.1016%2fj.scitotenv.2020.140497&partnerID=40&md5=bf80a9bb43c398727dc3eeee02b590cb,"Global Centre for Environmental Remediation (GCER), University of Newcastle, Callaghan, 2308, NSW, Australia; Global Innovative Centre for Advanced Nanomaterials (GICAN), University of Newcastle, Callaghan, 2308, NSW, Australia; School of Agriculture and Resources, Vinh University, Viet Nam; NSW Department of Primary Industries, Biosecurity and Food Safety, Taree, 2430, NSW, Australia; Lancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, United Kingdom; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Port Stephens Fisheries Institute, NSW Department of Primary Industries, Port Stephens, 2316, NSW, Australia","Idowu O., Global Centre for Environmental Remediation (GCER), University of Newcastle, Callaghan, 2308, NSW, Australia; Tran T.K.A., Global Innovative Centre for Advanced Nanomaterials (GICAN), University of Newcastle, Callaghan, 2308, NSW, Australia, School of Agriculture and Resources, Vinh University, Viet Nam; Webster G., NSW Department of Primary Industries, Biosecurity and Food Safety, Taree, 2430, NSW, Australia; Chapman I., NSW Department of Primary Industries, Biosecurity and Food Safety, Taree, 2430, NSW, Australia; Baker P., NSW Department of Primary Industries, Biosecurity and Food Safety, Taree, 2430, NSW, Australia; Farrel H., NSW Department of Primary Industries, Biosecurity and Food Safety, Taree, 2430, NSW, Australia; Zammit A., NSW Department of Primary Industries, Biosecurity and Food Safety, Taree, 2430, NSW, Australia; Semple K.T., Lancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, United Kingdom; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; O'Connor W., Port Stephens Fisheries Institute, NSW Department of Primary Industries, Port Stephens, 2316, NSW, Australia; Thavamani P., Global Innovative Centre for Advanced Nanomaterials (GICAN), University of Newcastle, Callaghan, 2308, NSW, Australia",Aquatic environment; Biological half-lives; Biomonitoring; Elimination rate constant; Polar PAHs; Saccostrea glomerata,"Animals; Australia; Biological Monitoring; Environmental Monitoring; Humans; Ostreidae; Polycyclic Aromatic Hydrocarbons; Polycyclic Compounds; Water Pollutants, Chemical; Australia; Camden Haven River; New South Wales; Ostreidae; Saccostrea glomerata; Aromatization; Health risks; Histology; Metabolites; Molluscs; Rate constants; Risk assessment; Tissue; 2 nitrofluorene; 9 nitroanthracene; acenaphthene; acenaphthylene; anthracene; anthracene derivative; benzo[a]pyrene; benzo[b]fluoranthene; benzo[k]fluoranthene; benz[a]anthracene; chrysene; dibenz[a,h]anthracene; fluoranthene; fluorene; indeno[1,2,3 cd]pyrene; lipid; phenanthrene; polycyclic aromatic compound; pyrene; unclassified drug; water; polycyclic aromatic hydrocarbon; polycyclic hydrocarbon; Aquatic environments; Bioavailable fraction; Biomonitoring; Control samples; Elimination rate; Human health risks; Oyster tissue; Polycyclic aromatic compounds; aquatic environment; bioavailability; biomonitoring; bivalve; concentration (composition); environmental risk; half life; health risk; metabolite; PAH; risk assessment; animal tissue; aquatic environment; Article; Australia; bioavailability; biological monitoring; concentration (parameter); controlled study; elimination rate constant; environmental exposure; environmental monitoring; estuary; nitration; nonhuman; oxygenation; priority journal; quantitative analysis; river; rock oyster; Saccostrea glomerata; sampling; water pollution; animal; biological monitoring; human; oyster; water pollutant; Polycyclic aromatic hydrocarbons",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85085571205
Atto B.; Eapen M.S.; Sharma P.; Frey U.; Ammit A.J.; Markos J.; Chia C.; Larby J.; Haug G.; Weber H.C.; Mabeza G.; Tristram S.; Myers S.; Geraghty D.P.; Flanagan K.L.; Hansbro P.M.; Sohal S.S.,"Atto, Brianna (57210193389); Eapen, Mathew Suji (56625716100); Sharma, Pawan (57202573033); Frey, Urs (7006533643); Ammit, Alaina J. (7003377421); Markos, James (36895683400); Chia, Collin (57204561315); Larby, Josie (57204563979); Haug, Greg (56560843300); Weber, Heinrich C. (7403097705); Mabeza, George (57210306920); Tristram, Stephen (6603307726); Myers, Stephen (35389074400); Geraghty, Dominic P. (7005038964); Flanagan, Katie L. (35473319600); Hansbro, Philip M. (6603119390); Sohal, Sukhwinder Singh (36449981500)",57210193389; 56625716100; 57202573033; 7006533643; 7003377421; 36895683400; 57204561315; 57204563979; 56560843300; 7403097705; 57210306920; 6603307726; 35389074400; 7005038964; 35473319600; 6603119390; 36449981500,New therapeutic targets for the prevention of infectious acute exacerbations of COPD: Role of epithelial adhesion molecules and inflammatory pathways,2019,Clinical Science,133,14,,1663,1703,40,38,10.1042/CS20181009,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069885280&doi=10.1042%2fCS20181009&partnerID=40&md5=7b6f5dd74611af329ca6b2d628658815,"Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland; Discipline of Medical Sciences, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Department of Respiratory Medicine, Launceston General Hospital, Launceston, 7250, TAS, Australia; Department of Respiratory Medicine, Tasmanian Health Services (THS), North West Hospital, Burnie, TAS, Australia; Clinical School, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; School of Health and Biomedical Science, RMIT University, Melbourne, VIC, Australia; Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia; Department of Infectious Disease, Launceston General Hospital, Launceston, 7250, TAS, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Atto B., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Sharma P., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia, Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; Frey U., University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland; Ammit A.J., Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia, Discipline of Medical Sciences, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Markos J., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, 7250, TAS, Australia; Chia C., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, 7250, TAS, Australia; Larby J., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, 7250, TAS, Australia; Haug G., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, 7250, TAS, Australia; Weber H.C., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Tasmanian Health Services (THS), North West Hospital, Burnie, TAS, Australia; Mabeza G., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Tasmanian Health Services (THS), North West Hospital, Burnie, TAS, Australia; Tristram S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Myers S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Geraghty D.P., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Flanagan K.L., Clinical School, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia, School of Health and Biomedical Science, RMIT University, Melbourne, VIC, Australia, Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia, Department of Infectious Disease, Launceston General Hospital, Launceston, 7250, TAS, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia",,"Animals; Anti-Bacterial Agents; Antiviral Agents; Bacterial Infections; Cell Adhesion Molecules; Humans; Pulmonary Disease, Chronic Obstructive; Virus Diseases; antibiotic agent; antivirus agent; beta 2 adrenergic receptor stimulating agent; carcinoembryonic antigen related cell adhesion molecule 1; corticosteroid; epidermal growth factor receptor; epithelial cell adhesion molecule; haemagglutinin a; hemagglutinin; influenza vaccine; intercellular adhesion molecule 1; muscarinic receptor blocking agent; nonstructural protein 1; phosphatidylinositol 3 kinase; protein kinase C; protein kinase R; sialic acid; unclassified drug; antiinfective agent; cell adhesion molecule; acute disease; antibiotic therapy; bacterial secretion system; cellular immunity; chronic obstructive lung disease; cytokine production; disease exacerbation; early intervention; host pathogen interaction; human; immunomodulation; influenza vaccination; lung function; macrophage; macrophage function; microbiome; nonhuman; oxidative stress; pharmaceutical care; phenotype; priority journal; prophylaxis; pulmonary rehabilitation; respiratory microbiome; Review; risk factor; signal transduction; animal; bacterial infection; chronic obstructive lung disease; complication; genetics; immunology; virus infection",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85069885280
Tu X.; Donovan C.; Kim R.Y.; Wark P.A.B.; Horvat J.C.; Hansbro P.M.,"Tu, Xiaofan (57222147245); Donovan, Chantal (55357105200); Kim, Richard Y. (35810406900); Wark, Peter A. B. (7003559516); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",57222147245; 55357105200; 35810406900; 7003559516; 9942405300; 6603119390,Asthma-COPD overlap: Current understanding and the utility of experimental models,2021,European Respiratory Review,30,159,190185,,,,28,10.1183/16000617.0185-2019,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101694428&doi=10.1183%2f16000617.0185-2019&partnerID=40&md5=56906088ca29bd175da00d49f74c39ac,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Centre for Inflammation, Centenary Institute, Camperdown, Australia; University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia","Tu X., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute, Camperdown, Australia, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute, Camperdown, Australia, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute, Camperdown, Australia, University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia",,"Asthma; Humans; Models, Theoretical; Pulmonary Disease, Chronic Obstructive; beta 2 adrenergic receptor stimulating agent; biological marker; corticosteroid; long acting drug; muscarinic receptor blocking agent; omalizumab; Article; asthma; asthma-chronic obstructive pulmonary disease overlap syndrome; chronic obstructive lung disease; clinical feature; disease classification; disease marker; disease model; experimental model; human; nonhuman; obstructive airway disease; pathogenesis; personalized medicine; phenotype; risk factor; asthma; chronic obstructive lung disease; theoretical model",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85101694428
Schanin J.; Gebremeskel S.; Korver W.; Falahati R.; Butuci M.; Haw T.J.; Nair P.M.; Liu G.; Hansbro N.G.; Hansbro P.M.; Evensen E.; Brock E.C.; Xu A.; Wong A.; Leung J.; Bebbington C.; Tomasevic N.; Youngblood B.A.,"Schanin, Julia (57217833792); Gebremeskel, Simon (56576250800); Korver, Wouter (6701320745); Falahati, Rustom (8919167500); Butuci, Melina (56676438500); Haw, Tatt Jhong (56625918900); Nair, Prema M. (55749131000); Liu, Gang (57189061134); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Evensen, Erik (6508346743); Brock, Emily C. (57205421287); Xu, Alan (59035096400); Wong, Alan (57218564745); Leung, John (58794209800); Bebbington, Christopher (6603082806); Tomasevic, Nenad (6603273602); Youngblood, Bradford A. (57205418420)",57217833792; 56576250800; 6701320745; 8919167500; 56676438500; 56625918900; 55749131000; 57189061134; 15055862300; 6603119390; 6508346743; 57205421287; 59035096400; 57218564745; 58794209800; 6603082806; 6603273602; 57205418420,A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation,2021,Mucosal Immunology,14,2,,366,376,10,63,10.1038/s41385-020-00336-9,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089563627&doi=10.1038%2fs41385-020-00336-9&partnerID=40&md5=ae554f076995c416b24b97bf40b9ea25,"Allakos, Inc Redwood City, 94065, CA, United States; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, NSW 2305 and The University of Newcastle, Callaghan, 2208, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, and University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, 2007, NSW, Australia; Basis Bioscience, LLC, Foster City, 94065, CA, United States","Schanin J., Allakos, Inc Redwood City, 94065, CA, United States; Gebremeskel S., Allakos, Inc Redwood City, 94065, CA, United States; Korver W., Allakos, Inc Redwood City, 94065, CA, United States; Falahati R., Allakos, Inc Redwood City, 94065, CA, United States; Butuci M., Allakos, Inc Redwood City, 94065, CA, United States; Haw T.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, NSW 2305 and The University of Newcastle, Callaghan, 2208, NSW, Australia; Nair P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, NSW 2305 and The University of Newcastle, Callaghan, 2208, NSW, Australia; Liu G., Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, and University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, 2007, NSW, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, NSW 2305 and The University of Newcastle, Callaghan, 2208, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, and University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, 2007, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton, NSW 2305 and The University of Newcastle, Callaghan, 2208, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, and University of Technology Sydney, School of Life Sciences, Faculty of Science, Ultimo, 2007, NSW, Australia; Evensen E., Basis Bioscience, LLC, Foster City, 94065, CA, United States; Brock E.C., Allakos, Inc Redwood City, 94065, CA, United States; Xu A., Allakos, Inc Redwood City, 94065, CA, United States; Wong A., Allakos, Inc Redwood City, 94065, CA, United States; Leung J., Allakos, Inc Redwood City, 94065, CA, United States; Bebbington C., Allakos, Inc Redwood City, 94065, CA, United States; Tomasevic N., Allakos, Inc Redwood City, 94065, CA, United States; Youngblood B.A., Allakos, Inc Redwood City, 94065, CA, United States",,"Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Cell Degranulation; Cigarette Smoking; Disease Models, Animal; Gene Expression Profiling; Immunoglobulin E; Interleukin-33; Lectins; Mast Cells; Mice; Mice, Transgenic; Neutrophil Activation; NF-kappa B; Pneumonia; Pulmonary Disease, Chronic Obstructive; Respiratory System; Signal Transduction; cigarette smoke; immunoglobulin E; immunoglobulin enhancer binding protein; interleukin 33; monoclonal antibody; siglec 8; tumor necrosis factor; unclassified drug; B lymphocyte antigen; immunoglobulin E; immunoglobulin enhancer binding protein; interleukin 33; lectin; leukocyte antigen; monoclonal antibody; SIGLEC8 protein, human; animal experiment; animal model; animal tissue; Article; cell activation; chronic obstructive lung disease; controlled study; drug effect; drug screening; female; immunocompetent cell; lung fibrosis; lung injury; male; mast cell; mouse; nonhuman; respiratory tract inflammation; signal transduction; transgenic mouse; animal; cigarette smoking; degranulation; disease model; gene expression profiling; genetics; immunology; leukocyte activation; mast cell; metabolism; pneumonia; respiratory system",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85089563627
Rutting S.; Zakarya R.; Bozier J.; Xenaki D.; Horvat J.C.; Wood L.G.; Hansbro P.M.; Oliver B.G.,"Rutting, Sandra (57202399992); Zakarya, Razia (57190844223); Bozier, Jack (57208555659); Xenaki, Dia (6507411538); Horvat, Jay C. (9942405300); Wood, Lisa G. (55859741700); Hansbro, Philip M. (6603119390); Oliver, Brian G. (15919869900)",57202399992; 57190844223; 57208555659; 6507411538; 9942405300; 55859741700; 6603119390; 15919869900,Dietary fatty acids amplify inflammatory responses to infection through p38 MAPK signaling,2019,American Journal of Respiratory Cell and Molecular Biology,60,5,,554,568,14,34,10.1165/rcmb.2018-0215OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065092540&doi=10.1165%2frcmb.2018-0215OC&partnerID=40&md5=5dd9c03c7da1ab621a71c8f3f9b05e15,"Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; School of Life Sciences, United States; University of Technology Sydney, Faculty of Science, Ultimo, Australia; Centre for Inflammation, Centenary Institute, Sydney, Australia","Rutting S., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Zakarya R., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia, School of Life Sciences, United States; Bozier J., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia, School of Life Sciences, United States; Xenaki D., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, University of Technology Sydney, Faculty of Science, Ultimo, Australia, Centre for Inflammation, Centenary Institute, Sydney, Australia; Oliver B.G., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia, School of Life Sciences, United States",Asthma exacerbations; Dietary fatty acids; Obese asthma; Primary lung fibroblasts; Viral infection,"Adult; Aged; alpha-Linolenic Acid; Arachidonic Acid; Cell Line; Docosahexaenoic Acids; Eicosapentaenoic Acid; Epithelial Cells; Female; Fibroblasts; Gene Expression Regulation; HeLa Cells; Humans; Interleukin-6; Interleukin-8; Lipopolysaccharides; Lung; Male; MAP Kinase Kinase 4; Middle Aged; p38 Mitogen-Activated Protein Kinases; Palmitic Acid; Poly I-C; Primary Cell Culture; Rhinovirus; Signal Transduction; Teichoic Acids; granulocyte macrophage colony stimulating factor; interleukin 6; interleukin 8; mitogen activated protein kinase p38; polyunsaturated fatty acid; RANTES; receptor activator of nuclear factor kappa B; saturated fatty acid; arachidonic acid; CXCL8 protein, human; docosahexaenoic acid; icosapentaenoic acid; IL6 protein, human; interleukin 6; interleukin 8; linolenic acid; lipopolysaccharide; lipoteichoic acid; mitogen activated protein kinase kinase 4; mitogen activated protein kinase p38; palmitic acid; polyinosinic polycytidylic acid; teichoic acid; adult; aged; Article; clinical article; comparative study; controlled study; cytokine production; cytokine release; fat intake; female; fibroblast; human; human cell; human tissue; immune response; male; MAPK signaling; middle aged; protein phosphorylation; respiratory tract infection; very elderly; Western blotting; cell line; drug effect; epithelium cell; gene expression regulation; genetics; growth, development and aging; HeLa cell line; immunology; lung; pathology; primary cell culture; Rhinovirus; signal transduction",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85065092540
Shinde T.; Hansbro P.M.; Sohal S.S.; Dingle P.; Eri R.; Stanley R.,"Shinde, Tanvi (57194025421); Hansbro, Philip M. (6603119390); Sohal, Sukhwinder Singh (36449981500); Dingle, Peter (57217312770); Eri, Rajaraman (57206207449); Stanley, Roger (7201941695)",57194025421; 6603119390; 36449981500; 57217312770; 57206207449; 7201941695,Microbiota modulating nutritional approaches to countering the effects of viral respiratory infections including SARS-CoV-2 through promoting metabolic and immune fitness with probiotics and plant bioactives,2020,Microorganisms,8,6,921,1,21,20,54,10.3390/microorganisms8060921,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087058939&doi=10.3390%2fmicroorganisms8060921&partnerID=40&md5=9b767dbc97f3e5fc011fb3ec7ce5b8cf,"Centre for Food Innovation, Tasmanian Institute of Agriculture, University of Tasmania, Launceston, 7250, TAS, Australia; Gut Health Research Group, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Dingle Wellness, South Fremantle, 6162, WA, Australia","Shinde T., Centre for Food Innovation, Tasmanian Institute of Agriculture, University of Tasmania, Launceston, 7250, TAS, Australia, Gut Health Research Group, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Dingle P., Dingle Wellness, South Fremantle, 6162, WA, Australia; Eri R., Gut Health Research Group, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, 7250, TAS, Australia; Stanley R., Centre for Food Innovation, Tasmanian Institute of Agriculture, University of Tasmania, Launceston, 7250, TAS, Australia",COVID-19; Dietary fiber; Dysbiosis; Functional foods; Gut microbiota; Innate immune response; Probiotic; Short-chain fatty acids (SCFAs); Synbiotic,,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85087058939
Bowerman K.L.; Rehman S.F.; Vaughan A.; Lachner N.; Budden K.F.; Kim R.Y.; Wood D.L.A.; Gellatly S.L.; Shukla S.D.; Wood L.G.; Yang I.A.; Wark P.A.; Hugenholtz P.; Hansbro P.M.,"Bowerman, Kate L. (55147965300); Rehman, Saima Firdous (57211047721); Vaughan, Annalicia (55935627600); Lachner, Nancy (55625753600); Budden, Kurtis F. (57191417986); Kim, Richard Y. (35810406900); Wood, David L. A. (55723732300); Gellatly, Shaan L. (26430804400); Shukla, Shakti D. (56367620800); Wood, Lisa G. (55859741700); Yang, Ian A. (7101797862); Wark, Peter A. (7003559516); Hugenholtz, Philip (55811879700); Hansbro, Philip M. (6603119390)",55147965300; 57211047721; 55935627600; 55625753600; 57191417986; 35810406900; 55723732300; 26430804400; 56367620800; 55859741700; 7101797862; 7003559516; 55811879700; 6603119390,Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease,2020,Nature Communications,11,1,5886,,,,245,10.1038/s41467-020-19701-0,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096212311&doi=10.1038%2fs41467-020-19701-0&partnerID=40&md5=4aff4c08f6882fa021c44fc5a6bf03cf,"Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and The University of Newcastle, Newcastle, NSW, Australia; Thoracic Research Centre, Faculty of Medicine, The University of Queensland, and Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia; Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia","Bowerman K.L., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia; Rehman S.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and The University of Newcastle, Newcastle, NSW, Australia; Vaughan A., Thoracic Research Centre, Faculty of Medicine, The University of Queensland, and Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia; Lachner N., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia; Budden K.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and The University of Newcastle, Newcastle, NSW, Australia; Kim R.Y., Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia; Wood D.L.A., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia; Gellatly S.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and The University of Newcastle, Newcastle, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and The University of Newcastle, Newcastle, NSW, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and The University of Newcastle, Newcastle, NSW, Australia; Yang I.A., Thoracic Research Centre, Faculty of Medicine, The University of Queensland, and Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and The University of Newcastle, Newcastle, NSW, Australia; Hugenholtz P., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and The University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, NSW, Australia",,"Adult; Amino Acids; Bacteria; Case-Control Studies; Feces; Female; Gastrointestinal Microbiome; Humans; Lipid Metabolism; Lipids; Lung; Male; Metabolomics; Microbiota; Middle Aged; Pulmonary Disease, Chronic Obstructive; Bacteria (microorganisms); Lachnospiraceae; Streptococcus; Streptococcus parasanguinis; Streptococcus vestibularis; amino acid; angiotensin 2 receptor antagonist; beta adrenergic receptor stimulating agent; beta carboline; biological marker; carglumic acid; cholinergic receptor blocking agent; cotinine; dicarboxylic acid; dipeptidyl carboxypeptidase inhibitor; dodecanedioate acid; fibronectin; glucosyltransferase; hemoglobin; lipid; n acetylglutamic acid; n acetylproline; n acetyltaurine; peptidoglycan; proton pump inhibitor; RNA 16S; salbutamol; serotonin uptake inhibitor; steroid; unclassified drug; undecanedioate acid; xenobiotic agent; YSIRK type signal peptide containing protein; amino acid; lipid; bacterium; biomarker; detection method; disease; metabolism; microbial activity; microorganism; pathogen; secondary metabolite; adult; Article; Bifidobacteriaceae; blood cell count; Bray Curtis distance; centrifugation; chronic obstructive lung disease; clinical article; cohort analysis; community analysis; controlled study; Desulfovibrio piger; Desulfovibrionaceae; diastolic blood pressure; dietary habit; disease associated gut microbiome; DNA extraction; electrospray mass spectrometry; eosinophil count; Eubacterium; fatty acid oxidation; fecal microbiota transplantation; female; fibre intake; forced expiratory volume; forced vital capacity; Gastranaerophilaceae; gene; gene sequence; genome centric analysis; global initiative for chronic obstructive lung disease criteria; gtfC gene; human; intestine flora; Intestinibacter bartlettii; KEGG; Lachnospiraceae; Lactobacillaceae; leukocyte differential count; lung function test; male; mass spectrometry; mean corpuscular hemoglobin; mean corpuscular volume; metabolic fingerprinting; metabolite; metabolomics; metagenome functional capacity; Micrococcaceae; middle aged; monocyte count; neutrophil count; partial least squares discriminant analysis; polymerase chain reaction; principal component analysis; pulse rate; red cell distribution width; Romboutsia timonensis; Rothia; Selenomonadaceae; sequence variant; smoking; spirometry; Streptococcaceae; Streptococcus; Streptococcus gordonii; Streptococcus sp000187445; Streptococcus sp001556435; Streptococcus vestibularis; systolic blood pressure; ultra performance liquid chromatography; Veillonellaceae; bacterium; case control study; chemistry; chronic obstructive lung disease; classification; feces; genetics; isolation and purification; lipid metabolism; lung; metabolism; metabolomics; microbiology; microflora",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85096212311
Chellappan D.K.; Yee L.W.; Xuan K.Y.; Kunalan K.; Rou L.C.; Jean L.S.; Ying L.Y.; Wie L.X.; Chellian J.; Mehta M.; Satija S.; Singh S.K.; Gulati M.; Dureja H.; Da Silva M.W.; Tambuwala M.M.; Gupta G.; Paudel K.R.; Wadhwa R.; Hansbro P.M.; Dua K.,"Chellappan, Dinesh K. (35811890500); Yee, Lim W. (57214896015); Xuan, Kong Y. (57214892682); Kunalan, Kishen (57214896233); Rou, Lim C. (57214898466); Jean, Leong S. (57214892679); Ying, Lee Y. (57214892727); Wie, Lee X. (57214896451); Chellian, Jestin (56993705500); Mehta, Meenu (7203024234); Satija, Saurabh (54581608400); Singh, Sachin K. (57206711834); Gulati, Monica (7006677671); Dureja, Harish (6507566948); Da Silva, Mateus Webba (57214899103); Tambuwala, Murtaza M. (36657816300); Gupta, Gaurav (15047988400); Paudel, Keshav R. (56539588400); Wadhwa, Ridhima (57159091700); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",35811890500; 57214896015; 57214892682; 57214896233; 57214898466; 57214892679; 57214892727; 57214896451; 56993705500; 7203024234; 54581608400; 57206711834; 7006677671; 6507566948; 57214899103; 36657816300; 15047988400; 56539588400; 57159091700; 6603119390; 15759138700,Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases,2020,Drug Development Research,81,4,,419,436,17,61,10.1002/ddr.21648,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079467896&doi=10.1002%2fddr.21648&partnerID=40&md5=47e33fd5b17bb6d1183988429fefcc95,"Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, Haryana, India; School of Pharmacy and Pharmaceutical Sciences, Ulster University, County Londonderry, United Kingdom; School of Phamacy, Suresh Gyan Vihar University, Jaipur, India; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India","Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Yee L.W., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Xuan K.Y., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Kunalan K., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Rou L.C., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Jean L.S., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Ying L.Y., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Wie L.X., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Mehta M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Singh S.K., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Dureja H., Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, Haryana, India; Da Silva M.W., School of Pharmacy and Pharmaceutical Sciences, Ulster University, County Londonderry, United Kingdom; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, County Londonderry, United Kingdom; Gupta G., School of Phamacy, Suresh Gyan Vihar University, Jaipur, India; Paudel K.R., School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Wadhwa R., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Hansbro P.M., School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India",nanoparticle; neutrophils; novel drug delivery; pulmonary; respiratory diseases,Animals; Chronic Disease; Drug Delivery Systems; Humans; Immune System; Inflammation; Neutrophils; Oxidative Stress; Respiratory Tract Diseases; nanocarrier; acute lung injury; adult respiratory distress syndrome; asthma; chronic obstructive lung disease; chronic respiratory tract disease; cystic fibrosis; drug delivery system; extracellular trap; human; lung cancer; lung infection; nanopharmaceutics; neutrophil; nonhuman; pneumonia; Review; target cell; animal; chronic disease; drug effect; immune system; immunology; inflammation; metabolism; neutrophil; oxidative stress; pathophysiology; respiratory tract disease,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85079467896
Woods J.J.; Skelding K.A.; Martin K.L.; Aryal R.; Sontag E.; Johnstone D.M.; Horvat J.C.; Hansbro P.M.; Milward E.A.,"Woods, Jason J. (57224600415); Skelding, Kathryn A. (9943411700); Martin, Kristy L. (57194415123); Aryal, Ritambhara (57211585658); Sontag, Estelle (7102557106); Johnstone, Daniel M. (15829670700); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Milward, Elizabeth A. (6603563509)",57224600415; 9943411700; 57194415123; 57211585658; 7102557106; 15829670700; 9942405300; 6603119390; 6603563509,Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer's disease etiology,2020,"Brain, Behavior, and Immunity",83,,,22,32,10,16,10.1016/j.bbi.2019.10.014,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074520570&doi=10.1016%2fj.bbi.2019.10.014&partnerID=40&md5=8d27aff716c18acf2d279d311567f7cb,"School of Biomedical Sciences and Pharmacy, University Drive, University of Newcastle, Callaghan, 2308, NSW, Australia; Discipline of Physiology and Bosch Institute, Anderson Stuart Building F13, University of Sydney, 2006, NSW, Australia; Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, 2305, NSW, Australia; Centre for Inflammation, Centenary Institute, Camperdown, 2050, NSW, Australia; Centre for Inflammation, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Woods J.J., School of Biomedical Sciences and Pharmacy, University Drive, University of Newcastle, Callaghan, 2308, NSW, Australia; Skelding K.A., School of Biomedical Sciences and Pharmacy, University Drive, University of Newcastle, Callaghan, 2308, NSW, Australia; Martin K.L., School of Biomedical Sciences and Pharmacy, University Drive, University of Newcastle, Callaghan, 2308, NSW, Australia, Discipline of Physiology and Bosch Institute, Anderson Stuart Building F13, University of Sydney, 2006, NSW, Australia; Aryal R., School of Biomedical Sciences and Pharmacy, University Drive, University of Newcastle, Callaghan, 2308, NSW, Australia; Sontag E., School of Biomedical Sciences and Pharmacy, University Drive, University of Newcastle, Callaghan, 2308, NSW, Australia; Johnstone D.M., Discipline of Physiology and Bosch Institute, Anderson Stuart Building F13, University of Sydney, 2006, NSW, Australia; Horvat J.C., Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, 2305, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University Drive, University of Newcastle, Callaghan, 2308, NSW, Australia, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, 2305, NSW, Australia, Centre for Inflammation, Centenary Institute, Camperdown, 2050, NSW, Australia, Centre for Inflammation, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Milward E.A., School of Biomedical Sciences and Pharmacy, University Drive, University of Newcastle, Callaghan, 2308, NSW, Australia",Alzheimer's disease; Brain; Chlamydia muridarum; Chlamydia pneumoniae; Immune response; Infection; Inflammation; Prevention; Risk factor; Treatment,Alzheimer Disease; Animals; Brain; Chlamydophila Infections; Chlamydophila pneumoniae; Humans; Reproducibility of Results; Uncertainty; amyloid; amyloid beta protein; Alzheimer disease; Borrelia burgdorferi; brain infection; central nervous system; Chlamydia pneumoniae; chlamydial pneumonia; Helicobacter pylori; human; Human alphaherpesvirus 1; Human herpesvirus 6; immune response; incidence; microglia; nervous system inflammation; neuropathology; nonhuman; pathogenesis; priority journal; Review; risk factor; Alzheimer disease; animal; brain; Chlamydophila infection; complication; microbiology; pathogenicity; reproducibility; uncertainty,Review,Final,,Scopus,2-s2.0-85074520570
Wadhwa R.; Dua K.; Adcock I.M.; Horvat J.C.; Kim R.Y.; Hansbro P.M.,"Wadhwa, Ridhima (57159091700); Dua, Kamal (15759138700); Adcock, Ian M. (7007066538); Horvat, Jay C. (9942405300); Kim, Richard Y. (35810406900); Hansbro, Philip M. (6603119390)",57159091700; 15759138700; 7007066538; 9942405300; 35810406900; 6603119390,Cellular mechanisms underlying steroid-resistant asthma,2019,European Respiratory Review,28,153,190096,,,,74,10.1183/16000617.0096-2019,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073656049&doi=10.1183%2f16000617.0096-2019&partnerID=40&md5=a76bc49b0959466d6459bb77f4976224,"Centre for Inflammation, Centenary Institute, Sydney, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Faculty of Science, University of Technology Sydney, Sydney, Australia","Wadhwa R., Centre for Inflammation, Centenary Institute, Sydney, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Adcock I.M., The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Horvat J.C., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Kim R.Y., Centre for Inflammation, Centenary Institute, Sydney, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Faculty of Science, University of Technology Sydney, Sydney, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Faculty of Science, University of Technology Sydney, Sydney, Australia",,Adrenal Cortex Hormones; Animals; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Drug Resistance; Humans; Lung; Molecular Targeted Therapy; Signal Transduction; biological product; cryopyrin; histone deacetylase 2; inflammasome; macrolide; microRNA 21; phosphatidylinositol 3 kinase; steroid; antiasthmatic agent; corticosteroid; Article; asthma; bacterial infection; disease association; disease course; disease exacerbation; disease severity; human; nonhuman; pathogenesis; phenotype; protein function; respiratory tract infection; viral respiratory tract infection; animal; asthma; bronchoconstriction; drug effect; drug resistance; lung; metabolism; molecularly targeted therapy; pathophysiology; signal transduction,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85073656049
Wadhwa R.; Bharathala S.; Aggarwal T.; Sehgal N.; Kumar N.; Gupta G.; Chellappan D.K.; Maurya P.K.; De Jesus Andreoli Pinto T.; Collet T.; Dureja H.; Hansbro P.M.; Dua K.,"Wadhwa, Ridhima (57159091700); Bharathala, Subhashini (57190844711); Aggarwal, Taru (57196053981); Sehgal, Nikita (57203322225); Kumar, Nitesh (57188637148); Gupta, Gaurav (15047988400); Chellappan, Dinesh Kumar (35811890500); Maurya, Pawan Kumar (15765644500); De Jesus Andreoli Pinto, Terezinha (7003263019); Collet, Trudi (36898251800); Dureja, Harish (6507566948); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",57159091700; 57190844711; 57196053981; 57203322225; 57188637148; 15047988400; 35811890500; 15765644500; 7003263019; 36898251800; 6507566948; 6603119390; 15759138700,Pulmonary Bioadhesive Drug Delivery Systems and Their Applications,2020,Bioadhesives in Drug Delivery,,,,371,390,19,4,10.1002/9781119640240.ch12,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129618554&doi=10.1002%2f9781119640240.ch12&partnerID=40&md5=9d41f84c766a26f58f44d3af51c44a87,"Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, Australia; Amity Institute of Biotechnology, Amity University, Uttar Pradesh, Noida, India; Amity Institute for Advanced Research & Studies (M&D), Amity University, Uttar Pradesh, Noida, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia; Department of Biochemistry, Central University of Haryana, Haryana, Jant-Pali, India; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Australia; Department of Pharmaceutical Sciences, Maharishi Dayanand University, Haryana, Rohtak, India; Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia","Wadhwa R., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, Australia; Bharathala S., Amity Institute of Biotechnology, Amity University, Uttar Pradesh, Noida, India; Aggarwal T., Amity Institute of Biotechnology, Amity University, Uttar Pradesh, Noida, India; Sehgal N., Amity Institute of Biotechnology, Amity University, Uttar Pradesh, Noida, India; Kumar N., Amity Institute for Advanced Research & Studies (M&D), Amity University, Uttar Pradesh, Noida, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia; Maurya P.K., Department of Biochemistry, Central University of Haryana, Haryana, Jant-Pali, India; De Jesus Andreoli Pinto T., Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Collet T., Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Australia; Dureja H., Department of Pharmaceutical Sciences, Maharishi Dayanand University, Haryana, Rohtak, India; Hansbro P.M., Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, Australia, Centre for Inflammation, Centenary Institute, Sydney, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia",Bioadhesive; Bioavailability; Drug delivery; Inhalers; Nanoparticles; Pulmonary disease,,Book chapter,Final,,Scopus,2-s2.0-85129618554
Xin G.L.L.; Khee Y.P.; Ying T.Y.; Chellian J.; Gupta G.; Kunnath A.P.; Nammi S.; Collet T.; Hansbro P.M.; Dua K.; Chellappan D.K.,"Xin, Griselda Lim Loo (57207989960); Khee, Yap Pui (57207994090); Ying, Tan Yoke (57207996642); Chellian, Jestin (56993705500); Gupta, Gaurav (15047988400); Kunnath, Anil Philip (28567859800); Nammi, Srinivas (6602547699); Collet, Trudi (36898251800); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",57207989960; 57207994090; 57207996642; 56993705500; 15047988400; 28567859800; 6602547699; 36898251800; 6603119390; 15759138700; 35811890500,Current Status on Immunological Therapies for Type 1 Diabetes Mellitus,2019,Current Diabetes Reports,19,5,22,,,,19,10.1007/s11892-019-1144-3,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063495475&doi=10.1007%2fs11892-019-1144-3&partnerID=40&md5=9fe9eec0fdcb977d983632d2139e68d2,"School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Science and Health, Western Sydney University, Sydney, 2751, NSW, Australia; NICM Health Research Institute, Western Sydney University, Sydney, 2751, NSW, Australia; Innovative Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, QLD, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, Newcastle, 2308, NSW, Australia","Xin G.L.L., School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Khee Y.P., School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Ying T.Y., School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Kunnath A.P., Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Nammi S., School of Science and Health, Western Sydney University, Sydney, 2751, NSW, Australia, NICM Health Research Institute, Western Sydney University, Sydney, 2751, NSW, Australia; Collet T., Innovative Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, QLD, Australia; Hansbro P.M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, Newcastle, 2308, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, Newcastle, 2308, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia",Antigenic agents; Immunotherapies; Non-antigenic agents; T1D,"Animals; Diabetes Mellitus, Type 1; Humans; Immunotherapy; Insulin; Mice, Inbred NOD; Tumor Necrosis Factor-alpha; abatacept; belatacept; CD3 antibody; chaperonin 60; cyclosporine; cytotoxic T lymphocyte antigen 4; etanercept; glutamate decarboxylase 65 antibody; insulin; interleukin 2; interleukin 4; mycophenolate mofetil; rapamycin; rituximab; thymocyte antibody; tumor necrosis factor inhibitor; insulin; tumor necrosis factor; cell therapy; clinical outcome; combination drug therapy; cytotoxic T lymphocyte; dendritic cell; drug effect; human; immune response; immunomodulation; immunotherapy; insulin dependent diabetes mellitus; macrophage; nonhuman; nonobese diabetic mouse; regulatory T lymphocyte; Review; time to treatment; animal; immunotherapy; insulin dependent diabetes mellitus",Review,Final,,Scopus,2-s2.0-85063495475
Lee J.M.; Mayall J.R.; Chevalier A.; McCarthy H.; Van Helden D.; Hansbro P.M.; Horvat J.C.; Jobling P.,"Lee, Jia Ming (57217075450); Mayall, Jemma R. (55607222700); Chevalier, Anne (57196690888); McCarthy, Huw (57217073584); Van Helden, Dirk (7004030752); Hansbro, Philip M. (6603119390); Horvat, Jay C. (9942405300); Jobling, Phillip (6701842567)",57217075450; 55607222700; 57196690888; 57217073584; 7004030752; 6603119390; 9942405300; 6701842567,Chlamydia muridarum infection differentially alters smooth muscle function in mouse uterine horn and cervix,2020,American Journal of Physiology - Endocrinology and Metabolism,318,6,,E981,E994,13,7,10.1152/AJPENDO.00513.2019,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086052330&doi=10.1152%2fAJPENDO.00513.2019&partnerID=40&md5=6f8168a4ba8bac1694173e08ea95c9d9,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Centenary Institute and the University of Technology Sydney, Sydney, NSW, Australia","Lee J.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Mayall J.R., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Chevalier A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; McCarthy H., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Van Helden D., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia, Centenary Institute and the University of Technology Sydney, Sydney, NSW, Australia; Horvat J.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Jobling P., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia",Cervical Contraction; Chlamydia Muridarum; Oxytocin; Prostaglandin; Uterine Contraction,"Animals; Cervix Uteri; Chlamydia Infections; Chlamydia muridarum; Cytokines; Dinoprost; Dinoprostone; Female; Gene Expression Regulation; Histamine; Histamine Agonists; Interleukin-1beta; Interleukin-6; Mice; Muscle Contraction; Muscle, Smooth; Myometrium; Oviducts; Oxytocics; Receptors, Oxytocin; Receptors, Prostaglandin; Receptors, Prostaglandin E, EP4 Subtype; Reproductive Tract Infections; RNA, Messenger; Uterine Contraction; Uterus; cytokine; histamine; messenger RNA; prostaglandin; cytokine; histamine; histamine agonist; IL1B protein, mouse; interleukin 1beta; interleukin 6; interleukin-6, mouse; messenger RNA; OXTR protein, mouse; oxytocic agent; oxytocin receptor; prostaglandin E receptor 4; prostaglandin E2; prostaglandin F2 alpha; prostaglandin F2alpha receptor; prostaglandin receptor; Ptger4 protein, mouse; animal experiment; animal model; animal tissue; Article; bacterial load; C57BL 6 mouse; Chlamydia muridarum infection; chlamydiasis; controlled study; female; gene; Il1b gene; Il6 gene; mouse; muscle contraction; muscle function; nonhuman; Otr gene; priority journal; protein expression; Ptger4 gene; smooth muscle; uterine cervix; uterus horn; wild type; animal; Chlamydia muridarum; chlamydiasis; drug effect; gene expression regulation; genetics; genital tract infection; immunology; metabolism; myometrium; oviduct; pathology; pathophysiology; physiology; smooth muscle; uterine cervix; uterus; uterus contraction",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85086052330
Donovan C.; Hansbro P.M.,"Donovan, Chantal (55357105200); Hansbro, Philip M. (6603119390)",55357105200; 6603119390,IL-33 in Chronic Respiratory Disease: From Preclinical to Clinical Studies,2020,ACS Pharmacology and Translational Science,3,1,,56,62,6,34,10.1021/acsptsci.9b00099,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088849862&doi=10.1021%2facsptsci.9b00099&partnerID=40&md5=6d5ac5ebd204d08d54cf98d9467f6b93,"Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia","Donovan C., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia",anti-IL-33; asthma; COPD; eosinophils; IL-33; ST2,cytokine antibody; interleukin 33; interleukin 33 antibody; monoclonal antibody; unclassified drug; asthma; chronic obstructive lung disease; clinical trial (topic); disease exacerbation; human; nonhuman; preclinical study; priority journal; protein targeting; respiratory tract disease; Review,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85088849862
Lo Bello F.; Ieni A.; Hansbro P.M.; Ruggeri P.; Di Stefano A.; Nucera F.; Coppolino I.; Monaco F.; Tuccari G.; Adcock I.M.; Caramori G.,"Lo Bello, Federica (57202941930); Ieni, Antonio (26021273500); Hansbro, Philip M. (6603119390); Ruggeri, Paolo (15923794000); Di Stefano, Antonino (36003195400); Nucera, Francesco (57202946185); Coppolino, Irene (57205402564); Monaco, Francesco (56941491100); Tuccari, Giovanni (7004479946); Adcock, Ian M. (7007066538); Caramori, Gaetano (7003847659)",57202941930; 26021273500; 6603119390; 15923794000; 36003195400; 57202946185; 57205402564; 56941491100; 7004479946; 7007066538; 7003847659,Role of the mucins in pathogenesis of COPD: implications for therapy,2020,Expert Review of Respiratory Medicine,14,5,,465,483,18,19,10.1080/17476348.2020.1739525,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082324542&doi=10.1080%2f17476348.2020.1739525&partnerID=40&md5=836fc6227c8830bb708cbd011160ae60,"Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, Messina, Italy; Centre for Inflammation, Centenary Institute, Sydney, University of Technology Sydney, Ultimo, Australia; Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell’Apparato Cardio Respiratorio, Istituti Clinici Scientifici Maugeri, IRCCS, Veruno, Italy; Unità Operativa Semplice Dipartimentale di Chirurgia Toracica, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), AOU Policlinico “G.martino”, Messina, Italy; Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom","Lo Bello F., Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Ieni A., Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, Messina, Italy; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, University of Technology Sydney, Ultimo, Australia; Ruggeri P., Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Di Stefano A., Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell’Apparato Cardio Respiratorio, Istituti Clinici Scientifici Maugeri, IRCCS, Veruno, Italy; Nucera F., Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Coppolino I., Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy; Monaco F., Unità Operativa Semplice Dipartimentale di Chirurgia Toracica, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), AOU Policlinico “G.martino”, Messina, Italy; Tuccari G., Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, Messina, Italy; Adcock I.M., Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom; Caramori G., Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy",MUC5AC; MUC5B; mucoactive drugs,"Humans; Mucins; Mucus; Pulmonary Disease, Chronic Obstructive; acetylcysteine; ambroxol; beta 2 adrenergic receptor stimulating agent; carbocisteine; dornase alfa; erdosteine; glucocorticoid; macrolide; mucin; mucin 5AC; mucin 5B; mucolytic agent; muscarinic M1 receptor antagonist; phosphodiesterase IV inhibitor; polymer; mucin; airway epithelium cell; bronchus tissue; chronic obstructive lung disease; clinical assessment; disease exacerbation; disease severity; drug effect; drug efficacy; epigenetics; epithelial lining fluid; glycoprotein synthesis; Haemophilus influenzae; human; Human respiratory syncytial virus; immunity; in vitro study; Influenza virus; lower respiratory tract; lung function; lung parenchyma; mucociliary clearance; mucus secretion; nonhuman; pathogenesis; pathophysiology; protein secretion; Pseudomonas aeruginosa; Review; Rhinovirus; single nucleotide polymorphism; sputum; Streptococcus pneumoniae; chronic obstructive lung disease; metabolism; mucus",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85082324542
Morris S.; Wright K.; Malyla V.; Britton W.J.; Hansbro P.M.; Manuneedhi Cholan P.; Oehlers S.H.,"Morris, Simone (57222023340); Wright, Kathryn (58462129200); Malyla, Vamshikrishna (57205128961); Britton, Warwick J. (7102477888); Hansbro, Philip M. (6603119390); Manuneedhi Cholan, Pradeep (57203768054); Oehlers, Stefan H. (35811120600)",57222023340; 58462129200; 57205128961; 7102477888; 6603119390; 57203768054; 35811120600,Exposure to the gut microbiota from cigarette smoke-exposed mice exacerbates cigarette smoke extract-induced inflammation in zebrafish larvae,2021,Current Research in Immunology,2,,,229,236,7,0,10.1016/j.crimmu.2021.12.001,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132255005&doi=10.1016%2fj.crimmu.2021.12.001&partnerID=40&md5=e8b9ae4f5a32919a34f8a2f88cf3069e,"Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Camperdown, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, Australia; The University of Sydney, Faculty of Medicine and Health, Camperdown, NSW, Australia","Morris S., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Camperdown, NSW, Australia; Wright K., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Camperdown, NSW, Australia; Malyla V., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Britton W.J., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Camperdown, NSW, Australia, Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia; Manuneedhi Cholan P., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Camperdown, NSW, Australia; Oehlers S.H., Tuberculosis Research Program at the Centenary Institute, The University of Sydney, Camperdown, NSW, Australia, The University of Sydney, Faculty of Medicine and Health, Camperdown, NSW, Australia",Cigarette smoke; Enterocolitis; Microbiota; Zebrafish,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85132255005
Dua K.; Wadhwa R.; Singhvi G.; Rapalli V.; Shukla S.D.; Shastri M.D.; Gupta G.; Satija S.; Mehta M.; Khurana N.; Awasthi R.; Maurya P.K.; Thangavelu L.; Rajeshkumar S.; Tambuwala M.M.; Collet T.; Hansbro P.M.; Chellappan D.K.,"Dua, Kamal (15759138700); Wadhwa, Ridhima (57159091700); Singhvi, Gautam (51864379500); Rapalli, Vamshikrishna (57202821805); Shukla, Shakti Dhar (56367620800); Shastri, Madhur D. (56007290800); Gupta, Gaurav (15047988400); Satija, Saurabh (54581608400); Mehta, Meenu (7203024234); Khurana, Navneet (53264160500); Awasthi, Rajendra (36866066100); Maurya, Pawan Kumar (15765644500); Thangavelu, Lakshmi (57221436939); Rajeshkumar, S. (57195616808); Tambuwala, Murtaza M. (36657816300); Collet, Trudi (36898251800); Hansbro, Philip M. (6603119390); Chellappan, Dinesh Kumar (35811890500)",15759138700; 57159091700; 51864379500; 57202821805; 56367620800; 56007290800; 15047988400; 54581608400; 7203024234; 53264160500; 36866066100; 15765644500; 57221436939; 57195616808; 36657816300; 36898251800; 6603119390; 35811890500,The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress,2019,Drug Development Research,80,6,,714,730,16,118,10.1002/ddr.21571,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069931304&doi=10.1002%2fddr.21571&partnerID=40&md5=553d969e2be1e215039c8a7135912389,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India; Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, India; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India; Department of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India; Nanobiomedicine Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, London, United Kingdom; Inovative Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia","Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia, Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Wadhwa R., Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India; Singhvi G., Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, India; Rapalli V., Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, India; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Shastri M.D., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Mehta M., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Khurana N., School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India; Awasthi R., Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India; Maurya P.K., Department of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India; Thangavelu L., Nanobiomedicine Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India; Rajeshkumar S., Nanobiomedicine Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, London, United Kingdom; Collet T., Inovative Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Hansbro P.M., Centenary Institute, Royal Prince Alfred Hospital, Camperdown, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia",delivery systems; nanocarriers; pulmonary; RNA interference; siRNA,"Animals; Drug Carriers; Humans; Respiratory Tract Diseases; RNA, Small Interfering; lipid; microRNA; nanocarrier; peptide; polymer; small interfering RNA; drug carrier; small interfering RNA; allergic airway inflammation; asthma; chronic respiratory tract disease; clinical trial; drug delivery system; drug efficacy; drug safety; gene targeting; human; immune response; lung; lung cancer; nonhuman; Review; animal; respiratory tract disease",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85069931304
Vaughan A.; Frazer Z.A.; Hansbro P.M.; Yang I.A.,"Vaughan, Annalicia (55935627600); Frazer, Zoe A. (57216299491); Hansbro, Philip M. (6603119390); Yang, Ian A. (7101797862)",55935627600; 57216299491; 6603119390; 7101797862,COPD and the gut-lung axis: The therapeutic potential of fibre,2019,Journal of Thoracic Disease,11,,,S2173,S2180,7,75,10.21037/jtd.2019.10.40,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081141529&doi=10.21037%2fjtd.2019.10.40&partnerID=40&md5=910aeaa71ad2bcd16cab740067ab690e,"UQ Thoracic Research Centre, Faculty of Medicine, University of Queensland, Room 2, Level 1, Clinical Sciences Building, Prince Charles Hospital, Rode Rd., Chermside, QLD, Australia; Department of Thoracic Medicine, Prince Charles Hospital, Brisbane, Australia; Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, Camperdown, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia","Vaughan A., UQ Thoracic Research Centre, Faculty of Medicine, University of Queensland, Room 2, Level 1, Clinical Sciences Building, Prince Charles Hospital, Rode Rd., Chermside, QLD, Australia, Department of Thoracic Medicine, Prince Charles Hospital, Brisbane, Australia; Frazer Z.A., UQ Thoracic Research Centre, Faculty of Medicine, University of Queensland, Room 2, Level 1, Clinical Sciences Building, Prince Charles Hospital, Rode Rd., Chermside, QLD, Australia, Department of Thoracic Medicine, Prince Charles Hospital, Brisbane, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, University of Technology Sydney, Faculty of Science, Camperdown, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Yang I.A., UQ Thoracic Research Centre, Faculty of Medicine, University of Queensland, Room 2, Level 1, Clinical Sciences Building, Prince Charles Hospital, Rode Rd., Chermside, QLD, Australia, Department of Thoracic Medicine, Prince Charles Hospital, Brisbane, Australia",Chronic obstructive pulmonary disease (COPD); Metagenomics; Microbiome,antibiotic agent; corticosteroid; age; asthma; body mass; chronic obstructive lung disease; cigarette smoking; diet; dietary fiber; drug use; dysbiosis; gender; human; intestine flora; nutrition; respiratory tract disease; Review,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85081141529
Maheshwari R.; Sharma P.; Tekade M.; Atneriya U.; Dua K.; Hansbro P.M.; Tekade R.K.,"Maheshwari, Rahul (54581307100); Sharma, Piyoosh (54581560600); Tekade, Muktika (56502403400); Atneriya, Umesh (57248148200); Dua, Kamal (15759138700); Hansbro, Philp M. (6603119390); Tekade, Rakesh K. (57204717123)",54581307100; 54581560600; 56502403400; 57248148200; 15759138700; 6603119390; 57204717123,Microsponge Embedded Tablets for Sustained Delivery of Nifedipine,2017,Pharmaceutical Nanotechnology,5,3,,192,202,10,38,10.2174/2211738505666170921125549,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125197802&doi=10.2174%2f2211738505666170921125549&partnerID=40&md5=79ba19680f84e43c0c9d95736f1aabad,"Pharmaceutical Research Lab, Department of Pharmaceutics, BM College of Pharmaceutical Education and Research, Khandwa Road, Madhya Pradesh, Indore, 452020, India; Sri Aurobindo Institute of Pharmacy, Indore-Ujjain State Highway, Near MR-10 Crossing, Indore, India; TIT College of Pharmacy, Technocrats Institute of Technology Campus, Anand Nagar, Raisen Road, MP, Bhopal, 462021, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; National Institute of Pharmaceutical Education and Research (NIPER) – Ahmedabad, Department of Pharmaceutics, Opposite Air Force Station Palaj, Gujarat, Gandhinagar, 382355, India; School of Pharmacy, Department of Pharmaceutical Technology, International Medical University, JalanJalil Perkasa 19, Kuala Lumpur, 57000, Malaysia","Maheshwari R., Pharmaceutical Research Lab, Department of Pharmaceutics, BM College of Pharmaceutical Education and Research, Khandwa Road, Madhya Pradesh, Indore, 452020, India, National Institute of Pharmaceutical Education and Research (NIPER) – Ahmedabad, Department of Pharmaceutics, Opposite Air Force Station Palaj, Gujarat, Gandhinagar, 382355, India; Sharma P., Sri Aurobindo Institute of Pharmacy, Indore-Ujjain State Highway, Near MR-10 Crossing, Indore, India; Tekade M., TIT College of Pharmacy, Technocrats Institute of Technology Campus, Anand Nagar, Raisen Road, MP, Bhopal, 462021, India; Atneriya U., Pharmaceutical Research Lab, Department of Pharmaceutics, BM College of Pharmaceutical Education and Research, Khandwa Road, Madhya Pradesh, Indore, 452020, India; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Tekade R.K., National Institute of Pharmaceutical Education and Research (NIPER) – Ahmedabad, Department of Pharmaceutics, Opposite Air Force Station Palaj, Gujarat, Gandhinagar, 382355, India, School of Pharmacy, Department of Pharmaceutical Technology, International Medical University, JalanJalil Perkasa 19, Kuala Lumpur, 57000, Malaysia",Cardiovascular diseases; Dissolution; Drug loading; Microsponge drug delivery; Microspong­e entrapped tablet; Nifedipine microsponges; Sustained release,drug content; microcrystalline cellulose; microsphere; microsponge; nifedipine; polymer; starch; unclassified drug; angle of repose; Article; bulk density; drug bioavailability; drug coating; drug delivery system; drug release; drug solubility; drug stability; emulsion; encapsulation; Hausner ratio; human; melting point; patient compliance; pore size distribution; scanning electron microscopy; solvent extraction; surface property; sustained drug release; tablet compression; tablet disintegration; tablet disintegration time; tablet formulation; tablet friability; tablet hardness; tablet property; tablet thickness; tapped density,Article,Final,,Scopus,2-s2.0-85125197802
Hansbro P.M.; Kim R.Y.; Starkey M.R.; Donovan C.; Dua K.; Mayall J.R.; Liu G.; Hansbro N.G.; Simpson J.L.; Wood L.G.; Hirota J.A.; Knight D.A.; Foster P.S.; Horvat J.C.,"Hansbro, Philip M. (6603119390); Kim, Richard Y. (35810406900); Starkey, Malcolm R. (35811293400); Donovan, Chantal (55357105200); Dua, Kamal (15759138700); Mayall, Jemma R. (55607222700); Liu, Gang (57189061134); Hansbro, Nicole G. (15055862300); Simpson, Jodie L. (7404326026); Wood, Lisa G. (55859741700); Hirota, Jeremy A. (7007085348); Knight, Darryl A. (7402350036); Foster, Paul S. (7201517569); Horvat, Jay C. (9942405300)",6603119390; 35810406900; 35811293400; 55357105200; 15759138700; 55607222700; 57189061134; 15055862300; 7404326026; 55859741700; 7007085348; 7402350036; 7201517569; 9942405300,"Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma",2017,Immunological Reviews,278,1,,41,62,21,121,10.1111/imr.12543,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021377025&doi=10.1111%2fimr.12543&partnerID=40&md5=192b9d36a9132276e81ad2817c2d39a0,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada","Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Dua K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Mayall J.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Liu G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Simpson J.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Hirota J.A., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; Knight D.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia",infection; novel therapies; obesity; pollution; severe asthma; steroid resistance,"Air Pollution; Animals; Anti-Asthmatic Agents; Asthma; Diet, High-Fat; Disease Models, Animal; Drug Resistance; Gene Expression Regulation; Humans; Obesity; Respiratory Hypersensitivity; Risk Factors; Severity of Illness Index; Signal Transduction; Steroids; Treatment Outcome; antibody; cryopyrin; cytokine; inflammasome; interleukin 1beta; microRNA; phosphatidylinositol 3 kinase; steroid; toll like receptor; antiasthmatic agent; steroid; air pollution; allergic airway inflammation; allergic asthma; disease course; disease severity; experimental model; human; lipid diet; nonhuman; obesity; priority journal; respiratory tract infection; Review; signal transduction; systematic review (topic); animal; asthma; complication; disease model; drug effects; drug resistance; gene expression regulation; metabolism; respiratory tract allergy; risk factor; severity of illness index; treatment outcome",Review,Final,,Scopus,2-s2.0-85021377025
Pinkerton J.W.; Kim R.Y.; Robertson A.A.B.; Hirota J.A.; Wood L.G.; Knight D.A.; Cooper M.A.; O'Neill L.A.J.; Horvat J.C.; Hansbro P.M.,"Pinkerton, James W. (56647761900); Kim, Richard Y. (35810406900); Robertson, Avril A.B. (15519764900); Hirota, Jeremy A. (7007085348); Wood, Lisa G. (55859741700); Knight, Darryl A. (7402350036); Cooper, Matthew A. (7404411451); O'Neill, Luke A.J. (7103393094); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",56647761900; 35810406900; 15519764900; 7007085348; 55859741700; 7402350036; 7404411451; 7103393094; 9942405300; 6603119390,Inflammasomes in the lung,2017,Molecular Immunology,86,,,44,55,11,142,10.1016/j.molimm.2017.01.014,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85010208944&doi=10.1016%2fj.molimm.2017.01.014&partnerID=40&md5=041ee11793ec2a014778a8d2f91f64c9,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia; James Hogg Research Centre, University of British Columbia, Vancouver, British Columbia, Canada; School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland","Pinkerton J.W., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia; Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia; Robertson A.A.B., Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia; Hirota J.A., James Hogg Research Centre, University of British Columbia, Vancouver, British Columbia, Canada; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia; Knight D.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia; Cooper M.A., Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia; O'Neill L.A.J., School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, New South Wales, Australia",Asthma; Chronic obstructive pulmonary disease; IL-1; Inflammasome; Lung,"Caspase 1; Chronic Disease; Humans; Immunity, Innate; Inflammasomes; Inflammation; Interleukin-18; Interleukin-1beta; Lung; Lung Diseases; Macrophages, Alveolar; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; cryopyrin; inflammasome; interleukin 18; interleukin 1beta; cryopyrin; inflammasome; interleukin 18; interleukin 1beta; interleukin 1beta converting enzyme; NLRP3 protein, human; adult respiratory distress syndrome; Article; asthma; chronic lung disease; chronic obstructive lung disease; community acquired pneumonia; cystic fibrosis; disease exacerbation; human; innate immunity; lung disease; lung fibrosis; nonhuman; priority journal; respiratory tract disease; biosynthesis; chronic disease; immunology; inflammation; innate immunity; lung; lung alveolus macrophage; metabolism; microbiology; secretion (process); signal transduction",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85010208944
Kim R.Y.; Horvat J.C.; Pinkerton J.W.; Starkey M.R.; Essilfie A.T.; Mayall J.R.; Nair P.M.; Hansbro N.G.; Jones B.; Haw T.J.; Sunkara K.P.; Nguyen T.H.; Jarnicki A.G.; Keely S.; Mattes J.; Adcock I.M.; Foster P.S.; Hansbro P.M.,"Kim, Richard Y. (35810406900); Horvat, Jay C. (9942405300); Pinkerton, James W. (56647761900); Starkey, Malcolm R. (35811293400); Essilfie, Ama T. (22955585600); Mayall, Jemma R. (55607222700); Nair, Prema M. (55749131000); Hansbro, Nicole G. (15055862300); Jones, Bernadette (56215070300); Haw, Tatt Jhong (56625918900); Sunkara, Krishna P. (57190382716); Nguyen, Thi Hiep (57209165993); Jarnicki, Andrew G. (6603137164); Keely, Simon (9739611200); Mattes, Joerg (7005999915); Adcock, Ian M. (7007066538); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",35810406900; 9942405300; 56647761900; 35811293400; 22955585600; 55607222700; 55749131000; 15055862300; 56215070300; 56625918900; 57190382716; 57209165993; 6603137164; 9739611200; 7005999915; 7007066538; 7201517569; 6603119390,"MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2",2017,Journal of Allergy and Clinical Immunology,139,2,,519,532,13,179,10.1016/j.jaci.2016.04.038,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979590841&doi=10.1016%2fj.jaci.2016.04.038&partnerID=40&md5=d600bf87b1acb8331b684680716b813e,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom","Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Pinkerton J.W., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Essilfie A.T., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Mayall J.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Nair P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Jones B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Haw T.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Sunkara K.P., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Nguyen T.H., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Jarnicki A.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Keely S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Mattes J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Adcock I.M., Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Foster P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia",airway hyperresponsiveness; Chlamydia species; corticosteroids; Haemophilus influenzae; histone deacetylase 2; influenza; miR-21; PI3 kinase; respiratory syncytial virus; Severe asthma,"Animals; Antagomirs; Asthma; Chlamydia muridarum; Dexamethasone; Disease Models, Animal; Drug Resistance; Gene Expression Regulation; Haemophilus influenzae; Histone Deacetylase 2; Humans; Influenza A Virus, H1N1 Subtype; Mice; Mice, Inbred BALB C; MicroRNAs; Phosphatidylinositol 3-Kinases; Phosphorylation; Pneumonia; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Respiratory Syncytial Viruses; Respiratory Tract Infections; 2 morpholino 8 phenylchromone; histone deacetylase 2; microRNA 21; phosphatidylinositol 3 kinase; protein kinase B; antagomir; dexamethasone; histone deacetylase 2; microRNA; MIRN21 microRNA, mouse; phosphatidylinositol 3 kinase; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; protein kinase B; Pten protein, mouse; animal experiment; animal model; Article; bacterial strain; Chlamydia muridarum; chlamydiasis; controlled study; experimental asthma; gene expression; Haemophilus influenzae; Human respiratory syncytial virus; mouse; nonhuman; pathogenesis; polymerase chain reaction; priority journal; respiratory tract infection; steroid insensitive experimental asthma; animal; asthma; Bagg albino mouse; disease model; drug resistance; gene expression regulation; genetics; human; immunology; Influenza A virus (H1N1); metabolism; phosphorylation; pneumonia; Respiratory Tract Infections",Article,Final,,Scopus,2-s2.0-84979590841
Singhvi G.; Girdhar V.; Patil S.; Gupta G.; Hansbro P.M.; Dua K.,"Singhvi, Gautam (51864379500); Girdhar, Vishal (57202204339); Patil, Shalini (55805564700); Gupta, Gaurav (15047988400); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",51864379500; 57202204339; 55805564700; 15047988400; 6603119390; 15759138700,Microbiome as therapeutics in vesicular delivery,2018,Biomedicine and Pharmacotherapy,104,,,738,741,3,19,10.1016/j.biopha.2018.05.099,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047399443&doi=10.1016%2fj.biopha.2018.05.099&partnerID=40&md5=43ca5f7a0a4b99a6bf030dc78ea6fd16,"Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, 302017, Jaipur, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia","Singhvi G., Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; Girdhar V., Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; Patil S., Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, 302017, Jaipur, India; Hansbro P.M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia",Biotherapeutics; Disease targeting; Microbiome; Microbiota; Vesicular drug delivery systems,"Animals; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Humans; Liposomes; Microbiota; Nanoparticles; liposome; nanoparticle; drug carrier; drug delivery system; genetic engineering; human; liposomal delivery; microbiome; microflora; nonhuman; priority journal; Review; animal; chemistry; drug delivery system; medicinal chemistry; physiology; procedures",Review,Final,,Scopus,2-s2.0-85047399443
Hansbro P.M.; Haw T.J.; Starkey M.R.; Miyake K.,"Hansbro, Philip M. (6603119390); Haw, Tatt Jhong (56625918900); Starkey, Malcolm R. (35811293400); Miyake, Kensuke (7401759553)",6603119390; 56625918900; 35811293400; 7401759553,Toll-like receptors in COPD,2017,European Respiratory Journal,49,5,1700739,,,,15,10.1183/13993003.00739-2017,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049870437&doi=10.1183%2f13993003.00739-2017&partnerID=40&md5=d52e45056a993ab439dc301cd8e364c6,"Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Division of Innate Immunity, Dept of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan","Hansbro P.M., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Haw T.J., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Miyake K., Division of Innate Immunity, Dept of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan",,"Humans; Pulmonary Disease, Chronic Obstructive; Toll-Like Receptor 4; Toll-Like Receptors; toll like receptor; toll like receptor 4; chronic obstructive lung disease; human",Editorial,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85049870437
Collison A.M.; Li J.; De Siqueira A.P.; Lv X.; Toop H.D.; Morris J.C.; Starkey M.R.; Hansbro P.M.; Zhang J.; Mattes J.,"Collison, Adam M. (23995251200); Li, Junyao (56199157100); De Siqueira, Ana Pereira (6507757990); Lv, Xuejiao (56489526100); Toop, Hamish D. (55312695800); Morris, Jonathan C. (35354969700); Starkey, Malcolm R. (35811293400); Hansbro, Philip M. (6603119390); Zhang, Jie (55957803100); Mattes, Joerg (7005999915)",23995251200; 56199157100; 6507757990; 56489526100; 55312695800; 35354969700; 35811293400; 6603119390; 55957803100; 7005999915,TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis,2019,BMC Pulmonary Medicine,19,1,31,,,,24,10.1186/s12890-019-0786-x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061255905&doi=10.1186%2fs12890-019-0786-x&partnerID=40&md5=a1ea56e09748d32e9e34e7e8e082e14e,"Experimental and Translational Respiratory Medicine Group, Hunter Medical Research Institute, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Callaghan, 2308, NSW, Australia; Priority Research Centre GrowUpWell, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia; Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Jilin University, Changchun Jilin, 130041, China; School of Chemistry, University of New South Wales, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia; Paediatric Respiratory and Sleep Medicine Department, Newcastle Children's Hospital, Kaleidoscope Newcastle, Australia","Collison A.M., Experimental and Translational Respiratory Medicine Group, Hunter Medical Research Institute, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre GrowUpWell, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia; Li J., Experimental and Translational Respiratory Medicine Group, Hunter Medical Research Institute, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre GrowUpWell, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Jilin University, Changchun Jilin, 130041, China; De Siqueira A.P., Experimental and Translational Respiratory Medicine Group, Hunter Medical Research Institute, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre GrowUpWell, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia; Lv X., Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Jilin University, Changchun Jilin, 130041, China; Toop H.D., School of Chemistry, University of New South Wales, Sydney, NSW, Australia; Morris J.C., School of Chemistry, University of New South Wales, Sydney, NSW, Australia; Starkey M.R., Priority Research Centre GrowUpWell, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia; Zhang J., Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Jilin University, Changchun Jilin, 130041, China; Mattes J., Experimental and Translational Respiratory Medicine Group, Hunter Medical Research Institute, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre GrowUpWell, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia, Paediatric Respiratory and Sleep Medicine Department, Newcastle Children's Hospital, Kaleidoscope Newcastle, Australia",E3 ubiquitin ligase; Fibrosis; MID1; PP2A; TRAIL,"Aged; Aged, 80 and over; Animals; Case-Control Studies; China; Collagen; Female; Humans; Male; Mice, Inbred BALB C; Mice, Knockout; Microtubule Proteins; Middle Aged; Nuclear Proteins; Protein Phosphatase 2; Proteins; Pulmonary Fibrosis; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Transcription Factors; Ubiquitin-Protein Ligases; 2 amino 4 (4 heptyloxyphenyl) 2 methylbutan 1 ol; antifibrotic agent; collagen; collagen alpha2; gelatinase B; messenger RNA; midline 1 protein; monocyte chemotactic protein 1; phosphoprotein phosphatase 2A; transforming growth factor beta1; tumor necrosis factor related apoptosis inducing ligand; ubiquitin protein ligase E3; unclassified drug; collagen; microtubule protein; Mid1 protein, human; Mid1 protein, mouse; nuclear protein; phosphoprotein phosphatase 2; protein; TNFSF10 protein, human; Tnfsf10 protein, mouse; transcription factor; tumor necrosis factor related apoptosis inducing ligand; ubiquitin protein ligase; adult; aged; animal cell; animal experiment; animal model; animal tissue; apoptosis; Article; bleomycin-induced pulmonary fibrosis; carbon monoxide diffusing capacity; cell proliferation; clinical article; collagen synthesis; controlled study; female; human; human tissue; lung diffusion capacity; lung fibroblast; lung fibrosis; male; mouse; nonhuman; transbronchial biopsy; upregulation; animal; Bagg albino mouse; blood; case control study; chemically induced; China; genetics; knockout mouse; lung fibrosis; metabolism; middle aged; pathology; signal transduction; very elderly",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85061255905
Usman B.; Sharma N.; Satija S.; Mehta M.; Vyas M.; Khatik G.L.; Khurana N.; Hansbro P.M.; Williams K.; Dua K.,"Usman, Bashir (57211210664); Sharma, Neha (57188952328); Satija, Saurabh (54581608400); Mehta, Meenu (7203024234); Vyas, Manish (56906731900); Khatik, Gopal L. (14031691500); Khurana, Navneet (53264160500); Hansbro, Philip M. (6603119390); Williams, Kylie (7404142756); Dua, Kamal (15759138700)",57211210664; 57188952328; 54581608400; 7203024234; 56906731900; 14031691500; 53264160500; 6603119390; 7404142756; 15759138700,Recent developments in alpha-glucosidase inhibitors for management of type-2 diabetes: An update,2019,Current Pharmaceutical Design,25,23,,2510,2525,15,70,10.2174/1381612825666190717104547,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071398252&doi=10.2174%2f1381612825666190717104547&partnerID=40&md5=6d8d92368777a80878706ea9cec0a507,"School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia","Usman B., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Sharma N., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Mehta M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Vyas M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Khatik G.L., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Khurana N., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Hansbro P.M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Williams K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia",Alpha-amylase; Alpha-glucosidase; Diabetes; Hyperglycemia; Insulin; Pancreas,"Blood Glucose; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; acarbose; alpha glucosidase inhibitor; Andrographis paniculata extract; antidiabetic agent; biguanide; catechin; cinnamon extract; Conyza Canadensis extract; dipeptidyl peptidase IV inhibitor; epicatechin; Ficus Deltoidea extract; glucagon like peptide 1 derivative; incretin; meglitinide; miglitol; naringenin; Orthosiphon Stamineus ethanolic extract; phloroglucinol; pyranoquinolinyl acrylic acid diastereomer derivative; pyridoxine; quercetin; quinazolinone 1,2,3 triazole derivative; Samanea Saman extract; sodium glucose cotransporter 2 inhibitor; sulfonylurea; Symplocos Cochinchinensis extract; thiazolinedione; unclassified drug; Undaria Pinnatifida extract; unindexed drug; voglibose; glycosidase inhibitor; disease classification; drug mechanism; drug safety; drug screening; drug structure; glycemic control; hormone release; human; insulin release; insulin resistance; non insulin dependent diabetes mellitus; nonhuman; pathophysiology; plant leaf; priority journal; Review; Undaria pinnatifida; glucose blood level; hyperglycemia; non insulin dependent diabetes mellitus",Review,Final,,Scopus,2-s2.0-85071398252
Foster P.S.; Maltby S.; Rosenberg H.F.; Tay H.L.; Hogan S.P.; Collison A.M.; Yang M.; Kaiko G.E.; Hansbro P.M.; Kumar R.K.; Mattes J.,"Foster, Paul S. (7201517569); Maltby, Steven (6507446799); Rosenberg, Helene F. (36788280500); Tay, Hock L. (55639898100); Hogan, Simon P. (56639502200); Collison, Adam M. (23995251200); Yang, Ming (56857729900); Kaiko, Gerard E. (21739529400); Hansbro, Philip M. (6603119390); Kumar, Rakesh K. (57203775042); Mattes, Joerg (7005999915)",7201517569; 6507446799; 36788280500; 55639898100; 56639502200; 23995251200; 56857729900; 21739529400; 6603119390; 57203775042; 7005999915,Modeling TH2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma,2017,Immunological Reviews,278,1,,20,40,20,109,10.1111/imr.12549,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020090520&doi=10.1111%2fimr.12549&partnerID=40&md5=ebebbfd80e2a86d4163c78b8f008cb30,"Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, United States; Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Paediatric Respiratory and Sleep Medicine Unit, Priority Research Centre for Healthy Lungs and GrowUpWell, University of Newcastle and Hunter Medical Research Institute, John Hunter Children's Hospital, Newcastle, NSW, Australia; Pathology, UNSW Sydney, School of Medical Sciences, Sydney, NSW, Australia","Foster P.S., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Maltby S., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Rosenberg H.F., Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, United States; Tay H.L., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Hogan S.P., Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Collison A.M., Paediatric Respiratory and Sleep Medicine Unit, Priority Research Centre for Healthy Lungs and GrowUpWell, University of Newcastle and Hunter Medical Research Institute, John Hunter Children's Hospital, Newcastle, NSW, Australia; Yang M., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Kaiko G.E., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences & Pharmacy, Faculty of Health and Hunter Medical Research Institute, The University of Newcastle, Callaghan, NSW, Australia; Kumar R.K., Pathology, UNSW Sydney, School of Medical Sciences, Sydney, NSW, Australia; Mattes J., Paediatric Respiratory and Sleep Medicine Unit, Priority Research Centre for Healthy Lungs and GrowUpWell, University of Newcastle and Hunter Medical Research Institute, John Hunter Children's Hospital, Newcastle, NSW, Australia",allergic inflammation; cytokine; innate immunity; microRNA; steroid resistance; T-helper cell,"Animals; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Asthma; Cell Communication; Chemokine CCL11; Cytokines; Disease Susceptibility; Drug Resistance; Humans; Immune System; Immunoglobulin E; Immunomodulation; MicroRNAs; Models, Biological; Respiratory Hypersensitivity; Signal Transduction; T-Lymphocyte Subsets; Th2 Cells; eotaxin; granulocyte macrophage colony stimulating factor; immunoglobulin E; interleukin 13; interleukin 3; interleukin 4; interleukin 5; monoclonal antibody; STAT6 protein; tumor necrosis factor related apoptosis inducing ligand; anti-IgE antibodies; antiasthmatic agent; antiidiotypic antibody; cytokine; eotaxin; immunoglobulin E; microRNA; airway epithelium cell; allergic airway inflammation; antigenic variation; asthma; cytokine production; disease exacerbation; eosinophil; human; immunopathogenesis; innate immunity; leukocyte migration; nonhuman; priority journal; respiratory tract inflammation; Review; signal transduction; Th2 cell; animal; asthma; biological model; cell communication; cytology; disease predisposition; drug resistance; genetics; immune system; immunology; immunomodulation; metabolism; pathology; respiratory tract allergy; T lymphocyte subpopulation; Th2 cell",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85020090520
Sunkara K.P.; Gupta G.; Hansbro P.M.; Dua K.; Bebawy M.,"Sunkara, Krishna P. (57190382716); Gupta, Gaurav (15047988400); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Bebawy, Mary (6506211522)",57190382716; 15047988400; 6603119390; 15759138700; 6506211522,Functional relevance of SATB1 in immune regulation and tumorigenesis,2018,Biomedicine and Pharmacotherapy,104,,,87,93,6,40,10.1016/j.biopha.2018.05.045,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047013361&doi=10.1016%2fj.biopha.2018.05.045&partnerID=40&md5=b90cb9799a9d46522277da1baf1cf9fd,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia","Sunkara K.P., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Apoptosis; EMT; Gene expression; Immune responses; Invasion; Metastasis; SATB1; Tumour,"Animals; Carcinogenesis; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Immunity; Matrix Attachment Region Binding Proteins; Neoplasms; binding protein; special AT rich sequence binding protein 1; unclassified drug; matrix attachment region binding protein; apoptosis; AT rich sequence; carcinogenesis; epithelial mesenchymal transition; gene targeting; human; immune response; immunoregulation; malignant neoplasm; metastasis; multidrug resistance; priority journal; Review; tumor growth; tumor immunity; tumor invasion; tumor microenvironment; animal; carcinogenesis; disease exacerbation; gene expression regulation; genetics; immunity; immunology; neoplasm; pathology",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85047013361
Keenan C.R.; Iannarella N.; Garnham A.L.; Brown A.C.; Kim R.Y.; Horvat J.C.; Hansbro P.M.; Nutt S.L.; Allan R.S.,"Keenan, Christine R. (37118918300); Iannarella, Nadia (57193393146); Garnham, Alexandra L. (57040848000); Brown, Alexandra C. (55637745000); Kim, Richard Y. (35810406900); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Nutt, Stephen L. (7004301216); Allan, Rhys S. (7201443562)",37118918300; 57193393146; 57040848000; 55637745000; 35810406900; 9942405300; 6603119390; 7004301216; 7201443562,Polycomb repressive complex 2 is a critical mediator of allergic inflammation,2019,JCI Insight,4,10,e127745,,,,15,10.1172/jci.insight.127745,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070659892&doi=10.1172%2fjci.insight.127745&partnerID=40&md5=aaaf27760cf7fe16ad81f5416768c7c5,"Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia","Keenan C.R., Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Iannarella N., Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia; Garnham A.L., Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia; Nutt S.L., Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Allan R.S., Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia, Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia",,"Animals; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Silencing; Inflammation; Lung; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Polycomb Repressive Complex 2; T-Lymphocytes; gsk 126; immunomodulating agent; methyltransferase; polycomb repressive complex 2; transcription factor EZH2; unclassified drug; Ezh2 protein, mouse; polycomb repressive complex 2; transcription factor EZH2; allergic disease; allergic inflammation; allergic inflammation; animal cell; animal experiment; animal model; animal tissue; apoptosis; Article; bioaccumulation; CD4+ T lymphocyte; cell expansion; controlled study; disease association; dose response; drug effect; drug efficacy; drug mechanism; epigenetics; gene silencing; immune response; in vivo study; lymphocyte count; mouse; nonhuman; signal transduction; single drug dose; T lymphocyte activation; treatment outcome; wild type; animal; C57BL mouse; genetic epigenesis; genetics; immunology; inflammation; lung; lymphocyte activation; pathology; T lymphocyte",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85070659892
Soni N.; Tekade M.; Kesharwani P.; Bhattacharya P.; Maheshwari R.; Dua K.; Hansbro P.M.; Tekade R.K.,"Soni, Namrata (56978764000); Tekade, Muktika (56502403400); Kesharwani, Prashant (36054993300); Bhattacharya, Pallab (52363195500); Maheshwari, Rahul (54581307100); Dua, Kamal (15759138700); Hansbro, Philp M. (6603119390); Tekade, Rakesh Kumar (57204717123)",56978764000; 56502403400; 36054993300; 52363195500; 54581307100; 15759138700; 6603119390; 57204717123,Recent advances in oncological submissions of dendrimer,2017,Current Pharmaceutical Design,23,21,,3084,3098,14,56,10.2174/1381612823666170329150201,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031733507&doi=10.2174%2f1381612823666170329150201&partnerID=40&md5=c9244bab04a1c088a04c998996a60f36,"Faculty of Health Sciences, Sam Higginbottom Institute of Agriculture, Technology and Sciences (Deemed University), Allahabad, UP, India; TIT College of Pharmacy, Technocrats Institute of Technology Campus, Anand Nagar, Raisen Road, Bhopal, 462021, MP, India; School of Pharmacy, Department of Pharmaceutical Technology, International Medical University, Jalan Jalil Perkasa 19, Kuala Lumpur, 57000, Malaysia; National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad, Opposite Air Force Station Palaj, Gandhinagar, 382355, Gujarat, India; Department of Pharmaceutics, BM College of Pharmaceutical Education & Research, Indore, 452020, MP, India; Graduate School of Health, University of Technology Sydney, Ultimo, Sydney, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia","Soni N., Faculty of Health Sciences, Sam Higginbottom Institute of Agriculture, Technology and Sciences (Deemed University), Allahabad, UP, India; Tekade M., TIT College of Pharmacy, Technocrats Institute of Technology Campus, Anand Nagar, Raisen Road, Bhopal, 462021, MP, India; Kesharwani P., School of Pharmacy, Department of Pharmaceutical Technology, International Medical University, Jalan Jalil Perkasa 19, Kuala Lumpur, 57000, Malaysia; Bhattacharya P., National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad, Opposite Air Force Station Palaj, Gandhinagar, 382355, Gujarat, India; Maheshwari R., Department of Pharmaceutics, BM College of Pharmaceutical Education & Research, Indore, 452020, MP, India; Dua K., Graduate School of Health, University of Technology Sydney, Ultimo, Sydney, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Tekade R.K., National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad, Opposite Air Force Station Palaj, Gandhinagar, 382355, Gujarat, India",Cancer diagnosis; Cancer therapy; Dendrimers; Malignant tumor morphology; Oncology; Surgical resection,Dendrimers; Humans; Neoplasm Metastasis; Neoplasms; antineoplastic agent; boron; dendrimer; membrane antigen; microRNA; peptide; photosensitizing agent; polyamidoamine; protein; radiopharmaceutical agent; small interfering RNA; dendrimer; antiangiogenic therapy; antigen expression; antigen specificity; biosafety; cancer chemotherapy; cancer diagnosis; cancer gene therapy; cancer growth; cancer morphology; cancer prognosis; cancer radiotherapy; cancer surgery; cancer survival; cancer therapy; cell damage; chemical structure; drug delivery system; gene delivery system; growth rate; human; malignant neoplasm; medical technology; molecular biology; molecular interaction; nanotechnology; nonhuman; oncology; photodynamic therapy; priority journal; purification; Review; synthesis; tumor vascularization; chemistry; metastasis; neoplasm; pathology,Review,Final,,Scopus,2-s2.0-85031733507
Awasthi R.; Roseblade A.; Hansbro P.M.; Rathbone M.J.; Dua K.; Bebawy M.,"Awasthi, Rajendra (36866066100); Roseblade, Ariane (55962671700); Hansbro, Philip Michael (6603119390); Rathbone, Michael John (7005254043); Dua, Kamal (15759138700); Bebawy, Mary (6506211522)",36866066100; 55962671700; 6603119390; 7005254043; 15759138700; 6506211522,Nanoparticles in cancer treatment: Opportunities and obstacles,2018,Current Drug Targets,19,14,,1696,1709,13,164,10.2174/1389450119666180326122831,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047070846&doi=10.2174%2f1389450119666180326122831&partnerID=40&md5=d6e115efce2917dd488dcdf6ffce1f46,"NKBR College of Pharmacy and Research Centre, Meerut, 45206, Uttar Pradesh, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, 2308, Australia; ULTI Pharmaceuticals, Hamilton, 3204, New Zealand; School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, Himachal Pradesh, India","Awasthi R., NKBR College of Pharmacy and Research Centre, Meerut, 45206, Uttar Pradesh, India; Roseblade A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, 2308, Australia; Rathbone M.J., ULTI Pharmaceuticals, Hamilton, 3204, New Zealand; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, Himachal Pradesh, India; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia",Cancer; Carbon nanotube; Cellular targeting; Chemotherapy; Diagnostics; Extracellular vesicles; Microparticles; MicroRNA; Multidrug resistance; Nanomedicine; Nanoprarticles; P-glycoprotein,"Antineoplastic Agents; Clinical Trials as Topic; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Nanoparticles; Neoplasms; Organ Specificity; ABC transporter; complementary DNA; complementary RNA; dendrimer; doxorubicin; epidermal growth factor receptor 2; glycoprotein; gold nanoparticle; ligand; liposome; macrogol 10000; magnetic nanoparticle; matrix metalloproteinase; nanocarrier; nanocrystal; nanoparticle; nanotube; paclitaxel; polycaprolactone; quantum dot; reactive oxygen metabolite; silica nanoparticle; silk fibroin; silver nanoparticle; small interfering RNA; solid lipid nanoparticle; stabilizing agent; ultrasmall superparamagnetic iron oxide; unindexed drug; vitronectin receptor; antineoplastic agent; nanoparticle; antineoplastic activity; apoptosis; bioavailability; biomedical technology assessment; cancer therapy; chemotherapy-induced peripheral neuropathy; cytotoxicity; DNA repair; drug cost; drug delivery system; drug mechanism; drug penetration; drug release; drug retention; drug stability; drug targeting; drug tumor level; endocytosis; gene expression; granite; human; loss of appetite; membrane microparticle; micelle; multidrug resistance; nanoencapsulation; nanomedicine; nanotechnology; nuclear magnetic resonance imaging; particle size; phenotype; proteomics; Review; tumor microenvironment; tumor vascularization; antibody specificity; chemistry; clinical trial (topic); drug resistance; neoplasm",Review,Final,,Scopus,2-s2.0-85047070846
Leung J.M.; Tiew P.Y.; Mac Aogáin M.; Budden K.F.; Yong V.F.L.; Thomas S.S.; Pethe K.; Hansbro P.M.; Chotirmall S.H.,"Leung, Janice M. (36087521200); Tiew, Pei Yee (57118125600); Mac Aogáin, Micheál (33667783800); Budden, Kurtis F. (57191417986); Yong, Valerie Fei Lee (57193742992); Thomas, Sangeeta S. (57193789747); Pethe, Kevin (57215569969); Hansbro, Philip M. (6603119390); Chotirmall, Sanjay H. (15757175700)",36087521200; 57118125600; 33667783800; 57191417986; 57193742992; 57193789747; 57215569969; 6603119390; 15757175700,The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD,2017,Respirology,22,4,,634,650,16,148,10.1111/resp.13032,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016552715&doi=10.1111%2fresp.13032&partnerID=40&md5=b78dd6145a19b18e26a58e1545a175e8,"Centre for Heart Lung Innovation, Vancouver, BC, Canada; Division of Respiratory Medicine, St Paul's Hospital, University of British Columbia, Vancouver, BC, Canada; Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia","Leung J.M., Centre for Heart Lung Innovation, Vancouver, BC, Canada, Division of Respiratory Medicine, St Paul's Hospital, University of British Columbia, Vancouver, BC, Canada; Tiew P.Y., Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore; Mac Aogáin M., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Budden K.F., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Yong V.F.L., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Thomas S.S., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Pethe K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore",acute exacerbations of chronic obstructive pulmonary disease; chronic obstructive pulmonary disease; colonization; infection; microbiome,"Acute Disease; Bacteria; Bacterial Infections; Disease Progression; Humans; Pulmonary Disease, Chronic Obstructive; Respiratory System; Respiratory Tract Infections; antibiotic agent; azithromycin; beta 2 adrenergic receptor stimulating agent; corticosteroid; macrolide; placebo; quinoline derived antiinfective agent; acute exacerbation of chronic obstructive pulmonary disease; adenovirus infection; airway remodeling; antibiotic resistance; atypical mycobacteriosis; bacterial colonization; bacterial load; chronic obstructive lung disease; disease exacerbation; fungal colonization; Haemophilus infection; human; lung aspergillosis; Moraxellaceae infection; mouse model; multidrug resistance; nonhuman; pathogenesis; pneumococcal infection; Pneumocystis pneumonia; prognosis; respiratory tract infection; respiratory tract inflammation; Review; superinfection; tuberculosis; acute disease; bacterial infection; bacterium; chronic obstructive lung disease; complication; disease exacerbation; isolation and purification; microbiology; respiratory system; respiratory tract infection",Review,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85016552715
Dua K.; Shukla S.D.; Tekade R.K.; Hansbro P.M.,"Dua, Kamal (15759138700); Shukla, Shakti D. (56367620800); Tekade, Rakesh K. (57204717123); Hansbro, Philip M. (6603119390)",15759138700; 56367620800; 57204717123; 6603119390,Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?,2017,Drug Delivery and Translational Research,7,1,,179,187,8,41,10.1007/s13346-016-0349-0,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009816123&doi=10.1007%2fs13346-016-0349-0&partnerID=40&md5=90ca9f62f7e42f604c08b28e259e75c0,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; National Institute of Pharmaceutical Education and Research, Gandhinagar, 382355, Gujarat, India","Dua K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Tekade R.K., National Institute of Pharmaceutical Education and Research, Gandhinagar, 382355, Gujarat, India; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia",Biofilms; Drug delivery; Pulmonary,Animals; Biofilms; Drug Delivery Systems; Drug Resistance; Humans; Respiratory Tract Diseases; antibiotic agent; antibiotic resistance; biofilm; disease association; drug delivery system; human; priority journal; respiratory tract disease; Review; animal; drug resistance; Respiratory Tract Diseases,Review,Final,,Scopus,2-s2.0-85009816123
Eapen M.S.; Sharma P.; Moodley Y.P.; Hansbro P.M.; Sohal S.S.,"Eapen, Mathew Suji (56625716100); Sharma, Pawan (57202573033); Moodley, Yuben P. (6602358911); Hansbro, Philip M. (6603119390); Sohal, Sukhwinder Singh (36449981500)",56625716100; 57202573033; 6602358911; 6603119390; 36449981500,Dysfunctional immunity and microbial adhesion molecules in smoking-induced pneumonia,2019,American Journal of Respiratory and Critical Care Medicine,199,2,,250,251,1,21,10.1164/rccm.201808-1553LE,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056161495&doi=10.1164%2frccm.201808-1553LE&partnerID=40&md5=44332291609a256cfb893b1f734af6a9,"University of Tasmania Tasmania, Australia; University of Technology Sydney, Sydney, Australia; University of Sydney, Sydney, Australia; Institute of Respiratory Health Perth, Australia; University of Western Australia Perth, Australia; Fiona Stanley Hospital, Murdoch, Australia; University of Technology, Sydney, Australia; University of Newcastle Callaghan, Australia; Hunter Medical Research Institute, Newcastle, Australia; Centenary Institute, Sydney, Australia","Eapen M.S., University of Tasmania Tasmania, Australia; Sharma P., University of Technology Sydney, Sydney, Australia, University of Sydney, Sydney, Australia; Moodley Y.P., Institute of Respiratory Health Perth, Australia, University of Western Australia Perth, Australia, Fiona Stanley Hospital, Murdoch, Australia; Hansbro P.M., University of Technology, Sydney, Australia, University of Newcastle Callaghan, Australia, Hunter Medical Research Institute, Newcastle, Australia, Centenary Institute, Sydney, Australia; Sohal S.S., University of Tasmania Tasmania, Australia",,Cell Adhesion Molecules; Humans; Macrophages; Pneumonia; Smoke; Smoking; CD68 antigen; cigarette smoke; corticosteroid; cytokine; inducible nitric oxide synthase; intercellular adhesion molecule 1; phosphorylcholine; Rac2 protein; thrombocyte activating factor receptor; cell adhesion molecule; bacterial infection; CD4+ T lymphocyte; CD8+ T lymphocyte; cell population; cellular immunity; chronic obstructive lung disease; corticosteroid therapy; epithelial attachment; Haemophilus influenzae; human; Letter; lung alveolus macrophage; macrophage; microbial adhesion; neutrophil; pneumonia; priority journal; Pseudomonas aeruginosa; smoking; Staphylococcus aureus; virus infection; smoke,Letter,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85056161495
Cameron G.J.M.; Jiang S.H.; Loering S.; Deshpande A.V.; Hansbro P.M.; Starkey M.R.,"Cameron, Guy J M (57203977896); Jiang, Simon H (36952990000); Loering, Svenja (57205469740); Deshpande, Aniruddh V (25822132400); Hansbro, Philip M (6603119390); Starkey, Malcolm R (35811293400)",57203977896; 36952990000; 57205469740; 25822132400; 6603119390; 35811293400,Emerging therapeutic potential of group 2 innate lymphoid cells in acute kidney injury,2019,Journal of Pathology,248,1,,9,15,6,15,10.1002/path.5242,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062539270&doi=10.1002%2fpath.5242&partnerID=40&md5=8e5bb63ef818cddbcf00b52745da54e0,"Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australia National University, Canberra, ACT, Australia; Department of Renal Medicine, The Canberra Hospital, Canberra, ACT, Australia; The John Hunter Children's Hospital, New Lambton Heights, NSW, Australia; Centre for inflammation, Centenary Institute, Sydney, NSW, Australia; Faculty of Science, University of Technology, Ultimo, NSW, Australia","Cameron G.J.M., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Jiang S.H., Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australia National University, Canberra, ACT, Australia, Department of Renal Medicine, The Canberra Hospital, Canberra, ACT, Australia; Loering S., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Deshpande A.V., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, The John Hunter Children's Hospital, New Lambton Heights, NSW, Australia; Hansbro P.M., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Centre for inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology, Ultimo, NSW, Australia; Starkey M.R., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia",acute kidney injury; alternatively activated macrophages; group 2 innate lymphoid cell; ILC2; innate immunity; ischemia–reperfusion injury; type 2 immunity,"Acute Kidney Injury; Adaptive Immunity; Animals; Cell- and Tissue-Based Therapy; Disease Models, Animal; Humans; Immunity, Innate; Interleukin-33; Lymphocyte Activation; Lymphocyte Subsets; Mice; interleukin 33; interleukin 33; acute kidney failure; adaptive immunity; cell therapy; experimental model; immune response; inflammatory cell; innate immunity; kidney injury; lymphoid cell; natural killer cell; nonhuman; priority journal; Review; acute kidney failure; animal; biological therapy; disease model; human; immunology; lymphocyte activation; lymphocyte subpopulation; mouse; procedures; transplantation",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85062539270
Ng Kee Kwong F.; Nicholson A.G.; Harrison C.L.; Hansbro P.M.; Adcock I.M.; Chung K.F.,"Ng Kee Kwong, Francois (55828297100); Nicholson, Andrew G. (7201890673); Harrison, Celeste L. (57191953268); Hansbro, Philip M. (6603119390); Adcock, Ian M. (7007066538); Chung, Kian Fan (35403525000)",55828297100; 7201890673; 57191953268; 6603119390; 7007066538; 35403525000,Is mitochondrial dysfunction a driving mechanism linking COPD to nonsmall cell lung carcinoma?,2017,European Respiratory Review,26,146,170040,,,,43,10.1183/16000617.0040-2017,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032486103&doi=10.1183%2f16000617.0040-2017&partnerID=40&md5=48b073f394dd966d32788da3c26a6bff,"Experimental Studies, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Dept of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom; School of Biomedical Sciences and Pharmacy, Newcastle, Australia; Airways Disease, National Heart and Lung Institute, Imperial College London, London, United Kingdom","Ng Kee Kwong F., Experimental Studies, National Heart and Lung Institute, Imperial College London, London, United Kingdom, Dept of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom; Nicholson A.G., Experimental Studies, National Heart and Lung Institute, Imperial College London, London, United Kingdom, Dept of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom; Harrison C.L., School of Biomedical Sciences and Pharmacy, Newcastle, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, Newcastle, Australia; Adcock I.M., Airways Disease, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Chung K.F., Experimental Studies, National Heart and Lung Institute, Imperial College London, London, United Kingdom",,"Animals; Carcinoma, Non-Small-Cell Lung; Cell Transformation, Neoplastic; Disease Models, Animal; Humans; Inflammation Mediators; Lung; Lung Neoplasms; Mitochondria; Mitochondrial Degradation; Mitochondrial Diseases; Mitochondrial Dynamics; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Risk Factors; Signal Transduction; Smoking; cigarette smoke; parkin; Pink1 protein; protein serine threonine kinase; reactive oxygen metabolite; unclassified drug; autacoid; chronic inflammation; chronic obstructive lung disease; disease association; disorders of mitochondrial functions; gene mutation; human; lung carcinogenesis; mitochondrial biogenesis; mitochondrial dynamics; mitochondrion; mitophagy; mouse model; non small cell lung cancer; nonhuman; oxidative stress; Review; risk factor; smoking; animal; cell transformation; chronic obstructive lung disease; disease model; disorders of mitochondrial functions; lung; lung tumor; metabolism; non small cell lung cancer; pathology; signal transduction",Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85032486103
Idowu O.; Semple K.T.; Ramadass K.; O'Connor W.; Hansbro P.; Thavamani P.,"Idowu, Oluyoye (57205270803); Semple, Kirk T. (56926918800); Ramadass, Kavitha (20436756800); O'Connor, Wayne (23025552100); Hansbro, Phil (6603119390); Thavamani, Palanisami (23567398800)",57205270803; 56926918800; 20436756800; 23025552100; 6603119390; 23567398800,Beyond the obvious: Environmental health implications of polar polycyclic aromatic hydrocarbons,2019,Environment International,123,,,543,557,14,290,10.1016/j.envint.2018.12.051,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059349141&doi=10.1016%2fj.envint.2018.12.051&partnerID=40&md5=cb3246025bcfe1b85520b7f872f5f81f,"Global Centre for Environmental Remediation (GCER), University of Newcastle, Callaghan, 2308, NSW, Australia; Lancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, United Kingdom; Global Innovative Centre for Advanced Nanomaterials (GICAN), University of Newcastle, Callaghan, 2308, NSW, Australia; Port Stephens Fisheries Institute, NSW Department of Primary Industries, Port Stephens, Australia; Centre for Inflammation, Centenary Institute, Australia; University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia","Idowu O., Global Centre for Environmental Remediation (GCER), University of Newcastle, Callaghan, 2308, NSW, Australia; Semple K.T., Lancaster Environment Centre, Lancaster University, Lancaster, LA1 4YQ, United Kingdom; Ramadass K., Global Innovative Centre for Advanced Nanomaterials (GICAN), University of Newcastle, Callaghan, 2308, NSW, Australia; O'Connor W., Port Stephens Fisheries Institute, NSW Department of Primary Industries, Port Stephens, Australia; Hansbro P., Centre for Inflammation, Centenary Institute, Australia, University of Technology Sydney, Faculty of Science, Ultimo, 2007, NSW, Australia; Thavamani P., Global Centre for Environmental Remediation (GCER), University of Newcastle, Callaghan, 2308, NSW, Australia",Carcinogenesis; Environmental health; Human health; Mutagenesis; Polar polycyclic aromatic hydrocarbons,"Biodegradation, Environmental; Biological Availability; Carcinogenesis; Carcinogens; DNA Damage; Environmental Health; Humans; Mutagens; Oxidative Stress; Polycyclic Aromatic Hydrocarbons; Aromatization; Gene expression; Health risks; International cooperation; Mineral oils; Mutagenesis; Oxygen; Pathology; Risk assessment; Toxicity; aromatic hydrocarbon receptor; heterocyclic compound; heterocyclic polycyclic aromatic hydrocarbon; homocyclic polycyclic aromatic hydrocarbon; nitrated polycyclic aromatic hydrocarbon; nitrogen; oxygen; oxygenated polycyclic aromatic hydrocarbon; polar polycyclic aromatic hydrocarbon; polycyclic aromatic hydrocarbon; sulfur; unclassified drug; water; carcinogen; mutagenic agent; polycyclic aromatic hydrocarbon; Carcinogenesis; Carcinogenic effects; Environmental health; Environmental mobility; Estrogenic activities; Human health; International agency for research on cancers; Toxicological effects; ecosystem health; endocrine disruptor; gene expression; mutagenicity; oxidative stress; PAH; public health; reactive oxygen species; air; carcinogenic activity; carcinogenicity; chemical composition; developmental toxicity; ecosystem restoration; environmental exposure; environmental health; environmental impact; genotoxicity; mutagenic activity; oxidative stress; physical chemistry; priority journal; Review; risk assessment; soil; teratogenicity; bioavailability; bioremediation; carcinogenesis; chemistry; DNA damage; drug effect; environmental health; human; Polycyclic aromatic hydrocarbons",Review,Final,All Open Access; Gold Open Access,Scopus,2-s2.0-85059349141
Liu G.; Cooley M.A.; Nair P.M.; Donovan C.; Hsu A.C.; Jarnicki A.G.; Haw T.J.; Hansbro N.G.; Ge Q.; Brown A.C.; Tay H.; Foster P.S.; Wark P.A.; Horvat J.C.; Bourke J.E.; Grainge C.L.; Argraves W.S.; Oliver B.G.; Knight D.A.; Burgess J.K.; Hansbro P.M.,"Liu, Gang (57189061134); Cooley, Marion A (21644972000); Nair, Prema M (55749131000); Donovan, Chantal (55357105200); Hsu, Alan C (49861516600); Jarnicki, Andrew G (6603137164); Haw, Tatt Jhong (56625918900); Hansbro, Nicole G (15055862300); Ge, Qi (57225753617); Brown, Alexandra C (55637745000); Tay, Hock (55639898100); Foster, Paul S (7201517569); Wark, Peter A (7003559516); Horvat, Jay C (9942405300); Bourke, Jane E (35770333500); Grainge, Chris L (57192248350); Argraves, W Scott (7006209539); Oliver, Brian G (15919869900); Knight, Darryl A (7402350036); Burgess, Janette K (7201650628); Hansbro, Philip M (6603119390)",57189061134; 21644972000; 55749131000; 55357105200; 49861516600; 6603137164; 56625918900; 15055862300; 57225753617; 55637745000; 55639898100; 7201517569; 7003559516; 9942405300; 35770333500; 57192248350; 7006209539; 15919869900; 7402350036; 7201650628; 6603119390,Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c,2017,Journal of Pathology,243,4,,510,523,13,89,10.1002/path.4979,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034273747&doi=10.1002%2fpath.4979&partnerID=40&md5=f3229940d4e355c9dcf4b5e296f3a1d3,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, Australia; Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Parkville, VIC, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, Groningen Research Institute of Asthma and COPD, Groningen, Netherlands","Liu G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Cooley M.A., Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Nair P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Hsu A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Jarnicki A.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia, Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, VIC, Australia; Haw T.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Ge Q., Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Tay H., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Bourke J.E., Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Parkville, VIC, Australia; Grainge C.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Argraves W.S., Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Oliver B.G., Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Knight D.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Burgess J.K., Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia, University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, Groningen Research Institute of Asthma and COPD, Groningen, Netherlands; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia",airway hyperresponsiveness; airway remodelling; allergic airway disease; asthma; collagen; fibrosis; fibulin-1; inflammation; lung function,"Actins; Airway Remodeling; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Calcium-Binding Proteins; Cells, Cultured; Coculture Techniques; Cytokines; Disease Models, Animal; Extracellular Matrix Proteins; Female; Genotype; Humans; Inflammation; Inflammation Mediators; Lung; Lymph Nodes; Mice, Inbred C57BL; Mice, Knockout; Phenotype; RNA Interference; Signal Transduction; T-Lymphocytes; Time Factors; Transfection; alpha smooth muscle actin; collagen; CXCL1 chemokine; fibronectin; fibulin; fibulin 1c; interleukin 13; interleukin 33; interleukin 5; mucin 5AC; mucin 5B; transcription factor GATA 3; transcription factor RUNX2; tumor necrosis factor; unclassified drug; actin; alpha-smooth muscle actin, mouse; autacoid; calcium binding protein; cytokine; fibulin; scleroprotein; airway remodeling; allergy; animal experiment; animal model; Article; asthma; coculture; controlled study; dendritic cell; Dermatophagoides; epithelium cell; extracellular matrix; female; gene deletion; human; human cell; inflammatory cell; lymph node; lymphatic drainage; mouse; muscle contractility; nonhuman; pneumonia; priority journal; protein protein interaction; respiratory tract disease; T lymphocyte; animal; asthma; bronchoconstriction; bronchus hyperreactivity; C57BL mouse; cell culture; deficiency; disease model; genetic transfection; genetics; genotype; immunology; inflammation; knockout mouse; lung; metabolism; pathophysiology; phenotype; RNA interference; signal transduction; time factor",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85034273747
Jones B.; Donovan C.; Liu G.; Gomez H.M.; Chimankar V.; Harrison C.L.; Wiegman C.H.; Adcock I.M.; Knight D.A.; Hirota J.A.; Hansbro P.M.,"Jones, Bernadette (56215070300); Donovan, Chantal (55357105200); Liu, Gang (57189061134); Gomez, Henry M. (57191960363); Chimankar, Vrushali (57191957166); Harrison, Celeste L. (57191953268); Wiegman, Cornelis H. (57063112500); Adcock, Ian M. (7007066538); Knight, Darryl A. (7402350036); Hirota, Jeremy A. (7007085348); Hansbro, Philip M. (6603119390)",56215070300; 55357105200; 57189061134; 57191960363; 57191957166; 57191953268; 57063112500; 7007066538; 7402350036; 7007085348; 6603119390,Animal models of COPD: What do they tell us?,2017,Respirology,22,1,,21,32,11,127,10.1111/resp.12908,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995489135&doi=10.1111%2fresp.12908&partnerID=40&md5=b590f11adcc27860c5df7a00139e725f,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia, London, United Kingdom; The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada","Jones B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia, London, United Kingdom; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia, London, United Kingdom; Liu G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia, London, United Kingdom; Gomez H.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia, London, United Kingdom; Chimankar V., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia, London, United Kingdom; Harrison C.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia, London, United Kingdom; Wiegman C.H., The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Adcock I.M., The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Knight D.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia, London, United Kingdom; Hirota J.A., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia, London, United Kingdom",animal models; chronic obstructive pulmonary disease; disease mechanisms; therapeutic targets; therapies,"Airway Remodeling; Animals; Disease Models, Animal; Disease Progression; Humans; Pulmonary Disease, Chronic Obstructive; 2 morpholino 8 phenylchromone; 4 [4 (4 fluorophenyl) 5 (2 methoxy 4 pyrimidinyl) 1 imidazolyl]cyclohexanol; abx il8; biological marker; cigarette smoke; lipopolysaccharide; mitogen activated protein kinase p38 inhibitor; monoclonal antibody; theophylline; unclassified drug; zd 0892; air pollution; airway remodeling; animal model; antiinflammatory activity; bacterial infection; bronchodilatation; Chlamydia pneumoniae; chronic obstructive lung disease; cytokine release; disease exacerbation; disease model; drug blood level; drug efficacy; drug research; drug targeting; ferret; guinea pig; innate immunity; low drug dose; lung emphysema; lung function; lung insufficiency; medical research; mouse; nonhuman; oxidative stress; pathophysiology; personalized medicine; phase 2 clinical trial (topic); pneumonia; priority journal; Pseudomonas aeruginosa; rat; Review; sex difference; symptomatology; virus infection; animal; chronic obstructive lung disease; human; pathology",Review,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84995489135
Rutting S.; Papanicolaou M.; Xenaki D.; Wood L.G.; Mullin A.M.; Hansbro P.M.; Oliver B.G.,"Rutting, Sandra (57202399992); Papanicolaou, Michael (57204551454); Xenaki, Dia (6507411538); Wood, Lisa G. (55859741700); Mullin, Alexander M. (57204547071); Hansbro, Philip M. (6603119390); Oliver, Brian G. (15919869900)",57202399992; 57204551454; 6507411538; 55859741700; 57204547071; 6603119390; 15919869900,"Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD",2018,Respiratory Research,19,1,211,,,,27,10.1186/s12931-018-0919-4,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056133603&doi=10.1186%2fs12931-018-0919-4&partnerID=40&md5=9882fe0af7171ca280c58b13121c6ec8,"Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, Australia","Rutting S., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Papanicolaou M., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia, School of Life Sciences, University of Technology Sydney, Sydney, Australia; Xenaki D., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Mullin A.M., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Oliver B.G., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia, School of Life Sciences, University of Technology Sydney, Sydney, Australia",Airway inflammation; COPD; Human pulmonary fibroblasts; Remodelling; ω-6 PUFAs,"Adult; Aged; Arachidonic Acid; Cells, Cultured; Extracellular Matrix Proteins; Fatty Acids, Omega-6; Female; Fibroblasts; Gene Expression; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; arachidonic acid; collagen type 1; cyclooxygenase 2; dexamethasone; fibronectin; interleukin 6; interleukin 8; messenger RNA; omega 6 fatty acid; perlecan; saturated fatty acid; scleroprotein; tenascin; tumor necrosis factor; arachidonic acid; autacoid; omega 6 fatty acid; scleroprotein; adult; Article; body mass; chronic obstructive lung disease; controlled study; cytokine production; cytokine release; cytotoxicity; disease association; enzyme linked immunosorbent assay; fat intake; female; fibroblast; gene expression; human; human cell; inflammation; major clinical study; male; aged; antagonists and inhibitors; biosynthesis; cell culture; chemically induced; chronic obstructive lung disease; drug effect; genetics; inflammation; metabolism; middle aged; pathology",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85056133603
Dua K.; Awasthi R.; Madan J.R.; Chellappan D.K.; Nalluri B.N.; Gupta G.; Bebawy M.; Hansbro P.M.,"Dua, Kamal (15759138700); Awasthi, Rajendra (36866066100); Madan, Jyotsana R. (26534689100); Chellappan, Dinesh K. (35811890500); Nalluri, Buchi N. (6505973092); Gupta, Gaurav (15047988400); Bebawy, Mary (6506211522); Hansbro, Philip M. (6603119390)",15759138700; 36866066100; 26534689100; 35811890500; 6505973092; 15047988400; 6506211522; 6603119390,Novel drug delivery approaches in treating pulmonary fibrosis,2018,Panminerva Medica,60,4,,238,240,2,9,10.23736/S0031-0808.18.03428-6,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052464337&doi=10.23736%2fS0031-0808.18.03428-6&partnerID=40&md5=b0218a7cecf959b48fe67ffaeb57c779,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, NSW, Australia; NKBR College of Pharmacy and Research Centre, Meerut, Uttar Pradesh, India; Department of Pharmaceutics, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, Maharashtra, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia; Department of Pharmaceutics, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, India; Jaipur National University, School of Pharmaceutical Sciences, Jagatpura, Jaipur, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Dua K., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Awasthi R., NKBR College of Pharmacy and Research Centre, Meerut, Uttar Pradesh, India; Madan J.R., Department of Pharmaceutics, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, Maharashtra, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia; Nalluri B.N., Department of Pharmaceutics, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, India; Gupta G., Jaipur National University, School of Pharmaceutical Sciences, Jagatpura, Jaipur, India; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia",,"Animals; Drug Delivery Systems; HEK293 Cells; Humans; Lipids; Lung; Lung Diseases; Medication Adherence; Mice; Nanocapsules; Pulmonary Fibrosis; RNA, Small Interfering; Th1 Cells; Th2 Cells; lipid; nanocapsule; small interfering RNA; animal; chemistry; drug delivery system; drug effect; HEK293 cell line; human; lung; lung disease; lung fibrosis; medication compliance; metabolism; mouse; Th1 cell; Th2 cell",Letter,Final,,Scopus,2-s2.0-85052464337
Pathinayake P.S.; Hsu A.C.-Y.; Waters D.W.; Hansbro P.M.; Wood L.G.; Wark P.A.B.,"Pathinayake, Prabuddha S. (55877978000); Hsu, Alan C.-Y. (49861516600); Waters, David W. (57194028630); Hansbro, Philip M. (6603119390); Wood, Lisa G. (55859741700); Wark, Peter A.B. (7003559516)",55877978000; 49861516600; 57194028630; 6603119390; 55859741700; 7003559516,Understanding the unfolded protein response in the pathogenesis of asthma,2018,Frontiers in Immunology,9,FEB,175,,,,41,10.3389/fimmu.2018.00175,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041746956&doi=10.3389%2ffimmu.2018.00175&partnerID=40&md5=9ac6cf3e07acacd3877a10798ac954b0,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia","Pathinayake P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hsu A.C.-Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Waters D.W., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia",Asthma; Endoplasmic reticulum stress; Inflammation; Innate immunity; Unfolded protein response,activating transcription factor 6; cryopyrin; glutathione; immunoglobulin E; interleukin 13; interleukin 4; interleukin 5; interleukin 9; transcription factor GATA 3; transforming growth factor beta; tumor necrosis factor receptor; allergen exposure; apoptosis; asthma; bronchus epithelium; Dermatophagoides; developmental disorder; endoplasmic reticulum; endoplasmic reticulum associated degradation; endoplasmic reticulum stress; human; immune response; immunoglobulin production; inflammation; inflammatory disease; lung infection; metabolic disorder; molecular pathology; nonhuman; oxidative stress; protein synthesis; receptor upregulation; respiratory epithelium; Review; signal transduction; unfolded protein response,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85041746956
Peel R.; Ren S.; Hure A.; Evans T.-J.; D'Este C.A.; Abhayaratna W.P.; Tonkin A.M.; Hopper I.; Thrift A.G.; Levi C.R.; Sturm J.; Durrheim D.; Hung J.; Briffa T.G.; Chew D.P.; Anderson P.; Moon L.; McEvoy M.; Hansbro P.M.; Newby D.A.; Attia J.R.,"Peel, Roseanne (55207142000); Ren, Shu (57189216570); Hure, Alexis (24070975100); Evans, Tiffany-Jane (26634998400); D'Este, Catherine A (6602084604); Abhayaratna, Walter P (12759938700); Tonkin, Andrew M (34572757300); Hopper, Ingrid (57208096319); Thrift, Amanda G (7004824524); Levi, Christopher R (26643279200); Sturm, Jonathan (7202194795); Durrheim, David (35551260900); Hung, Joseph (35409388600); Briffa, Tom G (6507675518); Chew, Derek P (7102026332); Anderson, Phil (24503016000); Moon, Lynelle (26641374700); McEvoy, Mark (8911690100); Hansbro, Philip M (6603119390); Newby, David A (7006580756); Attia, John R (7003299759)",55207142000; 57189216570; 24070975100; 26634998400; 6602084604; 12759938700; 34572757300; 57208096319; 7004824524; 26643279200; 7202194795; 35551260900; 35409388600; 6507675518; 7102026332; 24503016000; 26641374700; 8911690100; 6603119390; 7006580756; 7003299759,"Evaluating recruitment strategies for AUSPICE, a large Australian community-based randomised controlled trial",2019,Medical Journal of Australia,210,9,,409,415,6,13,10.5694/mja2.50117,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063394750&doi=10.5694%2fmja2.50117&partnerID=40&md5=29a4e21e05c11d724d4129fc8cc91558,"University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia; National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia; Australian National University Medical School, Canberra Hospital, Canberra, ACT, Australia; Monash University, Melbourne, VIC, Australia; Sir Charles Gairdner Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA, Australia; Flinders University, Adelaide, SA, Australia; Australian Institute of Health and Welfare, Canberra, ACT, Australia; Centenary UTS Centre for Inflammation, Sydney, NSW, Australia; Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, NSW, Australia","Peel R., University of Newcastle, Newcastle, NSW, Australia; Ren S., University of Newcastle, Newcastle, NSW, Australia; Hure A., University of Newcastle, Newcastle, NSW, Australia; Evans T.-J., Hunter Medical Research Institute, Newcastle, NSW, Australia; D'Este C.A., National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia; Abhayaratna W.P., Australian National University Medical School, Canberra Hospital, Canberra, ACT, Australia; Tonkin A.M., Monash University, Melbourne, VIC, Australia; Hopper I., Monash University, Melbourne, VIC, Australia; Thrift A.G., Monash University, Melbourne, VIC, Australia; Levi C.R., University of Newcastle, Newcastle, NSW, Australia; Sturm J., University of Newcastle, Newcastle, NSW, Australia; Durrheim D., University of Newcastle, Newcastle, NSW, Australia; Hung J., Sir Charles Gairdner Hospital, Perth, WA, Australia, University of Western Australia, Perth, WA, Australia; Briffa T.G., University of Western Australia, Perth, WA, Australia; Chew D.P., Flinders University, Adelaide, SA, Australia; Anderson P., Australian Institute of Health and Welfare, Canberra, ACT, Australia; Moon L., Australian Institute of Health and Welfare, Canberra, ACT, Australia; McEvoy M., University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., University of Newcastle, Newcastle, NSW, Australia, Centenary UTS Centre for Inflammation, Sydney, NSW, Australia; Newby D.A., University of Newcastle, Newcastle, NSW, Australia; Attia J.R., University of Newcastle, Newcastle, NSW, Australia, Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, NSW, Australia",Clinical trials as topic; Public health; Randomized controlled trial as topic; Social media; Vaccine preventable disease; Vaccines,Advertising; Australia; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Patient Acceptance of Health Care; Patient Selection; Pneumococcal Vaccines; Social Media; Surveys and Questionnaires; 23-valent pneumococcal capsular polysaccharide vaccine; Pneumococcus vaccine; advertising; Australia; cardiovascular disease; clinical trial; controlled study; female; human; male; middle aged; multicenter study; patient attitude; patient selection; procedures; questionnaire; randomized controlled trial; social media,Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85063394750
Girkin J.L.; Hatchwell L.M.; Collison A.M.; Starkey M.R.; Hansbro P.M.; Yagita H.; Foster P.S.; Mattes J.,"Girkin, Jason L. (55978746600); Hatchwell, Luke M. (55555432700); Collison, Adam M. (23995251200); Starkey, Malcolm R. (35811293400); Hansbro, Philip M. (6603119390); Yagita, Hideo (55192275000); Foster, Paul S. (7201517569); Mattes, Joerg (7005999915)",55978746600; 55555432700; 23995251200; 35811293400; 6603119390; 55192275000; 7201517569; 7005999915,TRAIL signaling is proinflammatory and proviral in a murine model of rhinovirus 1B infection,2017,American Journal of Physiology - Lung Cellular and Molecular Physiology,312,1,,L89,L99,10,19,10.1152/ajplung.00200.2016,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85008324808&doi=10.1152%2fajplung.00200.2016&partnerID=40&md5=0d8e2a65711a0a0a1f7b304b92b7b644,"Experimental and Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Priority Research Centre GrowUpWell, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Microbiology, Asthma, and Airways Research Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Department of Immunology, Juntendo University, School of Medicine, Tokyo, Japan; Paediatric Respiratory and Sleep Medicine Unit, John Hunter Children’s Hospital, Newcastle, Australia","Girkin J.L., Experimental and Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Hatchwell L.M., Experimental and Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Priority Research Centre GrowUpWell, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Collison A.M., Experimental and Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Priority Research Centre GrowUpWell, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Priority Research Centre GrowUpWell, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Microbiology, Asthma, and Airways Research Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Microbiology, Asthma, and Airways Research Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Yagita H., Department of Immunology, Juntendo University, School of Medicine, Tokyo, Japan; Foster P.S., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Mattes J., Experimental and Translational Respiratory Medicine Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Priority Research Centre GrowUpWell, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia, Paediatric Respiratory and Sleep Medicine Unit, John Hunter Children’s Hospital, Newcastle, Australia",Asthma; Inflammation; Rhinovirus; TRAIL; Tumor necrosis factor-related apoptosis-inducing ligand,"Animals; Antiviral Agents; Bronchial Hyperreactivity; Dendritic Cells; Disease Models, Animal; Epithelial Cells; HeLa Cells; Humans; Hypersensitivity; Inflammation; Inflammation Mediators; Interferon Type I; Killer Cells, Natural; Male; Mice, Inbred BALB C; Phosphoprotein Phosphatases; Picornaviridae Infections; Proteins; Pyroglyphidae; Rhinovirus; RNA, Messenger; Signal Transduction; T-Lymphocytes; TNF-Related Apoptosis-Inducing Ligand; Virus Replication; CXCL2 chemokine; methacholine; tumor necrosis factor related apoptosis inducing ligand; antivirus agent; autacoid; interferon; messenger RNA; Mid1 protein, mouse; phosphoprotein phosphatase; protein; tumor necrosis factor related apoptosis inducing ligand; airway epithelial cell; animal experiment; animal model; apoptosis; Article; bronchoalveolar lavage fluid; cell lysate; controlled study; Dermatophagoides; embryo; enzyme linked immunosorbent assay; flow cytometry; HeLa cell line; human; human cell; infectious dose; lung lavage; macrophage; male; mouse; natural killer cell; nonhuman; plasmacytoid dendritic cell; priority journal; reverse transcription polymerase chain reaction; rhinovirus 1b infection; Rhinovirus infection; signal transduction; TUNEL assay; virus load; virus replication; animal; Bagg albino mouse; bronchus hyperreactivity; deficiency; dendritic cell; disease model; drug effects; epithelium cell; genetics; hypersensitivity; immunology; inflammation; metabolism; parasitology; pathology; physiology; picornavirus infection; Pyroglyphidae; Rhinovirus; T lymphocyte; virology; virus replication",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85008324808
Nair P.M.; Starkey M.R.; Haw T.J.; Liu G.; Horvat J.C.; Morris J.C.; Verrills N.M.; Clark A.R.; Ammit A.J.; Hansbro P.M.,"Nair, P.M. (55749131000); Starkey, M.R. (35811293400); Haw, T.J. (56625918900); Liu, G. (57189061134); Horvat, J.C. (9942405300); Morris, J.C. (35354969700); Verrills, N.M. (6602391112); Clark, A.R. (7404479336); Ammit, A.J. (7003377421); Hansbro, P.M. (6603119390)",55749131000; 35811293400; 56625918900; 57189061134; 9942405300; 35354969700; 6602391112; 7404479336; 7003377421; 6603119390,Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice,2017,Allergy: European Journal of Allergy and Clinical Immunology,72,12,,1891,1903,12,22,10.1111/all.13212,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021179259&doi=10.1111%2fall.13212&partnerID=40&md5=f53c2b7710415050ed537bfef82316dc,"Priority Research Centres for Healthy Lungs, Grow up Well and Cancer Research, Innovation and Translation, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; School of Chemistry, University of New South Wales, Sydney, NSW, Australia; Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia","Nair P.M., Priority Research Centres for Healthy Lungs, Grow up Well and Cancer Research, Innovation and Translation, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Starkey M.R., Priority Research Centres for Healthy Lungs, Grow up Well and Cancer Research, Innovation and Translation, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Haw T.J., Priority Research Centres for Healthy Lungs, Grow up Well and Cancer Research, Innovation and Translation, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Liu G., Priority Research Centres for Healthy Lungs, Grow up Well and Cancer Research, Innovation and Translation, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Horvat J.C., Priority Research Centres for Healthy Lungs, Grow up Well and Cancer Research, Innovation and Translation, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Morris J.C., School of Chemistry, University of New South Wales, Sydney, NSW, Australia; Verrills N.M., Priority Research Centres for Healthy Lungs, Grow up Well and Cancer Research, Innovation and Translation, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Clark A.R., Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; Ammit A.J., Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Priority Research Centres for Healthy Lungs, Grow up Well and Cancer Research, Innovation and Translation, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia",allergic airway disease; asthma; inflammation; protein phosphatase 2A; ubiquitin proteasome system,"Airway Remodeling; Animals; Anti-Asthmatic Agents; Biomarkers; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Inflammation Mediators; Mice; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Phosphatase 2; Respiratory Hypersensitivity; RNA, Messenger; 2 amino 4 [4 (heptyloxy)phenyl] 2 methylbutan 1 ol; bortezomib; fingolimod; immunoglobulin E; interleukin 13; interleukin 33; interleukin 5; ovalbumin; phosphoprotein phosphatase 2A; proteasome; thymic stromal lymphopoietin; unclassified drug; antiasthmatic agent; autacoid; biological marker; cytokine; enzyme inhibitor; messenger RNA; phosphoprotein phosphatase 2; proteasome; proteasome inhibitor; airway remodeling; animal cell; animal experiment; animal tissue; antibody blood level; Article; asthma; basement membrane; bronchoalveolar lavage fluid; clinical feature; controlled study; cytokine production; Dermatophagoides; disease severity; enzyme activity; enzyme inhibition; enzyme linked immunosorbent assay; eosinophil; female; histopathology; immunoglobulin blood level; leukocyte; leukocyte differential count; long term exposure; lung function; lung homogenate; lung lavage; lymphocyte; macrophage; mouse; mucous cell; neutrophil; nonhuman; priority journal; protein expression; protein isolation; animal; antagonists and inhibitors; disease model; gene expression; genetics; metabolism; pathology; respiratory tract allergy",Article,Final,,Scopus,2-s2.0-85021179259
Kim R.Y.; Pinkerton J.W.; Essilfie A.T.; Robertson A.A.B.; Baines K.J.; Brown A.C.; Mayall J.R.; Ali M.K.; Starkey M.R.; Hansbro N.G.; Hirota J.A.; Wood L.G.; Simpson J.L.; Knight D.A.; Wark P.A.; Gibson P.G.; O'Neill L.A.J.; Cooper M.A.; Horvat J.C.; Hansbro P.M.,"Kim, Richard Y. (35810406900); Pinkerton, James W. (56647761900); Essilfie, Ama T. (22955585600); Robertson, Avril A.B. (15519764900); Baines, Katherine J. (35078051200); Brown, Alexandra C. (55637745000); Mayall, Jemma R. (55607222700); Ali, M. Khadem (57194408422); Starkey, Malcolm R. (35811293400); Hansbro, Nicole G. (15055862300); Hirota, Jeremy A. (7007085348); Wood, Lisa G. (55859741700); Simpson, Jodie L. (7404326026); Knight, Darryl A. (7402350036); Wark, Peter A. (7003559516); Gibson, Peter G. (7202414199); O'Neill, Luke A.J. (7103393094); Cooper, Matthew A. (7404411451); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",35810406900; 56647761900; 22955585600; 15519764900; 35078051200; 55637745000; 55607222700; 57194408422; 35811293400; 15055862300; 7007085348; 55859741700; 7404326026; 7402350036; 7003559516; 7202414199; 7103393094; 7404411451; 9942405300; 6603119390,"Role for NLRP3 inflammasome-mediated, IL-1β-dependent responses in severe, steroid-resistant asthma",2017,American Journal of Respiratory and Critical Care Medicine,196,3,,283,297,14,328,10.1164/rccm.201609-1830OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026810825&doi=10.1164%2frccm.201609-1830OC&partnerID=40&md5=68e2c45a98df0011cf02f0ee8ecec9ab,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia; James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland","Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Pinkerton J.W., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Essilfie A.T., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Robertson A.A.B., Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia; Baines K.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Brown A.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Mayall J.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Ali M.K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Hirota J.A., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Simpson J.L., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Knight D.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Gibson P.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; O'Neill L.A.J., School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland; Cooper M.A., Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia",IL-1β; MCC950; Nucleotide-binding oligomerization domain-like receptor family; Pyrin domain-containing 3; Steroidresistant asthma,"Animals; Asthma; Disease Models, Animal; Drug Resistance; Interleukin-1beta; Mice; Mice, Inbred BALB C; NLR Family, Pyrin Domain-Containing 3 Protein; Severity of Illness Index; Treatment Outcome; beclometasone dipropionate; cryopyrin; dexamethasone; inflammasome; interleukin 1beta; interleukin 1beta converting enzyme; messenger RNA; cryopyrin; interleukin 1beta; Nlrp3 protein, mouse; animal experiment; animal model; Article; bronchoalveolar lavage fluid; Chlamydia muridarum; chlamydiasis; comparative study; controlled study; corticosteroid therapy; cytokine response; disease severity; drug megadose; experimental asthma; forced expiratory volume; gene expression; Haemophilus infection; Haemophilus influenzae; lung function; mouse; neutrophil count; nonhuman; priority journal; protein targeting; respiratory tract allergy; respiratory tract infection; severe steroid resistant asthma; animal; asthma; Bagg albino mouse; disease model; drug resistance; genetics; immunology; metabolism; severity of illness index; treatment outcome",Article,Final,,Scopus,2-s2.0-85026810825
Wood L.G.; Li Q.; Scott H.A.; Rutting S.; Berthon B.S.; Gibson P.G.; Hansbro P.M.; Williams E.; Horvat J.; Simpson J.L.; Young P.; Oliver B.G.; Baines K.J.,"Wood, Lisa G. (55859741700); Li, Qian (57191695894); Scott, Hayley A. (7402297708); Rutting, Sandra (57202399992); Berthon, Bronwyn S. (49660949300); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390); Williams, Evan (57190070659); Horvat, Jay (9942405300); Simpson, Jodie L. (7404326026); Young, Paul (7402037987); Oliver, Brian G. (15919869900); Baines, Katherine J. (35078051200)",55859741700; 57191695894; 7402297708; 57202399992; 49660949300; 7202414199; 6603119390; 57190070659; 9942405300; 7404326026; 7402037987; 15919869900; 35078051200,"Saturated fatty acids, obesity, and the nucleotide oligomerization domain–like receptor protein 3 (NLRP3) inflammasome in asthmatic patients",2019,Journal of Allergy and Clinical Immunology,143,1,,305,315,10,99,10.1016/j.jaci.2018.04.037,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049005829&doi=10.1016%2fj.jaci.2018.04.037&partnerID=40&md5=d3d5decd47fe344edcaa36d88700cd25,"Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia; Woolcock Institute of Medical Research, Sydney, Australia","Wood L.G., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Li Q., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Scott H.A., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Rutting S., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia, Woolcock Institute of Medical Research, Sydney, Australia; Berthon B.S., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Gibson P.G., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Williams E., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Horvat J., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Simpson J.L., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Young P., Woolcock Institute of Medical Research, Sydney, Australia; Oliver B.G., Woolcock Institute of Medical Research, Sydney, Australia; Baines K.J., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia",airway inflammation; asthma; Fatty acids; IL-1β; inflammasome; obesity; saturated fat,"Adult; Aged; Asthma; Cell Line; Cross-Sectional Studies; Fatty Acids; Female; Gene Expression Regulation; Humans; Inflammasomes; Interleukin-1beta; Leukocyte Count; Male; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Nod1 Signaling Adaptor Protein; Obesity; Sputum; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; carbohydrate; caspase recruitment domain protein 4; cryopyrin; ficoll; inflammasome; interleukin 1beta; lipopolysaccharide; omega 6 fatty acid; palmitic acid; saturated fatty acid; toll like receptor 4; tumor necrosis factor; caspase recruitment domain protein 4; cryopyrin; fatty acid; IL1B protein, human; inflammasome; NLRP3 protein, human; NOD1 protein, human; TLR4 protein, human; toll like receptor 4; tumor necrosis factor; adult; Article; asthma; cell count; comparative study; controlled study; cross-sectional study; crossover procedure; density gradient; fat intake; female; gene expression; high calorie diet; human; major clinical study; male; monocyte; neutrophil; obesity; observational study; priority journal; protein secretion; randomized controlled trial; respiratory tract inflammation; sputum level; upregulation; aged; cell line; drug effect; gene expression regulation; immunology; leukocyte count; middle aged; pathology; sputum",Article,Final,,Scopus,2-s2.0-85049005829
Eapen M.S.; Hansbro P.M.; McAlinden K.; Kim R.Y.; Ward C.; Hackett T.-L.; Walters E.H.; Sohal S.S.,"Eapen, Mathew Suji (56625716100); Hansbro, Philip M. (6603119390); McAlinden, Kielan (57193794597); Kim, Richard Y. (35810406900); Ward, Chris (57196516302); Hackett, Tillie-Louise (15765031200); Walters, Eugene H. (7102865814); Sohal, Sukhwinder Singh (36449981500)",56625716100; 6603119390; 57193794597; 35810406900; 57196516302; 15765031200; 7102865814; 36449981500,Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD),2017,Scientific Reports,7,1,13392,,,,142,10.1038/s41598-017-13888-x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031765601&doi=10.1038%2fs41598-017-13888-x&partnerID=40&md5=4885dac898ad73414f090f3347388d67,"NHMRC Centre for Research Excellence for Chronic Respiratory Disease, School of Medicine, University of Tasmania, Hobart, TAS, Australia; School of Health Sciences, Faculty of Health, University of Tasmania, Launceston, TAS, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Woolcock Institute of Medical Research, University Technology Sydney, Sydney, NSW, Australia; Institute of Cellular Medicine, University of Newcastle, Newcastle Upon Tyne, United Kingdom; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada","Eapen M.S., NHMRC Centre for Research Excellence for Chronic Respiratory Disease, School of Medicine, University of Tasmania, Hobart, TAS, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; McAlinden K., Woolcock Institute of Medical Research, University Technology Sydney, Sydney, NSW, Australia; Kim R.Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Ward C., Institute of Cellular Medicine, University of Newcastle, Newcastle Upon Tyne, United Kingdom; Hackett T.-L., Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada, UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada; Walters E.H., NHMRC Centre for Research Excellence for Chronic Respiratory Disease, School of Medicine, University of Tasmania, Hobart, TAS, Australia; Sohal S.S., NHMRC Centre for Research Excellence for Chronic Respiratory Disease, School of Medicine, University of Tasmania, Hobart, TAS, Australia, School of Health Sciences, Faculty of Health, University of Tasmania, Launceston, TAS, Australia",,"Arginase; Biomarkers; Bronchoalveolar Lavage; Cytokines; Female; Gene Expression; Humans; Immunohistochemistry; Immunophenotyping; Leukocyte Count; Macrophage Activation; Macrophages; Macrophages, Alveolar; Male; Phenotype; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Smokers; arginase; arginase I, human; biological marker; cytokine; chronic obstructive lung disease; female; gene expression; genetics; human; immunohistochemistry; immunology; immunophenotyping; leukocyte count; lung alveolus macrophage; lung lavage; macrophage; macrophage activation; male; metabolism; pathology; phenotype; respiratory mucosa; smoking",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85031765601
AL-Kouba J.; Wilkinson A.N.; Starkey M.R.; Rudraraju R.; Werder R.B.; Liu X.; Law S.-C.; Horvat J.C.; Brooks J.F.; Hill G.R.; Davies J.M.; Phipps S.; Hansbro P.M.; Steptoe R.J.,"AL-Kouba, Jane (37010872200); Wilkinson, Andrew N. (7201828890); Starkey, Malcolm R. (35811293400); Rudraraju, Rajeev (6602210524); Werder, Rhiannon B. (56168852800); Liu, Xiao (56693423400); Law, Soi-Cheng (55218550300); Horvat, Jay C. (9942405300); Brooks, Jeremy F. (57193554592); Hill, Geoffrey R. (55586304200); Davies, Janet M. (7404982353); Phipps, Simon (7005395199); Hansbro, Philip M. (6603119390); Steptoe, Raymond J. (6701551792)",37010872200; 7201828890; 35811293400; 6602210524; 56168852800; 56693423400; 55218550300; 9942405300; 57193554592; 55586304200; 7404982353; 7005395199; 6603119390; 6701551792,"Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation",2017,JCI Insight,2,11,e85742,,,,15,10.1172/jci.insight.85742,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046592394&doi=10.1172%2fjci.insight.85742&partnerID=40&md5=3225e0d4ba8abbc1886a0802338114bd,"University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia; Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; School of Biomedical Sciences, University of Queensland, Brisbane, Australia; QIMR Berghofer Medical Research Institute, Brisbane, Australia; School of Medicine, University of Queensland, Brisbane, Australia","AL-Kouba J., University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia; Wilkinson A.N., University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia; Starkey M.R., Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Rudraraju R., University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia; Werder R.B., School of Biomedical Sciences, University of Queensland, Brisbane, Australia; Liu X., University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia; Law S.-C., University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia; Horvat J.C., Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Brooks J.F., University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia; Hill G.R., QIMR Berghofer Medical Research Institute, Brisbane, Australia; Davies J.M., School of Medicine, University of Queensland, Brisbane, Australia; Phipps S., School of Biomedical Sciences, University of Queensland, Brisbane, Australia; Hansbro P.M., Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Steptoe R.J., University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia",,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85046592394
Hsu A.C.-Y.; Dua K.; Starkey M.R.; Haw T.-J.; Nair P.M.; Nichol K.; Zammit N.; Grey S.T.; Baines K.J.; Foster P.S.; Hansbro P.M.; Wark P.A.,"Hsu, Alan C.-Y. (49861516600); Dua, Kamal (15759138700); Starkey, Malcolm R. (35811293400); Haw, Tatt-Jhong (56625918900); Nair, Prema M. (55749131000); Nichol, Kristy (57195914143); Zammit, Nathan (55496445800); Grey, Shane T. (7006366319); Baines, Katherine J. (35078051200); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390); Wark, Peter A. (7003559516)",49861516600; 15759138700; 35811293400; 56625918900; 55749131000; 57195914143; 55496445800; 7006366319; 35078051200; 7201517569; 6603119390; 7003559516,MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD,2017,JCI Insight,2,7,e90443,,,,101,10.1172/jci.insight.90443,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85037613347&doi=10.1172%2fjci.insight.90443&partnerID=40&md5=a5afcfe54fb7fe476b245a835e5f217b,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Transplantation Immunology Group, Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia","Hsu A.C.-Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Dua K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Haw T.-J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Nair P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Nichol K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Zammit N., Transplantation Immunology Group, Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, Australia; Grey S.T., Transplantation Immunology Group, Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, Australia; Baines K.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia; Wark P.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia",,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85037613347
Moheimani F.; Koops J.; Williams T.; Reid A.T.; Hansbro P.M.; Wark P.A.; Knight D.A.,"Moheimani, Fatemeh (36157216000); Koops, Jorinke (57203242142); Williams, Teresa (57191973027); Reid, Andrew T. (39561518600); Hansbro, Philip M. (6603119390); Wark, Peter A. (7003559516); Knight, Darryl A. (7402350036)",36157216000; 57203242142; 57191973027; 39561518600; 6603119390; 7003559516; 7402350036,"Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics",2018,Respiratory Research,19,1,145,,,,48,10.1186/s12931-018-0851-7,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051035942&doi=10.1186%2fs12931-018-0851-7&partnerID=40&md5=ba248961d403f9dba99cb7d9c3c00357,"The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia; The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia; University of Groningen, Department of Molecular Pharmacology, Groningen, Netherlands; University of Victoria, Department of Biochemistry and Microbiology, Victoria, Canada; John Hunter Hospital, Department of Respiratory and Sleep Medicine, Newcastle, NSW, Australia; University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, Canada","Moheimani F., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia; Koops J., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Groningen, Department of Molecular Pharmacology, Groningen, Netherlands; Williams T., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of Victoria, Department of Biochemistry and Microbiology, Victoria, Canada; Reid A.T., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia; Wark P.A., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, John Hunter Hospital, Department of Respiratory and Sleep Medicine, Newcastle, NSW, Australia; Knight D.A., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia, University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, Canada",Airway remodeling; Epithelial cells; Influenza A virus; MicroRNA; Severe asthma,"Adult; Aged; Asthma; Basigin; Cells, Cultured; Female; Histone Deacetylases; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; MicroRNAs; Middle Aged; Repressor Proteins; Respiratory Mucosa; CD147 antigen; histone deacetylase 4; microRNA 20a; microRNA 22; BSG protein, human; CD147 antigen; HDAC4 protein, human; histone deacetylase; microRNA; MIRN22 microRNA, human; repressor protein; adaptive immunity; adult; Article; asthma; bronchus epithelium; CD147 gene; cell differentiation; cell proliferation; clinical article; controlled study; female; gene; gene expression; HDAC4 gene; human; human cell; influenza A (H1N1); innate immunity; male; oncogene c myc; protein expression; SP1 gene; aged; asthma; biosynthesis; cell culture; influenza; Influenza A virus (H1N1); metabolism; middle aged; pathology; respiratory mucosa",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85051035942
Donovan C.; Hansbro P.M.,"Donovan, Chantal (55357105200); Hansbro, Philip M. (6603119390)",55357105200; 6603119390,TRPA1: A potential target for cold-induced airway disease?,2019,Respirology,24,3,,193,194,1,2,10.1111/resp.13453,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058715227&doi=10.1111%2fresp.13453&partnerID=40&md5=859ee3b0cecd916495dc17b7f3ed5955,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Centre for Inflammation, Centenary Institute and School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia","Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute and School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia",asthma; cytokine; inflammation,"Animals; Asthma; Cold Temperature; Disease; Inflammation; Mice; Respiratory System; Temperature; TRPA1 Cation Channel; transient receptor potential channel A1; transient receptor potential channel A1; Trpa1 protein, mouse; allergic asthma; cold; Editorial; human; nonhuman; priority journal; animal; asthma; cold; diseases; inflammation; mouse; respiratory system; temperature",Editorial,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85058715227
Aggarwal T.; Wadhwa R.; Thapliyal N.; Gupta R.; Hansbro P.M.; Dua K.; Maurya P.K.,"Aggarwal, Taru (57196053981); Wadhwa, Ridhima (57159091700); Thapliyal, Noopur (57203866042); Gupta, Riya (57694324300); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Maurya, Pawan Kumar (15765644500)",57196053981; 57159091700; 57203866042; 57694324300; 6603119390; 15759138700; 15765644500,Recent trends of nano-material as antimicrobial agents,2019,Nanotechnology in Modern Animal Biotechnology: Recent Trends and Future Perspectives,,,,173,193,20,6,10.1007/978-981-13-6004-6_5,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066882449&doi=10.1007%2f978-981-13-6004-6_5&partnerID=40&md5=34f3bd90c6838b319627302b0f3821ed,"ICAR-National Research Centre on Plant Biotechnology, Lal-Bahadur Shastri Centre, IARI, New Delhi, India; Faculty of Life Science and Biotechnology, South Asian University, New Delhi, India; Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Department of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India","Aggarwal T., ICAR-National Research Centre on Plant Biotechnology, Lal-Bahadur Shastri Centre, IARI, New Delhi, India; Wadhwa R., Faculty of Life Science and Biotechnology, South Asian University, New Delhi, India; Thapliyal N., Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; Gupta R., Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia; Dua K., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Maurya P.K., Department of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India",Antimicrobial; Biofilm; Drug resistance; Nanomaterial; Oxidative stress; Toxicity,,Book chapter,Final,,Scopus,2-s2.0-85066882449
Camlin N.J.; Jarnicki A.G.; Vanders R.L.; Walters K.A.; Hansbro P.M.; McLaughlin E.A.; Holt J.E.,"Camlin, N.J. (56426532900); Jarnicki, A.G. (6603137164); Vanders, R.L. (55773360100); Walters, K.A. (17344479000); Hansbro, P.M. (6603119390); McLaughlin, E.A. (57565084300); Holt, J.E. (7402069863)",56426532900; 6603137164; 55773360100; 17344479000; 6603119390; 57565084300; 7402069863,"Grandmaternal smoke exposure reduces female fertility in a murine model, with great-grandmaternal smoke exposure unlikely to have an effect",2017,Human Reproduction,32,6,,1270,1281,11,9,10.1093/humrep/dex073,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026915066&doi=10.1093%2fhumrep%2fdex073&partnerID=40&md5=2261cda95c1929b11422f9a0e1a37015,"School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia; Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, 2308, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle, Callaghan, 2308, NSW, Australia; School of Women's and Children's Health, University of New South Wales, Sydney, 2052, NSW, Australia; School of Biological Sciences, University of Auckland, Auckland, 1010, New Zealand","Camlin N.J., School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, 2308, NSW, Australia; Jarnicki A.G., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Callaghan, 2308, NSW, Australia; Vanders R.L., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Callaghan, 2308, NSW, Australia; Walters K.A., School of Women's and Children's Health, University of New South Wales, Sydney, 2052, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle, Callaghan, 2308, NSW, Australia; McLaughlin E.A., School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, 2308, NSW, Australia, School of Biological Sciences, University of Auckland, Auckland, 1010, New Zealand; Holt J.E., Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, 2308, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia",Cigarette smoke; Grandmaternal; Great-grandmaternal; Multigenerational; Oocyte; Ovary; Subfertility; Transgenerational,"Animals; Apoptosis; Biomarkers; Cigarette Smoking; Ectogenesis; Female; Fetal Development; Fluorescent Antibody Technique; Immunohistochemistry; Infertility, Female; Lactation; Maternal Exposure; Mice, Inbred C57BL; Oocytes; Oogenesis; Ovary; Pregnancy; Prenatal Exposure Delayed Effects; Severity of Illness Index; Time-to-Pregnancy; cigarette smoke; cycline; follitropin; gonadotropin; luteinizing hormone; Muellerian inhibiting factor; biological marker; adult; ambient air; animal cell; animal experiment; animal tissue; apoptosis; Article; breeding; cell proliferation; controlled study; diestrus; embryo; female; female fertility; female genital tract parameters; follitropin blood level; grandmaternal smoke exposure; great grandmaternal smoke exposure; histology; immunoblotting; immunocytochemistry; immunofluorescence test; kinetochore; lactation; litter size; luteinizing hormone blood level; maternal smoking; meiosis; metaphase; mouse; nonhuman; oocyte quality; ovarian quality; ovary follicle; ovulation; ploidy; pregnancy; preimplantation embryo; prenatal exposure; reproductive health; sister chromatid; spindle pole; time to pregnancy; TUNEL assay; young adult; animal; apoptosis; blood; C57BL mouse; cigarette smoking; comparative study; drug effects; ectogenesis; female infertility; fetus development; fluorescent antibody technique; immunohistochemistry; maternal exposure; metabolism; oocyte; oocyte development; ovary; pathology; pathophysiology; severity of illness index",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85026915066
Shastri M.D.; Shukla S.D.; Chong W.C.; Dua K.; Peterson G.M.; Patel R.P.; Hansbro P.M.; Eri R.; O'Toole R.F.,"Shastri, Madhur D. (56007290800); Shukla, Shakti Dhar (56367620800); Chong, Wai Chin (57192809246); Dua, Kamal (15759138700); Peterson, Gregory M. (7402563175); Patel, Rahul P. (36849078400); Hansbro, Philip M. (6603119390); Eri, Rajaraman (57206207449); O'Toole, Ronan F. (7005094224)",56007290800; 56367620800; 57192809246; 15759138700; 7402563175; 36849078400; 6603119390; 57206207449; 7005094224,Role of oxidative stress in the pathology and management of human tuberculosis,2018,Oxidative Medicine and Cellular Longevity,2018,,7695364,,,,110,10.1155/2018/7695364,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056254937&doi=10.1155%2f2018%2f7695364&partnerID=40&md5=addb8acc1c6c803545f1b0ff9dcfbd45,"School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia; Department of Molecular and Translational Science, Monash University, Clayton, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Pharmacy, College of Health and Medicine, University of Tasmania, Hobart, Australia; School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia; Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland","Shastri M.D., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia; Chong W.C., Department of Molecular and Translational Science, Monash University, Clayton, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Peterson G.M., Pharmacy, College of Health and Medicine, University of Tasmania, Hobart, Australia; Patel R.P., Pharmacy, College of Health and Medicine, University of Tasmania, Hobart, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia; Eri R., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; O'Toole R.F., School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia, Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland",,"Activation; Antibiotics; Bacteria; Cells; Diseases; Shape; Stresses; Survival; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Lung; Mycobacterium tuberculosis; Oxidative Stress; Tuberculosis; Antibiotics; Bacteria; Biological organs; Macrophages; Nitric oxide; antioxidant; oxidizing agent; prodrug; reactive oxygen metabolite; tuberculostatic agent; tuberculostatic agent; Alveolar macrophages; Antioxidant defense; Biological mechanisms; Intracellular survival; Multidrug-resistant tuberculosis; Mycobacterium tuberculosis; Reactive oxygen species; Superoxide dismutases; antibiotic resistance; antibiotic therapy; human; lung tuberculosis; multidrug resistant tuberculosis; Mycobacterium tuberculosis; nonhuman; oxidative stress; pathogenesis; phagocyte; Review; tuberculosis; drug effect; lung; microbiology; pathology; tuberculosis; Tubes (components)",Review,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85056254937
Wadhwa R.; Aggarwal T.; Thapliyal N.; Chellappan D.K.; Gupta G.; Gulati M.; Collet T.; Oliver B.; Williams K.; Hansbro P.M.; Dua K.; Maurya P.K.,"Wadhwa, Ridhima (57159091700); Aggarwal, Taru (57196053981); Thapliyal, Noopur (57203866042); Chellappan, Dinesh Kumar (35811890500); Gupta, Gaurav (15047988400); Gulati, Monica (7006677671); Collet, Trudi (36898251800); Oliver, Brian (15919869900); Williams, Kylie (7404142756); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Maurya, Pawan Kumar (15765644500)",57159091700; 57196053981; 57203866042; 35811890500; 15047988400; 7006677671; 36898251800; 15919869900; 7404142756; 6603119390; 15759138700; 15765644500,Nanoparticle-based drug delivery for chronic obstructive pulmonary disorder and asthma,2019,Nanotechnology in Modern Animal Biotechnology: Concepts and Applications,,,,59,73,14,21,10.1016/B978-0-12-818823-1.00005-3,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081606434&doi=10.1016%2fB978-0-12-818823-1.00005-3&partnerID=40&md5=ae68ea2041b34baeafac15668e20847f,"Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India; Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Malaysia; Department of Biochemistry, University of Allahabad, Allahabad, Uttar Pradesh, India; Laboratory of Extracellular Matrix and Gene Expression Regulation, Department of Structural and Functional Biology - Institute of Biology - UNICAMP, Brazil; Indigenous Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Broadway, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, NSW, Australia; Centre for InflammationCentenary Institute, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Broadway, NSW, Australia; Department of Biochemistry, Central University of Haryana, Haryana, India","Wadhwa R., Faculty of Life Sciences and Biotechnology, South Asian University, New Delhi, India; Aggarwal T., Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India; Thapliyal N., Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Malaysia; Gupta G., Department of Biochemistry, University of Allahabad, Allahabad, Uttar Pradesh, India; Gulati M., Laboratory of Extracellular Matrix and Gene Expression Regulation, Department of Structural and Functional Biology - Institute of Biology - UNICAMP, Brazil; Collet T., Indigenous Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Oliver B., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, NSW, Australia; Williams K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Broadway, NSW, Australia; Hansbro P.M., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, NSW, Australia, Centre for InflammationCentenary Institute, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Broadway, NSW, Australia; Maurya P.K., Department of Biochemistry, Central University of Haryana, Haryana, India",Asthma; Chronic obstructive pulmonary disease; Nanoparticles; Therapeutics; Toxicity,,Book chapter,Final,,Scopus,2-s2.0-85081606434
Conickx G.; Mestdagh P.; Cobos F.A.; Verhamme F.M.; Maes T.; Vanaudenaerde B.M.; Seys L.J.M.; Lahousse L.; Kim R.Y.; Hsu A.C.; Wark P.A.; Hansbro P.M.; Joos G.F.; Vandesompele J.; Bracke K.R.; Brusselle G.G.,"Conickx, Griet (56712859600); Mestdagh, Pieter (25724578400); Cobos, Francisco Avila (57189244609); Verhamme, Fien M. (56008794900); Maes, Tania (6603579162); Vanaudenaerde, Bart M. (7801354724); Seys, Leen J. M. (56008740500); Lahousse, Lies (54780129500); Kim, Richard Y. (35810406900); Hsu, Alan C. (49861516600); Wark, Peter A. (7003559516); Hansbro, Philip M. (6603119390); Joos, Guy F. (7102353943); Vandesompele, Jo (6701639561); Bracke, Ken R. (8338303000); Brusselle, Guy G. (57197253407)",56712859600; 25724578400; 57189244609; 56008794900; 6603579162; 7801354724; 56008740500; 54780129500; 35810406900; 49861516600; 7003559516; 6603119390; 7102353943; 6701639561; 8338303000; 57197253407,MicroRNA profiling reveals a role for MicroRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease,2017,American Journal of Respiratory and Critical Care Medicine,195,1,,43,56,13,121,10.1164/rccm.201506-1182OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85008694230&doi=10.1164%2frccm.201506-1182OC&partnerID=40&md5=3f63dea4d9f42bcd0bbf77b9fc2a14eb,"Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, Ghent, B-9000, Belgium; Center for Medical Genetics, Ghent University, Ghent, Belgium; Department of Clinical and Experimental Medicine, Laboratory for Respiratory Diseases, Lung Transplantation Unit, KU Leuven-University of Leuven, Leuven, Belgium; Priority Research Centres for Asthma and Respiratory Diseases and Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia","Conickx G., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, Ghent, B-9000, Belgium; Mestdagh P., Center for Medical Genetics, Ghent University, Ghent, Belgium; Cobos F.A., Center for Medical Genetics, Ghent University, Ghent, Belgium; Verhamme F.M., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, Ghent, B-9000, Belgium; Maes T., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, Ghent, B-9000, Belgium; Vanaudenaerde B.M., Department of Clinical and Experimental Medicine, Laboratory for Respiratory Diseases, Lung Transplantation Unit, KU Leuven-University of Leuven, Leuven, Belgium; Seys L.J.M., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, Ghent, B-9000, Belgium; Lahousse L., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, Ghent, B-9000, Belgium; Kim R.Y., Priority Research Centres for Asthma and Respiratory Diseases and Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hsu A.C., Priority Research Centres for Asthma and Respiratory Diseases and Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Wark P.A., Priority Research Centres for Asthma and Respiratory Diseases and Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centres for Asthma and Respiratory Diseases and Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Joos G.F., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, Ghent, B-9000, Belgium; Vandesompele J., Center for Medical Genetics, Ghent University, Ghent, Belgium; Bracke K.R., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, Ghent, B-9000, Belgium; Brusselle G.G., Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, Ghent, B-9000, Belgium",Chronic obstructive pulmonary disease; Lung; microRNA; microRNA-218,"Adult; Aged; Animals; Bronchi; Case-Control Studies; Female; Gene Expression Profiling; Humans; Lung; Male; Mice; MicroRNAs; Middle Aged; Oligonucleotide Array Sequence Analysis; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Reverse Transcriptase Polymerase Chain Reaction; cigarette smoke; corticosteroid; messenger RNA; microRNA; microRNA 218 5p; RNA directed DNA polymerase; unclassified drug; microRNA; MIRN218 microRNA, human; adult; aged; airflow; airway obstruction; animal model; Article; bronchus biopsy; bronchus mucosa; cellular distribution; chronic obstructive lung disease; cohort analysis; controlled study; corticosteroid therapy; down regulation; epithelium cell; female; gene expression; gene expression profiling; gene function; gene set enrichment analysis; genetic analysis; high throughput screening; histopathology; human; human cell; human tissue; in vitro study; in vivo study; inflammation; lung; lung cancer; lung parenchyma; lung resection; major clinical study; male; middle aged; mouse; nonhuman; priority journal; protein microarray; quantitative analysis; reverse transcription polymerase chain reaction; RNA sequence; smoking; animal; bronchus; case control study; DNA microarray; gene expression profiling; genetics; metabolism; physiology; Pulmonary Disease, Chronic Obstructive; respiratory mucosa; reverse transcription polymerase chain reaction",Article,Final,,Scopus,2-s2.0-85008694230
Dua K.; Hansbro N.G.; Hansbro P.M.,"Dua, Kamal (15759138700); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390)",15759138700; 15055862300; 6603119390,Steroid resistance and concomitant respiratory infections: A challenging battle in pulmonary clinic,2017,EXCLI Journal,16,,,981,985,4,4,10.17179/excli2017-425,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038435704&doi=10.17179%2fexcli2017-425&partnerID=40&md5=08d8a2014509d901a6633bda34c0d87f,"Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, Ultimo, 2007, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, J Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia","Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, Ultimo, 2007, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, J Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Hansbro N.G., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, J Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, J Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia",,corticosteroid; cytokine; phosphatidylinositol 3 kinase; placebo; steroid; zanamivir; asthma; chlamydiasis; chronic obstructive lung disease; comorbidity; disease association; disease course; disease exacerbation; disease predisposition; disease severity; health care facility; host resistance; human; infection sensitivity; influenza; innate immunity; Letter; mycoplasmosis; nonhuman; quality of life; respiratory syncytial virus infection; respiratory tract allergy; respiratory tract infection; respiratory tract inflammation; Rhinovirus infection; viral respiratory tract infection; virus virulence; wheezing,Letter,Final,,Scopus,2-s2.0-85038435704
Awasthi R.; Singh A.K.; Mishra G.; Maurya A.; Chellappan D.K.; Gupta G.; Hansbro P.M.; Dua K.,"Awasthi, Rajendra (36866066100); Singh, Anurag Kumar (57202898165); Mishra, Gaurav (7102625853); Maurya, Anand (57213671923); Chellappan, Dinesh Kumar (35811890500); Gupta, Gaurav (15047988400); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",36866066100; 57202898165; 7102625853; 57213671923; 35811890500; 15047988400; 6603119390; 15759138700,An overview of circular RNAs,2018,Advances in Experimental Medicine and Biology,1087,,,3,14,11,21,10.1007/978-981-13-1426-1_1,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054225100&doi=10.1007%2f978-981-13-1426-1_1&partnerID=40&md5=30aebad392faff286ed674d688b64bb5,"Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India; Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India; NKBR College of Pharmacy and Research Centre, Meerut, Uttar Pradesh, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; School of Pharmaceutical Sciences, Jaipur National University, Jaipur, India; School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia","Awasthi R., Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India; Singh A.K., Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India; Mishra G., NKBR College of Pharmacy and Research Centre, Meerut, Uttar Pradesh, India; Maurya A., NKBR College of Pharmacy and Research Centre, Meerut, Uttar Pradesh, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jaipur, India; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Dua K., School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia",Circular RNAs; cirRNA; Gene expression; Translation,"Blotting, Northern; Computational Biology; Gene Expression Regulation; In Situ Hybridization, Fluorescence; MicroRNAs; Polymerase Chain Reaction; Protein Biosynthesis; RNA; RNA Processing, Post-Transcriptional; RNA, Long Noncoding; circ ZNF609; circular RNA; cirMbl; microRNA; unclassified drug; untranslated RNA; long untranslated RNA; microRNA; RNA; RNA, circular; algorithm; alternative RNA splicing; fluorescence in situ hybridization; gene expression; genome; high throughput sequencing; human; immunoprecipitation; internal ribosome entry site; nonhuman; Northern blotting; open reading frame; polymerase chain reaction; priority journal; ribosome; RNA sequence; RNA structure; RNA translation; biology; chemistry; gene expression regulation; genetics; procedures; protein synthesis; RNA processing",Book chapter,Final,,Scopus,2-s2.0-85054225100
Huff R.D.; Hsu A.C.-Y.; Nichol K.S.; Jones B.; Knight D.A.; Wark P.A.B.; Hansbro P.M.; Hirota J.A.,"Huff, Ryan D. (57191570360); Hsu, Alan C-Y. (49861516600); Nichol, Kristy S. (57195914143); Jones, Bernadette (56215070300); Knight, Darryl A. (7402350036); Wark, Peter A. B. (7003559516); Hansbro, Philip M. (6603119390); Hirota, Jeremy A. (7007085348)",57191570360; 49861516600; 57195914143; 56215070300; 7402350036; 7003559516; 6603119390; 7007085348,Regulation of xanthine dehydrogensase gene expression and uric acid production in human airway epithelial cells,2017,PLoS ONE,12,9,e0184260,,,,18,10.1371/journal.pone.0184260,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030033321&doi=10.1371%2fjournal.pone.0184260&partnerID=40&md5=9f5744280c37663fb1d088c6271f2e88,"Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Firestone Institute for Respiratory Health, Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada","Huff R.D., Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Hsu A.C.-Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Nichol K.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Jones B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Knight D.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hirota J.A., Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, Firestone Institute for Respiratory Health, Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada",,"Adult; Aged; Allergens; Animals; Asthma; Bronchi; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Female; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Humans; Interferon-gamma; Male; Mice; Mice, Inbred BALB C; Middle Aged; Pulmonary Disease, Chronic Obstructive; Pyroglyphidae; Smoke; Smoking; Tobacco Products; Tumor Necrosis Factor-alpha; Uric Acid; Xanthine Dehydrogenase; cigarette smoke; epidermal growth factor; uric acid; xanthine dehydrogenase; allergen; gamma interferon; smoke; tumor necrosis factor; uric acid; xanthine dehydrogenase; adult; aged; airway epithelium cell; animal experiment; animal model; Article; asthma; cell density; chronic obstructive lung disease; clinical article; controlled study; cytokine production; Dermatophagoides pteronyssinus; female; gene expression regulation; human; human cell; immunopathology; in vitro study; in vivo study; male; middle aged; mouse; nonhuman; polymerase chain reaction; protein analysis; protein function; quantitative analysis; synthesis; XDH gene; animal; Bagg albino mouse; bronchus; cell culture; cytology; disease model; drug effects; epithelium cell; gene expression profiling; metabolism; Pyroglyphidae; smoke; smoking; tobacco",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85030033321
Eapen M.S.; Hansbro P.M.; Larsson‑Callerfelt A.-K.; Jolly M.K.; Myers S.; Sharma P.; Jones B.; Rahman M.A.; Markos J.; Chia C.; Larby J.; Haug G.; Hardikar A.; Weber H.C.; Mabeza G.; Cavalheri V.; Khor Y.H.; McDonald C.F.; Sohal S.S.,"Eapen, Mathew Suji (56625716100); Hansbro, Philip M. (6603119390); Larsson‑Callerfelt, Anna-Karin (57204560268); Jolly, Mohit K. (55906762400); Myers, Stephen (35389074400); Sharma, Pawan (57202573033); Jones, Bernadette (56215070300); Rahman, Md Atiqur (57225857381); Markos, James (36895683400); Chia, Collin (57204561315); Larby, Josie (57204563979); Haug, Greg (56560843300); Hardikar, Ashutosh (6602989972); Weber, Heinrich C. (7403097705); Mabeza, George (57210306920); Cavalheri, Vinicius (24831494000); Khor, Yet H. (36966533400); McDonald, Christine F. (57202615369); Sohal, Sukhwinder Singh (36449981500)",56625716100; 6603119390; 57204560268; 55906762400; 35389074400; 57202573033; 56215070300; 57225857381; 36895683400; 57204561315; 57204563979; 56560843300; 6602989972; 7403097705; 57210306920; 24831494000; 36966533400; 57202615369; 36449981500,Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities,2018,Drugs,78,16,,1717,1740,23,62,10.1007/s40265-018-1001-8,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056204229&doi=10.1007%2fs40265-018-1001-8&partnerID=40&md5=2c3dd40c9888b0489323245bbb4a5b0f,"Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle and Centenary Institute and University of Technology Sydney, Lot 1 Kookaburra Circuit, New Lambton Heights, Sydney, NSW, Australia; Lung Biology, Department of Experimental Medical Science, Lund University, Lund, Sweden; Center for Theoretical Biological Physics, Rice University, Houston, TX, United States; Discipline of Medical Sciences, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Department of Respiratory Medicine, Launceston General Hospital, Launceston, TAS, Australia; School of Physiotherapy and Exercise Science, Faculty of Health Sciences, Curtin University, Perth, WA, Australia; Institute for Respiratory Health, Sir Charles Gairdner Hospital, Nedlands, WA, Australia; Department of Allergy, Immunology and Respiratory Medicine, Alfred Health, Melbourne, VIC, Australia; Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, VIC, Australia; Institute for Breathing and Sleep, Heidelberg, VIC, Australia; School of Medicine, University of Melbourne, Melbourne, VIC, Australia; Department of Cardiothoracic Surgery, Royal Hobart Hospital, Hobart, TAS, Australia; Department of Respiratory Medicine, Tasmanian Health Services (THS), North West Hospital, Burnie, TAS, Australia; Centre for BioSystems Science and Engineering, Indian Institute of Science, Bangalore, 560012, India","Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle and Centenary Institute and University of Technology Sydney, Lot 1 Kookaburra Circuit, New Lambton Heights, Sydney, NSW, Australia; Larsson‑Callerfelt A.-K., Lung Biology, Department of Experimental Medical Science, Lund University, Lund, Sweden; Jolly M.K., Center for Theoretical Biological Physics, Rice University, Houston, TX, United States, Centre for BioSystems Science and Engineering, Indian Institute of Science, Bangalore, 560012, India; Myers S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia; Sharma P., Discipline of Medical Sciences, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Jones B., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle and Centenary Institute and University of Technology Sydney, Lot 1 Kookaburra Circuit, New Lambton Heights, Sydney, NSW, Australia; Rahman M.A., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle and Centenary Institute and University of Technology Sydney, Lot 1 Kookaburra Circuit, New Lambton Heights, Sydney, NSW, Australia; Markos J., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, TAS, Australia; Chia C., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, TAS, Australia; Larby J., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, TAS, Australia; Haug G., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Launceston General Hospital, Launceston, TAS, Australia; Hardikar A., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia, Department of Cardiothoracic Surgery, Royal Hobart Hospital, Hobart, TAS, Australia; Weber H.C., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Tasmanian Health Services (THS), North West Hospital, Burnie, TAS, Australia; Mabeza G., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia, Department of Respiratory Medicine, Tasmanian Health Services (THS), North West Hospital, Burnie, TAS, Australia; Cavalheri V., School of Physiotherapy and Exercise Science, Faculty of Health Sciences, Curtin University, Perth, WA, Australia, Institute for Respiratory Health, Sir Charles Gairdner Hospital, Nedlands, WA, Australia; Khor Y.H., Department of Allergy, Immunology and Respiratory Medicine, Alfred Health, Melbourne, VIC, Australia, Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, VIC, Australia, Institute for Breathing and Sleep, Heidelberg, VIC, Australia, School of Medicine, University of Melbourne, Melbourne, VIC, Australia; McDonald C.F., Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, VIC, Australia, Institute for Breathing and Sleep, Heidelberg, VIC, Australia, School of Medicine, University of Melbourne, Melbourne, VIC, Australia; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Locked Bag-1322, Newnham Drive, Launceston, 7248, TAS, Australia",,proteinase; angiogenesis; cancer chemotherapy; cancer radiotherapy; cell plasticity; chemoprophylaxis; chronic obstructive lung disease; cigarette smoking; DNA damage; DNA repair; endothelium cell; epigenetics; epithelial mesenchymal transition; exercise; exosome; extracellular matrix; genetic predisposition; human; immune response; inflammation; lung cancer; lung resection; molecular mechanics; multimodality cancer therapy; nonhuman; oxidative stress; pathophysiology; perioperative period; Review; systemic therapy,Review,Final,,Scopus,2-s2.0-85056204229
Mateer S.W.; Mathe A.; Bruce J.; Liu G.; Maltby S.; Fricker M.; Goggins B.J.; Tay H.L.; Marks E.; Burns G.; Kim R.Y.; Minahan K.; Walker M.M.; Callister R.C.; Foster P.S.; Horvat J.C.; Hansbro P.M.; Keely S.,"Mateer, Sean W. (56595055500); Mathe, Andrea (56018778600); Bruce, Jessica (7201835540); Liu, Gang (57189061134); Maltby, Steven (6507446799); Fricker, Michael (26638839800); Goggins, Bridie J. (55894233100); Tay, Hock L. (55639898100); Marks, Ellen (56594581600); Burns, Grace (57191080549); Kim, Richard Y. (35810406900); Minahan, Kyra (35574254300); Walker, Marjorie M. (7403868685); Callister, Robert C. (7003270835); Foster, Paul S. (7201517569); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Keely, Simon (9739611200)",56595055500; 56018778600; 7201835540; 57189061134; 6507446799; 26638839800; 55894233100; 55639898100; 56594581600; 57191080549; 35810406900; 35574254300; 7403868685; 7003270835; 7201517569; 9942405300; 6603119390; 9739611200,IL-6 Drives Neutrophil-Mediated Pulmonary Inflammation Associated with Bacteremia in Murine Models of Colitis,2018,American Journal of Pathology,188,7,,1625,1639,14,49,10.1016/j.ajpath.2018.03.016,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048759876&doi=10.1016%2fj.ajpath.2018.03.016&partnerID=40&md5=3353b920e3ed8e2ce7b2128b5459cec2,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia; Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia","Mateer S.W., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Mathe A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Bruce J., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Liu G., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Maltby S., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Fricker M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Goggins B.J., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Tay H.L., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Marks E., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Burns G., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Kim R.Y., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Minahan K., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Walker M.M., Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Callister R.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia; Foster P.S., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Horvat J.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Keely S., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia",,"Animals; Bacteremia; Colitis; Dextran Sulfate; Disease Models, Animal; Female; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrophils; Pneumonia; dextran sulfate; interleukin 6; trinitrobenzenesulfonic acid; dextran sulfate; interleukin 6; animal cell; animal experiment; animal model; animal tissue; Article; bacteremia; bone marrow; colitis; controlled study; cytokine release; dextran sulfate sodium-induced colitis; female; fever; infant; lung blood vessel; mouse; neutrophil; nonhuman; pathogenesis; pneumonia; priority journal; trinitrobenzene sulfonic acid-induced colitis; animal; bacteremia; Bagg albino mouse; C57BL mouse; chemically induced; colitis; complication; disease model; drug effect; immunology; metabolism; neutrophil; pathology; pneumonia",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85048759876
Chellappan D.K.; Ng Z.Y.; Wong J.-Y.; Hsu A.; Wark P.; Hansbro N.; Taylor J.; Panneerselvam J.; Madheswaran T.; Gupta G.; Bebawy M.; Hansbro P.M.; Dua K.,"Chellappan, Dinesh K. (35811890500); Ng, Zhao Yin (57196059428); Wong, Jin-Ying (57197761155); Hsu, Alan (49861516600); Wark, Peter (7003559516); Hansbro, Nicole (15055862300); Taylor, Jack (57194595107); Panneerselvam, Jithendra (57201993010); Madheswaran, Thiagarajan (55505311000); Gupta, Gaurav (15047988400); Bebawy, Mary (6506211522); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700)",35811890500; 57196059428; 57197761155; 49861516600; 7003559516; 15055862300; 57194595107; 57201993010; 55505311000; 15047988400; 6506211522; 6603119390; 15759138700,Immunological axis of curcumin-loaded vesicular drug delivery systems,2018,Future Medicinal Chemistry,10,8,,839,844,5,24,10.4155/fmc-2017-0245,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046657301&doi=10.4155%2ffmc-2017-0245&partnerID=40&md5=82641b3777a808e4ccf6a3ef21684050,"School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; School of Medicine and Public Health, University of Newcastle, Newcastle, 2308, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan, 302017, India","Chellappan D.K., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Ng Z.Y., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Wong J.-Y., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Hsu A., School of Medicine and Public Health, University of Newcastle, Newcastle, 2308, NSW, Australia; Wark P., School of Medicine and Public Health, University of Newcastle, Newcastle, 2308, NSW, Australia; Hansbro N., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308, NSW, Australia; Taylor J., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Panneerselvam J., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Madheswaran T., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan, 302017, India; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308, NSW, Australia; Dua K., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia",curcumin; drug delivery; immunological axis; liposomes; nanoparticles; vesicular systems,Analgesics; Anti-Inflammatory Agents; Antineoplastic Agents; Curcumin; Drug Carriers; Drug Delivery Systems; Humans; Liposomes; Nanoparticles; Solubility; curcumin; liposome; analgesic agent; antiinflammatory agent; antineoplastic agent; curcumin; drug carrier; nanoparticle; analgesic activity; antibacterial activity; antiinflammatory activity; antineoplastic activity; antioxidant activity; drug delivery system; drug formulation; drug safety; drug structure; gene targeting; immune system; liposomal delivery; nanotechnology; priority journal; protein targeting; Review; vesicular drug delivery system; chemistry; drug delivery system; human; solubility,Review,Final,,Scopus,2-s2.0-85046657301
Sohal S.S.; Hansbro P.M.; Shukla S.D.; Eapen M.S.; Walters E.H.,"Sohal, Sukhwinder Singh (36449981500); Hansbro, Philip M. (6603119390); Shukla, Shakti Dhar (56367620800); Eapen, Mathew Suji (56625716100); Walters, Eugene Haydn (7102865814)",36449981500; 6603119390; 56367620800; 56625716100; 7102865814,Potential Mechanisms of Microbial Pathogens in Idiopathic Interstitial Lung Disease,2017,Chest,152,4,,899,900,1,13,10.1016/j.chest.2017.05.024,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030720911&doi=10.1016%2fj.chest.2017.05.024&partnerID=40&md5=5f3ac7b6b7d753159a139ee06ea0f3e7,"Breathe Well Centre of Research Excellence for Chronic Respiratory Disease and Lung Ageing, University of Tasmania, Launceston, Australia; School of Health Sciences, University of Tasmania, Launceston, Australia; Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia","Sohal S.S., Breathe Well Centre of Research Excellence for Chronic Respiratory Disease and Lung Ageing, University of Tasmania, Launceston, Australia, School of Health Sciences, University of Tasmania, Launceston, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Eapen M.S., Breathe Well Centre of Research Excellence for Chronic Respiratory Disease and Lung Ageing, University of Tasmania, Launceston, Australia; Walters E.H., Breathe Well Centre of Research Excellence for Chronic Respiratory Disease and Lung Ageing, University of Tasmania, Launceston, Australia",,"Humans; Lung; Lung Diseases, Interstitial; corticosteroid; intercellular adhesion molecule 1; thrombocyte activating factor receptor; chronic obstructive lung disease; disease association; disease exacerbation; disease predisposition; follow up; human; interstitial lung disease; Letter; medication compliance; nonhuman; nontypeable Haemophilus influenzae; pneumococcal infection; priority journal; protein expression; risk factor; Streptococcus pneumoniae; lung",Letter,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85030720911
Nair P.M.; Starkey M.R.; Haw T.J.; Ruscher R.; Liu G.; Maradana M.R.; Thomas R.; O'Sullivan B.J.; Hansbro P.M.,"Nair, Prema M. (55749131000); Starkey, Malcolm R. (35811293400); Haw, Tatt Jhong (56625918900); Ruscher, Roland (16403188900); Liu, Gang (57189061134); Maradana, Muralidhara R. (55623655700); Thomas, Ranjeny (35430984400); O'Sullivan, Brendan J. (35791435100); Hansbro, Philip M. (6603119390)",55749131000; 35811293400; 56625918900; 16403188900; 57189061134; 55623655700; 35430984400; 35791435100; 6603119390,RelB-deficient dendritic cells promote the development of spontaneous allergic airway inflammation,2018,American Journal of Respiratory Cell and Molecular Biology,58,3,,352,365,13,13,10.1165/rcmb.2017-0242OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045220247&doi=10.1165%2frcmb.2017-0242OC&partnerID=40&md5=099cf97bf65b249a0849d832b6cc44af,"Priority Research Centre GrowUpWell, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Department of Laboratory Medicine and Pathology, United States; Center for Immunology, University of Minnesota, Minneapolis, MN, United States; Diamantina Institute, Translational Research Institute, University of Queensland, Woolloongabba, QLD, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia","Nair P.M., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Starkey M.R., Priority Research Centre GrowUpWell, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Haw T.J., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Ruscher R., Department of Laboratory Medicine and Pathology, United States, Center for Immunology, University of Minnesota, Minneapolis, MN, United States, Diamantina Institute, Translational Research Institute, University of Queensland, Woolloongabba, QLD, Australia; Liu G., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; Maradana M.R., Diamantina Institute, Translational Research Institute, University of Queensland, Woolloongabba, QLD, Australia; Thomas R., Diamantina Institute, Translational Research Institute, University of Queensland, Woolloongabba, QLD, Australia; O'Sullivan B.J., Diamantina Institute, Translational Research Institute, University of Queensland, Woolloongabba, QLD, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia",Allergic airway disease; Dendritic cells; RelB,"Adoptive Transfer; Airway Remodeling; Animals; Asthma; Chemokines; Dendritic Cells; Female; Immunoglobulin E; Male; Mice; Mice, Knockout; Pneumonia; Th2 Cells; Transcription Factor RelB; carbon tetrachloride; collagen; eotaxin; gamma interferon; gamma interferon inducible protein 10; immunoglobulin E; interleukin 13; interleukin 17; interleukin 25; interleukin 33; interleukin 4; interleukin 5; macrophage inflammatory protein 1alpha; macrophage inflammatory protein 1beta; methacholine; monocyte chemotactic protein 1; thymic stromal lymphopoietin; thymus and activation regulated chemokine; transcription factor FOXP3; transcription factor RelB; chemokine; immunoglobulin E; Relb protein, mouse; transcription factor RelB; adoptive transfer; airway remodeling; allergic airway inflammation; animal cell; animal tissue; CD4+ T lymphocyte; CD8+ T lymphocyte; comparative study; controlled study; dendritic cell; Editorial; eosinophil count; female; flow cytometry; immunoglobulin blood level; leukocyte count; lung parenchyma; lymphocyte count; macrophage; male; mouse; mucous cell; neutrophil count; nonhuman; animal; asthma; blood; dendritic cell; genetics; immunology; knockout mouse; pathology; pneumonia; Th2 cell; transplantation",Article,Final,,Scopus,2-s2.0-85045220247
Shukla S.D.; Hansbro P.M.; Walters E.H.,"Shukla, Shakti Dhar (56367620800); Hansbro, Philip M. (6603119390); Walters, Eugene Haydn (7102865814)",56367620800; 6603119390; 7102865814,Upregulated pneumococcal adhesion molecule (Platelet-activating factor receptor) may predispose COPD patients to Community-Acquired pneumonia,2017,International Journal of COPD,12,,,3111,3113,2,4,10.2147/COPD.S151142,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032728465&doi=10.2147%2fCOPD.S151142&partnerID=40&md5=6c58a75d25d8e80cdf1537d8b92294ef,"School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Medicine, University of Tasmania, Hobart, TAS, Australia","Shukla S.D., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Walters E.H., School of Medicine, University of Tasmania, Hobart, TAS, Australia",,"Blood Platelets; Community-Acquired Infections; Humans; Pneumonia; Pulmonary Disease, Chronic Obstructive; Streptococcus pneumoniae; cigarette smoke; thrombocyte activating factor receptor; bacterial virulence; bacterium adherence; chronic obstructive lung disease; community acquired pneumonia; disease association; disease exacerbation; disease predisposition; host resistance; human; Letter; nonhuman; pathogenesis; pneumococcal infection; protein expression; smoking; upregulation; chronic obstructive lung disease; community acquired infection; pneumonia; Streptococcus pneumoniae; thrombocyte",Letter,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85032728465
Schofield Z.V.; Croker D.; Robertson A.A.B.; Massey N.L.; Donovan C.; Tee E.; Edwards D.; Woodruff T.M.; Halai R.; Hansbro P.M.; Cooper M.A.,"Schofield, Zoe V. (59237270200); Croker, Daniel (7801377215); Robertson, Avril A. B. (15519764900); Massey, Nicholas L. (57200243933); Donovan, Chantal (55357105200); Tee, Ernest (37027335800); Edwards, David (56810149400); Woodruff, Trent M. (7005693216); Halai, Reena (23480037800); Hansbro, Philip M. (6603119390); Cooper, Matthew A. (7404411451)",59237270200; 7801377215; 15519764900; 57200243933; 55357105200; 37027335800; 56810149400; 7005693216; 23480037800; 6603119390; 7404411451,Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling,2018,Scientific Reports,8,1,17819,,,,5,10.1038/s41598-018-36242-1,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058593596&doi=10.1038%2fs41598-018-36242-1&partnerID=40&md5=614cff1ff616982e193c3c91bd104cf5,"Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; School of Biomedical Sciences, The University of Queensland, Brisbane, Australia; The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia; Priority Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, NSW, Australia","Schofield Z.V., Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; Croker D., Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia, School of Biomedical Sciences, The University of Queensland, Brisbane, Australia; Robertson A.A.B., The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia; Massey N.L., Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; Donovan C., Priority Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, NSW, Australia; Tee E., Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; Edwards D., Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; Woodruff T.M., School of Biomedical Sciences, The University of Queensland, Brisbane, Australia; Halai R., Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; Hansbro P.M., Priority Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, Newcastle, NSW, Australia; Cooper M.A., Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia",,"Animals; CHO Cells; Cricetulus; Cyclic AMP; Fatty Acids, Volatile; Humans; Ligands; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptors, Cell Surface; Second Messenger Systems; cell surface receptor; cyclic AMP; G-protein coupled receptor 43, human; ligand; MAPK1 protein, human; MAPK3 protein, human; mitogen activated protein kinase 1; mitogen activated protein kinase 3; volatile fatty acid; animal; chemistry; CHO cell line; Cricetulus; drug effect; human; MAPK signaling; metabolism; mouse; second messenger; synthesis",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85058593596
Dua K.; Hansbro N.G.; Foster P.S.; Hansbro P.M.,"Dua, Kamal (15759138700); Hansbro, Nicole G. (15055862300); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",15759138700; 15055862300; 7201517569; 6603119390,MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases,2017,Drug Delivery and Translational Research,7,1,,168,178,10,42,10.1007/s13346-016-0343-6,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009783158&doi=10.1007%2fs13346-016-0343-6&partnerID=40&md5=8dfd09ba8cf996151a997c61eea8046d,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia","Dua K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia",Drug delivery; miRNAs; Pulmonary,Animals; Drug Delivery Systems; Humans; Lung Diseases; MicroRNAs; microRNA; microRNA; biogenesis; drug delivery system; drug formulation; human; in vivo study; lung disease; nonhuman; pneumonia; priority journal; Review; RNA analysis; animal; genetics; Lung Diseases,Review,Final,,Scopus,2-s2.0-85009783158
Wadhwa R.; Pandey P.; Gupta G.; Aggarwal T.; Kumar N.; Mehta M.; Satija S.; Gulati M.; Madan J.; Dureja H.; Balusamy S.R.; Perumalsamy H.; Maurya P.K.; Collet T.; Tambuwala M.M.; Hansbro P.M.; Chellappan D.K.; Dua K.,"Wadhwa, Ridhima (57159091700); Pandey, Parijat (56583499400); Gupta, Gaurav (15047988400); Aggarwal, Taru (57196053981); Kumar, Nitesh (57188637148); Mehta, Meenu (7203024234); Satija, Saurabh (54581608400); Gulati, Monica (7006677671); Madan, Jyotsna (26534689100); Dureja, Harish (6507566948); Balusamy, Sri R. (39261087900); Perumalsamy, Haribalan (35345748600); Maurya, Pawan K. (15765644500); Collet, Trudi (36898251800); Tambuwala, Murtaza M. (36657816300); Hansbro, Philip M. (6603119390); Chellappan, Dinesh Kumar (35811890500); Dua, Kamal (15759138700)",57159091700; 56583499400; 15047988400; 57196053981; 57188637148; 7203024234; 54581608400; 7006677671; 26534689100; 6507566948; 39261087900; 35345748600; 15765644500; 36898251800; 36657816300; 6603119390; 35811890500; 15759138700,Emerging complexity and the need for advanced drug delivery in targeting Candida species,2019,Current Topics in Medicinal Chemistry,19,28,,2593,2609,16,26,10.2174/1568026619666191026105308,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077224808&doi=10.2174%2f1568026619666191026105308&partnerID=40&md5=ed3f336f09dc4d5f36b979597d6e0c71,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Shri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak, 124001, India; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, 302 017, Jaipur, India; Amity Institute of Biotechnology, Amity University, Noida, 201303, India; Amity Institute for Advanced Research & Studies (M&D), Amity University, Noida, 201303, India; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Department of Pharmaceutics, Smt. Kashibai Navale College of Pharmacy, Kondhwa, Pune, 411048, Maharashtra, India; Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, 124001, Haryana, India; Department of Food Science and Biotechnology, Sejong University, Gwangjin-gu, Seoul, 05006, South Korea; Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin, 446-701, South Korea; Department of Biochemistry, Central University of Haryana, Jant-Pali, Mahendergarh District, 123031, Haryana, India; Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, QLD, Australia; School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County Londonderry, BT52 1SA, United Kingdom; School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, 173 229, Himachal Pradesh, India","Wadhwa R., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Pandey P., Shri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak, 124001, India; Gupta G., School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, 302 017, Jaipur, India; Aggarwal T., Amity Institute of Biotechnology, Amity University, Noida, 201303, India; Kumar N., Amity Institute for Advanced Research & Studies (M&D), Amity University, Noida, 201303, India; Mehta M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Gulati M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Madan J., Department of Pharmaceutics, Smt. Kashibai Navale College of Pharmacy, Kondhwa, Pune, 411048, Maharashtra, India; Dureja H., Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, 124001, Haryana, India; Balusamy S.R., Department of Food Science and Biotechnology, Sejong University, Gwangjin-gu, Seoul, 05006, South Korea; Perumalsamy H., Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin, 446-701, South Korea; Maurya P.K., Department of Biochemistry, Central University of Haryana, Jant-Pali, Mahendergarh District, 123031, Haryana, India; Collet T., Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, QLD, Australia; Tambuwala M.M., School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County Londonderry, BT52 1SA, United Kingdom; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, 173 229, Himachal Pradesh, India",Antifungal therapy; Candida; Immune cells; Immune-compromised patients; Novel drug delivery system; Receptor-mediated recognition,Animals; Antifungal Agents; Candida; Candidiasis; Drug Delivery Systems; Humans; Microbial Sensitivity Tests; Species Specificity; amphotericin B; echinocandin; fluconazole; itraconazole; miconazole; nystatin; posaconazole; voriconazole; antifungal agent; adaptive immunity; antifungal activity; bacterial virulence; Candida albicans; Candida glabrata; Candida hemulonii; Candida parapsilosis; Candida rugose; Candida tropicalis; candidiasis; cell transfer; drug delivery system; drug design; drug incompatibility; drug resistance; drug targeting; drug transport; human; immunocompetent cell; innate immunity; macrophage; morbidity; mortality rate; neutrophil; nonhuman; Pichia kudriavzevii; Review; stress; animal; Candida; candidiasis; classification; drug effect; immunology; microbial sensitivity test; microbiology; species difference,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85077224808
Cameron G.J.M.; Cautivo K.M.; Loering S.; Jiang S.H.; Deshpande A.V.; Foster P.S.; McKenzie A.N.J.; Molofsky A.B.; Hansbro P.M.; Starkey M.R.,"Cameron, Guy J.M. (57203977896); Cautivo, Kelly M. (24764612200); Loering, Svenja (57205469740); Jiang, Simon H. (36952990000); Deshpande, Aniruddh V. (25822132400); Foster, Paul S. (7201517569); McKenzie, Andrew N.J. (7101774635); Molofsky, Ari B. (6507364021); Hansbro, Philip M. (6603119390); Starkey, Malcolm R. (35811293400)",57203977896; 24764612200; 57205469740; 36952990000; 25822132400; 7201517569; 7101774635; 6507364021; 6603119390; 35811293400,Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury,2019,Frontiers in Immunology,10,MAR,826,,,,29,10.3389/fimmu.2019.00826,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065657489&doi=10.3389%2ffimmu.2019.00826&partnerID=40&md5=81e7cbc7d6a512a84215e7db56a24365,"Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australia National University, Canberra, ACT, Australia; Department of Renal Medicine, Canberra Hospital, Canberra, ACT, Australia; John Hunter Children's Hospital, New Lambton Heights, NSW, Australia; MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Francis Crick Avenue, Cambridge, United Kingdom; Centre for inflammation, Centenary Institute, Sydney, NSW, Australia; Faculty of Science, University of Technology, Ultimo, NSW, Australia","Cameron G.J.M., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Cautivo K.M., Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States; Loering S., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Jiang S.H., Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australia National University, Canberra, ACT, Australia, Department of Renal Medicine, Canberra Hospital, Canberra, ACT, Australia; Deshpande A.V., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, John Hunter Children's Hospital, New Lambton Heights, NSW, Australia; Foster P.S., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; McKenzie A.N.J., MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Francis Crick Avenue, Cambridge, United Kingdom; Molofsky A.B., Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States; Hansbro P.M., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Centre for inflammation, Centenary Institute, Sydney, NSW, Australia, Faculty of Science, University of Technology, Ultimo, NSW, Australia; Starkey M.R., Priority Research Centre's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia",Group 2 innate lymphoid cell; IL-13; IL-5; ILC2; IRI; Ischemia-reperfusion injury; Kidney; Renal,Acute Kidney Injury; Animals; Biomarkers; Disease Susceptibility; Humans; Kidney; Lymphocytes; Obesity; Reperfusion Injury; Respiratory Tract Diseases; collagen; hyaluronic acid binding protein; interleukin 25; interleukin 33; interleukin 5; lymphatic endothelial hyaluronan receptor 1; membrane antigen; unclassified drug; biological marker; animal experiment; animal model; Article; cell activation; chronic kidney failure; disease severity; experimental kidney disease; flow cytometry; gene expression; histopathology; homeostasis and regulation; immunofluorescence; lymphoid cell; male; mouse; mRNA expression level; nonhuman; real time polymerase chain reaction; renal ischemia reperfusion injury; reverse transcription polymerase chain reaction; risk factor; RNA extraction; RT2 profiler array; staining; statistical analysis; t distributed stochastic neighbor embedding; acute kidney failure; animal; complication; disease predisposition; human; immunology; kidney; lymphocyte; obesity; reperfusion injury; respiratory tract disease,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85065657489
Stifter S.A.; Matthews A.Y.; Mangan N.E.; Fung K.Y.; Drew A.; Tate M.D.; Soares Da Costa T.P.; Hampsey D.; Mayall J.; Hansbro P.M.; Minambres A.G.; Eid S.G.; Mak J.; Scoble J.; Lovrecz G.; DeWeerd N.A.; Hertzog P.J.,"Stifter, Sebastian A. (55357516800); Matthews, Antony Y. (9632535100); Mangan, Niamh E. (6506688263); Fung, Ka Yee (57189090775); Drew, Alexander (57524735500); Tate, Michelle D. (22939334200); Soares Da Costa, Tatiana P. (55911127300); Hampsey, Daniel (55383350800); Mayall, Jemma (55607222700); Hansbro, Phil M. (6603119390); Minambres, Albert Garcia (57201013525); Eid, Sahar G. (35217621100); Mak, Johnson (55630513700); Scoble, Judy (7005691185); Lovrecz, George (6602383138); DeWeerd, Nicole A. (6508220812); Hertzog, Paul J. (7005991492)",55357516800; 9632535100; 6506688263; 57189090775; 57524735500; 22939334200; 55911127300; 55383350800; 55607222700; 6603119390; 57201013525; 35217621100; 55630513700; 7005691185; 6602383138; 6508220812; 7005991492,"Defining the distinct, intrinsic properties of the novel type i interferon, IFNϵ",2018,Journal of Biological Chemistry,293,9,,3168,3179,11,31,10.1074/jbc.M117.800755,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042880363&doi=10.1074%2fjbc.M117.800755&partnerID=40&md5=9b696fce21316b1595b6db90ab9d2ade,"Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, VIC, Australia; Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, 3086, VIC, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2300, NSW, Australia; School of Medicine, Deakin University, Geelong, 3220, VIC, Australia; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Animal Health Laboratory, Geelong, 3220, VIC, Australia; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, 4222, QLD, Australia; CSIRO Manufacturing, Parkville, 3052, VIC, Australia; Mycobacterial Laboratory, Centenary Institute, Camperdown, 2050, NSW, Australia; Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, VIC, Australia","Stifter S.A., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Mycobacterial Laboratory, Centenary Institute, Camperdown, 2050, NSW, Australia; Matthews A.Y., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia; Mangan N.E., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia; Fung K.Y., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, VIC, Australia; Drew A., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia; Tate M.D., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia; Soares Da Costa T.P., Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, 3086, VIC, Australia; Hampsey D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2300, NSW, Australia; Mayall J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2300, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2300, NSW, Australia; Minambres A.G., School of Medicine, Deakin University, Geelong, 3220, VIC, Australia, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Animal Health Laboratory, Geelong, 3220, VIC, Australia; Eid S.G., School of Medicine, Deakin University, Geelong, 3220, VIC, Australia, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Animal Health Laboratory, Geelong, 3220, VIC, Australia; Mak J., School of Medicine, Deakin University, Geelong, 3220, VIC, Australia, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Animal Health Laboratory, Geelong, 3220, VIC, Australia, Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, 4222, QLD, Australia; Scoble J., CSIRO Manufacturing, Parkville, 3052, VIC, Australia; Lovrecz G., CSIRO Manufacturing, Parkville, 3052, VIC, Australia; DeWeerd N.A., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia; Hertzog P.J., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, 3168, VIC, Australia, Department of Molecular and Translational Sciences, School of Clinical Sciences at Monash Health, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia",,"Animals; Anti-Bacterial Agents; Antiviral Agents; Cell Proliferation; Chlamydia; Female; Humans; Immunity, Mucosal; Interferon Type I; Mice; Phosphorylation; Protein Conformation, alpha-Helical; RAW 264.7 Cells; Receptors, Interferon; Reproduction; Signal Transduction; STAT1 Transcription Factor; Antibiotics; Chemical activation; Glycoproteins; alpha interferon receptor; alpha interferon receptor 1; alphan1 interferon; beta interferon; beta interferon receptor; beta interferon receptor 1; epsilon interferon; interferon; recombinant epsilon interferon; STAT1 protein; unclassified drug; antiinfective agent; antivirus agent; interferon; interferon receptor; Anti-bacterial activity; Antiviral activities; Functional characterization; Intrinsic activities; Intrinsic property; Signaling activity; Signaling pathways; Type i interferons; alpha helix; animal cell; animal experiment; animal model; antibacterial activity; antiproliferative activity; antiviral activity; Article; B lymphocyte; human; human cell; Human immunodeficiency virus; JAK-STAT signaling; lymphocyte activation; mouse; natural killer cell; nonhuman; priority journal; protein analysis; protein expression; protein folding; protein function; protein purification; signal transduction; T lymphocyte; virus replication; animal; cell proliferation; chemistry; Chlamydia; drug effect; female; metabolism; mucosal immunity; phosphorylation; RAW 264.7 cell line; reproduction; Diseases",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85042880363
Dua K.; Gupta G.; Chellappan D.K.; Shukla S.; Hansbro P.M.,"Dua, Kamal (15759138700); Gupta, Gaurav (15047988400); Chellappan, Dinesh K. (35811890500); Shukla, Shakti (56367620800); Hansbro, Philip M. (6603119390)",15759138700; 15047988400; 35811890500; 56367620800; 6603119390,Targeting bacterial biofilms in pulmonary diseases in pediatric population,2019,Minerva Pediatrica,71,3,,309,310,1,8,10.23736/S0026-4946.16.04711-3,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065311825&doi=10.23736%2fS0026-4946.16.04711-3&partnerID=40&md5=823b0a77f42ab0e2c77d9d6c49f25806,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia; Centre for Inflammation, Centenary Institute, Sydeny, Australia; School of Pharmaceutical Sciences, Jaipur National University, Jaipur, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Faculty of Science, University of Technology, Sydney, Ultimo, Australia","Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia, Centre for Inflammation, Centenary Institute, Sydeny, Australia; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jaipur, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Shukla S., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia, Centre for Inflammation, Centenary Institute, Sydeny, Australia, Faculty of Science, University of Technology, Sydney, Ultimo, Australia",,"Anti-Bacterial Agents; Bacteria; Biofilms; Child; Drug Resistance, Bacterial; Humans; Lung Diseases; antibiotic agent; antiinfective agent; antibiofilm activity; antibiotic resistance; antibiotic therapy; bacterial strain; biofilm; chronic respiratory tract disease; drug targeting; human; Letter; pediatric patient; pediatrics; recurrent infection; respiratory tract infection; bacterium; child; drug effect; isolation and purification; lung disease; microbiology",Letter,Final,,Scopus,2-s2.0-85065311825
Bazett M.; Biala A.; Huff R.D.; Zeglinksi M.R.; Hansbro P.M.; Bosiljcic M.; Gunn H.; Kalyan S.; Hirota J.A.,"Bazett, Mark (47860927300); Biala, Agnieszka (57194214153); Huff, Ryan D. (57191570360); Zeglinksi, Matthew R. (36618522500); Hansbro, Philip M. (6603119390); Bosiljcic, Momir (57203177464); Gunn, Hal (56673885200); Kalyan, Shirin (6507763306); Hirota, Jeremy A. (7007085348)",47860927300; 57194214153; 57191570360; 36618522500; 6603119390; 57203177464; 56673885200; 6507763306; 7007085348,Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation,2017,Respiratory Research,18,1,92,,,,21,10.1186/s12931-017-0577-y,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019174596&doi=10.1186%2fs12931-017-0577-y&partnerID=40&md5=28f2b7b0070b5769ef29ec83029c55f3,"Qu Biologics Inc., Vancouver, V5T 4T5, BC, Canada; University of British Columbia, Department of Medicine, Division of Respiratory Medicine, Vancouver, V6H 3Z6, BC, Canada; University of British Columbia, ICORD Research Centre, Vancouver, V5Z 1M5, BC, Canada; The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia; University of British Columbia, Department of Medicine, Division of Endocrinology, CeMCOR, Vancouver, V5Z 1M9, BC, Canada; McMaster University, Firestone Institute for Respiratory Health, Division of Respirology, Department of Medicine, Hamilton, L8N 4A6, ON, Canada","Bazett M., Qu Biologics Inc., Vancouver, V5T 4T5, BC, Canada; Biala A., University of British Columbia, Department of Medicine, Division of Respiratory Medicine, Vancouver, V6H 3Z6, BC, Canada; Huff R.D., University of British Columbia, Department of Medicine, Division of Respiratory Medicine, Vancouver, V6H 3Z6, BC, Canada; Zeglinksi M.R., University of British Columbia, ICORD Research Centre, Vancouver, V5Z 1M5, BC, Canada; Hansbro P.M., The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, NSW, Australia; Bosiljcic M., Qu Biologics Inc., Vancouver, V5T 4T5, BC, Canada; Gunn H., Qu Biologics Inc., Vancouver, V5T 4T5, BC, Canada; Kalyan S., Qu Biologics Inc., Vancouver, V5T 4T5, BC, Canada, University of British Columbia, Department of Medicine, Division of Endocrinology, CeMCOR, Vancouver, V5Z 1M9, BC, Canada; Hirota J.A., University of British Columbia, Department of Medicine, Division of Respiratory Medicine, Vancouver, V6H 3Z6, BC, Canada, McMaster University, Firestone Institute for Respiratory Health, Division of Respirology, Department of Medicine, Hamilton, L8N 4A6, ON, Canada",COPD; Immunomodulators; Klebsiella; Mucosal immunology,"Animals; Cigarette Smoking; Cytokines; Disease Models, Animal; Female; Immunotherapy; Inflammation Mediators; Klebsiella; Mice; Mice, Inbred C57BL; Pneumonia; Treatment Outcome; Vaccines, Inactivated; chemokine; cigarette smoke; CXCL9 chemokine; cytokine; gamma interferon; gamma interferon inducible protein 10; granulocyte colony stimulating factor; growth factor; interleukin 17; interleukin 6; RANTES; autacoid; cytokine; inactivated vaccine; ambient air; animal experiment; animal model; Article; body weight; bronchodilatation; chronic obstructive lung disease; cigarette smoke induced lung inflammation; clinical protocol; controlled study; cytokine production; disease course; emphysema; female; immune response; immunopathology; immunotherapy; Klebsiella; lung lavage; lymphocyte; macromolecule; macrophage; monocyte; mouse; neutrophil; nonhuman; pathogenesis; pneumonia; risk factor; scoring system; smoking; symptomatology; animal; C57BL mouse; cigarette smoking; disease model; immunology; pneumonia; procedures; treatment outcome",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85019174596
Ge L.; Habiel D.M.; Hansbro P.M.; Kim R.Y.; Gharib S.A.; Edelman J.D.; Königshoff M.; Parimon T.; Brauer R.; Huang Y.; Allen J.; Jiang D.; Kurkciyan A.A.; Mizuno T.; Stripp B.R.; Noble P.W.; Hogaboam C.M.; Chen P.,"Ge, Lingyin (57191343749); Habiel, David M. (23008076200); Hansbro, Phil M. (6603119390); Kim, Richard Y. (35810406900); Gharib, Sina A. (35334319300); Edelman, Jeffery D. (7005652926); Königshoff, Melanie (23028319700); Parimon, Tanyalak (12803373300); Brauer, Rena (24576545200); Huang, Ying (57191342809); Allen, Jenieke (56493686900); Jiang, Dianhua (7401574331); Kurkciyan, Adrianne A. (56891420200); Mizuno, Takako (55011561400); Stripp, Barry R. (7005622170); Noble, Paul W. (7101969623); Hogaboam, Cory M. (7005896872); Chen, Peter (57216740880)",57191343749; 23008076200; 6603119390; 35810406900; 35334319300; 7005652926; 23028319700; 12803373300; 24576545200; 57191342809; 56493686900; 7401574331; 56891420200; 55011561400; 7005622170; 7101969623; 7005896872; 57216740880,miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways,2016,JCI Insight,1,20,e90301,,,,42,10.1172/jci.insight.90301,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055609245&doi=10.1172%2fjci.insight.90301&partnerID=40&md5=6728638221ef26adf88d74560633fe13,"Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, United States; Comprehensive Pneumology Center, Ludwig Maximilians University, University Hospital Grosshadern, Helmholtz Zentrum Munchen, Munich, Germany","Ge L., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Habiel D.M., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kim R.Y., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Gharib S.A., Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, United States; Edelman J.D., Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, United States; Königshoff M., Comprehensive Pneumology Center, Ludwig Maximilians University, University Hospital Grosshadern, Helmholtz Zentrum Munchen, Munich, Germany; Parimon T., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Brauer R., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Huang Y., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Allen J., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Jiang D., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Kurkciyan A.A., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Mizuno T., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Stripp B.R., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Noble P.W., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Hogaboam C.M., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Chen P., Department of Medicine, Division of Pulmonary and Critical Care Medicine, Women’s Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States",,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85055609245
Ng S.W.; Chan Y.; Chellappan D.K.; Madheswaran T.; Zeeshan F.; Chan Y.L.; Collet T.; Gupta G.; Oliver B.G.; Wark P.; Hansbro N.; Hsu A.; Hansbro P.M.; Dua K.; Panneerselvam J.,"Ng, Sin Wi (57204711291); Chan, Yinghan (57204707263); Chellappan, Dinesh Kumar (35811890500); Madheswaran, Thiagarajan (55505311000); Zeeshan, Farrukh (26654611200); Chan, Yik Lung (56292121300); Collet, Trudi (36898251800); Gupta, Gaurav (15047988400); Oliver, Brian G. (15919869900); Wark, Peter (7003559516); Hansbro, Nicole (15055862300); Hsu, Alan (49861516600); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Panneerselvam, Jithendra (57201993010)",57204711291; 57204707263; 35811890500; 55505311000; 26654611200; 56292121300; 36898251800; 15047988400; 15919869900; 7003559516; 15055862300; 49861516600; 6603119390; 15759138700; 57201993010,Molecular modulators of celastrol as the keystones for its diverse pharmacological activities,2019,Biomedicine and Pharmacotherapy,109,,,1785,1792,7,85,10.1016/j.biopha.2018.11.051,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056760395&doi=10.1016%2fj.biopha.2018.11.051&partnerID=40&md5=d97a34f5a591465637448d2fb8c380c8,"School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Indigenous Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, 4059, Queensland, Australia; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia","Ng S.W., School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Chan Y., School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Zeeshan F., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Chan Y.L., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Collet T., Indigenous Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, 4059, Queensland, Australia; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Oliver B.G., School of Life Sciences, Faculty of Science, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Wark P., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Hansbro N., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Hsu A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Dua K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia",Anti-cancer; Anti-diabetic; Anti-inflammatory; Anti-obesity; Celastrol; Molecular modulators; Neuroprotective,"Animals; Arthritis, Rheumatoid; Biological Products; Drug Discovery; Humans; Inflammation; Metabolic Diseases; Plants, Medicinal; Tripterygium; Triterpenes; celastrol; biological product; tripterine; triterpene; anti obesity activity; antidiabetic activity; antiinflammatory activity; antineoplastic activity; drug activity; drug mechanism; human; medicinal plant; neuroprotection; nonhuman; pharmacological parameters; priority journal; Review; animal; chemistry; drug development; inflammation; isolation and purification; metabolic disorder; metabolism; procedures; rheumatoid arthritis; trends; Tripterygium",Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85056760395
Waters D.W.; Blokland K.E.C.; Pathinayake P.S.; Wei L.; Schuliga M.; Jaffar J.; Westall G.P.; Hansbro P.M.; Prele C.M.; Mutsaers S.E.; Bartlett N.W.; Burgess J.K.; Grainge C.L.; Knight D.A.,"Waters, David W. (57194028630); Blokland, Kaj E. C. (57203368707); Pathinayake, Prabuddha S. (55877978000); Wei, Lan (57280074400); Schuliga, Michael (8677386100); Jaffar, Jade (16042610400); Westall, Glen P. (6506799233); Hansbro, Philip M. (6603119390); Prele, Cecilia M. (6507419393); Mutsaers, Steven E. (6701371866); Bartlett, Nathan W. (7005608564); Burgess, Janette K. (7201650628); Grainge, Christopher L. (57192248350); Knight, Darryl A. (7402350036)",57194028630; 57203368707; 55877978000; 57280074400; 8677386100; 16042610400; 6506799233; 6603119390; 6507419393; 6701371866; 7005608564; 7201650628; 57192248350; 7402350036,STAT3 regulates the onset of oxidant-induced senescence in lung fibroblasts,2019,American Journal of Respiratory Cell and Molecular Biology,61,1,,61,73,12,54,10.1165/rcmb.2018-0328OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068326994&doi=10.1165%2frcmb.2018-0328OC&partnerID=40&md5=0296b6f741636ffd57f43799801f8692,"School of Biomedical Sciences and Pharmacy, Medical Sciences Building, University of Newcastle, MS606 University Drive, Callaghan, 2308, NSW, Australia; National Health and Medical Research Council, Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, NSW, Australia; Department of Pathology and Medical Biology, Groningen, Netherlands; Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Prahran, VIC, Australia; Centre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, Nedlands, WA, Australia; Institute for Respiratory Health, University of Western Australia, Nedlands, WA, Australia","Waters D.W., School of Biomedical Sciences and Pharmacy, Medical Sciences Building, University of Newcastle, MS606 University Drive, Callaghan, 2308, NSW, Australia, National Health and Medical Research Council, Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, NSW, Australia; Blokland K.E.C., School of Biomedical Sciences and Pharmacy, Medical Sciences Building, University of Newcastle, MS606 University Drive, Callaghan, 2308, NSW, Australia, National Health and Medical Research Council, Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, NSW, Australia, Department of Pathology and Medical Biology, Groningen, Netherlands, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; Pathinayake P.S., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Wei L., School of Biomedical Sciences and Pharmacy, Medical Sciences Building, University of Newcastle, MS606 University Drive, Callaghan, 2308, NSW, Australia; Schuliga M., School of Biomedical Sciences and Pharmacy, Medical Sciences Building, University of Newcastle, MS606 University Drive, Callaghan, 2308, NSW, Australia; Jaffar J., Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Prahran, VIC, Australia; Westall G.P., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, Medical Sciences Building, University of Newcastle, MS606 University Drive, Callaghan, 2308, NSW, Australia; Prele C.M., Centre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, Nedlands, WA, Australia, Institute for Respiratory Health, University of Western Australia, Nedlands, WA, Australia; Mutsaers S.E., Centre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, Nedlands, WA, Australia, Institute for Respiratory Health, University of Western Australia, Nedlands, WA, Australia; Bartlett N.W., School of Biomedical Sciences and Pharmacy, Medical Sciences Building, University of Newcastle, MS606 University Drive, Callaghan, 2308, NSW, Australia; Burgess J.K., Department of Pathology and Medical Biology, Groningen, Netherlands; Grainge C.L., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Knight D.A., School of Biomedical Sciences and Pharmacy, Medical Sciences Building, University of Newcastle, MS606 University Drive, Callaghan, 2308, NSW, Australia, National Health and Medical Research Council, Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, NSW, Australia",Fibroblast; Fibrosis; Mitochondrial dysfunction; Senescence; Signal transducer and activator of transcription 3,Cell Nucleus; Cell Respiration; Cellular Senescence; Fibroblasts; Humans; Lung; Mitochondria; Oxidants; Phenotype; Phosphorylation; Polycyclic Compounds; Protein Transport; STAT3 Transcription Factor; beta galactosidase; interleukin 6; messenger RNA; oxidizing agent; protein p21; STAT3 protein; superoxide; oxidizing agent; polycyclic hydrocarbon; STA-21; STAT3 protein; Article; bioaccumulation; cell nucleus; chronic lung disease; controlled study; cytokine production; disease course; fibrosing alveolitis; human; human cell; lung fibroblast; mitochondrial respiration; mitochondrion; nuclear localization signal; phenotype; protein localization; protein targeting; proton transport; regulatory mechanism; senescence; cell aging; cell respiration; drug effect; fibroblast; lung; metabolism; pathology; phosphorylation; protein transport,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85068326994
Starkey M.R.; McKenzie A.N.; Belz G.T.; Hansbro P.M.,"Starkey, Malcolm R. (35811293400); McKenzie, Andrew Nj. (7101774635); Belz, Gabrielle T. (7102682937); Hansbro, Philip M. (6603119390)",35811293400; 7101774635; 7102682937; 6603119390,Pulmonary group 2 innate lymphoid cells: surprises and challenges,2019,Mucosal Immunology,12,2,,299,311,12,59,10.1038/s41385-018-0130-4,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060348495&doi=10.1038%2fs41385-018-0130-4&partnerID=40&md5=4d9610e1965f9d4d6c88e04b6b88137e,"Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle and Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0QH, United Kingdom; Division of Molecular Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, VIC, Australia; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, 3010, VIC, Australia; Centre for Inflammation, Faculty of Science, Centenary Institute, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Starkey M.R., Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle and Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia; McKenzie A.N., MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0QH, United Kingdom; Belz G.T., Division of Molecular Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, VIC, Australia, Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, 3010, VIC, Australia; Hansbro P.M., Priority Research Centre’s GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle and Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia, Centre for Inflammation, Faculty of Science, Centenary Institute, University of Technology Sydney, Ultimo, 2007, NSW, Australia",,"Aging; Animals; Cytokines; Homeostasis; Hormones; Humans; Immunity, Innate; Lung; Lymphocytes; Neurotransmitter Agents; Pneumonia; Th2 Cells; neurotransmitter; programmed death 1 receptor; sex hormone; agents interacting with transmitter, hormone or drug receptors; cytokine; hormone; age; allergic airway inflammation; asthma; chronic inflammation; chronic lung disease; circadian rhythm; cytokine production; dendritic cell; group 2 innate lymphoid cell; human; immunomodulation; influenza A; lung fibrosis; lymphoid cell; nonhuman; pathogenesis; pneumonia; priority journal; regulatory T lymphocyte; respiratory syncytial virus infection; respiratory tract infection; respiratory tract inflammation; Review; Rhinovirus infection; aging; animal; homeostasis; immunology; innate immunity; lung; lymphocyte; metabolism; physiology; Th2 cell",Review,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85060348495
Sohal S.S.; Hansbro P.M.; Walters E.H.,"Sohal, Sukhwinder Singh (36449981500); Hansbro, Philip M. (6603119390); Walters, Eugene Haydn (7102865814)",36449981500; 6603119390; 7102865814,"Epithelial mesenchymal transition in chronic obstructive pulmonary disease, a precursor for epithelial cancers: Understanding and translation to early therapy",2017,Annals of the American Thoracic Society,14,9,,1491,1492,1,14,10.1513/AnnalsATS.201705-387LE,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029361732&doi=10.1513%2fAnnalsATS.201705-387LE&partnerID=40&md5=18115858d197f1a69fd0bdf3fc79a8dc,"University of Tasmania, Launceston, TAS, Australia; University of Newcastle, Newcastle, NSW, Australia","Sohal S.S., University of Tasmania, Launceston, TAS, Australia; Hansbro P.M., University of Newcastle, Newcastle, NSW, Australia; Walters E.H., University of Tasmania, Launceston, TAS, Australia",,"Epithelial-Mesenchymal Transition; Humans; Lung; Lung Neoplasms; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; corticosteroid; basement membrane; causality; chronic obstructive lung disease; disease association; early intervention; epithelial mesenchymal transition; human; Letter; lung cancer; lung function; nuclear reprogramming; precancer; randomized controlled trial (topic); respiratory epithelium; smoking; epithelial mesenchymal transition; lung; lung tumor; secondary prevention",Letter,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85029361732
Chellappan D.K.; Hansbro P.M.; Dua K.; Hsu A.; Gupta G.; Ng Z.Y.; Wong J.-Y.; Chellian J.; Panneerselvam J.,"Chellappan, Dinesh Kumar (35811890500); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Hsu, Alan (49861516600); Gupta, Gaurav (15047988400); Ng, Zhao Yin (57196059428); Wong, Jin-Ying (57197761155); Chellian, Jestin (56993705500); Panneerselvam, Jithendra (57201993010)",35811890500; 6603119390; 15759138700; 49861516600; 15047988400; 57196059428; 57197761155; 56993705500; 57201993010,Vesicular Systems Containing Curcumin and Their Applications in Respiratory Disorders – A Mini Review,2017,Pharmaceutical Nanotechnology,5,4,,250,254,4,17,10.2174/2211738505666170808094635,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046666807&doi=10.2174%2f2211738505666170808094635&partnerID=40&md5=7d388ee2d82e3bdb475e514bb7288228,"School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, 2308, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; School of Medicine and Public Health, The University of Newcastle, 2308, NSW, Australia; School of Pharmaceutical Sciences, Jaipur National University, Jagat-pura, Jaipur, India","Chellappan D.K., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, The University of Newcastle, 2308, NSW, Australia; Dua K., School of Biomedical Sciences and Pharmacy, The University of Newcastle, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, 2007, NSW, Australia; Hsu A., School of Medicine and Public Health, The University of Newcastle, 2308, NSW, Australia; Gupta G., School of Medicine and Public Health, The University of Newcastle, 2308, NSW, Australia, School of Pharmaceutical Sciences, Jaipur National University, Jagat-pura, Jaipur, India; Ng Z.Y., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Wong J.-Y., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Chellian J., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Panneerselvam J., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia",Curcumin; Liposomes; Nanotechnology; Niosomes; Respiratory diseases; Vesicular systems,antioxidant; chitosan; curcumin; cytokine; glutathione; immunoglobulin E; nanoparticle; allergic rhinitis; asthma; biocompatibility; biological activity; cell proliferation; chronic obstructive lung disease; cumin; drug delivery system; drug formulation; endocytosis; gene expression; human; immune response; leukocyte differential count; lung alveolus epithelium cell; lung cancer; lung disease; lung lavage; nanotechnology; particle size; respiratory tract disease; Review; signal transduction; upregulation,Review,Final,,Scopus,2-s2.0-85046666807
Periyalil H.A.; Wood L.G.; Wright T.A.; Karihaloo C.; Starkey M.R.; Miu A.S.; Baines K.J.; Hansbro P.M.; Gibson P.G.,"Periyalil, H.A. (55880370800); Wood, L.G. (55859741700); Wright, T.A. (57650607900); Karihaloo, C. (57444708600); Starkey, M.R. (35811293400); Miu, A.S. (57201293693); Baines, K.J. (35078051200); Hansbro, P.M. (6603119390); Gibson, P.G. (7202414199)",55880370800; 55859741700; 57650607900; 57444708600; 35811293400; 57201293693; 35078051200; 6603119390; 7202414199,Obese asthmatics are characterized by altered adipose tissue macrophage activation,2018,Clinical and Experimental Allergy,48,6,,641,649,8,44,10.1111/cea.13109,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044245852&doi=10.1111%2fcea.13109&partnerID=40&md5=f12433f83f0fe7f796b1f9bb93023247,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Department of Surgery, John Hunter Hospital, New Lambton Heights, NSW, Australia; Priority Research Centre Grow-Up-Well, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia","Periyalil H.A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Wright T.A., Department of Surgery, John Hunter Hospital, New Lambton Heights, NSW, Australia; Karihaloo C., Department of Surgery, John Hunter Hospital, New Lambton Heights, NSW, Australia; Starkey M.R., Priority Research Centre Grow-Up-Well, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Miu A.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Department of Surgery, John Hunter Hospital, New Lambton Heights, NSW, Australia; Baines K.J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Priority Research Centre Grow-Up-Well, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Gibson P.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia",adipose tissue; asthma; inflammation; macrophage activation; obesity,Adipose Tissue; Adult; Asthma; Biomarkers; Body Composition; Cross-Sectional Studies; Female; Flow Cytometry; Gene Expression Profiling; Humans; Inflammation; Macrophage Activation; Macrophages; Male; Middle Aged; Obesity; Phenotype; Respiratory Function Tests; C reactive protein; CD163 antigen; biological marker; adipose tissue; adult; Article; asthma; bariatric surgery; controlled study; cross-sectional study; enzyme linked immunosorbent assay; female; flow cytometry; human; human tissue; immunophenotyping; intra-abdominal fat; leukocyte differential count; macrophage activation; major clinical study; male; moderate persistent asthma; obesity; priority journal; protein blood level; respiratory tract inflammation; severe persistent asthma; sputum analysis; subcutaneous fat; adipose tissue; asthma; body composition; complication; gene expression profiling; immunology; inflammation; lung function test; macrophage; macrophage activation; metabolism; middle aged; obesity; pathology; phenotype,Article,Final,,Scopus,2-s2.0-85044245852
Dua K.; Shukla S.D.; Pinto T.D.J.A.; Hansbro P.M.,"Dua, Kamal (15759138700); Shukla, Shakti Dhar (56367620800); Pinto, Terezinha De Jesus Andreoli (7003263019); Hansbro, Philip Michael (6603119390)",15759138700; 56367620800; 7003263019; 6603119390,Nanotechnology: Advancing the translational respiratory research,2017,Interventional Medicine and Applied Science,9,1,,39,41,2,32,10.1556/1646.9.2017.1.02,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016982526&doi=10.1556%2f1646.9.2017.1.02&partnerID=40&md5=14965b58c1d34ec2398289233766f823,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, NSW 2305, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil","Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, NSW 2305, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, NSW 2305, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Pinto T.D.J.A., Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, NSW 2305, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia",Drug delivery; Nanoparticulate; Nanotechnology; Respiratory; Translational,antineoplastic agent; ciprofloxacin; gambogic acid; hydroxyapatite; hypocrellin B; ibuprofen; kelch like ECH associated protein 1; microRNA; palivizumab; peginterferon; photosensitizing agent; reactive oxygen metabolite; small interfering RNA; transcription factor Nrf2; Article; asthma; chronic obstructive lung disease; drug delivery system; gene targeting; human; Human respiratory syncytial virus; lung cancer; lung fibrosis; nanotechnology; photodynamic therapy; regenerative medicine; respiratory tract disease; respiratory tract infection; Staphylococcus aureus; tissue engineering; translational research,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85016982526
Dua K.; Malyla V.; Singhvi G.; Wadhwa R.; Krishna R.V.; Shukla S.D.; Shastri M.D.; Chellappan D.K.; Maurya P.K.; Satija S.; Mehta M.; Gulati M.; Hansbro N.; Collet T.; Awasthi R.; Gupta G.; Hsu A.; Hansbro P.M.,"Dua, Kamal (15759138700); Malyla, Vamshikrishna (57205128961); Singhvi, Gautam (51864379500); Wadhwa, Ridhima (57159091700); Krishna, Rapalli Vamshi (57202194696); Shukla, Shakti Dhar (56367620800); Shastri, Madhur D. (56007290800); Chellappan, Dinesh Kumar (35811890500); Maurya, Pawan Kumar (15765644500); Satija, Saurabh (54581608400); Mehta, Meenu (7203024234); Gulati, Monica (7006677671); Hansbro, Nicole (15055862300); Collet, Trudi (36898251800); Awasthi, Rajendra (36866066100); Gupta, Gaurav (15047988400); Hsu, Alan (49861516600); Hansbro, Philip M. (6603119390)",15759138700; 57205128961; 51864379500; 57159091700; 57202194696; 56367620800; 56007290800; 35811890500; 15765644500; 54581608400; 7203024234; 7006677671; 15055862300; 36898251800; 36866066100; 15047988400; 49861516600; 6603119390,Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems,2019,Chemico-Biological Interactions,299,,,168,178,10,110,10.1016/j.cbi.2018.12.009,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058706707&doi=10.1016%2fj.cbi.2018.12.009&partnerID=40&md5=33e869e5b33eccabc1d8b8edcc77a3bb,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; Faculty of Life Sciences and Biotechnology, South Asian University, Akbar Bhawan, Chanakyapuri, 110021, New Delhi, India; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Department of Biochemistry, Central University of Haryana, Jant-Pali, Mahendergarh District, 123031, Haryana, India; School of Pharmaceutical Sciences, Lovely Faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144441, Punjab, India; Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Indigenous Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, Queensland, Australia; Amity Institute of Pharmacy, Amity University, Sec. 125, Noida, 201303, Uttar Pradesh, India; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India","Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Malyla V., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Singhvi G., Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; Wadhwa R., Faculty of Life Sciences and Biotechnology, South Asian University, Akbar Bhawan, Chanakyapuri, 110021, New Delhi, India; Krishna R.V., Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Shastri M.D., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Maurya P.K., Department of Biochemistry, Central University of Haryana, Jant-Pali, Mahendergarh District, 123031, Haryana, India; Satija S., School of Pharmaceutical Sciences, Lovely Faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144441, Punjab, India; Mehta M., School of Pharmaceutical Sciences, Lovely Faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144441, Punjab, India; Gulati M., School of Pharmaceutical Sciences, Lovely Faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144441, Punjab, India; Hansbro N., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Collet T., Indigenous Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, Queensland, Australia; Awasthi R., Amity Institute of Pharmacy, Amity University, Sec. 125, Noida, 201303, Uttar Pradesh, India; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Hsu A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia",Asthma; COPD; Drug delivery; Lung cancer; Respiratory diseases,"Anti-Inflammatory Agents; Dendrimers; Drug Delivery Systems; Emulsions; Humans; Liposomes; Lung Diseases, Obstructive; Microspheres; Nanoparticles; Oxidative Stress; anthocyanin; budesonide; colchicine; dendrimer; dexamethasone; drug carrier; fluticasone propionate; liposome; microparticle; microsphere; nanoparticle; paclitaxel; quercetin; solid lipid nanoparticle; unclassified drug; antiinflammatory agent; allergic airway inflammation; chronic obstructive lung disease; chronic respiratory tract disease; disease burden; drug delivery system; drug efficacy; human; lung fibrosis; mucoadhesion; nanoemulsion; nonhuman; outcome assessment; oxidative stress; particle size; quality of life; respiratory tract disease; Review; trend study; chemistry; drug delivery system; drug effect; emulsion; metabolism; pathology",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85058706707
Dua K.; De Jesus Andreoli Pinto T.; Chellappan D.K.; Gupta G.; Bebawy M.; Hansbro P.M.,"Dua, Kamal (15759138700); De Jesus Andreoli Pinto, Terezinlia (7003263019); Chellappan, Dinesh K. (35811890500); Gupta, Gaurav (15047988400); Bebawy, Mary (6506211522); Hansbro, Philip M. (6603119390)",15759138700; 7003263019; 35811890500; 15047988400; 6506211522; 6603119390,Advancements in nano drug delivery systems: A challenge for biofilms in respiratory diseases,2018,Panminerva Medica,60,1,,35,36,1,14,10.23736/S0031-0808.18.03402-X,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045902368&doi=10.23736%2fS0031-0808.18.03402-X&partnerID=40&md5=12b619f37a4c5632242afda15286ea7b,"Department of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia; Priority Research Centre For Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, Australia; Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; School of Pharmaceutical Sciences, Jaipur National University, Jaipur, India","Dua K., Department of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia, Priority Research Centre For Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, Australia; De Jesus Andreoli Pinto T., Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jaipur, India; Bebawy M., Department of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; Hansbro P.M., Department of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia, Priority Research Centre For Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, Australia",,"Anti-Infective Agents; Bacterial Adhesion; Biofilms; Cystic Fibrosis; Deoxycholic Acid; Drug Delivery Systems; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Nanomedicine; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive; Staphylococcus aureus; Ursodeoxycholic Acid; antiinfective agent; deoxycholic acid; ursodeoxycholic acid; bacterium adherence; biofilm; chemistry; chronic obstructive lung disease; cystic fibrosis; drug delivery system; Escherichia coli; human; methicillin resistant Staphylococcus aureus; microbiology; nanomedicine; procedures; Pseudomonas aeruginosa; Staphylococcus aureus",Letter,Final,,Scopus,2-s2.0-85045902368
Eapen M.S.; Sharma P.; Thompson I.E.; Lu W.; Myers S.; Hansbro P.M.; Sohal S.S.,"Eapen, Mathew Suji (56625716100); Sharma, Pawan (57202573033); Thompson, Isobel E. (57204755895); Lu, Wenying (57202573402); Myers, Stephen (35389074400); Hansbro, Philip M. (6603119390); Sohal, Sukhwinder Singh (36449981500)",56625716100; 57202573033; 57204755895; 57202573402; 35389074400; 6603119390; 36449981500,Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapies,2019,Laboratory Investigation,99,2,,150,157,7,23,10.1038/s41374-018-0146-0,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057029522&doi=10.1038%2fs41374-018-0146-0&partnerID=40&md5=897b69accc501d9addad99b799f7c635,"Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Medical Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia","Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Sharma P., Medical Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; Thompson I.E., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Lu W., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Myers S., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia",,"Airway Remodeling; Epithelial-Mesenchymal Transition; Heparin-binding EGF-like Growth Factor; Humans; Pulmonary Disease, Chronic Obstructive; epidermal growth factor; epidermal growth factor receptor; heparin binding epidermal growth factor; heparin binding epidermal growth factor; cell plasticity; chronic obstructive lung disease; epithelial mesenchymal transition; epithelium cell; extracellular matrix; human; priority journal; respiratory mucosa; Review; smoking; airway remodeling; epithelial mesenchymal transition; metabolism; pathophysiology; physiology",Review,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85057029522
Rutting S.; Xenaki D.; Lau E.; Horvat J.; Wood L.G.; Hansbro P.M.; Oliver B.G.,"Rutting, Sandra (57202399992); Xenaki, Dia (6507411538); Lau, Edmund (28167531900); Horvat, Jay (9942405300); Wood, Lisa G. (55859741700); Hansbro, Philip M. (6603119390); Oliver, Brian G. (15919869900)",57202399992; 6507411538; 28167531900; 9942405300; 55859741700; 6603119390; 15919869900,"Dietary omega-6, but not omega-3, polyunsaturated or saturated fatty acids increase inflammation in primary lung mesenchymal cells",2018,American Journal of Physiology - Lung Cellular and Molecular Physiology,314,6,,L922,L935,13,19,10.1152/ajplung.00438.2017,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048232006&doi=10.1152%2fajplung.00438.2017&partnerID=40&md5=931567624ddd95d3df0661d29cb3d62b,"Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia; Department of Respiratory Medicine, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; School of Life Sciences, University of Technology Sydney, Sydney, Australia","Rutting S., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia, Department of Respiratory Medicine, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; Xenaki D., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia; Lau E., Department of Respiratory Medicine, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; Horvat J., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Oliver B.G., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia, School of Life Sciences, University of Technology Sydney, Sydney, Australia",Airway inflammation; Arachidonic acid; Dietary fatty acids; Human pulmonary fibroblasts; Obese asthma; ω-6 PUFA,"Aged; Extracellular Signal-Regulated MAP Kinases; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Humans; Inflammation; Interleukin-6; Interleukin-8; Lung; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; Middle Aged; NF-kappa B; Phosphatidylinositol 3-Kinases; arachidonic acid; immunoglobulin enhancer binding protein; interleukin 6; interleukin 8; messenger RNA; mitogen activated protein kinase kinase 1; omega 3 fatty acid; omega 6 fatty acid; phosphatidylinositol 3 kinase; prostaglandin synthase; saturated fatty acid; stress activated protein kinase; synaptophysin; tumor necrosis factor; IL6 protein, human; IL8 protein, human; immunoglobulin enhancer binding protein; interleukin 6; interleukin 8; mitogen activated protein kinase; omega 3 fatty acid; omega 6 fatty acid; phosphatidylinositol 3 kinase; adult; airway cell; airway smooth muscle cell; Article; BEAS-2B cell line; controlled study; cytokine release; disease severity; epithelium cell; fat intake; female; HBEC cell line (bronchial epithelium); human; human cell; in vitro study; lung; major clinical study; male; MAPK signaling; mesenchyme cell; middle aged; obesity; priority journal; respiratory tract inflammation; steroid therapy; upregulation; aged; drug effect; inflammation; lung; mesenchymal stem cell; metabolism; pathology",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85048232006
Budden K.F.; Gellatly S.L.; Wood D.L.A.; Cooper M.A.; Morrison M.; Hugenholtz P.; Hansbro P.M.,"Budden, Kurtis F. (57191417986); Gellatly, Shaan L. (26430804400); Wood, David L. A. (55723732300); Cooper, Matthew A. (7404411451); Morrison, Mark (7201675268); Hugenholtz, Philip (55811879700); Hansbro, Philip M. (6603119390)",57191417986; 26430804400; 55723732300; 7404411451; 7201675268; 55811879700; 6603119390,Emerging pathogenic links between microbiota and the gut-lung axis,2017,Nature Reviews Microbiology,15,1,,55,63,8,1038,10.1038/nrmicro.2016.142,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989950823&doi=10.1038%2fnrmicro.2016.142&partnerID=40&md5=533cc4dba74ef1fe805963f8152fc2e1,"Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, 4072, QLD, Australia; Institute for Molecular Bioscience, University of Queensland, Brisbane, 4072, QLD, Australia; University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, 4072, QLD, Australia","Budden K.F., Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; Gellatly S.L., Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; Wood D.L.A., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, 4072, QLD, Australia; Cooper M.A., Institute for Molecular Bioscience, University of Queensland, Brisbane, 4072, QLD, Australia; Morrison M., University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, 4072, QLD, Australia; Hugenholtz P., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, 4072, QLD, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia",,Bacteria; Dysbiosis; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Lung; Lung Diseases; Respiratory Tract Infections; asthma; dysbiosis; gut lung axis; human; immunity; intestine flora; lung; meta analysis (topic); metabolite; microbial metabolism; microflora; nonhuman; organismal interaction; priority journal; respiratory tract infection; Review; bacterium; classification; dysbiosis; gastrointestinal tract; intestine flora; lung; lung disease; metabolism; microbiology; physiology,Review,Final,,Scopus,2-s2.0-84989950823
Chellappan D.K.; Sivam N.S.; Teoh K.X.; Leong W.P.; Fui T.Z.; Chooi K.; Khoo N.; Yi F.J.; Chellian J.; Cheng L.L.; Dahiya R.; Gupta G.; Singhvi G.; Nammi S.; Hansbro P.M.; Dua K.,"Chellappan, Dinesh Kumar (35811890500); Sivam, Nandhini S. (57204036833); Teoh, Kai Xiang (57204033803); Leong, Wai Pan (57204037004); Fui, Tai Zhen (57204034541); Chooi, Kien (57204035522); Khoo, Nico (57204035980); Yi, Fam Jia (57204040803); Chellian, Jestin (56993705500); Cheng, Lim Lay (57204032948); Dahiya, Rajiv (7102833633); Gupta, Gaurav (15047988400); Singhvi, Gautam (51864379500); Nammi, Srinivas (6602547699); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700)",35811890500; 57204036833; 57204033803; 57204037004; 57204034541; 57204035522; 57204035980; 57204040803; 56993705500; 57204032948; 7102833633; 15047988400; 51864379500; 6602547699; 6603119390; 15759138700,Gene therapy and type 1 diabetes mellitus,2018,Biomedicine and Pharmacotherapy,108,,,1188,1200,12,60,10.1016/j.biopha.2018.09.138,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054194572&doi=10.1016%2fj.biopha.2018.09.138&partnerID=40&md5=f3e36ee88e1d92a6662792a6c8333ef9,"Department of Life Sciences, International Medical University, Kuala Lumpur, 57000, Malaysia; School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Laboratory of Peptide Research and Development, School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Department of Pharmacy, Birla Institute of Technology & Science (BITS), Pilani, Pilani Campus, 333031, Rajasthan, India; School of Science and Health, Western Sydney University, 2751, NSW, Australia; NICM Health Research Institute, Western Sydney University, 2751, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW 2308, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, Himachal Pradesh, India","Chellappan D.K., Department of Life Sciences, International Medical University, Kuala Lumpur, 57000, Malaysia; Sivam N.S., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Teoh K.X., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Leong W.P., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Fui T.Z., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Chooi K., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Khoo N., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Yi F.J., School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia; Chellian J., Department of Life Sciences, International Medical University, Kuala Lumpur, 57000, Malaysia; Cheng L.L., Department of Life Sciences, International Medical University, Kuala Lumpur, 57000, Malaysia; Dahiya R., Laboratory of Peptide Research and Development, School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Singhvi G., Department of Pharmacy, Birla Institute of Technology & Science (BITS), Pilani, Pilani Campus, 333031, Rajasthan, India; Nammi S., School of Science and Health, Western Sydney University, 2751, NSW, Australia, NICM Health Research Institute, Western Sydney University, 2751, NSW, Australia; Hansbro P.M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW 2308, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW 2308, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, Himachal Pradesh, India",Autoimmune disease; Gene therapy; Insulin; Proteins; Type 1 diabetes mellitus,"Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Genetic Engineering; Genetic Therapy; Humans; Immunotherapy; Vaccination; abatacept; adenovirus vector; alpha 1 antitrypsin; antisense oligonucleotide; betacellulin; cyclosporine; DNA vaccine; glucokinase; glutamate decarboxylase 65; imatinib; insulin; interleukin 15; interleukin 2; leptin; neurogenin 3; pirinixic acid; polymer; prednisone; proinsulin; proinsulin ii; rapamycin; recombinant interleukin 10; rituximab; somatomedin C; T lymphocyte receptor; thymocyte antibody; transcription factor FOXP3; transcription factor PDX 1; transforming growth factor beta1; unclassified drug; unindexed drug; Adeno associated virus 8; Adenoviridae; adipose derived stem cell; DNA immunization; electroporation; Epstein Barr virus; gene delivery system; gene overexpression; gene therapy; gene transfer; genetic engineering; hematopoietic stem cell transplantation; Herpes simplex virus; human; hydrodynamics based transfection; immunotherapy; insulin dependent diabetes mellitus; Lentivirus; nonhuman; nonviral gene delivery system; pancreas islet transplantation; plasmid; priority journal; publication; regulatory T lymphocyte; Retroviridae; Review; animal; clinical trial (topic); genetics; insulin dependent diabetes mellitus; vaccination",Review,Final,All Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85054194572
Nair P.M.; Starkey M.R.; Haw T.J.; Liu G.; Collison A.M.; Mattes J.; Wark P.A.; Morris J.C.; Verrills N.M.; Clark A.R.; Ammit A.J.; Hansbro P.M.,"Nair, Prema M (55749131000); Starkey, Malcolm R (35811293400); Haw, Tatt Jhong (56625918900); Liu, Gang (57189061134); Collison, Adam M (23995251200); Mattes, Joerg (7005999915); Wark, Peter A. (7003559516); Morris, Jonathan C (35354969700); Verrills, Nikki M (6602391112); Clark, Andrew R (7404479336); Ammit, Alaina J (7003377421); Hansbro, Philip M (6603119390)",55749131000; 35811293400; 56625918900; 57189061134; 23995251200; 7005999915; 7003559516; 35354969700; 6602391112; 7404479336; 7003377421; 6603119390,Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease,2019,Clinical and Translational Immunology,8,10,e01084,,,,15,10.1002/cti2.1084,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074187807&doi=10.1002%2fcti2.1084&partnerID=40&md5=1452c25e63f178c60404f190183c29bd,"Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; School of Chemistry, University of New South Wales, Sydney, NSW, Australia; Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Centenary Institute, Centre for Inflammation, University of Technology Sydney, Sydney, NSW, Australia","Nair P.M., Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Starkey M.R., Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Haw T.J., Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Liu G., Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Collison A.M., Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Mattes J., Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Wark P.A., Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Morris J.C., School of Chemistry, University of New South Wales, Sydney, NSW, Australia; Verrills N.M., Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Clark A.R., Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; Ammit A.J., Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., Priority Research Centres for Healthy Lungs, Grow Up Well and Cancer Research, Innovation and Translation, Hunter Medical Research Institute, University of Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia, Centenary Institute, Centre for Inflammation, University of Technology Sydney, Sydney, NSW, Australia",chronic obstructive pulmonary disease; inflammation; protein phosphatase 2A; tristetraprolin; ubiquitin–proteasome system,bortezomib; cigarette smoke; CXCL1 chemokine; CXCL2 chemokine; interleukin 6; macrophage elastase; tristetraprolin; tumor necrosis factor; airway remodeling; airway resistance; animal experiment; animal model; Article; chronic obstructive lung disease; controlled study; disease severity; emphysema; female; forced expiratory volume; forced vital capacity; leukocyte; lung function; lung homogenate; lung parenchyma; lymphocyte; macrophage; mouse; mRNA expression level; neutrophil; nonhuman; pathogenesis; pneumonia; priority journal; total lung capacity,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85074187807
Shukla S.D.; Budden K.F.; Neal R.; Hansbro P.M.,"Shukla, Shakti D. (56367620800); Budden, Kurtis F. (57191417986); Neal, Rachael (57201587411); Hansbro, Philip M. (6603119390)",56367620800; 57191417986; 57201587411; 6603119390,"Microbiome effects on immunity, health and disease in the lung",2017,Clinical and Translational Immunology,6,3,e133,,,,232,10.1038/cti.2017.6,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031409310&doi=10.1038%2fcti.2017.6&partnerID=40&md5=6193f3b265c3a2fc83069356a4001193,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, Newcastle, 2305, NSW, Australia","Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, Newcastle, 2305, NSW, Australia; Budden K.F., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, Newcastle, 2305, NSW, Australia; Neal R., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, Newcastle, 2305, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, Newcastle, 2305, NSW, Australia",,asthma; chronic lung disease; chronic obstructive lung disease; chronic respiratory tract disease; cystic fibrosis; diet; dysbiosis; health; human; immune response; immunity; immunoregulation; intestine flora; lung microbiome; microbiome; microflora; pathogenesis; priority journal; Review; risk factor,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85031409310
Dua K.; Hansbro N.G.; Foster P.S.; Hansbro P.M.,"Dua, Kamal (15759138700); Hansbro, Nicole G. (15055862300); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",15759138700; 15055862300; 7201517569; 6603119390,Targeting microRNAs: Promising future therapeutics in the treatment of allergic airway disease,2018,Critical Reviews in Eukaryotic Gene Expression,28,2,,125,127,2,4,10.1615/CritRevEukaryotGeneExpr.2018022218,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052523963&doi=10.1615%2fCritRevEukaryotGeneExpr.2018022218&partnerID=40&md5=7301708b12d8976a9b10bc389f5d39c3,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia","Dua K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia",Airway; Asthma; MicroRNAs; Short non-coding RNAs,"Asthma; Gene Expression Regulation; Humans; MicroRNAs; Respiratory Hypersensitivity; Respiratory System; RNA, Messenger; microRNA; messenger RNA; microRNA; Article; asthma; bronchus muscle; gene expression; gene targeting; human; macrophage; nonhuman; pathogenesis; priority journal; real time polymerase chain reaction; respiratory tract allergy; gene expression regulation; genetics; pathology; respiratory system; respiratory tract allergy",Article,Final,,Scopus,2-s2.0-85052523963
Kedzierski L.; Tate M.D.; Hsu A.C.; Kolesnik T.B.; Linossi E.M.; Dagley L.; Dong Z.; Freeman S.; Infusini G.; Starkey M.R.; Bird N.L.; Chatfield S.M.; Babon J.J.; Huntington N.; Belz G.; Webb A.; Wark P.A.; Nicola N.A.; Xu J.; Kedzierska K.; Hansbro P.M.; Nicholson S.E.,"Kedzierski, Lukasz (6602378121); Tate, Michelle D. (22939334200); Hsu, Alan C. (49861516600); Kolesnik, Tatiana B. (7003402994); Linossi, Edmond M. (55151150500); Dagley, Laura (55566188700); Dong, Zhaoguang (57193667681); Freeman, Sarah (57193672705); Infusini, Giuseppe (6507698382); Starkey, Malcolm R. (35811293400); Bird, Nicola L. (55215481700); Chatfield, Simon M. (57193669063); Babon, Jeffrey J. (13605440600); Huntington, Nicholas (55922608600); Belz, Gabrielle (7102682937); Webb, Andrew (57210993119); Wark, Peter Ab. (7003559516); Nicola, Nicos A. (7102817958); Xu, Jianqing (55830926700); Kedzierska, Katherine (8374461700); Hansbro, Philip M. (6603119390); Nicholson, Sandra E. (7101734064)",6602378121; 22939334200; 49861516600; 7003402994; 55151150500; 55566188700; 57193667681; 57193672705; 6507698382; 35811293400; 55215481700; 57193669063; 13605440600; 55922608600; 7102682937; 57210993119; 7003559516; 7102817958; 55830926700; 8374461700; 6603119390; 7101734064,Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling,2017,eLife,6,,e20444,,,,63,10.7554/eLife.20444,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015651225&doi=10.7554%2feLife.20444&partnerID=40&md5=c6b4a1eb782b89a477fadf1aab546daa,"The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; Department of Medical Biology, University of Melbourne, Parkville, Australia; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Australia; Monash University, Clayton, Australia; Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Shanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Australia","Kedzierski L., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Tate M.D., Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Australia, Monash University, Clayton, Australia; Hsu A.C., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Kolesnik T.B., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Linossi E.M., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Dagley L., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Dong Z., Shanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China; Freeman S., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Infusini G., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Starkey M.R., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Bird N.L., Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Australia; Chatfield S.M., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Babon J.J., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Huntington N., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Belz G., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Webb A., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Wark P.A., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Nicola N.A., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia; Xu J., Shanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China; Kedzierska K., Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Nicholson S.E., The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, Department of Medical Biology, University of Melbourne, Parkville, Australia",,"Animals; Body Weight; Cytokines; Disease Models, Animal; Humans; Influenza A virus; Mice; Mice, Knockout; Orthomyxoviridae Infections; Receptor, Epidermal Growth Factor; Signal Transduction; Suppressor of Cytokine Signaling Proteins; Viral Load; epidermal growth factor receptor; fluticasone propionate plus salmeterol xinafoate; gamma interferon; granulocyte colony stimulating factor; interleukin 6; macrophage inflammatory protein 1beta; monocyte chemotactic protein 1; peptides and proteins; phosphatidylinositol 3 kinase; salbutamol; small interfering RNA; suppressor of cytokine signaling 5; tiotropium bromide; unclassified drug; cytokine; EGFR protein, human; EGFR protein, mouse; epidermal growth factor receptor; SOCS5 protein, human; Socs5 protein, mouse; suppressor of cytokine signaling; adult; aged; airway epithelium cell; animal experiment; animal tissue; Article; bone marrow; chromatin immunoprecipitation; chronic obstructive lung disease; controlled study; disease predisposition; disease severity; enzyme activity; enzyme linked immunosorbent assay; experimental influenza; female; flow cytometry; fluorescence activated cell sorting; human; immunoblotting; immunohistochemistry; immunophenotyping; inflammation; Influenza A virus; intracellular signaling; lung lavage; male; mass spectrometry; mouse; neutrophil chemotaxis; nonhuman; protein expression; real time polymerase chain reaction; upregulation; virus load; weight reduction; animal; antagonists and inhibitors; body weight; deficiency; disease model; immunology; knockout mouse; metabolism; orthomyxovirus infection; pathology; secretion (process); signal transduction; virology",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85015651225
Terlizzi M.; Molino A.; Colarusso C.; Donovan C.; Imitazione P.; Somma P.; Aquino R.P.; Hansbro P.M.; Pinto A.; Sorrentino R.,"Terlizzi, Michela (55605037100); Molino, Antonio (7005073386); Colarusso, Chiara (57191250457); Donovan, Chantal (55357105200); Imitazione, Pasquale (57190155386); Somma, Pasquale (6603169043); Aquino, Rita P. (7006620872); Hansbro, Philip M. (6603119390); Pinto, Aldo (7402306499); Sorrentino, Rosalinda (14065472200)",55605037100; 7005073386; 57191250457; 55357105200; 57190155386; 6603169043; 7006620872; 6603119390; 7402306499; 14065472200,Activation of the absent in melanoma 2 inflammasome in peripheral blood mononuclear cells from Idiopathic pulmonary fibrosis patients leads to the release of pro-fibrotic mediators,2018,Frontiers in Immunology,9,APR,670,,,,30,10.3389/fimmu.2018.00670,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045022385&doi=10.3389%2ffimmu.2018.00670&partnerID=40&md5=d7b66dd7a6956e1849e13269312e992a,"Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy; ImmunePharma s.r.l., University of Salerno, Fisciano, Salerno, Italy; Respiratory Division, Department of Respiratory Medicine, University of Naples Federico II, Naples, Italy; PhD Program in Drug Discovery and Development, Department of Pharmacy, University of Salerno, Fisciano, Italy; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Anatomy and Pathology, Ospedale dei Colli 'Monaldi-CTO', Naples, Italy","Terlizzi M., Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy, ImmunePharma s.r.l., University of Salerno, Fisciano, Salerno, Italy; Molino A., Respiratory Division, Department of Respiratory Medicine, University of Naples Federico II, Naples, Italy; Colarusso C., Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy, ImmunePharma s.r.l., University of Salerno, Fisciano, Salerno, Italy, PhD Program in Drug Discovery and Development, Department of Pharmacy, University of Salerno, Fisciano, Italy; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Imitazione P., Respiratory Division, Department of Respiratory Medicine, University of Naples Federico II, Naples, Italy; Somma P., Department of Anatomy and Pathology, Ospedale dei Colli 'Monaldi-CTO', Naples, Italy; Aquino R.P., Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy, ImmunePharma s.r.l., University of Salerno, Fisciano, Salerno, Italy; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Pinto A., Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy, ImmunePharma s.r.l., University of Salerno, Fisciano, Salerno, Italy; Sorrentino R., Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy, ImmunePharma s.r.l., University of Salerno, Fisciano, Salerno, Italy",Absent in melanoma 2 inflammasome; Caspase-4; Idiopathic pulmonary fibrosis; IL-18; IL-1α,bleomycin; inflammasome; interleukin 1beta; toll like receptor 4; airway remodeling; Article; bronchoalveolar lavage fluid; cell infiltration; extracellular matrix; fibrosing alveolitis; fibrosis; flow cytometry; human; lactate dehydrogenase blood level; lung fibrosis; melanoma; mouse; nonhuman; peripheral blood mononuclear cell; prognosis; reverse transcription polymerase chain reaction; RNA extraction,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85045022385
Eapen M.S.; Sharma P.; Gaikwad A.V.; Lu W.; Myers S.; Hansbro P.M.; Sohal S.S.,"Eapen, Mathew Suji (56625716100); Sharma, Pawan (57202573033); Gaikwad, Archana Vijay (57209282002); Lu, Wenying (57202573402); Myers, Stephen (35389074400); Hansbro, Philip M. (6603119390); Sohal, Sukhwinder Singh (36449981500)",56625716100; 57202573033; 57209282002; 57202573402; 35389074400; 6603119390; 36449981500,Epithelial–mesenchymal transition is driven by transcriptional and post transcriptional modulations in copd: Implications for disease progression and new therapeutics,2019,International Journal of COPD,14,,,1603,1610,7,23,10.2147/COPD.S208428,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071282231&doi=10.2147%2fCOPD.S208428&partnerID=40&md5=dbf6134569174778c5e33b619a41e469,"Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Medical Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia","Eapen M.S., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Sharma P., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia, Medical Sciences, University of Technology Sydney, Sydney, 2007, NSW, Australia, Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, 2037, NSW, Australia; Gaikwad A.V., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Lu W., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Myers S., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and the University of Newcastle, Newcastle, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, 2007, NSW, Australia; Sohal S.S., Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, 7248, TAS, Australia",Cancer; EGFR; EMT; Epithelial-to-mesenchymal transition; Fibrosis; HuR; Inflammation; MMP; TGFβ,"Airway Remodeling; Cigarette Smoking; Disease Progression; Epithelial-Mesenchymal Transition; Humans; Lung; Pulmonary Disease, Chronic Obstructive; corticosteroid derivative; ELAV like protein 1; transcription factor ZEB1; transforming growth factor beta; Wnt protein; cell plasticity; chronic obstructive lung disease; cigarette smoking; disease course; epithelial mesenchymal transition; human; Note; pathogenesis; pollution; protein expression; protein function; transcription regulation; Wnt signaling; airway remodeling; chronic obstructive lung disease; cigarette smoking; disease exacerbation; lung; pathology; pathophysiology",Note,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85071282231
Stevens R.L.; McNeil H.P.; Wensing L.A.; Shin K.; Wong G.W.; Hansbro P.M.; Krilis S.A.,"Stevens, Richard L. (7403202252); McNeil, H. Patrick (7006243093); Wensing, Lislaine A. (56217945200); Shin, Kichul (55420103800); Wong, G. William (7402527670); Hansbro, Philip M. (6603119390); Krilis, Steven A. (7005510030)",7403202252; 7006243093; 56217945200; 55420103800; 7402527670; 6603119390; 7005510030,Experimental arthritis is dependent on mouse mast cell protease-5,2017,Journal of Biological Chemistry,292,13,,5392,5404,12,12,10.1074/jbc.M116.773416,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016633068&doi=10.1074%2fjbc.M116.773416&partnerID=40&md5=6ecf93ccf0a8914605d6fe467172ca13,"Department of Infectious Diseases, Immunology, and Sexual Health, St. George Hospital, St. George and Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Research and Education Centre, 4-10 South St., Kogarah, Sydney, 2217, NSW, Australia; Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308, NSW, Australia; Faculty of Medicine and Health Sciences, Macquarie University, 2109, NSW, Australia; Department of Immunology, Biomedical Sciences Institute, University of Sao Paulo, Sao Paulo, 05508900, Brazil; Division of Rheumatology, Seoul Metropolitan Government, Seoul National University (SMG-SNU), Boramae Medical Center, Seoul, 07061, South Korea; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, 21205, MD, United States; Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Newcastle, 2308, NSW, Australia","Stevens R.L., Department of Infectious Diseases, Immunology, and Sexual Health, St. George Hospital, St. George and Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Research and Education Centre, 4-10 South St., Kogarah, Sydney, 2217, NSW, Australia, Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308, NSW, Australia; McNeil H.P., Faculty of Medicine and Health Sciences, Macquarie University, 2109, NSW, Australia; Wensing L.A., Department of Infectious Diseases, Immunology, and Sexual Health, St. George Hospital, St. George and Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Research and Education Centre, 4-10 South St., Kogarah, Sydney, 2217, NSW, Australia, Department of Immunology, Biomedical Sciences Institute, University of Sao Paulo, Sao Paulo, 05508900, Brazil; Shin K., Division of Rheumatology, Seoul Metropolitan Government, Seoul National University (SMG-SNU), Boramae Medical Center, Seoul, 07061, South Korea; Wong G.W., Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, 21205, MD, United States; Hansbro P.M., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Newcastle, 2308, NSW, Australia; Krilis S.A., Department of Infectious Diseases, Immunology, and Sexual Health, St. George Hospital, St. George and Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Research and Education Centre, 4-10 South St., Kogarah, Sydney, 2217, NSW, Australia, Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308, NSW, Australia",,"Animals; Arthritis, Experimental; Carboxypeptidases A; Chymases; Humans; Mast Cells; Mice; Mice, Inbred C57BL; Secretory Vesicles; Antigen-antibody reactions; Bone; Diseases; Genes; Granulation; Plants (botany); Proteins; carboxypeptidase A; eotaxin 2; exopeptidase; fibronectin; gelatinase B; interleukin 3; interleukin 9; macrophage inflammatory protein 1; mast cell protease 5; messenger RNA; PADGEM protein; proteinase; proteoglycan; somatomedin C; unclassified drug; vascular cell adhesion molecule 1; carboxypeptidase A; chymase; Cma1 protein, mouse; Cpa3 protein, mouse; Amino acid sequence; Disease models; Homologous recombination; Metalloproteinases; Nucleotide sequences; Peritoneal cavity; Secretory granules; Transgenic mice; animal cell; animal experiment; animal model; animal tissue; Article; autolysis; bone marrow derived mast cell; C57BL 6 mouse; controlled study; disease association; exocytosis; experimental arthritis; gene; gene disruption; gene expression; gene targeting; homologous recombination; human; in vivo study; jejunum mucosa; mast cell; mMCP 5 gene; mouse; nonhuman; peritoneal cavity; protein expression; protein function; protein processing; protein structure; signal transduction; transgenic mouse; trichinosis; wild type; animal; Arthritis, Experimental; C57BL mouse; deficiency; enzymology; mast cell; metabolism; pathology; physiology; secretory vesicle; Mammals",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85016633068
Soon L.; Ng P.Q.; Chellian J.; Madheswaran T.; Panneerselvam J.; Gupta G.; Nammi S.; Hansbro N.; Hsu A.; Dureja H.; Mehta M.; Satija S.; Hansbro P.M.; Dua K.; Collet T.; Chellappan D.K.,"Soon, Laura (57211559755); Ng, Phui Qi (57205271584); Chellian, Jestin (56993705500); Madheswaran, Thiagarajan (55505311000); Panneerselvam, Jithendra (57201993010); Gupta, Gaurav (15047988400); Nammi, Srinivas (6602547699); Hansbro, Nicole (15055862300); Hsu, Alan (49861516600); Dureja, Harish (6507566948); Mehta, Meenu (7203024234); Satija, Saurabh (54581608400); Hansbro, Philip Michael (6603119390); Dua, Kamal (15759138700); Collet, Trudi (36898251800); Chellappan, Dinesh Kumar (35811890500)",57211559755; 57205271584; 56993705500; 55505311000; 57201993010; 15047988400; 6602547699; 15055862300; 49861516600; 6507566948; 7203024234; 54581608400; 6603119390; 15759138700; 36898251800; 35811890500,Therapeutic potential of artemisia vulgaris: An insight into underlying immunological mechanisms,2019,"Journal of Environmental Pathology, Toxicology and Oncology",38,3,,205,216,11,19,10.1615/JEnvironPatholToxicolOncol.2019029397,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074417985&doi=10.1615%2fJEnvironPatholToxicolOncol.2019029397&partnerID=40&md5=3e06d28807fff398fdd14d87119d435b,"School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Department of Pharmacology, School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, 302017, Jaipur, India; School of Science and Health, Western Sydney University, 2751, NSW, Australia; NICM Health Research Institute, Western Sydney University, 2751, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI, School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, 124001, Haryana, India; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, Punjab, 144411, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Indigenous Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, 4059, QLD, Australia","Soon L., School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Ng P.Q., School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Chellian J., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Panneerselvam J., Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia; Gupta G., Department of Pharmacology, School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, 302017, Jaipur, India; Nammi S., School of Science and Health, Western Sydney University, 2751, NSW, Australia, NICM Health Research Institute, Western Sydney University, 2751, NSW, Australia; Hansbro N., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI, School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Hsu A., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI, School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia; Dureja H., Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, 124001, Haryana, India; Mehta M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, Punjab, 144411, India; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, Punjab, 144411, India; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI, School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Faculty of Science, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Dua K., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI, School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, 2308, NSW, Australia, Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, 2007, NSW, Australia; Collet T., Indigenous Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, 4059, QLD, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia",Anti-inflammatory; Anticancer; Antidiabetic; Antimicrobial; Antioxidant; Artemisia vulgaris; Hypolipidemic,"Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Artemisia; Hypolipidemic Agents; Phytotherapy; Plant Extracts; Plants, Medicinal; Artemisia vulgaris extract; antiinfective agent; antiinflammatory agent; antilipemic agent; antineoplastic agent; antioxidant; plant extract; antidiabetic activity; antiinflammatory activity; antimicrobial activity; antineoplastic activity; antioxidant activity; apoptosis; Artemisia vulgaris; Article; cooking; drug cytotoxicity; drug mechanism; drug potency; herbal medicine; human; hypolipemia; hypolipidemic activity; immunoreactivity; nonhuman; oxidative stress; plant growth; priority journal; Artemisia; chemistry; medicinal plant; phytotherapy",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85074417985
Nixon B.; Johnston S.D.; Skerrett-Byrne D.A.; Anderson A.L.; Stanger S.J.; Bromfield E.G.; Martin J.H.; Hansbro P.M.; Dun M.D.,"Nixon, Brett (34571659200); Johnston, Stephen D. (55171472400); Skerrett-Byrne, David A. (57200648755); Anderson, Amanda L. (36055954400); Stanger, Simone J. (55193089500); Bromfield, Elizabeth G. (55143329400); Martin, Jacinta H. (56650359200); Hansbro, Philip M. (6603119390); Dun, Matthew D. (36547795700)",34571659200; 55171472400; 57200648755; 36055954400; 55193089500; 55143329400; 56650359200; 6603119390; 36547795700,Modification of crocodile spermatozoa refutes the tenet that post-testicular sperm maturation is restricted to mammals,2019,Molecular and Cellular Proteomics,18,,,S59,S76,17,30,10.1074/mcp.RA118.000904,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063299090&doi=10.1074%2fmcp.RA118.000904&partnerID=40&md5=b6dac8aaa2c578bc0b4fc0f7e9804d5a,"Priority Research Centre for Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia; School of Agriculture and Food Science, University of Queensland, Gatton, 4343, QLD, Australia; 储Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, University of Newcastle, Newcastle, 2308, NSW, Australia; Priority Research Centre for Cancer Research, Innovation and Translation, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, 2308, NSW, Australia","Nixon B., Priority Research Centre for Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia; Johnston S.D., School of Agriculture and Food Science, University of Queensland, Gatton, 4343, QLD, Australia; Skerrett-Byrne D.A., Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia; Anderson A.L., Priority Research Centre for Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia; Stanger S.J., Priority Research Centre for Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia; Bromfield E.G., Priority Research Centre for Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia; Martin J.H., Priority Research Centre for Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia; Hansbro P.M., Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia, 储Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, University of Newcastle, Newcastle, 2308, NSW, Australia; Dun M.D., Hunter Medical Research Institute, New Lambton Heights, 2305, NSW, Australia, Priority Research Centre for Cancer Research, Innovation and Translation, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, 2308, NSW, Australia",,Alligators and Crocodiles; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Gene Ontology; Male; Mammals; Molecular Sequence Annotation; Peptides; Phosphopeptides; Phosphorylation; Proteome; Proteomics; Reproducibility of Results; Sperm Capacitation; Sperm Maturation; Sperm Motility; Spermatozoa; Testis; amino acid; phosphoprotein; carbonyl cyanide chlorophenylhydrazone; peptide; phosphopeptide; proteome; animal cell; Article; controlled study; Crocodylus porosus; male; molecular evolution; nonhuman; phosphoproteomics; priority journal; protein phosphorylation; quantitative analysis; signal transduction; spermatozoon capacitation; spermatozoon maturation; animal; crocodilian; drug effect; gene ontology; mammal; metabolism; molecular genetics; phosphorylation; physiology; proteomics; reproducibility; spermatozoon; spermatozoon maturation; spermatozoon motility; testis,Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85063299090
Reid A.T.; Veerati P.C.; Gosens R.; Bartlett N.W.; Wark P.A.; Grainge C.L.; Stick S.M.; Kicic A.; Moheimani F.; Hansbro P.M.; Knight D.A.,"Reid, Andrew T. (39561518600); Veerati, Punnam Chander (57200127768); Gosens, Reinoud (6602543993); Bartlett, Nathan W. (7005608564); Wark, Peter A. (7003559516); Grainge, Chris L. (57192248350); Stick, Stephen M. (35373713500); Kicic, Anthony (6507472922); Moheimani, Fatemeh (36157216000); Hansbro, Philip M. (6603119390); Knight, Darryl A. (7402350036)",39561518600; 57200127768; 6602543993; 7005608564; 7003559516; 57192248350; 35373713500; 6507472922; 36157216000; 6603119390; 7402350036,Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches,2018,Pharmacology and Therapeutics,185,,,155,169,14,24,10.1016/j.pharmthera.2017.12.009,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85039860053&doi=10.1016%2fj.pharmthera.2017.12.009&partnerID=40&md5=90d89ea5ed2ea0edff572dba13d771db,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New South Wales, Australia; Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia; School of Paediatrics and Child Health, University of Western Australia, Nedlands, 6009, Western Australia, Australia; Telethon Kids Institute, University of Western Australia, Nedlands, 6009, Western Australia, Australia; Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, 6001, Western Australia, Australia; Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, 6009, Western Australia, Australia; Occupation and Environment, School of Public Health, Curtin University, Bentley, 6102, Western Australia, Australia; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada","Reid A.T., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New South Wales, Australia; Veerati P.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New South Wales, Australia; Gosens R., Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands; Bartlett N.W., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New South Wales, Australia; Wark P.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New South Wales, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia; Grainge C.L., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New South Wales, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia; Stick S.M., School of Paediatrics and Child Health, University of Western Australia, Nedlands, 6009, Western Australia, Australia, Telethon Kids Institute, University of Western Australia, Nedlands, 6009, Western Australia, Australia, Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, 6001, Western Australia, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, 6009, Western Australia, Australia; Kicic A., School of Paediatrics and Child Health, University of Western Australia, Nedlands, 6009, Western Australia, Australia, Telethon Kids Institute, University of Western Australia, Nedlands, 6009, Western Australia, Australia, Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, 6001, Western Australia, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, 6009, Western Australia, Australia, Occupation and Environment, School of Public Health, Curtin University, Bentley, 6102, Western Australia, Australia; Moheimani F., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New South Wales, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New South Wales, Australia; Knight D.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, New South Wales, Australia, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada",Asthma; COPD; Cystic fibrosis; Epithelium; Goblet cell; Mechanical stress; micro-RNA; Monoclonal antibody therapy; Mucus; Signaling pathways; Therapeutic,Animals; Cell Differentiation; Goblet Cells; Humans; Respiratory Tract Diseases; Signal Transduction; beta catenin; epidermal growth factor receptor; interleukin 2; microRNA; monoclonal antibody; Notch receptor; protein; STAT6 protein; Wnt protein; asthma; cell differentiation; chronic bronchitis; chronic lung disease; chronic obstructive lung disease; cystic fibrosis; goblet cell; human; mechanical stress; priority journal; Review; signal transduction; virus infection; animal; goblet cell; pathology; physiology; respiratory tract disease,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85039860053
Dua K.; Rapalli V.K.; Shukla S.D.; Singhvi G.; Shastri M.D.; Chellappan D.K.; Satija S.; Mehta M.; Gulati M.; Pinto T.D.J.A.; Gupta G.; Hansbro P.M.,"Dua, Kamal (15759138700); Rapalli, Vamshi Krishna (57202821805); Shukla, Shakti Dhar (56367620800); Singhvi, Gautam (51864379500); Shastri, Madhur D. (56007290800); Chellappan, Dinesh Kumar (35811890500); Satija, Saurabh (54581608400); Mehta, Meenu (7203024234); Gulati, Monica (7006677671); Pinto, Terezinha De Jesus Andreoli (7003263019); Gupta, Gaurav (15047988400); Hansbro, Philip M. (6603119390)",15759138700; 57202821805; 56367620800; 51864379500; 56007290800; 35811890500; 54581608400; 7203024234; 7006677671; 7003263019; 15047988400; 6603119390,Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches,2018,Biomedicine and Pharmacotherapy,107,,,1218,1229,11,78,10.1016/j.biopha.2018.08.101,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052487103&doi=10.1016%2fj.biopha.2018.08.101&partnerID=40&md5=b9ad890ec2b13a847f3b06b72d1a2ece,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; School of Pharmaceutical Sciences, Lovely faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144441, Punjab, India; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, 302017, Jaipur, India","Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Rapalli V.K., Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; Shukla S.D., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; Singhvi G., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, 333031, India; Shastri M.D., School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Satija S., School of Pharmaceutical Sciences, Lovely faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144441, Punjab, India; Mehta M., School of Pharmaceutical Sciences, Lovely faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144441, Punjab, India; Gulati M., School of Pharmaceutical Sciences, Lovely faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, 144441, Punjab, India; Pinto T.D.J.A., Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, 302017, Jaipur, India; Hansbro P.M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia",Controlled release; Drug delivery; Mycobacterium tuberculosis; Oxidative stress,"Animals; Antitubercular Agents; Delayed-Action Preparations; Drug Delivery Systems; Humans; Mycobacterium tuberculosis; Oxidative Stress; Tuberculosis, Multidrug-Resistant; cell penetrating peptide; dendrimer; liposome; microRNA; microsphere; nanocarrier; nanostructured lipid carrier; polypeptide antibiotic agent; solid lipid nanoparticle; tuberculostatic agent; unclassified drug; tuberculostatic agent; antibiotic resistance; controlled release formulation; drug delivery system; human; multidrug resistance; multidrug resistant tuberculosis; Mycobacterium tuberculosis; nanotechnology; nonhuman; oxidative stress; priority journal; Review; tuberculosis; animal; delayed release formulation; drug delivery system; drug effect; isolation and purification; multidrug resistant tuberculosis; Mycobacterium tuberculosis; oxidative stress",Review,Final,,Scopus,2-s2.0-85052487103
Knight D.A.; Hansbro P.M.,"Knight, D.A. (7402350036); Hansbro, P.M. (6603119390)",7402350036; 6603119390,Restricted access or access all areas? a new cadherin-like protein upregulated in the inflamed esophagus,2018,Mucosal Immunology,11,1,,1,2,1,1,10.1038/mi.2017.56,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038826963&doi=10.1038%2fmi.2017.56&partnerID=40&md5=406c33785067f47cfabc44683bc0a161,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, New South Wales, Australia; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia","Knight D.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, New South Wales, Australia, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, New South Wales, Australia",,Cadherins; Esophagus; cadherin; cadherin like protein; tight junction protein; unclassified drug; cadherin; adherens junction; CD4+ T lymphocyte; disease association; environmental factor; esophagitis; gastrointestinal mucosa; human; immunoregulation; intestine epithelium; mucosal immunity; nonhuman; Note; permeability barrier; priority journal; Th2 cell; upregulation; esophagus,Note,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-85038826963
Dua K.; Chellappan D.K.; Singhvi G.; De Jesus Andreoli Pinto T.; Gupta G.; Hansbro P.M.,"Dua, Kamal (15759138700); Chellappan, Dinesh K. (35811890500); Singhvi, Gautam (51864379500); De Jesus Andreoli Pinto, Terezinha (7003263019); Gupta, Gaurav (15047988400); Hansbro, Philip M. (6603119390)",15759138700; 35811890500; 51864379500; 7003263019; 15047988400; 6603119390,Targeting micrornas using nanotechnology in pulmonary diseases,2018,Panminerva Medica,60,4,,230,231,1,24,10.23736/S0031-0808.18.03459-6,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058896958&doi=10.23736%2fS0031-0808.18.03459-6&partnerID=40&md5=2c5279387fd9e50f8c29a5136c3358db,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; School of Biomedical Sciences and Pharmacy, University of newcastle, callaghan, Australia; Priority research centre for Healthy Lungs, Hunter medical research institute, newcastle, Australia; Department of Life Sciences, School of Pharmacy, international medical University, Bukit Jalil, Malaysia; Department of Pharmacy, Birla institute of Technology and Science (BiTS), Pilani, India; Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; School of Pharmaceutical Sciences, Jaipur national University, Jagatpura, India; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Dua K., School of Biomedical Sciences and Pharmacy, University of newcastle, callaghan, Australia, Priority research centre for Healthy Lungs, Hunter medical research institute, newcastle, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Chellappan D.K., School of Biomedical Sciences and Pharmacy, University of newcastle, callaghan, Australia, Department of Life Sciences, School of Pharmacy, international medical University, Bukit Jalil, Malaysia; Singhvi G., Department of Pharmacy, Birla institute of Technology and Science (BiTS), Pilani, India; De Jesus Andreoli Pinto T., Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Gupta G., School of Pharmaceutical Sciences, Jaipur national University, Jagatpura, India; Hansbro P.M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia, School of Biomedical Sciences and Pharmacy, University of newcastle, callaghan, Australia, Priority research centre for Healthy Lungs, Hunter medical research institute, newcastle, Australia",,"Animals; Asthma; Cystic Fibrosis; Drug Delivery Systems; Gold; Humans; Lipids; Lung Diseases; Metal Nanoparticles; MicroRNAs; Nanotechnology; Pulmonary Disease, Chronic Obstructive; RNA, Small Interfering; Titanium; gold; lipid; metal nanoparticle; microRNA; small interfering RNA; titanium; titanium dioxide; animal; asthma; chemistry; chronic obstructive lung disease; cystic fibrosis; drug delivery system; genetics; human; lung disease; metabolism; nanotechnology; procedures",Letter,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85058896958
Gupta G.; Chellappan D.K.; De Jesus Andreoli Pinto T.; Hansbro P.M.; Bebawy M.; Dua K.,"Gupta, Gaurav (15047988400); Chellappan, Dinesh K. (35811890500); De Jesus Andreoli Pinto, Terezinha (7003263019); Hansbro, Philip M. (6603119390); Bebawy, Mary (6506211522); Dua, Kamal (15759138700)",15047988400; 35811890500; 7003263019; 6603119390; 6506211522; 15759138700,Tumor suppressor role of miR-503,2018,Panminerva Medica,60,1,,17,24,7,77,10.23736/S0031-0808.17.03386-9,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045956281&doi=10.23736%2fS0031-0808.17.03386-9&partnerID=40&md5=debdf7eff91b32401e53705267e972c5,"School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, India; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; De Jesus Andreoli Pinto T., Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia",Genes; MIRN503 microRNA; Neoplasms; Tumor suppressor,"3' Untranslated Regions; Animals; Apoptosis; Cell Movement; Cell Proliferation; Gene Silencing; Genes, Tumor Suppressor; Humans; Mice; Mice, Knockout; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Prognosis; RNA, Untranslated; Transcription, Genetic; microRNA; MIRN503 microRNA, human; Mirn503 microRNA, mouse; untranslated RNA; 3' untranslated region; animal; apoptosis; cell motion; cell proliferation; gene silencing; genetic transcription; genetics; human; knockout mouse; metabolism; metastasis; mouse; neoplasm; physiology; prognosis; tumor invasion; tumor suppressor gene",Review,Final,,Scopus,2-s2.0-85045956281
Hardy S.A.; Mabotuwana N.S.; Murtha L.A.; Coulter B.; Sanchez-Bezanilla S.; Al-Omary M.S.; Senanayake T.; Loering S.; Starkey M.; Lee R.J.; Rainer P.P.; Hansbro P.M.; Boyle A.J.,"Hardy, Sean A. (57196034731); Mabotuwana, Nishani S. (57196033700); Murtha, Lucy A. (55210289700); Coulter, Brianna (57206730802); Sanchez-Bezanilla, Sonia (57206725770); Al-Omary, Mohammed S. (24167811700); Senanayake, Tharindu (57206726038); Loering, Svenja (57205469740); Starkey, Malcolm (35811293400); Lee, Randall J. (7408201639); Rainer, Peter P. (35590576100); Hansbro, Philip M. (6603119390); Boyle, Andrew J. (35568329400)",57196034731; 57196033700; 55210289700; 57206730802; 57206725770; 24167811700; 57206726038; 57205469740; 35811293400; 7408201639; 35590576100; 6603119390; 35568329400,Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction,2019,PLoS ONE,14,2,e0212230,,,,29,10.1371/journal.pone.0212230,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061932423&doi=10.1371%2fjournal.pone.0212230&partnerID=40&md5=63bd977607dab01f908b647a0c60fa88,"School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Priority Research Centre’s for Healthy Lungs and GrowUpWell, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Department of Cardiovascular Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia; Department of Medicine, Division of Cardiology, University of California San Francisco, San Francisco, CA, United States; Edyth and Eli Broad Center for Regenerative Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, United States; Division of Cardiology, Medical University of Graz, Graz, Austria; Centre for inflammation, Centenary Institute, Sydney, NSW, Australia; University of Technology, Faculty of Science, Ultimo, NSW, Australia","Hardy S.A., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Mabotuwana N.S., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Murtha L.A., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Coulter B., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Sanchez-Bezanilla S., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre’s for Healthy Lungs and GrowUpWell, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Al-Omary M.S., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Department of Cardiovascular Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia; Senanayake T., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Loering S., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre’s for Healthy Lungs and GrowUpWell, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Starkey M., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre’s for Healthy Lungs and GrowUpWell, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Lee R.J., Department of Medicine, Division of Cardiology, University of California San Francisco, San Francisco, CA, United States, Edyth and Eli Broad Center for Regenerative Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, United States; Rainer P.P., Division of Cardiology, Medical University of Graz, Graz, Austria; Hansbro P.M., Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre’s for Healthy Lungs and GrowUpWell, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Centre for inflammation, Centenary Institute, Sydney, NSW, Australia, University of Technology, Faculty of Science, Ultimo, NSW, Australia; Boyle A.J., School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Department of Cardiovascular Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia",,"Aging; Animals; Extracellular Matrix Proteins; Female; Gene Expression Regulation; Heart Ventricles; Humans; Male; Mice; Myocardial Infarction; Myocardium; angiotensin II; collagen type 1; extracellular matrix protein 1; mitogen activated protein kinase 1; mitogen activated protein kinase 3; protein kinase B; recombinant transforming growth factor beta1; scleroprotein; unclassified drug; ECM1 protein, human; Ecm1 protein, mouse; scleroprotein; adult; aging; animal cell; animal experiment; animal model; animal tissue; Article; bone marrow cell; C57BL 6 mouse; CAEC cell line; cardiac muscle cell; cardiomyopathy; cell stimulation; cohort analysis; controlled study; female; flow cytometry; fluorescence in situ hybridization; granulocyte; heart cell culture; heart fibroblast; heart infarction; heart left ventricle; heart left ventricle overload; heart muscle fibrosis; human; human cell; human tissue; immunoblotting; inflammatory cell; left anterior descending coronary artery; male; mouse; nonhuman; protein expression; real time polymerase chain reaction; smooth muscle cell line; upregulation; young adult; aging; animal; biosynthesis; cardiac muscle; gene expression regulation; heart infarction; heart ventricle; metabolism; pathology",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85061932423
Donovan C.; Starkey M.R.; Kim R.Y.; Rana B.M.J.; Barlow J.L.; Jones B.; Haw T.J.; Mono Nair P.; Budden K.; Cameron G.J.M.; Horvat J.C.; Wark P.A.; Foster P.S.; McKenzie A.N.J.; Hansbro P.M.,"Donovan, Chantal (55357105200); Starkey, Malcolm R. (35811293400); Kim, Richard Y. (35810406900); Rana, Batika M. J. (56732635100); Barlow, Jillian L. (12902806900); Jones, Bernadette (56215070300); Haw, Tatt Jhong (56625918900); Mono Nair, Prema (57203995268); Budden, Kurtis (57191417986); Cameron, Guy J.M. (57203977896); Horvat, Jay C. (9942405300); Wark, Peter A. (7003559516); Foster, Paul S. (7201517569); McKenzie, Andrew N. J. (7101774635); Hansbro, Philip M. (6603119390)",55357105200; 35811293400; 35810406900; 56732635100; 12902806900; 56215070300; 56625918900; 57203995268; 57191417986; 57203977896; 9942405300; 7003559516; 7201517569; 7101774635; 6603119390,Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease,2019,Journal of Leukocyte Biology,105,1,,143,150,7,48,10.1002/JLB.3AB0518-178R,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053931106&doi=10.1002%2fJLB.3AB0518-178R&partnerID=40&md5=102ad9d315659143770ced3fb4882514,"Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, United Kingdom; The Centenary Institute and the School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia","Donovan C., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Starkey M.R., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Kim R.Y., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Rana B.M.J., Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, United Kingdom; Barlow J.L., Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, United Kingdom; Jones B., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Haw T.J., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Mono Nair P., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Budden K., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Cameron G.J.M., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Wark P.A., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia; McKenzie A.N.J., Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, United Kingdom; Hansbro P.M., Priority Research Centres for Healthy Lungs and GrowUpWell, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia, The Centenary Institute and the School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia",COPD; emphysema; ILC2s; inflammation; remodelling; T cells,"Airway Remodeling; Airway Resistance; Animals; B-Lymphocytes; Body Weight; Cell Count; Collagen; Homeodomain Proteins; Immunity, Innate; Interleukins; Mice, Inbred C57BL; Pneumonia; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Respiratory Hypersensitivity; T-Lymphocytes; cigarette smoke; collagen; interleukin 33; collagen; homeodomain protein; interleukin derivative; RAG-1 protein; airway remodeling; animal cell; animal experiment; animal model; Article; B lymphocyte; chronic obstructive lung disease; controlled study; lung alveolus; lung emphysema; lung function; lymphocyte function; lymphoid cell; mouse; nonhuman; priority journal; T lymphocyte; airway resistance; animal; B lymphocyte; body weight; C57BL mouse; cell count; chronic obstructive lung disease; complication; immunology; innate immunity; metabolism; pathology; pathophysiology; pneumonia; respiratory tract allergy; T lymphocyte",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-85053931106
Ramsahai J.M.; Hansbro P.M.; Wark P.A.B.,"Ramsahai, J. Michael (57200448272); Hansbro, Philip M. (6603119390); Wark, Peter A.B. (7003559516)",57200448272; 6603119390; 7003559516,Mechanisms and management of asthma exacerbations,2019,American Journal of Respiratory and Critical Care Medicine,199,4,,423,432,9,118,10.1164/rccm.201810-1931CI,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061620849&doi=10.1164%2frccm.201810-1931CI&partnerID=40&md5=f8de82ca442f7ab0df967d69c5c98d6f,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Division of Respiratory Medicine, Department of Medicine, University of Calgary, Alberta Health Services, Calgary, AB, Canada; Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia","Ramsahai J.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Division of Respiratory Medicine, Department of Medicine, University of Calgary, Alberta Health Services, Calgary, AB, Canada; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia; Wark P.A.B., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, Newcastle, 2305, NSW, Australia",Asthma; Asthma exacerbations; Management of acute asthma; Virus-induced asthma exacerbations,Acute Disease; Anti-Asthmatic Agents; Asthma; Humans; bronchodilating agent; corticosteroid; magnesium sulfate; antiasthmatic agent; acute disease; asthma; corticosteroid therapy; disease control; disease exacerbation; environmental factor; epidemiological data; human; medication therapy management; priority journal; respiratory tract inflammation; Review; Rhinovirus infection; seasonal variation; self care; type 2 airway inflammation; acute disease; asthma,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85061620849
Fricker M.; Goggins B.J.; Mateer S.; Jones B.; Kim R.Y.; Gellatly S.L.; Jarnicki A.G.; Powell N.; Oliver B.G.; Radford-Smith G.; Talley N.J.; Walker M.M.; Keely S.; Hansbro P.M.,"Fricker, Michael (26638839800); Goggins, Bridie J. (55894233100); Mateer, Sean (56595055500); Jones, Bernadette (56215070300); Kim, Richard Y. (35810406900); Gellatly, Shaan L. (26430804400); Jarnicki, Andrew G. (6603137164); Powell, Nicholas (16064267600); Oliver, Brian G. (15919869900); Radford-Smith, Graham (57204578190); Talley, Nicholas J. (36045241200); Walker, Marjorie M. (7403868685); Keely, Simon (9739611200); Hansbro, Philip M. (6603119390)",26638839800; 55894233100; 56595055500; 56215070300; 35810406900; 26430804400; 6603137164; 16064267600; 15919869900; 57204578190; 36045241200; 7403868685; 9739611200; 6603119390,Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction,2018,JCI insight,3,3,,,,,105,10.1172/jci.insight.94040,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048784203&doi=10.1172%2fjci.insight.94040&partnerID=40&md5=765f584af688aa282f6c150d84c822bd,"Priority research Centre for Healthy Lungs, University of Newcastle and; Hunter Medical Research Institute, Newcastle, NSW, Australia; Faculty of Translational Medicine, Guy's and St. Thomas' and King's College London Comprehensive Biomedical Research Centre, Great Maze Pond, London, United Kingdom; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; School of Life Sciences, University of Technology, Sydney, NSW, Australia; School of Medicine, University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, NSW, Australia","Fricker M., Priority research Centre for Healthy Lungs, University of Newcastle and, Hunter Medical Research Institute, Newcastle, NSW, Australia; Goggins B.J., Hunter Medical Research Institute, Newcastle, NSW, Australia; Mateer S., Hunter Medical Research Institute, Newcastle, NSW, Australia; Jones B., Priority research Centre for Healthy Lungs, University of Newcastle and, Hunter Medical Research Institute, Newcastle, NSW, Australia; Kim R.Y., Priority research Centre for Healthy Lungs, University of Newcastle and, Hunter Medical Research Institute, Newcastle, NSW, Australia; Gellatly S.L., Priority research Centre for Healthy Lungs, University of Newcastle and, Hunter Medical Research Institute, Newcastle, NSW, Australia; Jarnicki A.G., Priority research Centre for Healthy Lungs, University of Newcastle and, Hunter Medical Research Institute, Newcastle, NSW, Australia; Powell N., Faculty of Translational Medicine, Guy's and St. Thomas' and King's College London Comprehensive Biomedical Research Centre, Great Maze Pond, London, United Kingdom; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, School of Life Sciences, University of Technology, Sydney, NSW, Australia; Radford-Smith G., School of Medicine, University of Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Talley N.J., Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, NSW, Australia; Walker M.M., Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, NSW, Australia; Keely S., Hunter Medical Research Institute, Newcastle, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, NSW, Australia; Hansbro P.M., Priority research Centre for Healthy Lungs, University of Newcastle and, Hunter Medical Research Institute, Newcastle, NSW, Australia, Priority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, NSW, Australia",COPD; Gastroenterology; hypoxia; Inflammatory bowel disease; Pulmonology,"Adult; Aged; Amino Acids, Dicarboxylic; Animals; Biopsy; Cell Hypoxia; Colon; Colonoscopy; Crohn Disease; Disease Models, Animal; Disease Progression; Female; Humans; Ileum; Intestinal Mucosa; Lung; Male; Mice; Mice, Inbred C57BL; Middle Aged; Oxidative Stress; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Risk Factors; Smoke; Smoking; Smoking Cessation; Time Factors; Tobacco; Trinitrobenzenesulfonic Acid; dicarboxylic amino acid; oxalylglycine; procollagen proline 2 oxoglutarate 4 dioxygenase; prolyl hydroxylase inhibitor; trinitrobenzenesulfonic acid; adult; adverse event; aged; animal; biopsy; C57BL mouse; cell hypoxia; chronic obstructive lung disease; colon; colonoscopy; Crohn disease; diagnostic imaging; disease exacerbation; disease model; drug effect; female; human; ileum; intestine mucosa; lung; lung gas exchange; male; metabolism; middle aged; mouse; oxidative stress; pathology; risk factor; smoke; smoking; smoking cessation; time factor; tobacco",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85048784203
Baines K.J.; Wright T.K.; Gibson P.G.; Powell H.; Hansbro P.M.; Simpson J.L.,"Baines, Katherine J. (35078051200); Wright, Thomas K. (56973255600); Gibson, Peter G. (7202414199); Powell, Heather (7101711366); Hansbro, Philip M. (6603119390); Simpson, Jodie L. (7404326026)",35078051200; 56973255600; 7202414199; 7101711366; 6603119390; 7404326026,Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD,2018,ERJ Open Research,4,4,00031-2018,,,,16,10.1183/23120541.00031-2018,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069875000&doi=10.1183%2f23120541.00031-2018&partnerID=40&md5=3f315c5e046ddd50dd8e7c7b8bcbabb2,"Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, Australia; Dept of Respiratory and Sleep Medicine, Hunter New England Area Health Service, Newcastle, Australia","Baines K.J., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, Australia; Wright T.K., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, Australia; Gibson P.G., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, Australia, Dept of Respiratory and Sleep Medicine, Hunter New England Area Health Service, Newcastle, Australia; Powell H., Dept of Respiratory and Sleep Medicine, Hunter New England Area Health Service, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, Australia; Simpson J.L., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, Australia",,ABC transporter; azithromycin; B cell receptor associated protein 31; carbon monoxide; CD14 antigen; CD18 antigen; CD83 antigen; CD86 antigen; complement factor D; dipeptidyl peptidase I; guanine nucleotide binding protein; HLA antigen; immunoglobulin Fc fragment; interferon induced transmembrane protein 3; interferon regulatory factor 7; interleukin enhancer binding factor 2; leukocyte immunoglobulin like receptor subfamily B member 1; leukosialin; lymphocyte transmembrane adaptor 1; major histocompatibility antigen class 1; major histocompatibility antigen class 2; placebo; protein kinase Syk; protein tyrosine phosphatase; RANTES; Rho guanine nucleotide dissociation inhibitor 2; tumor necrosis factor; unclassified drug; unindexed drug; vascular endothelial growth inhibitor; zinc finger protein; aged; antigen presentation; Article; blood sampling; cell viability; chronic obstructive lung disease; controlled study; disease exacerbation; down regulation; female; gene expression; gene ontology; genome-wide association study; human; immune response; leukocyte differential count; major clinical study; major histocompatibility complex; male; microarray analysis; modified Medical Research Council dyspnoea scale; neutrophil; neutrophil count; prick test; randomized controlled trial; RNA extraction; smoking; spirometry; sputum analysis; upregulation; visual analog scale; whole genome sequencing,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85069875000
Awasthi R.; Rathbone M.J.; Hansbro P.M.; Bebawy M.; Dua K.,"Awasthi, Rajendra (36866066100); Rathbone, Michael John (7005254043); Hansbro, Philip Michael (6603119390); Bebawy, Mary (6506211522); Dua, Kamal (15759138700)",36866066100; 7005254043; 6603119390; 6506211522; 15759138700,Therapeutic prospects of microRNAs in cancer treatment through nanotechnology,2018,Drug Delivery and Translational Research,8,1,,97,110,13,39,10.1007/s13346-017-0440-1,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040073483&doi=10.1007%2fs13346-017-0440-1&partnerID=40&md5=a70d3339cd055665753b3ed1e0a4eb16,"NKBR College of Pharmacy and Research Centre, Meerut, 45206, Uttar Pradesh, India; ULTI Pharmaceuticals, Hamilton, 3204, New Zealand; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, 2308, Australia","Awasthi R., NKBR College of Pharmacy and Research Centre, Meerut, 45206, Uttar Pradesh, India; Rathbone M.J., ULTI Pharmaceuticals, Hamilton, 3204, New Zealand, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, 2308, Australia; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia; Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, Callaghan, 2308, Australia",Cancer; Extracellular vesicles; Metastasis; Microparticles; MicroRNA; Multidrug resistance; Nanotechnology; P-Glycoprotein,"Animals; Biosensing Techniques; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; MicroRNAs; Nanoparticles; Nanotechnology; Neoplasms; microRNA; nanoparticle; animal; drug resistance; genetic procedures; genetics; human; metabolism; multidrug resistance; nanotechnology; neoplasm",Review,Final,,Scopus,2-s2.0-85040073483
Loering S.; Cameron G.J.M.; Starkey M.R.; Hansbro P.M.,"Loering, Svenja (57205469740); Cameron, Guy J. M. (57203977896); Starkey, Malcolm R (35811293400); Hansbro, Philip M (6603119390)",57205469740; 57203977896; 35811293400; 6603119390,Lung development and emerging roles for type 2 immunity,2019,Journal of Pathology,247,5,,686,696,10,31,10.1002/path.5211,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060178684&doi=10.1002%2fpath.5211&partnerID=40&md5=218165161c72b16f4ec4b2255a0a6707,"Priority Research Center's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Center for Inflammation, Centenary Institute and The School of Life Sciences, University of Technology, Sydney, NSW, Australia","Loering S., Priority Research Center's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Cameron G.J.M., Priority Research Center's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Starkey M.R., Priority Research Center's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Center's GrowUpWell and Healthy Lungs, School of Biomedical Sciences and Pharmacy, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia, Center for Inflammation, Centenary Institute and The School of Life Sciences, University of Technology, Sydney, NSW, Australia",alveolarisation; bronchopulmonary dysplasia; group 2 innate lymphoid cells; ILC2; lung development; macrophages; postnatal development; respiratory infection; stem cells; type 2 immunity,"Adaptive Immunity; Angiotensin II; Animals; Bronchi; Fetal Development; Humans; Lung; Mesenchymal Stem Cells; Mice; Neovascularization, Physiologic; Pneumonia; Regeneration; Signal Transduction; interleukin 13; angiotensin II; angiogenesis; basal cell; branching morphogenesis; cell regeneration; human; immunity; immunocompetent cell; inflammation; lung alveolus macrophage; lung development; lung dysplasia; lymphoid cell; mesenchyme cell; pneumonia; postnatal care; postnatal development; prematurity; priority journal; Review; signal transduction; type 2 immunity; adaptive immunity; animal; bronchus; cytology; embryology; fetus development; growth, development and aging; immunology; lung; mesenchymal stem cell; mouse; pathophysiology; physiology; regeneration",Review,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85060178684
Chotirmall S.H.; Gellatly S.L.; Budden K.F.; Mac Aogain M.; Shukla S.D.; Wood D.L.A.; Hugenholtz P.; Pethe K.; Hansbro P.M.,"Chotirmall, Sanjay H. (15757175700); Gellatly, Shaan L. (26430804400); Budden, Kurtis F. (57191417986); Mac Aogain, Micheál (33667783800); Shukla, Shakti D. (56367620800); Wood, David L.A. (55723732300); Hugenholtz, Philip (55811879700); Pethe, Kevin (57215569969); Hansbro, Philip M. (6603119390)",15757175700; 26430804400; 57191417986; 33667783800; 56367620800; 55723732300; 55811879700; 57215569969; 6603119390,Microbiomes in respiratory health and disease: An Asia-Pacific perspective,2017,Respirology,22,2,,240,250,10,99,10.1111/resp.12971,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009830159&doi=10.1111%2fresp.12971&partnerID=40&md5=e162cc4c24c0b18c4c5b773eecdaee52,"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia","Chotirmall S.H., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Gellatly S.L., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Budden K.F., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Mac Aogain M., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Shukla S.D., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Wood D.L.A., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia; Hugenholtz P., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia; Pethe K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia",asthma; chronic obstructive pulmonary disease; cystic fibrosis; gut; health; microbiome; mouse model; prevention; respiratory disease; treatment,"Aging; Air Pollution; Asia, Southeastern; Australia; Diet; Far East; Gastrointestinal Microbiome; Humans; Microbiota; New Zealand; Respiratory System; Respiratory Tract Diseases; Smoke; antibiotic agent; cigarette smoke; short chain fatty acid; aging; air pollution; antibiotic resistance; asthma; Bacteroidetes; Bifidobacterium; bronchiectasis; chronic obstructive lung disease; commensal; cystic fibrosis; diet; disease exacerbation; disease severity; drug dose reduction; drug megadose; dysbiosis; Firmicutes; human; immunosenescence; intestine flora; lung infection; microbial diversity; microbiome; nonhuman; prevalence; prognosis; Proteobacteria; respiratory tract disease; Review; smoking; Australia; Far East; immunology; microbiology; microflora; New Zealand; respiratory system; respiratory tract disease; smoke; Southeast Asia",Review,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85009830159
Obeidat M.; Dvorkin-Gheva A.; Li X.; Bossé Y.; Brandsma C.-A.; Nickle D.C.; Hansbro P.M.; Faner R.; Agusti A.; Paré P.D.; Stampfli M.R.; Sin D.D.,"Obeidat, Ma’en (35574347000); Dvorkin-Gheva, Anna (53363411300); Li, Xuan (57381885500); Bossé, Yohan (6602449865); Brandsma, Corry-Anke (22833246900); Nickle, David C. (57210846479); Hansbro, Philip M. (6603119390); Faner, Rosa (6507910788); Agusti, Alvar (57200597227); Paré, Peter D. (7103044327); Stampfli, Martin R. (7003418430); Sin, Don D. (57202594563)",35574347000; 53363411300; 57381885500; 6602449865; 22833246900; 57210846479; 6603119390; 6507910788; 57200597227; 7103044327; 7003418430; 57202594563,The Overlap of Lung Tissue Transcriptome of Smoke Exposed Mice with Human Smoking and COPD,2018,Scientific Reports,8,1,11881,,,,19,10.1038/s41598-018-30313-z,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051252252&doi=10.1038%2fs41598-018-30313-z&partnerID=40&md5=527e42e1f8356840726e91c23d65f017,"The University of British Columbia Center for Heart Lung Innovation, St Paul’s Hospital, Vancouver, Canada; Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, Hamilton, ON, Canada; Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada; Department of Molecular Medicine, Laval University, Québec, Canada; University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, Netherlands; Merck & Co., Inc., MRL, Kenilworth, NJ, United States; Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia; Fundacio Clinic per a la Recerca Biomedica Barcelona, Barcelona, Spain; Respiratory Institute, Hospital Clinic, University of Barcelona, Institut d’investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Respiratory Division, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medicine, Firestone Institute of Respiratory Health at St. Joseph’s Healthcare, McMaster University, Hamilton, ON, Canada","Obeidat M., The University of British Columbia Center for Heart Lung Innovation, St Paul’s Hospital, Vancouver, Canada; Dvorkin-Gheva A., Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, Hamilton, ON, Canada; Li X., The University of British Columbia Center for Heart Lung Innovation, St Paul’s Hospital, Vancouver, Canada; Bossé Y., Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada, Department of Molecular Medicine, Laval University, Québec, Canada; Brandsma C.-A., University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, Netherlands; Nickle D.C., Merck & Co., Inc., MRL, Kenilworth, NJ, United States; Hansbro P.M., Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Faner R., Fundacio Clinic per a la Recerca Biomedica Barcelona, Barcelona, Spain; Agusti A., Fundacio Clinic per a la Recerca Biomedica Barcelona, Barcelona, Spain, Respiratory Institute, Hospital Clinic, University of Barcelona, Institut d’investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Paré P.D., The University of British Columbia Center for Heart Lung Innovation, St Paul’s Hospital, Vancouver, Canada, Respiratory Division, Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Stampfli M.R., Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, Hamilton, ON, Canada, Department of Medicine, Firestone Institute of Respiratory Health at St. Joseph’s Healthcare, McMaster University, Hamilton, ON, Canada; Sin D.D., The University of British Columbia Center for Heart Lung Innovation, St Paul’s Hospital, Vancouver, Canada, Respiratory Division, Department of Medicine, University of British Columbia, Vancouver, BC, Canada",,"Animals; Humans; Lung; Mice; Pulmonary Disease, Chronic Obstructive; Smoke; Smoking; Transcriptome; transcriptome; adverse event; animal; chronic obstructive lung disease; genetics; human; lung; metabolism; mouse; smoke; smoking",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85051252252
Dua K.; Bebawy M.; Awasthi R.; Tekade R.K.; Tekade M.; Gupta G.; Pinto T.D.J.A.; Hansbro P.M.,"Dua, Kamal (15759138700); Bebawy, Mary (6506211522); Awasthi, Rajendra (36866066100); Tekade, Rakesh K. (57204717123); Tekade, Muktika (56502403400); Gupta, Gaurav (15047988400); Pinto, Terezinha De Jesus Andreoli (7003263019); Hansbro, Philip M. (6603119390)",15759138700; 6506211522; 36866066100; 57204717123; 56502403400; 15047988400; 7003263019; 6603119390,Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems,2017,Pharmaceutical Nanotechnology,5,4,,243,249,6,41,10.2174/2211738505666170808095258,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046684392&doi=10.2174%2f2211738505666170808095258&partnerID=40&md5=ecfa0cb55c7c053f7181c9da1cd4294e,"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia; School of Pharmaceutical Sciences, Shoolini University, Himachal Pradesh, Solan, 173229, India; NKBR College of Pharmacy & Research Centre, Uttar Pradesh, Meerut, 245 206, India; National Institute of Pharmaceutical Education and Research, Gujarat, Gandhinagar, 382355, India; TIT College of Pharmacy, Technocrats Institute of Technology, Anand Nagar, MP, Bhopal, 462021, India; School of Pharmacy, Jaipur National University, Delhi-Agra Bypass, Jagatpura, Jaipur, 302017, India; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil","Dua K., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia, School of Pharmaceutical Sciences, Shoolini University, Himachal Pradesh, Solan, 173229, India; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Awasthi R., NKBR College of Pharmacy & Research Centre, Uttar Pradesh, Meerut, 245 206, India; Tekade R.K., National Institute of Pharmaceutical Education and Research, Gujarat, Gandhinagar, 382355, India; Tekade M., TIT College of Pharmacy, Technocrats Institute of Technology, Anand Nagar, MP, Bhopal, 462021, India; Gupta G., School of Pharmacy, Jaipur National University, Delhi-Agra Bypass, Jagatpura, Jaipur, 302017, India; Pinto T.D.J.A., Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Hansbro P.M., School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, 2308, NSW, Australia",Cancer; Chitosan; Nanomedicine; Nanoparticles; Pulmonary; Respiratory,carboxymethyl chitosan; chitosan; chitosan derivative; chitosan nanoparticle; microRNA; n succinyl chitosan; nanocarrier; nanoparticle; pegylated chitosan; small interfering RNA; thiolated chitosan; trimethyl chitosan; unclassified drug; asthma; biocompatibility; biodegradability; cell adhesion; chemical structure; chronic obstructive lung disease; drug delivery system; human; lung cancer; lung fibrosis; nanomedicine; nanotechnology; patent; patient compliance; respiratory tract disease; Review,Review,Final,,Scopus,2-s2.0-85046684392
Mehta M.; Deeksha; Sharma N.; Vyas M.; Khurana N.; Maurya P.K.; Singh H.; Andreoli de Jesus T.P.; Dureja H.; Chellappan D.K.; Gupta G.; Wadhwa R.; Collet T.; Hansbro P.M.; Dua K.; Satija S.,"Mehta, Meenu (7203024234); Deeksha (59019265000); Sharma, Neha (57188952328); Vyas, Manish (56906731900); Khurana, Navneet (53264160500); Maurya, Pawan Kumar (15765644500); Singh, Harjeet (57211295911); Andreoli de Jesus, Terezinha Pinto (57207461634); Dureja, Harish (6507566948); Chellappan, Dinesh Kumar (35811890500); Gupta, Gaurav (15047988400); Wadhwa, Ridhima (57159091700); Collet, Trudi (36898251800); Hansbro, Philip M. (6603119390); Dua, Kamal (15759138700); Satija, Saurabh (54581608400)",7203024234; 59019265000; 57188952328; 56906731900; 53264160500; 15765644500; 57211295911; 57207461634; 6507566948; 35811890500; 15047988400; 57159091700; 36898251800; 6603119390; 15759138700; 54581608400,Interactions with the macrophages: An emerging targeted approach using novel drug delivery systems in respiratory diseases,2019,Chemico-Biological Interactions,304,,,10,19,9,90,10.1016/j.cbi.2019.02.021,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062567225&doi=10.1016%2fj.cbi.2019.02.021&partnerID=40&md5=54791105e783a10b105537f77cababdd,"School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Department of Biochemistry, Central University of Haryana, Jant-Pali, Mahendergarh District, 123031, Haryana, India; National Medicinal Plants Board, Ministry of AYUSH, New Delhi, India; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, 124001, Haryana, India; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Faculty of Life Science and Biotechnology, South Asian University, Akbar Bhawan, Chanakyapuri, 110021, New Delhi, India; Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, Queensland, Australia; Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia","Mehta M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Deeksha, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Sharma N., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Vyas M., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Khurana N., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India; Maurya P.K., Department of Biochemistry, Central University of Haryana, Jant-Pali, Mahendergarh District, 123031, Haryana, India; Singh H., National Medicinal Plants Board, Ministry of AYUSH, New Delhi, India; Andreoli de Jesus T.P., Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Dureja H., Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, 124001, Haryana, India; Chellappan D.K., Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia; Gupta G., School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, 302017, India; Wadhwa R., Faculty of Life Science and Biotechnology, South Asian University, Akbar Bhawan, Chanakyapuri, 110021, New Delhi, India; Collet T., Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, 4059, Queensland, Australia; Hansbro P.M., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Dua K., Centre for Inflammation, Centenary Institute, Sydney, 2050, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, 2007, NSW, Australia; Satija S., School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, 144411, Punjab, India",Antimicrobial peptides; Asthma; Inflammation; Macrophages; Nanoparticles; Novel drug delivery systems; Respiratory diseases,"Drug Delivery Systems; Humans; Inflammation; Macrophages; Respiratory Tract Diseases; 6 [2 (dimethylamino)ethylamino] 3 hydroxy 7h indeno[2,1 c]quinolin 7 one; amikacin; amphotericin B lipid complex; antiasthmatic agent; beclometasone dipropionate; chitosan gamma interferon pDNA nanoparticle; cisplatin; dendrimer; Dermatophagoide spteronyssius vaccine; epidermal growth factor seeking nanoparticle; glucocorticoid; inorganic nanoparticle; isoniazid; ketotifen fumarate; liposome; methylprednisolone; microsphere; mitogen activated protein kinase p38 inhibitor; nanoparticle; ofloxacin; paclitaxel; phosphodiesterase IV inhibitor; polypeptide antibiotic agent; rifabutin; rifampicin; small interfering RNA; solid lipid nanoparticle; transcription factor Nrf2; unclassified drug; vaccine; aerosol; antigen expression; antigen presenting cell; apoptosis; aspergillosis; asthma; bacterial gene; cell interaction; cellular secretion; chronic obstructive lung disease; cigarette smoking; colloid; cytokine release; dendritic cell; disease exacerbation; drug absorption; drug activity; drug approval; drug bioavailability; drug blood level; drug delivery system; drug efficacy; drug formulation; drug half life; drug potency; drug solubility; drug stability; drug targeting; drug uptake; efferocytosis; emphysema; encapsulation; enzyme activity; first pass effect; gene delivery system; human; immunomodulation; inflammation; influenza; lipophilicity; lung alveolus macrophage; lung cancer; lung carcinogenesis; lung fibrosis; lung granuloma; lung tuberculosis; lung tumor; macrophage; macrophage activation; macrophage function; micelle; nanoemulsion; nanosuspension; nanotechnology; nebulization; nonhuman; pathophysiology; patient attitude; patient compliance; phagocytosis; pneumonia; polymorphonuclear cell; prophylaxis; protein function; protein targeting; pulmonary hypertension; repeated drug dose; respiratory syncytial virus infection; respiratory tract disease; Review; Rhinovirus infection; side effect; Streptococcus pneumoniae; Th2 cell; therapeutic index; tuberculosis; tumor associated leukocyte; drug effect; inflammation; macrophage; respiratory tract disease",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85062567225
Rutting S.; Xenaki D.; Malouf M.; Horvat J.C.; Wood L.G.; Hansbro P.M.; Oliver B.G.,"Rutting, Sandra (57202399992); Xenaki, Dia (6507411538); Malouf, Monique (7003499112); Horvat, Jay C. (9942405300); Wood, Lisa G. (55859741700); Hansbro, Philip M. (6603119390); Oliver, Brian G. (15919869900)",57202399992; 6507411538; 7003499112; 9942405300; 55859741700; 6603119390; 15919869900,Short-chain fatty acids increase tnfα-induced inflammation in primary human lung mesenchymal cells through the activation of p38 mapk,2019,American Journal of Physiology - Lung Cellular and Molecular Physiology,316,1,,L157,L174,17,41,10.1152/ajplung.00306.2018,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059241986&doi=10.1152%2fajplung.00306.2018&partnerID=40&md5=744627a86feccf8e78ae9a6a1df0a119,"Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Thoracic Medicine and Lung Transplantation, Saint Vincent’s Hospital, Sydney, NSW, Australia; Graduate School of Health, Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia","Rutting S., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Xenaki D., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia; Malouf M., Thoracic Medicine and Lung Transplantation, Saint Vincent’s Hospital, Sydney, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Wood L.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW, Australia, Graduate School of Health, Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia; Oliver B.G., Respiratory Cellular and Molecular Biology, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia",Asthma; Free fatty acid receptor 3; Human lung mesenchymal cells; Inflammation; Short-chain fatty acids,"Adult; Aged; Cells, Cultured; Fatty Acids, Volatile; Female; Fibroblasts; Humans; Inflammation; Interleukin-6; Interleukin-8; Lung; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; Middle Aged; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha; butyric acid; interleukin 6; interleukin 8; mitogen activated protein kinase p38; propionic acid; short chain fatty acid; tumor necrosis factor; cell surface receptor; CXCL8 protein, human; FFAR3 protein, human; G protein coupled receptor; G-protein coupled receptor 43, human; IL6 protein, human; interleukin 6; interleukin 8; mitogen activated protein kinase p38; tumor necrosis factor; volatile fatty acid; adult; aged; airway epithelium cell; Article; asthma; controlled study; cytokine release; female; human; human cell; in vitro study; limit of detection; long term exposure; lung; lung fibroblast; major clinical study; male; MAPK signaling; mesenchyme cell; middle aged; priority journal; protein phosphorylation; signal transduction; THP-1 cell line; cell culture; drug effect; fibroblast; inflammation; lung; mesenchymal stem cell; metabolism; pathology; smooth muscle cell",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85059241986
Ng Z.Y.; Wong J.-Y.; Panneerselvam J.; Madheswaran T.; Kumar P.; Pillay V.; Hsu A.; Hansbro N.; Bebawy M.; Wark P.; Hansbro P.; Dua K.; Chellappan D.K.,"Ng, Zhao Yin (57196059428); Wong, Jin-Ying (57197761155); Panneerselvam, Jithendra (57201993010); Madheswaran, Thiagarajan (55505311000); Kumar, Pradeep (7403960277); Pillay, Viness (56711693300); Hsu, Alan (49861516600); Hansbro, Nicole (15055862300); Bebawy, Mary (6506211522); Wark, Peter (7003559516); Hansbro, Philip (6603119390); Dua, Kamal (15759138700); Chellappan, Dinesh Kumar (35811890500)",57196059428; 57197761155; 57201993010; 55505311000; 7403960277; 56711693300; 49861516600; 15055862300; 6506211522; 7003559516; 6603119390; 15759138700; 35811890500,Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthma,2018,Colloids and Surfaces B: Biointerfaces,172,,,51,59,8,89,10.1016/j.colsurfb.2018.08.027,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051637884&doi=10.1016%2fj.colsurfb.2018.08.027&partnerID=40&md5=d9420d433b228685521ae889d7d8dccc,"School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Department of Pharmaceutical Technology, International Medical University, Kuala Lumpur, Malaysia; Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Life Sciences, International Medical University, Kuala Lumpur, Malaysia; Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box: 123, Broadway, 2007, NSW, Australia","Ng Z.Y., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Wong J.-Y., School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; Panneerselvam J., Department of Pharmaceutical Technology, International Medical University, Kuala Lumpur, Malaysia; Madheswaran T., Department of Pharmaceutical Technology, International Medical University, Kuala Lumpur, Malaysia; Kumar P., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Pillay V., Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Hsu A., Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Hansbro N., Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Bebawy M., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box: 123, Broadway, 2007, NSW, Australia; Wark P., Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Hansbro P., Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia; Dua K., Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights, Newcastle, 2305, NSW, Australia, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, P.O. Box: 123, Broadway, 2007, NSW, Australia; Chellappan D.K., Department of Life Sciences, International Medical University, Kuala Lumpur, Malaysia",Asthma; Curcumin; Inflammation; Liposomes; Molecular modelling; Pro-inflammatory markers,"Asthma; Biomarkers; Cell Line; Computer Simulation; Curcumin; Drug Liberation; Humans; Inflammation; Liposomes; Models, Molecular; Particle Size; Spectroscopy, Fourier Transform Infrared; Static Electricity; Biochemistry; Cell culture; Controlled drug delivery; Disease control; Drug products; Encapsulation; Intelligent control; Liposomes; Molecular mechanics; Molecular modeling; Particle size; Pathology; Zeta potential; curcumin; interleukin 6; interleukin 8; lipopolysaccharide; phosphatidylcholine; salbutamol; tumor necrosis factor; biological marker; curcumin; liposome; Anti-inflammatory activity; Anti-inflammatory effects; Asthma; Curcumin; Drug encapsulation efficiency; Inflammation; Molecular mechanics simulation; Pro-inflammatory markers; antiinflammatory activity; Article; asthma; controlled study; dispersion; dispersity; drug formulation; drug release; drug structure; drug synthesis; encapsulation; energy; in vitro study; lipid metabolism; liposomal delivery; particle size; priority journal; protein expression; zeta potential; asthma; cell line; chemistry; computer simulation; human; inflammation; infrared spectroscopy; metabolism; molecular model; pathology; static electricity; Diseases",Article,Final,,Scopus,2-s2.0-85051637884
Haw T.J.; Starkey M.R.; Pavlidis S.; Fricker M.; Arthurs A.L.; Nair P.M.; Liu G.; Hanish I.; Kim R.Y.; Foster P.S.; Horvat J.C.; Adcock I.M.; Hansbro P.M.,"Haw, Tatt Jhong (56625918900); Starkey, Malcolm R. (35811293400); Pavlidis, Stelios (56642790400); Fricker, Michael (26638839800); Arthurs, Anya L. (57201154892); Nair, Prema M. (55749131000); Liu, Gang (57189061134); Hanish, Irwan (55572056100); Kim, Richard Y. (35810406900); Foster, Paul S. (7201517569); Horvat, Jay C. (9942405300); Adcock, Ian M. (7007066538); Hansbro, Philip M. (6603119390)",56625918900; 35811293400; 56642790400; 26638839800; 57201154892; 55749131000; 57189061134; 55572056100; 35810406900; 7201517569; 9942405300; 7007066538; 6603119390,Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease,2018,American Journal of Physiology - Lung Cellular and Molecular Physiology,314,2,,L298,L317,19,58,10.1152/ajplung.00154.2017,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043603056&doi=10.1152%2fajplung.00154.2017&partnerID=40&md5=cbae92d9afcdb4fa8a172497327e074d,"Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Priority Research Centre for Grow Up Well, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia","Haw T.J., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia, Priority Research Centre for Grow Up Well, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Pavlidis S., The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Fricker M., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Arthurs A.L., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Nair P.M., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Liu G., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Hanish I., Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia; Kim R.Y., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia; Adcock I.M., The Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Hansbro P.M., Priority Research Centre for Healthy Lungs, School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute and University of Newcastle, Callaghan, NSW, Australia",Cigarette smoke; COPD; Emphysema; TLR2; TLR4,"Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Emphysema; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Knockout; Pneumonia; Pulmonary Disease, Chronic Obstructive; Tobacco; Toll-Like Receptor 2; Toll-Like Receptor 4; collagen; CXCL1 chemokine; macrophage derived chemokine; macrophage elastase; macrophage inflammatory protein 1alpha; macrophage inflammatory protein 1beta; messenger RNA; monocyte chemotactic protein 1; monocyte chemotactic protein 5; mucin 5AC; toll like receptor 2; toll like receptor 4; Tlr2 protein, mouse; Tlr4 protein, mouse; toll like receptor 2; toll like receptor 4; airway epithelium cell; airway remodeling; animal cell; animal experiment; animal model; animal tissue; apoptosis; Article; chronic obstructive lung disease; cigarette smoking; controlled study; female; flow cytometry; histopathology; inflammatory cell; lung alveolus macrophage; lung disease; lung fibrosis; lung function; lung parenchyma; macrophage; monocyte; mouse; myeloid dendritic cell; neutrophil; nonhuman; pathogenesis; pneumonia; priority journal; protein expression; protein function; respiratory tract inflammation; animal; Bagg albino mouse; bronchoalveolar lavage fluid; chemically induced; chronic obstructive lung disease; emphysema; human; knockout mouse; metabolism; pathology; physiology; pneumonia; tobacco; toxicity",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-85043603056
Ali M.K.; Kim R.Y.; Karim R.; Mayall J.R.; Martin K.L.; Shahandeh A.; Abbasian F.; Starkey M.R.; Loustaud-Ratti V.; Johnstone D.; Milward E.A.; Hansbro P.M.; Horvat J.C.,"Ali, Md Khadem (57194408422); Kim, Richard Y. (35810406900); Karim, Rafia (57194419768); Mayall, Jemma R. (55607222700); Martin, Kristy L. (57194415123); Shahandeh, Ali (57194416049); Abbasian, Firouz (24465110100); Starkey, Malcolm R. (35811293400); Loustaud-Ratti, Veronique (36157275500); Johnstone, Daniel (15829670700); Milward, Elizabeth A. (6603563509); Hansbro, Philip M. (6603119390); Horvat, Jay C. (9942405300)",57194408422; 35810406900; 57194419768; 55607222700; 57194415123; 57194416049; 24465110100; 35811293400; 36157275500; 15829670700; 6603563509; 6603119390; 9942405300,Role of iron in the pathogenesis of respiratory disease,2017,International Journal of Biochemistry and Cell Biology,88,,,181,195,14,75,10.1016/j.biocel.2017.05.003,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020022102&doi=10.1016%2fj.biocel.2017.05.003&partnerID=40&md5=7fcb12535f13e0a57570ab932714d9b2,"School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Global Centre for Environmental Remediation, Faculty of Science, University of Newcastle, Callaghan, 2308, NSW, Australia; U850 INSERM, University of Limoges, CHU Limoges, Limoges, F-87000, France; The University of Sydney, Bosch Institute and Discipline of Physiology, Sydney, 2000, NSW, Australia","Ali M.K., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Kim R.Y., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Karim R., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Mayall J.R., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Martin K.L., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Shahandeh A., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Abbasian F., Global Centre for Environmental Remediation, Faculty of Science, University of Newcastle, Callaghan, 2308, NSW, Australia; Starkey M.R., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Loustaud-Ratti V., U850 INSERM, University of Limoges, CHU Limoges, Limoges, F-87000, France; Johnstone D., The University of Sydney, Bosch Institute and Discipline of Physiology, Sydney, 2000, NSW, Australia; Milward E.A., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia; Horvat J.C., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, Callaghan, 2308, NSW, Australia",Host–pathogen interaction; Immunity; Infection; Iron; Lung disease,Animals; Homeostasis; Humans; Iron; Respiratory Tract Diseases; Respiratory Tract Infections; iron; iron; asthma; chronic obstructive lung disease; cystic fibrosis; fibrosing alveolitis; homeostasis; human; innate immunity; iron absorption; lung cancer; lung disease; lung emphysema; pathogenesis; regulatory mechanism; respiratory tract disease; respiratory tract infection; Review; smoking; animal; immunology; metabolism; respiratory tract disease; respiratory tract infection,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-85020022102
McIlroy D.J.; Minahan K.; Keely S.; Lott N.; Hansbro P.; Smith D.W.; Balogh Z.J.,"McIlroy, Daniel J. (55924934900); Minahan, Kyra (35574254300); Keely, Simon (9739611200); Lott, Natalie (55549863500); Hansbro, Philip (6603119390); Smith, Doug W. (59099974300); Balogh, Zsolt J. (7006637520)",55924934900; 35574254300; 9739611200; 55549863500; 6603119390; 59099974300; 7006637520,Reduced deoxyribonuclease enzyme activity in response to high postinjury mitochondrial DNA concentration provides a therapeutic target for Systemic Inflammatory Response Syndrome,2018,Journal of Trauma and Acute Care Surgery,85,2,,354,358,4,23,10.1097/TA.0000000000001919,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051118793&doi=10.1097%2fTA.0000000000001919&partnerID=40&md5=c2f2f07aa050121d390f52d5cdbc4840,"Department of Traumatology, University of Newcastle, Newcastle, NSW, Australia; Department of Traumatology, John Hunter Hospital and University of Newcastle, Newcastle, 2310, NSW, Australia; School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia; Priority Research Centre for Translational Neuroscience and Mental Health, Discipline of Anatomy, School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia","McIlroy D.J., Department of Traumatology, University of Newcastle, Newcastle, NSW, Australia; Minahan K., School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia; Keely S., School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia; Lott N., Department of Traumatology, John Hunter Hospital and University of Newcastle, Newcastle, 2310, NSW, Australia; Hansbro P., School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia; Smith D.W., Priority Research Centre for Translational Neuroscience and Mental Health, Discipline of Anatomy, School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Balogh Z.J., Department of Traumatology, John Hunter Hospital and University of Newcastle, Newcastle, 2310, NSW, Australia",MOF; mtDNA; NETs; SIRS; trauma,"Adult; Case-Control Studies; Cell-Free Nucleic Acids; Deoxyribonucleases; DNA, Mitochondrial; Female; Humans; Injury Severity Score; Male; Middle Aged; Multiple Organ Failure; Prospective Studies; Systemic Inflammatory Response Syndrome; cell nucleus DNA; deoxyribonuclease; mitochondrial DNA; cell free nucleic acid; deoxyribonuclease; mitochondrial DNA; adult; blood transfusion; blunt trauma; Conference Paper; enzyme activity; female; femur shaft fracture; fracture; human; human cell; injury scale; intensive care unit; intramedullary nailing; length of stay; major clinical study; male; open reduction (procedure); osteosynthesis; perioperative period; polymerase chain reaction; postoperative period; preoperative period; priority journal; prospective study; quantitative analysis; systemic inflammatory response syndrome; systolic blood pressure; traumatology; blood; case control study; middle aged; multiple organ failure; systemic inflammatory response syndrome",Conference paper,Final,,Scopus,2-s2.0-85051118793
Shukla S.D.; Hansbro P.M.; Walters E.H.,"Shukla, Shakti Dhar (56367620800); Hansbro, Philip Michael (6603119390); Walters, Eugene Haydn (7102865814)",56367620800; 6603119390; 7102865814,Blocking rhinoviral adhesion molecule (ICAM-1): Potential to prevent COPD exacerbations,2017,International Journal of COPD,12,,,1413,1414,1,6,10.2147/COPD.S138612,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019896133&doi=10.2147%2fCOPD.S138612&partnerID=40&md5=0571d25881c3622a97c594e2cb430492,"Priority Research Centre for Healthy Lungs, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Medicine, University of Tasmania, Hobart, TAS, Australia","Shukla S.D., Priority Research Centre for Healthy Lungs, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Walters E.H., School of Medicine, University of Tasmania, Hobart, TAS, Australia",,"Cell Adhesion Molecules; Humans; Intercellular Adhesion Molecule-1; Pulmonary Disease, Chronic Obstructive; Rhinovirus; intercellular adhesion molecule 1; messenger RNA; thrombocyte activating factor receptor; cell adhesion molecule; intercellular adhesion molecule 1; acute exacerbation of chronic obstructive pulmonary disease; Article; asthma; chronic obstructive lung disease; common cold; Haemophilus influenzae; human; nonhuman; respiratory epithelium; respiratory tract infection; Rhinovirus; smoking; Streptococcus pneumoniae; Rhinovirus",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85019896133
Plank M.W.; Maltby S.; Tay H.L.; Stewart J.; Eyers F.; Hansbro P.M.; Foster P.S.,"Plank, Maximilian W. (23486258000); Maltby, Steven (6507446799); Tay, Hock L. (55639898100); Stewart, Jessica (57193562267); Eyers, Fiona (6506572937); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569)",23486258000; 6507446799; 55639898100; 57193562267; 6506572937; 6603119390; 7201517569,MicroRNA expression is altered in an ovalbumin-induced asthma model and targeting miR-155 with antagomirs reveals cellular specificity,2015,PLoS ONE,10,12,0144810,,,,59,10.1371/journal.pone.0144810,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956877537&doi=10.1371%2fjournal.pone.0144810&partnerID=40&md5=9104c345655387482597c9e347f5cf79,"Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2300, NSW, Australia","Plank M.W., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2300, NSW, Australia; Maltby S., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2300, NSW, Australia; Tay H.L., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2300, NSW, Australia; Stewart J., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2300, NSW, Australia; Eyers F., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2300, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2300, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, 2300, NSW, Australia",,"Animals; Asthma; Dexamethasone; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Humans; Lung; Mice; Mice, Inbred BALB C; MicroRNAs; Oligonucleotides; Organ Specificity; Ovalbumin; antagomir; antagomir 155; dexamethasone; isoflurane; microRNA; microRNA 1224 5p; microRNA 130b 3p; microRNA 135a 1 3p; microRNA 135b 5p; microRNA 139 3p; microRNA 142 3p; microRNA 144 3p; microRNA 155; microRNA 155 5p; microRNA 188 5p; microRNA 1897 5p; microRNA 18a 5p; microRNA 193b 3p; microRNA 21a 5p; microRNA 223 3p; microRNA 328 3p; microRNA 362 5p; microRNA 378a 3p; microRNA 378a 5p; microRNA 449a 5p; microRNA 451a; microRNA 486 5p; microRNA let 7d 3p; ovalbumin; unclassified drug; unindexed drug; dexamethasone; microRNA; Mirn155 microRNA, mouse; oligonucleotide; ovalbumin; allergic asthma; animal cell; animal experiment; animal model; animal tissue; Article; bone marrow cell; cell population; cell specificity; controlled study; gene control; gene expression profiling; gene function; gene identification; gene targeting; genetic analysis; immunocompetent cell; in vitro study; in vivo study; lymphocyte; mouse; nonhuman; pathogenesis; phenotype; animal; antagonists and inhibitors; antibody specificity; asthma; Bagg albino mouse; chemically induced; comparative study; disease model; gene expression profiling; gene expression regulation; genetics; human; lung; metabolism; pathology",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84956877537
Hallstrand T.S.; Hackett T.L.; Altemeier W.A.; Matute-Bello G.; Hansbro P.M.; Knight D.A.,"Hallstrand, Teal S. (6603197136); Hackett, Tillie L. (15765031200); Altemeier, William A. (36007077800); Matute-Bello, Gustavo (6603357256); Hansbro, Philip M. (6603119390); Knight, Darryl A. (7402350036)",6603197136; 15765031200; 36007077800; 6603357256; 6603119390; 7402350036,Airway epithelial regulation of pulmonary immune homeostasis and inflammation,2014,Clinical Immunology,151,1,,1,15,14,189,10.1016/j.clim.2013.12.003,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893401365&doi=10.1016%2fj.clim.2013.12.003&partnerID=40&md5=30e64bfad7552948542b8782bf61416e,"Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, United States; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia","Hallstrand T.S., Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, United States; Hackett T.L., Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Altemeier W.A., Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, United States; Matute-Bello G., Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, United States; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Knight D.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia",Asthma; Chemokine; Chronic-obstructive pulmonary disease; Epithelium; Host defense; Tight junctions,"Adaptive Immunity; Air Pollutants; Bacterial Proteins; Chemokines, CC; Cytokines; Homeostasis; Humans; Immunity, Innate; Interleukin-17; Interleukins; Lung; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Smoke; Tobacco; Asthma; Chemokine; Chronic-obstructive pulmonary disease; Epithelium; Host defense; Tight junctions; caveolin 1; cigarette smoke; interleukin 25; interleukin 33; thymic stromal lymphopoietin; adaptive immunity; air pollutant; biosensor; cell adhesion; chemotaxis; dendritic cell; eosinophil; host resistance; human; immune response; immunoregulation; innate immunity; lymphocyte activation; pneumonia; priority journal; respiratory epithelium; respiratory tract infection; review; tight junction",Review,Final,,Scopus,2-s2.0-84893401365
Moheimani F.; Roth H.M.; Cross J.; Reid A.T.; Shaheen F.; Warner S.M.; Hirota J.A.; Kicic A.; Hallstrand T.S.; Kahn M.; Stick S.M.; Hansbro P.M.; Hackett T.-L.; Knight D.A.,"Moheimani, Fatemeh (36157216000); Roth, Hollis M. (55388755000); Cross, Jennifer (7402348915); Reid, Andrew T. (39561518600); Shaheen, Furquan (24367375600); Warner, Stephanie M. (23394240600); Hirota, Jeremy A. (7007085348); Kicic, Anthony (6507472922); Hallstrand, Teal S. (6603197136); Kahn, Michael (7402055370); Stick, Stephen M. (35373713500); Hansbro, Philip M. (6603119390); Hackett, Tillie-Louise (15765031200); Knight, Darryl A. (7402350036)",36157216000; 55388755000; 7402348915; 39561518600; 24367375600; 23394240600; 7007085348; 6507472922; 6603197136; 7402055370; 35373713500; 6603119390; 15765031200; 7402350036,Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair,2015,International Journal of Biochemistry and Cell Biology,68,,4686,59,69,10,39,10.1016/j.biocel.2015.08.014,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941028135&doi=10.1016%2fj.biocel.2015.08.014&partnerID=40&md5=db5ae841f27acbe6691c0580c3ebec74,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; UBC Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada; Telethon Kids Institute, Centre for Health Research, University of Western Australia, Nedlands, 6009, Western Australia, Australia; Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, 6001, Western Australia, Australia; School of Paediatrics and Child Health, Centre for Health Research, University of Western Australia, Nedlands, Australia; Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, 6009, Western Australia, Australia; Department of Medicine, Division of Pulmonary and Critical Care, University of Washington, Seattle, WA, United States; Norris Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA, United States","Moheimani F., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Roth H.M., UBC Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada; Cross J., UBC Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada; Reid A.T., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Shaheen F., UBC Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada; Warner S.M., UBC Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada; Hirota J.A., UBC Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada; Kicic A., Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada, Telethon Kids Institute, Centre for Health Research, University of Western Australia, Nedlands, 6009, Western Australia, Australia, Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, 6001, Western Australia, Australia, School of Paediatrics and Child Health, Centre for Health Research, University of Western Australia, Nedlands, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, 6009, Western Australia, Australia; Hallstrand T.S., Department of Medicine, Division of Pulmonary and Critical Care, University of Washington, Seattle, WA, United States; Kahn M., Norris Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, CA, United States; Stick S.M., Telethon Kids Institute, Centre for Health Research, University of Western Australia, Nedlands, 6009, Western Australia, Australia, Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, 6001, Western Australia, Australia, School of Paediatrics and Child Health, Centre for Health Research, University of Western Australia, Nedlands, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, 6009, Western Australia, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Hackett T.-L., UBC Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada; Knight D.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada",Airway epithelium; Epithelial-mesenchymal transition; ICG-001; Wound repair; β-Catenin/CBP,"Actins; Asthma; beta Catenin; Bicyclo Compounds, Heterocyclic; Cell Differentiation; Cell Movement; Cell Proliferation; E1A-Associated p300 Protein; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibronectins; Gene Expression Regulation; Humans; Keratin-19; Keratin-5; Peptide Fragments; Primary Cell Culture; Pyrimidinones; Respiratory Mucosa; Sialoglycoproteins; Signal Transduction; Transcription Factors; Transforming Growth Factor beta1; alpha smooth muscle actin; beta catenin; cytokeratin 14; cytokeratin 19; cytokeratin 5; E1A associated p300 protein; fibronectin; histone acetyltransferase PCAF; n benzyl 1,2,3,4,8,9 hexahydro 6 (4 hydroxybenzyl) 8 (1 naphthylmethyl) 4,7 dioxo 2h pyrazino[1,2 a]pyrimidine 1(6h) carboxamide; STAT3 protein; transcription factor; uvomorulin; ACTA2 protein, human; actin; beta catenin; bone sialoprotein (35-62), human; CTNNB1 protein, human; cytokeratin 19; cytokeratin 5; E1A associated p300 protein; EP300 protein, human; fibronectin; fused heterocyclic rings; peptide fragment; pyrimidinone derivative; sialoglycoprotein; snail family transcription factors; transcription factor; transforming growth factor beta1; Article; asthma; cell cycle arrest; cell differentiation; cell function; cell junction; cell migration; cell proliferation; cell regeneration; cell structure; controlled study; down regulation; epithelial mesenchymal transition; epithelium cell; fibroblast; gene expression; genetic transcription; human; human cell; plasticity; protein content; protein expression; protein phosphorylation; respiratory epithelium; signal transduction; wound closure; antagonists and inhibitors; cell motion; cytology; drug effects; epithelial mesenchymal transition; gene expression regulation; genetics; metabolism; pathology; primary cell culture; respiratory tract mucosa; signal transduction",Article,Final,,Scopus,2-s2.0-84941028135
Gold M.J.; Hiebert P.R.; Park H.Y.; Stefanowicz D.; Le A.; Starkey M.R.; Deane A.; Brown A.C.; Liu G.; Horvat J.C.; Ibrahim Z.A.; Sukkar M.B.; Hansbro P.M.; Carlsten C.; Vaneeden S.; Sin D.D.; McNagny K.M.; Knight D.A.; Hirota J.A.,"Gold, M.J. (7402444023); Hiebert, P.R. (35213146400); Park, H.Y. (57218127297); Stefanowicz, D. (26031843700); Le, A. (57614374900); Starkey, M.R. (35811293400); Deane, A. (55571783900); Brown, A.C. (55637745000); Liu, G. (57189061134); Horvat, J.C. (9942405300); Ibrahim, Z.A. (55832846700); Sukkar, M.B. (7003439011); Hansbro, P.M. (6603119390); Carlsten, C. (6602448695); Vaneeden, S. (7006188955); Sin, D.D. (57202594563); McNagny, K.M. (6701876377); Knight, D.A. (7402350036); Hirota, J.A. (7007085348)",7402444023; 35213146400; 57218127297; 26031843700; 57614374900; 35811293400; 55571783900; 55637745000; 57189061134; 9942405300; 55832846700; 7003439011; 6603119390; 6602448695; 7006188955; 57202594563; 6701876377; 7402350036; 7007085348,Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization,2016,Mucosal Immunology,9,3,,809,820,11,63,10.1038/mi.2015.104,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964990175&doi=10.1038%2fmi.2015.104&partnerID=40&md5=ed07d4565d02e79f55422ad7f66905e6,"Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada; James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, South Korea; Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia; Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia; Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada","Gold M.J., Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada; Hiebert P.R., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; Park H.Y., Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, South Korea; Stefanowicz D., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; Le A., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; Starkey M.R., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Deane A., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Brown A.C., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Liu G., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Horvat J.C., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Ibrahim Z.A., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia, Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia; Sukkar M.B., Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, Australia, Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia; Carlsten C., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada, Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; Vaneeden S., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; Sin D.D., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; McNagny K.M., Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; Knight D.A., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Hirota J.A., James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada, Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada",,"Animals; Antigens, Dermatophagoides; Cell Proliferation; Cells, Cultured; Environmental Exposure; Female; Humans; Hypersensitivity; Immunity, Mucosal; Immunization; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Particulate Matter; Pyroglyphidae; Respiratory Mucosa; T-Lymphocytes; Toll-Like Receptor 4; Uric Acid; cyclic AMP; high mobility group B1 protein; indometacin; interleukin 1alpha; interleukin 33; losartan; urate oxidase; uric acid; verlukast; house dust allergen; particulate matter; Tlr4 protein, mouse; toll like receptor 4; uric acid; acid secretion; air pollution; allergic reaction; animal cell; animal experiment; Article; CD4+ T lymphocyte; cell proliferation; confocal microscopy; controlled study; cytokine production; Dermatophagoides; enzyme inhibition; female; gene expression; human; human cell; human tissue; in vivo study; innate immunity; lung alveolus epithelium; lymphoid cell; morbidity; mortality; mouse; nonhuman; particulate matter; priority journal; respiratory tract mucosa; sensitization; stimulus response; Th2 cell; uric acid blood level; animal; C57BL mouse; cell culture; environmental exposure; genetics; hypersensitivity; immunization; immunology; knockout mouse; lung; metabolism; mucosal immunity; particulate matter; pathology; physiology; Pyroglyphidae; respiratory mucosa; T lymphocyte",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84964990175
Hansbro P.M.; Knight D.A.,"Hansbro, Philip M. (6603119390); Knight, Darryl A. (7402350036)",6603119390; 7402350036,Are lymphoid follicles important in the pathogenesis of chronic obstructive pulmonary disease?,2013,American Journal of Respiratory and Critical Care Medicine,188,3,,267,269,2,1,10.1164/rccm.201306-1073ED,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881121048&doi=10.1164%2frccm.201306-1073ED&partnerID=40&md5=60b48dd0afb5cfaec7b6248f6604b0a4,"Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia","Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Knight D.A., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia",,"Animals; Chemokine CXCL13; Female; Gene Expression Regulation; Humans; Male; Pulmonary Disease, Chronic Obstructive; RNA, Messenger; Smoke; Smoking; Tobacco; autoantibody; B cell maturation antigen; CXCL13 chemokine; CXCL9 chemokine; immunoglobulin A; immunoglobulin G; immunoglobulin M; macrophage inflammatory protein 3beta; B lymphocyte; CD8+ T lymphocyte; chronic inflammation; chronic obstructive lung disease; clinical feature; dendritic cell; editorial; gene expression; human; inflammatory cell; lung lavage; lymph follicle; macrophage; neutrophil; nonhuman; pathogenesis; priority journal; risk assessment",Editorial,Final,,Scopus,2-s2.0-84881121048
Sobinoff A.P.; Sutherland J.M.; Beckett E.L.; Stanger S.J.; Johnson R.; Jarnicki A.G.; Mccluskey A.; St John J.C.; Hansbro P.M.; Mclaughlin E.A.,"Sobinoff, A.P. (36495791100); Sutherland, J.M. (35774667100); Beckett, E.L. (36620958500); Stanger, S.J. (55193089500); Johnson, R. (57213392674); Jarnicki, A.G. (6603137164); Mccluskey, A. (7004402361); St John, J.C. (8781160700); Hansbro, P.M. (6603119390); Mclaughlin, E.A. (57565084300)",36495791100; 35774667100; 36620958500; 55193089500; 57213392674; 6603137164; 7004402361; 8781160700; 6603119390; 57565084300,Damaging legacy: Maternal cigarette smoking has long-term consequences for male offspring fertility,2014,Human Reproduction,29,12,,2719,2735,16,45,10.1093/humrep/deu235,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924360724&doi=10.1093%2fhumrep%2fdeu235&partnerID=40&md5=3eeeeacf39e508223766e000722ec377,"PRC in Chemical Biology, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia; Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, 2308, NSW, Australia; Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Newcastle, Callaghan, 2308, NSW, Australia; Centre for Genetic Diseases, MIMR-PHI Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia; Monash Medical Centre, Monash Institute of Medical Research, Clayton, 3168, VIC, Australia","Sobinoff A.P., PRC in Chemical Biology, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, 2308, NSW, Australia; Sutherland J.M., PRC in Chemical Biology, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, 2308, NSW, Australia; Beckett E.L., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Newcastle, Callaghan, 2308, NSW, Australia; Stanger S.J., PRC in Chemical Biology, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, 2308, NSW, Australia; Johnson R., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Newcastle, Callaghan, 2308, NSW, Australia; Jarnicki A.G., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Newcastle, Callaghan, 2308, NSW, Australia; Mccluskey A., Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, 2308, NSW, Australia; St John J.C., Centre for Genetic Diseases, MIMR-PHI Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, 3168, VIC, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Newcastle, Callaghan, 2308, NSW, Australia; Mclaughlin E.A., PRC in Chemical Biology, School of Environmental and Life Sciences, University of Newcastle, Callaghan, 2308, NSW, Australia, Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, 2308, NSW, Australia, Monash Medical Centre, Monash Institute of Medical Research, Clayton, 3168, VIC, Australia",Cigarette smoking; DNA damage; spermatogenesis; subfertility; testis,"Animals; Apoptosis; DNA Damage; Female; Infertility, Male; Lactation; Male; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Sertoli Cells; Smoking; Spermatogenesis; Animalia; Mus; cigarette smoke; mitochondrial DNA; sex hormone; ambient air; animal experiment; animal model; apoptosis; Article; binding assay; C57BL 6 mouse; cell population; cell structure; chronic obstructive lung disease; comet assay; controlled study; DNA damage; exposure; female; female subfertility; fertility; germ cell; gestational age; histology; lung parenchyma; male; maternal smoking; microarray analysis; mitochondrial genome; mouse; next generation sequencing; nonhuman; oxidative stress; polymerase chain reaction; pregnancy; progeny; quantitative analysis; reproductive health; reproductive toxicity; Sertoli cell; spermatogenesis; spermatozoon; spermatozoon count; spermatozoon motility; testis; weaning; zona pellucida; adverse effects; animal; C57BL mouse; cytology; Infertility, Male; lactation; prenatal exposure; smoking",Article,Final,,Scopus,2-s2.0-84924360724
Fricker M.; Deane A.; Hansbro P.M.,"Fricker, Michael (26638839800); Deane, Andrew (55571783900); Hansbro, Philip M. (6603119390)",26638839800; 55571783900; 6603119390,Animal models of chronic obstructive pulmonary disease,2014,Expert Opinion on Drug Discovery,9,6,,629,645,16,145,10.1517/17460441.2014.909805,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901254158&doi=10.1517%2f17460441.2014.909805&partnerID=40&md5=9f87f8b800313ae7c31eacc86c5ba858,"University of Newcastle and Hunter Medical Research Institute, Priority Research Centre for Asthma and Respiratory Disease, New Lambton Heights, NSW, Australia","Fricker M., University of Newcastle and Hunter Medical Research Institute, Priority Research Centre for Asthma and Respiratory Disease, New Lambton Heights, NSW, Australia; Deane A., University of Newcastle and Hunter Medical Research Institute, Priority Research Centre for Asthma and Respiratory Disease, New Lambton Heights, NSW, Australia; Hansbro P.M., University of Newcastle and Hunter Medical Research Institute, Priority Research Centre for Asthma and Respiratory Disease, New Lambton Heights, NSW, Australia",Animal model; Chemokine; Chronic obstructive pulmonary disease; Cigarette; Cytokine; Emphysema; Guinea pig; Immune system; Inflammation; Lung; Lymphocyte; Macrophage; Mast cell; Model; Mouse; Neutrophil; Oxidative stress; Protease; Pulmonary; Rat,"Animals; Disease Models, Animal; Disease Progression; Humans; Mice; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; chemokine; cigarette smoke; cytokine; age; airway remodeling; animal model; bacterium; cachexia; Charlson Comorbidity Index; chronic obstructive lung disease; disease course; disease exacerbation; emphysema; gender; guinea pig; immunocompetent cell; influenza; lung function; morbidity; mortality; mouse; mucus; nonhuman; osteoporosis; oxidative stress; pathogenesis; pneumonia; priority journal; pulmonary hypertension; rat; review; risk factor; smoking cessation; species; virus; animal; disease model; human; pathophysiology; Pulmonary Disease, Chronic Obstructive; smoking",Review,Final,,Scopus,2-s2.0-84901254158
Essilfie A.-T.; Horvat J.C.; Kim R.Y.; Mayall J.R.; Pinkerton J.W.; Beckett E.L.; Starkey M.R.; Simpson J.L.; Foster P.S.; Gibson P.G.; Hansbro P.M.,"Essilfie, Ama-Tawiah (22955585600); Horvat, Jay C. (9942405300); Kim, Richard Y. (35810406900); Mayall, Jemma R. (55607222700); Pinkerton, James W. (56647761900); Beckett, Emma L. (36620958500); Starkey, Malcolm R. (35811293400); Simpson, Jodie L. (7404326026); Foster, Paul S. (7201517569); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390)",22955585600; 9942405300; 35810406900; 55607222700; 56647761900; 36620958500; 35811293400; 7404326026; 7201517569; 7202414199; 6603119390,Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma,2015,Thorax,70,5,,458,467,9,118,10.1136/thoraxjnl-2014-206067,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929457101&doi=10.1136%2fthoraxjnl-2014-206067&partnerID=40&md5=dcf70872fa6363f51a98efee6df338e9,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia","Essilfie A.-T., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Kim R.Y., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Mayall J.R., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Pinkerton J.W., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Beckett E.L., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Starkey M.R., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Simpson J.L., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Gibson P.G., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia",,"Amoxicillin; Animals; Anti-Bacterial Agents; Asthma; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Dexamethasone; Disease Models, Animal; Female; Glucocorticoids; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C; amoxicillin plus clavulanic acid; clarithromycin; interleukin 17; tumor necrosis factor alpha; amoxicillin; antiinfective agent; clarithromycin; dexamethasone; glucocorticoid; animal experiment; animal model; animal tissue; antibacterial activity; antiinflammatory activity; Article; cellular immunity; chlamydiasis; clinical feature; controlled study; cytokine response; drug effect; drug efficacy; drug response; experimental asthma; female; Haemophilus infection; immunomodulation; lung infection; mouse; nonhuman; priority journal; respiratory tract allergy; Th2 cell; animal; asthma; Bagg albino mouse; Chlamydophila Infections; Chlamydophila pneumoniae; complication; disease model; Haemophilus Infections; Haemophilus influenzae",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84929457101
Camlin N.J.; Sobinoff A.P.; Sutherland J.M.; Beckett E.L.; Jarnicki A.G.; Vanders R.L.; Hansbro P.M.; McLaughlin E.A.; Holt J.E.,"Camlin, Nicole J. (56426532900); Sobinoff, Alexander P. (36495791100); Sutherland, Jessie M. (35774667100); Beckett, Emma L. (36620958500); Jarnicki, Andrew G. (6603137164); Vanders, Rebecca L. (55773360100); Hansbro, Philip M. (6603119390); McLaughlin, Eileen A. (57565084300); Holt, Janet E. (7402069863)",56426532900; 36495791100; 35774667100; 36620958500; 6603137164; 55773360100; 6603119390; 57565084300; 7402069863,Maternal smoke exposure impairs the long-term fertility of female offspring in a murine model,2016,Biology of Reproduction,94,2,39,,,,54,10.1095/biolreprod.115.135848,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961221365&doi=10.1095%2fbiolreprod.115.135848&partnerID=40&md5=d471a57ad1c2bc05ae8ec50fb9673efd,"School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, Australia; Telomere Length Regulation Group, Children's Medical Research Institute, Westmead, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; School of Biological Sciences, University of Auckland, Auckland, New Zealand","Camlin N.J., School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, Australia; Sobinoff A.P., School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, Australia, Telomere Length Regulation Group, Children's Medical Research Institute, Westmead, NSW, Australia; Sutherland J.M., School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Beckett E.L., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Jarnicki A.G., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Vanders R.L., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; McLaughlin E.A., School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, Australia, School of Biological Sciences, University of Auckland, Auckland, New Zealand; Holt J.E., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia",Cigarette smoke; In utero; Oocyte; Ovary; Subfertility,Animals; Female; Fertility; Maternal Exposure; Mice; Oocytes; Ovarian Follicle; Ovary; Oxidative Stress; Pregnancy; Smoke; Sperm-Ovum Interactions; cigarette smoke; smoke; adult; adulthood; adverse outcome; animal cell; animal experiment; apoptosis; Article; cell proliferation; controlled study; environmental exposure; female; female fertility; female subfertility; lactation; male; maternal smoking; metaphase; mouse; nonhuman; oocyte; ovary; ovary follicle cell; oxidative stress; priority journal; somatic cell; spindle cell; adverse effects; animal; drug effects; fertility; maternal exposure; metabolism; ovary follicle; pregnancy; smoke,Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-84961221365
Hansbro P.M.; Kaiko G.E.; Foster P.S.,"Hansbro, Philip M. (6603119390); Kaiko, Gerard E (21739529400); Foster, Paul S. (7201517569)",6603119390; 21739529400; 7201517569,Cytokine/anti-cytokine therapy - Novel treatments for asthma?,2011,British Journal of Pharmacology,163,1,,81,95,14,134,10.1111/j.1476-5381.2011.01219.x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953718767&doi=10.1111%2fj.1476-5381.2011.01219.x&partnerID=40&md5=ec5e029f1c8b5f22e1fc7df20a4dd520,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; David Maddison Clinical Sciences Building, Cnr King and Watt Sts, Newcastle, NSW 2300, Australia","Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, David Maddison Clinical Sciences Building, Cnr King and Watt Sts, Newcastle, NSW 2300, Australia; Kaiko G.E., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",animal models; asthma; cytokine; human clinical trials; therapy; treatment,Animals; Asthma; Clinical Trials as Topic; Cytokines; Humans; Inflammation; adalimumab; beta 2 adrenergic receptor stimulating agent; corticosteroid; cytokine; gamma interferon antibody; golimumab; granulocyte macrophage colony stimulating factor antibody; infliximab; interleukin 13 antibody; interleukin 17 antibody; interleukin 25; interleukin 25 antibody; interleukin 27; interleukin 33; interleukin 33 antibody; interleukin 4 antibody; interleukin 4 receptor; interleukin 4 receptor alpha; interleukin 5 antibody; interleukin 9; interleukin 9 antibody; mepolizumab; pascolizumab; piktrakinra; placebo; reslizumab; thymic stromal lymphopoietin; thymic stromal lymphopoietin antibody; tumor necrosis factor alpha; unclassified drug; unindexed drug; antiinflammatory activity; asthma; CD4+ T lymphocyte; dendritic cell; drug efficacy; drug inhibition; drug safety; human; macrophage; neutrophil; nonhuman; pathogenesis; phenotype; priority journal; quality of life; review; single drug dose; smooth muscle fiber,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-79953718767
Thorburn A.N.; Foster P.S.; Gibson P.G.; Hansbro P.M.,"Thorburn, Alison N. (35485821500); Foster, Paul S. (7201517569); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390)",35485821500; 7201517569; 7202414199; 6603119390,Components of streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells,2012,Journal of Immunology,188,9,,4611,4620,9,79,10.4049/jimmunol.1101299,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860331287&doi=10.4049%2fjimmunol.1101299&partnerID=40&md5=975d1cbff95eae53399b16e00e4f4ac9,"Centre for Asthma and Respiratory Disease, Newcastle, NSW 2300, Australia; Department of Immunology, Monash University, Clayton, VIC 3800, Australia; Hunter Medical Research Institute, Newcastle, NSW 2300, Australia","Thorburn A.N., Centre for Asthma and Respiratory Disease, Newcastle, NSW 2300, Australia, Department of Immunology, Monash University, Clayton, VIC 3800, Australia; Foster P.S., Department of Immunology, Monash University, Clayton, VIC 3800, Australia, Hunter Medical Research Institute, Newcastle, NSW 2300, Australia; Gibson P.G., Centre for Asthma and Respiratory Disease, Newcastle, NSW 2300, Australia, Hunter Medical Research Institute, Newcastle, NSW 2300, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Newcastle, NSW 2300, Australia, Department of Immunology, Monash University, Clayton, VIC 3800, Australia, Hunter Medical Research Institute, Newcastle, NSW 2300, Australia",,"Adoptive Transfer; Animals; Asthma; Bacterial Capsules; Bacterial Proteins; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Mucus; Natural Killer T-Cells; Oligodeoxyribonucleotides; Streptococcus pneumoniae; Streptolysins; T-Lymphocytes, Regulatory; Th2 Cells; antiasthmatic agent; CpG oligodeoxynucleotide; microbial products not classified elsewhere; pneumolysoid; type 3 polysaccharide; unclassified drug; adoptive transfer; allergic asthma; animal cell; animal experiment; animal model; animal tissue; article; bacterial cell wall; combination chemotherapy; controlled study; cytokine release; drug efficacy; drug mechanism; eosinophil; female; immune deficiency; immunoregulation; mouse; natural killer cell; nonhuman; priority journal; regulatory T lymphocyte; Streptococcus pneumoniae; T cell depletion; Th2 cell",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84860331287
Vijaykrishna D.; Deng Y.-M.; Su Y.C.F.; Fourment M.; Iannello P.; Arzey G.C.; Hansbro P.M.; Edla Arzey K.; Kirkland P.D.; Warner S.; O'Riley K.; Barr I.G.; Smith G.J.D.; Hurt A.C.,"Vijaykrishna, Dhanasekaran (15070312600); Deng, Yi-Mo (7401531140); Su, Yvonne C. F. (7404456219); Fourment, Mathieu (12040665600); Iannello, Pina (8520355300); Arzey, George G. (6602897806); Hansbro, Philip M. (6603119390); Edla Arzey, K. (55841374000); Kirkland, Peter D. (56243457600); Warner, Simone (23983839400); O'Riley, Kim (6506489871); Barr, Ian G. (7004651416); Smith, Gavin J. D. (8344015800); Hurt, Aeron C. (6603378203)",15070312600; 7401531140; 7404456219; 12040665600; 8520355300; 6602897806; 6603119390; 55841374000; 56243457600; 23983839400; 6506489871; 7004651416; 8344015800; 6603378203,The recent establishment of North American H10 lineage influenza viruses in Australian wild waterfowl and the evolution of Australian avian influenza viruses,2013,Journal of Virology,87,18,,10182,10189,7,37,10.1128/JVI.03437-12,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883303403&doi=10.1128%2fJVI.03437-12&partnerID=40&md5=d18d8b34ee852a3e2129ad9f6838ff71,"Laboratory of Virus Evolution, Duke-NUS Graduate Medical School, Singapore; WHO Collaborating Centre for Reference and Research on Influenza, Parkville, VIC, Australia; Elizabeth Macarthur Agricultural Institute, Menangle, NSW, Australia; Hunter Medical Research Institute, University of Newcastle, New Lambton, NSW, Australia; Biosciences Research Division, Department of Primary Industries, Bundoora, VIC, Australia; Duke Global Health Institute, Duke University, Durham, NC, United States; Monash University, School of Applied Science and Engineering, Churchill, VIC, Australia","Vijaykrishna D., Laboratory of Virus Evolution, Duke-NUS Graduate Medical School, Singapore; Deng Y.-M., WHO Collaborating Centre for Reference and Research on Influenza, Parkville, VIC, Australia; Su Y.C.F., Laboratory of Virus Evolution, Duke-NUS Graduate Medical School, Singapore; Fourment M., Laboratory of Virus Evolution, Duke-NUS Graduate Medical School, Singapore; Iannello P., WHO Collaborating Centre for Reference and Research on Influenza, Parkville, VIC, Australia; Arzey G.C., Elizabeth Macarthur Agricultural Institute, Menangle, NSW, Australia; Hansbro P.M., Hunter Medical Research Institute, University of Newcastle, New Lambton, NSW, Australia; Edla Arzey K., Elizabeth Macarthur Agricultural Institute, Menangle, NSW, Australia; Kirkland P.D., Elizabeth Macarthur Agricultural Institute, Menangle, NSW, Australia; Warner S., Biosciences Research Division, Department of Primary Industries, Bundoora, VIC, Australia; O'Riley K., Biosciences Research Division, Department of Primary Industries, Bundoora, VIC, Australia; Barr I.G., WHO Collaborating Centre for Reference and Research on Influenza, Parkville, VIC, Australia; Smith G.J.D., Laboratory of Virus Evolution, Duke-NUS Graduate Medical School, Singapore, Duke Global Health Institute, Duke University, Durham, NC, United States; Hurt A.C., WHO Collaborating Centre for Reference and Research on Influenza, Parkville, VIC, Australia, Monash University, School of Applied Science and Engineering, Churchill, VIC, Australia",,"Animals; Australia; Birds; Cluster Analysis; Evolution, Molecular; Hemagglutinin Glycoproteins, Influenza Virus; Influenza A virus; Influenza in Birds; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Poultry; RNA, Viral; Sequence Analysis, DNA; animal cell; article; Australia; avian influenza virus; climate change; controlled study; disease control; disease surveillance; ducks and geese; endemic disease; hemagglutinin gene; Influenza virus A H10N7; molecular evolution; nonhuman; North America; phylogeny; population dynamics; priority journal; sequence alignment; virus gene; virus isolation; virus strain",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-84883303403
Kim R.Y.; Rae B.; Neal R.; Donovan C.; Pinkerton J.; Balachandran L.; Starkey M.R.; Knight D.A.; Horvat J.C.; Hansbro P.M.,"Kim, Richard Y. (35810406900); Rae, Brittany (57336626800); Neal, Rachel (57201587411); Donovan, Chantal (55357105200); Pinkerton, James (56647761900); Balachandran, Lohis (57877075900); Starkey, Malcolm R. (35811293400); Knight, Darryl A. (7402350036); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",35810406900; 57336626800; 57201587411; 55357105200; 56647761900; 57877075900; 35811293400; 7402350036; 9942405300; 6603119390,Elucidating novel disease mechanisms in severe asthma,2016,Clinical and Translational Immunology,5,7,e91,,,,29,10.1038/CTI.2016.37,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020191174&doi=10.1038%2fCTI.2016.37&partnerID=40&md5=1f8f8de65b62418bad12f1644fc9684d,"Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Kim R.Y., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Rae B., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Neal R., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Donovan C., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Pinkerton J., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Balachandran L., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Starkey M.R., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Knight D.A., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",,,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85020191174
Starkey M.R.; Nguyen D.H.; Brown A.C.; Essilfie A.-T.; Kim R.Y.; Yagita H.; Horvat J.C.; Hansbro P.M.,"Starkey, Malcolm R. (35811293400); Nguyen, Duc H. (54886138200); Brown, Alexandra C. (55637745000); Essilfie, Ama-Tawiah (22955585600); Kim, Richard Y. (35810406900); Yagita, Hideo (55192275000); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",35811293400; 54886138200; 55637745000; 22955585600; 35810406900; 55192275000; 9942405300; 6603119390,Programmed death ligand 1 promotes early-life chlamydia respiratory infection-induced severe allergic airway disease,2016,American Journal of Respiratory Cell and Molecular Biology,54,4,,493,503,10,20,10.1165/rcmb.2015-0204OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963779025&doi=10.1165%2frcmb.2015-0204OC&partnerID=40&md5=53964c173962c8adf28b92b75bf984ac,"Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan","Starkey M.R., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Nguyen D.H., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Brown A.C., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Essilfie A.-T., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Kim R.Y., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Yagita H., Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan; Horvat J.C., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia; Hansbro P.M., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2315, NSW, Australia",Airway hyperresponsiveness; Asthma; Chlamydia respiratory infection; Infant; PD-L1,"Animals; Antigens, CD274; Chlamydia Infections; Disease Susceptibility; Interleukin-13 Receptor alpha2 Subunit; Mice; Mice, Inbred BALB C; Programmed Cell Death 1 Receptor; Respiratory Hypersensitivity; Respiratory Tract Infections; RNA, Messenger; CD4 antigen; interleukin 13; messenger RNA; neutralizing antibody; programmed death 1 ligand 1; programmed death 1 ligand 2; Cd274 protein, mouse; interleukin 13 receptor alpha2; messenger RNA; Pdcd1 protein, mouse; programmed death 1 ligand 1; programmed death 1 receptor; animal experiment; Article; CD4+ T lymphocyte; CD8+ T lymphocyte; chlamydiasis; controlled study; dendritic cell; disease severity; flow cytometry; gene expression; histopathology; infant; lung function; lung homogenate; lung weight; monocyte; mouse; nonhuman; respiratory tract allergy; respiratory tract infection; animal; Bagg albino mouse; chlamydiasis; complication; disease predisposition; genetics; metabolism; physiology; Respiratory Hypersensitivity; respiratory tract infection",Article,Final,,Scopus,2-s2.0-84963779025
Rahman M.M.; Prabhala P.; Rumzhum N.N.; Patel B.S.; Wickop T.; Hansbro P.M.; Verrills N.M.; Ammit A.J.,"Rahman, Md. Mostafizur (57193353117); Prabhala, Pavan (6504321497); Rumzhum, Nowshin N. (55151455300); Patel, Brijeshkumar S. (56344477500); Wickop, Thomas (57190428774); Hansbro, Philip M. (6603119390); Verrills, Nicole M. (6602391112); Ammit, Alaina J. (7003377421)",57193353117; 6504321497; 55151455300; 56344477500; 57190428774; 6603119390; 6602391112; 7003377421,TLR2 ligation induces corticosteroid insensitivity in A549 lung epithelial cells: Anti-inflammatory impact of PP2A activators,2016,International Journal of Biochemistry and Cell Biology,78,,,279,287,8,9,10.1016/j.biocel.2016.07.030,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979928385&doi=10.1016%2fj.biocel.2016.07.030&partnerID=40&md5=d21cd06819ddcbe930b249ccdd3c4dc5,"Faculty of Pharmacy, University of Sydney, NSW, Australia; Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, NSW, Australia; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia","Rahman M.M., Faculty of Pharmacy, University of Sydney, NSW, Australia; Prabhala P., Faculty of Pharmacy, University of Sydney, NSW, Australia; Rumzhum N.N., Faculty of Pharmacy, University of Sydney, NSW, Australia; Patel B.S., Faculty of Pharmacy, University of Sydney, NSW, Australia; Wickop T., Faculty of Pharmacy, University of Sydney, NSW, Australia; Hansbro P.M., Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia; Verrills N.M., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, NSW, Australia; Ammit A.J., Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia",Corticosteroid insensitivity; MKP-1; PP2A; TLR2,"Adrenal Cortex Hormones; Anti-Inflammatory Agents; Cell Line; Drug Resistance; Dual Specificity Phosphatase 1; Enzyme Activation; Humans; Ligands; Lipopeptides; Lung; Oxidation-Reduction; Protein Binding; Protein Phosphatase 2; Toll-Like Receptor 2; Up-Regulation; bacterial protein; dexamethasone; fingolimod; glucocorticoid receptor; I kappa B alpha; immunoglobulin enhancer binding protein; interleukin 6; ligand; lipoprotein; mitogen activated protein kinase; mitogen activated protein kinase p38; mitogen activated protein kinase phosphatase 1; phosphoprotein phosphatase 2A; stress activated protein kinase; theophylline; toll like receptor 2; transcription factor RelA; tumor necrosis factor alpha; antiinflammatory agent; corticosteroid; lipopeptide; mitogen activated protein kinase phosphatase 1; Pam(3)CSK(4) peptide; phosphoprotein phosphatase 2; protein binding; TLR2 protein, human; toll like receptor 2; A549 cell line; antiinflammatory activity; Article; cell nucleus; controlled study; cytokine release; disease exacerbation; human; human cell; oxidation; oxidative stress; respiratory tract inflammation; upregulation; cell line; cytology; drug effects; drug resistance; enzyme activation; lung; metabolism; oxidation reduction reaction",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84979928385
Asquith K.L.; Horvat J.C.; Kaiko G.E.; Carey A.J.; Beagley K.W.; Hansbro P.M.; Foster P.S.,"Asquith, Kelly L. (6507212626); Horvat, Jay C. (9942405300); Kaiko, Gerard E. (21739529400); Carey, Alison J. (8713721100); Beagley, Kenneth W. (7005403437); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569)",6507212626; 9942405300; 21739529400; 8713721100; 7005403437; 6603119390; 7201517569,Interleukin-13 Promotes Susceptibility to Chlamydial Infection of the Respiratory and Genital Tracts,2011,PLoS Pathogens,7,5,e1001339,,,,68,10.1371/journal.ppat.1001339,https://www.scopus.com/inward/record.uri?eid=2-s2.0-79958050343&doi=10.1371%2fjournal.ppat.1001339&partnerID=40&md5=18a3f14d9370dbc2231814b2d5b145fa,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Australia","Asquith K.L., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kaiko G.E., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Carey A.J., Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Australia; Beagley K.W., Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia",,"Animals; Bacterial Load; CD4-Positive T-Lymphocytes; Chlamydia Infections; Chlamydia muridarum; Disease Susceptibility; Epithelial Cells; Female; Immunity, Innate; Interferon-gamma; Interleukin-10; Interleukin-13; Lung; Macrophages; Mice; Mice, Inbred BALB C; Mice, Knockout; Respiratory Tract Infections; Vaginal Diseases; Bacteria (microorganisms); Chlamydia muridarum; Chlamydiae; Mus; gamma interferon; interleukin 10; interleukin 13; gamma interferon; interleukin 10; animal cell; animal experiment; animal model; article; bacterial growth; bacterial load; CD4+ T lymphocyte; chlamydiasis; controlled study; disease association; disease severity; epithelium cell; gene expression; genital tract infection; in vitro study; in vivo study; infection sensitivity; inflammation; innate immunity; lung alveolus epithelium; macrophage; mouse; nonhuman; respiratory tract infection; T cell depletion; wild type; animal; Bagg albino mouse; Chlamydia; disease predisposition; female; immunology; lung; metabolism; microbiology; mouse mutant; pathogenicity; vagina disease",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-79958050343
Olson S.H.; Parmley J.; Soos C.; Gilbert M.; Latorre-Margalef N.; Hall J.S.; Hansbro P.M.; Leighton F.; Munster V.; Joly D.,"Olson, Sarah H. (55574244943); Parmley, Jane (8221810900); Soos, Catherine (36244609600); Gilbert, Martin (7202762498); Latorre-Margalef, Neus (16024886800); Hall, Jeffrey S. (8439374700); Hansbro, Phillip M. (6603119390); Leighton, Frederick (35480965100); Munster, Vincent (9332531900); Joly, Damien (7005670706)",55574244943; 8221810900; 36244609600; 7202762498; 16024886800; 8439374700; 6603119390; 35480965100; 9332531900; 7005670706,Sampling strategies and biodiversity of influenza A subtypes in wild birds,2014,PLoS ONE,9,3,e90826,,,,50,10.1371/journal.pone.0090826,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897148224&doi=10.1371%2fjournal.pone.0090826&partnerID=40&md5=2862eb62515ca7074ec06d06983da974,"Wildlife Conservation Society, Bronx, NY, United States; Canadian Cooperative Wildlife Health Centre, Department of Pathobiology, University of Guelph, Guelph, ON, Canada; Environment Canada, Science and Technology Branch, Saskatoon, SK, Canada; Centre for Ecology and Evolution in Microbial Model Systems (EEMiS), Linnaeus University, Kalmar, Sweden; Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA, United States; United States Geological Survey (USGS), National Wildlife Health Center, Madison, WI, United States; Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Canadian Cooperative Wildlife Health Centre, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States; Metabiota, Nanaimo, BC, Canada","Olson S.H., Wildlife Conservation Society, Bronx, NY, United States; Parmley J., Canadian Cooperative Wildlife Health Centre, Department of Pathobiology, University of Guelph, Guelph, ON, Canada; Soos C., Environment Canada, Science and Technology Branch, Saskatoon, SK, Canada; Gilbert M., Wildlife Conservation Society, Bronx, NY, United States; Latorre-Margalef N., Centre for Ecology and Evolution in Microbial Model Systems (EEMiS), Linnaeus University, Kalmar, Sweden, Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA, United States; Hall J.S., United States Geological Survey (USGS), National Wildlife Health Center, Madison, WI, United States; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Leighton F., Canadian Cooperative Wildlife Health Centre, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada; Munster V., Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States; Joly D., Metabiota, Nanaimo, BC, Canada",,"Animals; Animals, Wild; Biodiversity; Birds; Geography; Host-Pathogen Interactions; Influenza A virus; Influenza in Birds; article; biodiversity; bird; host pathogen interaction; Influenza virus A; nonhuman; population abundance; species distribution; species richness; species translocation; virus detection; virus strain; wild animal",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84897148224
Tay H.L.; Kaiko G.E.; Plank M.; Li J.; Maltby S.; Essilfie A.-T.; Jarnicki A.; Yang M.; Mattes J.; Hansbro P.M.; Foster P.S.,"Tay, Hock L. (55639898100); Kaiko, Gerard E. (21739529400); Plank, Maximilian (23486258000); Li, JingJing (55983696800); Maltby, Steven (6507446799); Essilfie, Ama-Tawiah (22955585600); Jarnicki, Andrew (6603137164); Yang, Ming (55703323200); Mattes, Joerg (7005999915); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569)",55639898100; 21739529400; 23486258000; 55983696800; 6507446799; 22955585600; 6603137164; 55703323200; 7005999915; 6603119390; 7201517569,Correction: Antagonism of miR-328 Increases the Antimicrobial Function of Macrophages and Neutrophils and Rapid Clearance of Non-typeable Haemophilus Influenzae (NTHi) from Infected Lung,2015,PLoS Pathogens,11,6,e1004956,,,,3,10.1371/journal.ppat.1004956,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955570589&doi=10.1371%2fjournal.ppat.1004956&partnerID=40&md5=a15be5d96cf74bcd7e75da5a196b7e38,,,,Erratum; error,Erratum,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84955570589
Jaffar J.; Unger S.; Corte T.J.; Keller M.; Wolters P.J.; Richeldi L.; Cerri S.; Prêle C.M.; Hansbro P.M.; Argraves W.S.; Oliver R.A.; Oliver B.G.; Black J.L.; Burgess J.K.,"Jaffar, Jade (16042610400); Unger, Sofia (56383473700); Corte, Tamera J. (57220408326); Keller, Michael (56383372400); Wolters, Paul J. (7005825515); Richeldi, Luca (7003874268); Cerri, Stefania (8580439400); Prêle, Cecilia M. (6507419393); Hansbro, Philip M. (6603119390); Argraves, William Scott (7006209539); Oliver, Rema A. (19640518500); Oliver, Brian G. (15919869900); Black, Judith L. (7402767206); Burgess, Janette K. (7201650628)",16042610400; 56383473700; 57220408326; 56383372400; 7005825515; 7003874268; 8580439400; 6507419393; 6603119390; 7006209539; 19640518500; 15919869900; 7402767206; 7201650628,Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis,2014,Chest,146,4,,1055,1063,8,39,10.1378/chest.13-2688,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907919354&doi=10.1378%2fchest.13-2688&partnerID=40&md5=5027a095e0e3eba6e8556eb4d7618bae,"Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Rd, Level 3 Cell Biology, Glebe, 2037, NSW, Australia; Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Royal Prince Alfred Hospital (Sydney Local Health District), Sydney, NSW, Australia; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, United States; Department of Respiratory Diseases, University Hospital of Modena, Modena, Italy; Department of Interstitial Lung Disease, University of Southampton, Southampton, United Kingdom; Centre for Asthma Allergy and Respiratory Research, Lung Institute of Western Australia, University of Western Australia, Australia; Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Priority Research Centre for Asthma and Respiratory Disease, New Lambton Heights, NSW, Australia; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Surgical and Orthopaedic Research Laboratories, Prince of Wales Clinical School, University of New South Wales, Randwick, NSW, Australia; School of Medical and Molecular Biosciences, University of Technology Sydney, Sydney, NSW, Australia","Jaffar J., Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Rd, Level 3 Cell Biology, Glebe, 2037, NSW, Australia, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia, Sydney Medical School, University of Sydney, Royal Prince Alfred Hospital (Sydney Local Health District), Sydney, NSW, Australia; Unger S., Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Rd, Level 3 Cell Biology, Glebe, 2037, NSW, Australia; Corte T.J., Sydney Medical School, University of Sydney, Royal Prince Alfred Hospital (Sydney Local Health District), Sydney, NSW, Australia; Keller M., Sydney Medical School, University of Sydney, Royal Prince Alfred Hospital (Sydney Local Health District), Sydney, NSW, Australia; Wolters P.J., Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, United States; Richeldi L., Department of Respiratory Diseases, University Hospital of Modena, Modena, Italy, Department of Interstitial Lung Disease, University of Southampton, Southampton, United Kingdom; Cerri S., Department of Respiratory Diseases, University Hospital of Modena, Modena, Italy; Prêle C.M., Centre for Asthma Allergy and Respiratory Research, Lung Institute of Western Australia, University of Western Australia, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, New Lambton Heights, NSW, Australia; Argraves W.S., Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Oliver R.A., Surgical and Orthopaedic Research Laboratories, Prince of Wales Clinical School, University of New South Wales, Randwick, NSW, Australia, School of Medical and Molecular Biosciences, University of Technology Sydney, Sydney, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Rd, Level 3 Cell Biology, Glebe, 2037, NSW, Australia; Black J.L., Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Rd, Level 3 Cell Biology, Glebe, 2037, NSW, Australia, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia, Sydney Medical School, University of Sydney, Royal Prince Alfred Hospital (Sydney Local Health District), Sydney, NSW, Australia; Burgess J.K., Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Rd, Level 3 Cell Biology, Glebe, 2037, NSW, Australia, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia, Sydney Medical School, University of Sydney, Royal Prince Alfred Hospital (Sydney Local Health District), Sydney, NSW, Australia",,"Aged; Aged, 80 and over; Australia; Biological Markers; Blotting, Western; Calcium-Binding Proteins; Cell Culture Techniques; Disease Progression; Female; Fibroblasts; Follow-Up Studies; Humans; Idiopathic Pulmonary Fibrosis; Immunohistochemistry; Italy; Male; Middle Aged; United States; fibulin; fibulin 1; unclassified drug; biological marker; calcium binding protein; fibulin; aged; Article; clinical article; composite physiologic index; controlled study; disease course; disease severity; female; fibrosing alveolitis; forced expiratory volume; forced vital capacity; human; human cell; human tissue; lung diffusion capacity; lung fibroblast; lung parenchyma; male; predictive value; progression free survival; protein blood level; respiratory tract parameters; survival time; total lung capacity; Australia; clinical trial; culture technique; fibroblast; fibrosing alveolitis; follow up; immunohistochemistry; Italy; metabolism; middle aged; multicenter study; United States; very elderly; Western blotting",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84907919354
Hansbro P.M.; Scott G.V.; Essilfie A.-T.; Kim R.Y.; Starkey M.R.; Nguyen D.H.; Allen P.D.; Kaiko G.E.; Yang M.; Horvat J.C.; Foster P.S.,"Hansbro, Philip M. (6603119390); Scott, Grace V. (55521841100); Essilfie, Ama-Tawiah (22955585600); Kim, Richard Y. (35810406900); Starkey, Malcolm R. (35811293400); Nguyen, Duc H. (54886138200); Allen, Paul D. (35236149300); Kaiko, Gerard E. (21739529400); Yang, Ming (56857729900); Horvat, Jay C. (9942405300); Foster, Paul S. (7201517569)",6603119390; 55521841100; 22955585600; 35810406900; 35811293400; 54886138200; 35236149300; 21739529400; 56857729900; 9942405300; 7201517569,Th2 cytokine antagonists: Potential treatments for severe asthma,2013,Expert Opinion on Investigational Drugs,22,1,,49,69,20,78,10.1517/13543784.2013.732997,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871013520&doi=10.1517%2f13543784.2013.732997&partnerID=40&md5=661ed358c197e3dd01493819c327654d,"University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2305, Level 2, Kookaburra Circuit, Australia; University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2300, Australia; Harvard Medical School, Boston, MA, United States","Hansbro P.M., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2305, Level 2, Kookaburra Circuit, Australia; Scott G.V., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2300, Australia; Essilfie A.-T., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2300, Australia; Kim R.Y., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2300, Australia; Starkey M.R., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2300, Australia; Nguyen D.H., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2300, Australia; Allen P.D., Harvard Medical School, Boston, MA, United States; Kaiko G.E., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2300, Australia; Yang M., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2300, Australia; Horvat J.C., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2300, Australia; Foster P.S., University of Newcastle, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle, NSW, 2305, Level 2, Kookaburra Circuit, Australia",Antagonists; Asthma; CRTH2; ERK; GM-CSF; IL-13; IL-25; IL-33; IL-4; IL-4Rα/IL-13Rα1; IL-5; IL-9; JAK; MicroRNA; Mouse models; Patient stratification; Small interfering oligonucleotides; ST2; STAT; Th2 cytokine; Therapy; TSLP,Animals; Anti-Asthmatic Agents; Asthma; Cytokines; Humans; Th2 Cells; antiasthmatic agent; antisense oligonucleotide; benralizumab; biological marker; corticosteroid; cytokine receptor antagonist; enokizumab; granulocyte macrophage colony stimulating factor; indoleacetic acid; interleukin 13; interleukin 25; interleukin 25 antibody; interleukin 33; interleukin 33 antibody; interleukin 4 antibody; interleukin 4 receptor alpha monoclonal antibody; interleukin 9; mepolizumab; microRNA; omalizumab; pascolizumab; phenylacetic acid derivative; pitrakinra; ramatroban; reslizumab; small interfering RNA; steroid; tetrahydroquinoline; thymic stromal lymphopoietin; transforming growth factor beta1; unclassified drug; asthma; cytokine production; cytokine release; dendritic cell; drug efficacy; eosinophil; forced expiratory volume; health care cost; human; macrophage; mast cell; patient compliance; regulatory T lymphocyte; review; signal transduction; steroid therapy; Th2 cell; unspecified side effect,Review,Final,,Scopus,2-s2.0-84871013520
Tang F.S.M.; Hansbro P.M.; Burgess J.K.; Ammit A.J.; Baines K.J.; Oliver B.G.,"Tang, Francesca S M (56985136900); Hansbro, Philip M (6603119390); Burgess, Janette K (7201650628); Ammit, Alaina J (7003377421); Baines, Katherine J (35078051200); Oliver, Brian G (15919869900)",56985136900; 6603119390; 7201650628; 7003377421; 35078051200; 15919869900,A novel immunomodulatory function of neutrophils on rhinovirus-Activated monocytes in vitro,2016,Thorax,71,11,,1039,1049,10,24,10.1136/thoraxjnl-2015-207781,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979084826&doi=10.1136%2fthoraxjnl-2015-207781&partnerID=40&md5=8401d9ca421a86f6045c5814b2f4ad40,"Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Road, Sydney, 2037, NSW, Australia; Discipline of Pharmacology, Faculty of Medicine, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia; Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, NSW, Australia; Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Centre for Health Technologies and Molecular Biosciences, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia","Tang F.S.M., Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Road, Sydney, 2037, NSW, Australia, Discipline of Pharmacology, Faculty of Medicine, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, NSW, Australia; Burgess J.K., Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Road, Sydney, 2037, NSW, Australia, Discipline of Pharmacology, Faculty of Medicine, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia, Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands; Ammit A.J., Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia; Baines K.J., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, University of Sydney, 431 Glebe Point Road, Sydney, 2037, NSW, Australia, Centre for Health Technologies and Molecular Biosciences, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia",Asthma; COPD Exacerbations; Innate Immunity; Neutrophil Biology; Respiratory Infection; Viral infection,Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Humans; In Vitro Techniques; Inflammation; Interleukin-6; Interleukin-8; Monocytes; Neutrophils; Picornaviridae Infections; Polymerase Chain Reaction; Rhinovirus; interleukin 6; interleukin 8; messenger RNA; programmed death 1 receptor; transforming growth factor beta1; interleukin 6; interleukin 8; Article; coculture; controlled study; cytokine production; cytokine release; enzyme linked immunosorbent assay; human; human cell; Human rhinovirus A16; immune response; immunomodulation; immunosuppressive treatment; in vitro study; monocyte; neutrophil; nonhuman; polymerase chain reaction; priority journal; quantitative analysis; Rhinovirus infection; immunology; inflammation; metabolism; monocyte; neutrophil; picornavirus infection; Rhinovirus,Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-84979084826
O'Reilly M.; Hansbro P.M.; Horvat J.C.; Beckett E.L.; Harding R.; Sozo F.,"O'Reilly, Megan (57198134621); Hansbro, Philip M. (6603119390); Horvat, Jay C. (9942405300); Beckett, Emma L. (36620958500); Harding, Richard (7201911358); Sozo, Foula (8915715900)",57198134621; 6603119390; 9942405300; 36620958500; 7201911358; 8915715900,Bronchiolar Remodeling in Adult Mice Following Neonatal Exposure to Hyperoxia: Relation to Growth,2014,Anatomical Record,297,4,,758,769,11,22,10.1002/ar.22867,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896319326&doi=10.1002%2far.22867&partnerID=40&md5=c30591e9b87e0e17c1c19d8a3cfbd330,"Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia; Priority Research Centre for Asthma, Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, 2308, Australia","O'Reilly M., Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia; Hansbro P.M., Priority Research Centre for Asthma, Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, 2308, Australia; Horvat J.C., Priority Research Centre for Asthma, Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, 2308, Australia; Beckett E.L., Priority Research Centre for Asthma, Respiratory Disease and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, 2308, Australia; Harding R., Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia; Sozo F., Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia",Airway smooth muscle; Bronchioles; Collagen; Epithelium; Hyperoxia; Lung function,"Animals; Animals, Newborn; Bronchioles; Hyperoxia; Male; Mice; Mice, Inbred C57BL; Pulmonary Alveoli; Respiratory Function Tests; Mus; airway smooth muscle; bronchioles; collagen; epithelium; hyperoxia; lung function; collagen; adult; ambient air; animal cell; animal experiment; animal tissue; article; autopsy; bronchiole; bronchus mucosa; ciliated epithelium; Clara cell; controlled study; environmental exposure; female; growth retardation; histology; hyperoxia; lung compliance; lung development; lung function; male; mouse; nonhuman; priority journal",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84896319326
Hsu A.C.-Y.; See H.V.; Hansbro P.M.; Wark P.A.B.,"Hsu, Alan C.-Y. (49861516600); See, Hayley V. (25226364800); Hansbro, Phil M. (6603119390); Wark, Peter A.B. (7003559516)",49861516600; 25226364800; 6603119390; 7003559516,Innate immunity to influenza in chronic airways diseases,2012,Respirology,17,8,,1166,1175,9,30,10.1111/j.1440-1843.2012.02200.x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867966848&doi=10.1111%2fj.1440-1843.2012.02200.x&partnerID=40&md5=972637b9fca8ee0bfa4c782dfe217375,"Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Centre for Asthma and Respiratory Disease, New Lambton Height, NSW 2305, Lookout Rd, Australia","Hsu A.C.-Y., Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia; See H.V., Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia; Wark P.A.B., Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Centre for Asthma and Respiratory Disease, New Lambton Height, NSW 2305, Lookout Rd, Australia",asthma; chronic obstructive pulmonary disease; influenza; innate immunity; viral infection,"Chronic Disease; Disease Susceptibility; Humans; Immune Tolerance; Immunity, Innate; Influenza A virus; Influenza, Human; Respiratory Tract Infections; Viral Nonstructural Proteins; antivirus agent; influenza vaccine; oseltamivir; toll like receptor; zanamivir; asthma; chronic obstructive lung disease; disease exacerbation; drug efficacy; human; immunomodulation; immunosuppressive treatment; influenza; influenza vaccination; Influenza virus A; innate immunity; oxidative stress; priority journal; review; Rhinovirus infection; smoking; virus morphology",Review,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84867966848
Chevalier N.; Thorburn A.N.; Macia L.; Tan J.; Juglair L.; Yagita H.; Yu D.; Hansbro P.M.; Mackay C.R.,"Chevalier, Nina (8238984900); Thorburn, Alison N. (35485821500); Macia, Laurence (15044953300); Tan, Jian (58631946000); Juglair, Laurent (56416478100); Yagita, Hideo (55192275000); Yu, Di (7404666250); Hansbro, Philip M. (6603119390); Mackay, Charles R. (25944725400)",8238984900; 35485821500; 15044953300; 58631946000; 56416478100; 55192275000; 7404666250; 6603119390; 25944725400,Inflammation and lymphopenia trigger autoimmunity by suppression of il-2-controlled regulatory t cell and increase of il-21-mediated effector t cell expansion,2014,Journal of Immunology,193,10,,4845,4858,13,20,10.4049/jimmunol.1302966,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84910131463&doi=10.4049%2fjimmunol.1302966&partnerID=40&md5=b7854bd4bf761016017d7b946691f5d8,"Department of Rheumatology and Clinical Immunology, University Medical Centre Freiburg, Hugstetter Strasse 55, Freiburg, 79106, Germany; Center for Immunology and Inflammation, Monash University Clayton, Melbourne, 3088, VIC, Australia; Immunology Department, Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia; Department of Immunology, Juntendo University School OfMedicine, Tokyo, 113-8421, Japan; Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2300, NSW, Australia","Chevalier N., Department of Rheumatology and Clinical Immunology, University Medical Centre Freiburg, Hugstetter Strasse 55, Freiburg, 79106, Germany, Center for Immunology and Inflammation, Monash University Clayton, Melbourne, 3088, VIC, Australia, Immunology Department, Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia; Thorburn A.N., Center for Immunology and Inflammation, Monash University Clayton, Melbourne, 3088, VIC, Australia; Macia L., Center for Immunology and Inflammation, Monash University Clayton, Melbourne, 3088, VIC, Australia; Tan J., Center for Immunology and Inflammation, Monash University Clayton, Melbourne, 3088, VIC, Australia; Juglair L., Center for Immunology and Inflammation, Monash University Clayton, Melbourne, 3088, VIC, Australia; Yagita H., Department of Immunology, Juntendo University School OfMedicine, Tokyo, 113-8421, Japan; Yu D., Center for Immunology and Inflammation, Monash University Clayton, Melbourne, 3088, VIC, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2300, NSW, Australia; Mackay C.R., Center for Immunology and Inflammation, Monash University Clayton, Melbourne, 3088, VIC, Australia",,"Animals; Arthritis; Autoimmunity; Cell Proliferation; Gene Expression Regulation; Immune Tolerance; Inflammation; Interleukin-2; Interleukins; Lymphopenia; Mice; Mice, Transgenic; Receptors, Interleukin-21; Signal Transduction; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; interleukin 2; interleukin 21; interleukin 21 receptor; interleukin 7; interleukin 7 receptor; transcription factor FOXP3; interleukin 2; interleukin 21; interleukin 21 receptor; interleukin derivative; animal cell; animal tissue; arthritis; Article; autoimmunity; CD4+ T lymphocyte; CD8+ T lymphocyte; cell expansion; cell lineage; controlled study; cytokine production; effector cell; immune response; immunological tolerance; immunopathogenesis; immunophenotyping; immunoreactivity; immunoregulation; inflammation; lymphocytopenia; molecular dynamics; mouse; nonhuman; polymerase chain reaction; protein aggregation; protein secretion; regulatory T lymphocyte; animal; arthritis; cell proliferation; complication; gene expression regulation; genetics; helper cell; immunology; inflammation; lymphocytopenia; pathology; regulatory T lymphocyte; signal transduction; transgenic mouse",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84910131463
Thorburn A.N.; Brown A.C.; Nair P.M.; Chevalier N.; Foster P.S.; Gibson P.G.; Hansbro P.M.,"Thorburn, Alison N. (35485821500); Brown, Alexandra C. (55637745000); Nair, Prema M. (55749131000); Chevalier, Nina (8238984900); Foster, Paul S. (7201517569); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390)",35485821500; 55637745000; 55749131000; 8238984900; 7201517569; 7202414199; 6603119390,Pneumococcal components induce regulatory T cells that attenuate the development of allergic airways disease by deviating and suppressing the immune response to allergen,2013,Journal of Immunology,191,8,,4112,4120,8,22,10.4049/jimmunol.1201232,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885437985&doi=10.4049%2fjimmunol.1201232&partnerID=40&md5=e3250a46afec4478b171999de1993c31,"Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia; Viruses, Infection/Immunity, Vaccines, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW 2315, Australia; Department of Immunology, Monash University, Clayton, VIC 3800, Australia; Department of Rheumatology and Clinical Immunology, University Medical Center, Freiburg 79085, Germany","Thorburn A.N., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia, Viruses, Infection/Immunity, Vaccines, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW 2315, Australia, Department of Immunology, Monash University, Clayton, VIC 3800, Australia; Brown A.C., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia, Viruses, Infection/Immunity, Vaccines, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW 2315, Australia; Nair P.M., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia, Viruses, Infection/Immunity, Vaccines, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW 2315, Australia; Chevalier N., Department of Immunology, Monash University, Clayton, VIC 3800, Australia, Department of Rheumatology and Clinical Immunology, University Medical Center, Freiburg 79085, Germany; Foster P.S., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia, Viruses, Infection/Immunity, Vaccines, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW 2315, Australia; Gibson P.G., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia, Viruses, Infection/Immunity, Vaccines, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW 2315, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia, Viruses, Infection/Immunity, Vaccines, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW 2315, Australia",,"Animals; Antigens, CD86; Asthma; Cells, Cultured; Dendritic Cells; Female; Inflammation; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Interleukin-6; Lung; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Ovalbumin; Polysaccharides, Bacterial; Receptors, CCR7; Streptococcus pneumoniae; T-Lymphocytes, Regulatory; Th17 Cells; Th2 Cells; Transforming Growth Factor beta; allergen; CD86 antigen; chemokine receptor CCR7; immunosuppressive agent; interleukin 2; interleukin 2 receptor alpha; Pneumococcus polysaccharide; pneumolysoid; transcription factor FOXP3; transforming growth factor beta; unclassified drug; allergic airway inflammation; animal cell; animal experiment; animal model; article; cell differentiation; cell expansion; cellular immunity; controlled study; drug mechanism; ex vivo study; female; functional status; immunosuppressive treatment; mouse; myeloid dendritic cell; nonhuman; priority journal; protein expression; protein protein interaction; regulatory T lymphocyte; Streptococcus pneumoniae; Th17 cell; Th2 cell",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84885437985
Grafton K.T.; Moir L.M.; Black J.L.; Hansbro N.G.; Hansbro P.M.; Burgess J.K.; Oliver B.G.,"Grafton, Karryn T. (35558542700); Moir, Lyn M. (8948395100); Black, Judith L. (7402767206); Hansbro, Nicole G. (15055862300); Hansbro, Philip M. (6603119390); Burgess, Janette K. (7201650628); Oliver, Brian G. (15919869900)",35558542700; 8948395100; 7402767206; 15055862300; 6603119390; 7201650628; 15919869900,"LF-15 & T7, synthetic peptides derived from tumstatin, attenuate aspects of airway remodelling in a murine model of chronic OVA-induced allergic airway disease",2014,PLoS ONE,9,1,e85655,,,,14,10.1371/journal.pone.0085655,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898670742&doi=10.1371%2fjournal.pone.0085655&partnerID=40&md5=6d6785791e8e95bf323d8dbbe6777cb6,"Woolcock Institute of Medical Research, Sydney, NSW, Australia; Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia","Grafton K.T., Woolcock Institute of Medical Research, Sydney, NSW, Australia, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Moir L.M., Woolcock Institute of Medical Research, Sydney, NSW, Australia, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Black J.L., Woolcock Institute of Medical Research, Sydney, NSW, Australia, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Hansbro N.G., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Burgess J.K., Woolcock Institute of Medical Research, Sydney, NSW, Australia, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, Sydney, NSW, Australia, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia",,"Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; Cell Survival; Collagen Type IV; Endothelial Cells; Humans; Lung; Mice; Mice, Inbred BALB C; Mitochondria; Neovascularization, Physiologic; Peptide Fragments; Primary Cell Culture; LF 15 peptide; ovalbumin; synthetic peptide; T3 peptide; T7 peptide; tumstatin; unclassified drug; vitronectin receptor; airway remodeling; airway resistance; allergic airway inflammation; animal experiment; animal model; animal tissue; antiangiogenic activity; article; cell viability; combination chemotherapy; drug protein binding; endothelium cell; growth inhibition; human; human cell; human tissue; in vitro study; in vivo study; lung blood vessel; lung endothelium; lung mitochondrion; mitochondrion; monotherapy; mouse; nonhuman; pneumonia; respiratory tract allergy",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84898670742
Chambers D.C.; Gellatly S.L.; Hugenholtz P.; Hansbro P.M.,"Chambers, Daniel C. (26424572400); Gellatly, Shaan L. (26430804400); Hugenholtz, Philip (55811879700); Hansbro, Philip M. (6603119390)",26424572400; 26430804400; 55811879700; 6603119390,JTD special edition 'Hot Topics in COPD'-The microbiome in COPD,2014,Journal of Thoracic Disease,6,11,,1525,1531,6,19,10.3978/j.issn.2072-1439.2014.11.08,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84917741087&doi=10.3978%2fj.issn.2072-1439.2014.11.08&partnerID=40&md5=10e25ccb57fd703978b2d4dd1f4912f4,"Qld Lung Transplant Service, The Prince Charles Hospital, Brisbane, Australia; School of Medicine, The University of Queensland, Brisbane, Australia; Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia; Hunter Medical Research Institute, Newcastle, Australia; Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia","Chambers D.C., Qld Lung Transplant Service, The Prince Charles Hospital, Brisbane, Australia, School of Medicine, The University of Queensland, Brisbane, Australia; Gellatly S.L., Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia, Hunter Medical Research Institute, Newcastle, Australia; Hugenholtz P., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences and Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia, Hunter Medical Research Institute, Newcastle, Australia",Chronic obstructive pulmonary disease (COPD); Metagenomics; Microbiome,RNA 16S; bronchiolitis obliterans; chronic obstructive lung disease; cystic fibrosis; DNA sequence; Haemophilus influenzae; high throughput sequencing; host pathogen interaction; human; intestine flora; microbiome; nonhuman; pathogenesis; polymerase chain reaction; Review,Review,Final,,Scopus,2-s2.0-84917741087
Wynne O.; Horvat J.C.; Kim R.Y.; Ong L.K.; Smith R.; Hansbro P.M.; Clifton V.L.; Hodgson D.M.,"Wynne, O. (57195730811); Horvat, J.C. (9942405300); Kim, R.Y. (35810406900); Ong, L.K. (56033871000); Smith, R. (7410301946); Hansbro, P.M. (6603119390); Clifton, V.L. (6603677237); Hodgson, D.M. (7201364433)",57195730811; 9942405300; 35810406900; 56033871000; 7410301946; 6603119390; 6603677237; 7201364433,Neonatal respiratory infection and adult re-infection: Effect on glucocorticoid and mineralocorticoid receptors in the hippocampus in BALB/c mice,2011,"Brain, Behavior, and Immunity",25,6,,1214,1222,8,4,10.1016/j.bbi.2011.03.014,https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960220801&doi=10.1016%2fj.bbi.2011.03.014&partnerID=40&md5=85743ba67080a94b22f786b354b67c39,"Laboratory of Neuroimmunology, University of Newcastle, Newcastle, NSW, Australia; Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, NSW, Australia; Department of Paediatrics and Reproductive Health, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia","Wynne O., Laboratory of Neuroimmunology, University of Newcastle, Newcastle, NSW, Australia, Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Kim R.Y., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Ong L.K., School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, NSW, Australia; Smith R., Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Clifton V.L., Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW, Australia, Department of Paediatrics and Reproductive Health, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia; Hodgson D.M., Laboratory of Neuroimmunology, University of Newcastle, Newcastle, NSW, Australia, Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW, Australia",Glucocorticoid receptor; Hippocampus; Infection; Mineralocorticoid receptor; Perinatal stress; Tyrosine hydroxylase,"Adrenal Glands; Age Factors; Animals; Animals, Newborn; Chlamydia Infections; Chlamydia muridarum; Corticosterone; Female; Gene Expression Regulation; Hippocampus; Male; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; Pneumonia, Bacterial; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Recurrence; Sex Characteristics; Specific Pathogen-Free Organisms; Tyrosine 3-Monooxygenase; corticosterone; glucocorticoid receptor; mineralocorticoid receptor; adulthood; animal experiment; animal model; article; chlamydiasis; controlled study; female; gene expression; hippocampus; male; mouse; newborn infection; nonhuman; priority journal; protein analysis; protein expression; quantitative analysis; radioimmunoassay; reinfection; respiratory tract infection; reverse transcription polymerase chain reaction; stress; Western blotting",Article,Final,,Scopus,2-s2.0-79960220801
Foster P.S.; Plank M.; Collison A.; Tay H.L.; Kaiko G.E.; Li J.; Johnston S.L.; Hansbro P.M.; Kumar R.K.; Yang M.; Mattes J.,"Foster, Paul S. (7201517569); Plank, Maximilian (23486258000); Collison, Adam (23995251200); Tay, Hock L. (55639898100); Kaiko, Gerard E. (21739529400); Li, Jingjing (55983696800); Johnston, Sebastian L. (7401781716); Hansbro, Philip M. (6603119390); Kumar, Rakesh K. (57203775042); Yang, Ming (56857729900); Mattes, Joerg (7005999915)",7201517569; 23486258000; 23995251200; 55639898100; 21739529400; 55983696800; 7401781716; 6603119390; 57203775042; 56857729900; 7005999915,The emerging role of microRNAs in regulating immune and inflammatory responses in the lung,2013,Immunological Reviews,253,1,,198,215,17,101,10.1111/imr.12058,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875784606&doi=10.1111%2fimr.12058&partnerID=40&md5=093760302f25ea8c93e8acc48f1c1f94,"Priority Research Centre for Asthma and Respiratory Disease, Dept of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Priority Research Centre for Asthma and Respiratory Disease, Discipline of Paediatrics and Child Health, School of Medicine and Public Health, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Airway Disease Infection, National Heart and Lung Institute, Medical Research Council and Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom; Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, Australia","Foster P.S., Priority Research Centre for Asthma and Respiratory Disease, Dept of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Plank M., Priority Research Centre for Asthma and Respiratory Disease, Dept of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Collison A., Priority Research Centre for Asthma and Respiratory Disease, Discipline of Paediatrics and Child Health, School of Medicine and Public Health, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Tay H.L., Priority Research Centre for Asthma and Respiratory Disease, Dept of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kaiko G.E., Priority Research Centre for Asthma and Respiratory Disease, Dept of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Li J., Priority Research Centre for Asthma and Respiratory Disease, Dept of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Johnston S.L., Airway Disease Infection, National Heart and Lung Institute, Medical Research Council and Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, London, United Kingdom; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Dept of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kumar R.K., Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, Australia; Yang M., Priority Research Centre for Asthma and Respiratory Disease, Dept of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Mattes J., Priority Research Centre for Asthma and Respiratory Disease, Discipline of Paediatrics and Child Health, School of Medicine and Public Health, Faculty of Health and Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia",Immune system; Infection; Inflammatory disease; Lung; MicroRNAs,"Animals; Disease Models, Animal; Humans; Immunity, Innate; Lung; Mice; MicroRNAs; Molecular Targeted Therapy; Pneumonia; Respiratory Tract Infections; microRNA; steroid; asthma; bacterial infection; cell function; defense mechanism; experimental model; host resistance; human; immune response; inflammation; inflammatory cell; inflammatory disease; innate immunity; lung; lung infection; nonhuman; pneumonia; priority journal; respiratory tract disease; review; virus infection",Review,Final,,Scopus,2-s2.0-84875784606
Starkey M.R.; Essilfie A.T.; Horvat J.C.; Kim R.Y.; Nguyen D.H.; Beagley K.W.; Mattes J.; Foster P.S.; Hansbro P.M.,"Starkey, M.R. (35811293400); Essilfie, A.T. (22955585600); Horvat, J.C. (9942405300); Kim, R.Y. (35810406900); Nguyen, D.H. (54886138200); Beagley, K.W. (7005403437); Mattes, J. (7005999915); Foster, P.S. (7201517569); Hansbro, P.M. (6603119390)",35811293400; 22955585600; 9942405300; 35810406900; 54886138200; 7005403437; 7005999915; 7201517569; 6603119390,Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease,2013,Mucosal Immunology,6,3,,569,579,10,53,10.1038/mi.2012.99,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876372773&doi=10.1038%2fmi.2012.99&partnerID=40&md5=de546db25ee4cc5e7be04c569a0d3055,"Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia","Starkey M.R., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Essilfie A.T., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Horvat J.C., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kim R.Y., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Nguyen D.H., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Beagley K.W., Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia; Mattes J., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Foster P.S., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Hansbro P.M., Center for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia",,interleukin 13; interleukin 13 antibody; interleukin 13 receptor alpha2; STAT6 protein; animal cell; animal experiment; animal model; animal tissue; article; cell hyperplasia; Chlamydia; chlamydiasis; controlled study; cytokine production; disease severity; drug effect; mouse; mucous cell; mucus secretion; nonhuman; priority journal; respiratory tract allergy; respiratory tract infection; wild type,Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84876372773
Jarnicki A.G.; Schilter H.; Liu G.; Wheeldon K.; Essilfie A.-T.; Foot J.S.; Yow T.T.; Jarolimek W.; Hansbro P.M.,"Jarnicki, A.G. (6603137164); Schilter, H. (23480284500); Liu, G. (57189061134); Wheeldon, K. (57191589586); Essilfie, A.-T. (22955585600); Foot, J.S. (36790740700); Yow, T.T. (55892962600); Jarolimek, W. (6603814673); Hansbro, Philip M (6603119390)",6603137164; 23480284500; 57189061134; 57191589586; 22955585600; 36790740700; 55892962600; 6603814673; 6603119390,"The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model",2016,British Journal of Pharmacology,173,22,,3161,3175,14,37,10.1111/bph.13573,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991821854&doi=10.1111%2fbph.13573&partnerID=40&md5=774751554c19558d4d90b06f421642fa,"Centre for Asthma and Respiratory Disease, The University of Newcastle, and Hunter Medical Research Institute, Newcastle, NSW, Australia; Drug Discovery Department, Pharmaxis Ltd., Sydney, NSW, Australia; Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, VIC, Australia","Jarnicki A.G., Centre for Asthma and Respiratory Disease, The University of Newcastle, and Hunter Medical Research Institute, Newcastle, NSW, Australia, Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, VIC, Australia; Schilter H., Drug Discovery Department, Pharmaxis Ltd., Sydney, NSW, Australia; Liu G., Centre for Asthma and Respiratory Disease, The University of Newcastle, and Hunter Medical Research Institute, Newcastle, NSW, Australia; Wheeldon K., Centre for Asthma and Respiratory Disease, The University of Newcastle, and Hunter Medical Research Institute, Newcastle, NSW, Australia; Essilfie A.-T., Centre for Asthma and Respiratory Disease, The University of Newcastle, and Hunter Medical Research Institute, Newcastle, NSW, Australia; Foot J.S., Drug Discovery Department, Pharmaxis Ltd., Sydney, NSW, Australia; Yow T.T., Drug Discovery Department, Pharmaxis Ltd., Sydney, NSW, Australia; Jarolimek W., Drug Discovery Department, Pharmaxis Ltd., Sydney, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, The University of Newcastle, and Hunter Medical Research Institute, Newcastle, NSW, Australia",,"Allylamine; Amine Oxidase (Copper-Containing); Animals; Benzamides; Disease Models, Animal; Enzyme Inhibitors; Female; Mice; Mice, Inbred C57BL; Pulmonary Disease, Chronic Obstructive; Smoking; 4 [2 (aminomethyl) 3 fluoro allyloxy] n tert butyl benzamide; amine oxide; CXCL1 chemokine; rolipram; semicarbazide derivative; tumor necrosis factor; unclassified drug; vascular adhesion protein 1; allylamine; amine oxidase (copper containing); benzamide derivative; enzyme inhibitor; PXS-4728A; animal cell; animal experiment; animal model; animal tissue; Article; cell transport; chronic obstructive lung disease; controlled study; cytokine production; dose response; emphysema; enzyme activity; enzyme repression; female; lung fibrosis; lung function; lung lavage; lymphocyte; macrophage; male; mouse; nonhuman; priority journal; treatment duration; treatment outcome; treatment response; analogs and derivatives; animal; antagonists and inhibitors; C57BL mouse; disease model; enzymology; metabolism; Pulmonary Disease, Chronic Obstructive; smoking",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84991821854
Ren S.; Hure A.; Peel R.; D'Este C.; Abhayaratna W.; Tonkin A.; Hopper I.; Thrift A.G.; Levi C.; Sturm J.; Durrheim D.; Hung J.; Briffa T.; Chew D.P.; Anderson P.; Moon L.; McEvoy M.; Hansbro P.; Newby D.; Attia J.,"Ren, Shu (57189216570); Hure, Alexis (24070975100); Peel, Roseanne (55207142000); D'Este, Catherine (6602084604); Abhayaratna, Walter (12759938700); Tonkin, Andrew (34572757300); Hopper, Ingrid (57208096319); Thrift, Amanda G. (7004824524); Levi, Christopher (26643279200); Sturm, Jonathan (7202194795); Durrheim, David (35551260900); Hung, Joseph (35409388600); Briffa, Thomas (6507675518); Chew, Derek P. (7102026332); Anderson, Phil (24503016000); Moon, Lynelle (26641374700); McEvoy, Mark (8911690100); Hansbro, Philip (6603119390); Newby, David (7006580756); Attia, John (7003299759)",57189216570; 24070975100; 55207142000; 6602084604; 12759938700; 34572757300; 57208096319; 7004824524; 26643279200; 7202194795; 35551260900; 35409388600; 6507675518; 7102026332; 24503016000; 26641374700; 8911690100; 6603119390; 7006580756; 7003299759,Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE),2016,American Heart Journal,177,,,58,65,7,34,10.1016/j.ahj.2016.04.003,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966393498&doi=10.1016%2fj.ahj.2016.04.003&partnerID=40&md5=9b209ca3e7d03af2b5abef06653ce43e,"School of Medicine and Public Health, University of Newcastle, NSW, Australia; National Centre for Epidemiology and Population Health (NCEPH), Research School of Population Health, Australian National University, ACT, Australia; Canberra Hospital, Australian National University Medical School, ACT, Australia; Department of Epidemiology and Preventive Medicine, Monash University, VIC, Australia; Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, VIC, Australia; Hunter New England Population Health, Hunter Medical Research Institute, NSW, Australia; School of Medicine and Pharmacology, University of Western Australia, WA, Australia; School of Population Health, University of Western Australia, WA, Australia; School of Medicine, Flinders University, SA, Australia; Australian Institute of Health and Welfare, ACT, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia","Ren S., School of Medicine and Public Health, University of Newcastle, NSW, Australia; Hure A., School of Medicine and Public Health, University of Newcastle, NSW, Australia; Peel R., School of Medicine and Public Health, University of Newcastle, NSW, Australia; D'Este C., National Centre for Epidemiology and Population Health (NCEPH), Research School of Population Health, Australian National University, ACT, Australia; Abhayaratna W., Canberra Hospital, Australian National University Medical School, ACT, Australia; Tonkin A., Department of Epidemiology and Preventive Medicine, Monash University, VIC, Australia; Hopper I., Department of Epidemiology and Preventive Medicine, Monash University, VIC, Australia; Thrift A.G., Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, VIC, Australia; Levi C., School of Medicine and Public Health, University of Newcastle, NSW, Australia; Sturm J., School of Medicine and Public Health, University of Newcastle, NSW, Australia; Durrheim D., Hunter New England Population Health, Hunter Medical Research Institute, NSW, Australia; Hung J., School of Medicine and Pharmacology, University of Western Australia, WA, Australia; Briffa T., School of Population Health, University of Western Australia, WA, Australia; Chew D.P., School of Medicine, Flinders University, SA, Australia; Anderson P., Australian Institute of Health and Welfare, ACT, Australia; Moon L., Australian Institute of Health and Welfare, ACT, Australia; McEvoy M., School of Medicine and Public Health, University of Newcastle, NSW, Australia; Hansbro P., School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia; Newby D., School of Medicine and Public Health, University of Newcastle, NSW, Australia; Attia J., School of Medicine and Public Health, University of Newcastle, NSW, Australia",,"Acute Coronary Syndrome; Antibodies, Bacterial; Atherosclerosis; Australia; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cross Reactions; Double-Blind Method; Humans; Lipoproteins, LDL; Middle Aged; Odds Ratio; Pneumococcal Vaccines; Pulse Wave Analysis; Stroke; Pneumococcus vaccine; bacterium antibody; low density lipoprotein; oxidized low density lipoprotein; Pneumococcus vaccine; acute coronary syndrome; adult; arterial wall thickness; Article; brain ischemia; cardiovascular disease; controlled study; double blind procedure; follow up; human; multicenter study; priority journal; pulse wave; randomized controlled trial; vaccination; acute coronary syndrome; atherosclerosis; Australia; Cardiovascular Diseases; Carotid Artery Diseases; clinical trial; cross reaction; diagnostic imaging; immunology; middle aged; odds ratio; Stroke",Article,Final,,Scopus,2-s2.0-84966393498
Hansbro P.M.; Starkey M.R.; Kim R.Y.; Stevens R.L.; Foster P.S.; Horvat J.C.,"Hansbro, P.M. (6603119390); Starkey, M.R. (35811293400); Kim, R.Y. (35810406900); Stevens, R.L. (7403202252); Foster, P.S. (7201517569); Horvat, J.C. (9942405300)",6603119390; 35811293400; 35810406900; 7403202252; 7201517569; 9942405300,Programming of the lung by early-life infection,2012,Journal of Developmental Origins of Health and Disease,3,3,,153,158,5,12,10.1017/S2040174412000050,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864765678&doi=10.1017%2fS2040174412000050&partnerID=40&md5=af1ee801c3ff4180fbe346c97e26d9b1,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United States","Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Starkey M.R., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kim R.Y., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Stevens R.L., Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United States; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia",developmental origins of disease; immunity; infection; lung structure; respiratory,,Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84864765678
Keely S.; Campbell E.L.; Baird A.W.; Hansbro P.M.; Shalwitz R.A.; Kotsakis A.; McNamee E.N.; Eltzschig H.K.; Kominsky D.J.; Colgan S.P.,"Keely, S. (9739611200); Campbell, E.L. (36109938100); Baird, A.W. (7201433015); Hansbro, P.M. (6603119390); Shalwitz, R.A. (6602152268); Kotsakis, A. (6602395421); McNamee, E.N. (35741298400); Eltzschig, H.K. (7004171285); Kominsky, D.J. (6602253295); Colgan, S.P. (7103148070)",9739611200; 36109938100; 7201433015; 6603119390; 6602152268; 6602395421; 35741298400; 7004171285; 6602253295; 7103148070,Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis,2014,Mucosal Immunology,7,1,,114,123,9,100,10.1038/mi.2013.29,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886073769&doi=10.1038%2fmi.2013.29&partnerID=40&md5=a59045c805153de94384f4dce319b8b9,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, John Hunter Hospital, NSW, Australia; Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, United States; School of Veterinary Medicine, University College Dublin, Dublin, Ireland; Aerpio Therapeutics, Cincinnati, OH, United States","Keely S., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, John Hunter Hospital, NSW, Australia; Campbell E.L., Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, United States; Baird A.W., School of Veterinary Medicine, University College Dublin, Dublin, Ireland; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, John Hunter Hospital, NSW, Australia; Shalwitz R.A., Aerpio Therapeutics, Cincinnati, OH, United States; Kotsakis A., Aerpio Therapeutics, Cincinnati, OH, United States; McNamee E.N., Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, United States; Eltzschig H.K., Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, United States; Kominsky D.J., Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, United States; Colgan S.P., Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, United States",,"Animals; Colitis; Disease Models, Animal; Endotoxemia; Female; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunity, Innate; Immunity, Mucosal; Intestinal Mucosa; Mice; Permeability; Piperazines; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Pyridones; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; akb 4924; cytokine; endotoxin; hypoxia inducible factor 1alpha; interleukin 10; interleukin 1beta; interleukin 6; procollagen proline 2 oxoglutarate 4 dioxygenase; prolyl hydroxylase inhibitor; tumor necrosis factor alpha; unclassified drug; adult; animal cell; animal experiment; animal model; animal tissue; article; bacteremia; colitis; colon mucosa; controlled study; disease activity; drug response; drug targeting; enzyme inhibition; epithelium; female; fever; hypothermia; immunomodulation; innate immunity; intestine mucosa permeability; mouse; nonhuman; priority journal; protein blood level; weight reduction",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-84886073769
Beckett E.L.; Phipps S.; Starkey M.R.; Horvat J.C.; Beagley K.W.; Foster P.S.; Hansbro P.M.,"Beckett, Emma L. (36620958500); Phipps, Simon (7005395199); Starkey, Malcolm R. (35811293400); Horvat, Jay C. (9942405300); Beagley, Kenneth W. (7005403437); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",36620958500; 7005395199; 35811293400; 9942405300; 7005403437; 7201517569; 6603119390,"TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life",2012,PLoS ONE,7,6,e39460,,,,61,10.1371/journal.pone.0039460,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862561725&doi=10.1371%2fjournal.pone.0039460&partnerID=40&md5=04da2c40e48f736dbbc67411d6b8e6b5,"Centre for Asthma and Respiratory Disease, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia","Beckett E.L., Centre for Asthma and Respiratory Disease, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Phipps S., School of Biomedical Sciences and Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia; Starkey M.R., Centre for Asthma and Respiratory Disease, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Beagley K.W., Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, The University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia",,"Animals; Animals, Newborn; CD8-Positive T-Lymphocytes; Chlamydia; Chlamydia Infections; Dendritic Cells; Disease Models, Animal; Female; Gene Expression Regulation; Interferon-gamma; Interleukin-17; Killer Cells, Natural; Lung; Lymphocyte Activation; Male; Mice; Mice, Knockout; Neutrophils; Phagocytosis; Pregnancy; Respiratory Tract Infections; Toll-Like Receptor 2; Toll-Like Receptor 4; Weight Gain; CD4 antigen; CD8 antigen; gamma interferon; interleukin 17; keratinocyte derived chemokine; macrophage inflammatory protein 2; toll like receptor 2; toll like receptor 4; adaptive immunity; animal cell; animal experiment; animal model; animal tissue; article; bone marrow cell; CD4+ T lymphocyte; CD8+ T lymphocyte; Chlamydia; controlled study; cytokine production; disease duration; disease severity; female; host resistance; immune response; inflammation; innate immunity; lung parenchyma; lymph node; lymphocyte proliferation; mouse; natural killer cell; neutrophil; nonhuman; persistent infection; phagocytosis; plasmacytoid dendritic cell; protein expression; respiratory tract infection; wild type",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84862561725
Ge Q.; Chen L.; Jaffar J.; Argraves W.S.; Twal W.O.; Hansbro P.; Black J.L.; Burgess J.K.; Oliver B.,"Ge, Qi (8948394200); Chen, Ling (57192609452); Jaffar, Jade (16042610400); Argraves, William Scott (7006209539); Twal, Waleed O. (6602659798); Hansbro, Phil (6603119390); Black, Judith L. (7402767206); Burgess, Janette K. (7201650628); Oliver, Brian (15919869900)",8948394200; 57192609452; 16042610400; 7006209539; 6602659798; 6603119390; 7402767206; 7201650628; 15919869900,Fibulin 1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts,2015,Scientific Reports,5,,9496,,,,32,10.1038/srep09496,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926501006&doi=10.1038%2fsrep09496&partnerID=40&md5=916df2d95c2145012686b3d7d58a8ab1,"Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia; Discipline of Pharmacology, Sydney Medical School, University of Sydney, 2006, NSW, Australia; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; School of Medical and Molecular Biosciences, University of Technology Sydney, Sydney, 2000, NSW, Australia; School of Biomedical Science and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia","Ge Q., Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia, Discipline of Pharmacology, Sydney Medical School, University of Sydney, 2006, NSW, Australia; Chen L., Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia; Jaffar J., Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia; Argraves W.S., Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Twal W.O., Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Hansbro P., School of Biomedical Science and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Black J.L., Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia, Discipline of Pharmacology, Sydney Medical School, University of Sydney, 2006, NSW, Australia; Burgess J.K., Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia, Discipline of Pharmacology, Sydney Medical School, University of Sydney, 2006, NSW, Australia; Oliver B., Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Sydney, 2037, NSW, Australia, Discipline of Pharmacology, Sydney Medical School, University of Sydney, 2006, NSW, Australia, School of Medical and Molecular Biosciences, University of Technology Sydney, Sydney, 2000, NSW, Australia",,"Calcium-Binding Proteins; Cell Adhesion; Cell Movement; Cell Proliferation; Cell Survival; Extracellular Matrix; Extracellular Matrix Proteins; Fibroblasts; Fibronectins; Heparan Sulfate Proteoglycans; Humans; Lung; Mitochondria; Peptide Fragments; Pulmonary Disease, Chronic Obstructive; Transforming Growth Factor beta1; calcium binding protein; extra domain A fibronectin, human; fibronectin; fibulin; peptide fragment; perlecan; proteoheparan sulfate; scleroprotein; transforming growth factor beta1; biosynthesis; cell adhesion; cell motion; cell proliferation; cell survival; chemistry; chronic obstructive lung disease; cytology; drug effects; extracellular matrix; fibroblast; human; lung; metabolism; mitochondrion",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84926501006
Dhouib R.; Othman D.S.M.P.; Lin V.; Lai X.J.; Wijesinghe H.G.S.; Essilfie A.-T.; Davis A.; Nasreen M.; Bernhardt P.V.; Hansbro P.M.; McEwan A.G.; Kappler U.,"Dhouib, Rabeb (15061097600); Othman, Dk. Seti Maimonah Pg (56107298100); Lin, Victor (57192554826); Lai, Xuanjie J. (57192545750); Wijesinghe, Hewa G.S. (57192542362); Essilfie, Ama-Tawiah (22955585600); Davis, Amanda (9044953000); Nasreen, Marufa (57192541596); Bernhardt, Paul V. (16672809500); Hansbro, Philip M. (6603119390); McEwan, Alastair G. (7102063435); Kappler, Ulrike (6603150947)",15061097600; 56107298100; 57192554826; 57192545750; 57192542362; 22955585600; 9044953000; 57192541596; 16672809500; 6603119390; 7102063435; 6603150947,"A novel, molybdenum-containing methionine sulfoxide reductase supports survival of Haemophilus influenzae in an in vivo model of infection",2016,Frontiers in Microbiology,7,NOV,1743,,,,27,10.3389/fmicb.2016.01743,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006757596&doi=10.3389%2ffmicb.2016.01743&partnerID=40&md5=5c281eaa7136ff93ec2e46a821183b14,"Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, New Lambton, NSW, Australia; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, AZ, United States","Dhouib R., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Othman D.S.M.P., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Lin V., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Lai X.J., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Wijesinghe H.G.S., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Essilfie A.-T., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, New Lambton, NSW, Australia; Davis A., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia, Department of Chemistry and Biochemistry, The University of Arizona, Tucson, AZ, United States; Nasreen M., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Bernhardt P.V., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, New Lambton, NSW, Australia; McEwan A.G., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Kappler U., Centre for Metals in Biology/Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia",DMSO reductase enzyme family; Haemophilus influenzae; Host-pathogen interaction; Methionine sulfoxide reductase; Molybdenum enzymes,calmodulin; hypochlorous acid; methionine sulfoxide; methionine sulfoxide reductase; molybdenum; nitric oxide reductase; amino acid sequence; animal experiment; animal model; animal tissue; Article; bacterial survival; bacterium culture; cell adhesion; cell invasion; cell metabolism; controlled study; enzyme assay; female; gene inactivation; gene overexpression; Haemophilus influenzae; host pathogen interaction; human; human cell; immunofluorescence; mouse; nonhuman; phylogeny; reverse transcription polymerase chain reaction; stereospecificity,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85006757596
McIlroy D.J.; Jarnicki A.G.; Au G.G.; Lott N.; Smith D.W.; Hansbro P.M.; Balogh Z.J.,"McIlroy, Daniel J. (55924934900); Jarnicki, Andrew G. (6603137164); Au, Gough G. (7003748612); Lott, Natalie (55549863500); Smith, Doug W. (59099974300); Hansbro, Philip M. (6603119390); Balogh, Zsolt J. (7006637520)",55924934900; 6603137164; 7003748612; 55549863500; 59099974300; 6603119390; 7006637520,Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery,2014,Journal of Critical Care,29,6,,1133.e1,1133.e5,,145,10.1016/j.jcrc.2014.07.013,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908138724&doi=10.1016%2fj.jcrc.2014.07.013&partnerID=40&md5=d08fc6dae833f9eba93b3292813da8a3,"Department of Traumatology, University of Newcastle, 2310, NSW, Australia; Centre for Asthma and Respiratory Disease and oSchool of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; Department of Traumatology, John Hunter Hospital and University of Newcastle, Newcastle, 2310, NSW, Australia; Centre for Translational Neuroscience and Mental Health Research, School of Biomedical Sciences and Pharmacy, University of Newcastle, and Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia","McIlroy D.J., Department of Traumatology, University of Newcastle, 2310, NSW, Australia; Jarnicki A.G., Centre for Asthma and Respiratory Disease and oSchool of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; Au G.G., Centre for Asthma and Respiratory Disease and oSchool of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; Lott N., Department of Traumatology, John Hunter Hospital and University of Newcastle, Newcastle, 2310, NSW, Australia; Smith D.W., Centre for Translational Neuroscience and Mental Health Research, School of Biomedical Sciences and Pharmacy, University of Newcastle, and Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease and oSchool of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, 2305, NSW, Australia; Balogh Z.J., Department of Traumatology, John Hunter Hospital and University of Newcastle, Newcastle, 2310, NSW, Australia",Mitochondrial DNA neutrophil extracellular traps; Multiple organ failure; NETosis; Trauma,"Adult; Arthroplasty, Replacement, Hip; Bacteremia; Case-Control Studies; DNA, Mitochondrial; Extracellular Traps; Fractures, Bone; Humans; Male; Middle Aged; Neutrophils; Systemic Inflammatory Response Syndrome; Wounds and Injuries; mitochondrial DNA; mitochondrial DNA; acetabulum fracture; adult; Article; blunt trauma; cell isolation; clinical article; controlled study; elective surgery; femur shaft fracture; fibula fracture; hospitalization; human; injury; intramedullary nailing; length of stay; male; mitochondrion; neutrophil; neutrophil extracellular trap; operation duration; pelvis fracture; pelvis surgery; systemic inflammatory response syndrome; tibia fracture; total hip prosthesis; traumatology; bacteremia; case control study; extracellular trap; Fractures, Bone; genetics; hip arthroplasty; immunology; middle aged",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-84908138724
Russell K.E.; Chung K.F.; Clarke C.J.; Durham A.L.; Mallia P.; Footitt J.; Johnston S.L.; Barnes P.J.; Hall S.R.; Simpson K.D.; Starkey M.R.; Hansbro P.M.; Adcock I.M.; Wiegman C.H.,"Russell, Kirsty E. (56499960300); Chung, Kian Fan (35403525000); Clarke, Colin J. (55980091900); Durham, Andrew L. (35309953500); Mallia, Patrick (9634259100); Footitt, Joseph (24279674000); Johnston, Sebastian L. (7401781716); Barnes, Peter J. (36064679400); Hall, Simon R. (58379709200); Simpson, Karen D. (20735716200); Starkey, Malcolm R. (35811293400); Hansbro, Philip M. (6603119390); Adcock, Ian M. (7007066538); Wiegman, Coen H. (57063112500)",56499960300; 35403525000; 55980091900; 35309953500; 9634259100; 24279674000; 7401781716; 36064679400; 58379709200; 20735716200; 35811293400; 6603119390; 7007066538; 57063112500,The MIF antagonist ISO-1 attenuates corticosteroid-insensitive inflammation and airways hyperresponsiveness in an ozone-induced model of COPD,2016,PLoS ONE,11,1,e0146102,,,,49,10.1371/journal.pone.0146102,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954563025&doi=10.1371%2fjournal.pone.0146102&partnerID=40&md5=9675eb4ef3cb8dc2f01b2bbd11bc1fcf,"Airway Disease Section, National Heart and Lung Institute, NIHR Respiratory Biomedical Research Unit, Royal Brompton NHS Foundation Trust, Imperial College London, London, United Kingdom; Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; RRI DPU, GlaxoSmithKline, Stevenage, United Kingdom; Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Russell K.E., Airway Disease Section, National Heart and Lung Institute, NIHR Respiratory Biomedical Research Unit, Royal Brompton NHS Foundation Trust, Imperial College London, London, United Kingdom; Chung K.F., Airway Disease Section, National Heart and Lung Institute, NIHR Respiratory Biomedical Research Unit, Royal Brompton NHS Foundation Trust, Imperial College London, London, United Kingdom; Clarke C.J., Airway Disease Section, National Heart and Lung Institute, NIHR Respiratory Biomedical Research Unit, Royal Brompton NHS Foundation Trust, Imperial College London, London, United Kingdom; Durham A.L., Airway Disease Section, National Heart and Lung Institute, NIHR Respiratory Biomedical Research Unit, Royal Brompton NHS Foundation Trust, Imperial College London, London, United Kingdom; Mallia P., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Footitt J., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Johnston S.L., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Barnes P.J., Airway Disease Section, National Heart and Lung Institute, NIHR Respiratory Biomedical Research Unit, Royal Brompton NHS Foundation Trust, Imperial College London, London, United Kingdom; Hall S.R., RRI DPU, GlaxoSmithKline, Stevenage, United Kingdom; Simpson K.D., RRI DPU, GlaxoSmithKline, Stevenage, United Kingdom; Starkey M.R., Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Adcock I.M., Airway Disease Section, National Heart and Lung Institute, NIHR Respiratory Biomedical Research Unit, Royal Brompton NHS Foundation Trust, Imperial College London, London, United Kingdom; Wiegman C.H., Airway Disease Section, National Heart and Lung Institute, NIHR Respiratory Biomedical Research Unit, Royal Brompton NHS Foundation Trust, Imperial College London, London, United Kingdom",,"Adrenal Cortex Hormones; Adult; Aged; Animals; Bronchoalveolar Lavage Fluid; Cell Count; Cytokines; Dexamethasone; Disease Models, Animal; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoxazoles; Lung; Macrophage Migration-Inhibitory Factors; Macrophages; Male; Middle Aged; Ozone; Pneumonia; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Respiratory Hypersensitivity; RNA, Messenger; Smoking; Sputum; 3 (4 hydroxyphenyl) 4,5 dihydro 5 isoxazole acetic acid methyl ester; cigarette smoke; corticosteroid; cytokine receptor antagonist; dexamethasone; hypoxia inducible factor 1alpha; macrophage migration inhibition factor; messenger RNA; ozone; unclassified drug; 3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazoleacetic acid methyl ester; corticosteroid; cytokine; dexamethasone; HIF1A protein, human; hypoxia inducible factor 1alpha; isoxazole derivative; macrophage migration inhibition factor; messenger RNA; adult; aged; animal cell; animal experiment; animal model; animal tissue; Article; blood sampling; body plethysmography; bronchoalveolar lavage fluid; chromatin immunoprecipitation; chronic obstructive lung disease; clinical article; controlled study; cytokine gene; cytokine release; drug mechanism; female; forced expiratory volume; forced vital capacity; gene expression; human; human cell; inflammation; lung alveolus macrophage; lung emphysema; lung parenchyma; male; Mif gene; mouse; nonhuman; oxidative stress; promoter region; protein expression; respiratory tract allergy; sensitivity analysis; sputum; adverse effects; animal; antagonists and inhibitors; cell count; complication; disease model; drug effects; genetics; lung; lung function test; macrophage; metabolism; middle aged; pathology; pathophysiology; pneumonia; Pulmonary Disease, Chronic Obstructive; Respiratory Hypersensitivity; smoking",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84954563025
Thorburn A.N.; Tseng H.-Y.; Donovan C.; Hansbro N.G.; Jarnicki A.G.; Foster P.S.; Gibson P.G.; Hansbro P.M.,"Thorburn, Alison N. (35485821500); Tseng, Hsin-Yi (35303758900); Donovan, Chantal (55357105200); Hansbro, Nicole G. (15055862300); Jarnicki, Andrew G. (6603137164); Foster, Paul S. (7201517569); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390)",35485821500; 35303758900; 55357105200; 15055862300; 6603137164; 7201517569; 7202414199; 6603119390,"TLR2, TLR4 AND MyD88 Mediate Allergic Airway Disease (AAD) and Streptococcus pneumoniae-Induced Suppression of AAD",2016,PLoS ONE,11,6,e0156402,,,,29,10.1371/journal.pone.0156402,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976253634&doi=10.1371%2fjournal.pone.0156402&partnerID=40&md5=6539ba9809b233e3f0e89e3cc47fc35e,"Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Thorburn A.N., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Tseng H.-Y., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Donovan C., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro N.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Jarnicki A.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Gibson P.G., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",,"Animals; Bronchoalveolar Lavage Fluid; Eosinophils; Female; Gene Expression Regulation; Hot Temperature; Immunotherapy; Lymph Nodes; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; Ovalbumin; Protective Factors; Respiratory Hypersensitivity; Signal Transduction; Spleen; Streptococcus pneumoniae; Th2 Cells; Toll-Like Receptor 2; Toll-Like Receptor 4; myeloid differentiation factor 88; ovalbumin; toll like receptor 2; toll like receptor 4; Myd88 protein, mouse; myeloid differentiation factor 88; Tlr2 protein, mouse; Tlr4 protein, mouse; toll like receptor 2; toll like receptor 4; allergic airway disease; animal cell; animal experiment; animal model; Article; blood; bronchoalveolar lavage fluid; controlled study; cytokine release; eosinophil; female; immunoregulation; mediastinum lymph node; mouse; nonhuman; respiratory tract allergy; spleen cell; Streptococcus pneumoniae; T lymphocyte; Th2 cell; animal; Bagg albino mouse; chemically induced; chemistry; gene expression regulation; genetics; heat; immunology; immunotherapy; lymph node; microbiology; pathology; procedures; protection; Respiratory Hypersensitivity; signal transduction; spleen; Streptococcus pneumoniae",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84976253634
Hansbro P.M.; Hamilton M.J.; Fricker M.; Gellatly S.L.; Jarnicki A.G.; Zheng D.; Frei S.M.; Wong G.W.; Hamadi S.; Zhou S.; Foster P.S.; Krilis S.A.; Stevens R.L.,"Hansbro, Philip M. (6603119390); Hamilton, Matthew J. (57202896754); Fricker, Michael (26638839800); Gellatly, Shaan L. (26430804400); Jarnicki, Andrew G. (6603137164); Zheng, Dominick (55075073500); Frei, Sandra M. (54916175300); Wong, G. William (7402527670); Hamadi, Sahar (55573697900); Zhou, Saijun (55631156500); Foster, Paul S. (7201517569); Krilis, Steven A. (7005510030); Stevens, Richard L. (7403202252)",6603119390; 57202896754; 26638839800; 26430804400; 6603137164; 55075073500; 54916175300; 7402527670; 55573697900; 55631156500; 7201517569; 7005510030; 7403202252,Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitis,2014,Journal of Biological Chemistry,289,26,,18214,18227,13,79,10.1074/jbc.M114.548594,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903516573&doi=10.1074%2fjbc.M114.548594&partnerID=40&md5=a26c19a0dd743f4f09c73dcb6fba11a6,"Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; Brigham and Women's Hospital, Dept. of Medicine, Division of Rheumatology, Immunology, and Allergy, Boston, MA 02115, 1 Jimmy Fund Way, United States; Department of Physiology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, United States; Department of Infectious Disease, Immunology, and Sexual Health, St. George Hospital, University of New South Wales, Kogarah, NSW 2217, Australia","Hansbro P.M., Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; Hamilton M.J., Brigham and Women's Hospital, Dept. of Medicine, Division of Rheumatology, Immunology, and Allergy, Boston, MA 02115, 1 Jimmy Fund Way, United States; Fricker M., Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; Gellatly S.L., Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; Jarnicki A.G., Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; Zheng D., Brigham and Women's Hospital, Dept. of Medicine, Division of Rheumatology, Immunology, and Allergy, Boston, MA 02115, 1 Jimmy Fund Way, United States; Frei S.M., Brigham and Women's Hospital, Dept. of Medicine, Division of Rheumatology, Immunology, and Allergy, Boston, MA 02115, 1 Jimmy Fund Way, United States; Wong G.W., Department of Physiology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, United States; Hamadi S., Brigham and Women's Hospital, Dept. of Medicine, Division of Rheumatology, Immunology, and Allergy, Boston, MA 02115, 1 Jimmy Fund Way, United States; Zhou S., Department of Infectious Disease, Immunology, and Sexual Health, St. George Hospital, University of New South Wales, Kogarah, NSW 2217, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; Krilis S.A., Department of Infectious Disease, Immunology, and Sexual Health, St. George Hospital, University of New South Wales, Kogarah, NSW 2217, Australia; Stevens R.L., Brigham and Women's Hospital, Dept. of Medicine, Division of Rheumatology, Immunology, and Allergy, Boston, MA 02115, 1 Jimmy Fund Way, United States",,"Animals; Colitis; Disease Models, Animal; Humans; Lung; Male; Mast Cells; Membrane Proteins; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Pulmonary Disease, Chronic Obstructive; Tryptases; Amino acids; Cell membranes; Mammals; Number theory; Smoke; Sodium sulfate; Sulfur compounds; Chronic Obstructive Pulmonary Disease (COPD); Inflammation; Inflammatory Bowel Disease (IBD); Mast Cell; Protease; calcium ionophore; cigarette smoke; CXCL2 chemokine; dextran sulfate; immunoglobulin E receptor; interleukin 6; messenger RNA; methacholine; protease serine member S31; proteinase; transmembrane tryptase; tryptase gamma; unclassified drug; Calcium ionophore; Chronic obstructive pulmonary disease; High-affinity IgE receptors; Homologous recombination; Inflammatory disease; Normal numbers; Nucleotide sequences; Therapeutic benefits; animal cell; animal experiment; animal model; animal tissue; article; cell activation; chronic obstructive lung disease; colitis; controlled study; cytochemistry; gene; histochemistry; histopathology; homologous recombination; LoxP site; lung alveolus macrophage; lung fibrosis; lung function; male; mast cell; mouse; mouse strain; nonhuman; nucleotide sequence; priority journal; Prss31 gene; sequence analysis; weight reduction; wild type; Pulmonary diseases",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84903516573
Haw T.J.; Starkey M.R.; Nair P.M.; Pavlidis S.; Liu G.; Nguyen D.H.; Hsu A.C.; Hanish I.; Kim R.Y.; Collison A.M.; Inman M.D.; Wark P.A.; Foster P.S.; Knight D.A.; Mattes J.; Yagita H.; Adcock I.M.; Horvat J.C.; Hansbro P.M.,"Haw, T.J. (56625918900); Starkey, M.R. (35811293400); Nair, P.M. (55749131000); Pavlidis, S. (56642790400); Liu, G. (57189061134); Nguyen, D.H. (54886138200); Hsu, A.C. (49861516600); Hanish, I. (55572056100); Kim, R.Y. (35810406900); Collison, A.M. (23995251200); Inman, M.D. (35453207500); Wark, P.A. (7003559516); Foster, P.S. (7201517569); Knight, D.A. (7402350036); Mattes, J. (7005999915); Yagita, H. (55192275000); Adcock, I.M. (7007066538); Horvat, J.C. (9942405300); Hansbro, P.M. (6603119390)",56625918900; 35811293400; 55749131000; 56642790400; 57189061134; 54886138200; 49861516600; 55572056100; 35810406900; 23995251200; 35453207500; 7003559516; 7201517569; 7402350036; 7005999915; 55192275000; 7007066538; 9942405300; 6603119390,A pathogenic role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive pulmonary disease,2016,Mucosal Immunology,9,4,,859,872,13,60,10.1038/mi.2015.111,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975828227&doi=10.1038%2fmi.2015.111&partnerID=40&md5=e2957f10b49772a2951eb3be93e2daca,"Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia; Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada; Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, 113-8421, Japan","Haw T.J., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Starkey M.R., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Nair P.M., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Pavlidis S., Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Liu G., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Nguyen D.H., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Hsu A.C., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Hanish I., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia, Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia; Kim R.Y., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Collison A.M., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Inman M.D., Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada; Wark P.A., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Foster P.S., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Knight D.A., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Mattes J., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Yagita H., Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, 113-8421, Japan; Adcock I.M., Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Horvat J.C., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia",,"Animals; Apoptosis; Disease Models, Animal; Female; Humans; Inflammation; Inflammation Mediators; Lung; Mice; Mice, Inbred BALB C; Mice, Knockout; Monocytes; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; RNA, Messenger; Smoking; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation; CD11b antigen; messenger RNA; tumor necrosis factor related apoptosis inducing ligand; autacoid; messenger RNA; Tnfsf10 protein, mouse; tumor necrosis factor related apoptosis inducing ligand; animal experiment; animal model; animal tissue; Article; chronic obstructive lung disease; collagen deposition; collagen synthesis; controlled study; cytokine production; emphysema; epithelium cell; female; lung function; monocyte; mouse; nonhuman; pathogenesis; priority journal; protein expression; protein function; animal; apoptosis; Bagg albino mouse; chronic obstructive lung disease; disease model; genetics; human; immunology; inflammation; knockout mouse; lung; metabolism; physiology; respiratory mucosa; smoking; upregulation",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-84975828227
Prieto-García A.; Zheng D.; Adachi R.; Xing W.; Lane W.S.; Chung K.; Anderson P.; Hansbro P.M.; Castells M.; Stevens R.L.,"Prieto-García, Alicia (6505837247); Zheng, Dominick (55075073500); Adachi, Roberto (16303328000); Xing, Wei (57197242271); Lane, William S. (7102391928); Chung, Kyungmee (55079298100); Anderson, Paul (7404424441); Hansbro, Philip M. (6603119390); Castells, Mariana (7005236795); Stevens, Richard L. (7403202252)",6505837247; 55075073500; 16303328000; 57197242271; 7102391928; 55079298100; 7404424441; 6603119390; 7005236795; 7403202252,Mast cell restricted mouse and human tryptase·heparin complexes hinder thrombin-induced coagulation of plasma and the generation of fibrin by proteolytically destroying fibrinogen,2012,Journal of Biological Chemistry,287,11,,7834,7844,10,48,10.1074/jbc.M111.325712,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858049301&doi=10.1074%2fjbc.M111.325712&partnerID=40&md5=4c4f92f3a350ce4647c4a8359cafb1f4,"Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, 1 Jimmy Fund Way, United States; Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States; Harvard Mass Spectrometry and Proteomics Resource Laboratory, FAS Center for Systems Biology, Harvard University, Cambridge, MA 02138, United States; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2300, Australia; Allergy Unit, Gregorio Marañón University Hospital, Madrid, Spain","Prieto-García A., Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, 1 Jimmy Fund Way, United States, Allergy Unit, Gregorio Marañón University Hospital, Madrid, Spain; Zheng D., Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, 1 Jimmy Fund Way, United States; Adachi R., Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States; Xing W., Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, 1 Jimmy Fund Way, United States; Lane W.S., Harvard Mass Spectrometry and Proteomics Resource Laboratory, FAS Center for Systems Biology, Harvard University, Cambridge, MA 02138, United States; Chung K., Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, 1 Jimmy Fund Way, United States; Anderson P., Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, 1 Jimmy Fund Way, United States; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2300, Australia; Castells M., Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, 1 Jimmy Fund Way, United States; Stevens R.L., Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA 02115, 1 Jimmy Fund Way, United States",,Animalia; Mammalia; Mus; Amino acids; Coagulation; Deposits; Encoding (symbols); Genes; Granulation; Histology; Mammals; Oligomers; Proteins; Tissue; fibrin; fibrinogen; heparin; immunoglobulin E; lysine; mast cell protease 6; mast cell protease 7; plasma protein; proteinase inhibitor; proteoglycan; serine proteinase; thrombin; tryptase; unclassified drug; Blood coagulation; Cleavage sites; Fibrin deposition; Plasma protein; Protease inhibitor; Proteoglycans; Secretory granules; Serine protease; alpha chain; animal cell; article; blood clotting; controlled study; edema; enzyme degradation; enzyme inactivation; fibrin deposition; gene; human; human cell; in vitro study; mast cell; mast cell degranulation; mouse; nonhuman; priority journal; protein degradation; protein expression; secretory granule; skin anaphylaxis; TPSAB1 gene; TPSB2 gene; Polysaccharides,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84858049301
Preston J.A.; Thorburn A.N.; Starkey M.R.; Beckett E.L.; Horvat J.C.; Wade M.A.; O'Sullivan B.J.; Thomas R.; Beagley K.W.; Gibson P.G.; Foster P.S.; Hansbro P.M.,"Preston, J.A. (59281082600); Thorburn, A.N. (35485821500); Starkey, M.R. (35811293400); Beckett, E.L. (36620958500); Horvat, J.C. (9942405300); Wade, M.A. (57196992336); O'Sullivan, B.J. (35791435100); Thomas, R. (35430984400); Beagley, K.W. (7005403437); Gibson, P.G. (7202414199); Foster, P.S. (7201517569); Hansbro, P.M. (6603119390)",59281082600; 35485821500; 35811293400; 36620958500; 9942405300; 57196992336; 35791435100; 35430984400; 7005403437; 7202414199; 7201517569; 6603119390,Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells,2011,European Respiratory Journal,37,1,,53,64,11,78,10.1183/09031936.00049510,https://www.scopus.com/inward/record.uri?eid=2-s2.0-79251540548&doi=10.1183%2f09031936.00049510&partnerID=40&md5=b37803d3efc280ce45c833fb327c3b68,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Immunology and Metabolic Medicine, Diamantina Institute for Cancer, University of Queensland, Brisbane, QLD, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia","Preston J.A., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Thorburn A.N., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Starkey M.R., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Beckett E.L., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Wade M.A., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; O'Sullivan B.J., Immunology and Metabolic Medicine, Diamantina Institute for Cancer, University of Queensland, Brisbane, QLD, Australia; Thomas R., Immunology and Metabolic Medicine, Diamantina Institute for Cancer, University of Queensland, Brisbane, QLD, Australia; Beagley K.W., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Gibson P.G., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",Allergic airways disease; Asthma; Immune modulation; Regulatory T-cell; Streptococcus pneumoniae; Suppression,"Animals; Asthma; Bronchial Hyperreactivity; Humans; Hypersensitivity; Immune System; Inflammation; Interleukin-2 Receptor alpha Subunit; Lung; Mice; Mice, Inbred BALB C; Respiratory Hypersensitivity; Streptococcal Infections; Streptococcus pneumoniae; T-Lymphocytes; T-Lymphocytes, Regulatory; airway; allergic disease; allergic reaction; allergy; animal experiment; animal model; animal tissue; antibody response; article; asthma; bacterial infection; cell count; cell hyperplasia; cell proliferation; cytokine release; eosinophil; goblet cell; helper cell; immune response; lymph node; lymphocyte proliferation; mouse; nonhuman; oocyte; pneumococcal infection; priority journal; regulatory T lymphocyte; respiratory tract disease; respiratory tract infection; sensitization; Streptococcus infection; Streptococcus pneumoniae; Th2 cell",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-79251540548
Rahman M.M.; Rumzhum N.N.; Hansbro P.M.; Morris J.C.; Clark A.R.; Verrills N.M.; Ammit A.J.,"Rahman, Md. Mostafizur (57193353117); Rumzhum, Nowshin N. (55151455300); Hansbro, Philip M. (6603119390); Morris, Jonathan C. (35354969700); Clark, Andrew R. (7404479336); Verrills, Nicole M. (6602391112); Ammit, Alaina J. (7003377421)",57193353117; 55151455300; 6603119390; 35354969700; 7404479336; 6602391112; 7003377421,Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells,2016,Cellular Signalling,28,4,,325,334,9,41,10.1016/j.cellsig.2016.01.009,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956699208&doi=10.1016%2fj.cellsig.2016.01.009&partnerID=40&md5=4120796bb55ef6596be43a2be0c3c9c5,"Faculty of Pharmacy, University of Sydney, 2006, NSW, Australia; Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, 2308, NSW, Australia; School of Chemistry, University of NSW, 2052, NSW, Australia; Centre for Translational Inflammation Research, School of Immunity and Infection, University of Birmingham, Edgbaston, B15 2TT, United Kingdom; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, 2308, NSW, Australia","Rahman M.M., Faculty of Pharmacy, University of Sydney, 2006, NSW, Australia; Rumzhum N.N., Faculty of Pharmacy, University of Sydney, 2006, NSW, Australia; Hansbro P.M., Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, 2308, NSW, Australia; Morris J.C., School of Chemistry, University of NSW, 2052, NSW, Australia; Clark A.R., Centre for Translational Inflammation Research, School of Immunity and Infection, University of Birmingham, Edgbaston, B15 2TT, United Kingdom; Verrills N.M., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, 2308, NSW, Australia; Ammit A.J., Faculty of Pharmacy, University of Sydney, 2006, NSW, Australia",Asthma; Inflammation; Protein phosphatase 2A; TNFα; Tristetraprolin,"Cell Line; Enzyme Activation; Epithelial Cells; Fingolimod Hydrochloride; Humans; Lung; Protein Phosphatase 2; Respiratory Mucosa; Tristetraprolin; 2 amino 4 (4 heptyloxyphenyl) 2 methylbutanol; antiinflammatory agent; fingolimod; interleukin 6; interleukin 8; messenger RNA; phosphoprotein phosphatase 2A; small interfering RNA; tristetraprolin; tumor necrosis factor alpha; unclassified drug; fingolimod; phosphoprotein phosphatase 2; tristetraprolin; ZFP36 protein, human; A549 cell line; antiinflammatory activity; Article; controlled study; cytokine production; cytokine release; enzyme activation; enzyme activity; gene expression; gene silencing; human; human cell; in vitro study; priority journal; respiratory tract inflammation; cell line; drug effects; enzyme activation; epithelium cell; genetics; lung; metabolism; respiratory mucosa",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84956699208
Hsu A.C.-Y.; Starkey M.R.; Hanish I.; Parsons K.; Haw T.J.; Howland L.J.; Barr I.; Mahony J.B.; Foster P.S.; Knight D.A.; Wark P.A.; Hansbro P.M.,"Hsu, Alan Chen-Yu (49861516600); Starkey, Malcolm R. (35811293400); Hanish, Irwan (55572056100); Parsons, Kristy (55047641400); Haw, Tatt Jhong (56625918900); Howland, Linda J. (36637506000); Barr, Ian (7004651416); Mahony, James B. (7102654582); Foster, Paul S. (7201517569); Knight, Darryl A. (7402350036); Wark, Peter A. (7003559516); Hansbro, Philip M. (6603119390)",49861516600; 35811293400; 55572056100; 55047641400; 56625918900; 36637506000; 7004651416; 7102654582; 7201517569; 7402350036; 7003559516; 6603119390,Targeting PI3K-p110α suppresses influenza virus infection in chronic obstructive pulmonary disease,2015,American Journal of Respiratory and Critical Care Medicine,191,9,,1012,1023,11,120,10.1164/rccm.201501-0188OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928983152&doi=10.1164%2frccm.201501-0188OC&partnerID=40&md5=99bb7852f6f1fd5c745d2ff6cdd115c0,"Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia; World Health Organization Collaborating Centre for Reference, Research on Influenza, Melbourne, VIC, Australia; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia","Hsu A.C.-Y., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Starkey M.R., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hanish I., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia; Parsons K., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Haw T.J., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Howland L.J., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Barr I., World Health Organization Collaborating Centre for Reference, Research on Influenza, Melbourne, VIC, Australia; Mahony J.B., Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada; Foster P.S., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Knight D.A., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Wark P.A., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Hansbro P.M., Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",Chronic obstructive pulmonary disease; Influenza; Innate immunity; PI3K,"Adult; Aged; Animals; Antiviral Agents; Bronchi; Cells, Cultured; Enzyme Inhibitors; Epithelial Cells; Female; Humans; Influenza, Human; Male; Mice; Middle Aged; Orthomyxoviridae Infections; Phosphatidylinositol 3-Kinases; Pulmonary Disease, Chronic Obstructive; antivirus agent; beta interferon; gamma interferon; gamma interferon inducible protein 10; interleukin 10; interleukin 6; interleukin 8; macrophage inflammatory protein 1alpha; phosphatidylinositol 3 kinase; protein p110; protein p110 alpha; retinoic acid inducible protein I; tumor necrosis factor alpha; unclassified drug; antivirus agent; enzyme inhibitor; phosphatidylinositol 3 kinase; adult; aged; animal experiment; animal model; Article; bronchus mucosa; chronic obstructive lung disease; clinical article; controlled study; cytokine release; enzyme inhibition; female; human; human cell; immune response; in vitro study; in vivo study; infection risk; infection sensitivity; influenza; innate immunity; lung function; lung lavage; male; middle aged; mouse; nonhuman; pneumonia; priority journal; protein targeting; virus entry; virus inactivation; virus load; virus replication; animal; bronchus; cell culture; comparative study; drug effects; epithelium cell; Influenza, Human; Orthomyxoviridae Infections; Pulmonary Disease, Chronic Obstructive; virology",Article,Final,,Scopus,2-s2.0-84928983152
Sokulsky L.A.; Collison A.M.; Nightingale S.; Le Fevre A.; Percival E.; Starkey M.R.; Hansbro P.M.; Foster P.S.; Mattes J.,"Sokulsky, Leon A. (56638608200); Collison, Adam M. (23995251200); Nightingale, Scott (31367591800); Le Fevre, Anna (58332306000); Percival, Elizabeth (57190741148); Starkey, Malcolm R. (35811293400); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569); Mattes, Joerg (7005999915)",56638608200; 23995251200; 31367591800; 58332306000; 57190741148; 35811293400; 6603119390; 7201517569; 7005999915,TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis,2016,American Journal of Physiology - Gastrointestinal and Liver Physiology,311,6,,G998,G1008,10,11,10.1152/ajpgi.00151.2016,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85005989496&doi=10.1152%2fajpgi.00151.2016&partnerID=40&md5=54cef08cba2196021eb856deab5aecba,"The Priority Research Centre GrowUpWell, Newcastle, Australia; Priority Research Centre for Lung Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Department of Gastroenterology and the Department of Respiratory and Sleep Medicine, John Hunter Children’s Hospital, Newcastle, Newcastle, Australia","Sokulsky L.A., The Priority Research Centre GrowUpWell, Newcastle, Australia; Collison A.M., The Priority Research Centre GrowUpWell, Newcastle, Australia; Nightingale S., The Priority Research Centre GrowUpWell, Newcastle, Australia; Le Fevre A., The Priority Research Centre GrowUpWell, Newcastle, Australia; Percival E., The Priority Research Centre GrowUpWell, Newcastle, Australia, Department of Gastroenterology and the Department of Respiratory and Sleep Medicine, John Hunter Children’s Hospital, Newcastle, Newcastle, Australia; Starkey M.R., The Priority Research Centre GrowUpWell, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Lung Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Foster P.S., Priority Research Centre for Lung Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Mattes J., The Priority Research Centre GrowUpWell, Newcastle, Australia, Department of Gastroenterology and the Department of Respiratory and Sleep Medicine, John Hunter Children’s Hospital, Newcastle, Newcastle, Australia",Eosinophilic esophagitis; MID 1; PP2A; Salmeterol; TRAIL,"Animals; Anti-Inflammatory Agents; Bronchodilator Agents; Case-Control Studies; Chemokine CCL11; Child; Cytokines; Dexamethasone; Egg Hypersensitivity; Eosinophilic Esophagitis; Female; Fibrosis; Humans; Interleukin-3; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Microtubule Proteins; Nuclear Proteins; Ovalbumin; Protein Phosphatase 2; Salmeterol Xinafoate; TNF-Related Apoptosis-Inducing Ligand; Transcription Factors; allergen; dexamethasone; eotaxin; interleukin 13; interleukin 5; messenger RNA; MID 1 protein; ovalbumin; phosphoprotein phosphatase 2A; protein; salmeterol xinafoate; thymic stromal lymphopoietin; tumor necrosis factor related apoptosis inducing ligand; unclassified drug; antiinflammatory agent; bronchodilating agent; Ccl11 protein, mouse; cytokine; dexamethasone; eotaxin; interleukin 3; interleukin 5; microtubule protein; Mid1 protein, human; nuclear protein; ovalbumin; phosphoprotein phosphatase 2; salmeterol xinafoate; thymic stromal lymphopoietin; TNFSF10 protein, human; transcription factor; tumor necrosis factor related apoptosis inducing ligand; adolescent; animal experiment; animal model; animal tissue; Article; child; clinical article; controlled study; down regulation; egg allergy; enzyme activation; eosinophilic esophagitis; esophagus biopsy; esophagus mucosa; female; human; human tissue; male; mouse; nonhuman; priority journal; protein blood level; protein expression; therapy effect; upregulation; animal; Bagg albino mouse; case control study; complication; deficiency; egg allergy; eosinophilic esophagitis; fibrosis; genetics; metabolism; pathology",Article,Final,,Scopus,2-s2.0-85005989496
Starkey M.R.; Kim R.Y.; Beckett E.L.; Schilter H.C.; Shim D.; Essilfie A.-T.; Nguyen D.H.; Beagley K.W.; Mattes J.; Mackay C.R.; Horvat J.C.; Hansbro P.M.,"Starkey, Malcolm R. (35811293400); Kim, Richard Y. (35810406900); Beckett, Emma L. (36620958500); Schilter, Heidi C. (23480284500); Shim, Doris (36194244400); Essilfie, Ama-Tawiah (22955585600); Nguyen, Duc H. (54886138200); Beagley, Kenneth W. (7005403437); Mattes, Joerg (7005999915); Mackay, Charles R. (25944725400); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",35811293400; 35810406900; 36620958500; 23480284500; 36194244400; 22955585600; 54886138200; 7005403437; 7005999915; 25944725400; 9942405300; 6603119390,Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice,2012,PLoS ONE,7,8,e42588,,,,24,10.1371/journal.pone.0042588,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864764856&doi=10.1371%2fjournal.pone.0042588&partnerID=40&md5=8aa67da1a56b30e44582e7606d38fb4e,"Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Immunology Program, Garvan Institute of Medical Research, Sydney, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Australia; Experimental and Translational Respiratory Group, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Hunter Medical Research Institute, Callaghan, Australia; Faculty of Medicine, Nursing and Health Services, Monash University, Clayton, Australia","Starkey M.R., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Kim R.Y., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Beckett E.L., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Schilter H.C., Immunology Program, Garvan Institute of Medical Research, Sydney, Australia; Shim D., Immunology Program, Garvan Institute of Medical Research, Sydney, Australia; Essilfie A.-T., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Nguyen D.H., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Beagley K.W., Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Australia; Mattes J., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia, Experimental and Translational Respiratory Group, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Hunter Medical Research Institute, Callaghan, Australia; Mackay C.R., Faculty of Medicine, Nursing and Health Services, Monash University, Clayton, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia",,"Animals; Animals, Newborn; Asthma; Bone Marrow Transplantation; Chlamydia Infections; Chlamydia muridarum; Female; Hematopoietic Stem Cells; Interleukin-13; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Pulmonary Alveoli; Transplantation Chimera; Transplantation, Homologous; Bacteria (microorganisms); Chlamydia muridarum; Mus; interleukin 13; interleukin 15; allergic airway inflammation; animal experiment; animal model; article; cell count; cell function; Chlamydia; chlamydiasis; controlled study; cytokine production; cytokine release; disease predisposition; disease severity; helper cell; hematopoietic cell; lung infection; mediastinum lymph node; mouse; newborn; nonhuman; protein function; Th2 cell",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84864764856
Wang W.; Hansbro P.M.; Foster P.S.; Yang M.,"Wang, Wan (36496115200); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569); Yang, Ming (56857729900)",36496115200; 6603119390; 7201517569; 56857729900,An alternate STAT6-independent pathway promotes eosinophil influx into blood during allergic airway inflammation,2011,PLoS ONE,6,3,e17766,,,,9,10.1371/journal.pone.0017766,https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952671198&doi=10.1371%2fjournal.pone.0017766&partnerID=40&md5=2f463a932c4a052997139b5232554d51,"Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW, Australia","Wang W., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW, Australia; Yang M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW, Australia",,"Animals; Bone Marrow; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Movement; Eosinophils; Female; Interleukin-5; Killer Cells, Natural; Lung; Lymphocyte Depletion; Male; Mice; Mice, Inbred BALB C; Neutralization Tests; Pneumonia; Respiratory Hypersensitivity; Signal Transduction; STAT6 Transcription Factor; Mus; eotaxin; eotaxin 2; interleukin 5; STAT6 protein; interleukin 5; STAT6 protein; Stat6 protein, mouse; allergic airway disease; allergic disease; animal cell; animal experiment; animal model; article; blood; bone marrow; CD4+ T lymphocyte; CD8+ T lymphocyte; cell transport; controlled study; cytokine production; enzyme linked immunosorbent assay; eosinophil; eosinophilic inflammation; female; immunopathogenesis; inflammation; lung disease; male; mouse; natural killer cell; nonhuman; polymerase chain reaction; protein blood level; protein expression; protein function; animal; Bagg albino mouse; biosynthesis; cell motion; eosinophil; immunology; lung; lymphocyte depletion; metabolism; pathology; pneumonia; respiratory tract allergy; serodiagnosis; signal transduction",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-79952671198
Simpson J.L.; McDonald V.M.; Baines K.J.; Oreo K.M.; Wang F.; Hansbro P.M.; Gibson P.G.,"Simpson, Jodie L. (7404326026); McDonald, Vanessa M. (12242373300); Baines, Katherine J. (35078051200); Oreo, Kevin M. (35277524200); Wang, Fang (57199195764); Hansbro, Philip M. (6603119390); Gibson, Peter G. (7202414199)",7404326026; 12242373300; 35078051200; 35277524200; 57199195764; 6603119390; 7202414199,"Influence of age, past smoking, and disease severity on tlr2, neutrophilic inflammation, and MMP-9 Levels in COPD",2013,Mediators of Inflammation,2013,,462934,,,,50,10.1155/2013/462934,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877305183&doi=10.1155%2f2013%2f462934&partnerID=40&md5=f224bc9c8b8804e84fd63f26a7962f54,"NHMRC Centre for Respiratory and Sleep Medicine, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia; Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia; Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia; School of Nursing and Midwifery, University of Newcastle, Callaghan, NSW 2308, Australia; Norman Bethune Medical College, Ji Lin University, Changchun 130021, China","Simpson J.L., NHMRC Centre for Respiratory and Sleep Medicine, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia, Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia; McDonald V.M., NHMRC Centre for Respiratory and Sleep Medicine, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia, Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia, School of Nursing and Midwifery, University of Newcastle, Callaghan, NSW 2308, Australia; Baines K.J., NHMRC Centre for Respiratory and Sleep Medicine, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia, Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia; Oreo K.M., NHMRC Centre for Respiratory and Sleep Medicine, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia, Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia; Wang F., Norman Bethune Medical College, Ji Lin University, Changchun 130021, China; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia; Gibson P.G., NHMRC Centre for Respiratory and Sleep Medicine, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, NSW 2305, Australia, Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia",,"Age Factors; Aged; Female; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Middle Aged; Neutrophils; Pulmonary Disease, Chronic Obstructive; Smoking; Toll-Like Receptor 2; beta adrenergic receptor stimulating agent; corticosteroid; gelatinase B; interleukin 1beta; interleukin 6; interleukin 8; leukocyte elastase; messenger RNA; tiotropium bromide; toll like receptor 2; gelatinase B; TLR2 protein, human; toll like receptor 2; gelatinase B; toll like receptor 2; adult; age; aging; article; bronchitis; cell assay; cell viability; chronic obstructive lung disease; controlled study; corticosteroid therapy; cytokine release; disease severity; eosinophil; forced expiratory volume; forced vital capacity; gene expression; granulocyte; human; human cell; inflammation; innate immunity; major clinical study; neutrophil; neutrophil count; peripheral circulation; priority journal; protein expression; smoking; sputum; age; aged; chronic obstructive lung disease; enzymology; female; genetics; immunology; male; metabolism; middle aged; pathology; smoking; chronic obstructive lung disease; immunology; inflammation; metabolism; neutrophil; smoking",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84877305183
Keely S.; Talley N.J.; Hansbro P.M.,"Keely, S. (9739611200); Talley, N.J. (36045241200); Hansbro, P.M. (6603119390)",9739611200; 36045241200; 6603119390,Pulmonary-intestinal cross-talk in mucosal inflammatory disease,2012,Mucosal Immunology,5,1,,7,18,11,303,10.1038/mi.2011.55,https://www.scopus.com/inward/record.uri?eid=2-s2.0-83655181133&doi=10.1038%2fmi.2011.55&partnerID=40&md5=32667958b574c7ad0dca69680205e385,"School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Faculty of Health, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia","Keely S., School of Biomedical Sciences and Pharmacy, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Talley N.J., Faculty of Health, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia",,alpha 1 antitrypsin; alpha tropomyosin; caspase recruitment domain protein 15; collagen; elastin; fibronectin; gelatin; gelatinase A; gelatinase B; interleukin 12; interleukin 13; interleukin 17; interleukin 17F; interleukin 1beta; interleukin 21; interleukin 22; interleukin 26; interleukin 6; leukocyte elastase; macrophage elastase; pattern recognition receptor; toll like receptor 2; toll like receptor 4; tropomyosin; tumor necrosis factor alpha; tumor necrosis factor inhibitor; autoimmunity; chronic obstructive lung disease; Crohn disease; cytokine release; disease association; drug efficacy; enteritis; enzyme regulation; gene mutation; genetic polymorphism; genetic risk; genetic susceptibility; heredity; human; incidence; interstitial lung disease; intestine flora; lymphocyte homing; membrane permeability; microbiome; nonhuman; pathogenesis; prevalence; priority journal; respiratory tract inflammation; review; risk factor; smoking; ulcerative colitis,Review,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-83655181133
Zouikr I.; Ahmed A.F.; Horvat J.C.; Beagley K.W.; Clifton V.L.; Ray A.; Thorne R.F.; Jarnicki A.G.; Hansbro P.M.; Hodgson D.M.,"Zouikr, Ihssane (55551887900); Ahmed, Abdulrzag F. (56447671700); Horvat, Jay C. (9942405300); Beagley, Kenneth W. (7005403437); Clifton, Vicki L. (6603677237); Ray, Allyson (55435196400); Thorne, Rick F. (7101652932); Jarnicki, Andrew G. (6603137164); Hansbro, Philip M. (6603119390); Hodgson, Deborah M. (7201364433)",55551887900; 56447671700; 9942405300; 7005403437; 6603677237; 55435196400; 7101652932; 6603137164; 6603119390; 7201364433,Programming of formalin-induced nociception by neonatal LPS exposure: Maintenance by peripheral and central neuroimmune activity,2015,"Brain, Behavior, and Immunity",44,,,235,246,11,15,10.1016/j.bbi.2014.10.014,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84918540467&doi=10.1016%2fj.bbi.2014.10.014&partnerID=40&md5=c840fcf374c70c39698b85a51ea58791,"Laboratory of Neuroimmunology, School of Psychology, University of Newcastle, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia; Institute of Health Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Robinson Institute, University of Adelaide, Adelaide, SA, Australia","Zouikr I., Laboratory of Neuroimmunology, School of Psychology, University of Newcastle, Newcastle, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Ahmed A.F., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Beagley K.W., Institute of Health Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Clifton V.L., Robinson Institute, University of Adelaide, Adelaide, SA, Australia; Ray A., Laboratory of Neuroimmunology, School of Psychology, University of Newcastle, Newcastle, NSW, Australia; Thorne R.F., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Jarnicki A.G., Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., Hunter Medical Research Institute, Newcastle, NSW, Australia; Hodgson D.M., Laboratory of Neuroimmunology, School of Psychology, University of Newcastle, Newcastle, NSW, Australia",Cytokines; Degranulation; Formalin test; Hippocampus; IL-1β; Inflammation; LPS; Mast cell; Neonatal immune challenge; Pain,"Animals; Animals, Newborn; Cell Count; Cell Degranulation; Encephalitis; Female; Formaldehyde; Hippocampus; Inflammation; Interleukin-1beta; Lipopolysaccharides; Male; Mast Cells; Motor Activity; Nociception; Pain; Pain Measurement; Rats; Rats, Wistar; interleukin 1beta; tolonium chloride; formaldehyde; interleukin 1beta; lipopolysaccharide; adult; animal experiment; animal tissue; Article; controlled study; cytokine response; enzyme linked immunosorbent assay; female; hippocampus; immune response; inflammatory pain; licking; male; mast cell; mast cell degranulation; nociception; nociceptive stimulation; nonhuman; rat; Western blotting; animal; blood; cell count; chemically induced; degranulation; encephalitis; immunology; inflammation; metabolism; motor activity; newborn; nociception; pain; pain measurement; physiology; Wistar rat",Article,Final,,Scopus,2-s2.0-84918540467
Balogh Z.J.; McIlroy D.J.; Smith D.W.; Hansbro P.M.,"Balogh, Zsolt J. (7006637520); McIlroy, Daniel J. (55924934900); Smith, Douglas W. (59099974300); Hansbro, Philip M. (6603119390)",7006637520; 55924934900; 59099974300; 6603119390,The origin and the role of mitochondrial DNA in postinjury inflammation,2013,Journal of Critical Care,28,6,,1099,1100,1,11,10.1016/j.jcrc.2013.08.027,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887405332&doi=10.1016%2fj.jcrc.2013.08.027&partnerID=40&md5=86969af04d277bc71a715dd689b651c1,"Department of Traumatology, John Hunter Hospital and University of Newcastle, Newcastle, NSW 2310, Australia; Department of Traumatology, University of Newcastle, Newcastle, NSW 2310, Australia; Priority Research Centre for Translational Neuroscience and Mental Health, Discipline of Anatomy, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW 2310, Australia; Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW 2310, Australia","Balogh Z.J., Department of Traumatology, John Hunter Hospital and University of Newcastle, Newcastle, NSW 2310, Australia; McIlroy D.J., Department of Traumatology, University of Newcastle, Newcastle, NSW 2310, Australia; Smith D.W., Priority Research Centre for Translational Neuroscience and Mental Health, Discipline of Anatomy, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW 2310, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW 2310, Australia",,"Biological Markers; DNA, Mitochondrial; Humans; Inflammation; Sepsis; Wounds and Injuries; mitochondrial DNA; acute lung injury; adult respiratory distress syndrome; apoptosis; disease severity; human; inflammation; innate immunity; letter; leukocyte; mitochondrion; multiple organ failure; nonhuman; phagocytosis; sepsis; shock",Letter,Final,,Scopus,2-s2.0-84887405332
Hsu A.C.-Y.; Parsons K.; Barr I.; Lowther S.; Middleton D.; Hansbro P.M.; Wark P.A.B.,"Hsu, Alan C.-Y. (49861516600); Parsons, Kristy (55047641400); Barr, Ian (7004651416); Lowther, Sue (8330613800); Middleton, Deborah (35427610100); Hansbro, Philip M. (6603119390); Wark, Peter A. B. (7003559516)",49861516600; 55047641400; 7004651416; 8330613800; 35427610100; 6603119390; 7003559516,Critical role of constitutive type i interferon response in bronchial epithelial cell to influenza infection,2012,PLoS ONE,7,3,e32947,,,,74,10.1371/journal.pone.0032947,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857735166&doi=10.1371%2fjournal.pone.0032947&partnerID=40&md5=591e8721ab5e3a672b410a3b9763e3a0,"Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, NSW, Australia; World Health Organization Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; The Commonwealth Scientific and Industrial Research Organization (CSIRO), Australian Animal Health Laboratory, Geelong, VIC, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia","Hsu A.C.-Y., Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, NSW, Australia; Parsons K., Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, NSW, Australia; Barr I., World Health Organization Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; Lowther S., The Commonwealth Scientific and Industrial Research Organization (CSIRO), Australian Animal Health Laboratory, Geelong, VIC, Australia; Middleton D., The Commonwealth Scientific and Industrial Research Organization (CSIRO), Australian Animal Health Laboratory, Geelong, VIC, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, NSW, Australia; Wark P.A.B., Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia",,"Animals; Apoptosis; Bronchi; Cell Line; Cycloheximide; Dogs; Epithelial Cells; Humans; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza, Human; Interferon Type I; Interferon-beta; Models, Biological; N-Acetylneuraminic Acid; Protein Synthesis Inhibitors; Orthomyxoviridae; beta interferon; glycoprotein; interferon; interferon receptor; retinoic acid inducible protein I; sialic acid; beta interferon; cycloheximide; interferon; n acetylneuraminic acid; protein synthesis inhibitor; apoptosis; article; bronchus mucosa; cell stimulation; controlled study; cytokine response; endocytosis; epithelium cell; human; human cell; infection sensitivity; influenza; influenza A (H3N2); influenza A (H5N1); innate immunity; interferon induction; interferon production; signal transduction; virus cell interaction; virus replication; animal; biological model; bronchus; cell line; chemistry; cytology; dog; epithelium cell; Influenza virus A H3N2; Influenza virus A H5N1; metabolism; virology",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84857735166
Prieto-García A.; Castells M.C.; Hansbro P.M.; Stevens R.L.,"Prieto-García, Alicia (6505837247); Castells, Mariana C. (7005236795); Hansbro, Philip M. (6603119390); Stevens, Richard L. (7403202252)",6505837247; 7005236795; 6603119390; 7403202252,Mast cell-restricted tetramer-forming tryptases and their beneficial roles in hemostasis and blood coagulation,2014,Immunology and Allergy Clinics of North America,34,2,,263,281,18,10,10.1016/j.iac.2014.01.001,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898811616&doi=10.1016%2fj.iac.2014.01.001&partnerID=40&md5=ff628b439eee1690e353e4ac321c3425,"Allergy Service, Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid 28007, Dr Esquerdo 46, Spain; Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, 1 Jimmy Fund Way, Smith Building, United States; Priority Research Centre forAsthma and Respiratory Disease, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW 2300, 1 Kookaburra Circuit, Australia","Prieto-García A., Allergy Service, Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid 28007, Dr Esquerdo 46, Spain; Castells M.C., Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, 1 Jimmy Fund Way, Smith Building, United States; Hansbro P.M., Priority Research Centre forAsthma and Respiratory Disease, Hunter Medical Research Institute and University of Newcastle, Newcastle, NSW 2300, 1 Kookaburra Circuit, Australia; Stevens R.L., Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, 1 Jimmy Fund Way, Smith Building, United States",Anaphylaxis; Fibrin thrombin-dependent coagulation; Fibrinogen; HTryptase-β; Mast cell; MMCP-6; MMCP-7,"Anaphylaxis; Blood Coagulation; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Histamine; Humans; Isoenzymes; Mast Cells; Mastocytosis; Protein Multimerization; Signal Transduction; Skin; Thrombin; Tryptases; chymase; fibrin; fibrinogen; heparin; proteoglycan; recombinant enzyme; recombinant mast cell protease 6; recombinant mast cell protease 7; recombinant tryptase beta; serglycin proteoglycan; tetramer; thrombin; tryptase; unclassified drug; fibrin; histamine; isoenzyme; thrombin; TPSAB1 protein, human; tryptase; amino acid sequence; anaphylaxis; anticoagulation; bioaccumulation; biotransformation; blood clot lysis; blood clotting; carboxy terminal sequence; chromosome 16p; drug efficacy; drug formulation; drug safety; drug targeting; enzyme activity; enzyme specificity; enzyme structure; fibrin deposition; gene; gene expression; gene function; gene identification; gene sequence; genetic variability; hemostasis; human; mast cell; mastocytosis; nonhuman; nucleotide sequence; priority journal; protein analysis; protein degradation; protein protein interaction; review; single nucleotide polymorphism; systemic mastocytosis; TPSAB1 gene; TPSAB2 gene; anaphylaxis; blood; blood clotting; chemistry; enzymology; gene expression regulation; genetics; mast cell; metabolism; pathology; protein multimerization; signal transduction; skin",Review,Final,,Scopus,2-s2.0-84898811616
Moores N.; Rogers D.I.; Rogers K.; Hansbro P.M.,"Moores, Nial (53980028200); Rogers, Danny I. (7402047658); Rogers, Ken (9742889200); Hansbro, Philip M. (6603119390)",53980028200; 7402047658; 9742889200; 6603119390,Reclamation of tidal flats and shorebird declines in Saemangeum and elsewhere in the Republic of Korea,2016,Emu,116,2,,136,146,10,65,10.1071/MU16006,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84968756892&doi=10.1071%2fMU16006&partnerID=40&md5=6ba7d589119d3a8e563c5cf0b32d8f7a,"Birds Korea, 1010 Samik Tower 3-Dong, Namcheon 2-Dong, Su Yeong-Gu, Busan, 613-762, South Korea; Arthur Rylah Institute of Environmental Research, PO Box 137, Heidelberg, 3084, VIC, Australia; 340 Ninks Road, St.Andrews, 3761, VIC, Australia; School of Biomedical Sciences and Pharmacy, Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, University of Newcastle, University Drive, Callaghan, 2308, NSW, Australia; Vaccines, Infection/Immunity, Viruses and Asthma Group, Hunger Medical Research Institute, Lot 1, Kookaburra Circuit, New Lambton Heights, 2305, NSW, Australia","Moores N., Birds Korea, 1010 Samik Tower 3-Dong, Namcheon 2-Dong, Su Yeong-Gu, Busan, 613-762, South Korea; Rogers D.I., Arthur Rylah Institute of Environmental Research, PO Box 137, Heidelberg, 3084, VIC, Australia; Rogers K., 340 Ninks Road, St.Andrews, 3761, VIC, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, Priority Research Centre for Healthy Lungs, Faculty of Health and Medicine, University of Newcastle, University Drive, Callaghan, 2308, NSW, Australia, Vaccines, Infection/Immunity, Viruses and Asthma Group, Hunger Medical Research Institute, Lot 1, Kookaburra Circuit, New Lambton Heights, 2305, NSW, Australia",East Asian-Australasian Flyway; Great Knot; migration; South Korea; Spoon-billed Sandpiper; Yellow Sea,Australasia; North Cholla; Pacific Ocean; Saemangeum Estuary; South Korea; Yellow Sea; Calidris tenuirostris; breeding site; coastal wetland; land reclamation; migratory species; population decline; reintroduction; sea wall; survival; tidal flat,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84968756892
Dhouib R.; Pg Othman D.S.M.; Essilfie A.-T.; Hansbro P.M.; Hanson J.O.; McEwan A.G.; Kappler U.,"Dhouib, Rabeb (15061097600); Pg Othman, Dk S.M. (55734711400); Essilfie, Ama-Tawiah (22955585600); Hansbro, Phil M. (6603119390); Hanson, Jeffrey O. (56454757800); McEwan, Alastair G. (7102063435); Kappler, Ulrike (6603150947)",15061097600; 55734711400; 22955585600; 6603119390; 56454757800; 7102063435; 6603150947,Maturation of molybdoenzymes and its influence on the pathogenesis of non-typeable Haemophilus influenzae,2015,Frontiers in Microbiology,6,NOV,1219,,,,10,10.3389/fmicb.2015.01219,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949761536&doi=10.3389%2ffmicb.2015.01219&partnerID=40&md5=b827b5538a43da80ff29b505f736c6f8,"Centre for Metals in Biology, Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Centre for Asthma and Respiratory Diseases and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; School of Biological Sciences, The University of Queensland, St. Lucia, QLD, Australia","Dhouib R., Centre for Metals in Biology, Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Pg Othman D.S.M., Centre for Metals in Biology, Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Essilfie A.-T., Centre for Asthma and Respiratory Diseases and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hanson J.O., School of Biological Sciences, The University of Queensland, St. Lucia, QLD, Australia; McEwan A.G., Centre for Metals in Biology, Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia; Kappler U., Centre for Metals in Biology, Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, Australia",Biofilm formation; Cell interactions; Enzyme maturation; Haemophilus influenzae; Molybdenum cofactor,bacterial enzyme; dimethyl sulfoxide reductase; formate dehydrogenase; methionine sulfoxide reductase; molybdenum enzyme; nitrate reductase; unclassified drug; anaerobic growth; animal experiment; animal model; Article; bacterium mutant; biofilm; bronchial epithelial cell line; cell adhesion assay; cell invasion assay; colony forming unit; controlled study; enzyme assay; female; gene locus; genetic similarity; Haemophilus infection; host pathogen interaction; human; human cell; immunofluorescence microscopy; mouse; neutrophil; nonhuman; nontypeable Haemophilus influenzae; pathogenesis; phenotype; protein expression; protein processing; Pseudomonas aeruginosa; real time polymerase chain reaction; Rhodobacter capsulatus; Rhodobacter sphaeroides; survival,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84949761536
Hirota J.A.; Alexis N.E.; Pui M.; Wong S.; Fung E.; Hansbro P.; Knight D.A.; Sin D.D.; Carlsten C.,"Hirota, Jeremy A. (7007085348); Alexis, Neil E. (6603908847); Pui, Mandy (55612694600); Wong, Szewing (56161863000); Fung, Elkie (56160940100); Hansbro, Phillip (6603119390); Knight, Darryl A. (7402350036); Sin, Don D. (57202594563); Carlsten, Chris (6602448695)",7007085348; 6603908847; 55612694600; 56161863000; 56160940100; 6603119390; 7402350036; 57202594563; 6602448695,PM10-stimulated airway epithelial cells activate primary human dendritic cells independent of uric acid: Application of an in vitro model system exposing dendritic cells to airway epithelial cell-conditioned media,2014,Respirology,19,6,,881,890,9,13,10.1111/resp.12316,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904575621&doi=10.1111%2fresp.12316&partnerID=40&md5=8c0dd6bec90d7780b0e9523ab7b050db,"James Hogg Research Centre, University of British Columbia, St. Paul's Hospital, Vancouver, BC V6Z-1Y6, 1081 Burrard Street, Canada; Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia","Hirota J.A., James Hogg Research Centre, University of British Columbia, St. Paul's Hospital, Vancouver, BC V6Z-1Y6, 1081 Burrard Street, Canada, Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; Alexis N.E., University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Pui M., Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; Wong S., Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; Fung E., Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; Hansbro P., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Knight D.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Sin D.D., James Hogg Research Centre, University of British Columbia, St. Paul's Hospital, Vancouver, BC V6Z-1Y6, 1081 Burrard Street, Canada; Carlsten C., Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada",air pollution; airway epithelial cell; dendritic cell; mucosal immunology; PM10,"Adult; Cell Differentiation; Cells, Cultured; Culture Media, Conditioned; Dendritic Cells; Epithelial Cells; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Interleukin-4; Male; Models, Biological; Particulate Matter; Phenotype; Reproducibility of Results; Respiratory System; Uric Acid; colony stimulating factor; interleukin 4; phorbol 13 acetate 12 myristate; uric acid; culture medium; granulocyte macrophage colony stimulating factor; interleukin 4; particulate matter; uric acid; air pollution; article; cell culture; cell fusion; controlled study; dendritic cell; environmental exposure; epithelium cell; flow cytometry; human; human cell; in vitro study; inflammatory cell; mediator; monocyte; particulate matter; peripheral blood mononuclear cell; phenotype; priority journal; respiratory epithelium; supernatant; urban area; adult; biological model; cell differentiation; culture medium; dendritic cell; drug effects; male; metabolism; particulate matter; pathology; pharmacology; reproducibility; respiratory system",Article,Final,,Scopus,2-s2.0-84904575621
Mateer S.W.; Maltby S.; Marks E.; Foster P.S.; Horvat J.C.; Hansbro P.M.; Keely S.,"Mateer, Sean W. (56595055500); Maltby, Steven (6507446799); Marks, Ellen (56594581600); Foster, Paul S. (7201517569); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Keely, Simon (9739611200)",56595055500; 6507446799; 56594581600; 7201517569; 9942405300; 6603119390; 9739611200,Potential mechanisms regulating pulmonary pathology in inflammatory bowel disease,2015,Journal of Leukocyte Biology,98,5,,727,737,10,42,10.1189/jlb.3RU1114-563R,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946053437&doi=10.1189%2fjlb.3RU1114-563R&partnerID=40&md5=12c158599c5877d230bb68415be92f32,"Gastrointestinal Research Group, Viruses/Infection/Immunity, New Lambton Heights, NSW, Australia; Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia","Mateer S.W., Gastrointestinal Research Group, Viruses/Infection/Immunity, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Maltby S., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Marks E., Gastrointestinal Research Group, Viruses/Infection/Immunity, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Foster P.S., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Horvat J.C., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Keely S., Gastrointestinal Research Group, Viruses/Infection/Immunity, New Lambton Heights, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia",Homing; Lung; Microbiome; Neutrophil; T cells,Animals; Dysbiosis; Humans; Inflammation; Inflammatory Bowel Diseases; Pneumonia; animal model; bronchiectasis; cell migration; cross presentation; dysbiosis; homeostasis; human; immune response; immunocompetent cell; immunopathogenesis; inflammation; inflammatory bowel disease; intestine flora; lung disease; lymphocyte homing; neutrophil; nonhuman; pneumonia; priority journal; Review; signal transduction; animal; complication; immunology; inflammatory bowel disease; pathology; pneumonia,Review,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84946053437
Griekspoor P.; Colles F.M.; McCarthy N.D.; Hansbro P.M.; Ashhurst-Smith C.; Olsen B.; Hasselquist D.; Maiden M.C.J.; Waldenström J.,"Griekspoor, Petra (15135449800); Colles, Frances M. (6507400264); McCarthy, Noel D. (8774236800); Hansbro, Philip M. (6603119390); Ashhurst-Smith, Chris (16024033000); Olsen, Björn (7201359257); Hasselquist, Dennis (7003573951); Maiden, Martin C. J. (7006019693); Waldenström, Jonas (7005795132)",15135449800; 6507400264; 8774236800; 6603119390; 16024033000; 7201359257; 7003573951; 7006019693; 7005795132,Marked host specificity and lack of phylogeographic population structure of Campylobacter jejuni in wild birds,2013,Molecular Ecology,22,5,,1463,1472,9,82,10.1111/mec.12144,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874405060&doi=10.1111%2fmec.12144&partnerID=40&md5=485f5599e876cb6ab904418aea6eb664,"Centre for Ecology and Evolution in Microbial Model Systems (EEMiS), Linnaeus University, SE-391 82 Kalmar, Sweden; Department of Zoology, University of Oxford, Oxford OX1 3PS, South Parks Road, United Kingdom; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2300, Australia; Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Department of Biology, Lund University, Ecology Building, SE-223 62 Lund, Sweden","Griekspoor P., Centre for Ecology and Evolution in Microbial Model Systems (EEMiS), Linnaeus University, SE-391 82 Kalmar, Sweden; Colles F.M., Department of Zoology, University of Oxford, Oxford OX1 3PS, South Parks Road, United Kingdom; McCarthy N.D., Department of Zoology, University of Oxford, Oxford OX1 3PS, South Parks Road, United Kingdom; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2300, Australia; Ashhurst-Smith C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2300, Australia; Olsen B., Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Hasselquist D., Department of Biology, Lund University, Ecology Building, SE-223 62 Lund, Sweden; Maiden M.C.J., Department of Zoology, University of Oxford, Oxford OX1 3PS, South Parks Road, United Kingdom; Waldenström J., Centre for Ecology and Evolution in Microbial Model Systems (EEMiS), Linnaeus University, SE-391 82 Kalmar, Sweden",disease emergence; epidemiology; host associations; Zoonotic disease,"Animals; Animals, Domestic; Animals, Wild; Australia; Bird Diseases; Birds; Campylobacter Infections; Campylobacter jejuni; Europe; Female; Gene Frequency; Genetic Loci; Genotype; Host Specificity; Humans; Male; Phylogeny; Phylogeography; Sequence Alignment; Sequence Analysis, DNA; Virulence; Animalia; Aves; Bacteria (microorganisms); Campylobacter jejuni; animal; animal disease; article; Australia; bird; bird disease; Campylobacter jejuni; campylobacteriosis; DNA sequence; domestic animal; Europe; female; gene frequency; gene locus; genetics; genotype; host range; human; isolation and purification; male; microbiology; phylogeny; phylogeography; sequence alignment; virulence; wild animal",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-84874405060
Starkey M.R.; Nguyen D.H.; Kim R.Y.; Nair P.M.; Brown A.C.; Essifie A.-T.; Horvat J.C.; Hansbro P.M.,"Starkey, Malcolm R. (35811293400); Nguyen, Duc H. (54886138200); Kim, Richard Y. (35810406900); Nair, Prema M. (55749131000); Brown, Alexandra C. (55637745000); Essifie, Ama-Tawiah (55748681300); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390)",35811293400; 54886138200; 35810406900; 55749131000; 55637745000; 55748681300; 9942405300; 6603119390,Programming of the lung in early life by bacterial infections predisposes to chronic respiratory disease,2013,Clinical Obstetrics and Gynecology,56,3,,566,576,10,14,10.1097/GRF.0b013e3182993a0c,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84882452828&doi=10.1097%2fGRF.0b013e3182993a0c&partnerID=40&md5=3b8c8791461cc7e1b45d8feccec2864e,"School of Biomedical Sciences and Pharmacy, Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, New Lambton Heights, NSW, Australia","Starkey M.R., School of Biomedical Sciences and Pharmacy, Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, New Lambton Heights, NSW, Australia; Nguyen D.H., School of Biomedical Sciences and Pharmacy, Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, New Lambton Heights, NSW, Australia; Kim R.Y., School of Biomedical Sciences and Pharmacy, Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, New Lambton Heights, NSW, Australia; Nair P.M., School of Biomedical Sciences and Pharmacy, Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, New Lambton Heights, NSW, Australia; Brown A.C., School of Biomedical Sciences and Pharmacy, Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, New Lambton Heights, NSW, Australia; Essifie A.-T., School of Biomedical Sciences and Pharmacy, Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, New Lambton Heights, NSW, Australia; Horvat J.C., School of Biomedical Sciences and Pharmacy, Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, New Lambton Heights, NSW, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, New Lambton Heights, NSW, Australia",asthma; chronic respiratory disease; COPD; early life; infection; therapy,"Asthma; Bacterial Infections; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Haemophilus Infections; Haemophilus influenzae; Humans; Immunologic Factors; Interleukin-13; Lung; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Streptococcal Infections; Streptococcal Vaccines; Streptococcus pneumoniae; Toll-Like Receptor 2; anrukinzumab; bacterial vaccine; ima 026; immunoglobulin G1 antibody; lebrikizumab; unclassified drug; article; asthma; asymptomatic infection; bacterial infection; bacterial meningitis; bacterial pneumonia; childhood disease; Chlamydia trachomatis; chlamydiasis; chronic lung disease; chronic respiratory tract disease; community acquired pneumonia; disease predisposition; Haemophilus influenzae; human; lung structure; nonhuman; Streptococcus pneumoniae; vaccination; wheezing",Article,Final,,Scopus,2-s2.0-84882452828
Grillo V.L.; Arzey K.E.; Hansbro P.M.; Hurt A.C.; Warner S.; Bergfeld J.; Burgess G.W.; Cookson B.; Dickason C.J.; Ferenczi M.; Hollingsworth T.; Hoque M.D.A.; Jackson R.B.; Klaassen M.; Kirkland P.D.; Kung N.Y.; Lisovski S.; O'Dea M.A.; O'Riley K.; Roshier D.; Skerratt L.F.; Tracey J.P.; Wang X.; Woods R.; Post L.,"Grillo, V.L. (57432223200); Arzey, K.E. (6507363704); Hansbro, P.M. (6603119390); Hurt, A.C. (6603378203); Warner, S. (23983839400); Bergfeld, J. (22633622200); Burgess, G.W. (7102788039); Cookson, B. (53863100400); Dickason, C.J. (57154099600); Ferenczi, M. (55237569800); Hollingsworth, T. (35195915800); Hoque, M.D.A. (58253916800); Jackson, R.B. (57213366285); Klaassen, M. (7004383496); Kirkland, P.D. (56243457600); Kung, N.Y. (36977766700); Lisovski, S. (30267694200); O'Dea, M.A. (23061467400); O'Riley, K. (6506489871); Roshier, D. (6602874337); Skerratt, L.F. (6701841892); Tracey, J.P. (8790263700); Wang, X. (59069122700); Woods, R. (8790263300); Post, L. (56156544900)",57432223200; 6507363704; 6603119390; 6603378203; 23983839400; 22633622200; 7102788039; 53863100400; 57154099600; 55237569800; 35195915800; 58253916800; 57213366285; 7004383496; 56243457600; 36977766700; 30267694200; 23061467400; 6506489871; 6602874337; 6701841892; 8790263700; 59069122700; 8790263300; 56156544900,Avian influenza in Australia: A summary of 5 years of wild bird surveillance,2015,Australian Veterinary Journal,93,11,,387,393,6,40,10.1111/avj.12379,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945114894&doi=10.1111%2favj.12379&partnerID=40&md5=bad91b7a0303bffc5cdcf063afe818b5,"Wildlife Health Australia, Mosman, NSW, Australia; Virology Laboratory, Elizabeth Macarthur Agricultural Institute, New South Wales, Department of Primary Industries, Camden, NSW, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; WHO Collaborating Centre for Reference and Research on Influenza, North Melbourne, VIC, Australia; Department of Economic Development, Jobs, Transport and Resource, Bundoora, VIC, Australia; Australian Animal Health Laboratory, CSIRO Animal Food and Health Sciences, Geelong, VIC, Australia; One Health Research Group, College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD, Australia; Australian Government Department of Agriculture, Cairns, QLD, Australia; Biosecurity SA, Primary Industries and Regions, Adelaide, SA, Australia; Centre for Integrative Ecology, Deakin University, Geelong, VIC, Australia; Department of Agriculture and Food, Bunbury, WA, Australia; Department of Primary Industries, Parks, Water and Environment, Launceston, TAS, Australia; Biosecurity Queensland, Department of Agriculture and Fisheries, Brisbane, QLD, Australia; Department of Agriculture and Food, South Perth, WA, Australia; Vertebrate Pest Research Unit, New South Wales, Department of Primary Industries, Forest Road, Orange, NSW, Australia; Australian Government Department of Agriculture, Canberra, ACT, Australia","Grillo V.L., Wildlife Health Australia, Mosman, NSW, Australia; Arzey K.E., Virology Laboratory, Elizabeth Macarthur Agricultural Institute, New South Wales, Department of Primary Industries, Camden, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hurt A.C., WHO Collaborating Centre for Reference and Research on Influenza, North Melbourne, VIC, Australia; Warner S., Department of Economic Development, Jobs, Transport and Resource, Bundoora, VIC, Australia; Bergfeld J., Australian Animal Health Laboratory, CSIRO Animal Food and Health Sciences, Geelong, VIC, Australia; Burgess G.W., One Health Research Group, College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD, Australia; Cookson B., Australian Government Department of Agriculture, Cairns, QLD, Australia; Dickason C.J., Biosecurity SA, Primary Industries and Regions, Adelaide, SA, Australia; Ferenczi M., Centre for Integrative Ecology, Deakin University, Geelong, VIC, Australia; Hollingsworth T., Department of Agriculture and Food, Bunbury, WA, Australia; Hoque M.D.A., One Health Research Group, College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD, Australia; Jackson R.B., Department of Primary Industries, Parks, Water and Environment, Launceston, TAS, Australia; Klaassen M., Centre for Integrative Ecology, Deakin University, Geelong, VIC, Australia; Kirkland P.D., Virology Laboratory, Elizabeth Macarthur Agricultural Institute, New South Wales, Department of Primary Industries, Camden, NSW, Australia; Kung N.Y., Biosecurity Queensland, Department of Agriculture and Fisheries, Brisbane, QLD, Australia; Lisovski S., Centre for Integrative Ecology, Deakin University, Geelong, VIC, Australia; O'Dea M.A., Department of Agriculture and Food, South Perth, WA, Australia; O'Riley K., Department of Economic Development, Jobs, Transport and Resource, Bundoora, VIC, Australia; Roshier D., Centre for Integrative Ecology, Deakin University, Geelong, VIC, Australia; Skerratt L.F., One Health Research Group, College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD, Australia; Tracey J.P., Vertebrate Pest Research Unit, New South Wales, Department of Primary Industries, Forest Road, Orange, NSW, Australia; Wang X., Department of Economic Development, Jobs, Transport and Resource, Bundoora, VIC, Australia; Woods R., Wildlife Health Australia, Mosman, NSW, Australia; Post L., Australian Government Department of Agriculture, Canberra, ACT, Australia",Australia; Avian influenza; Biosecurity; Surveillance; Wild birds,"Animals; Animals, Wild; Antibodies, Viral; Australia; Birds; Feces; Geography; Influenza A virus; Influenza in Birds; Linear Models; Oropharynx; Polymerase Chain Reaction; Population Surveillance; virus antibody; animal; Australia; bird; blood; feces; geography; health survey; Influenza A virus; Influenza in Birds; isolation and purification; oropharynx; polymerase chain reaction; statistical model; virology; wild animal",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84945114894
Hsu A.C.-Y.; Loo S.-L.; Fathi Aghdam F.; Parsons K.; Hansbro P.M.; Wark P.A.B.,"Hsu, Alan Chen-Yu (49861516600); Loo, Su-Ling (57193119561); Fathi Aghdam, Faezeh (57879013100); Parsons, Kristy (55047641400); Hansbro, Philip M. (6603119390); Wark, Peter A.B. (7003559516)",49861516600; 57193119561; 57879013100; 55047641400; 6603119390; 7003559516,Airway Epithelial and Early Innate Immune Responses to Virus Infections,2014,Human Respiratory Viral Infections,,,,29,44,15,0,10.1201/b16778-3,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137507537&doi=10.1201%2fb16778-3&partnerID=40&md5=fcf86b8630296797a70e2d7b6ec58b3e,"Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Hunter Medical Research Institute, University of Newcastle, John Hunter Hospital, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, NSW, Australia","Hsu A.C.-Y., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Loo S.-L., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Fathi Aghdam F., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Parsons K., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Wark P.A.B., Hunter Medical Research Institute, University of Newcastle, John Hunter Hospital, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, NSW, Australia",,,Book chapter,Final,,Scopus,2-s2.0-85137507537
Fung K.Y.; Mangan N.E.; Cumming H.; Horvat J.C.; Mayall J.R.; Stifter S.A.; De Weerd N.; Roisman L.C.; Rossjohn J.; Robertson S.A.; Schjenken J.E.; Parker B.; Gargett C.E.; Nguyen H.P.T.; Carr D.J.; Hansbro P.M.; Hertzog P.J.,"Fung, Ka Yee (57189090775); Mangan, Niamh E. (6506688263); Cumming, Helen (55659236900); Horvat, Jay C. (9942405300); Mayall, Jemma R. (55607222700); Stifter, Sebastian A. (55357516800); De Weerd, Nicole (6508220812); Roisman, Laila C. (6507808712); Rossjohn, Jamie (7004498521); Robertson, Sarah A. (58547079800); Schjenken, John E. (39962383400); Parker, Belinda (7202766819); Gargett, Caroline E. (6603881846); Nguyen, Hong P. T. (57004132600); Carr, Daniel J. (13402960300); Hansbro, Philip M. (6603119390); Hertzog, Paul J. (7005991492)",57189090775; 6506688263; 55659236900; 9942405300; 55607222700; 55357516800; 6508220812; 6507808712; 7004498521; 58547079800; 39962383400; 7202766819; 6603881846; 57004132600; 13402960300; 6603119390; 7005991492,Interferon-ε protects the female reproductive tract from viral and bacterial infection,2013,Science,339,6123,,1033c,,,189,10.1126/science.1233321,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874396777&doi=10.1126%2fscience.1233321&partnerID=40&md5=410ff09e2746d5202bb0a234eb2f9fd0,"Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Robinson Institute, School of Paediatrics and Reproductive Health, University of Adelaide, SA, Australia; Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia; Ritchie Centre, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia; Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia; Department of Ophthalmology, Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States","Fung K.Y., Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia; Mangan N.E., Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia; Cumming H., Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Mayall J.R., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Stifter S.A., Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia; De Weerd N., Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia; Roisman L.C., Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Rossjohn J., Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Robertson S.A., Robinson Institute, School of Paediatrics and Reproductive Health, University of Adelaide, SA, Australia; Schjenken J.E., Robinson Institute, School of Paediatrics and Reproductive Health, University of Adelaide, SA, Australia; Parker B., Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia; Gargett C.E., Ritchie Centre, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia, Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia; Nguyen H.P.T., Ritchie Centre, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia; Carr D.J., Department of Ophthalmology, Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hertzog P.J., Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia",,epsilon interferon; interferon; unclassified drug; Chlamydia; Chlamydiaceae infection; epithelium cell; gynecologic disease; herpes simplex; Herpes simplex virus 2; hormonal regulation; human; infection sensitivity; innate immunity; nonhuman; note; priority journal; protein function,Note,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84874396777
Essilfie A.-T.; Simpson J.L.; Horvat J.C.; Preston J.A.; Dunkley M.L.; Foster P.S.; Gibson P.G.; Hansbro P.M.,"Essilfie, Ama-Tawiah (22955585600); Simpson, Jodie L. (7404326026); Horvat, Jay C. (9942405300); Preston, Julie A. (59281082600); Dunkley, Margaret L. (7004316090); Foster, Paul S. (7201517569); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390)",22955585600; 7404326026; 9942405300; 59281082600; 7004316090; 7201517569; 7202414199; 6603119390,Haemophilus influenzae infection drives IL-17-mediated neutrophilic Allergic airways disease,2011,PLoS Pathogens,7,10,e1002244,,,,146,10.1371/journal.ppat.1002244,https://www.scopus.com/inward/record.uri?eid=2-s2.0-80055072377&doi=10.1371%2fjournal.ppat.1002244&partnerID=40&md5=5ac9189b9fb55058a4ee7748b90057b8,"Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Hunter Immunology, Newcastle, Australia","Essilfie A.-T., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Simpson J.L., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Horvat J.C., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Preston J.A., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Dunkley M.L., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Hunter Immunology, Newcastle, Australia; Foster P.S., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Gibson P.G., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia",,"Animals; Asthma; Disease Models, Animal; Eosinophils; Female; Haemophilus Infections; Haemophilus influenzae; Immunity, Cellular; Inflammation; Interferon-gamma; Interleukin-13; Interleukin-17; Interleukin-5; Mice; Mice, Inbred BALB C; Neutrophils; Ovalbumin; Phenotype; T-Lymphocytes, Regulatory; Th17 Cells; Haemophilus influenzae; Mus; gamma interferon; interleukin 13; interleukin 17; interleukin 22; interleukin 5; neutralizing antibody; ovalbumin; gamma interferon; interleukin 13; interleukin 17; interleukin 5; ovalbumin; adaptive immunity; allergic airway disease; allergic asthma; animal experiment; animal model; article; clinical feature; controlled study; eosinophil; female; fluorescence activated cell sorting; Haemophilus infection; Haemophilus influenzae; inflammation; innate immunity; macrophage; mouse; neutrophil; nonhuman; respiratory tract disease; sensitization; T lymphocyte; Th17 cell; animal; asthma; Bagg albino mouse; cellular immunity; cytology; disease model; immunology; metabolism; microbiology; neutrophil; pathogenicity; pathology; phenotype; regulatory T lymphocyte",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-80055072377
Yang M.; Kumar R.K.; Hansbro P.M.; Foster P.S.,"Yang, Ming (56857729900); Kumar, Rakesh K. (57203775042); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569)",56857729900; 57203775042; 6603119390; 7201517569,Emerging roles of pulmonary macrophages in driving the development of severe asthma,2012,Journal of Leukocyte Biology,91,4,,557,569,12,86,10.1189/jlb.0711357,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860877293&doi=10.1189%2fjlb.0711357&partnerID=40&md5=b78ac71d2d69d67127483b227ce21f5b,"Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, Australia","Yang M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Kumar R.K., Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Callaghan, Australia",Airway hyper-responsiveness; Innate immunity; Steroid resistance,"Animals; Asthma; Cytokines; Drug Resistance; Glucocorticoids; Humans; Inflammation; Macrophages, Alveolar; Severity of Illness Index; Signal Transduction; gamma interferon; glucocorticoid; interleukin 33; lipopolysaccharide; macrophage migration inhibition factor; prednisolone; tumor necrosis factor alpha; asthma; bacterial infection; bronchus hyperreactivity; corticosteroid therapy; disease severity; human; immunopathogenesis; lung alveolus macrophage; macrophage activation; nonhuman; phenotype; priority journal; review; signal transduction; virus infection",Review,Final,,Scopus,2-s2.0-84860877293
Beckett E.L.; Stevens R.L.; Jarnicki A.G.; Kim R.Y.; Hanish I.; Hansbro N.G.; Deane A.; Keely S.; Horvat J.C.; Yang M.; Oliver B.G.; Van Rooijen N.; Inman M.D.; Adachi R.; Soberman R.J.; Hamadi S.; Wark P.A.; Foster P.S.; Hansbro P.M.,"Beckett, Emma L. (36620958500); Stevens, Richard L. (7403202252); Jarnicki, Andrew G. (6603137164); Kim, Richard Y. (35810406900); Hanish, Irwan (55572056100); Hansbro, Nicole G. (15055862300); Deane, Andrew (55571783900); Keely, Simon (9739611200); Horvat, Jay C. (9942405300); Yang, Ming (56857729900); Oliver, Brian G. (15919869900); Van Rooijen, Nico (35428581800); Inman, Mark D. (35453207500); Adachi, Roberto (16303328000); Soberman, Roy J. (7005453401); Hamadi, Sahar (55573697900); Wark, Peter A. (7003559516); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",36620958500; 7403202252; 6603137164; 35810406900; 55572056100; 15055862300; 55571783900; 9739611200; 9942405300; 56857729900; 15919869900; 35428581800; 35453207500; 16303328000; 7005453401; 55573697900; 7003559516; 7201517569; 6603119390,A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis,2013,Journal of Allergy and Clinical Immunology,131,3,,752,762.e7,,214,10.1016/j.jaci.2012.11.053,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875224340&doi=10.1016%2fj.jaci.2012.11.053&partnerID=40&md5=0e0e3bb304bd36433e6a50ffda143151,"Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Department of Medicine, Harvard Medical School, Boston, MA, United States; Brigham and Women's Hospital, Boston, MA, United States; Sydney Medical School, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Department of Molecular Cell Biology, Vrije Universiteit Medical Center, Amsterdam, Netherlands; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada; Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States; Massachusetts General Hospital, Boston, MA, United States; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia","Beckett E.L., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Stevens R.L., Department of Medicine, Harvard Medical School, Boston, MA, United States, Brigham and Women's Hospital, Boston, MA, United States; Jarnicki A.G., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Kim R.Y., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Hanish I., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Hansbro N.G., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Deane A., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Keely S., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Horvat J.C., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Yang M., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Oliver B.G., Sydney Medical School, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Van Rooijen N., Department of Molecular Cell Biology, Vrije Universiteit Medical Center, Amsterdam, Netherlands; Inman M.D., Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada; Adachi R., Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States; Soberman R.J., Department of Medicine, Harvard Medical School, Boston, MA, United States, Massachusetts General Hospital, Boston, MA, United States; Hamadi S., Brigham and Women's Hospital, Boston, MA, United States; Wark P.A., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Foster P.S., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia",airway remodeling; chronic obstructive pulmonary disease; Cigarette smoke; emphysema; htryptase-β; inflammation; lung function; macrophage; mast cell; mouse mast cell protease 6; protease,chemokine; cigarette smoke; cytokine; dexamethasone; tryptase; airway remodeling; animal experiment; animal model; article; cell function; chronic obstructive lung disease; controlled study; disease exacerbation; emphysema; experimental model; female; heart; inflammation; lung function; macrophage; mast cell; mouse; mucus secretion; nonhuman; pathogenesis; pneumococcal infection; priority journal; protein expression; skeletal muscle; Streptococcus pneumoniae,Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84875224340
Hirota J.A.; Gold M.J.; Hiebert P.R.; Parkinson L.G.; Wee T.; Smith D.; Hansbro P.M.; Carlsten C.; VanEeden S.; Sin D.D.; McNagny K.M.; Knight D.A.,"Hirota, Jeremy A. (7007085348); Gold, Matthew J. (7402444023); Hiebert, Paul R. (35213146400); Parkinson, Leigh G. (56450500600); Wee, Tracee (56467839500); Smith, Dirk (57192811946); Hansbro, Phil M. (6603119390); Carlsten, Chris (6602448695); VanEeden, Stephan (7006188955); Sin, Don D. (57202594563); McNagny, Kelly M. (6701876377); Knight, Darryl A. (7402350036)",7007085348; 7402444023; 35213146400; 56450500600; 56467839500; 57192811946; 6603119390; 6602448695; 7006188955; 57202594563; 6701876377; 7402350036,"The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 μm",2015,American Journal of Respiratory Cell and Molecular Biology,52,1,,96,105,9,78,10.1165/rcmb.2014-0158OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920283137&doi=10.1165%2frcmb.2014-0158OC&partnerID=40&md5=7fcc437c4ecb41e90676ef4f717a48f1,"James Hogg Research Centre, University of British Columbia, Vancouver, BC V6Z 1Y6, BC, Canada; Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; Department of Inflammation Research, Amgen, Seattle, WA, United States; Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle Australia, Callaghan, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle Australia, Callaghan, NSW, Australia","Hirota J.A., James Hogg Research Centre, University of British Columbia, Vancouver, BC V6Z 1Y6, BC, Canada, Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; Gold M.J., Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; Hiebert P.R., James Hogg Research Centre, University of British Columbia, Vancouver, BC V6Z 1Y6, BC, Canada; Parkinson L.G., James Hogg Research Centre, University of British Columbia, Vancouver, BC V6Z 1Y6, BC, Canada; Wee T., James Hogg Research Centre, University of British Columbia, Vancouver, BC V6Z 1Y6, BC, Canada; Smith D., Department of Inflammation Research, Amgen, Seattle, WA, United States; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle Australia, Callaghan, NSW, Australia; Carlsten C., James Hogg Research Centre, University of British Columbia, Vancouver, BC V6Z 1Y6, BC, Canada, Vancouver Coastal Health Research Institute, Vancouver General Hospital, Vancouver, BC, Canada; VanEeden S., James Hogg Research Centre, University of British Columbia, Vancouver, BC V6Z 1Y6, BC, Canada; Sin D.D., James Hogg Research Centre, University of British Columbia, Vancouver, BC V6Z 1Y6, BC, Canada; McNagny K.M., Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; Knight D.A., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle Australia, Callaghan, NSW, Australia, School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle Australia, Callaghan, NSW, Australia",Air pollution; Airway epithelium; Allergic sensitization; Asthma; Human,"Adaptive Immunity; Animals; Asthma; Carrier Proteins; Cell Line, Transformed; Cytokines; Dendritic Cells; Humans; Immunity, Innate; Inflammasomes; Mice; Mice, Inbred BALB C; Particulate Matter; Receptors, Interleukin-1 Type I; Respiratory Mucosa; Signal Transduction; Mus; cyclin dependent kinase 4; granulocyte macrophage colony stimulating factor; inflammasome; interleukin 1 receptor type I; interleukin 1beta; macrophage inflammatory protein 3alpha; nucleotide binding domain leucine rich repeat protein 3 inflammasome; telomerase reverse transcriptase; unclassified drug; carrier protein; CIAS1 protein, mouse; cytokine; IL1R1 protein, human; IL1R1 protein, mouse; inflammasome; interleukin 1 receptor type I; NLRP3 protein, human; particulate matter; adaptive immunity; air pollution; animal experiment; animal model; antigen presentation; Article; cell activation; cell migration; controlled study; cytokine production; dendritic cell; dose response; environmental exposure; epithelium cell; female; granulocyte; human; human cell; in vitro study; innate immunity; macrophage; mouse; neutrophilia; nonhuman; particulate matter; protein domain; respiratory epithelium; sensitization; wild type; adaptive immunity; animal; asthma; Bagg albino mouse; chemically induced; drug effects; immunology; innate immunity; particulate matter; pathology; respiratory tract mucosa; signal transduction; transformed cell line",Article,Final,,Scopus,2-s2.0-84920283137
Hansbro P.M.; Jarnicki A.G.,"Hansbro, Philip M. (6603119390); Jarnicki, Andrew G. (6603137164)",6603119390; 6603137164,Macrolides for macrophages in chronic obstructive pulmonary disease,2012,Respirology,17,5,,739,740,1,5,10.1111/j.1440-1843.2012.02186.x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862994387&doi=10.1111%2fj.1440-1843.2012.02186.x&partnerID=40&md5=0ea36360919844b8945095af17a61cd8,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Jarnicki A.G., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",chronic obstructive pulmonary disease; exacerbations; macrolides; macrophage; phagocytosis,"Anti-Bacterial Agents; Azithromycin; Escherichia coli; Female; Humans; Macrophages; Macrophages, Alveolar; Male; Phagocytosis; Pulmonary Disease, Chronic Obstructive; azithromycin; beta adrenergic receptor stimulating agent; elastase; erythromycin; gelatinase B; granulocyte macrophage colony stimulating factor; interleukin 1beta; interleukin 4; interleukin 6; interleukin 8; methylxanthine derivative; placebo; tumor necrosis factor alpha; airway obstruction; bacterial infection; bronchiolitis obliterans; chronic obstructive lung disease; cystic fibrosis; cytokine production; deterioration; disease association; disease course; disease exacerbation; disease severity; dyspnea; editorial; human; immunomodulation; long term care; lung alveolus macrophage; lung transplantation; personalized medicine; phagocytosis; priority journal; quality of life; sputum level; virus infection",Editorial,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84862994387
Sobinoff A.P.; Beckett E.L.; Jarnicki A.G.; Sutherland J.M.; McCluskey A.; Hansbro P.M.; McLaughlin E.A.,"Sobinoff, A.P. (36495791100); Beckett, E.L. (36620958500); Jarnicki, A.G. (6603137164); Sutherland, J.M. (35774667100); McCluskey, A. (7004402361); Hansbro, P.M. (6603119390); McLaughlin, E.A. (57565084300)",36495791100; 36620958500; 6603137164; 35774667100; 7004402361; 6603119390; 57565084300,Scrambled and fried: Cigarette smoke exposure causes antral follicle destruction and oocyte dysfunction through oxidative stress,2013,Toxicology and Applied Pharmacology,271,2,,156,167,11,73,10.1016/j.taap.2013.05.009,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880443874&doi=10.1016%2fj.taap.2013.05.009&partnerID=40&md5=64c8727e3609204c6a03fbe3b52e74f0,"Reproductive Science Group, School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW 2308, Australia; Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, NSW 2308, Australia; Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia","Sobinoff A.P., Reproductive Science Group, School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW 2308, Australia, Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, NSW 2308, Australia; Beckett E.L., Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia; Jarnicki A.G., Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia; Sutherland J.M., Reproductive Science Group, School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW 2308, Australia, Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, NSW 2308, Australia; McCluskey A., Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, NSW 2308, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia; McLaughlin E.A., Reproductive Science Group, School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW 2308, Australia, Priority Research Centre for Chemical Biology, University of Newcastle, Callaghan, NSW 2308, Australia",Atresia; Bioactivation; Cigarette; Infertility; Ovotoxicity; Oxidative stress,"Animals; Caspases; DNA Damage; Female; Fertility; Fertilization; Immunohistochemistry; In Situ Nick-End Labeling; Infertility, Female; Lipid Peroxidation; Litter Size; Mice; Mice, Inbred C57BL; Microarray Analysis; Mitochondria; Oocytes; Ovarian Follicle; Ovary; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; RNA; Signal Transduction; Tobacco Smoke Pollution; Atresia; Bioactivation; Cigarette; Infertility; Ovotoxicity; Oxidative stress; cigarette smoke; cytochrome P450 2E1; reactive oxygen metabolite; animal cell; animal experiment; animal model; apoptosis; article; cell destruction; chronic obstructive lung disease; controlled study; detoxification; enzyme induction; female; lipid peroxidation; microarray analysis; mitochondrion; mouse; nonhuman; oocyte; ovary follicle cell; ovulation; oxidative stress; prenatal exposure; self fertilization",Article,Final,,Scopus,2-s2.0-84880443874
Rahman M.M.; Prünte L.; Lebender L.F.; Patel B.S.; Gelissen I.; Hansbro P.M.; Morris J.C.; Clark A.R.; Verrills N.M.; Ammit A.J.,"Rahman, Md Mostafizur (57193353117); Prünte, Laura (57191982277); Lebender, Leonard F. (57191981811); Patel, Brijeshkumar S. (56344477500); Gelissen, Ingrid (6603154740); Hansbro, Philip M. (6603119390); Morris, Jonathan C. (35354969700); Clark, Andrew R. (7404479336); Verrills, Nicole M. (6602391112); Ammit, Alaina J. (7003377421)",57193353117; 57191982277; 57191981811; 56344477500; 6603154740; 6603119390; 35354969700; 7404479336; 6602391112; 7003377421,"The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells",2016,Scientific Reports,6,,37297,,,,26,10.1038/srep37297,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995609161&doi=10.1038%2fsrep37297&partnerID=40&md5=38841afca986224e9b841ae9c51aec02,"Faculty of Pharmacy, University of Sydney, Sydney, 2006, NSW, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; School of Chemistry, University of NSW, 2052, NSW, Australia; Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, B15 2TT, United Kingdom; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, 2308, NSW, Australia; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia","Rahman M.M., Faculty of Pharmacy, University of Sydney, Sydney, 2006, NSW, Australia; Prünte L., Faculty of Pharmacy, University of Sydney, Sydney, 2006, NSW, Australia; Lebender L.F., Faculty of Pharmacy, University of Sydney, Sydney, 2006, NSW, Australia; Patel B.S., Faculty of Pharmacy, University of Sydney, Sydney, 2006, NSW, Australia; Gelissen I., Faculty of Pharmacy, University of Sydney, Sydney, 2006, NSW, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, 2308, NSW, Australia; Morris J.C., School of Chemistry, University of NSW, 2052, NSW, Australia; Clark A.R., Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, B15 2TT, United Kingdom; Verrills N.M., School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, 2308, NSW, Australia; Ammit A.J., Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia, School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia",,"A549 Cells; Cyclooxygenase 2; Dinoprostone; Enzyme Activation; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Interleukin-6; Interleukin-8; Lung; Lysophospholipids; Organophosphates; Protein Phosphatase 2; Sphingosine; Tumor Necrosis Factor-alpha; cyclooxygenase 2; FTY 720P; interleukin 6; interleukin 8; lysophospholipid; organophosphate; phosphoprotein phosphatase 2; prostaglandin E2; sphingosine; sphingosine 1-phosphate; tumor necrosis factor; A-549 cell line; analogs and derivatives; drug effect; enzyme activation; epithelium cell; gene expression regulation; genetics; human; inflammation; lung; metabolism; pathology",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84995609161
Hsu A.C.-Y.; Parsons K.; Moheimani F.; Knight D.A.; Hansbro P.M.; Fujita T.; Wark P.A.,"Hsu, Alan C.-Y. (49861516600); Parsons, Kristy (55047641400); Moheimani, Fatemeh (36157216000); Knight, Darryl A. (7402350036); Hansbro, Philip M. (6603119390); Fujita, Takashi (55485893300); Wark, Peter A. (7003559516)",49861516600; 55047641400; 36157216000; 7402350036; 6603119390; 55485893300; 7003559516,Impaired antiviral stress granule and IFN-β enhanceosome formation enhances susceptibility to influenza infection in chronic obstructive pulmonary disease epithelium,2016,American Journal of Respiratory Cell and Molecular Biology,55,1,,117,127,10,43,10.1165/rcmb.2015-0306OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988977653&doi=10.1165%2frcmb.2015-0306OC&partnerID=40&md5=5d36cfd8045a74e47aca2f0e52cd49be,"Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Height, Newcastle, 2305, NSW, Australia; Department of Anesthesiology, Pharmacology, and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Laboratory of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto, Japan; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Castle, NSW, Australia","Hsu A.C.-Y., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Height, Newcastle, 2305, NSW, Australia; Parsons K., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Height, Newcastle, 2305, NSW, Australia; Moheimani F., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Height, Newcastle, 2305, NSW, Australia; Knight D.A., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Height, Newcastle, 2305, NSW, Australia, Department of Anesthesiology, Pharmacology, and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Height, Newcastle, 2305, NSW, Australia; Fujita T., Laboratory of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto, Japan; Wark P.A., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Height, Newcastle, 2305, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Castle, NSW, Australia",Chronic obstructive pulmonary disease; IFN-β; Influenza,"Antiviral Agents; Bronchi; Cytoplasmic Granules; Disease Susceptibility; eIF-2 Kinase; Epithelial Cells; Epithelium; Female; Humans; Influenza, Human; Interferon-beta; Male; MicroRNAs; Middle Aged; p300-CBP Transcription Factors; Phosphorylation; Pulmonary Disease, Chronic Obstructive; Stress, Physiological; Virus Replication; antagomir; beta interferon; corticosteroid; E1A associated p300 protein; enhanceosome; protein kinase R; antivirus agent; beta interferon; histone acetyltransferase PCAF; microRNA; MIRN132 microRNA, human; p300-CBP-associated factor; protein kinase R; adult; Article; bronchus mucosa; cell granule; cell stress; chronic obstructive lung disease; controlled study; corticosteroid therapy; ectopic expression; female; human; human cell; infection sensitivity; influenza A (H1N1); Influenza A virus (H1N1); Influenza virus; interferon induction; lung alveolus epithelium; male; nonhuman; protein expression; regulatory mechanism; virus replication; bronchus; chronic obstructive lung disease; complication; disease predisposition; epithelium; epithelium cell; immunology; influenza; metabolism; middle aged; pathology; phosphorylation; physiological stress; virology",Article,Final,,Scopus,2-s2.0-84988977653
Vanders R.L.; Murphy V.E.; Gibson P.G.; Hansbro P.M.; Wark P.A.B.,"Vanders, Rebecca L. (55773360100); Murphy, Vanessa E. (7006804832); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390); Wark, Peter A.B. (7003559516)",55773360100; 7006804832; 7202414199; 6603119390; 7003559516,CD8 T cells and dendritic cells: Key players in the attenuated maternal immune response to influenza infection,2015,Journal of Reproductive Immunology,107,,,1,9,8,22,10.1016/j.jri.2014.09.051,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921054511&doi=10.1016%2fj.jri.2014.09.051&partnerID=40&md5=4756a9b8adc338c13ea2f53ac5347e40,"Centre for Asthma and Respiratory Diseases, The University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia; The Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia","Vanders R.L., Centre for Asthma and Respiratory Diseases, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Murphy V.E., Centre for Asthma and Respiratory Diseases, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Gibson P.G., Centre for Asthma and Respiratory Diseases, The University of Newcastle, Newcastle, NSW, Australia, The Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases, The University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia; Wark P.A.B., Centre for Asthma and Respiratory Diseases, The University of Newcastle, Newcastle, NSW, Australia, The Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia",CD8T cells; Dendritic cells (DCs); H1N1pdm09; Infection; Influenza; Pregnancy,"Animals; CD8-Positive T-Lymphocytes; Dendritic Cells; Female; Humans; Influenza, Human; Maternal Exposure; Mice; Pregnancy; Pregnancy Complications, Infectious; CD8 antigen; adult respiratory distress syndrome; CD8+ T lymphocyte; death; dendritic cell; disease severity; hospitalization; human; immune response; immunocompetent cell; immunological tolerance; infection sensitivity; influenza; Influenza virus; intensive care unit; nonhuman; pneumonia; pregnancy; priority journal; respiratory virus; Review; animal; CD8+ T lymphocyte; dendritic cell; environmental exposure; female; immunology; influenza; mouse; pathology; pregnancy complication",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84921054511
Hansbro P.M.; Starkey M.R.; Mattes J.; Horvat J.C.,"Hansbro, Philip M. (6603119390); Starkey, Malcolm R. (35811293400); Mattes, Joerg (7005999915); Horvat, Jay C. (9942405300)",6603119390; 35811293400; 7005999915; 9942405300,Pulmonary immunity during respiratory infections in early life and the development of severe asthma,2014,Annals of the American Thoracic Society,11,,,S297,S302,5,30,10.1513/AnnalsATS.201402-086AW,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84919621465&doi=10.1513%2fAnnalsATS.201402-086AW&partnerID=40&md5=c4e51f0b99688096a7a1614ac586ee5d,"Faculty of Health, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Pediatric Respiratory and Sleep Medicine Unit, Newcastle Children's Hospital, Kaleidoscope, New Lambton Heights, NSW, Australia; Hunter Medical Research Institute, Kookaburra Circuit, New Lambton Heights, Newcastle, 2315, NSW, Australia","Hansbro P.M., Faculty of Health, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Hunter Medical Research Institute, Kookaburra Circuit, New Lambton Heights, Newcastle, 2315, NSW, Australia; Starkey M.R., Faculty of Health, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; Mattes J., Faculty of Health, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia, Pediatric Respiratory and Sleep Medicine Unit, Newcastle Children's Hospital, Kaleidoscope, New Lambton Heights, NSW, Australia; Horvat J.C., Faculty of Health, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia",Asthma; Chlamydia; Early life; IL-13; Tumor necrosis factor-related apoptosis-inducing ligand,"Age Factors; Allergens; Animals; Asthma; Cytokines; Humans; Immunity, Cellular; Lung; Mice; Respiratory Tract Infections; Severity of Illness Index; antigen; bronchodilating agent; corticosteroid; interleukin 13; tumor necrosis factor related apoptosis inducing ligand; allergen; cytokine; adulthood; allergic airway disease; allergic airway inflammation; Article; asthma; bacterial infection; Chlamydia; chronic disease; chronic lung disease; cytokine response; disease severity; gene deletion; histopathology; human; Human respiratory syncytial virus; immune response; immunity; infection prevention; infection sensitivity; inflammation; lung function; lung structure; mouse model; mucus hypersecretion; Mycoplasma; newborn infection; nonhuman; protein expression; respiratory tract allergy; respiratory tract disease; respiratory tract infection; Rhinovirus; weight reduction; age; animal; asthma; cellular immunity; complication; immunology; lung; mouse; respiratory tract infection; severity of illness index",Article,Final,,Scopus,2-s2.0-84919621465
Rehaume L.M.; Mondot S.; Aguirre De Cárcer D.; Velasco J.; Benham H.; Hasnain S.Z.; Bowman J.; Ruutu M.; Hansbro P.M.; McGuckin M.A.; Morrison M.; Thomas R.,"Rehaume, Linda M. (14014230900); Mondot, Stanislas (24399495300); Aguirre De Cárcer, Daniel (22633587200); Velasco, Jared (55274502900); Benham, Helen (35745781800); Hasnain, Sumaira Z. (36070549800); Bowman, Jaclyn (57212471085); Ruutu, Merja (57197575194); Hansbro, Philip M. (6603119390); McGuckin, Michael A. (7005603176); Morrison, Mark (7201675268); Thomas, Ranjeny (35430984400)",14014230900; 24399495300; 22633587200; 55274502900; 35745781800; 36070549800; 57212471085; 57197575194; 6603119390; 7005603176; 7201675268; 35430984400,"ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice",2014,Arthritis and Rheumatology,66,10,,2780,2792,12,146,10.1002/art.38773,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908374585&doi=10.1002%2fart.38773&partnerID=40&md5=1898933b4dd6c62effe25a7aff396be4,"University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, 4102, QLD, Australia; Animal, Food and Health Sciences, Commonwealth Scientific and Industrial Research Organisation, Brisbane, QLD, Australia; Translational Research Institute, University of Queensland, Brisbane, QLD, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Rehaume L.M., University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, 4102, QLD, Australia; Mondot S., Animal, Food and Health Sciences, Commonwealth Scientific and Industrial Research Organisation, Brisbane, QLD, Australia; Aguirre De Cárcer D., Animal, Food and Health Sciences, Commonwealth Scientific and Industrial Research Organisation, Brisbane, QLD, Australia; Velasco J., University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, 4102, QLD, Australia; Benham H., University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, 4102, QLD, Australia; Hasnain S.Z., Translational Research Institute, University of Queensland, Brisbane, QLD, Australia; Bowman J., University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, 4102, QLD, Australia; Ruutu M., University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, 4102, QLD, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; McGuckin M.A., Translational Research Institute, University of Queensland, Brisbane, QLD, Australia; Morrison M., Animal, Food and Health Sciences, Commonwealth Scientific and Industrial Research Organisation, Brisbane, QLD, Australia; Thomas R., University of Queensland Diamantina Institute, 37 Kent Street, Woolloongabba, 4102, QLD, Australia",,"Animals; Genetic Predisposition to Disease; Genotype; Ileitis; Interleukin-23; Mice; Mice, Inbred BALB C; Mice, Knockout; Microbiota; Severity of Illness Index; Spondylarthritis; Toll-Like Receptor 4; ZAP-70 Protein-Tyrosine Kinase; curdlan; interleukin 17; interleukin 23; protein kinase ZAP 70; T lymphocyte receptor; tight junction protein; toll like receptor 4; interleukin 23; protein kinase ZAP 70; Tlr4 protein, mouse; toll like receptor 4; allele; animal experiment; Article; cell loss; controlled study; cytokine production; disease severity; endoplasmic reticulum stress; enzyme linked immunosorbent assay; flow cytometry; gene disruption; genotype; goblet cell; host; ileitis; inflammation; intestine flora; microbiome; mouse; nonhuman; peritoneal cavity; prospective study; protein expression; pyrosequencing; real time polymerase chain reaction; signal transduction; spondylarthritis; treatment outcome; weaning; animal; Bagg albino mouse; genetic predisposition; genetics; ileitis; knockout mouse; metabolism; microbiology; microflora; severity of illness index; spondylarthritis",Article,Final,,Scopus,2-s2.0-84908374585
Franklin B.S.; Bossaller L.; De Nardo D.; Ratter J.M.; Stutz A.; Engels G.; Brenker C.; Nordhoff M.; Mirandola S.R.; Al-Amoudi A.; Mangan M.S.; Zimmer S.; Monks B.G.; Fricke M.; Schmidt R.E.; Espevik T.; Jones B.; Jarnicki A.G.; Hansbro P.M.; Busto P.; Marshak-Rothstein A.; Hornemann S.; Aguzzi A.; Kastenmüller W.; Latz E.,"Franklin, Bernardo S. (7103223674); Bossaller, Lukas (6503927181); De Nardo, Dominic (8254619000); Ratter, Jacqueline M. (56215329200); Stutz, Andrea (35071964700); Engels, Gudrun (9842615500); Brenker, Christoph (37039410600); Nordhoff, Mark (57189495745); Mirandola, Sandra R. (12240080600); Al-Amoudi, Ashraf (6602578934); Mangan, Matthew S. (24376948400); Zimmer, Sebastian (26665221300); Monks, Brian G. (6701488620); Fricke, Martin (57196492018); Schmidt, Reinhold E. (56393151400); Espevik, Terje (7005312470); Jones, Bernadette (56215070300); Jarnicki, Andrew G. (6603137164); Hansbro, Philip M. (6603119390); Busto, Patricia (6602549962); Marshak-Rothstein, Ann (57207548276); Hornemann, Simone (6602199264); Aguzzi, Adriano (7102605630); Kastenmüller, Wolfgang (8757956000); Latz, Eicke (6603435284)",7103223674; 6503927181; 8254619000; 56215329200; 35071964700; 9842615500; 37039410600; 57189495745; 12240080600; 6602578934; 24376948400; 26665221300; 6701488620; 57196492018; 56393151400; 7005312470; 56215070300; 6603137164; 6603119390; 6602549962; 57207548276; 6602199264; 7102605630; 8757956000; 6603435284,The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation,2014,Nature Immunology,15,8,,727,737,10,616,10.1038/ni.2913,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904692363&doi=10.1038%2fni.2913&partnerID=40&md5=647016c979cbb9e6fa0a077448e10cf4,"Institute of Innate Immunity, University Hospitals, University of Bonn, Bonn, Germany; Department of Immunology and Rheumatology, Hannover Medical School, Hannover, Germany; Department of Infectious Diseases and Immunology, University of Massachusetts, Medical School, Worcester, MA, United States; German Center for Neurodegenerative Diseases, Bonn, Germany; Department of Medicine/Cardiology, University Hospitals, University of Bonn, Bonn, Germany; Center of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia; University Hospital Zürich, Institute of Neuropathology, Zürich, Switzerland; Institute of Molecular Medicine and Experimental Immunology, University Hospitals, University of Bonn, Bonn, Germany","Franklin B.S., Institute of Innate Immunity, University Hospitals, University of Bonn, Bonn, Germany; Bossaller L., Department of Immunology and Rheumatology, Hannover Medical School, Hannover, Germany, Department of Infectious Diseases and Immunology, University of Massachusetts, Medical School, Worcester, MA, United States; De Nardo D., Institute of Innate Immunity, University Hospitals, University of Bonn, Bonn, Germany; Ratter J.M., Institute of Innate Immunity, University Hospitals, University of Bonn, Bonn, Germany; Stutz A., Institute of Innate Immunity, University Hospitals, University of Bonn, Bonn, Germany; Engels G., Institute of Innate Immunity, University Hospitals, University of Bonn, Bonn, Germany; Brenker C., German Center for Neurodegenerative Diseases, Bonn, Germany; Nordhoff M., German Center for Neurodegenerative Diseases, Bonn, Germany; Mirandola S.R., German Center for Neurodegenerative Diseases, Bonn, Germany; Al-Amoudi A., German Center for Neurodegenerative Diseases, Bonn, Germany; Mangan M.S., Institute of Innate Immunity, University Hospitals, University of Bonn, Bonn, Germany, German Center for Neurodegenerative Diseases, Bonn, Germany; Zimmer S., Department of Medicine/Cardiology, University Hospitals, University of Bonn, Bonn, Germany; Monks B.G., Institute of Innate Immunity, University Hospitals, University of Bonn, Bonn, Germany, Department of Infectious Diseases and Immunology, University of Massachusetts, Medical School, Worcester, MA, United States; Fricke M., Department of Immunology and Rheumatology, Hannover Medical School, Hannover, Germany; Schmidt R.E., Department of Immunology and Rheumatology, Hannover Medical School, Hannover, Germany; Espevik T., Center of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Jones B., Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia; Jarnicki A.G., Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia; Busto P., Department of Infectious Diseases and Immunology, University of Massachusetts, Medical School, Worcester, MA, United States; Marshak-Rothstein A., Department of Infectious Diseases and Immunology, University of Massachusetts, Medical School, Worcester, MA, United States; Hornemann S., University Hospital Zürich, Institute of Neuropathology, Zürich, Switzerland; Aguzzi A., University Hospital Zürich, Institute of Neuropathology, Zürich, Switzerland; Kastenmüller W., Institute of Molecular Medicine and Experimental Immunology, University Hospitals, University of Bonn, Bonn, Germany; Latz E., Institute of Innate Immunity, University Hospitals, University of Bonn, Bonn, Germany, Department of Infectious Diseases and Immunology, University of Massachusetts, Medical School, Worcester, MA, United States, German Center for Neurodegenerative Diseases, Bonn, Germany, Center of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway",,"Amino Acid Chloromethyl Ketones; Animals; Antibodies; Apoptosis; Autoantibodies; Autoimmune Diseases; Carrier Proteins; Caspase 1; Caspase Inhibitors; Cell Communication; Cytoskeletal Proteins; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Lysosomes; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Phagocytosis; Prions; Pseudomonas aeruginosa; Pseudomonas Infections; Signal Transduction; adaptor asc protein; adaptor protein; autoantibody; inflammasome; interleukin 1beta; interleukin 1beta converting enzyme; unclassified drug; animal experiment; article; autoimmune disease; cell communication; cell damage; cell death; confocal microscopy; controlled study; enzyme activation; extracellular fluid; extracellular matrix; extracellular space; flow cytometry; human; human cell; inflammation; inflammatory disease; lung lavage; lysosome; macrophage; mouse; nonhuman; phagocytosis; priority journal; protein function; protein processing; protein protein interaction; protein secretion; pyroptosis",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-84904692363
Sozo F.; Horvat J.C.; Essilfie A.-T.; O'Reilly M.; Hansbro P.M.; Harding R.,"Sozo, Foula (8915715900); Horvat, Jay C. (9942405300); Essilfie, Ama-Tawiah (22955585600); O'Reilly, Megan (57198134621); Hansbro, Philip M. (6603119390); Harding, Richard (7201911358)",8915715900; 9942405300; 22955585600; 57198134621; 6603119390; 7201911358,Altered lung function at mid-adulthood in mice following neonatal exposure to hyperoxia,2015,Respiratory Physiology and Neurobiology,218,,,21,27,6,15,10.1016/j.resp.2015.07.004,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938789466&doi=10.1016%2fj.resp.2015.07.004&partnerID=40&md5=b3190423c15d5ac2dd8a98808105773d,"Department of Anatomy and Developmental Biology, Monash University, 3800, VIC, Australia; Centre for Asthma and Respiratory Disease, The Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia; Department of Pediatrics, Women and Children's Health Research Institute, University of Alberta, Edmonton, T6G 2E1, AB, Canada","Sozo F., Department of Anatomy and Developmental Biology, Monash University, 3800, VIC, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, The Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia; Essilfie A.-T., Centre for Asthma and Respiratory Disease, The Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia; O'Reilly M., Department of Anatomy and Developmental Biology, Monash University, 3800, VIC, Australia, Department of Pediatrics, Women and Children's Health Research Institute, University of Alberta, Edmonton, T6G 2E1, AB, Canada; Hansbro P.M., Centre for Asthma and Respiratory Disease, The Hunter Medical Research Institute, The University of Newcastle, Newcastle, 2308, NSW, Australia; Harding R., Department of Anatomy and Developmental Biology, Monash University, 3800, VIC, Australia",Airway reactivity; Developmental origins of adult disease; Forced maneuvers; Forced oscillometry,"Animals; Animals, Newborn; Body Weight; Bronchoconstrictor Agents; Disease Models, Animal; Female; Hyperoxia; Lung; Lung Volume Measurements; Male; Methacholine Chloride; Mice, Inbred C57BL; Sex Characteristics; methacholine; oxygen; bronchoconstricting agent; methacholine chloride; adulthood; airway resistance; ambient air; animal experiment; Article; birth weight; controlled study; drug dose increase; exposure; female; forced expiratory volume; forced vital capacity; functional residual capacity; hyperoxia; inspiratory capacity; inspiratory reserve volume; lung compliance; lung development; lung function; lung function test; lung insufficiency; male; mouse; newborn; nonhuman; oscillometry; postnatal growth; prematurity; priority journal; sex difference; tidal volume; total lung capacity; animal; body weight; C57BL mouse; disease model; drug effects; growth, development and aging; hyperoxia; lung; lung volume; pathophysiology; sexual development",Article,Final,,Scopus,2-s2.0-84938789466
Ormerod K.L.; Wood D.L.A.; Lachner N.; Gellatly S.L.; Daly J.N.; Parsons J.D.; Dal'Molin C.G.O.; Palfreyman R.W.; Nielsen L.K.; Cooper M.A.; Morrison M.; Hansbro P.M.; Hugenholtz P.,"Ormerod, Kate L. (55147965300); Wood, David L.A. (55723732300); Lachner, Nancy (55625753600); Gellatly, Shaan L. (26430804400); Daly, Joshua N. (55183984400); Parsons, Jeremy D. (7402708504); Dal'Molin, Cristiana G.O. (55991497000); Palfreyman, Robin W. (35783362100); Nielsen, Lars K. (7202609649); Cooper, Matthew A. (7404411451); Morrison, Mark (7201675268); Hansbro, Philip M. (6603119390); Hugenholtz, Philip (55811879700)",55147965300; 55723732300; 55625753600; 26430804400; 55183984400; 7402708504; 55991497000; 35783362100; 7202609649; 7404411451; 7201675268; 6603119390; 55811879700,Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals,2016,Microbiome,4,,36,,,,478,10.1186/s40168-016-0181-2,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84997541867&doi=10.1186%2fs40168-016-0181-2&partnerID=40&md5=d6d9dcd0ba007588accdc88286ebdfb8,"Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia; Priority Research Centre for Healthy Lungs, The University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; QFAB Bioinformatics, The University of Queensland, Brisbane, Australia; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; Microbial Biology and Metagenomics, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia","Ormerod K.L., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia; Wood D.L.A., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia; Lachner N., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia; Gellatly S.L., Priority Research Centre for Healthy Lungs, The University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Daly J.N., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia; Parsons J.D., QFAB Bioinformatics, The University of Queensland, Brisbane, Australia; Dal'Molin C.G.O., Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia; Palfreyman R.W., Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia; Nielsen L.K., Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia; Cooper M.A., Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia; Morrison M., Microbial Biology and Metagenomics, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia; Hansbro P.M., Priority Research Centre for Healthy Lungs, The University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; Hugenholtz P., Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia",Comparative genomics; Gut microbiome; Homeothermaceae; Metagenomics; Population genomes; S24-7,"Animals; Bacteroidetes; Feces; Gastrointestinal Tract; Genome, Bacterial; Guinea Pigs; Host-Pathogen Interactions; Humans; Metagenomics; Mice; Microbiota; Phascolarctidae; Phylogeny; Polysaccharides; carbohydrate; glycan; polysaccharide; RNA 16S; animal experiment; Article; Bacteroidales; Candidatus Homeothermaceae; dysbiosis; feces analysis; female; gastrointestinal tract; gene sequence; genetic analysis; human; intestine flora; marker gene; molecular genetics; mouse; nonhuman; phylogenetic tree; phylogeny; priority journal; sequence homology; animal; bacterial genome; Bacteroidetes; feces; genetics; guinea pig; host pathogen interaction; isolation and purification; koala; metabolism; metagenomics; microbiology; microflora; physiology; procedures",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84997541867
Hsu A.C.-Y.; Barr I.; Hansbro P.M.; Wark P.A.,"Hsu, Alan Chen-Yu (49861516600); Barr, Ian (7004651416); Hansbro, Philip M. (6603119390); Wark, Peter A. (7003559516)",49861516600; 7004651416; 6603119390; 7003559516,Human influenza is more effective than avian influenza at antiviral suppression in airway cells,2011,American Journal of Respiratory Cell and Molecular Biology,44,6,,906,913,7,36,10.1165/rcmb.2010-0157OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955393095&doi=10.1165%2frcmb.2010-0157OC&partnerID=40&md5=bfdfcb328f8d403c73cc2e25efc76882,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; World Health Organization Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia","Hsu A.C.-Y., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Barr I., World Health Organization Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Wark P.A., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia",Antiviral; IFN; Influenza; Innate immune response,"Animals; Antiviral Agents; Birds; Bronchi; Cell Line; Dogs; Epithelial Cells; Flow Cytometry; Humans; Immunity, Innate; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza in Birds; Influenza, Human; Kidney; Aves; Avian influenza virus; Orthomyxoviridae; beta interferon; gamma interferon; nonstructural protein 1; sialic acid; antiviral therapy; article; avian influenza virus; bronchial epithelium cell; epithelium cell; genetic code; human; human cell; Influenza virus A H3N2; lung alveolus cell; nonhuman; protein function; signal transduction; virus expression; virus replication",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-79955393095
Jennings P.C.; Merriman J.A.; Beckett E.L.; Hansbro P.M.; Jones K.T.,"Jennings, Phoebe C. (37034129800); Merriman, Julie A. (7004022093); Beckett, Emma L. (36620958500); Hansbro, Philip M. (6603119390); Jones, Keith T. (7404727750)",37034129800; 7004022093; 36620958500; 6603119390; 7404727750,Increased zona pellucida thickness and meiotic spindle disruption in oocytes from cigarette smoking mice,2011,Human Reproduction,26,4,,878,884,6,46,10.1093/humrep/deq393,https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952822093&doi=10.1093%2fhumrep%2fdeq393&partnerID=40&md5=eb0a0c4d462339aed182e0178cfbd309,"School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia","Jennings P.C., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia; Merriman J.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia; Beckett E.L., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia, Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia; Hansbro P.M., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia, Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, Australia; Jones K.T., School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia",environmental effects; meiosis; oocyte quality; smoking; zona pellucida,Mus; tubulin; animal experiment; animal model; animal tissue; article; cell structure; chromatin; chromosome; chronic obstructive lung disease; cigarette smoking; clinical study; confocal microscopy; controlled study; female; female fertility; in vitro study; lung emphysema; lung parenchyma; meiosis; mouse; nonhuman; oocyte development; oocyte maturation; oocyte retrieval; quality control; thickness; zona pellucida,Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-79952822093
Keely S.; Hansbro P.M.,"Keely, Simon (9739611200); Hansbro, Philip M. (6603119390)",9739611200; 6603119390,Lung-gut cross talk : A potential mechanism for intestinal dysfunction in patients with COPD,2014,Chest,145,2,,199,200,1,38,10.1378/chest.13-2077,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893661300&doi=10.1378%2fchest.13-2077&partnerID=40&md5=7110cdcb65079e52d2f854e0222cff91,"School of Biomedical Science and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia","Keely S., School of Biomedical Science and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia; Hansbro P.M., School of Biomedical Science and Pharmacy, University of Newcastle, Callaghan, 2308, NSW, Australia",,"Activities of Daily Living; Female; Humans; Intestines; Male; Pulmonary Disease, Chronic Obstructive; lactic acid; atrophic gastritis; cell damage; chronic obstructive lung disease; Crohn disease; digestive system function disorder; disease association; editorial; human; intestine cell; intestine ischemia; intestine mucosa permeability; intestine perfusion; lactate blood level; lung capacity; malabsorption; physical activity; priority journal; smoking",Editorial,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84893661300
Baillet A.C.; Rehaume L.M.; Benham H.; O'Meara C.P.; Armitage C.W.; Ruscher R.; Brizard G.; Harvie M.C.G.; Velasco J.; Hansbro P.M.; Forrester J.V.; Degli-Esposti M.A.; Beagley K.W.; Thomas R.,"Baillet, Athan C. (16038832200); Rehaume, Linda M. (14014230900); Benham, Helen (35745781800); O'Meara, Connor P. (56051713800); Armitage, Charles W. (36652335800); Ruscher, Roland (16403188900); Brizard, Geraldine (6506227104); Harvie, Marina C. G. (6603246046); Velasco, Jared (55274502900); Hansbro, Phillip M. (6603119390); Forrester, John V. (7201453754); Degli-Esposti, Mariapia A. (54790550500); Beagley, Kenneth W. (7005403437); Thomas, Ranjeny (35430984400)",16038832200; 14014230900; 35745781800; 56051713800; 36652335800; 16403188900; 6506227104; 6603246046; 55274502900; 6603119390; 7201453754; 54790550500; 7005403437; 35430984400,High Chlamydia burden promotes tumor necrosis factor-dependent reactive arthritis in SKG mice,2015,Arthritis and Rheumatology,67,6,,1535,1547,12,36,10.1002/art.39041,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929878759&doi=10.1002%2fart.39041&partnerID=40&md5=12c3dcdc8e2347d0a6ffefb9a899047e,"University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia; Queensland University of Technology, Brisbane, QLD, Australia; Lions Eye Institute, Nedlands, WA, Australia; Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; University of Aberdeen Medical School, Aberdeen, United Kingdom; University of West Australia, Crawley, WA, Australia; University of Queensland Diamantina Institute, Translational Research Institute, 37 Kent Street, Woolloongabba, 4102, QLD, Australia","Baillet A.C., University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia; Rehaume L.M., University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia; Benham H., University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia; O'Meara C.P., Queensland University of Technology, Brisbane, QLD, Australia; Armitage C.W., Queensland University of Technology, Brisbane, QLD, Australia; Ruscher R., University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia; Brizard G., Lions Eye Institute, Nedlands, WA, Australia; Harvie M.C.G., Queensland University of Technology, Brisbane, QLD, Australia; Velasco J., University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia; Hansbro P.M., Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Forrester J.V., Lions Eye Institute, Nedlands, WA, Australia, University of Aberdeen Medical School, Aberdeen, United Kingdom; Degli-Esposti M.A., Lions Eye Institute, Nedlands, WA, Australia, University of West Australia, Crawley, WA, Australia; Beagley K.W., Queensland University of Technology, Brisbane, QLD, Australia; Thomas R., University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia, University of Queensland Diamantina Institute, Translational Research Institute, 37 Kent Street, Woolloongabba, 4102, QLD, Australia",,"Animals; Antibodies, Bacterial; Arthritis, Reactive; Chlamydia Infections; Chlamydia muridarum; Female; Inflammatory Bowel Diseases; Interferon-gamma; Interleukin-17; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Psoriasis; Reproductive Tract Infections; Respiratory Tract Infections; T-Lymphocytes; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha; Vaginosis, Bacterial; bacterial DNA; beta glucan; doxycycline; etanercept; gamma interferon; interleukin 17; outer membrane protein; protein kinase ZAP 70; rifampicin; tumor necrosis factor; tumor necrosis factor receptor; bacterium antibody; gamma interferon; tumor necrosis factor alpha; adaptive immunity; animal cell; animal experiment; animal model; animal tissue; Article; bacterial load; bone marrow cell; CD4+ T lymphocyte; cell proliferation; Chlamydia muridarum; chlamydiasis; conjunctivitis; controlled study; cytokine production; cytokine response; disease severity; enthesitis; female; hind paw; histology; infection control; inflammatory bowel disease; innate immunity; male; mouse; nonhuman; priority journal; psoriasis; reactive arthritis; regulatory T lymphocyte; respiratory tract infection; sacroiliitis; spondylarthritis; synovitis; T cell depletion; vaginitis; animal; Bagg albino mouse; Chlamydia muridarum; chlamydiasis; genital tract infection; immunology; inbred mouse strain; reactive arthritis; T lymphocyte",Article,Final,,Scopus,2-s2.0-84929878759
Kim R.Y.; Pinkerton J.W.; Gibson P.G.; Cooper M.A.; Horvat J.C.; Hansbro P.M.,"Kim, Richard Y (35810406900); Pinkerton, James W (56647761900); Gibson, Peter G (7202414199); Cooper, Matthew A (7404411451); Horvat, Jay C (9942405300); Hansbro, Philip M (6603119390)",35810406900; 56647761900; 7202414199; 7404411451; 9942405300; 6603119390,Inflammasomes in COPD and neutrophilic asthma,2015,Thorax,70,12,,1199,1201,2,111,10.1136/thoraxjnl-2014-206736,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957865023&doi=10.1136%2fthoraxjnl-2014-206736&partnerID=40&md5=00ad124ce46b5a7d4b0d213debede77f,"Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia","Kim R.Y., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Pinkerton J.W., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Gibson P.G., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Cooper M.A., Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia; Horvat J.C., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",,"Asthma; Carrier Proteins; Caspase 1; Cytokines; Gene Expression Profiling; Humans; Inflammasomes; Interleukin-1beta; Neutrophils; Pulmonary Disease, Chronic Obstructive; Smoking; carrier protein; cytokine; inflammasome; interleukin 1beta; interleukin 1beta converting enzyme; NLRP3 protein, human; asthma; chronic obstructive lung disease; gene expression profiling; genetics; human; neutrophil; pathophysiology; physiology; smoking",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84957865023
Singanayagam A.; Glanville N.; Walton R.P.; Aniscenko J.; Pearson R.M.; Pinkerton J.W.; Horvat J.C.; Hansbro P.M.; Bartlett N.W.; Johnston S.L.,"Singanayagam, Aran (58326971200); Glanville, Nicholas (23488491900); Walton, Ross P. (23491144800); Aniscenko, Julia (36550124000); Pearson, Rebecca M. (55891932000); Pinkerton, James W. (56647761900); Horvat, Jay C. (9942405300); Hansbro, Philip M. (6603119390); Bartlett, Nathan W. (7005608564); Johnston, Sebastian L. (7401781716)",58326971200; 23488491900; 23491144800; 36550124000; 55891932000; 56647761900; 9942405300; 6603119390; 7005608564; 7401781716,A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD,2015,Clinical Science,129,3,,245,258,13,37,10.1042/CS20140654,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937511650&doi=10.1042%2fCS20140654&partnerID=40&md5=eb60315262089ab5979769df2aa709ce,"Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, W2 1PG, United Kingdom; Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute and University of Newcastle, Newcastle, 2305, NSW, Australia","Singanayagam A., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, W2 1PG, United Kingdom; Glanville N., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, W2 1PG, United Kingdom; Walton R.P., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, W2 1PG, United Kingdom; Aniscenko J., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, W2 1PG, United Kingdom; Pearson R.M., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, W2 1PG, United Kingdom; Pinkerton J.W., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute and University of Newcastle, Newcastle, 2305, NSW, Australia; Horvat J.C., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute and University of Newcastle, Newcastle, 2305, NSW, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute and University of Newcastle, Newcastle, 2305, NSW, Australia; Bartlett N.W., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, W2 1PG, United Kingdom, Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute and University of Newcastle, Newcastle, 2305, NSW, Australia; Johnston S.L., Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, W2 1PG, United Kingdom",Chronic obstructive pulmonary disease; Exacerbation; Inflammation; Mouse models; Rhinovirus,"Animals; Asthma; Chemokines; Disease Models, Animal; Female; Lipopolysaccharides; Mice, Inbred C57BL; Picornaviridae Infections; Pulmonary Disease, Chronic Obstructive; Rhinovirus; Time Factors; CXCL1 chemokine; elastase; gamma interferon inducible protein 10; lipopolysaccharide; RANTES; tumor necrosis factor alpha; chemokine; animal cell; animal experiment; animal model; Article; chronic obstructive lung disease; disease exacerbation; immune response; immunopathology; inflammation; mouse; mouse model; mucus secretion; nonhuman; priority journal; protein expression; protein secretion; Rhinovirus; T lymphocyte; animal; asthma; C57BL mouse; chronic obstructive lung disease; disease model; female; immunology; picornavirus infection; Rhinovirus; time; virology",Article,Final,All Open Access; Green Open Access; Hybrid Gold Open Access,Scopus,2-s2.0-84937511650
Simpson J.L.; Baines K.J.; Horvat J.C.; Essilfie A.-T.; Brown A.C.; Tooze M.; McDonald V.M.; Gibson P.G.; Hansbro P.M.,"Simpson, Jodie L. (7404326026); Baines, Katherine J. (35078051200); Horvat, Jay C. (9942405300); Essilfie, Ama-Tawiah (22955585600); Brown, Alexandra C. (55637745000); Tooze, Melinda (55200786900); McDonald, Vanessa M. (12242373300); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390)",7404326026; 35078051200; 9942405300; 22955585600; 55637745000; 55200786900; 12242373300; 7202414199; 6603119390,"COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species",2016,Respirology,21,4,,697,704,7,56,10.1111/resp.12734,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955296344&doi=10.1111%2fresp.12734&partnerID=40&md5=c5ea512de99807b7065731480b42c3b6,"Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia; Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton Heights, NSW, Australia","Simpson J.L., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia; Baines K.J., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia; Horvat J.C., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia; Essilfie A.-T., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia; Brown A.C., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia; Tooze M., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia; McDonald V.M., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton Heights, NSW, Australia; Gibson P.G., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton Heights, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, Callaghan, NSW, Australia",bacteria; chronic obstructive pulmonary disease; inflammation; pathogen,"Adult; Aged; Bacillus; Bacterial Load; Case-Control Studies; Female; Haemophilus influenzae; Humans; Interleukin-1beta; Leukocyte Count; Leukocyte Elastase; Male; Middle Aged; Neutrophils; Pulmonary Disease, Chronic Obstructive; Sputum; Streptococcus pneumoniae; Surveys and Questionnaires; Young Adult; interleukin 1beta; leukocyte elastase; interleukin 1beta; leukocyte elastase; adult; Article; Bacillus; bacterial load; bacterium culture; bacterium detection; cell count; chronic obstructive lung disease; clinical assessment; cohort analysis; controlled study; emphysema; female; Haemophilus influenzae; human; inflammation; lung diffusion capacity; lung insufficiency; major clinical study; male; neutrophil; pathogenesis; priority journal; real time polymerase chain reaction; smoking; sputum analysis; sputum level; St. George Respiratory Questionnaire; Streptococcus pneumoniae; supernatant; aged; Bacillus; bacterial load; case control study; chemistry; chronic obstructive lung disease; cytology; Haemophilus influenzae; isolation and purification; leukocyte count; microbiology; middle aged; neutrophil; pathophysiology; questionnaire; sputum; Streptococcus pneumoniae; young adult",Article,Final,,Scopus,2-s2.0-84955296344
Starkey M.R.; Jarnicki A.G.; Essilfie A.-T.; Gellatly S.L.; Kim R.Y.; Brown A.C.; Foster P.S.; Horvat J.C.; Hansbro P.M.,"Starkey, Malcolm Ronald (35811293400); Jarnicki, Andrew Gregory (6603137164); Essilfie, Ama-Tawiah (22955585600); Gellatly, Shaan Lae (26430804400); Kim, Richard Yong (35810406900); Brown, Alexandra Cerelina (55637745000); Foster, Paul Stephen (7201517569); Horvat, Jay Christopher (9942405300); Hansbro, Philip Michael (6603119390)",35811293400; 6603137164; 22955585600; 26430804400; 35810406900; 55637745000; 7201517569; 9942405300; 6603119390,Murine models of infectious exacerbations of airway inflammation,2013,Current Opinion in Pharmacology,13,3,,337,344,7,63,10.1016/j.coph.2013.03.005,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879096032&doi=10.1016%2fj.coph.2013.03.005&partnerID=40&md5=178432b695c12f6ea3a9b1c2784dcfca,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia","Starkey M.R., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Jarnicki A.G., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Essilfie A.-T., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Gellatly S.L., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kim R.Y., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Brown A.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia",,"Animals; Bacterial Infections; Disease Models, Animal; Humans; Lung Diseases; Virus Diseases; corticosteroid; CXCL1 chemokine; CXCL2 chemokine; elastase; gamma interferon; house dust allergen; immunoglobulin E; interleukin 13; interleukin 17; interleukin 27; interleukin 4 receptor alpha; interleukin 5; lipopolysaccharide; ovalbumin; transcription factor FOXP3; transcription factor GATA 3; asthma; Chlamydia; chlamydiasis; chronic obstructive lung disease; cystic fibrosis; cytokine production; disease exacerbation; disease model; disease severity; Haemophilus influenzae; immune response; immunological tolerance; infection sensitivity; influenza; Influenza virus; lung structure; medical research; mouse; nonhuman; priority journal; protein expression; Pseudomonas aeruginosa; Respiratory syncytial pneumovirus; respiratory syncytial virus infection; respiratory tract infection; respiratory tract inflammation; review; Rhinovirus; Rhinovirus infection; smoking; Streptococcus pneumoniae; Th1 cell; Th17 cell; Th2 cell",Review,Final,,Scopus,2-s2.0-84879096032
Suthers B.; Hansbro P.; Thambar S.; McEvoy M.; Peel R.; Attia J.,"Suthers, B. (57192952582); Hansbro, P. (6603119390); Thambar, S. (57212863574); McEvoy, M. (8911690100); Peel, R. (55207142000); Attia, J. (7003299759)",57192952582; 6603119390; 57212863574; 8911690100; 55207142000; 7003299759,Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease,2012,Vaccine,30,27,,3983,3985,2,21,10.1016/j.vaccine.2012.03.084,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861479380&doi=10.1016%2fj.vaccine.2012.03.084&partnerID=40&md5=6ff325034754c81d7340cdfa55bc8fe6,"Dept of Medicine, John Hunter Hospital, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Centre for Clinical Epidemiology and Biostatistics, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia","Suthers B., Dept of Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Hansbro P., School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Thambar S., Dept of Medicine, John Hunter Hospital, Newcastle, NSW, Australia; McEvoy M., Centre for Clinical Epidemiology and Biostatistics, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Peel R., Centre for Clinical Epidemiology and Biostatistics, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Attia J., Dept of Medicine, John Hunter Hospital, Newcastle, NSW, Australia, Centre for Clinical Epidemiology and Biostatistics, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia",Anti-oxLDL antibodies; Cardiovascular disease; Ox-LDL; Pneumococcal vaccine,"Aged; Antibodies, Bacterial; Atherosclerosis; Autoantibodies; Cardiovascular Diseases; Female; Humans; Immunoglobulin G; Lipoproteins, LDL; Male; Middle Aged; Pneumococcal Vaccines; Vaccination; antibody; autoantibody; immunoglobulin G antibody; oxidized low density lipoprotein antibody; pneumococcal antibody; Pneumococcus vaccine; unclassified drug; adult; aged; antibody response; antibody titer; article; cardiovascular disease; controlled study; drug effect; female; human; major clinical study; male; medical record review; pneumococcal infection; priority journal; self report; vaccination",Article,Final,,Scopus,2-s2.0-84861479380
Li J.J.; Tay H.L.; Plank M.; Essilfie A.-T.; Hansbro P.M.; Foster P.S.; Yang M.,"Li, Jing Jing (55983696800); Tay, Hock L. (55639898100); Plank, Maximilian (23486258000); Essilfie, Ama-Tawiah (22955585600); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569); Yang, Ming (56857729900)",55983696800; 55639898100; 23486258000; 22955585600; 6603119390; 7201517569; 56857729900,Activation of olfactory receptors on mouse pulmonary macrophages promotes monocyte chemotactic protein-1 production,2013,PLoS ONE,8,11,e80148,,,,40,10.1371/journal.pone.0080148,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84894061267&doi=10.1371%2fjournal.pone.0080148&partnerID=40&md5=e6c4af5327fa00b8284afb2fe0ae2757,"Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia","Li J.J., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Tay H.L., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Plank M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Essilfie A.-T., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia; Yang M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia",,"Aldehydes; Animals; Cells, Cultured; Chemokine CCL2; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Lipopolysaccharides; Macrophages, Alveolar; Mice; Mice, Inbred BALB C; Olfactory Receptor Neurons; Oligonucleotide Array Sequence Analysis; Phagocytosis; Real-Time Polymerase Chain Reaction; Up-Regulation",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84894061267
Moheimani F.; Hsu A.C.-Y.; Reid A.T.; Williams T.; Kicic A.; Stick S.M.; Hansbro P.M.; Wark P.A.B.; Knight D.A.,"Moheimani, Fatemeh (36157216000); Hsu, Alan C-Y (49861516600); Reid, Andrew T (39561518600); Williams, Teresa (57191973027); Kicic, Anthony (6507472922); Stick, Stephen M. (35373713500); Hansbro, Philip M. (6603119390); Wark, Peter A.B. (7003559516); Knight, Darryl A. (7402350036)",36157216000; 49861516600; 39561518600; 57191973027; 6507472922; 35373713500; 6603119390; 7003559516; 7402350036,The genetic and epigenetic landscapes of the epithelium in asthma,2016,Respiratory Research,17,1,119,,,,70,10.1186/s12931-016-0434-4,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995578524&doi=10.1186%2fs12931-016-0434-4&partnerID=40&md5=5982746db3c132e3dbb7feafe3866e40,"The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia; The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, NSW, Australia; University of Victoria, Department of Biochemistry and Microbiology, VIC, Canada; The University of Western Australia, Telethon Kids Institute, Centre for Health Research, Nedlands, 6009, WA, Australia; Princess Margaret Hospital for Children, Department of Respiratory Medicine, Perth, 6001, WA, Australia; The University of Western Australia, School of Paediatrics and Child Health, Nedlands, 6009, WA, Australia; The University of Western Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, Nedlands, 6009, WA, Australia; John Hunter Hospital, Department of Respiratory and Sleep Medicine, NSW, Australia; University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, Canada","Moheimani F., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, NSW, Australia; Hsu A.C.-Y., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, NSW, Australia; Reid A.T., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, NSW, Australia; Williams T., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, NSW, Australia, University of Victoria, Department of Biochemistry and Microbiology, VIC, Canada; Kicic A., The University of Western Australia, Telethon Kids Institute, Centre for Health Research, Nedlands, 6009, WA, Australia, Princess Margaret Hospital for Children, Department of Respiratory Medicine, Perth, 6001, WA, Australia, The University of Western Australia, School of Paediatrics and Child Health, Nedlands, 6009, WA, Australia, The University of Western Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, Nedlands, 6009, WA, Australia; Stick S.M., The University of Western Australia, Telethon Kids Institute, Centre for Health Research, Nedlands, 6009, WA, Australia, Princess Margaret Hospital for Children, Department of Respiratory Medicine, Perth, 6001, WA, Australia, The University of Western Australia, School of Paediatrics and Child Health, Nedlands, 6009, WA, Australia, The University of Western Australia, Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, Nedlands, 6009, WA, Australia; Hansbro P.M., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, NSW, Australia; Wark P.A.B., The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, NSW, Australia, John Hunter Hospital, Department of Respiratory and Sleep Medicine, NSW, Australia; Knight D.A., The University of Newcastle, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, HMRI building, Callaghan, 2308, NSW, Australia, The University of Newcastle, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, NSW, Australia, University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, Canada",Asthma; DNA methylation; Epithelial cells; Genes; Histone acetylation; MicroRNA,ADAM protein; biological marker; corticosteroid; cystatin; DNA; histone; interleukin 1 receptor associated kinase 3; interleukin 33; microRNA; microRNA 19a; tezepelumab; unclassified drug; untranslated RNA; ADAM33 gene; airway epithelial cell; asthma; CDHR3 gene; cellular distribution; CST1 gene; DNA methylation; DNA modification; drug targeting; environmental exposure; epigenetics; gene; gene expression regulation; gene function; gene identification; gene sequence; gene targeting; gene technology; genetic association; genetic linkage; genetic susceptibility; genome-wide association study; GSDMB gene; histone modification; human; IL 33 gene; IRAKM gene; nonhuman; ORMDL3 gene; pathogenesis; PCDH1 gene; prediction; respiratory epithelium; Review; transcription regulation,Review,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84995578524
Liu G.; Cooley M.A.; Jarnicki A.G.; Hsu A.C.-Y.; Nair P.M.; Haw T.J.; Fricker M.; Gellatly S.L.; Kim R.Y.; Inman M.D.; Tjin G.; Wark P.A.B.; Walker M.M.; Horvat J.C.; Oliver B.G.; Argraves W.S.; Knight D.A.; Burgess J.K.; Hansbro P.M.,"Liu, Gang (57189061134); Cooley, Marion A. (21644972000); Jarnicki, Andrew G. (6603137164); Hsu, Alan C.-Y. (49861516600); Nair, Prema M. (55749131000); Haw, Tatt Jhong (56625918900); Fricker, Michael (26638839800); Gellatly, Shaan L. (26430804400); Kim, Richard Y. (35810406900); Inman, Mark D. (58899738300); Tjin, Gavin (55614885600); Wark, Peter A.B. (7003559516); Walker, Marjorie M. (7403868685); Horvat, Jay C. (9942405300); Oliver, Brian G. (15919869900); Argraves, W. Scott (7006209539); Knight, Darryl A. (7402350036); Burgess, Janette K. (7201650628); Hansbro, Philip M. (6603119390)",57189061134; 21644972000; 6603137164; 49861516600; 55749131000; 56625918900; 26638839800; 26430804400; 35810406900; 58899738300; 55614885600; 7003559516; 7403868685; 9942405300; 15919869900; 7006209539; 7402350036; 7201650628; 6603119390,Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases,2016,JCI Insight,1,9,e86380,,,,109,10.1172/jci.insight.86380,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009778283&doi=10.1172%2fjci.insight.86380&partnerID=40&md5=7dff04d8a7e090752d280d1a88030109,"Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada; Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; School of Life Sciences, University of Technology, Sydney, NSW, Australia; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Discipline of Pharmacology, Sydney Medical School, University of Sydney, NSW, Australia; Department of Pathology and Medical Biology, University of Groningen, University Medical Center, Groningen, Netherlands","Liu G., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Cooley M.A., Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Jarnicki A.G., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hsu A.C.-Y., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Nair P.M., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Haw T.J., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Fricker M., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Gellatly S.L., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Kim R.Y., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Inman M.D., Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada; Tjin G., Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia; Wark P.A.B., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Walker M.M., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Horvat J.C., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Oliver B.G., Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia, School of Life Sciences, University of Technology, Sydney, NSW, Australia; Argraves W.S., Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, United States; Knight D.A., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Burgess J.K., Woolcock Institute of Medical Research, Discipline of Pharmacology, University of Sydney, Sydney, NSW, Australia, Discipline of Pharmacology, Sydney Medical School, University of Sydney, NSW, Australia, Department of Pathology and Medical Biology, University of Groningen, University Medical Center, Groningen, Netherlands; Hansbro P.M., Priority Research for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",,,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85009778283
Essilfie A.-T.; Simpson J.L.; Dunkley M.L.; Morgan L.C.; Oliver B.G.; Gibson P.G.; Foster P.S.; Hansbro P.M.,"Essilfie, Ama-Tawiah (22955585600); Simpson, Jodie L. (7404326026); Dunkley, Margaret L. (7004316090); Morgan, Lucy C. (7201987754); Oliver, Brian G. (15919869900); Gibson, Peter G. (7202414199); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",22955585600; 7404326026; 7004316090; 7201987754; 15919869900; 7202414199; 7201517569; 6603119390,Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma,2012,Thorax,67,7,,588,599,11,140,10.1136/thoraxjnl-2011-200160,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862754513&doi=10.1136%2fthoraxjnl-2011-200160&partnerID=40&md5=823135365dc90f705374e5fc0a6028e7,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia; Hunter Immunology Ltd., Newcastle, NSW, Australia; Department of Thoracic Medicine, Concord Repatriation General Hospital, Concord, NSW, Australia; Sydney Medical School, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia","Essilfie A.-T., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Simpson J.L., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia; Dunkley M.L., Hunter Immunology Ltd., Newcastle, NSW, Australia; Morgan L.C., Department of Thoracic Medicine, Concord Repatriation General Hospital, Concord, NSW, Australia; Oliver B.G., Sydney Medical School, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia; Gibson P.G., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",,dexamethasone; gamma interferon; interleukin 13; interleukin 17; interleukin 5; L selectin; toll like receptor 2; toll like receptor 4; animal cell; animal experiment; animal model; animal tissue; article; asthma; bacterial colonization; cell activation; cell count; cell maturation; cell transport; clinical feature; controlled study; cytokine release; cytokine response; disease association; drug response; drug sensitivity; female; Haemophilus influenzae; immunomodulation; influenza; innate immunity; lung infection; macrophage; mouse; neutrophil; neutrophilic asthma; nonhuman; phagocyte; priority journal; protein expression; receptor down regulation; respiratory tract allergy; Th17 cell,Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-84862754513
Temple S.E.L.; Hansbro P.,"Temple, Suzanna E. L. (7004577066); Hansbro, Phil (6603119390)",7004577066; 6603119390,New insights into the immune response to pneumococci,2011,Current Respiratory Medicine Reviews,7,4,,257,261,4,0,10.2174/157339811798281188,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858313746&doi=10.2174%2f157339811798281188&partnerID=40&md5=e087e6cc2f68a9ea4967b81a78278ae3,"School of Medicine and Pharmacology, University of Western Australia, Lung Institute of Western Australia, Perth, WA, 6000, Level 4, MRF Building Rear 50 Murray Street, Australia; Centre for Asthma and Respiratory Disease, The University of Newcastle and Vaccines, Infection, Viruses and Asthma (VIVA), Hunter Medical Research Institute, Newcastle, Australia","Temple S.E.L., School of Medicine and Pharmacology, University of Western Australia, Lung Institute of Western Australia, Perth, WA, 6000, Level 4, MRF Building Rear 50 Murray Street, Australia; Hansbro P., Centre for Asthma and Respiratory Disease, The University of Newcastle and Vaccines, Infection, Viruses and Asthma (VIVA), Hunter Medical Research Institute, Newcastle, Australia",Streptococcus pneumoniae; T cells,B7 antigen; CD4 antigen; CD40 ligand; CD86 antigen; cytotoxic T lymphocyte antigen 4; gamma interferon; interleukin 10; interleukin 17; lymphotoxin; major histocompatibility antigen class 1; major histocompatibility antigen class 2; transcription factor FOXP3; acquired immune deficiency syndrome; B lymphocyte; Candida; CD4+ T lymphocyte; CD8+ T lymphocyte; cell proliferation; cytokine release; dendritic cell; helper cell; human; immune response; Klebsiella; macrophage; nonhuman; priority journal; regulatory T lymphocyte; review; Streptococcus pneumonia; Th17 cell,Review,Final,,Scopus,2-s2.0-84858313746
Simpson J.L.; Powell H.; Baines K.J.; Milne D.; Coxson H.O.; Hansbro P.M.; Gibson P.G.,"Simpson, Jodie L. (7404326026); Powell, Heather (7101711366); Baines, Katherine J. (35078051200); Milne, David (7102931866); Coxson, Harvey O. (6603681233); Hansbro, Philip M. (6603119390); Gibson, Peter G. (7202414199)",7404326026; 7101711366; 35078051200; 7102931866; 6603681233; 6603119390; 7202414199,"The effect of azithromycin in adults with stable neutrophilic COPD: A double blind randomised, placebo controlled trial",2014,PLoS ONE,9,8,e105609,,,,71,10.1371/journal.pone.0105609,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921001401&doi=10.1371%2fjournal.pone.0105609&partnerID=40&md5=6cc02834f0f03ab907108a877d84553a,"Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Department of Respiratory and Sleep Medicine, Hunter New England Area Health Service, Newcastle, NSW, Australia; Auckland District Health Board, Auckland, New Zealand; Department of Radiology, James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada","Simpson J.L., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Powell H., Department of Respiratory and Sleep Medicine, Hunter New England Area Health Service, Newcastle, NSW, Australia; Baines K.J., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Milne D., Auckland District Health Board, Auckland, New Zealand; Coxson H.O., Department of Radiology, James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada; Hansbro P.M., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia; Gibson P.G., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, Hunter New England Area Health Service, Newcastle, NSW, Australia",,"Adult; Aged; Anti-Bacterial Agents; Azithromycin; Double-Blind Method; Female; Humans; Interleukin-8; Leukocyte Elastase; Male; Middle Aged; Neutrophils; Pulmonary Disease, Chronic Obstructive; Sputum; azithromycin; interleukin 8; leukocyte elastase; placebo; antiinfective agent; azithromycin; IL8 protein, human; interleukin 8; leukocyte elastase; add on therapy; adult; article; bacterial count; bacterial load; bacterium isolation; bronchitis; chronic obstructive lung disease; clinical article; computer assisted tomography; controlled study; disease exacerbation; disease severity; double blind procedure; drug efficacy; drug mechanism; female; human; leukocyte differential count; male; middle aged; neutrophil count; neutrophilic bronchitis; neutrophilic chronic obstructive lung disease; nonhuman; onset age; randomized controlled trial; sputum analysis; treatment duration; aged; clinical trial; metabolism; microbiology; multicenter study; neutrophil; pathology; Pulmonary Disease, Chronic Obstructive; sputum",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84921001401
Tolosa J.M.; Parsons K.S.; Hansbro P.M.; Smith R.; Wark P.B.,"Tolosa, Jorge M. (23096007200); Parsons, Kristy S. (55047641400); Hansbro, Philip M. (6603119390); Smith, Roger (7410301946); Wark, Peter B. (7003559516)",23096007200; 55047641400; 6603119390; 7410301946; 7003559516,The placental protein syncytin-1 impairs antiviral responses and exaggerates inflammatory responses to influenza,2015,PLoS ONE,10,4,e118629,,,,24,10.1371/journal.pone.0118629,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927534581&doi=10.1371%2fjournal.pone.0118629&partnerID=40&md5=cf0916121f3aa723bfb6fb159d578b69,"Mothers and Babies Research Centre and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia","Tolosa J.M., Mothers and Babies Research Centre and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Parsons K.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Smith R., Mothers and Babies Research Centre and Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Wark P.B., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia",,"Adolescent; Adult; Cytokines; Dendritic Cells; Disease Susceptibility; Female; Gene Expression Regulation; Gene Products, env; Humans; Inflammation; Influenza A Virus, H1N1 Subtype; Monocytes; Placenta; Pregnancy; Pregnancy Proteins; T-Lymphocytes, Helper-Inducer; Young Adult; alpha interferon; gamma interferon; interleukin 10; interleukin 1beta; interleukin 2; interleukin 6; placenta protein; syncytin 1; unclassified drug; cytokine; placenta protein; syncytin; virus envelope protein; Article; CD4+ T lymphocyte; cell population; cell viability; cytokine release; cytokine response; cytotoxicity; dendritic cell; female; human; human cell; influenza A (H1N1); Influenza virus A H1N1; nonhuman; oligomerization; pandemic influenza; pregnant woman; protein expression; virus strain; adolescent; adult; disease predisposition; drug effects; gene expression regulation; helper cell; immunology; inflammation; Influenza A virus (H1N1); metabolism; monocyte; physiology; placenta; pregnancy; secretion (process); virology; young adult",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84927534581
Wynne O.; Horvat J.C.; Smith R.; Hansbro P.M.; Clifton V.L.; Hodgson D.M.,"Wynne, O. (57195730811); Horvat, J.C. (9942405300); Smith, R. (7410301946); Hansbro, P.M. (6603119390); Clifton, V.L. (6603677237); Hodgson, D.M. (7201364433)",57195730811; 9942405300; 7410301946; 6603119390; 6603677237; 7201364433,Effect of neonatal respiratory infection on adult BALB/c hippocampal glucocorticoid and mineralocorticoid receptors,2012,Developmental Psychobiology,54,5,,568,575,7,2,10.1002/dev.20615,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861940047&doi=10.1002%2fdev.20615&partnerID=40&md5=3ed66bf3d9885d7638d8a72d823703a5,"Laboratory of Neuroimmunology School of Psychology, University of Newcastle, Callaghan, NSW 2308, Building W, University Drive, Australia; Mothers, Babies Research Centre, Hunter Medical Research Institute, John Hunter Hospital, Hunter Region Mail Centre, Newcastle, NSW 2310, Locked Bag 1, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle 2300, Level 3, David Maddison Clinical Services Building, Australia; School of Paediatrics and Reproductive Health, University of Adelaide, Medical School North, Adelaide, SA 5005, Level 6, Frome Road, Australia","Wynne O., Laboratory of Neuroimmunology School of Psychology, University of Newcastle, Callaghan, NSW 2308, Building W, University Drive, Australia, Mothers, Babies Research Centre, Hunter Medical Research Institute, John Hunter Hospital, Hunter Region Mail Centre, Newcastle, NSW 2310, Locked Bag 1, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle 2300, Level 3, David Maddison Clinical Services Building, Australia; Smith R., Mothers, Babies Research Centre, Hunter Medical Research Institute, John Hunter Hospital, Hunter Region Mail Centre, Newcastle, NSW 2310, Locked Bag 1, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, Newcastle 2300, Level 3, David Maddison Clinical Services Building, Australia; Clifton V.L., School of Paediatrics and Reproductive Health, University of Adelaide, Medical School North, Adelaide, SA 5005, Level 6, Frome Road, Australia; Hodgson D.M., Laboratory of Neuroimmunology School of Psychology, University of Newcastle, Callaghan, NSW 2308, Building W, University Drive, Australia, Mothers, Babies Research Centre, Hunter Medical Research Institute, John Hunter Hospital, Hunter Region Mail Centre, Newcastle, NSW 2310, Locked Bag 1, Australia",Glucocorticoid receptor; Hippocampus; Infection; Mineralocorticoid receptor; Neonate; Stress,"Analysis of Variance; Animals; Chlamydia Infections; Chlamydia muridarum; Corticosterone; Female; Gene Expression; Glucocorticoids; Hippocampus; Male; Mice; Mice, Inbred BALB C; Polymerase Chain Reaction; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; RNA, Messenger; Sex Factors; Stress, Physiological; Time; Bacteria (microorganisms); Chlamydia; Chlamydia muridarum; corticosterone; glucocorticoid; glucocorticoid receptor; messenger RNA; mineralocorticoid receptor; analysis of variance; animal; article; Bagg albino mouse; blood; Chlamydia; chlamydiasis; female; gene expression; genetics; hippocampus; male; metabolism; mouse; pathophysiology; physiological stress; polymerase chain reaction; sex difference; time",Article,Final,,Scopus,2-s2.0-84861940047
Wynne O.; Horvat J.C.; Osei-Kumah A.; Smith R.; Hansbro P.M.; Clifton V.L.; Hodgson D.M.,"Wynne, O. (57195730811); Horvat, J.C. (9942405300); Osei-Kumah, A. (24466916500); Smith, R. (7410301946); Hansbro, P.M. (6603119390); Clifton, V.L. (6603677237); Hodgson, D.M. (7201364433)",57195730811; 9942405300; 24466916500; 7410301946; 6603119390; 6603677237; 7201364433,Early life infection alters adult BALB/c hippocampal gene expression in a sex specific manner,2011,Stress,14,3,,247,261,14,19,10.3109/10253890.2010.532576,https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953885687&doi=10.3109%2f10253890.2010.532576&partnerID=40&md5=e13404ab44a3ff14b13bebc8a5e34a9b,"Laboratory of Neuroimmunology, University of Newcastle, Newcastle, NSW 2308, Australia; Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Department of Paediatrics and Reproductive Health, Faculty of Health Sciences, University of Adelaide, Adelaide, SA 5000, Australia; School of Psychology, Building W, University of Newcastle, Callaghan, NSW 2308, Australia","Wynne O., Laboratory of Neuroimmunology, University of Newcastle, Newcastle, NSW 2308, Australia, Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Osei-Kumah A., Department of Paediatrics and Reproductive Health, Faculty of Health Sciences, University of Adelaide, Adelaide, SA 5000, Australia; Smith R., Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW 2308, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2308, Australia; Clifton V.L., Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW 2308, Australia, Department of Paediatrics and Reproductive Health, Faculty of Health Sciences, University of Adelaide, Adelaide, SA 5000, Australia; Hodgson D.M., Laboratory of Neuroimmunology, University of Newcastle, Newcastle, NSW 2308, Australia, Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle, NSW 2308, Australia, School of Psychology, Building W, University of Newcastle, Callaghan, NSW 2308, Australia",glucocorticoid receptor; hippocampus; HPA; infection; Microarray; neonatal stress,"Animals; Animals, Newborn; Chlamydia Infections; Chlamydia muridarum; Down-Regulation; Female; Gene Expression Profiling; Hippocampus; Male; Mice; Mice, Inbred BALB C; Protein Array Analysis; Receptors, Glucocorticoid; RNA, Messenger; Sex Factors; Signal Transduction; Up-Regulation; beta actin; corticotropin releasing factor; cyclin dependent kinase inhibitor 1A; glucocorticoid receptor; major histocompatibility antigen class 2; orexin; oxytocin; prolactin; RNA; vasopressin; animal cell; animal experiment; animal model; article; brain tissue; cell maturation; Chlamydia; controlled study; convalescence; female; gene control; gene expression; gene expression profiling; genetic association; helper cell; hippocampus; immune response; immunogenetics; major histocompatibility complex; male; microarray analysis; mouse; nervous system development; nervous system function; newborn; newborn infection; nonhuman; pneumonia; priority journal; real time polymerase chain reaction; sex ratio; signal transduction; upregulation",Article,Final,,Scopus,2-s2.0-79953885687
Tay H.L.; Kaiko G.E.; Plank M.; Li J.J.; Maltby S.; Essilfie A.-T.; Jarnicki A.; Yang M.; Mattes J.; Hansbro P.M.; Foster P.S.,"Tay, Hock L. (55639898100); Kaiko, Gerard E. (21739529400); Plank, Maximilian (23486258000); Li, JingJing (55983696800); Maltby, Steven (6507446799); Essilfie, Ama-Tawiah (22955585600); Jarnicki, Andrew (6603137164); Yang, Ming (56857729900); Mattes, Joerg (7005999915); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569)",55639898100; 21739529400; 23486258000; 55983696800; 6507446799; 22955585600; 6603137164; 56857729900; 7005999915; 6603119390; 7201517569,Antagonism of miR-328 Increases the Antimicrobial Function of Macrophages and Neutrophils and Rapid Clearance of Non-typeable Haemophilus Influenzae (NTHi) from Infected Lung,2015,PLoS Pathogens,11,4,e1004549,,,21,58,10.1371/journal.ppat.1004549,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929492776&doi=10.1371%2fjournal.ppat.1004549&partnerID=40&md5=e7fdf080600ee7bae7bd9f87432d8b1b,"Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Priority Research Centre for Asthma and Respiratory Disease, Discipline of Paediatrics and Child Health, School of Medicine and Public Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia","Tay H.L., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kaiko G.E., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Plank M., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Li J.J., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Maltby S., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Essilfie A.-T., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Jarnicki A., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Yang M.; Mattes J., Priority Research Centre for Asthma and Respiratory Disease, Discipline of Paediatrics and Child Health, School of Medicine and Public Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Foster P.S., Priority Research Centre for Asthma and Respiratory Disease, Department of Microbiology and Immunology, School of Pharmacy and Biomedical Sciences, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia",,"Animals; Flow Cytometry; Fluorescent Antibody Technique; Haemophilus Infections; Haemophilus influenzae; Humans; Macrophages; Male; Mice; Mice, Inbred BALB C; MicroRNAs; Neutrophils; Oligonucleotide Array Sequence Analysis; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Bacteria (microorganisms); Haemophilus influenzae; antagomir; cathepsin D; cigarette smoke; microRNA; microRNA 328; mitogen activated protein kinase p38; reactive oxygen metabolite; stress activated protein kinase; unclassified drug; microRNA; MIRN328 microRNA, human; MIRN328 microRNA, mouse; adult; animal experiment; animal model; animal tissue; antimicrobial activity; Article; bacterial clearance; cigarette smoke-induced emphysema; controlled study; flow cytometry; Haemophilus influenzae; human; human cell; immune deficiency; immune response; immunofluorescence test; intracellular signaling; lung infection; macrophage; male; mouse; neutrophil; nonhuman; phagocytosis; protein expression; real time polymerase chain reaction; regulatory mechanism; respiratory burst; reverse transcription polymerase chain reaction; RNA isolation; upregulation; validation process; animal; antagonists and inhibitors; Bagg albino mouse; DNA microarray; fluorescent antibody technique; genetics; Haemophilus infection; Haemophilus influenzae; immunology; macrophage; neutrophil; respiratory tract infection",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84929492776
King P.T.; Sharma R.; O'Sullivan K.; Selemidis S.; Lim S.; Radhakrishna N.; Lo C.; Prasad J.; Callaghan J.; McLaughlin P.; Farmer M.; Steinfort D.; Jennings B.; Ngui J.; Broughton B.R.S.; Thomas B.; Essilfie A.-T.; Hickey M.; Holmes P.W.; Hansbro P.; Bardin P.G.; Holdsworth S.R.,"King, Paul T. (25954168500); Sharma, Roleen (56573134600); O'Sullivan, Kim (7005875262); Selemidis, Stavros (7801641528); Lim, Steven (55446141000); Radhakrishna, Naghmeh (6508149866); Lo, Camden (39061714900); Prasad, Jyotika (57189496007); Callaghan, Judy (7101794543); McLaughlin, Peter (57212663301); Farmer, Michael (18534342900); Steinfort, Daniel (23135614400); Jennings, Barton (54928306700); Ngui, James (24576830800); Broughton, Bradley R. S. (12781950700); Thomas, Belinda (14120315000); Essilfie, Ama-Tawiah (22955585600); Hickey, Michael (7103379217); Holmes, Peter W. (57189762636); Hansbro, Philip (6603119390); Bardin, Philip G. (7006391749); Holdsworth, Stephen R. (7006410662)",25954168500; 56573134600; 7005875262; 7801641528; 55446141000; 6508149866; 39061714900; 57189496007; 7101794543; 57212663301; 18534342900; 23135614400; 54928306700; 24576830800; 12781950700; 14120315000; 22955585600; 7103379217; 57189762636; 6603119390; 7006391749; 7006410662,Nontypeable haemophilus influenzae induces sustained lung oxidative stress and protease expression,2015,PLoS ONE,10,3,e0120371,,,,51,10.1371/journal.pone.0120371,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925832868&doi=10.1371%2fjournal.pone.0120371&partnerID=40&md5=26551d82c51d88ec2fbb0d43b4dee2ba,"Monash University Department of Medicine/Monash Medical Centre, Melbourne, Australia; Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; Department of Pharmacology, Monash University, Melbourne, Australia; Monash Micro Imaging, Monash University, Melbourne, Australia; Clinical Immunology, Monash Medical Centre, Melbourne, Australia; Monash Institute of Medical Research, Melbourne, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia","King P.T., Monash University Department of Medicine/Monash Medical Centre, Melbourne, Australia, Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; Sharma R., Monash University Department of Medicine/Monash Medical Centre, Melbourne, Australia, Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; O'Sullivan K., Monash University Department of Medicine/Monash Medical Centre, Melbourne, Australia; Selemidis S., Department of Pharmacology, Monash University, Melbourne, Australia; Lim S., Monash University Department of Medicine/Monash Medical Centre, Melbourne, Australia; Radhakrishna N., Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; Lo C., Monash Micro Imaging, Monash University, Melbourne, Australia; Prasad J., Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; Callaghan J., Monash Micro Imaging, Monash University, Melbourne, Australia; McLaughlin P., Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; Farmer M., Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; Steinfort D., Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; Jennings B., Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; Ngui J., Clinical Immunology, Monash Medical Centre, Melbourne, Australia; Broughton B.R.S., Department of Pharmacology, Monash University, Melbourne, Australia; Thomas B., Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia, Monash Institute of Medical Research, Melbourne, Australia; Essilfie A.-T., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Hickey M., Monash University Department of Medicine/Monash Medical Centre, Melbourne, Australia; Holmes P.W., Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia; Hansbro P., School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Bardin P.G., Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia, Monash Institute of Medical Research, Melbourne, Australia; Holdsworth S.R., Monash University Department of Medicine/Monash Medical Centre, Melbourne, Australia",,"Animals; Bacterial Typing Techniques; Bronchoalveolar Lavage; Cell Polarity; Deoxyribonucleases; Endopeptidases; Extracellular Space; Extracellular Traps; Female; Haemophilus influenzae; Humans; Lung; Macrophages; Male; Mice, Inbred BALB C; Middle Aged; Oxidative Stress; Phagocytes; Reactive Oxygen Species; Bacteria (microorganisms); Haemophilus influenzae; Mus; 3 nitrotyrosine; deoxyribonuclease; macrophage elastase; proteinase; reactive oxygen metabolite; proteinase; reactive oxygen metabolite; adult; amino acid synthesis; animal experiment; animal model; animal tissue; Article; cell activation; chronic obstructive lung disease; controlled study; enzyme synthesis; extracellular trap; female; fibroblast; Haemophilus infection; human; human cell; innate immunity; lung alveolus epithelium; lung alveolus macrophage; major clinical study; male; mouse; nonhuman; nontypeable Haemophilus influenzae; oxidative stress; phagocyte; pneumonia; protein expression; animal; bacterium identification; Bagg albino mouse; cell polarity; enzymology; extracellular space; Haemophilus influenzae; lung; lung lavage; macrophage; metabolism; middle aged; pathology; physiology",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-84925832868
Griekspoor P.; Hansbro P.M.; Waldenström J.; Olsen B.,"Griekspoor, Petra (15135449800); Hansbro, Philip M. (6603119390); Waldenström, Jonas (7005795132); Olsen, Björn (7201359257)",15135449800; 6603119390; 7005795132; 7201359257,Campylobacter jejuni sequence types show remarkable spatial and temporal stability in Blackbirds,2015,Infection Ecology and Epidemiology,5,1,28383,,,,6,10.3402/IEE.V5.28383,https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048761757&doi=10.3402%2fIEE.V5.28383&partnerID=40&md5=58d8353d471cdecdfb5a1f37f7d6578d,"Section for Zoonotic Ecology and Epidemiology, Centre for Ecology and Evolution in Microbial Model Systems (EEMiS), School of Natural Sciences, Linnaeus University, Kalmar, Sweden; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Zoonosis Science Center, IMBIM, Uppsala University, Uppsala, Sweden","Griekspoor P., Section for Zoonotic Ecology and Epidemiology, Centre for Ecology and Evolution in Microbial Model Systems (EEMiS), School of Natural Sciences, Linnaeus University, Kalmar, Sweden; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Waldenström J., Section for Zoonotic Ecology and Epidemiology, Centre for Ecology and Evolution in Microbial Model Systems (EEMiS), School of Natural Sciences, Linnaeus University, Kalmar, Sweden, Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Olsen B., Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, Zoonosis Science Center, IMBIM, Uppsala University, Uppsala, Sweden",Blackbird; Campylobacter jejuni; gastrointestinal pathogen; MLST; population structure,article; Australia; Azores; bacterium isolate; blackbird; Campylobacter jejuni; genotype; host range; infectious agent; multilocus sequence typing; nonhuman; population structure; poultry; purifying selection; Sweden,Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-85048761757
Starkey M.R.; Nguyen D.H.; Essilfie A.T.; Kim R.Y.; Hatchwell L.M.; Collison A.M.; Yagita H.; Foster P.S.; Horvat J.C.; Mattes J.; Hansbro P.M.,"Starkey, M.R. (35811293400); Nguyen, D.H. (54886138200); Essilfie, A.T. (22955585600); Kim, R.Y. (35810406900); Hatchwell, L.M. (55555432700); Collison, A.M. (23995251200); Yagita, H. (55192275000); Foster, P.S. (7201517569); Horvat, J.C. (9942405300); Mattes, J. (7005999915); Hansbro, P.M. (6603119390)",35811293400; 54886138200; 22955585600; 35810406900; 55555432700; 23995251200; 55192275000; 7201517569; 9942405300; 7005999915; 6603119390,Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease,2014,Mucosal Immunology,7,3,,478,488,10,46,10.1038/mi.2013.65,https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899561991&doi=10.1038%2fmi.2013.65&partnerID=40&md5=36ec7f3577ca47586f7f7e71025e92e6,"Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Department of Immunology, Juntendo University School of Medicine, Hongo, Bunkyoku, Tokyo, Japan; Pediatric Respiratory and Sleep Medicine Unit, Newcastle Children's Hospital, Newcastle, NSW, Australia","Starkey M.R., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Nguyen D.H., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Essilfie A.T., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Kim R.Y., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Hatchwell L.M., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Collison A.M., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Yagita H., Department of Immunology, Juntendo University School of Medicine, Hongo, Bunkyoku, Tokyo, Japan; Foster P.S., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Horvat J.C., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Mattes J., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia, Pediatric Respiratory and Sleep Medicine Unit, Newcastle Children's Hospital, Newcastle, NSW, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia",,"Animals; Animals, Newborn; Antibodies, Neutralizing; Apoptosis; Chlamydia Infections; Chlamydia muridarum; Disease Models, Animal; Disease Progression; Gene Expression; Mice; Mice, Knockout; Mucus; NF-kappa B; Pneumonia; Pulmonary Alveoli; Receptors, TNF-Related Apoptosis-Inducing Ligand; Respiratory Hypersensitivity; Respiratory Tract Infections; TNF-Related Apoptosis-Inducing Ligand; death receptor 5; immunoglobulin enhancer binding protein; neutralizing antibody; tumor necrosis factor related apoptosis inducing ligand; tumor necrosis factor related apoptosis inducing ligand receptor; immunoglobulin enhancer binding protein; neutralizing antibody; tumor necrosis factor related apoptosis inducing ligand; tumor necrosis factor related apoptosis inducing ligand receptor; animal cell; animal experiment; animal tissue; apoptosis; article; CD4+ T lymphocyte; CD8+ T lymphocyte; chlamydiasis; chronic lung disease; controlled study; early life stress; histopathology; human; immune response; inflammation; inflammatory cell; lung alveolus macrophage; mouse; mucus secretion; neutrophil; newborn; newborn disease; nonhuman; plasmacytoid dendritic cell; pneumonia; priority journal; protein expression; protein function; respiratory tract infection; weight gain; animal; antagonists and inhibitors; Chlamydia; deficiency; disease course; disease model; gene expression; genetics; knockout mouse; lung alveolus; metabolism; microbiology; mucus; pathology; respiratory tract allergy; respiratory tract infection; secretion (process)",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-84899561991
O'Brien R.O.; Taske N.L.; Hansbro P.M.; Matthaei K.I.; Hogan S.P.; Denborough M.A.; Foster P.S.,"O'Brien, Robert O. (36764416400); Taske, Nichole L. (6507699251); Hansbro, Philip M. (6603119390); Matthaei, Klaus I. (57204851819); Hogan, Simon P. (7102358818); Denborough, Michael A. (7006750469); Foster, Paul S. (7201517569)",36764416400; 6507699251; 6603119390; 57204851819; 7102358818; 7006750469; 7201517569,Exclusion of defects in the skeletal muscle specific regions of the DHPR α1 subunit as frequent causes of malignant hyperthermia,1995,Journal of Medical Genetics,32,11,,913,914,1,6,,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028845669&partnerID=40&md5=576bdc27d7f74d9db29d78584ea7fd44,"Div. of Biochem. and Molec. Biology, John Curtin Sch. of Medical Research, Australian National University, Canberra, ACT 0200, Australia","O'Brien R.O., Div. of Biochem. and Molec. Biology, John Curtin Sch. of Medical Research, Australian National University, Canberra, ACT 0200, Australia; Taske N.L., Div. of Biochem. and Molec. Biology, John Curtin Sch. of Medical Research, Australian National University, Canberra, ACT 0200, Australia; Hansbro P.M., Div. of Biochem. and Molec. Biology, John Curtin Sch. of Medical Research, Australian National University, Canberra, ACT 0200, Australia; Matthaei K.I., Div. of Biochem. and Molec. Biology, John Curtin Sch. of Medical Research, Australian National University, Canberra, ACT 0200, Australia; Hogan S.P., Div. of Biochem. and Molec. Biology, John Curtin Sch. of Medical Research, Australian National University, Canberra, ACT 0200, Australia; Denborough M.A., Div. of Biochem. and Molec. Biology, John Curtin Sch. of Medical Research, Australian National University, Canberra, ACT 0200, Australia; Foster P.S., Div. of Biochem. and Molec. Biology, John Curtin Sch. of Medical Research, Australian National University, Canberra, ACT 0200, Australia",,complementary DNA; dihydropyridine; receptor subunit; ryanodine receptor; amino acid substitution; article; comparative study; congenital disorder; genetic susceptibility; human; human cell; human tissue; malignant hyperthermia; molecular genetics; point mutation; priority journal; receptor gene; skeletal muscle,Article,Final,,Scopus,2-s2.0-0028845669
Asquith K.L.; Ramshaw H.S.; Hansbro P.M.; Beagley K.W.; Lopez A.F.; Foster P.S.,"Asquith, Kelly L. (6507212626); Ramshaw, Hayley S. (18034642300); Hansbro, Philip M. (6603119390); Beagley, Kenneth W. (7005403437); Lopez, Angel F. (7401455851); Foster, Paul S. (7201517569)",6507212626; 18034642300; 6603119390; 7005403437; 7401455851; 7201517569,The IL-3/IL-5/GM-CSF common β receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation,2008,Journal of Immunology,180,2,,1199,1206,7,108,10.4049/jimmunol.180.2.1199,https://www.scopus.com/inward/record.uri?eid=2-s2.0-40449117731&doi=10.4049%2fjimmunol.180.2.1199&partnerID=40&md5=935d62e58a2771ad5ff6c74f46a7fe27,"School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, Australia; Division of Molecular Biosciences, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia; Department of Human Immunology, Institute of Medical and Veterinary Science, Hanson Institute, Adelaide, SA, Australia; Centre for Asthma and Respiratory Diseases, David Maddison Building, Newcastle, NSW 2300, Corner of King and Watt Streets, Australia","Asquith K.L., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, Australia; Ramshaw H.S., Department of Human Immunology, Institute of Medical and Veterinary Science, Hanson Institute, Adelaide, SA, Australia; Hansbro P.M., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, Australia; Beagley K.W., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, Australia; Lopez A.F., Department of Human Immunology, Institute of Medical and Veterinary Science, Hanson Institute, Adelaide, SA, Australia; Foster P.S., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, Australia, Division of Molecular Biosciences, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia, Centre for Asthma and Respiratory Diseases, David Maddison Building, Newcastle, NSW 2300, Corner of King and Watt Streets, Australia",,"Allergens; Animals; Asthma; Cell Movement; Cytokine Receptor Common beta Subunit; Cytokines; Dendritic Cells; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-3; Interleukin-5; Lymphocyte Activation; Macrophages, Alveolar; Mice; Mice, Mutant Strains; Respiratory Hypersensitivity; Signal Transduction; Th2 Cells; allergen; antigen; beta adrenergic receptor; cytokine; gamma interferon; granulocyte macrophage colony stimulating factor; immunoglobulin E; interleukin 13; interleukin 3; interleukin 4; interleukin 5; CD131 antigen; cytokine; granulocyte macrophage colony stimulating factor; interleukin 3; interleukin 5; animal experiment; animal model; animal tissue; article; asthma; bone marrow cell; bronchus mucus; cell expansion; cell infiltration; cell migration; cell proliferation; cellular immunity; controlled study; cytokine production; dendritic cell; effector cell; eosinophil; hypersensitivity; lung infiltrate; mouse; mucus secretion; nonhuman; priority journal; Th2 cell; transgenic mouse; animal; cell motion; genetics; immunology; lung alveolus macrophage; lymphocyte activation; metabolism; mouse mutant; physiology; respiratory tract allergy; signal transduction",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-40449117731
Li J.J.; Wang W.; Baines K.J.; Bowden N.A.; Hansbro P.M.; Gibson P.G.; Kumar R.K.; Foster P.S.; Yang M.,"Li, Jing Jing (55983696800); Wang, Wan (36496115200); Baines, Katherine J. (35078051200); Bowden, Nikola A. (12240401700); Hansbro, Philip M. (6603119390); Gibson, Peter G. (7202414199); Kumar, Rakesh K. (57203775042); Foster, Paul S. (7201517569); Yang, Ming (56857729900)",55983696800; 36496115200; 35078051200; 12240401700; 6603119390; 7202414199; 57203775042; 7201517569; 56857729900,IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages,2010,Journal of Immunology,185,7,,4401,4409,8,101,10.4049/jimmunol.1001039,https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958117957&doi=10.4049%2fjimmunol.1001039&partnerID=40&md5=23c6ab8c3c7f8d1dbbf3ded0f1bb0670,"Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States; School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States; Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Region Mail Centre, Newcastle, Australia; Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia","Li J.J., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States, School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States; Wang W., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States, School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States; Baines K.J., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States, Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Region Mail Centre, Newcastle, Australia; Bowden N.A., School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States; Hansbro P.M., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States, School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States; Gibson P.G., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States, Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Region Mail Centre, Newcastle, Australia; Kumar R.K., Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States, School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States; Yang M., Centre for Asthma and Respiratory Disease, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States, School of Biomedical Sciences and Pharmacy, University of Newcastle, Hunter Medical Research Institute, Callaghan, United States",,"Animals; Asthma; Bronchial Hyperreactivity; Cell Separation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Antibody Technique; Glucocorticoids; Humans; Interferon-gamma; Interleukins; Macrophage Activation; Macrophages, Alveolar; Mice; Mice, Inbred BALB C; Mice, Knockout; Myeloid Differentiation Factor 88; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; CD11b antigen; CD14 antigen; dexamethasone; gamma interferon; glucocorticoid receptor; interleukin 27; lipopolysaccharide; myeloid differentiation factor 88; glucocorticoid; Il27 protein, mouse; interleukin derivative; Myd88 protein, mouse; myeloid differentiation factor 88; airway resistance; article; asthma; cell nucleus; controlled study; cytokine production; lung alveolus macrophage; macrophage; mouse; nonhuman; priority journal; protein localization; sputum analysis; translocation line; animal; asthma; Bagg albino mouse; bronchus hyperreactivity; cell separation; enzyme linked immunosorbent assay; flow cytometry; fluorescent antibody technique; human; immunology; macrophage activation; metabolism; mouse mutant; reverse transcription polymerase chain reaction; signal transduction",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-77958117957
Hansbro P.M.; Beagley K.W.; Horvat J.C.; Gibson P.G.,"Hansbro, Philip M. (6603119390); Beagley, Kenneth W. (7005403437); Horvat, Jay C. (9942405300); Gibson, Peter G. (7202414199)",6603119390; 7005403437; 9942405300; 7202414199,Role of atypical bacterial infection of the lung in predisposition/ protection of asthma,2004,Pharmacology and Therapeutics,101,3,,193,210,17,90,10.1016/j.pharmthera.2003.10.007,https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542404089&doi=10.1016%2fj.pharmthera.2003.10.007&partnerID=40&md5=6ea73f1c70ce5d59ca0fb7181d2b289a,"School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia; Vaccines, Immunol./Infect., V., Hunter Medical Research Institute, New Lambton, NSW 2305, Locked Bag 1, Australia; Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Region Mail Centre, Newcastle, NSW 2310, Locked Bag 1, Australia; Bacteriology Research Unit, Vaccines, Immunol./Infect., V., Royal Newcastle Hospital, Newcastle, NSW 2300, Australia","Hansbro P.M., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Vaccines, Immunol./Infect., V., Hunter Medical Research Institute, New Lambton, NSW 2305, Locked Bag 1, Australia, Bacteriology Research Unit, Vaccines, Immunol./Infect., V., Royal Newcastle Hospital, Newcastle, NSW 2300, Australia; Beagley K.W., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Vaccines, Immunol./Infect., V., Hunter Medical Research Institute, New Lambton, NSW 2305, Locked Bag 1, Australia; Horvat J.C., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Vaccines, Immunol./Infect., V., Hunter Medical Research Institute, New Lambton, NSW 2305, Locked Bag 1, Australia; Gibson P.G., Vaccines, Immunol./Infect., V., Hunter Medical Research Institute, New Lambton, NSW 2305, Locked Bag 1, Australia, Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Region Mail Centre, Newcastle, NSW 2310, Locked Bag 1, Australia",Allergy treatment; Ang1; Angiopoietin; Asthma; BHR; Bronchial hyperresponsiveness; Chlamydia pneumoniae; Heat shock protein; Hsp; ICS; IFN; Ig; IL; Immunoglobulin; Inhaled corticosteroids; Interferon; Interleukin; Mopn; Mycoplasma pneumoniae; Prevention,Adrenal Cortex Hormones; Anti-Bacterial Agents; Asthma; Bacterial Infections; Bacterial Vaccines; Chlamydophila pneumoniae; Disease Susceptibility; Humans; Lung; Mycoplasma pneumoniae; antibiotic agent; clarithromycin; corticosteroid; immunoglobulin E; immunoglobulin E antibody; interleukin 4 antibody; interleukin 5 antibody; leukotriene receptor blocking agent; macrolide; monoclonal antibody; penicillin G; quinoline derived antiinfective agent; tetracycline derivative; acute disease; airway obstruction; allergic asthma; asthma; bacterial infection; Chlamydophila pneumoniae; chronic disease; clinical feature; disease association; disease exacerbation; disease predisposition; drug safety; drug use; eosinophilia; genetic predisposition; helper cell; human; hypothesis; immune response; immunoglobulin production; immunology; inflammatory disease; lung infection; Mycoplasma pneumoniae; nonhuman; pathophysiology; prevalence; priority journal; prophylaxis; protection; review; Th1 cell; vaccination; wheezing,Review,Final,,Scopus,2-s2.0-1542404089
Berry L.J.; Hickey D.K.; Skelding K.A.; Bao S.; Rendina A.M.; Hansbro P.M.; Gockel C.M.; Beagley K.W.,"Berry, Linda J. (8131799800); Hickey, Danica K. (9943841400); Skelding, Kathryn A. (9943411700); Bao, Shisan (7201558181); Rendina, Amanda M. (8131800300); Hansbro, Philip M. (6603119390); Gockel, Christine M. (12769285300); Beagley, Kenneth W. (7005403437)",8131799800; 9943841400; 9943411700; 7201558181; 8131800300; 6603119390; 12769285300; 7005403437,Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection,2004,Infection and Immunity,72,2,,1019,1028,9,136,10.1128/IAI.72.2.1019-1028.2004,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0842326199&doi=10.1128%2fIAI.72.2.1019-1028.2004&partnerID=40&md5=232fadc4723b95c3863ef339f8f18917,"School of Biomedical Science, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Environ. and Life Sciences, Fac. of Science and Info. Technol., University of Newcastle, Newcastle, NSW, Australia; Department of Pathology, University of Sydney, Sydney, NSW, Australia; Department of Microbiology, University of Buffalo, Buffalo, NY, United States; Discipline of Immunol./Microbiol., School of Biomedical Science, University of Newcastle, Callaghan, NSW 2308, Australia","Berry L.J., School of Biomedical Science, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hickey D.K., School of Biomedical Science, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Skelding K.A., School of Biomedical Science, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Bao S., Department of Pathology, University of Sydney, Sydney, NSW, Australia; Rendina A.M., School of Environ. and Life Sciences, Fac. of Science and Info. Technol., University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., School of Biomedical Science, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia; Gockel C.M., Department of Microbiology, University of Buffalo, Buffalo, NY, United States; Beagley K.W., School of Biomedical Science, University of Newcastle, Hunter Medical Research Institute, Newcastle, NSW, Australia, Discipline of Immunol./Microbiol., School of Biomedical Science, University of Newcastle, Callaghan, NSW 2308, Australia",,"Adjuvants, Immunologic; Administration, Cutaneous; Animals; Bacterial Vaccines; Chlamydia Infections; Chlamydia trachomatis; Cholera Toxin; Female; Genital Diseases, Female; Immunization; Immunoglobulin A; Immunoglobulin G; Interferon Type II; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Porins; RNA, Messenger; Vagina; beta actin; cholera toxin; cytokine; gamma interferon; immunoglobulin A; immunoglobulin G; immunological adjuvant; interleukin 4; neutralizing antibody; oligodeoxynucleotide; outer membrane protein; recombinant protein; vaccine; animal cell; animal model; antibody response; article; Chlamydia; chlamydiasis; controlled study; CpG island; enzyme linked immunosorbent assay; female; gene expression; genital tract infection; immunization; mouse; nonhuman; nucleotide sequence; polymerase chain reaction; priority journal; protein purification; Th1 cell; transcutaneous immunization",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-0842326199
Kaiko G.E.; Phipps S.; Hickey D.K.; Chuan E.L.; Hansbro P.M.; Foster P.S.; Beagley K.W.,"Kaiko, Gerard E. (21739529400); Phipps, Simon (7005395199); Hickey, Danica K. (9943841400); Chuan, En Lam (26030233600); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569); Beagley, Kenneth W. (7005403437)",21739529400; 7005395199; 9943841400; 26030233600; 6603119390; 7201517569; 7005403437,Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity,2008,Journal of Immunology,180,4,,2225,2232,7,54,10.4049/jimmunol.180.4.2225,https://www.scopus.com/inward/record.uri?eid=2-s2.0-42149111673&doi=10.4049%2fjimmunol.180.4.2225&partnerID=40&md5=19d58ee4fdfe48dcc4cf67ff66480e5a,"School of Biomedical Sciences, Asthma and Respiratory Diseases Priority Research Centre, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; John Curtin School for Medical Research, Australian National University, Canberra, ACT, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4059, 60 Musk Avenue, Australia","Kaiko G.E., School of Biomedical Sciences, Asthma and Respiratory Diseases Priority Research Centre, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Phipps S., School of Biomedical Sciences, Asthma and Respiratory Diseases Priority Research Centre, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Hickey D.K., School of Biomedical Sciences, Asthma and Respiratory Diseases Priority Research Centre, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Chuan E.L., School of Biomedical Sciences, Asthma and Respiratory Diseases Priority Research Centre, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., School of Biomedical Sciences, Asthma and Respiratory Diseases Priority Research Centre, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia; Foster P.S., School of Biomedical Sciences, Asthma and Respiratory Diseases Priority Research Centre, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia, John Curtin School for Medical Research, Australian National University, Canberra, ACT, Australia; Beagley K.W., School of Biomedical Sciences, Asthma and Respiratory Diseases Priority Research Centre, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia, John Curtin School for Medical Research, Australian National University, Canberra, ACT, Australia, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4059, 60 Musk Avenue, Australia",,"Animals; Bone Marrow Cells; Bronchial Hyperreactivity; Cells, Cultured; Chlamydia Infections; Chlamydia muridarum; Coculture Techniques; Cytokines; Dendritic Cells; Immunophenotyping; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, Transgenic; Th2 Cells; B7 antigen; CD86 antigen; cytokine; interleukin 10; interleukin 12; interleukin 13; interleukin 6; tumor necrosis factor alpha; cytokine; adoptive transfer; airway resistance; animal cell; animal experiment; animal model; antigen expression; antigen presentation; antigen presenting cell; article; asthma; Bagg albino mouse; bone marrow; bronchus hyperreactivity; CD4+ T lymphocyte; cell function; cell secretion; cellular immunity; Chlamydia; chlamydiasis; controlled study; cytokine release; dendritic cell; disease exacerbation; lung compliance; lung lavage; lymphocyte proliferation; male; mouse; nonhuman; phenotype; priority journal; Th2 cell; animal; bone marrow cell; bronchus hyperreactivity; cell culture; Chlamydia; chlamydiasis; coculture; immunology; immunophenotyping; metabolism; microbiology; mouse mutant; pathophysiology; secretion; transgenic mouse",Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-42149111673
Burgess J.K.; Boustany S.; Moir L.M.; Weckmann M.; Lau J.Y.; Grafton K.; Baraket M.; Hansbro P.M.; Hansbro N.G.; Foster P.S.; Black J.L.; Oliver B.G.,"Burgess, Janette K. (7201650628); Boustany, Sarah (6507871448); Moir, Lyn M. (8948395100); Weckmann, Markus (23487584400); Lau, Justine Y. (35115095800); Grafton, Karryn (35558542700); Baraket, Melissa (6602516393); Hansbro, Philip M. (6603119390); Hansbro, Nicole G. (15055862300); Foster, Paul S. (7201517569); Black, Judith L. (7402767206); Oliver, Brian G. (15919869900)",7201650628; 6507871448; 8948395100; 23487584400; 35115095800; 35558542700; 6602516393; 6603119390; 15055862300; 7201517569; 7402767206; 15919869900,"Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness",2010,American Journal of Respiratory and Critical Care Medicine,181,2,,106,115,9,66,10.1164/rccm.200904-0631OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-74949114437&doi=10.1164%2frccm.200904-0631OC&partnerID=40&md5=56b9ff6460b31eeb5a14b01623187693,"Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia; Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia; Woolcock Institute of Medical Research, University of Sydney, Newcastle, NSW, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Burgess J.K., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Newcastle, NSW, Australia; Boustany S., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia; Moir L.M., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Newcastle, NSW, Australia; Weckmann M., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia; Lau J.Y., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia; Grafton K., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia; Baraket M., Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Newcastle, NSW, Australia; Hansbro P.M., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro N.G., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Black J.L., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Newcastle, NSW, Australia; Oliver B.G., Cooperative Research Centre for Asthma and Airways, University of Sydney, Newcastle, NSW, Australia, Discipline of Pharmacology, University of Sydney, Newcastle, NSW, Australia, Woolcock Institute of Medical Research, University of Sydney, Newcastle, NSW, Australia",Angiogenesis; Asthma; Collagen; Type IV collagen α3 chain,"Adolescent; Adult; Aged; Aged, 80 and over; Airway Remodeling; Animals; Asthma; Autoantigens; Biopsy; Bronchi; Bronchial Hyperreactivity; Bronchitis; Bronchoscopy; Cell Division; Collagen Type IV; Disease Models, Animal; Endothelial Cells; Eosinophilia; Female; Humans; Interleukin-13; Lung; Male; Mice; Microscopy, Fluorescence; Middle Aged; Neovascularization, Pathologic; Respiratory Hypersensitivity; Vascular Endothelial Growth Factor A; Young Adult; interleukin 13; tumstatin; vasculotropin; airway; allergic disease; angiogenesis; animal experiment; animal model; animal tissue; article; asthma; bronchiectasis; bronchus biopsy; bronchus hyperreactivity; cell infiltration; chronic obstructive lung disease; controlled study; cystic fibrosis; dot hybridization; human; human tissue; immunohistochemistry; in vitro study; inflammation; inflammatory cell; lung endothelium; lung lavage; mouse; mucus secretion; Murinae; nonhuman; priority journal; protein blood level; protein expression; protein function; regulatory mechanism; respiratory tract disease; tissue level",Article,Final,,Scopus,2-s2.0-74949114437
Horvat J.C.; Starkey M.R.; Kim R.Y.; Beagley K.W.; Preston J.A.; Gibson P.G.; Foster P.S.; Hansbro P.M.,"Horvat, Jay C. (9942405300); Starkey, Malcolm R. (35811293400); Kim, Richard Y. (35810406900); Beagley, Kenneth W. (7005403437); Preston, Julie A. (59281082600); Gibson, Peter G. (7202414199); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",9942405300; 35811293400; 35810406900; 7005403437; 59281082600; 7202414199; 7201517569; 6603119390,Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease,2010,Journal of Immunology,184,8,,4159,4169,10,78,10.4049/jimmunol.0902287,https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952746227&doi=10.4049%2fjimmunol.0902287&partnerID=40&md5=b901151b243d62f32708b847c01afc2c,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia","Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Starkey M.R., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Kim R.Y., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Beagley K.W., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; Preston J.A., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Gibson P.G., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",,"Allergens; Animals; Asthma; Chlamydia Infections; Chlamydia muridarum; Disease Models, Animal; Female; Immunophenotyping; Inflammation; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Neutrophils; Ovalbumin; Respiratory Hypersensitivity; Th1 Cells; Th2 Cells; allergen; gamma interferon; interleukin 12; interleukin 17; interleukin 5; methacholine; allergen; ovalbumin; allergic asthma; animal cell; animal experiment; animal model; animal tissue; article; cell hyperplasia; chlamydiasis; controlled study; cytokine release; eosinophil; female; immunopathogenesis; lymphocytopoiesis; mouse; mucous cell; mucus secretion; neutrophil; neutrophilia; nonhuman; phenotype; priority journal; protein expression; sensitization; T lymphocyte; Th1 cell; Th17 cell; Th2 cell; animal; asthma; Bagg albino mouse; Chlamydia; disease model; immunology; immunophenotyping; inflammation; microbiology; neutrophil chemotaxis; pathology; respiratory tract allergy",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-77952746227
Gasanov U.; Hughes D.; Hansbro P.M.,"Gasanov, Uta (10539337500); Hughes, Denise (7403464541); Hansbro, Philip M. (6603119390)",10539337500; 7403464541; 6603119390,Methods for the isolation and identification of Listeria spp. and Listeria monocytogenes: A review,2005,FEMS Microbiology Reviews,29,5,,851,875,24,326,10.1016/j.femsre.2004.12.002,https://www.scopus.com/inward/record.uri?eid=2-s2.0-26244448056&doi=10.1016%2fj.femsre.2004.12.002&partnerID=40&md5=580cac121c28456e2784b0d521fb4a00,"Biomedical Sciences, Faculty of Health, University of Newcastle, Australia; Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia; DH MICRO Consulting, Peelwood, NSW 2583, 457 Montana Rd, Australia; Bacteriology Research Group, Viruses, Immunity/Infection, Vaccines and Asthma (VIVA), Royal Newcastle Hospital, Newcastle, NSW 2300, Australia","Gasanov U., Biomedical Sciences, Faculty of Health, University of Newcastle, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia; Hughes D., DH MICRO Consulting, Peelwood, NSW 2583, 457 Montana Rd, Australia; Hansbro P.M., Biomedical Sciences, Faculty of Health, University of Newcastle, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia, Bacteriology Research Group, Viruses, Immunity/Infection, Vaccines and Asthma (VIVA), Royal Newcastle Hospital, Newcastle, NSW 2300, Australia",Culture; Environment; Epidemiology; Food; Identification; Isolation; Listeria; Molecular; Phenotyping; Serology,"Animals; Bacterial Typing Techniques; Bacteriological Techniques; Environmental Microbiology; Food Microbiology; Humans; Listeria; Listeria Infections; Listeria monocytogenes; Listeria; Listeria monocytogenes; antibody; biochemical marker; DNA; phosphatidylinositol 4,5 bisphosphate phosphodiesterase; RNA; accuracy; bacterial transmission; bacteriophage typing; bacterium colony; bacterium culture; bacterium identification; bacterium isolation; cell viability; conformation; denaturing gradient gel electrophoresis; DNA hybridization; DNA microarray; DNA sequence; environment; enzyme linked immunosorbent assay; fermentation; food; food analysis; food and drug administration; gene targeting; hemolysis; immunoassay; isolation procedure; Listeria; Listeria monocytogenes; microbiological examination; molecular typing; multilocus enzyme electrophoresis; nonhuman; nucleic acid sequence based amplification; phenotype; polymerase chain reaction; quantitative analysis; random amplified polymorphic DNA; real time polymerase chain reaction; restriction fragment length polymorphism; restriction mapping; reverse transcription polymerase chain reaction; review; ribotyping; sensitivity analysis; serotyping; single strand conformation polymorphism; standard; test strip; time",Review,Final,,Scopus,2-s2.0-26244448056
Sharkhuu T.; Matthaei K.I.; Forbes E.; Mahalingam S.; Hogan S.P.; Hansbro P.M.; Foster P.S.,"Sharkhuu, T. (6508187460); Matthaei, K.I. (57204851819); Forbes, E. (57203570312); Mahalingam, S. (12241751100); Hogan, S.P. (7102358818); Hansbro, P.M. (6603119390); Foster, P.S. (7201517569)",6508187460; 57204851819; 57203570312; 12241751100; 7102358818; 6603119390; 7201517569,Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity,2006,Clinical and Experimental Allergy,36,12,,1575,1583,8,99,10.1111/j.1365-2222.2006.02595.x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845460525&doi=10.1111%2fj.1365-2222.2006.02595.x&partnerID=40&md5=7c44f92dda71bec19924c006f2af2eff,"Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia; School of Health Sciences, University of Canberra, Canberra, ACT, Australia; Allergy and Immunology Division, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Faculty of Health, University of Newcastle, Royal Newcastle Hospital, New Castle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia; Faculty of Health, University of Newcastle, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia","Sharkhuu T., Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia; Matthaei K.I., Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia; Forbes E., Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia; Mahalingam S., School of Health Sciences, University of Canberra, Canberra, ACT, Australia; Hogan S.P., Allergy and Immunology Division, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Hansbro P.M., Faculty of Health, University of Newcastle, Royal Newcastle Hospital, New Castle, NSW, Australia; Foster P.S., Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia, Hunter Medical Research Institute, Newcastle, NSW, Australia, Faculty of Health, University of Newcastle, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia",Allergy/asthma; Inflammation; Interleukins; Mouse model,"Animals; Arginase; Asthma; Biological Markers; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cells, Cultured; Chemokines, CC; Cytokines; Interleukin-13; Interleukin-17; Interleukin-4; Lung; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Knockout; Mucus; Pneumonia; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; STAT6 Transcription Factor; Th2 Cells; argininosuccinate synthase; cytokine; eotaxin; interleukin 25; allergic disease; animal tissue; article; asthma; bronchus hyperreactivity; controlled study; histopathology; lung lavage; mouse; nonhuman; pneumonia; priority journal; Th2 cell",Article,Final,,Scopus,2-s2.0-33845460525
Hansbro N.G.; Horvat J.C.; Wark P.A.; Hansbro P.M.,"Hansbro, Nicole G. (15055862300); Horvat, Jay C. (9942405300); Wark, Peter A. (7003559516); Hansbro, Philip M. (6603119390)",15055862300; 9942405300; 7003559516; 6603119390,Understanding the mechanisms of viral induced asthma: New therapeutic directions,2008,Pharmacology and Therapeutics,117,3,,313,353,40,110,10.1016/j.pharmthera.2007.11.002,https://www.scopus.com/inward/record.uri?eid=2-s2.0-39549106885&doi=10.1016%2fj.pharmthera.2007.11.002&partnerID=40&md5=09cf1eab59597f3c23c7e9a268574457,"Priority Research Centre for Asthma and Respiratory Disease, Faculty of Health, The University of Newcastle, NSW 2308, Australia; Vaccines, Immunology/Infection, Viruses and Asthma Group, Locked Bag 1 New Lambton, NSW 2305, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital and Sleep Medicine, School of Medical Practice, Newcastle, Australia","Hansbro N.G., Priority Research Centre for Asthma and Respiratory Disease, Faculty of Health, The University of Newcastle, NSW 2308, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Locked Bag 1 New Lambton, NSW 2305, Australia; Horvat J.C., Priority Research Centre for Asthma and Respiratory Disease, Faculty of Health, The University of Newcastle, NSW 2308, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Locked Bag 1 New Lambton, NSW 2305, Australia; Wark P.A., Priority Research Centre for Asthma and Respiratory Disease, Faculty of Health, The University of Newcastle, NSW 2308, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Locked Bag 1 New Lambton, NSW 2305, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital and Sleep Medicine, School of Medical Practice, Newcastle, Australia; Hansbro P.M., Priority Research Centre for Asthma and Respiratory Disease, Faculty of Health, The University of Newcastle, NSW 2308, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Locked Bag 1 New Lambton, NSW 2305, Australia",Allergy; Asthma; Exacerbation; Induction; Prevention; Respiratory syncytial virus; Rhinovirus; Treatment,"Adrenal Cortex Hormones; Adrenergic beta-Agonists; Angiogenesis Inhibitors; Animals; Antibodies; Antioxidants; Antiviral Agents; Asthma; Common Cold; Disease Susceptibility; Humans; Immunization, Passive; Interferon Type I; Macrolides; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Rhinovirus; Viral Vaccines; allergen; alpha interferon; beta adrenergic receptor stimulating agent; butylated hydroxyanisole; corticosteroid; intercellular adhesion molecule 1; interferon; ketolide; live vaccine; oxazolinyl isoaxole derivative; placebo; pleconaril; recombinant intercellular adhesion molecule 1; respiratory syncytial virus vaccine; rupintrivir; telithromycin; unclassified drug; angiogenesis; antibody response; asthma; atopy; bronchiolitis; CD4 CD8 ratio; CD8+ T lymphocyte; clinical trial; disease exacerbation; disease predisposition; drug activity; drug efficacy; drug formulation; drug inhibition; drug synthesis; flu like syndrome; headache; human; immunogenicity; innate immunity; leukopenia; nausea; nonhuman; priority journal; Respiratory syncytial pneumovirus; respiratory tract infection; review; Rhinovirus; Th2 cell; unspecified side effect; virus pneumonia; wheezing",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-39549106885
Skelding K.A.; Hickey D.K.; Horvat J.C.; Bao S.; Roberts K.G.; Finnie J.M.; Hansbro P.M.; Beagley K.W.,"Skelding, Kathryn A. (9943411700); Hickey, Danica K. (9943841400); Horvat, Jay C. (9942405300); Bao, Shisan (7201558181); Roberts, Kathryn G. (39561559700); Finnie, Jane M. (57203969989); Hansbro, Philip M. (6603119390); Beagley, Kenneth W. (7005403437)",9943411700; 9943841400; 9942405300; 7201558181; 39561559700; 57203969989; 6603119390; 7005403437,Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection,2006,Vaccine,24,3,,355,366,11,36,10.1016/j.vaccine.2005.07.104,https://www.scopus.com/inward/record.uri?eid=2-s2.0-29044444338&doi=10.1016%2fj.vaccine.2005.07.104&partnerID=40&md5=b010aa696eab166f745a6079092fe5e3,"School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia; Newcastle Australia and Hunter Medical Research Institute, Newcastle, Australia; Department of Pathology, University of Sydney, Sydney, Australia","Skelding K.A., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Newcastle Australia and Hunter Medical Research Institute, Newcastle, Australia; Hickey D.K., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Newcastle Australia and Hunter Medical Research Institute, Newcastle, Australia; Horvat J.C., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Newcastle Australia and Hunter Medical Research Institute, Newcastle, Australia; Bao S., Department of Pathology, University of Sydney, Sydney, Australia; Roberts K.G., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Newcastle Australia and Hunter Medical Research Institute, Newcastle, Australia; Finnie J.M., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Newcastle Australia and Hunter Medical Research Institute, Newcastle, Australia; Hansbro P.M., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Newcastle Australia and Hunter Medical Research Institute, Newcastle, Australia; Beagley K.W., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia, Newcastle Australia and Hunter Medical Research Institute, Newcastle, Australia",Bronchoalveolar lavage; Chlamydia; IgA; Intranasal immunization; Lung; Respiratory tract infection; Transcutaneous immunization,"Administration, Intranasal; Animals; Bacterial Vaccines; Bronchoalveolar Lavage Fluid; Chlamydia Infections; Chlamydia muridarum; Cytokines; DNA, Bacterial; Female; Immunization Schedule; Immunoglobulin A; Immunoglobulin G; Injections, Subcutaneous; Lung; Lymph Nodes; Mice; Mice, Inbred BALB C; Respiratory Tract Infections; Vaccines, Synthetic; antibody; cholera toxin; CpG oligodeoxynucleotide; cytokine; gamma interferon; immunoglobulin A; immunoglobulin G; immunological adjuvant; major outer membrane protein; messenger RNA; outer membrane protein; unclassified drug; adjuvant therapy; animal cell; animal experiment; animal model; animal tissue; antibody production; antibody response; antibody specificity; article; body weight; cell secretion; cell stimulation; Chlamydia; comparative study; controlled study; disease model; drain; drug effect; female; immune response; immunization; immunoglobulin blood level; in vitro study; lung lavage; lung parenchyma; lymph node; mononuclear cell; mouse; nonhuman; priority journal; provocation test; real time polymerase chain reaction; respiratory tract infection; serum; weight gain; weight reduction",Article,Final,,Scopus,2-s2.0-29044444338
Yang M.; Mattes J.; Hansbro P.M.; Foster P.S.,"Yang, Ming (56857729900); Mattes, Joerg (7005999915); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569)",56857729900; 7005999915; 6603119390; 7201517569,Employment of microRNA profiles and RNA interference and antagomirs for the characterization and treatment of respiratory disease,2006,Drug Discovery Today: Therapeutic Strategies,3,3,,325,332,7,5,10.1016/j.ddstr.2006.10.001,https://www.scopus.com/inward/record.uri?eid=2-s2.0-33751285540&doi=10.1016%2fj.ddstr.2006.10.001&partnerID=40&md5=e8d07de3cb54f0927b98740eae38113a,"Centre for Asthma and Respiratory Disease, School of Biomedical Sciences, Faculty of Health, Callaghan, NSW 2300, Australia; The Division of Molecular Biosciences, The John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia","Yang M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences, Faculty of Health, Callaghan, NSW 2300, Australia, The Division of Molecular Biosciences, The John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia; Mattes J., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences, Faculty of Health, Callaghan, NSW 2300, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences, Faculty of Health, Callaghan, NSW 2300, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences, Faculty of Health, Callaghan, NSW 2300, Australia, The Division of Molecular Biosciences, The John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia",,liposome; microRNA; short hairpin RNA; small interfering RNA; adenovirus vector; clinical feature; cluster analysis; drug efficacy; expression vector; gene expression; gene function; lentivirus vector; molecular mechanics; nonhuman; nonviral gene delivery system; plasmid vector; regulatory mechanism; respiratory tract disease; retrovirus vector; review; RNA analysis; RNA interference; viral gene delivery system,Review,Final,,Scopus,2-s2.0-33751285540
Thorburn A.N.; Hansbro P.M.,"Thorburn, Alison N. (35485821500); Hansbro, Philip M. (6603119390)",35485821500; 6603119390,Harnessing regulatory T cells to suppress asthma: From Potential to therapy,2010,American Journal of Respiratory Cell and Molecular Biology,43,5,,511,519,8,83,10.1165/rcmb.2009-0342TR,https://www.scopus.com/inward/record.uri?eid=2-s2.0-78149274601&doi=10.1165%2frcmb.2009-0342TR&partnerID=40&md5=f1f7b085bf1f9bb163cb65eb77a50c42,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Thorburn A.N., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",Asthma; Forkhead box p3; Immunoregulatory therapy; Regulatory t cell,"Animals; Asthma; Biological Markers; Humans; Immune Tolerance; T-Lymphocytes, Regulatory; 5' nucleotidase; activin A; B7 antigen; biological marker; CD103 antigen; CD137 antigen; CD39 antigen; CD69 antigen; CD86 antigen; cytokine; cytotoxic T lymphocyte antigen 4; fibrinogen like protein 2; galectin 1; granzyme; interleukin 10; interleukin 2; interleukin 2 receptor; interleukin 2 receptor alpha; interleukin 35; interleukin 7 receptor; interleukin 9; lymphocyte function associated antigen 1; major histocompatibility antigen class 2; neuropilin 1; OX40 ligand; perforin; protein; retinoic acid; transcription factor FOXP3; transforming growth factor beta; unclassified drug; biological marker; antigen presentation; antigen presenting cell; asthma; B lymphocyte; Bifidobacterium animalis; CD25+ T lymphocyte; cell contact; cell proliferation; cytokine release; dendritic cell; gene; Heligmosomoides polygyrus; human; immune response; immunological tolerance; immunomodulation; immunoregulation; Lactobacillus reuteri; Lactobacillus rhamnosus; Litomosoides sigmodontis; lymphocyte activation gene 3; Mycobacterium vaccae; natural killer T cell; Nippostrongylus brasiliensis; nonhuman; protein expression; regulatory T lymphocyte; review; Schistosoma japonicum; Schistosoma mansoni; Streptococcus pneumoniae; Th17 cell; Toxoplasma gondii; animal; asthma; immunology",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-78149274601
Schorah C.J.; Bishop N.; Wales J.K.; Hansbro P.M.; Habibzadeh N.,"Schorah, C.J. (35876627800); Bishop, N. (57212914597); Wales, J.K. (16183064200); Hansbro, P.M. (6603119390); Habibzadeh, N. (6603115374)",35876627800; 57212914597; 16183064200; 6603119390; 6603115374,Blood vitamin C concentrations in patients with diabetes mellitus,1988,International Journal for Vitamin and Nutrition Research,58,3,,312,318,6,19,,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023764172&partnerID=40&md5=f8bf9c780843979452383b8a6fce22ec,United Kingdom,"Schorah C.J., United Kingdom; Bishop N., United Kingdom; Wales J.K., United Kingdom; Hansbro P.M., United Kingdom; Habibzadeh N., United Kingdom",,"Adult; Aged; Ascorbic Acid; Blood Glucose; Comparative Study; Diabetes Mellitus, Insulin-Dependent; Diabetes Mellitus, Non-Insulin-Dependent; Female; Human; Leukocytes; Male; Middle Age; Nutritional Status; Support, Non-U.S. Gov't; ascorbic acid; blood analysis; diabetes mellitus; human; human cell; insulin dependent diabetes mellitus; leukocyte; major clinical study; non insulin dependent diabetes mellitus; plasma",Article,Final,,Scopus,2-s2.0-0023764172
Hansbro P.M.; Byard S.J.; Bushby R.J.; Turnbull P.J.H.; Boden N.; Saunders M.R.; Novelli R.; Reid D.G.,"Hansbro, Philip M. (6603119390); Byard, Stephen J. (6507391172); Bushby, Richard J. (7004975975); Turnbull, Paul J.H. (35958247000); Boden, Neville (7006693378); Saunders, Martin R. (57224802203); Novelli, Riccardo (13003018300); Reid, David G. (7402153977)",6603119390; 6507391172; 7004975975; 35958247000; 7006693378; 57224802203; 13003018300; 7402153977,The conformational behaviour of phosphatidylinositol in model membranes: 2H-NMR studies,1992,BBA - Biomembranes,1112,2,,187,196,9,35,10.1016/0005-2736(92)90391-X,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026478946&doi=10.1016%2f0005-2736%2892%2990391-X&partnerID=40&md5=42e202215fac34aae7d6c7949cd48b7a,"School of Chemistry, University of Leeds, Leeds, United Kingdom; Chemistry Support, SmithKline Beecham Pharmaceuticals, Welwyn, Herts, The Frythe, United Kingdom; Migraine Programme, SmithKline Beecham Pharmaceuticals, Welwyn, Herts, The Frythe, United Kingdom; Analytical Sciences Department, SmithKline Beachan Pharmaceuticals, Welwyn, Herts, The Frythe, United Kingdom","Hansbro P.M., School of Chemistry, University of Leeds, Leeds, United Kingdom; Byard S.J., School of Chemistry, University of Leeds, Leeds, United Kingdom; Bushby R.J., School of Chemistry, University of Leeds, Leeds, United Kingdom; Turnbull P.J.H., School of Chemistry, University of Leeds, Leeds, United Kingdom; Boden N., School of Chemistry, University of Leeds, Leeds, United Kingdom; Saunders M.R., Chemistry Support, SmithKline Beecham Pharmaceuticals, Welwyn, Herts, The Frythe, United Kingdom; Novelli R., Migraine Programme, SmithKline Beecham Pharmaceuticals, Welwyn, Herts, The Frythe, United Kingdom; Reid D.G., Analytical Sciences Department, SmithKline Beachan Pharmaceuticals, Welwyn, Herts, The Frythe, United Kingdom","Model membrane; NMR, <sup>2</sup>H-; Phosphatidylinositol","Chemistry, Physical; Deuterium; Hydrogen Bonding; Lipid Bilayers; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Phosphatidylinositols; Support, Non-U.S. Gov't; deuterium; dimyristoylphosphatidylinositol; unclassified drug; article; chemical structure; isotope labeling; membrane structure; model; priority journal; synthesis",Article,Final,,Scopus,2-s2.0-0026478946
Hazlewood L.C.; Wood L.G.; Hansbro P.M.; Foster P.S.,"Hazlewood, Leia C. (26434272500); Wood, Lisa G. (55859741700); Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569)",26434272500; 55859741700; 6603119390; 7201517569,Dietary lycopene supplementation suppresses Th2 responses and lung eosinophilia in a mouse model of allergic asthma,2011,Journal of Nutritional Biochemistry,22,1,,95,100,5,54,10.1016/j.jnutbio.2009.12.003,https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649980068&doi=10.1016%2fj.jnutbio.2009.12.003&partnerID=40&md5=f3764eb6ec7f6e73d9f964901f515dba,"Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia","Hazlewood L.C., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Wood L.G., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",Airway inflammation; Antioxidants; Asthma; Eosinophils; Lycopene; Th2 response,"Animals; Asthma; Bronchoalveolar Lavage Fluid; Carotenoids; Cell Count; Cells, Cultured; Cytokines; Dietary Supplements; Immunoglobulin G; Inflammation Mediators; Lung; Lymph Nodes; Lymphocyte Count; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Phytotherapy; Pulmonary Eosinophilia; Th2 Cells; Mus; cytokine; immunoglobulin G1; interleukin 4; interleukin 5; lyc o mato; lycopene; ovalbumin; unclassified drug; allergic asthma; animal experiment; animal model; article; controlled study; cytokine production; cytokine release; diet supplementation; inflammatory cell; Loeffler pneumonia; lung function; lung lavage; male; mouse; nonhuman; Th2 cell",Article,Final,,Scopus,2-s2.0-78649980068
Stephenson J.; Budd G.M.; Manning J.; Hansbro P.,"Stephenson, Jon (8393313100); Budd, G.M. (7101797440); Manning, J. (8589829800); Hansbro, P. (6603119390)",8393313100; 7101797440; 8589829800; 6603119390,"Major eruption-induced changes to the McDonald Islands, southern Indian Ocean",2005,Antarctic Science,17,2,,259,266,7,10,10.1017/S095410200500266X,https://www.scopus.com/inward/record.uri?eid=2-s2.0-20744458294&doi=10.1017%2fS095410200500266X&partnerID=40&md5=ffb90e893223630ccfa40baa8d671d76,"School of Earth Sciences, James Cook University, Townsville, QLD 4811, Australia; School of Exercise and Sport Science, Faculty of Health Sciences, University of Sydney, Lidcombe, NSW 2141, PO Box 170, Australia; Geoscience Australia, Canberra, ACT 2601, GPO Box 378, Australia; Department of Immunology and Microbiology, University of Newcastle, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia","Stephenson J., School of Earth Sciences, James Cook University, Townsville, QLD 4811, Australia; Budd G.M., School of Exercise and Sport Science, Faculty of Health Sciences, University of Sydney, Lidcombe, NSW 2141, PO Box 170, Australia; Manning J., Geoscience Australia, Canberra, ACT 2601, GPO Box 378, Australia; Hansbro P., Department of Immunology and Microbiology, University of Newcastle, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia",Fauna; King penguin; Lava domes; Lava spines; Ship hazards; Sub-Antarctic; Volcanism,Heard Island and McDonald Islands; Indian Ocean; Indian Ocean islands; McDonald Island; oceanic regions; World; Aptenodytes; Aptenodytes patagonicus; Chrysolophus; Eudyptes chrysolophus; Spheniscidae; coastal landform; volcanic eruption; volcanic landform; volcanism,Article,Final,,Scopus,2-s2.0-20744458294
Kaiko G.E.; Horvat J.C.; Beagley K.W.; Hansbro P.M.,"Kaiko, Gerard E. (21739529400); Horvat, Jay C. (9942405300); Beagley, Kenneth W. (7005403437); Hansbro, Philip M. (6603119390)",21739529400; 9942405300; 7005403437; 6603119390,Immunological decision-making: How does the immune system decide to mount a helper T-cell response?,2008,Immunology,123,3,,326,338,12,525,10.1111/j.1365-2567.2007.02719.x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-38649090061&doi=10.1111%2fj.1365-2567.2007.02719.x&partnerID=40&md5=d36cde59c82bf6fe86465f49e6e8f37b,"School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia; Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Discipline of Infection and Immunity, David Maddison Clinical Sciences Building, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia","Kaiko G.E., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Horvat J.C., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Beagley K.W., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro P.M., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia, Discipline of Infection and Immunity, David Maddison Clinical Sciences Building, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia",Dendritic cell; Polarization; T-cell; Th1; Th17; Th2,"B-Lymphocytes; Cell Differentiation; Dendritic Cells; Epigenesis, Genetic; Humans; Interleukin-17; Lymphocyte Activation; Signal Transduction; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Th1 Cells; Th2 Cells; Toll-Like Receptors; cytokine; immunoglobulin enhancer binding protein; mitogen activated protein kinase; STAT protein; toll like receptor; antigen presenting cell; B lymphocyte; CD4+ T lymphocyte; cell differentiation; cell division; cell lineage; cell maturation; cell polarity; dendritic cell; epigenetics; gene structure; granulocyte; helper cell; human; immune response; immune system; medical research; nonhuman; phenotype; priority journal; review; signal transduction; Th1 cell; Th2 cell",Review,Final,All Open Access; Green Open Access,Scopus,2-s2.0-38649090061
Gasanov U.; Koina C.; Beagley K.W.; Aitken R.J.; Hansbro P.M.,"Gasanov, Uta (10539337500); Koina, Craig (6507556420); Beagley, Kenneth W. (7005403437); Aitken, R. John (7201959888); Hansbro, Philip M. (6603119390)",10539337500; 6507556420; 7005403437; 7201959888; 6603119390,Identification of the insulin-like growth factor II receptor as a novel receptor for binding and invasion by Listeria monocytogenes,2006,Infection and Immunity,74,1,,566,577,11,11,10.1128/IAI.74.1.566-577.2006,https://www.scopus.com/inward/record.uri?eid=2-s2.0-29644447372&doi=10.1128%2fIAI.74.1.566-577.2006&partnerID=40&md5=cd477ed5616c624ee7018c849104d6ea,"School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia; Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Environmental and Life Sciences, Faculty of Science and Mathematics, University of Newcastle, Newcastle, NSW, Australia; Bacteriology Research Group, David Maddison Clinical Sciences Building, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia","Gasanov U., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Koina C., Environmental and Life Sciences, Faculty of Science and Mathematics, University of Newcastle, Newcastle, NSW, Australia; Beagley K.W., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Aitken R.J., Environmental and Life Sciences, Faculty of Science and Mathematics, University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunology/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia, Bacteriology Research Group, David Maddison Clinical Sciences Building, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia",,"Animals; Bacterial Adhesion; Cell Line; Chromatography, Affinity; Fibroblasts; Humans; Listeria monocytogenes; Mice; Peptide Library; Peptides; Receptor, IGF Type 2; mannose 6 phosphate; peptide; somatomedin B receptor; synthetic peptide; affinity purification; amino acid sequence; animal cell; article; bacterium adherence; bacterium invasion; binding site; cattle; cell invasion; controlled study; fetal calf serum; immobilized cell; Listeria innocua; Listeria monocytogenes; listeriosis; mammal cell; nonhuman; phage display; priority journal; purification; receptor binding",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-29644447372
Hansbro P.M.; Foster P.S.; Hogan S.P.; Ozaki S.; Denborough M.A.,"Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569); Hogan, Simon P. (7102358818); Ozaki, Shiochiro (35493461800); Denborough, Michael A. (7006750469)",6603119390; 7201517569; 7102358818; 35493461800; 7006750469,"Purification and characterization of D-myo-Inositol (1,4,5)/(1,3,4,5)-polyphosphate 5-phosphatase from skeletal muscle",1994,Archives of Biochemistry and Biophysics,311,1,,47,54,7,4,10.1006/abbi.1994.1207,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028292622&doi=10.1006%2fabbi.1994.1207&partnerID=40&md5=de094b1244d93b82486cf512053252e6,"Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, GPO Box 334, Australia; Department of Resources Chemistry, Faculty of Engineering, Ehime University, Matsuyama 790, 3 Bunkyo-cho, Japan","Hansbro P.M., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, GPO Box 334, Australia; Foster P.S., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, GPO Box 334, Australia; Hogan S.P., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, GPO Box 334, Australia; Ozaki S., Department of Resources Chemistry, Faculty of Engineering, Ehime University, Matsuyama 790, 3 Bunkyo-cho, Japan; Denborough M.A., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, GPO Box 334, Australia",,"2,3-Diphosphoglycerate; Animal; Chromatography, Affinity; Chromatography, Ion Exchange; Diphosphoglyceric Acids; Electrophoresis, Polyacrylamide Gel; Hydrolysis; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Isoelectric Point; Kinetics; Magnesium; Molecular Weight; Muscles; Phosphoric Monoester Hydrolases; Sarcoplasmic Reticulum; Swine; Animalia; Sus scrofa; synaptojanin; unclassified drug; animal tissue; article; calcium homeostasis; enzyme kinetics; enzyme purification; nonhuman; priority journal; skeletal muscle; swine",Article,Final,,Scopus,2-s2.0-0028292622
Thorburn A.N.; Hansbro P.M.; Gibson P.G.,"Thorburn, Alison N. (35485821500); Hansbro, Philip M. (6603119390); Gibson, Peter G. (7202414199)",35485821500; 6603119390; 7202414199,Pneumococcal vaccines for allergic airways diseases,2009,Expert Opinion on Biological Therapy,9,5,,621,629,8,17,10.1517/14712590902916999,https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649114590&doi=10.1517%2f14712590902916999&partnerID=40&md5=07c0eb8e5c7c8d53e27b862a42c0b8e2,"University of Newcastle, Hunter Medical Research Institute, Centre for Asthma and Respiratory Disease, Newcastle, NSW 2305, Australia","Thorburn A.N., University of Newcastle, Hunter Medical Research Institute, Centre for Asthma and Respiratory Disease, Newcastle, NSW 2305, Australia; Hansbro P.M., University of Newcastle, Hunter Medical Research Institute, Centre for Asthma and Respiratory Disease, Newcastle, NSW 2305, Australia; Gibson P.G., University of Newcastle, Hunter Medical Research Institute, Centre for Asthma and Respiratory Disease, Newcastle, NSW 2305, Australia",Allergy; Asthma; Eosinophil; Immunoregulatory; Infection; Streptococcus pneumoniae; T regulatory cell; Vaccine,"Animals; Asthma; Humans; Hypersensitivity; Pneumococcal Infections; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Streptococcus pneumoniae; BCG vaccine; Pneumococcus vaccine; polysaccharide vaccine; allergic asthma; clinical trial; disease course; eosinophilia; human; immune response; immunopathology; immunoregulation; immunotherapy; nonhuman; pathogenesis; pneumococcal infection; prevalence; regulatory T lymphocyte; review; risk assessment; Streptococcus pneumoniae; vaccination",Review,Final,,Scopus,2-s2.0-67649114590
FOSTER P.S.; HOGAN S.P.; HANSBRO P.M.; O'BRIEN R.; POTTER B.V.L.; OZAKI S.; DENBOROUGH M.A.,"FOSTER, Paul S. (7201517569); HOGAN, Simon P. (7102358818); HANSBRO, Philip M. (6603119390); O'BRIEN, Robert (36764416400); POTTER, Barry V. L. (16073310200); OZAKI, Shoichiro (35493461800); DENBOROUGH, Michael A. (7006750469)",7201517569; 7102358818; 6603119390; 36764416400; 16073310200; 35493461800; 7006750469,"The metabolism of d‐myo‐inositol 1,4,5‐trisphosphate and d‐myo‐inositol 1,3,4,5‐tetrakisphosphate by porcine skeletal muscle",1994,European Journal of Biochemistry,222,3,,955,964,9,14,10.1111/j.1432-1033.1994.tb18946.x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028287593&doi=10.1111%2fj.1432-1033.1994.tb18946.x&partnerID=40&md5=3f439363872e5629d7a96c426fdd223a,"Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, Australia; School of Pharmacy and Pharmacology, Institute for Life Sciences, University of Bath, Bath, United Kingdom; Department of Resources Chemistry, Faculty of Engineering, Ehime University, Japan","FOSTER P.S., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, Australia; HOGAN S.P., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, Australia; HANSBRO P.M., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, Australia; O'BRIEN R., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, Australia; POTTER B.V.L., School of Pharmacy and Pharmacology, Institute for Life Sciences, University of Bath, Bath, United Kingdom; OZAKI S., Department of Resources Chemistry, Faculty of Engineering, Ehime University, Japan; DENBOROUGH M.A., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, Australia",,"Adenosine Triphosphate; Animal; Calcium; Cell Fractionation; Chromatography, High Pressure Liquid; Inositol; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Kinetics; Magnesium; Muscles; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Solubility; Subcellular Fractions; Support, Non-U.S. Gov't; Swine; Animalia; Suidae; Sus scrofa; inositol 1,3,4,5 tetrakisphosphate; inositol 1,4,5 trisphosphate; animal tissue; article; enzyme kinetics; nonhuman; phosphoinositide metabolism; priority journal; signal transduction; skeletal muscle; swine",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-0028287593
Thorburn A.N.; O'Sullivan B.J.; Thomas R.; Kumar R.K.; Foster P.S.; Gibson P.G.; Hansbro P.M.,"Thorburn, Alison N. (35485821500); O'Sullivan, Brendan J. (35791435100); Thomas, Ranjeny (35430984400); Kumar, Rakesh K. (57203775042); Foster, Paul S. (7201517569); Gibson, Peter G. (7202414199); Hansbro, Philip M. (6603119390)",35485821500; 35791435100; 35430984400; 57203775042; 7201517569; 7202414199; 6603119390,Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease,2010,Thorax,65,12,,1053,1060,7,63,10.1136/thx.2009.131508,https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649631700&doi=10.1136%2fthx.2009.131508&partnerID=40&md5=ba0db0b10d50921e2c4c545add691ba3,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; University of Queensland, Diamantina Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia; Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia","Thorburn A.N., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; O'Sullivan B.J., University of Queensland, Diamantina Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia; Thomas R., University of Queensland, Diamantina Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia; Kumar R.K., Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia; Gibson P.G., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia",,immunoglobulin E; Pneumococcus vaccine; allergic airway disease; animal experiment; animal model; article; asthma; drug effect; drug efficacy; eosinophil; female; fluorescence activated cell sorting; immunoglobulin blood level; immunoregulation; mouse; mucus secretion; nonhuman; priority journal; prophylaxis; regulatory T lymphocyte; respiratory tract disease; Th2 cell,Article,Final,All Open Access; Bronze Open Access; Green Open Access,Scopus,2-s2.0-78649631700
Chen X.J.; Hansbro P.M.; Clark-Walker G.D.,"Chen, X.J. (9534687900); Hansbro, P.M. (6603119390); Clark-Walker, G.D. (7006174044)",9534687900; 6603119390; 7006174044,Suppression of p0 lethality by mitochondrial ATP synthase F1 mutations in Kluyveromyces lactis occurs in the absence of F0,1998,Molecular and General Genetics,259,5,,457,467,10,17,10.1007/s004380050836,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031595734&doi=10.1007%2fs004380050836&partnerID=40&md5=c5056e55b525c68c303009ef9ced056f,"Molec. and Cellular Genetics Group, Res. School of Biological Sciences, Australian National University, Canberra, ACT 2601, GPO Box 475, Australia","Chen X.J., Molec. and Cellular Genetics Group, Res. School of Biological Sciences, Australian National University, Canberra, ACT 2601, GPO Box 475, Australia; Hansbro P.M., Molec. and Cellular Genetics Group, Res. School of Biological Sciences, Australian National University, Canberra, ACT 2601, GPO Box 475, Australia; Clark-Walker G.D., Molec. and Cellular Genetics Group, Res. School of Biological Sciences, Australian National University, Canberra, ACT 2601, GPO Box 475, Australia",F<sub>1</sub> assembly F<sub>0</sub> subunits; F<sub>1</sub>F<sub>0</sub>-ATP synthase; Kluyveromyces lactis; MGI genes,"Alleles; Amino Acid Sequence; Cell Division; Ethidium; Gene Deletion; Genes, Fungal; Genotype; In Situ Hybridization; Kluyveromyces; Mitochondria; Molecular Sequence Data; Mutagenesis, Insertional; Mutation; Phenotype; Proton-Translocating ATPases; Restriction Mapping; Sequence Alignment; Sequence Analysis, DNA; Suppression, Genetic; Kluyveromyces lactis; ethidium bromide; mitochondrial dna; proton transporting adenosine triphosphate synthase; ethidium; proton transporting adenosine triphosphatase; article; controlled study; enzyme subunit; fungal genetics; fungus mutant; gene disruption; gene isolation; kluyveromyces; lethal mutant; nonhuman; nucleotide sequence; priority journal; protein assembly; allele; amino acid sequence; cell division; DNA sequence; drug effect; enzymology; fungal gene; gene deletion; gene expression regulation; gene repression; genetics; genotype; growth, development and aging; in situ hybridization; Kluyveromyces; metabolism; mitochondrion; molecular genetics; mutation; phenotype; restriction mapping; sequence alignment",Article,Final,,Scopus,2-s2.0-0031595734
Hansbro P.M.; Warner S.; Tracey J.P.; Arzey K.E.; Selleck P.; O'Riley K.; Beckett E.L.; Bunn C.; Kirkland P.D.; Vijaykrishna D.; Olsen B.; Hurt A.C.,"Hansbro, Philip M. (6603119390); Warner, Simone (23983839400); Tracey, John P. (8790263700); Arzey, K. Edla (6507363704); Selleck, Paul (6701547852); O'Riley, Kim (6506489871); Beckett, Emma L. (36620958500); Bunn, Chris (7006051170); Kirkland, Peter D. (56243457600); Vijaykrishna, Dhanasekaran (15070312600); Olsen, Bjorn (7201359257); Hurt, Aeron C. (6603378203)",6603119390; 23983839400; 8790263700; 6507363704; 6701547852; 6506489871; 36620958500; 7006051170; 56243457600; 15070312600; 7201359257; 6603378203,"Surveillance and analysis of avian influenza viruses, Australia",2010,Emerging Infectious Diseases,16,12,,1896,1904,8,66,10.3201/eid1612.100776,https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649557193&doi=10.3201%2feid1612.100776&partnerID=40&md5=0a25df49ee95739f674f742db6bfd40e,"The University of Newcastle, Newcastle, NSW, Australia; Department of Primary Industries, Attwood, VIC, Australia; Orange Agricultural Institute, Orange, NSW, Australia; Elizabeth Macarthur Agriculture Institute, Menangle, NSW, Australia; Australian Animal Health Laboratories, Geelong, VIC, Australia; Department of Agriculture, Fisheries and Forestry, Canberra, ACT, Australia; Duke-NUS Graduate Medical School, Singapore; Kalmar University, Kalmar, Sweden; Uppsala University, Uppsala, Sweden; World Health Organization Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia","Hansbro P.M., The University of Newcastle, Newcastle, NSW, Australia; Warner S., Department of Primary Industries, Attwood, VIC, Australia; Tracey J.P., Orange Agricultural Institute, Orange, NSW, Australia; Arzey K.E., Elizabeth Macarthur Agriculture Institute, Menangle, NSW, Australia; Selleck P., Australian Animal Health Laboratories, Geelong, VIC, Australia; O'Riley K., Department of Primary Industries, Attwood, VIC, Australia; Beckett E.L., The University of Newcastle, Newcastle, NSW, Australia; Bunn C., Department of Agriculture, Fisheries and Forestry, Canberra, ACT, Australia; Kirkland P.D., Elizabeth Macarthur Agriculture Institute, Menangle, NSW, Australia; Vijaykrishna D., Duke-NUS Graduate Medical School, Singapore; Olsen B., Kalmar University, Kalmar, Sweden, Uppsala University, Uppsala, Sweden; Hurt A.C., World Health Organization Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia",,"Animal Migration; Animals; Australia; Birds; Cloaca; Environmental Monitoring; Feces; Humans; Influenza A virus; Influenza in Birds; Influenza, Human; Phylogeny; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Seasons; article; Australia; autumn; avian influenza virus; controlled study; disease surveillance; duck; epidemic; feces analysis; geographic distribution; Influenza virus A H7N7; migratory species; nonhuman; phylogeny; polymerase chain reaction; poultry farming; quantitative analysis; reverse transcription polymerase chain reaction; risk assessment; seasonal variation; virus detection; virus identification; virus strain; virus typing; virus virulence",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-78649557193
Beagley K.; Huston W.M.; Hansbro P.M.; Timms P.,"Beagley, Kenneth (7005403437); Huston, Wilhelmina M. (6603412284); Hansbro, Philip M. (6603119390); Timms, Peter (7006114444)",7005403437; 6603412284; 6603119390; 7006114444,Chlamydial infection of immune cells: Altered function and implications for disease,2009,Critical Reviews in Immunology,29,4,,275,305,30,68,,https://www.scopus.com/inward/record.uri?eid=2-s2.0-69149083126&partnerID=40&md5=8fde8c8e922597d0a455321dd2dff491,"Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4059, 60 Musk Avenue, Australia; Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, University Drive, Australia","Beagley K., Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4059, 60 Musk Avenue, Australia; Huston W.M., Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4059, 60 Musk Avenue, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Callaghan, NSW 2308, University Drive, Australia; Timms P., Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4059, 60 Musk Avenue, Australia",Chlamydia pneumoniae; Chlamydia psittaci; Chlamydia trachcomatis; Dendritic cell; Macrophage; Monocyte; Polymorphonuclear leukocyte,Animals; Chlamydia; Chlamydia Infections; Dendritic Cells; Evolution; Humans; Inflammation; Macrophages; Monocytes; cytokine; immunoglobulin enhancer binding protein; Alzheimer disease; apoptosis; asthma; astrocyte; bacterial growth; bacterial pneumonia; bacterial virulence; bone marrow cell; cell adhesion; cell line; cellular immunity; Chlamydia; Chlamydia trachomatis; chlamydiasis; Chlamydophila pneumoniae; community acquired pneumonia; coronary artery disease; cytokine production; dendritic cell; foam cell; glia cell; human; infertility; lung alveolus macrophage; lymphoma; macrophage; macrophage migration; mast cell; monocyte; multiple sclerosis; nerve cell; neutrophil; nonhuman; pelvic inflammatory disease; peritoneum macrophage; persistent infection; priority journal; reactive arthritis; review; T lymphocyte; trachoma,Review,Final,,Scopus,2-s2.0-69149083126
Lau J.Y.; Oliver B.G.; Baraket M.; Beckett E.L.; Hansbro N.G.; Moir L.M.; Wilton S.D.; Williams C.; Foster P.S.; Hansbro P.M.; Black J.L.; Burgess J.K.,"Lau, Justine Y. (35115095800); Oliver, Brian G. (15919869900); Baraket, Melissa (6602516393); Beckett, Emma L. (36620958500); Hansbro, Nicole G. (15055862300); Moir, Lyn M. (8948395100); Wilton, Steve D. (57221091578); Williams, Carolyn (57699766900); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390); Black, Judith L. (7402767206); Burgess, Janette K. (7201650628)",35115095800; 15919869900; 6602516393; 36620958500; 15055862300; 8948395100; 57221091578; 57699766900; 7201517569; 6603119390; 7402767206; 7201650628,Fibulin-1 is increased in asthma - a novel mediator of airway remodeling?,2010,PLoS ONE,5,10,e13360,,,,47,10.1371/journal.pone.0013360,https://www.scopus.com/inward/record.uri?eid=2-s2.0-78149452349&doi=10.1371%2fjournal.pone.0013360&partnerID=40&md5=35d9cdccccc2de6e07946bc03197ecb3,"Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia; Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia; Woolcock Institute of Medical Research, Sydney, NSW, Australia; Centre for Asthma and Respiratory Disease and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Perth, WA, Australia; Lung Institute of Western Australia and the Centre for Asthma, Allergy and Respiratory Research, University of Western Australia, Perth, WA, Australia","Lau J.Y., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia; Oliver B.G., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia, Woolcock Institute of Medical Research, Sydney, NSW, Australia; Baraket M., Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia, Woolcock Institute of Medical Research, Sydney, NSW, Australia; Beckett E.L., Centre for Asthma and Respiratory Disease and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro N.G., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Centre for Asthma and Respiratory Disease and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Moir L.M., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia, Woolcock Institute of Medical Research, Sydney, NSW, Australia; Wilton S.D., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Perth, WA, Australia, Lung Institute of Western Australia and the Centre for Asthma, Allergy and Respiratory Research, University of Western Australia, Perth, WA, Australia; Williams C., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Lung Institute of Western Australia and the Centre for Asthma, Allergy and Respiratory Research, University of Western Australia, Perth, WA, Australia; Foster P.S., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Centre for Asthma and Respiratory Disease and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Centre for Asthma and Respiratory Disease and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Black J.L., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia, Woolcock Institute of Medical Research, Sydney, NSW, Australia; Burgess J.K., Cooperative Research Centre for Asthma and Airways, Sydney, NSW, Australia, Discipline of Pharmacology, The University of Sydney, Sydney, NSW, Australia, Woolcock Institute of Medical Research, Sydney, NSW, Australia",,"Animals; Asthma; Base Sequence; Blotting, Western; Bronchoalveolar Lavage Fluid; Calcium-Binding Proteins; Case-Control Studies; Cell Movement; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibronectins; Humans; Mice; Mice, Inbred BALB C; Muscle, Smooth; Polymerase Chain Reaction; RNA, Messenger; Trachea; Murinae; antisense oligonucleotide; fibulin; fibulin 1; fibulin 1c; fibulin 1D; messenger RNA; regulator protein; transforming growth factor beta; unclassified drug; calcium binding protein; fibronectin; fibulin; messenger RNA; airway remodeling; animal experiment; animal model; article; asthma; bronchus biopsy; cell migration; cell proliferation; controlled study; disease severity; dot hybridization; enzyme linked immunosorbent assay; gene expression regulation; human; human cell; human tissue; immunohistochemistry; in vitro study; in vivo study; lung alveolus cell; lung lavage; major clinical study; male; mouse; nonhuman; protein analysis; protein blood level; protein expression; protein function; protein synthesis; real time polymerase chain reaction; upregulation; Western blotting; wound healing; animal; Bagg albino mouse; blood; case control study; cell culture; cell motion; disease model; genetics; histology; metabolism; nucleotide sequence; pathology; polymerase chain reaction; smooth muscle; trachea",Article,Final,All Open Access; Gold Open Access; Green Open Access,Scopus,2-s2.0-78149452349
Starkey M.R.; Horvat J.C.; Kim R.Y.; Hansbro P.M.,"Starkey, Malcolm R. (35811293400); Horvat, Jay C. (9942405300); Kim, Richard Y. (35810406900); Hansbro, Philip M. (6603119390)",35811293400; 9942405300; 35810406900; 6603119390,Reply,2010,Journal of Allergy and Clinical Immunology,125,6,,1415,,,0,10.1016/j.jaci.2010.03.033,https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952741002&doi=10.1016%2fj.jaci.2010.03.033&partnerID=40&md5=e104d7ea1d1687f47d546457029bbdc3,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Australia","Starkey M.R., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Australia; Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Australia; Kim R.Y., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Australia",,allergic asthma; allergy; asthma; chlamydiasis; disease association; disease exacerbation; human; immunomodulation; inflammation; letter; lung function; lung structure; nonhuman; onset age; pathogenesis; priority journal; Th1 cell; Th17 cell,Letter,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-77952741002
Haynes L.; Arzey E.; Bell C.; Buchanan N.; Burgess G.; Cronan V.; Dickason C.; Field H.; Gibbs S.; Hansbro P.M.; Hollingsworth T.; Hurt A.C.; Kirkland P.; McCracken H.; O'Connor J.; Tracey J.; Wallner J.; Warner S.; Woods R.; Bunn C.,"Haynes, L. (57214582293); Arzey, E. (35195190300); Bell, C. (57214532867); Buchanan, N. (35195286000); Burgess, G. (7102788039); Cronan, V. (35195428000); Dickason, C. (57154099600); Field, H. (7102982727); Gibbs, S. (7103264144); Hansbro, P.M. (6603119390); Hollingsworth, T. (35195915800); Hurt, A.C. (6603378203); Kirkland, P. (56243457600); McCracken, H. (7004244658); O'Connor, J. (57198287478); Tracey, J. (8790263700); Wallner, J. (35197124400); Warner, S. (23983839400); Woods, R. (8790263300); Bunn, C. (7006051170)",57214582293; 35195190300; 57214532867; 35195286000; 7102788039; 35195428000; 57154099600; 7102982727; 7103264144; 6603119390; 35195915800; 6603378203; 56243457600; 7004244658; 57198287478; 8790263700; 35197124400; 23983839400; 8790263300; 7006051170,Australian surveillance for avian influenza viruses in wild birds between July 2005 and June 2007,2009,Australian Veterinary Journal,87,7,,266,272,6,44,10.1111/j.1751-0813.2009.00446.x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-65349092562&doi=10.1111%2fj.1751-0813.2009.00446.x&partnerID=40&md5=fe6038b80473403aa568c046842184a5,"Australian Wildlife Health Network, Mosman, NSW 2088, PO Box 20, Australia; Elizabeth Macarthur Agricultural Institute, Department of Primary Industries New South Wales, Camden, NSW, Australia; Department of Primary Industries and Water, New Town, TAS, Australia; Primary Industries and Resources South Australia, Glenside, SA, Australia; School of Veterinary and Biomedical Sciences, James Cook University, QLD, Australia; Migratory and Marine Biodiversity, Department of the Environment, Water, Heritage and the Arts, Canberra, ACT, Australia; Disease Surveillance, Primary Industries and Resources South Australia, Flaxley, SA, Australia; Animal Research Institute, Department of Primary Industries Queensland, Moorooka, QLD, Australia; Australian Animal Health Laboratory, East Geelong, VIC, Australia; Centre for Asthma and Respiratory Disease (CARD), Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Department of Agriculture and Food, Bunbury, WA, Australia; WHO Collaborating Centre for Reference and Research on Influenza, Parkville, VIC, Australia; Melbourne Zoo, Parkville, VIC, Australia; Birds Australia, Carlton, VIC, Australia; Vertebrate Pest Research Unit, New South Wales Department of Primary Industries, Orange, NSW, Australia; AQIS Northern Australian Quarantine Strategy, Canberra, ACT, Australia; Department of Primary Industries Victoria, Attwood, VIC, Australia; Product Integrity, Animal and Plant Health, Department of Agriculture, Fisheries and Forestry Australia, Canberra, ACT, Australia","Haynes L., Australian Wildlife Health Network, Mosman, NSW 2088, PO Box 20, Australia; Arzey E., Elizabeth Macarthur Agricultural Institute, Department of Primary Industries New South Wales, Camden, NSW, Australia; Bell C., Department of Primary Industries and Water, New Town, TAS, Australia; Buchanan N., Primary Industries and Resources South Australia, Glenside, SA, Australia; Burgess G., School of Veterinary and Biomedical Sciences, James Cook University, QLD, Australia; Cronan V., Migratory and Marine Biodiversity, Department of the Environment, Water, Heritage and the Arts, Canberra, ACT, Australia; Dickason C., Disease Surveillance, Primary Industries and Resources South Australia, Flaxley, SA, Australia; Field H., Animal Research Institute, Department of Primary Industries Queensland, Moorooka, QLD, Australia; Gibbs S., Australian Animal Health Laboratory, East Geelong, VIC, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease (CARD), Hunter Medical Research Institute, University of Newcastle, NSW, Australia; Hollingsworth T., Department of Agriculture and Food, Bunbury, WA, Australia; Hurt A.C., WHO Collaborating Centre for Reference and Research on Influenza, Parkville, VIC, Australia; Kirkland P., Elizabeth Macarthur Agricultural Institute, Department of Primary Industries New South Wales, Camden, NSW, Australia; McCracken H., Melbourne Zoo, Parkville, VIC, Australia; O'Connor J., Birds Australia, Carlton, VIC, Australia; Tracey J., Vertebrate Pest Research Unit, New South Wales Department of Primary Industries, Orange, NSW, Australia; Wallner J., AQIS Northern Australian Quarantine Strategy, Canberra, ACT, Australia; Warner S., Department of Primary Industries Victoria, Attwood, VIC, Australia; Woods R., Australian Wildlife Health Network, Mosman, NSW 2088, PO Box 20, Australia; Bunn C., Product Integrity, Animal and Plant Health, Department of Agriculture, Fisheries and Forestry Australia, Canberra, ACT, Australia",Australia; Avian influenza; H5; H7; Surveillance; Wild birds,"Animals; Anseriformes; Antibodies, Viral; Australia; Bird Diseases; Charadriiformes; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Influenza A virus; Influenza in Birds; Polymerase Chain Reaction; Prevalence; Viral Matrix Proteins; Anatidae; Anseriformes; Aves; Avian influenza virus; Charadriiformes; Influenza A virus; Influenzavirus A; Orthomyxoviridae; matrix protein; virus antibody; virus DNA; animal; animal disease; article; Australia; avian influenza; bird disease; blood; Charadriiformes; chemistry; ducks and geese; enzyme linked immunosorbent assay; genetics; Influenza virus A; isolation and purification; polymerase chain reaction; prevalence; virology",Article,Final,,Scopus,2-s2.0-65349092562
Preston J.A.; Beagley K.W.; Gibson P.G.; Hansbro P.M.,"Preston, J.A. (59281082600); Beagley, K.W. (7005403437); Gibson, P.G. (7202414199); Hansbro, Philip M. (6603119390)",59281082600; 7005403437; 7202414199; 6603119390,Genetic background affects susceptibility in nonfatal pneumococcal bronchopneumonia,2004,European Respiratory Journal,23,2,,224,231,7,33,10.1183/09031936.03.00081403,https://www.scopus.com/inward/record.uri?eid=2-s2.0-1042280989&doi=10.1183%2f09031936.03.00081403&partnerID=40&md5=5882d64816b7363f2e1853437fd87803,"Discipline of Immunology/Microbiol., School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia; Respiratory and Sleep Medicine, Hunter Medical Research Institute, School of Medical Practice, Newcastle, NSW, Australia; Vaccines Immunity/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, New Lambton, NSW, Australia; Bacteriology Research Unit, Vacc. Immun./Infect. Viruses/Asthma, Discipline of Immunology/Microbiol., Newcastle, NSW 2300, David Maddison Clin. Sci. Building, Australia","Preston J.A., Discipline of Immunology/Microbiol., School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia, Vaccines Immunity/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, New Lambton, NSW, Australia; Beagley K.W., Discipline of Immunology/Microbiol., School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia, Vaccines Immunity/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, New Lambton, NSW, Australia; Gibson P.G., Respiratory and Sleep Medicine, Hunter Medical Research Institute, School of Medical Practice, Newcastle, NSW, Australia, Vaccines Immunity/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, New Lambton, NSW, Australia; Hansbro P.M., Discipline of Immunology/Microbiol., School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia, Vaccines Immunity/Infection, Viruses and Asthma Group, Hunter Medical Research Institute, New Lambton, NSW, Australia, Bacteriology Research Unit, Vacc. Immun./Infect. Viruses/Asthma, Discipline of Immunology/Microbiol., Newcastle, NSW 2300, David Maddison Clin. Sci. Building, Australia",Genetic background; Immune response; Infection; Nonfatal; Pneumococcus; Streptococcus pneumoniae,"Adult; Animals; Bronchopneumonia; Colony Count, Microbial; Disease Models, Animal; Female; Genetic Predisposition to Disease; Genotype; Humans; Leukocyte Count; Lung; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Genetic; Neutrophils; Phagocytosis; Pneumonia, Pneumococcal; Respiratory Burst; animal experiment; animal model; animal tissue; article; bacterial colonization; bacterial strain; blood sampling; bronchopneumonia; cell population; controlled study; disease predisposition; female; genetic susceptibility; histopathology; human; immune response; immunocompetent cell; lobar pneumonia; lymphocyte count; mouse; neutrophil; nonhuman; phagocytosis; priority journal; statistical significance; Streptococcus pneumoniae",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-1042280989
Hansbro P.M.; Chen X.J.; Clark-Walker G.D.,"Hansbro, Philip M. (6603119390); Chen, Xin Jie (9534687900); Clark-Walker, G. Desmond (7006174044)",6603119390; 9534687900; 7006174044,Allele-specific expression of the Mgi- phenotype on disruption of the F1-ATPase delta-subunit gene in Kluyveromyces lactis,1998,Current Genetics,33,1,,46,51,5,6,10.1007/s002940050307,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031951162&doi=10.1007%2fs002940050307&partnerID=40&md5=9ebb602436551d724dca2c2358cefe68,"Molec. and Cellular Genetics Group, Res. School of Biological Sciences, Australian National University, Canberra City, ACT 2601, PO Box 475, Australia; Department of Pathology, University of Cambridge, Cambridge, CB2 6PD, United Kingdom","Hansbro P.M., Molec. and Cellular Genetics Group, Res. School of Biological Sciences, Australian National University, Canberra City, ACT 2601, PO Box 475, Australia, Department of Pathology, University of Cambridge, Cambridge, CB2 6PD, United Kingdom; Chen X.J., Molec. and Cellular Genetics Group, Res. School of Biological Sciences, Australian National University, Canberra City, ACT 2601, PO Box 475, Australia; Clark-Walker G.D., Molec. and Cellular Genetics Group, Res. School of Biological Sciences, Australian National University, Canberra City, ACT 2601, PO Box 475, Australia",ATPδ-disruption; F<sub>1</sub>-ATPase δ-subunit gene; Kluyveromyces lactis; Mitochondrial genome integrity,"Alleles; Amino Acid Sequence; Base Sequence; Cloning, Molecular; DNA, Fungal; DNA, Mitochondrial; Genes, Fungal; Kluyveromyces; Molecular Sequence Data; Mutagenesis, Insertional; Phenotype; Proton-Translocating ATPases; Sequence Analysis, DNA; Species Specificity; Eukaryota; Kluyveromyces; Kluyveromyces lactis; Saccharomyces cerevisiae; ethidium bromide; mitochondrial dna; proton transporting adenosine triphosphate synthase; article; enzyme subunit; gene disruption; kluyveromyces; lethal gene; nonhuman; phenotype; priority journal; sequence homology",Article,Final,,Scopus,2-s2.0-0031951162
Wang W.; Li J.J.; Foster P.S.; Hansbro P.M.; Yang M.,"Wang, Wan (36496115200); Li, Jing Jing (55983696800); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390); Yang, Ming (56857729900)",36496115200; 55983696800; 7201517569; 6603119390; 56857729900,Potential therapeutic targets for steroid-resistant asthma,2010,Current Drug Targets,11,8,,957,970,13,61,10.2174/138945010791591412,https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956929721&doi=10.2174%2f138945010791591412&partnerID=40&md5=c959a980066d549fdab5ca937b605ba8,"Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle NSW 2300, cnr Watt and King Streets, Australia","Wang W., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle NSW 2300, cnr Watt and King Streets, Australia; Li J.J., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle NSW 2300, cnr Watt and King Streets, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle NSW 2300, cnr Watt and King Streets, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle NSW 2300, cnr Watt and King Streets, Australia; Yang M., Centre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle NSW 2300, cnr Watt and King Streets, Australia",Asthma; Glucocorticoid; Inflammation; microRNA; Steroid-resistant; Stress; Therapeutic targets; Transcription factor,Animals; Anti-Asthmatic Agents; Asthma; Drug Delivery Systems; Drug Design; Drug Resistance; Glucocorticoids; Humans; Severity of Illness Index; Signal Transduction; cell receptor; gamma interferon; glucocorticoid; glycoprotein P; glycoprotein p 170; histone deacetylase; lipopolysaccharide; macrophage migration inhibition factor; microRNA; transcription factor; unclassified drug; vitamin D; antiasthmatic agent; glucocorticoid; acute pancreatitis; article; asthma; bone metabolism; coughing; drug treatment failure; epigenetics; fever; gene expression regulation; growth retardation; health care cost; heart infarction; human; innate immunity; insomnia; mood change; musculoskeletal pain; oropharynx candidiasis; pathogenesis; psychosis; seizure; sepsis; side effect; signal transduction; skin manifestation; steroid resistant asthma; steroid therapy; stomach irritation; Th17 cell; throat irritation; vascular fragility; weight gain; withdrawal syndrome; animal; asthma; drug delivery system; drug design; drug effect; drug resistance; hospitalization; pathophysiology; review,Article,Final,,Scopus,2-s2.0-77956929721
Ashhurst-Smith C.; Hall S.T.; Walker P.; Stuart J.; Hansbro P.M.; Blackwell C.C.,"Ashhurst-Smith, Christopher (16024033000); Hall, Sharron T. (7402711253); Walker, Paul (57001294000); Stuart, John (7202133439); Hansbro, Philip M. (6603119390); Blackwell, C. Caroline (7101812755)",16024033000; 7402711253; 57001294000; 7202133439; 6603119390; 7101812755,Isolation of Alloiococcus otitidis from Indigenous and non-Indigenous Australian children with chronic otitis media with effusion,2007,FEMS Immunology and Medical Microbiology,51,1,,163,170,7,35,10.1111/j.1574-695X.2007.00297.x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548560597&doi=10.1111%2fj.1574-695X.2007.00297.x&partnerID=40&md5=f9e835676a30838c50254707747777b3,"Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW, Australia; School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia; Microbiology and Immunology, University of Newcastle, Newcastle, NSW, Australia; School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, NSW, Australia; John Hunter Children's Hospital, Newcastle, NSW, Australia; Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW 2305, Australia","Ashhurst-Smith C., Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW, Australia, School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia, Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW 2305, Australia; Hall S.T., School of Biomedical Sciences, University of Newcastle, Newcastle, NSW, Australia, Microbiology and Immunology, University of Newcastle, Newcastle, NSW, Australia, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, John Hunter Hospital, Newcastle, NSW, Australia; Walker P., School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, John Hunter Children's Hospital, Newcastle, NSW, Australia; Stuart J., School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, John Hunter Children's Hospital, Newcastle, NSW, Australia; Hansbro P.M., Microbiology and Immunology, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, John Hunter Hospital, Newcastle, NSW, Australia; Blackwell C.C., Microbiology and Immunology, University of Newcastle, Newcastle, NSW, Australia, Hunter Medical Research Institute, John Hunter Hospital, Newcastle, NSW, Australia",Alloiococcus otitidis; Chronic otitis media; Indigenous children,"Child; Child, Preschool; Chronic Disease; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Infant; Otitis Media with Effusion; Polymerase Chain Reaction; Reagent Kits, Diagnostic; azithromycin; clarithromycin; erythromycin; macrolide; penicillin G; alloiococcus otitidis; antibiotic sensitivity; article; child; chronic otitis media; controlled study; effusion; gene amplification; genetic analysis; Gram positive bacterium; human; incubation time; major clinical study; myringotomy; nonhuman; priority journal",Article,Final,,Scopus,2-s2.0-34548560597
Clark-Walker G.D.; Hansbro P.M.; Gibson F.; Chen X.J.,"Clark-Walker, G. Desmond (7006174044); Hansbro, Philip M. (6603119390); Gibson, Frank (7101616155); Chen, Xin Jie (9534687900)",7006174044; 6603119390; 7101616155; 9534687900,Mutant residues suppressing ρ0-lethality in Kluyveromyces lactis occur at contact sites between subunits of F1-ATPase,2000,Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology,1478,1,,125,137,12,26,10.1016/S0167-4838(00)00003-0,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034673742&doi=10.1016%2fS0167-4838%2800%2900003-0&partnerID=40&md5=50c4e7d8ec6dab8295cd680d4b767589,"Molec. Genetics and Evolution Group, Res. Sch. Biol. Sci., Australian N., Canberra City, ACT 2601, Australia","Clark-Walker G.D., Molec. Genetics and Evolution Group, Res. Sch. Biol. Sci., Australian N., Canberra City, ACT 2601, Australia; Hansbro P.M., Molec. Genetics and Evolution Group, Res. Sch. Biol. Sci., Australian N., Canberra City, ACT 2601, Australia; Gibson F., Molec. Genetics and Evolution Group, Res. Sch. Biol. Sci., Australian N., Canberra City, ACT 2601, Australia; Chen X.J., Molec. Genetics and Evolution Group, Res. Sch. Biol. Sci., Australian N., Canberra City, ACT 2601, Australia",ρ<sup>0</sup>-lethality; atp suppressor mutation; F<sub>1</sub>-ATPase; Kluyveromyces lactis,"Alleles; Crystallography; Genes, Lethal; Genes, Suppressor; Genotype; Kluyveromyces; Mitochondria; Models, Molecular; Mutation; Proton-Translocating ATPases; Bovinae; Kluyveromyces lactis; adenosine triphosphatase; mitochondrial DNA; article; deletion mutant; enzyme activity; Kluyveromyces; lethality; phenotype; priority journal; sequence analysis",Article,Final,,Scopus,2-s2.0-0034673742
Preston J.A.; Essilfie A.-T.; Horvat J.C.; Wade M.A.; Beagley K.W.; Gibson P.G.; Foster P.S.; Hansbro P.M.,"Preston, Julie A. (59281082600); Essilfie, Ama-Tawiah (22955585600); Horvat, Jay C. (9942405300); Wade, Margaret A. (57196992336); Beagley, Kenneth W. (7005403437); Gibson, Peter G. (7202414199); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",59281082600; 22955585600; 9942405300; 57196992336; 7005403437; 7202414199; 7201517569; 6603119390,Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae,2007,Vaccine,25,48,,8154,8162,8,71,10.1016/j.vaccine.2007.09.034,https://www.scopus.com/inward/record.uri?eid=2-s2.0-35848933938&doi=10.1016%2fj.vaccine.2007.09.034&partnerID=40&md5=1d9614d5228f5e0c9d931c6885ba38ca,"Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences, Faculty of Health, Newcastle, Australia; Vaccines, Immunity, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia; Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia; Respiratory and Sleep Medicine, School of Medical Practice, University of Newcastle, Newcastle, Australia; Division of Molecular BioSciences, John Curtin School of Medical Research, Australian National University, Canberra, Australia","Preston J.A., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences, Faculty of Health, Newcastle, Australia, Vaccines, Immunity, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia; Essilfie A.-T., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences, Faculty of Health, Newcastle, Australia, Vaccines, Immunity, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia; Horvat J.C., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences, Faculty of Health, Newcastle, Australia, Vaccines, Immunity, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia; Wade M.A., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences, Faculty of Health, Newcastle, Australia, Vaccines, Immunity, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia; Beagley K.W., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences, Faculty of Health, Newcastle, Australia, Vaccines, Immunity, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia; Gibson P.G., Vaccines, Immunity, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia, Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia, Respiratory and Sleep Medicine, School of Medical Practice, University of Newcastle, Newcastle, Australia; Foster P.S., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences, Faculty of Health, Newcastle, Australia, Vaccines, Immunity, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia, Division of Molecular BioSciences, John Curtin School of Medical Research, Australian National University, Canberra, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences, Faculty of Health, Newcastle, Australia, Vaccines, Immunity, Viruses and Asthma Group, Hunter Medical Research Institute, Newcastle, Australia",Asthma; Immunomodulation; Streptococcus pneumoniae,"Allergens; Animals; Antigens, Bacterial; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Mice; Mice, Inbred BALB C; Ovalbumin; Respiratory Hypersensitivity; Streptococcus pneumoniae; T-Lymphocytes; ovalbumin; Pneumococcus vaccine; allergic airway disease; animal cell; animal experiment; animal model; animal tissue; article; asthma; cell count; cell hyperplasia; controlled study; cytokine production; eosinophil; female; goblet cell; immune response; immunization; immunomodulation; immunotherapy; lung lavage; mouse; nonhuman; priority journal; sensitization; Streptococcus pneumoniae; T lymphocyte",Article,Final,,Scopus,2-s2.0-35848933938
Horvat J.C.; Beagley K.W.; Wade M.A.; Preston J.A.; Hansbro N.G.; Hickey D.K.; Kaiko G.E.; Gibson P.G.; Foster P.S.; Hansbro P.M.,"Horvat, Jay C. (9942405300); Beagley, Kenneth W. (7005403437); Wade, Margaret A. (57196992336); Preston, Julie A. (59281082600); Hansbro, Nicole G. (15055862300); Hickey, Danica K. (9943841400); Kaiko, Gerard E. (21739529400); Gibson, Peter G. (7202414199); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",9942405300; 7005403437; 57196992336; 59281082600; 15055862300; 9943841400; 21739529400; 7202414199; 7201517569; 6603119390,Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease,2007,American Journal of Respiratory and Critical Care Medicine,176,6,,556,564,8,117,10.1164/rccm.200607-1005OC,https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548641831&doi=10.1164%2frccm.200607-1005OC&partnerID=40&md5=5c89b3fd60a67f892ca51f9b3742704b,"School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia; Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia; Respiratory and Sleep Medicine, School of Medical Practice, University of Newcastle, Newcastle, NSW, Australia; Division of Biosciences, John Curtin School of Medical Research, Australian National University, Canberra, Australia; Discipline of Immunology and Microbiology, David Maddison Clinical Sciences Building, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia","Horvat J.C., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Beagley K.W., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Wade M.A., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Preston J.A., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hansbro N.G., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Hickey D.K., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Kaiko G.E., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia; Gibson P.G., Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia, Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia, Respiratory and Sleep Medicine, School of Medical Practice, University of Newcastle, Newcastle, NSW, Australia; Foster P.S., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia, Division of Biosciences, John Curtin School of Medical Research, Australian National University, Canberra, Australia; Hansbro P.M., School of Biomedical Sciences, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia, Vaccines, Immunity, Viruses, and Asthma Group, Hunter Medical Research Institute, Newcastle, NSW, Australia, Discipline of Immunology and Microbiology, David Maddison Clinical Sciences Building, Royal Newcastle Hospital, Newcastle, NSW 2300, Australia",Asthma; Chlamydia; Immunity; Infection; T cells,"Animals; Animals, Newborn; Asthma; Chlamydia; Chlamydia Infections; Colony Count, Microbial; Cytokines; Disease Models, Animal; Disease Progression; Female; Follow-Up Studies; Immunity, Cellular; Mice; Mice, Inbred BALB C; Pregnancy; Prognosis; T-Lymphocytes; antibody; cytokine; ovalbumin; adolescent; animal experiment; animal model; animal tissue; antibody producing cell; article; asthma; bronchus hyperreactivity; chlamydiasis; Chlamydophila pneumoniae; controlled study; cytokine production; eosinophilia; female; helper cell; histopathology; immunopathogenesis; mouse; mucus secretion; newborn; newborn infection; nonhuman; priority journal; T lymphocyte activation; weight gain",Article,Final,All Open Access; Green Open Access,Scopus,2-s2.0-34548641831
Hurt A.C.; Hansbro P.M.; Selleck P.; Olsen B.; Minton C.; Hampson A.W.; Barr I.G.,"Hurt, A.C. (6603378203); Hansbro, P.M. (6603119390); Selleck, P. (6701547852); Olsen, B. (7201359257); Minton, C. (6601969215); Hampson, A.W. (7005339919); Barr, I.G. (7004651416)",6603378203; 6603119390; 6701547852; 7201359257; 6601969215; 7005339919; 7004651416,Isolation of avian influenza viruses from two different transhemispheric migratory shorebird species in Australia,2006,Archives of Virology,151,11,,2301,2309,8,52,10.1007/s00705-006-0784-1,https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750353514&doi=10.1007%2fs00705-006-0784-1&partnerID=40&md5=78585604b1e7b7d90d3f48bdcbb19e39,"World Health Organisation Collaborating Centre for Reference and Research on Influenza, Parkville, Australia; School of Applied Sciences, Monash University, Churchill, Australia; Hunter Medical Research Institute, School of Biomedical Sciences, University of Newcastle, Callaghan, Australia; CSIRO Australian Animal Health Laboratory, Geelong, Australia; Section for Zoonotic Ecology and Epidemiology, Department of Biology and Environmental Science, Kalmar University, Kalmar, Sweden; Department of Infectious Diseases, Umeå University, Umeå, Sweden; Australasian Wader Studies Group, Australia; WHO Influenza Centre, WHO Collaborating Centre for Reference and Research on Influenza, Parkville, Vic. 3052, 45 Poplar Rd., Australia","Hurt A.C., World Health Organisation Collaborating Centre for Reference and Research on Influenza, Parkville, Australia, School of Applied Sciences, Monash University, Churchill, Australia, WHO Influenza Centre, WHO Collaborating Centre for Reference and Research on Influenza, Parkville, Vic. 3052, 45 Poplar Rd., Australia; Hansbro P.M., Hunter Medical Research Institute, School of Biomedical Sciences, University of Newcastle, Callaghan, Australia; Selleck P., CSIRO Australian Animal Health Laboratory, Geelong, Australia; Olsen B., Section for Zoonotic Ecology and Epidemiology, Department of Biology and Environmental Science, Kalmar University, Kalmar, Sweden, Department of Infectious Diseases, Umeå University, Umeå, Sweden; Minton C., Australasian Wader Studies Group, Australia; Hampson A.W., World Health Organisation Collaborating Centre for Reference and Research on Influenza, Parkville, Australia, School of Applied Sciences, Monash University, Churchill, Australia; Barr I.G., World Health Organisation Collaborating Centre for Reference and Research on Influenza, Parkville, Australia, School of Applied Sciences, Monash University, Churchill, Australia",,"Animal Migration; Animals; Australia; Charadriiformes; Chickens; Hemagglutinins, Viral; Influenza A virus; Influenza in Birds; Molecular Sequence Data; Neuraminidase; Phylogeny; Sequence Analysis, DNA; Siberia; Aves; Avian influenza virus; Calidris acuminata; Calidris ruficollis; Gallus gallus; Orthomyxoviridae; sialidase; virus hemagglutinin; animal; article; Australia; avian influenza; Charadriiformes; chicken; classification; DNA sequence; genetics; Influenza virus A; isolation and purification; molecular genetics; nucleotide sequence; pathogenicity; phylogeny; population migration; Russian Federation; virology",Article,Final,All Open Access; Bronze Open Access,Scopus,2-s2.0-33750353514
Hansbro P.M.; Foster P.S.; Liu C.; Potter B.V.L.; Denborough M.A.,"Hansbro, Philip M. (6603119390); Foster, Paul S. (7201517569); Liu, Changsheng (55680713600); Potter, Barry V. L. (16073310200); Denborough, Michael A. (7006750469)",6603119390; 7201517569; 55680713600; 16073310200; 7006750469,Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism,1994,Biochemical and Biophysical Research Communications,200,1,,8,15,7,3,10.1006/bbrc.1994.1407,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028232620&doi=10.1006%2fbbrc.1994.1407&partnerID=40&md5=52dafe8ac2963e17f7e082c60eccf3ac,"Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia; School of Pharmacy and Pharmacology, Institute for Life Sciences, University of Bath, Bath, BA2 7AY, Claverton Down, United Kingdom","Hansbro P.M., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia; Foster P.S., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia; Liu C., School of Pharmacy and Pharmacology, Institute for Life Sciences, University of Bath, Bath, BA2 7AY, Claverton Down, United Kingdom; Potter B.V.L., School of Pharmacy and Pharmacology, Institute for Life Sciences, University of Bath, Bath, BA2 7AY, Claverton Down, United Kingdom; Denborough M.A., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia",,"Animal; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Kinetics; Muscles; Organothiophosphorus Compounds; Phosphoric Monoester Hydrolases; Phosphotransferases (Alcohol Group Acceptor); Support, Non-U.S. Gov't; Swine; Animalia; Sus scrofa; inositol derivative; synaptojanin; unclassified drug; animal tissue; article; dephosphorylation; inhibition kinetics; nonhuman; phosphoinositide metabolism; priority journal; skeletal muscle; swine",Article,Final,,Scopus,2-s2.0-0028232620
Hogan S.P.; Foster P.S.; Hansbro P.M.; Ozaki S.; Denborough M.A.,"Hogan, Simon P. (7102358818); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390); Ozaki, Shoichiro (35493461800); Denborough, Michael A. (7006750469)",7102358818; 7201517569; 6603119390; 35493461800; 7006750469,"Detection and partial purification of inositol 1,4,5-trisphosphate 3-kinase from porcine skeletal muscle",1994,Cellular Signalling,6,2,,233,243,10,5,10.1016/0898-6568(94)90081-7,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028236824&doi=10.1016%2f0898-6568%2894%2990081-7&partnerID=40&md5=0335db77f1018c1405f2d6e8fc38cf60,"Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, G.P.O. Box 334, Australia; Department of Resources Chemistry, Faculty of Engineering, Ehime University, Matsuyama, 790, 3 Bunkyo-cho, Japan","Hogan S.P., Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, G.P.O. Box 334, Australia; Foster P.S.; Hansbro P.M.; Ozaki S., Department of Resources Chemistry, Faculty of Engineering, Ehime University, Matsuyama, 790, 3 Bunkyo-cho, Japan; Denborough M.A.",3; 4; 5)P<sub>3</sub> 3-kinase; 5)P<sub>4</sub>; affinity chromatography; calcium; calmodulin; Ins(1; skeletal muscle,"Animal; Calcium; Calmodulin; Chromatography, Affinity; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Molecular Weight; Muscles; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Swine; Suidae; Animalia; Suidae; Sus scrofa; calcium; calmodulin; inositol trisphosphate 3 kinase; affinity chromatography; animal tissue; article; enzyme activation; enzyme kinetics; enzyme purification; nonhuman; priority journal; skeletal muscle; swine",Article,Final,,Scopus,2-s2.0-0028236824
Wood L.G.; Hazlewood L.C.; Foster P.S.; Hansbro P.M.,"Wood, L.G. (55859741700); Hazlewood, L.C. (26434272500); Foster, P.S. (7201517569); Hansbro, P.M. (6603119390)",55859741700; 26434272500; 7201517569; 6603119390,Lyprinol reduces inflammation and improves lung function in a mouse model of allergic airways disease,2010,Clinical and Experimental Allergy,40,12,,1785,1793,8,19,10.1111/j.1365-2222.2010.03503.x,https://www.scopus.com/inward/record.uri?eid=2-s2.0-78349263400&doi=10.1111%2fj.1365-2222.2010.03503.x&partnerID=40&md5=484061e5fa2ac47c7d0ba95fa77deecb,"Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia","Wood L.G., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hazlewood L.C., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Foster P.S., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Diseases, Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia",ω-3; Asthma; Eosinophil; Fish oil; Lyprinol; Th2 response,"Animals; Asthma; Bronchoalveolar Lavage Fluid; Dietary Supplements; Disease Models, Animal; Eosinophils; Fatty Acids, Omega-3; Fish Oils; Inflammation; Lipids; Lung; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Respiratory Hypersensitivity; Th2 Cells; fish oil; gamma interferon; immunoglobulin G1; immunoglobulin G2a; interleukin 13; interleukin 4; interleukin 5; lyprinol; omega 3 fatty acid; ovalbumin; animal experiment; animal model; article; asthma; body mass; cytokine release; diet supplementation; eosinophil; immunoglobulin blood level; lung function; lung lavage; male; mouse; mucous cell; nonhuman; priority journal; Th2 cell",Article,Final,,Scopus,2-s2.0-78349263400
Wood L.G.; Simpson J.L.; Hansbro P.M.; Gibson P.G.,"Wood, Lisa G. (55859741700); Simpson, Jodie L. (7404326026); Hansbro, Philip M. (6603119390); Gibson, Peter G. (7202414199)",55859741700; 7404326026; 6603119390; 7202414199,Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia,2010,Free Radical Research,44,2,,146,154,8,107,10.3109/10715760903362576,https://www.scopus.com/inward/record.uri?eid=2-s2.0-74549186515&doi=10.3109%2f10715760903362576&partnerID=40&md5=7732c85141894bc86503109ec5a34521,"Centre for Asthma and Respiratory Disease, University of Newcastle, Callaghan, NSW, Australia; Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton, NSW, Australia","Wood L.G., Centre for Asthma and Respiratory Disease, University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton, NSW, Australia; Simpson J.L., Centre for Asthma and Respiratory Disease, University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton, NSW, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, University of Newcastle, Callaghan, NSW, Australia; Gibson P.G., Centre for Asthma and Respiratory Disease, University of Newcastle, Callaghan, NSW, Australia, Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton, NSW, Australia",8-isoprostane; Airway infl ammation; Asthma; Bacteria; IL-8; Oxidative stress,Adult; Aged; Asthma; Bacteria; Dinoprost; Female; Humans; Inflammation; Interleukin-8; Male; Middle Aged; Neutrophils; Oxidative Stress; Sputum; Bacteria (microorganisms); 8 isoprostane; interleukin 8; sodium chloride; adult; article; asthma; bacterium culture; cell count; controlled study; disease association; Enterobacteriaceae; female; Haemophilus influenzae; human; major clinical study; male; Moraxella catarrhalis; neutrophil; neutrophilia; oxidative stress; Pseudomonas aeruginosa; respiratory tract disease; respiratory tract infection; sputum analysis; Staphylococcus aureus,Article,Final,,Scopus,2-s2.0-74549186515
Bushby R.J.; Byard S.J.; Hansbro P.M.; Reid D.G.,"Bushby, Richard J. (7004975975); Byard, Stephen J. (6507391172); Hansbro, Philip M. (6603119390); Reid, David G. (7402153977)",7004975975; 6507391172; 6603119390; 7402153977,The conformational behaviour of phosphatidylinositol,1990,Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism,1044,2,,231,236,5,16,10.1016/0005-2760(90)90307-J,https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025306007&doi=10.1016%2f0005-2760%2890%2990307-J&partnerID=40&md5=b2892437ca1649cee29dbb58c1972b3f,"The School of Chemistry, The University, LeedsU.K.; Smith Kline and French Research Ltd. WelwynU.K, United Kingdom","Bushby R.J., The School of Chemistry, The University, LeedsU.K.; Byard S.J., The School of Chemistry, The University, LeedsU.K.; Hansbro P.M., The School of Chemistry, The University, LeedsU.K.; Reid D.G., Smith Kline and French Research Ltd. WelwynU.K, United Kingdom","Conformational analysis; NMR, <sup>1</sup>H-; Phosphatidylinositol; Phospholipid","Dimethyl Sulfoxide; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Molecular Conformation; Phosphatidylinositols; Stereoisomerism; Support, Non-U.S. Gov't; Temperature; phosphatidylinositol; phospholipid; article; biological model; conformation; priority journal; proton nuclear magnetic resonance",Article,Final,,Scopus,2-s2.0-0025306007
Horvat J.C.; Starkey M.R.; Kim R.Y.; Phipps S.; Gibson P.G.; Beagley K.W.; Foster P.S.; Hansbro P.M.,"Horvat, Jay C. (9942405300); Starkey, Malcolm R. (35811293400); Kim, Richard Y. (35810406900); Phipps, Simon (7005395199); Gibson, Peter G. (7202414199); Beagley, Kenneth W. (7005403437); Foster, Paul S. (7201517569); Hansbro, Philip M. (6603119390)",9942405300; 35811293400; 35810406900; 7005395199; 7202414199; 7005403437; 7201517569; 6603119390,Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology,2010,Journal of Allergy and Clinical Immunology,125,3,,617,625.e6,,98,10.1016/j.jaci.2009.10.018,https://www.scopus.com/inward/record.uri?eid=2-s2.0-77649273626&doi=10.1016%2fj.jaci.2009.10.018&partnerID=40&md5=ab5e43bb1f71ad2e42d4c49806776425,"Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Australia","Horvat J.C., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Starkey M.R., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Kim R.Y., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Phipps S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Gibson P.G., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Beagley K.W., Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Australia; Foster P.S., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Hansbro P.M., Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia",Asthma; Chlamydia; dendritic cell; IL-13; immunologic programming; infant; lung function; lung structure; neonate,interleukin 13; ovalbumin; aging; airway hyperresponsiveness; airway inflammation; animal experiment; animal model; article; Bagg albino mouse; bone marrow cell; CD4+ T lymphocyte; cell count; chlamydial pneumonia; controlled study; cytokine release; dendritic cell; eosinophil count; immunomodulation; immunopathology; lung alveolus; lung function; lung structure; lymph node; newborn; newborn infection; nonhuman; priority journal; protein expression; rat; respiratory tract allergy; respiratory tract disease; sensitization; symptomatology; Th2 cell,Article,Final,,Scopus,2-s2.0-77649273626